data_1jh3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jh3 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.212 -0.909 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.95 -54.49 21.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 122.389 2.359 . . . . 0.0 112.162 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.43 -23.75 62.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.766 0.793 . . . . 0.0 109.394 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.58 -32.92 23.53 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -173.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.8 mt -71.49 -48.51 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 171.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -52.73 -58.52 6.6 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.63 0.65 . . . . 0.0 111.176 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -74.6 -24.71 58.92 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.642 1.11 . . . . 0.0 110.239 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.72 -40.26 97.29 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.551 ' C ' ' H ' ' A' ' 21' ' ' ASP . 45.9 m-85 -126.42 12.69 7.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -163.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.06 9.08 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 129.776 3.23 . . . . 0.0 113.68 163.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 19' ' ' PHE . 23.7 t70 -78.41 -38.22 42.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.752 2.421 . . . . 0.0 108.48 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.34 168.34 10.75 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.375 1.47 . . . . 0.0 109.58 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.92 178.11 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.13 1.887 . . . . 0.0 110.327 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 p -129.48 171.97 12.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.08 1.752 . . . . 0.0 109.874 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -137.67 166.56 23.66 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.863 1.265 . . . . 0.0 108.646 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 p -139.62 133.94 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.15 179.07 4.06 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 119.114 0.87 . . . . 0.0 109.961 163.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -78.75 15.82 0.99 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.536 1.534 . . . . 0.0 113.989 -163.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.8 -176.92 38.87 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -163.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.4 149.45 5.99 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -163.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.82 153.49 41.9 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.894 -0.768 . . . . 0.0 111.051 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -161.28 131.3 3.43 Favored Pre-proline 0 CA--C 1.509 -0.604 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -165.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -68.65 148.61 72.41 Favored 'Trans proline' 0 N--CA 1.436 -1.901 0 C-N-CA 121.69 1.593 . . . . 0.0 110.355 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.264 0.0 OUTLIER -44.85 -41.04 6.72 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.96 -1.473 . . . . 0.0 112.485 178.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.0 p -80.89 -7.75 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.92 2.088 . . . . 0.0 114.886 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -104.53 -30.95 9.69 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 117.648 -1.168 . . . . 0.0 108.508 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -80.84 -20.2 42.92 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 121.593 1.997 . . . . 0.0 110.094 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -29.22 53.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 120.971 1.714 . . . . 0.0 109.866 173.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -46.85 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.295 1.838 . . . . 0.0 107.033 -172.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.4 m -57.24 -52.55 64.88 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 129.939 3.295 . . . . 0.0 109.221 167.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.15 -10.27 59.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.028 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.51 29.69 15.81 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 122.842 1.246 . . . . 0.0 111.926 166.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mp -77.92 -51.05 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -156.85 99.47 2.02 Favored Pre-proline 0 C--N 1.344 0.364 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.75 -15.97 10.51 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.911 2.407 . . . . 0.0 113.617 -172.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.5 t -76.61 115.26 16.2 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -52.36 -37.61 56.63 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.183 1.356 . . . . 0.0 114.419 -164.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -54.44 43.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.099 0.863 . . . . 0.0 109.595 172.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -58.94 -47.77 83.88 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.736 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.27 -55.08 7.73 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.378 1.471 . . . . 0.0 110.383 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -65.0 -34.32 78.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 116.594 -1.67 . . . . 0.0 111.577 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.34 -36.36 58.28 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.777 1.626 . . . . 0.0 112.378 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -17.6 63.34 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.131 1.372 . . . . 0.0 110.543 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -92.32 -52.73 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 116.482 -1.723 . . . . 0.0 111.895 166.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -69.92 -6.5 33.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 120.488 1.495 . . . . 0.0 111.577 -170.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.515 ' C ' ' H ' ' A' ' 58' ' ' ALA . 4.3 m120 -79.9 139.77 36.98 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.2 26.29 0.44 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.025 1.774 . . . . 0.0 113.526 164.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -115.59 5.06 14.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.691 2.396 . . . . 0.0 111.403 170.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.319 0.0 OUTLIER -106.63 94.13 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 124.52 2.105 . . . . 0.0 106.065 163.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -79.99 106.73 12.23 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.026 168.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.7 t -83.81 124.61 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.622 HD21 ' HG3' ' A' ' 78' ' ' ARG . 63.4 m-20 53.5 27.39 6.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.96 -2.41 59.94 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.258 -1.301 . . . . 0.0 113.748 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -119.32 122.68 42.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.365 1.583 . . . . 0.0 107.151 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.46 109.0 0.49 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -143.02 103.83 4.22 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 -171.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.461 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -127.91 45.3 2.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.867 2.067 . . . . 0.0 112.863 -163.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -154.42 154.12 32.7 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.975 0.91 . . . . 0.0 110.615 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 81.9 t -63.36 -38.19 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.785 1.234 . . . . 0.0 109.748 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.77 -2.21 60.49 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.83 -0.983 . . . . 0.0 113.061 171.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.33 -57.0 2.93 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.842 1.321 . . . . 0.0 111.391 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.458 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -141.28 148.17 21.56 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 121.164 1.802 . . . . 0.0 111.098 178.083 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.9 mt -112.38 -93.11 0.46 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 163.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 p -108.43 -170.24 1.64 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -169.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.12 73.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.755 1.222 . . . . 0.0 113.504 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.4 -17.95 64.94 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.107 0.963 . . . . 0.0 111.161 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.458 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 58.1 t-80 -86.48 -5.99 59.01 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.523 -0.736 . . . . 0.0 110.665 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.622 ' HG3' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -119.53 -64.99 1.21 Allowed 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.095 1.316 . . . . 0.0 110.512 178.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.59 178.38 7.41 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 164.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.75 -26.05 56.36 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.592 -0.693 . . . . 0.0 112.095 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.82 84.15 0.17 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 124.651 1.12 . . . . 0.0 113.299 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.12 -82.83 0.57 Allowed 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 167.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -119.55 -165.62 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.813 2.045 . . . . 0.0 108.171 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.18 138.64 12.7 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 163.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.7 t -83.99 139.27 17.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 166.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.9 mm -115.62 94.48 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.9 ttm-85 -91.46 75.13 5.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 -174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -78.98 92.59 4.97 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -51.19 -32.57 29.0 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.103 1.335 . . . . 0.0 113.425 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.402 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.26 -12.59 60.51 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.78 -1.424 . . . . 0.0 112.962 177.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -135.91 -97.55 0.23 Allowed 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 127.161 2.185 . . . . 0.0 105.864 -174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.485 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -159.17 -159.89 0.8 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 120.889 1.677 . . . . 0.0 109.415 174.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.485 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -110.23 75.9 0.96 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.058 2.143 . . . . 0.0 108.475 -167.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -78.23 164.56 24.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -171.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.0 tp -125.03 129.89 51.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.476 -164.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.6 mm -125.02 129.27 73.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.463 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 13.1 ttp180 -131.47 -177.15 4.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 124.064 1.888 . . . . 0.0 110.92 164.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.463 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -123.67 165.63 16.89 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 126.273 1.829 . . . . 0.0 110.743 173.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 127.148 2.179 . . . . 0.0 111.465 178.05 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.02 -57.08 8.57 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 124.043 0.937 . . . . 0.0 111.225 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.85 -21.94 66.5 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.541 0.525 . . . . 0.0 110.706 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -82.74 -37.19 25.0 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.789 0.835 . . . . 0.0 109.624 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.4 mt -67.71 -45.07 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -55.47 -60.44 3.42 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.775 1.171 . . . . 0.0 110.541 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -75.89 -20.18 58.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.377 -0.827 . . . . 0.0 110.27 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.66 -38.44 90.03 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.435 ' C ' ' H ' ' A' ' 21' ' ' ASP . 51.7 m-85 -126.58 11.75 7.37 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.629 0.772 . . . . 0.0 112.841 -164.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -56.18 7.19 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.73 2.412 . . . . 0.0 115.322 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 19' ' ' PHE . 12.0 t70 -78.29 -34.78 48.6 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.243 1.417 . . . . 0.0 109.263 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.5 165.25 14.83 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 125.883 1.673 . . . . 0.0 108.251 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -68.98 177.72 4.78 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.801 1.667 . . . . 0.0 110.542 168.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 p -120.85 -177.59 3.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.999 1.72 . . . . 0.0 109.551 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -142.86 160.96 39.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.769 1.228 . . . . 0.0 109.362 164.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.88 136.35 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 C-N-CA 125.282 1.433 . . . . 0.0 108.271 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -118.8 179.05 4.26 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 119.123 0.874 . . . . 0.0 110.042 163.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -89.81 56.94 3.67 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 120.415 -1.428 . . . . 0.0 109.703 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.03 -158.94 19.75 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.723 0.678 . . . . 0.0 112.324 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.29 123.53 1.76 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.254 1.0 OUTLIER -59.91 130.47 46.89 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.203 1.501 . . . . 0.0 107.182 171.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -151.85 140.16 13.3 Favored Pre-proline 0 CA--C 1.507 -0.687 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -163.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.7 152.78 29.46 Favored 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 121.495 1.463 . . . . 0.0 110.689 -167.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.356 0.4 OUTLIER -47.15 -33.17 4.9 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.416 173.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.83 -15.51 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.476 ' CD ' ' HZ1' ' A' ' 47' ' ' LYS . 58.0 mm-40 -105.6 -42.04 5.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.1 -31.33 67.66 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 116.806 -1.569 . . . . 0.0 108.696 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -27.19 34.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 121.51 1.959 . . . . 0.0 109.562 -174.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -47.85 42.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 125.692 1.597 . . . . 0.0 107.976 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -34.79 78.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.313 0.645 . . . . 0.0 109.965 173.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.51 -14.32 59.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.237 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.46 27.88 21.22 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 164.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 mp -78.37 -45.93 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.7 108.14 2.17 Favored Pre-proline 0 C--N 1.343 0.316 0 CA-C-N 120.532 1.515 . . . . 0.0 106.945 167.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.45 -15.59 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.227 1.952 . . . . 0.0 112.183 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.0 m -88.19 105.85 17.8 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 -169.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HZ1' ' CD ' ' A' ' 36' ' ' GLU . 20.9 tptt -52.18 -32.58 36.8 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -163.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -54.65 42.32 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.341 1.428 . . . . 0.0 109.619 169.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -57.39 -48.13 79.89 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 117.801 -1.095 . . . . 0.0 108.603 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.4 -61.61 1.83 Allowed 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 125.189 1.556 . . . . 0.0 110.14 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -62.84 -25.67 68.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 115.923 -1.989 . . . . 0.0 112.656 -174.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.68 -40.7 28.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 121.745 2.066 . . . . 0.0 112.988 168.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.96 -13.93 41.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.355 1.062 . . . . 0.0 111.41 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.1 mt -89.22 -64.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 C-N-CA 126.626 1.97 . . . . 0.0 109.04 163.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -61.89 -11.25 12.06 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.902 1.281 . . . . 0.0 112.21 -165.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 58' ' ' ALA . 5.1 m120 -82.45 131.37 35.22 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 118.824 0.738 . . . . 0.0 111.365 172.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.42 36.26 0.56 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 126.585 2.04 . . . . 0.0 111.716 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -117.18 -1.43 11.85 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 127.185 2.194 . . . . 0.0 111.027 165.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.339 0.0 OUTLIER -91.75 92.11 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 121.726 2.057 . . . . 0.0 106.501 163.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -80.66 100.8 8.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.924 -1.944 . . . . 0.0 108.101 171.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.8 t -80.2 128.88 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.484 HD22 ' CD2' ' A' ' 79' ' ' LEU 0.257 65.9 m-80 64.23 -6.63 0.26 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.65 4.6 26.45 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.137 1.351 . . . . 0.0 112.795 -169.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.87 119.33 32.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 108.56 0.78 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.344 1.458 . . . . 0.0 107.142 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.5 mt -141.4 88.17 2.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.89 25.05 3.34 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.996 1.318 . . . . 0.0 113.59 -173.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.66 154.77 46.53 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.54 -43.01 96.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 126.869 2.067 . . . . 0.0 110.803 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.6 -9.74 59.27 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.65 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.45 -47.49 7.41 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 117.562 -1.208 . . . . 0.0 112.24 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.09 135.04 37.11 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 CA-C-N 121.423 1.92 . . . . 0.0 113.308 178.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.5 mt -113.86 -97.3 0.44 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 163.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -97.87 -177.13 3.66 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.39 -1.444 . . . . 0.0 114.404 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.446 ' HB3' ' CE2' ' A' ' 98' ' ' TYR . . . -63.19 -37.78 88.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 120.967 -1.083 . . . . 0.0 113.119 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.55 -17.73 62.3 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.15 0.887 . . . . 0.0 111.11 174.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -81.22 -15.99 54.02 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.487 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.442 ' HG3' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -112.16 -59.58 1.98 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 120.223 1.374 . . . . 0.0 111.175 -173.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.484 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.08 -171.51 3.01 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.163 1.385 . . . . 0.0 110.265 166.288 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -53.61 -6.21 0.07 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 129.307 3.043 . . . . 0.0 114.725 163.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.85 79.89 1.48 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.954 1.264 . . . . 0.0 111.489 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 -63.61 0.55 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.306 0.642 . . . . 0.0 110.112 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -156.1 -169.58 3.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.022 2.929 . . . . 0.0 106.915 -175.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -154.5 152.67 30.38 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 119.605 -1.934 . . . . 0.0 107.07 163.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.7 151.43 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 C-N-CA 124.048 0.939 . . . . 0.0 109.337 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.8 mm -132.85 96.66 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 127.249 2.22 . . . . 0.0 108.011 -171.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -96.3 86.88 4.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -82.05 110.62 17.45 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.62 -20.17 45.26 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-N 120.123 1.329 . . . . 0.0 115.252 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -11.69 60.88 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.124 1.962 . . . . 0.0 111.228 171.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -148.59 -156.05 0.69 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.014 2.126 . . . . 0.0 107.453 -165.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -150.75 0.35 Allowed 'General case' 0 C--O 1.248 0.979 0 CA-C-O 122.883 1.325 . . . . 0.0 111.615 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.87 77.33 1.36 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.802 2.441 . . . . 0.0 109.018 -164.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -78.34 165.35 23.95 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.489 -0.757 . . . . 0.0 109.457 -170.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.2 tt -128.54 128.16 43.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -164.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -127.08 135.64 63.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 124.369 1.068 . . . . 0.0 108.89 -169.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.515 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 9.4 ttt180 -139.29 -176.6 4.58 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 125.657 2.646 . . . . 0.0 114.335 167.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.515 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -115.86 161.04 19.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 112.451 -2.159 . . . . 0.0 107.866 163.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 C-N-CA 126.727 2.011 . . . . 0.0 107.462 -174.802 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -57.38 12.97 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.804 1.641 . . . . 0.0 110.919 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.41 -20.87 65.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.833 0.288 . . . . 0.0 111.516 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.76 -38.89 27.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.848 1.259 . . . . 0.0 110.355 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.6 mt -69.19 -51.01 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.71 1.204 . . . . 0.0 107.951 172.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.92 -57.61 8.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.154 0.888 . . . . 0.0 110.517 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.99 -23.41 58.26 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.231 -0.918 . . . . 0.0 110.472 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.61 95.76 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -119.35 9.54 11.67 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -165.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -55.55 -9.57 0.52 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.645 2.378 . . . . 0.0 116.451 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.68 -29.34 45.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.678 1.591 . . . . 0.0 111.198 175.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.06 163.08 17.87 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.07 172.88 13.82 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 CA-C-O 122.855 1.106 . . . . 0.0 109.375 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.8 p -120.55 171.85 8.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 113.197 -1.819 . . . . 0.0 108.073 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -137.11 152.91 50.54 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.94 134.66 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -125.86 152.58 45.33 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 122.599 1.19 . . . . 0.0 111.045 163.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -81.5 53.7 2.16 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 126.31 1.844 . . . . 0.0 110.965 -169.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.56 174.81 50.13 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.395 1.95 . . . . 0.0 114.015 166.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.75 149.07 16.15 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -75.18 151.87 38.47 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.13 0.49 . . . . 0.0 111.56 164.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.7 t -160.94 135.09 5.14 Favored Pre-proline 0 CA--C 1.513 -0.474 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -163.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.15 147.33 42.49 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 121.641 1.561 . . . . 0.0 111.16 -174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.336 0.3 OUTLIER -49.63 -30.05 8.25 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.675 175.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.04 -18.51 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -97.6 -46.69 5.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.075 -0.964 . . . . 0.0 108.424 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.6 -22.76 56.61 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 116.426 -1.749 . . . . 0.0 109.621 -168.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.98 -25.59 29.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 121.259 1.845 . . . . 0.0 109.9 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.7 -46.74 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -59.61 -40.63 88.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.663 1.985 . . . . 0.0 110.234 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.41 -17.73 56.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.481 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.51 34.67 6.88 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 163.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 mp -78.45 -53.14 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.13 95.63 2.35 Favored Pre-proline 0 C--N 1.349 0.549 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.11 -18.02 14.71 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.6 2.2 . . . . 0.0 113.128 -171.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.1 t -75.75 109.51 9.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -57.03 -27.84 61.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -163.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -49.39 66.69 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.726 1.603 . . . . 0.0 110.491 169.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -57.97 -50.46 73.3 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.26 -58.23 3.86 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 125.936 2.023 . . . . 0.0 109.703 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -58.7 -35.31 72.44 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 117.82 -1.086 . . . . 0.0 111.387 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -73.58 -45.83 50.87 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 118.103 -1.439 . . . . 0.0 112.089 170.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.22 -12.81 22.3 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.513 1.125 . . . . 0.0 111.7 -174.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 56.7 mt -89.41 -66.88 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 127.763 2.425 . . . . 0.0 109.07 164.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -71.58 -1.88 15.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.939 1.245 . . . . 0.0 113.331 -164.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.2 m120 -80.05 130.79 35.53 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.233 -0.917 . . . . 0.0 110.377 164.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.78 6.6 0.34 Allowed Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.967 -0.458 . . . . 0.0 114.025 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -81.78 -8.27 59.68 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 116.701 -1.618 . . . . 0.0 111.746 169.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.359 0.0 OUTLIER -92.77 92.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 125.569 2.604 . . . . 0.0 108.099 164.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -79.45 99.42 7.2 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 111.447 -2.615 . . . . 0.0 108.208 170.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.1 t -82.17 127.8 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.462 HD22 ' CD2' ' A' ' 79' ' ' LEU . 5.9 m-80 61.37 7.48 1.76 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.46 7.96 56.54 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.867 1.223 . . . . 0.0 113.077 -171.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -121.73 117.93 27.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 106.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.726 1.61 . . . . 0.0 109.114 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.6 mt -142.33 89.73 2.18 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -172.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.31 39.56 2.57 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.939 2.096 . . . . 0.0 112.755 -164.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -151.47 161.71 42.23 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.471 -1.393 . . . . 0.0 112.17 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.52 -26.37 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.149 1.38 . . . . 0.0 110.252 164.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.43 -14.28 74.5 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-O 119.417 -0.657 . . . . 0.0 113.344 167.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.53 -58.84 2.3 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.779 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -138.91 144.48 29.54 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 CA-C-N 121.143 1.792 . . . . 0.0 113.221 -177.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.61 -93.14 0.43 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 101.355 -3.572 . . . . 0.0 101.355 163.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 p -108.79 -170.99 1.76 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.11 -44.49 83.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.496 1.119 . . . . 0.0 113.79 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.05 -15.89 62.57 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.238 0.926 . . . . 0.0 112.197 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -87.98 0.97 55.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.916 0.886 . . . . 0.0 109.762 173.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -79.58 0.59 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 167.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.462 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -91.09 -168.51 2.08 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.538 1.135 . . . . 0.0 109.848 176.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.01 0.05 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.869 2.867 . . . . 0.0 115.317 171.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.23 50.13 3.09 Favored Glycine 0 C--N 1.337 0.585 0 O-C-N 120.991 -1.068 . . . . 0.0 111.734 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -104.58 -65.92 1.0 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 172.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.44 ' H ' HD13 ' A' ' 79' ' ' LEU . 53.9 m-85 -145.3 -167.16 2.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.772 1.629 . . . . 0.0 107.153 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.89 140.95 13.77 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.923 1.238 . . . . 0.0 109.106 163.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 t -93.55 150.63 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.775 1.23 . . . . 0.0 108.568 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.2 mm -132.44 97.63 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 C-N-CA 126.767 2.027 . . . . 0.0 108.262 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -97.76 90.47 4.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.54 94.18 7.99 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.17 112.56 2.67 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt 137.53 -50.66 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 131.496 3.919 . . . . 0.0 107.773 -164.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.0 -110.51 0.35 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.04 -154.78 0.57 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-N 120.049 1.295 . . . . 0.0 109.173 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -115.0 78.85 1.2 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.971 2.508 . . . . 0.0 108.226 -164.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -78.14 169.41 18.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.049 -1.032 . . . . 0.0 109.078 -175.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.8 tp -127.02 131.38 51.01 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.775 -171.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.21 133.05 69.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 125.104 1.362 . . . . 0.0 107.37 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.498 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 7.8 ttt180 -145.39 -177.18 5.43 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 124.534 2.111 . . . . 0.0 111.783 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.498 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -126.12 159.33 33.16 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 112.636 -2.075 . . . . 0.0 111.59 164.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.476 0 C-N-CA 126.82 2.048 . . . . 0.0 106.1 165.415 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.213 -0.849 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.98 81.01 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 119.988 -1.695 . . . . 0.0 113.515 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.29 -29.89 67.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.553 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -72.63 -36.5 68.05 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.2 mt -73.15 -52.25 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 127.101 2.161 . . . . 0.0 107.921 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.62 -47.06 87.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.953 -175.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -80.14 -27.11 39.11 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.815 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.86 -37.6 93.49 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 126.047 1.784 . . . . 0.0 109.975 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -123.56 12.28 9.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.12 -164.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -57.96 -9.01 1.16 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.42 -12.79 60.03 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.228 1.411 . . . . 0.0 111.726 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.23 168.53 11.41 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 120.617 -1.302 . . . . 0.0 108.888 167.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.09 174.67 12.44 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.678 1.585 . . . . 0.0 110.865 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -127.2 150.31 49.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.679 1.592 . . . . 0.0 109.0 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 38.2 t80 -134.96 159.5 41.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.505 1.048 . . . . 0.0 108.767 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.4 t -138.85 132.3 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 124.465 1.106 . . . . 0.0 108.623 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -113.23 -174.48 2.46 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 123.18 0.592 . . . . 0.0 110.501 163.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -87.96 8.79 24.69 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -163.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.55 176.35 32.65 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 120.907 -1.121 . . . . 0.0 110.859 -164.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.08 139.22 1.68 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -164.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.38 148.02 49.59 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.8 t -155.0 132.5 6.43 Favored Pre-proline 0 CA--C 1.51 -0.582 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -167.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.91 150.53 73.4 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.468 2.112 . . . . 0.0 110.975 -173.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.332 0.0 OUTLIER -49.82 -34.48 19.79 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.306 174.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -76.71 -14.88 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.531 1.932 . . . . 0.0 114.165 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -94.18 -40.1 10.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 120.278 1.399 . . . . 0.0 109.944 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.8 -24.46 58.65 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 116.89 -1.529 . . . . 0.0 108.989 -172.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.13 -33.84 65.76 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 121.068 1.758 . . . . 0.0 109.833 172.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.19 -48.82 30.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.14 1.776 . . . . 0.0 106.849 -169.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -65.73 -34.12 77.46 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.569 1.547 . . . . 0.0 110.023 170.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.36 -14.17 59.52 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 120.675 1.579 . . . . 0.0 111.353 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.7 21.61 33.52 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 164.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mm -78.36 -39.92 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -171.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 m -157.3 95.58 2.11 Favored Pre-proline 0 C--N 1.342 0.244 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.71 -14.18 15.87 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.705 2.27 . . . . 0.0 113.649 -168.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 t -81.72 109.44 16.12 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.261 48.8 mttt -59.2 -21.88 60.15 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -163.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -65.56 -55.2 19.02 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.487 1.494 . . . . 0.0 110.317 166.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -54.02 -50.41 66.71 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.52 -60.15 2.54 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 124.61 1.194 . . . . 0.0 110.976 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -68.53 -25.41 64.91 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 116.334 -1.793 . . . . 0.0 111.93 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -86.68 -25.35 24.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 121.239 1.836 . . . . 0.0 112.979 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.02 -31.86 69.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 125.496 1.518 . . . . 0.0 107.643 166.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 mp -77.43 -59.42 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 115.285 -2.293 . . . . 0.0 108.811 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -11.46 24.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.703 1.592 . . . . 0.0 112.659 -170.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.5 m-80 -81.22 137.99 35.83 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.851 1.31 . . . . 0.0 113.378 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.76 2.91 0.06 OUTLIER Glycine 0 CA--C 1.538 1.476 0 CA-C-N 113.034 -1.894 . . . . 0.0 114.999 164.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -79.43 -18.71 51.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 128.18 2.592 . . . . 0.0 112.436 172.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.356 0.0 OUTLIER -96.28 97.75 6.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 124.499 2.095 . . . . 0.0 108.896 178.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.13 93.46 9.58 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 111.185 -2.734 . . . . 0.0 105.158 175.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 p -78.63 136.93 22.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 103.056 -2.942 . . . . 0.0 103.056 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.459 HD22 ' CD2' ' A' ' 79' ' ' LEU . 1.8 m-80 57.41 23.05 8.55 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 119.258 0.935 . . . . 0.0 110.917 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.62 7.88 83.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.439 1.971 . . . . 0.0 114.206 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -134.98 125.25 26.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.337 1.568 . . . . 0.0 109.166 -166.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.79 117.48 3.69 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.841 0.856 . . . . 0.0 109.321 -173.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.1 mt -147.93 114.06 5.85 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 170.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.53 17.46 10.45 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.17 149.43 41.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.418 -0.801 . . . . 0.0 109.805 -174.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.06 -35.66 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 124.887 1.275 . . . . 0.0 109.962 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.17 -17.37 69.97 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.248 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.5 -49.11 10.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.734 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mt -138.74 129.19 33.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 120.069 1.304 . . . . 0.0 111.452 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.6 mt -114.76 -95.2 0.47 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 103.247 -2.871 . . . . 0.0 103.247 163.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.21 -175.46 3.02 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.65 -1.281 . . . . 0.0 113.828 -173.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.86 -44.32 70.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.506 1.123 . . . . 0.0 113.261 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -75.05 -8.52 56.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.686 0.755 . . . . 0.0 111.386 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -93.31 -4.22 52.09 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.066 -1.021 . . . . 0.0 111.203 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -66.96 1.03 Allowed 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 120.863 -1.148 . . . . 0.0 108.786 175.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.459 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -89.54 -175.23 4.63 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 126.399 1.88 . . . . 0.0 107.699 173.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.94 -12.39 1.97 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.384 1.473 . . . . 0.0 113.889 166.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.85 79.17 0.96 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 125.517 1.532 . . . . 0.0 112.535 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -141.17 -49.17 0.41 Allowed 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 117.798 -1.096 . . . . 0.0 113.142 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -155.78 -170.57 3.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.945 2.498 . . . . 0.0 107.059 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.25 130.76 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 120.09 -1.631 . . . . 0.0 107.199 163.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.36 133.42 29.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 mm -111.05 106.85 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 167.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.48 79.47 2.11 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 176.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.1 ttm105 -85.1 109.97 18.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.29 -18.49 2.3 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.764 1.65 . . . . 0.0 114.756 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -47.01 -39.18 12.09 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.928 1.364 . . . . 0.0 111.793 169.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -142.27 -78.06 0.25 Allowed 'General case' 0 C--N 1.338 0.096 0 CA-C-O 117.976 -1.011 . . . . 0.0 108.435 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.36 -152.63 0.32 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.667 1.576 . . . . 0.0 111.997 -171.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.98 75.12 1.65 Allowed 'General case' 0 N--CA 1.47 0.529 1 C-N-CA 132.208 4.203 . . . . 0.0 113.298 -175.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.73 140.02 38.36 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 120.145 -1.597 . . . . 0.0 108.053 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.19 144.72 25.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.54 -175.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 mp -133.16 138.91 50.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 124.52 1.128 . . . . 0.0 108.622 173.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 ttm105 -136.43 -176.61 4.4 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.316 1.532 . . . . 0.0 111.781 163.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.23 163.06 13.71 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.92 1.688 . . . . 0.0 108.85 163.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 C-N-CA 127.487 2.315 . . . . 0.0 109.72 -175.22 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.214 -0.765 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.54 -55.15 38.7 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 119.921 -1.737 . . . . 0.0 113.134 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.4 -23.17 60.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.65 -35.31 70.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.739 1.216 . . . . 0.0 109.467 175.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt -73.9 -53.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 C-N-CA 127.715 2.406 . . . . 0.0 106.892 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -55.13 -53.53 54.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.526 -1.225 . . . . 0.0 111.355 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -73.29 -31.22 63.92 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 120.38 1.445 . . . . 0.0 109.46 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.52 -34.43 89.45 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 125.335 1.445 . . . . 0.0 110.552 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -128.25 11.7 6.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.603 0.761 . . . . 0.0 111.813 -167.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -59.16 -5.55 0.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.053 2.141 . . . . 0.0 115.942 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.29 -28.82 47.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.793 -0.567 . . . . 0.0 110.295 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.21 170.46 6.5 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.0 177.32 7.9 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 CA-C-N 121.099 1.428 . . . . 0.0 109.231 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.4 p -125.46 145.56 50.03 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -108.93 156.24 19.93 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.942 1.297 . . . . 0.0 108.307 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.99 133.97 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 126.2 1.8 . . . . 0.0 107.936 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.63 -171.39 2.37 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 121.401 0.619 . . . . 0.0 111.093 163.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -100.08 13.58 33.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.844 1.657 . . . . 0.0 112.156 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.1 172.57 36.79 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.712 1.149 . . . . 0.0 113.375 -172.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.32 -85.39 1.87 Allowed Glycine 0 C--N 1.333 0.361 0 N-CA-C 106.686 -2.565 . . . . 0.0 106.686 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.33 150.08 21.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.251 1.42 . . . . 0.0 109.714 163.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -161.76 152.14 14.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 167.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.16 139.64 91.24 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.448 2.099 . . . . 0.0 113.168 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.293 0.9 OUTLIER -49.55 -32.65 12.95 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 169.172 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.407 ' HA ' HD11 ' A' ' 54' ' ' ILE . 5.7 p -74.59 -11.72 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 128.047 2.539 . . . . 0.0 115.086 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -103.03 -44.16 5.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.945 0.793 . . . . 0.0 109.224 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.05 -22.8 58.15 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 116.96 -1.495 . . . . 0.0 109.735 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.82 -23.26 27.25 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 120.706 1.594 . . . . 0.0 110.146 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -48.33 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.459 1.504 . . . . 0.0 107.243 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 t -68.63 -37.96 80.14 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.033 1.333 . . . . 0.0 109.31 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.83 -18.78 53.47 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.374 0.534 . . . . 0.0 112.052 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.23 33.36 6.59 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 118.819 0.736 . . . . 0.0 111.52 164.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.38 -49.89 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 172.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.35 107.46 3.35 Favored Pre-proline 0 C--N 1.349 0.553 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 169.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -81.36 -18.21 8.53 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.268 1.978 . . . . 0.0 113.255 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.5 t -86.4 106.34 17.37 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -58.82 -18.04 28.91 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -163.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.402 HH21 ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -73.33 -50.48 21.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 121.786 2.085 . . . . 0.0 110.47 167.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -42.96 70.13 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 116.468 -1.729 . . . . 0.0 107.31 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.63 -63.49 1.12 Allowed 'General case' 0 C--O 1.216 -0.681 0 CA-C-O 117.429 -1.272 . . . . 0.0 109.094 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.327 2.8 ttt-85 -60.2 -22.89 63.51 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 115.01 -2.424 . . . . 0.0 113.11 -170.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.402 ' CD ' HH21 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -84.46 -29.88 25.71 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 121.664 2.029 . . . . 0.0 114.116 166.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.56 -20.32 64.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.95 1.25 . . . . 0.0 111.644 171.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.407 HD11 ' HA ' ' A' ' 35' ' ' VAL . 4.3 mp -87.22 -62.45 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 CA-C-O 116.833 -1.556 . . . . 0.0 108.356 163.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -64.32 -7.49 9.73 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 120.065 1.302 . . . . 0.0 111.607 -165.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 58' ' ' ALA . 4.1 m-80 -82.66 135.67 34.97 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.64 0.733 . . . . 0.0 111.838 173.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -74.2 40.26 1.05 Allowed Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.068 -1.423 . . . . 0.0 111.682 165.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -124.24 0.52 8.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 127.302 2.241 . . . . 0.0 111.146 164.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.323 0.0 OUTLIER -91.61 99.41 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 122.086 2.221 . . . . 0.0 106.385 163.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -86.84 115.06 24.01 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.666 1.987 . . . . 0.0 107.462 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 63' ' ' GLY . 15.3 t -98.08 127.64 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 174.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.5 HD22 ' CD2' ' A' ' 79' ' ' LEU . 1.2 m-80 67.24 -14.06 0.2 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.862 1.265 . . . . 0.0 112.915 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 61' ' ' VAL . . . 128.44 -8.17 6.6 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.705 2.097 . . . . 0.0 111.66 -170.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -110.08 124.48 51.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 119.205 1.502 . . . . 0.0 107.338 -169.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.47 111.39 1.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt -146.4 89.17 1.83 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.19 35.09 1.2 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.156 1.783 . . . . 0.0 113.069 -171.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -140.26 144.04 36.26 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.269 -0.895 . . . . 0.0 112.361 -167.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.82 -36.57 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 126.49 1.916 . . . . 0.0 109.668 168.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.7 -16.11 69.58 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.607 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.7 -52.87 4.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 116.978 -1.486 . . . . 0.0 110.271 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp -138.13 138.98 42.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 121.376 1.898 . . . . 0.0 112.706 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.97 -75.18 0.64 Allowed 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 102.367 -3.198 . . . . 0.0 102.367 163.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.419 ' HB ' ' H ' ' A' ' 75' ' ' ALA . 22.1 p -131.06 -142.21 0.23 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.419 ' H ' ' HB ' ' A' ' 74' ' ' THR . . . -89.06 -48.68 7.25 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 124.777 1.231 . . . . 0.0 111.768 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -8.15 55.15 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.038 0.923 . . . . 0.0 109.625 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -86.47 -9.31 56.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.337 1.455 . . . . 0.0 111.887 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.8 -71.9 0.67 Allowed 'General case' 0 C--N 1.34 0.156 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -170.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.5 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -91.22 -169.53 2.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 126.52 1.928 . . . . 0.0 110.028 172.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.01 -3.62 0.37 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.898 1.679 . . . . 0.0 113.674 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.52 78.46 1.41 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -133.77 -59.25 0.85 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.914 0.357 . . . . 0.0 111.471 167.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -148.95 -177.61 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.478 2.311 . . . . 0.0 106.283 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.76 153.88 43.71 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 163.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.8 t -124.48 134.43 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.0 mm -125.28 95.28 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.328 1.851 . . . . 0.0 107.528 -169.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -89.31 88.84 7.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.04 120.14 23.81 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 163.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.63 -22.18 59.01 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.729 1.157 . . . . 0.0 114.051 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -3.74 52.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.509 1.524 . . . . 0.0 111.879 173.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -144.15 -131.52 0.08 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -159.73 0.97 Allowed 'General case' 0 C--O 1.242 0.668 0 CA-C-N 120.64 1.564 . . . . 0.0 109.843 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.43 83.89 4.25 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 129.418 3.087 . . . . 0.0 110.441 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -78.39 164.24 24.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.22 129.94 44.0 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 -164.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.5 mm -126.98 123.0 61.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -163.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.538 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 6.4 ttt180 -134.33 -178.72 5.18 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 125.376 2.512 . . . . 0.0 115.34 171.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.538 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -137.99 143.15 40.51 Favored 'General case' 0 N--CA 1.427 -1.582 1 C-N-CA 131.837 4.055 . . . . 0.0 105.829 -172.975 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 125.819 1.648 . . . . 0.0 110.084 -175.384 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.81 -55.91 22.19 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 123.523 0.729 . . . . 0.0 111.833 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.64 -19.02 63.62 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.667 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.35 -41.87 46.72 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 123.868 0.867 . . . . 0.0 109.167 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.1 mt -72.74 -51.19 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -57.52 -46.99 83.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.334 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -78.07 -30.45 49.68 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.673 1.124 . . . . 0.0 110.194 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.55 -33.83 86.26 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -124.03 17.32 9.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.954 0.501 . . . . 0.0 112.083 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -14.16 16.98 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -78.99 -21.3 47.23 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.452 1.501 . . . . 0.0 111.716 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.95 161.61 29.95 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -175.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -83.23 172.79 10.36 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.245 1.296 . . . . 0.0 110.702 -169.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.8 p -127.09 170.57 12.22 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.068 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -139.03 154.89 48.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.277 1.431 . . . . 0.0 107.831 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 p -138.41 125.85 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 123.884 0.873 . . . . 0.0 109.931 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -117.49 -168.13 1.44 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 171.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -84.94 12.13 8.1 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 127.789 2.436 . . . . 0.0 116.022 -163.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.04 -177.39 8.6 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -164.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.78 133.39 1.61 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -168.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.08 149.76 40.25 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 117.575 0.688 . . . . 0.0 111.236 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -160.92 140.33 7.9 Favored Pre-proline 0 CA--C 1.51 -0.574 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -168.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.34 150.97 33.19 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 121.508 1.472 . . . . 0.0 110.973 -172.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.333 0.3 OUTLIER -48.46 -34.62 11.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.222 -1.353 . . . . 0.0 112.098 173.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.03 -29.89 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 117.786 -1.102 . . . . 0.0 113.68 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -91.68 -40.12 11.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.737 1.153 . . . . 0.0 109.389 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.59 -30.72 66.15 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 117.093 -1.432 . . . . 0.0 108.399 -174.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.11 -22.26 25.48 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 121.054 1.752 . . . . 0.0 110.333 -172.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.75 -50.97 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 171.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.82 -39.7 95.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.498 1.119 . . . . 0.0 108.621 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.09 47.11 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.915 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.07 33.88 7.5 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 166.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.78 -43.47 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -148.44 109.6 3.63 Favored Pre-proline 0 C--O 1.224 -0.288 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 164.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.3 -15.71 11.24 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.548 2.165 . . . . 0.0 113.391 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.5 t -81.25 115.81 20.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -58.54 -30.01 66.79 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.62 1.555 . . . . 0.0 112.89 -168.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -52.33 24.47 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.637 173.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -54.79 -49.96 69.67 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.62 -58.45 3.82 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 126.375 1.87 . . . . 0.0 110.005 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -58.07 -33.79 69.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 117.045 -1.455 . . . . 0.0 113.218 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -80.77 -34.75 34.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.016 1.734 . . . . 0.0 112.926 173.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -15.6 62.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.452 1.501 . . . . 0.0 111.248 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.5 mt -86.65 -61.68 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 125.41 1.484 . . . . 0.0 108.86 163.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -72.98 -5.47 38.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -163.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.1 m-80 -81.01 131.81 35.33 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 163.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.31 2.98 0.08 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.856 0.741 . . . . 0.0 114.876 167.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -79.1 11.32 2.84 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.099 2.159 . . . . 0.0 111.451 169.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.38 0.0 OUTLIER -111.77 90.05 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 124.98 2.324 . . . . 0.0 104.735 163.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -78.9 96.69 5.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 111.36 -2.655 . . . . 0.0 104.807 172.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 p -78.49 134.58 27.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.614 HD22 ' CD2' ' A' ' 79' ' ' LEU . 1.8 m-20 60.11 14.36 4.41 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 122.004 2.183 . . . . 0.0 114.221 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.67 -4.77 69.38 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.535 1.541 . . . . 0.0 113.723 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -121.82 127.95 51.14 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.912 1.856 . . . . 0.0 108.521 -166.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 105.06 0.64 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.466 1.506 . . . . 0.0 108.302 -172.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.9 mt -140.09 100.89 4.03 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 120.234 1.379 . . . . 0.0 107.964 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.38 27.06 9.11 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.827 2.851 . . . . 0.0 110.559 -168.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -140.39 131.3 26.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.707 1.203 . . . . 0.0 112.138 -164.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 p -59.12 -36.39 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 126.568 1.947 . . . . 0.0 110.682 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.11 -19.49 68.11 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 119.283 -0.732 . . . . 0.0 112.771 173.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.23 -37.84 13.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.109 1.364 . . . . 0.0 114.486 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mt -142.41 123.58 11.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 120.729 1.604 . . . . 0.0 110.69 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.3 mt -107.26 -95.24 0.37 Allowed 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 102.676 -3.083 . . . . 0.0 102.676 163.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.42 -173.05 2.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.065 1.302 . . . . 0.0 114.346 -173.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.24 -41.07 87.86 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.253 -0.904 . . . . 0.0 112.395 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -65.17 -17.22 64.3 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.001 0.92 . . . . 0.0 112.734 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -93.73 4.14 54.38 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.984 1.714 . . . . 0.0 109.682 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.27 -61.34 1.09 Allowed 'General case' 0 C--N 1.35 0.592 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.938 170.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.614 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -91.07 -170.31 2.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.441 1.473 . . . . 0.0 109.101 169.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -43.8 -49.36 8.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.548 1.139 . . . . 0.0 109.664 163.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.05 81.68 0.11 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 125.604 1.574 . . . . 0.0 114.363 172.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -141.74 -46.1 0.36 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.269 0.534 . . . . 0.0 111.902 165.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -131.8 -177.52 4.47 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 125.502 1.521 . . . . 0.0 108.476 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -161.3 132.53 5.42 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.302 1.841 . . . . 0.0 106.72 163.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.25 145.4 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 170.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.4 mm -125.88 98.48 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 C-N-CA 126.442 1.897 . . . . 0.0 106.792 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -97.12 82.35 3.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.466 HH21 ' CB ' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -79.28 61.39 3.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.398 1.879 . . . . 0.0 109.309 -174.221 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 27.19 -82.7 0.0 OUTLIER Glycine 0 CA--C 1.527 0.784 0 C-N-CA 130.292 3.806 . . . . 0.0 116.598 171.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -51.74 -55.05 21.96 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.745 1.618 . . . . 0.0 109.97 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.24 176.9 8.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.894 1.678 . . . . 0.0 109.414 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.72 -146.07 0.08 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.707 1.242 . . . . 0.0 111.743 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -118.16 82.31 1.82 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.295 2.238 . . . . 0.0 109.506 -163.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -78.92 168.34 19.84 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.274 -0.891 . . . . 0.0 108.894 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.5 tp -121.9 131.38 54.0 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.766 -171.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.44 133.42 66.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -144.08 172.08 13.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.578 1.18 . . . . 0.0 109.989 171.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.86 163.29 21.56 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.611 1.164 . . . . 0.0 108.417 163.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.52 0 C-N-CA 127.017 2.127 . . . . 0.0 110.026 173.295 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.218 -0.596 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.5 -49.91 69.51 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 120.347 -1.471 . . . . 0.0 110.836 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 -28.8 65.97 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 118.55 -1.26 . . . . 0.0 109.906 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -79.38 -24.31 42.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.218 1.007 . . . . 0.0 110.146 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.0 mt -74.08 -54.76 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.837 1.655 . . . . 0.0 106.901 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -57.27 -48.59 78.5 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.812 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -81.22 -24.87 37.11 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.417 1.008 . . . . 0.0 110.437 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.43 -38.88 96.38 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -121.48 14.47 11.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 123.726 0.31 . . . . 0.0 111.468 -164.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -54.22 -11.64 0.52 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -78.36 -13.27 59.92 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.918 2.087 . . . . 0.0 110.413 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.446 ' CG1' ' HE2' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -127.92 155.45 77.6 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 126.26 1.824 . . . . 0.0 106.337 169.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.65 169.43 20.89 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.71 1.607 . . . . 0.0 110.463 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.8 p -104.25 175.63 5.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.637 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -136.75 160.31 39.23 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 163.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.43 132.12 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 171.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.98 172.61 6.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 164.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -100.08 57.74 0.98 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.655 -1.278 . . . . 0.0 111.681 -164.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.15 -171.63 9.91 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.98 148.19 2.22 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 -164.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -73.11 149.67 42.87 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.909 -0.759 . . . . 0.0 110.389 164.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.5 t -158.42 132.62 5.15 Favored Pre-proline 0 CA--C 1.505 -0.752 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -163.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -74.41 154.81 45.77 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 C-N-CA 121.715 1.61 . . . . 0.0 110.251 -173.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.397 0.6 OUTLIER -53.94 -29.99 44.69 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.482 176.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.6 p -70.25 -24.78 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -90.86 -43.77 9.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 120.31 1.414 . . . . 0.0 108.508 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -73.78 -28.31 61.6 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 116.943 -1.503 . . . . 0.0 109.49 -171.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.08 -31.29 25.4 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.713 1.597 . . . . 0.0 109.327 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 t -64.6 -51.5 66.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -66.62 -34.75 78.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.152 1.381 . . . . 0.0 109.998 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.4 -15.65 58.44 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.726 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.38 23.36 19.46 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 166.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.93 -43.37 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 m -156.34 101.12 2.07 Favored Pre-proline 0 C--N 1.349 0.562 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 171.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.62 -18.68 10.49 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 121.771 1.647 . . . . 0.0 113.431 -173.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.3 t -86.34 106.34 17.32 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -174.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -57.22 -22.19 39.22 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -164.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.55 -45.99 56.6 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 121.828 2.104 . . . . 0.0 111.095 169.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -51.81 67.84 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.59 -52.93 34.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 125.447 1.717 . . . . 0.0 110.586 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -57.08 -37.97 72.66 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 117.295 -1.336 . . . . 0.0 111.102 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -84.04 -24.89 30.27 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 116.736 -1.986 . . . . 0.0 113.296 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.449 ' CG ' ' HZ3' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -62.16 -23.19 66.45 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 112.22 172.317 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.0 mt -84.95 -63.7 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 C-N-CA 126.211 1.804 . . . . 0.0 107.3 168.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.52 -5.13 10.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 119.916 1.235 . . . . 0.0 112.783 -164.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 58' ' ' ALA . 7.0 m120 -81.5 132.26 35.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 164.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.06 10.76 0.06 OUTLIER Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.246 1.403 . . . . 0.0 115.119 164.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -79.52 -12.67 59.86 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 116.253 -1.832 . . . . 0.0 112.964 165.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.491 ' HB ' ' CG ' ' A' ' 88' ' ' ARG 0.362 0.0 OUTLIER -99.74 87.79 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 125.881 2.753 . . . . 0.0 107.741 177.128 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -79.32 99.08 6.95 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 109.698 -3.41 . . . . 0.0 106.654 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.84 137.34 22.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.525 HD22 ' CD2' ' A' ' 79' ' ' LEU . 0.9 OUTLIER 60.19 4.56 0.67 Allowed 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 120.657 1.572 . . . . 0.0 113.132 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 -2.15 47.69 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.492 1.52 . . . . 0.0 114.035 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -124.18 129.07 50.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.852 1.826 . . . . 0.0 108.979 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.51 110.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.515 1.526 . . . . 0.0 108.386 -171.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -141.22 70.42 1.35 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.128 0.966 . . . . 0.0 109.023 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.97 31.94 0.21 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -170.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -143.62 159.44 42.45 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.7 t -68.01 -27.42 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.971 2.509 . . . . 0.0 111.48 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.11 -7.57 85.09 Favored Glycine 0 C--N 1.333 0.401 0 O-C-N 121.393 -0.817 . . . . 0.0 112.552 168.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.44 -57.64 2.92 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 117.914 -1.041 . . . . 0.0 108.298 170.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp -136.17 137.34 48.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 120.596 1.544 . . . . 0.0 113.475 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.1 mt -108.12 -87.02 0.5 Allowed 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 100.571 -3.862 . . . . 0.0 100.571 163.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.48 -174.42 2.51 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 120.861 -1.15 . . . . 0.0 113.803 -169.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.0 -48.72 75.37 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -70.11 -15.34 62.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.175 0.898 . . . . 0.0 111.224 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -81.3 -10.34 59.59 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.928 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.21 -77.15 0.57 Allowed 'General case' 0 C--N 1.343 0.306 0 O-C-N 120.789 -1.194 . . . . 0.0 108.095 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.525 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -90.55 -171.51 3.09 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 125.66 1.584 . . . . 0.0 109.328 177.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -47.78 -26.27 1.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.72 2.008 . . . . 0.0 115.362 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.34 64.56 0.31 Allowed Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 126.01 1.767 . . . . 0.0 111.261 -169.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -133.27 -81.3 0.48 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -127.36 -166.39 1.6 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.845 1.258 . . . . 0.0 108.781 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.34 122.35 4.49 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 120.78 -1.2 . . . . 0.0 107.899 165.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.5 128.12 38.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.2 mm -116.24 98.03 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -92.37 85.62 5.43 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.491 ' CG ' ' HB ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -89.65 113.97 25.52 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 166.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.84 2.88 1.13 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.449 ' HZ3' ' CG ' ' A' ' 53' ' ' ASP . 6.6 ttpm? -58.2 -45.44 87.58 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.154 1.477 . . . . 0.0 109.573 164.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.446 ' HE2' ' CG1' ' A' ' 22' ' ' VAL . 61.7 tttt -131.76 -90.44 0.43 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HG3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -152.82 -152.39 0.42 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 120.878 1.672 . . . . 0.0 111.523 -167.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.404 ' CD1' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -94.68 79.5 3.76 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 129.897 3.279 . . . . 0.0 110.244 -176.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.4 144.38 35.95 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 119.95 -1.719 . . . . 0.0 107.219 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.1 tp -97.93 139.07 34.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.3 mm -126.6 135.71 62.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -135.37 174.01 11.09 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 122.655 1.217 . . . . 0.0 111.568 164.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.19 163.44 12.24 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 163.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.41 0 C-N-CA 127.671 2.388 . . . . 0.0 109.071 -176.932 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.146 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.82 -58.44 4.59 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.684 0.794 . . . . 0.0 111.139 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.13 -25.14 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.072 0.396 . . . . 0.0 111.026 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -73.73 -39.28 64.4 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.3 mt -70.31 -52.12 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.371 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.37 -48.22 82.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.494 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -72.12 -35.94 69.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.356 0.98 . . . . 0.0 109.155 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.79 -38.2 93.59 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -117.46 13.39 14.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.059 0.544 . . . . 0.0 110.458 -169.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -15.57 4.96 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.406 1.883 . . . . 0.0 113.939 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -78.04 -11.23 59.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 127.427 2.291 . . . . 0.0 111.598 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.76 172.84 6.63 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 167.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.85 -174.24 2.08 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.145 2.563 . . . . 0.0 110.111 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.4 p -135.35 175.45 9.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.594 1.157 . . . . 0.0 109.085 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -138.53 161.32 37.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.265 0.939 . . . . 0.0 109.075 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.8 t -138.81 139.64 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 124.713 1.205 . . . . 0.0 108.032 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.69 172.16 8.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.505 1.145 . . . . 0.0 112.705 163.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.19 33.08 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 128.641 2.776 . . . . 0.0 111.204 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.84 -170.87 31.95 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.543 -0.723 . . . . 0.0 112.058 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.78 145.54 2.98 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -164.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -67.98 148.16 51.45 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.306 0.574 . . . . 0.0 110.653 167.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.8 t -156.77 133.75 6.53 Favored Pre-proline 0 CA--C 1.511 -0.539 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -163.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.42 152.01 60.09 Favored 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 122.069 1.846 . . . . 0.0 110.989 -172.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.442 1.0 OUTLIER -51.69 -30.4 21.89 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.552 174.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.437 ' HA ' ' CD1' ' A' ' 54' ' ' ILE . 7.7 p -78.11 -14.87 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.512 1.525 . . . . 0.0 114.71 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.36 -49.05 6.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.114 0.87 . . . . 0.0 109.055 166.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.9 -23.88 60.77 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 117.381 -1.295 . . . . 0.0 109.051 -166.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -33.4 60.52 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 120.822 1.646 . . . . 0.0 109.639 176.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -75.3 -46.86 37.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -175.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -38.07 89.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.542 1.937 . . . . 0.0 109.39 175.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.64 -24.08 45.47 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.108 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.17 23.12 11.68 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 124.096 0.855 . . . . 0.0 111.482 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.3 -39.66 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -174.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -145.15 113.6 4.86 Favored Pre-proline 0 C--O 1.225 -0.193 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.45 -15.08 5.37 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.778 2.319 . . . . 0.0 113.3 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -84.8 132.67 34.39 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -65.04 -35.48 81.3 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 119.583 1.083 . . . . 0.0 111.034 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -55.47 24.21 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 120.028 1.285 . . . . 0.0 108.945 177.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -49.3 76.71 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.033 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.13 -51.85 49.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.694 1.134 . . . . 0.0 112.366 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -60.0 -39.89 87.35 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 117.678 -1.153 . . . . 0.0 110.238 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.26 -32.05 49.44 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.777 1.172 . . . . 0.0 112.351 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -50.28 -39.81 46.46 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 35' ' ' VAL . 43.8 mt -84.85 -49.99 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 115.66 -2.114 . . . . 0.0 109.597 -174.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -66.99 -10.83 53.75 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 125.382 1.676 . . . . 0.0 111.489 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.2 m120 -83.52 137.3 33.93 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 174.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.66 0.42 0.45 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-N 115.067 -0.969 . . . . 0.0 114.419 164.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -78.95 -4.13 48.34 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.58 1.552 . . . . 0.0 111.617 172.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.445 HG13 ' NH2' ' A' ' 88' ' ' ARG 0.393 0.0 OUTLIER -106.78 92.43 2.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 CA-C-O 125.06 2.362 . . . . 0.0 109.125 171.546 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.97 93.59 7.58 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 109.913 -3.312 . . . . 0.0 105.067 169.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 p -78.31 127.33 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 102.375 -3.195 . . . . 0.0 102.375 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.64 HD22 ' CD2' ' A' ' 79' ' ' LEU . 1.2 m-80 76.34 -52.39 0.6 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.464 1.906 . . . . 0.0 110.499 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.45 3.89 0.02 OUTLIER Glycine 0 CA--C 1.533 1.182 1 C-N-CA 130.731 4.015 . . . . 0.0 111.063 170.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -112.82 116.25 29.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -163.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.08 105.74 0.93 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.9 mt -140.82 68.13 1.35 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.332 0.969 . . . . 0.0 109.547 -168.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.97 56.47 3.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.111 1.764 . . . . 0.0 112.535 -172.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -148.34 151.19 34.93 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.763 0.825 . . . . 0.0 112.928 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.32 -38.01 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.765 2.426 . . . . 0.0 110.699 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.14 -10.19 68.55 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 119.027 -0.874 . . . . 0.0 112.307 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.62 -55.6 3.8 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 117.213 -1.375 . . . . 0.0 109.664 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -136.25 134.53 50.02 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 CA-C-N 120.585 1.539 . . . . 0.0 113.613 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.3 mt -108.27 -86.41 0.51 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 163.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 p -115.57 -168.94 1.49 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.33 93.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.634 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -70.2 -17.26 63.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.71 1.141 . . . . 0.0 110.93 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -82.7 0.16 44.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.464 1.106 . . . . 0.0 110.92 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 -62.97 0.9 Allowed 'General case' 0 C--N 1.345 0.379 0 O-C-N 120.785 -1.197 . . . . 0.0 110.033 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.64 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.06 -175.22 4.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.452 2.301 . . . . 0.0 109.528 172.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -52.81 -28.66 23.64 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.983 1.313 . . . . 0.0 112.852 172.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.46 73.47 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 126.355 1.931 . . . . 0.0 111.675 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -139.04 -79.23 0.33 Allowed 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 117.614 0.707 . . . . 0.0 109.403 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -126.71 -170.8 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.109 1.764 . . . . 0.0 109.13 -173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.12 116.72 4.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 163.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.84 138.46 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 170.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.9 mm -123.1 104.63 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.788 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -92.67 83.92 4.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 170.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.445 ' NH2' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -78.48 82.22 4.76 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 169.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -49.28 -34.26 17.65 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.395 1.474 . . . . 0.0 111.932 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -69.39 15.19 0.07 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.709 1.204 . . . . 0.0 113.635 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -162.69 -82.96 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.855 2.462 . . . . 0.0 108.868 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.55 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -157.73 -169.21 2.78 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 123.364 1.554 . . . . 0.0 110.163 -176.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.55 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 12.0 m-30 -107.03 76.83 1.12 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.985 2.114 . . . . 0.0 111.704 -168.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -79.43 172.31 13.96 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.606 1.162 . . . . 0.0 112.129 -173.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.0 tp -140.66 137.53 33.63 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.377 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.15 141.83 45.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.716 1.606 . . . . 0.0 109.013 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.478 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 7.5 ttt180 -134.39 179.73 6.09 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 124.57 2.129 . . . . 0.0 109.392 163.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.478 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -121.25 162.14 20.74 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.257 163.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 125.169 1.388 . . . . 0.0 112.111 176.214 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.218 -0.553 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.94 -51.61 68.49 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.081 -1.637 . . . . 0.0 112.438 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.89 -29.69 69.64 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.258 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.92 -31.96 61.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.78 2.032 . . . . 0.0 110.3 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 mt -76.38 -56.39 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 126.338 1.855 . . . . 0.0 106.38 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.27 -49.63 63.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.715 0.689 . . . . 0.0 112.519 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.84 -35.59 62.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.14 -40.61 95.91 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -115.58 16.49 16.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 124.035 0.491 . . . . 0.0 110.565 -165.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -55.79 -12.07 1.19 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -102.67 -2.51 28.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 129.25 3.02 . . . . 0.0 113.209 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.79 169.72 8.38 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -84.13 173.19 9.13 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 CA-C-N 121.189 1.46 . . . . 0.0 109.878 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.8 p -128.87 158.16 39.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.878 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 61.6 t80 -135.08 153.76 51.92 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 p -128.49 131.8 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.41 172.69 8.15 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 123.114 1.435 . . . . 0.0 113.523 164.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -80.92 37.98 0.44 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 128.162 2.585 . . . . 0.0 112.43 -164.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.21 -171.53 5.0 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.706 1.146 . . . . 0.0 113.703 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.71 137.04 0.76 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -167.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.17 137.0 57.35 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.378 1.089 . . . . 0.0 109.73 175.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.24 138.5 14.18 Favored Pre-proline 0 CA--C 1.514 -0.427 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -163.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -70.7 145.13 50.91 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.628 2.219 . . . . 0.0 110.776 -169.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.284 0.0 OUTLIER -47.35 -36.74 9.96 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.426 177.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.08 -15.88 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.707 2.003 . . . . 0.0 114.355 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -88.36 -44.23 10.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 120.088 1.313 . . . . 0.0 108.807 164.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -77.09 -18.18 58.18 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 116.847 -1.549 . . . . 0.0 109.888 -168.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.39 -34.69 63.37 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 121.144 1.793 . . . . 0.0 109.751 171.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -49.14 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 C-N-CA 126.338 1.855 . . . . 0.0 106.054 -169.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 3.9 m -60.92 -40.89 94.88 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 128.53 2.732 . . . . 0.0 110.687 169.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.79 -11.09 59.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.904 1.229 . . . . 0.0 113.038 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.25 20.39 49.22 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.682 1.128 . . . . 0.0 112.199 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.86 -39.74 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.794 1.637 . . . . 0.0 106.836 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.74 111.32 1.32 Allowed Pre-proline 0 C--N 1.344 0.358 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 167.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.11 -13.47 7.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.149 1.899 . . . . 0.0 112.414 -174.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 m -90.44 101.49 14.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 -164.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -41.44 -37.46 1.06 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -163.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.48 -54.06 33.75 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.226 1.376 . . . . 0.0 110.168 171.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -59.16 -42.05 89.8 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.728 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.49 -55.58 18.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 123.836 0.855 . . . . 0.0 110.415 175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 mtt85 -55.2 -42.46 73.32 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.173 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -79.78 -33.5 40.49 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 119.989 1.268 . . . . 0.0 112.125 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.63 -29.43 68.01 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 116.592 -1.67 . . . . 0.0 107.636 171.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -81.74 -51.76 14.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-N 120.34 1.427 . . . . 0.0 110.848 174.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -69.6 -7.11 35.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.76 1.624 . . . . 0.0 111.458 -172.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.8 m-80 -81.07 134.95 35.75 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 171.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.59 8.25 0.2 Allowed Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.383 -1.232 . . . . 0.0 114.674 164.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -84.32 -16.22 43.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.213 1.507 . . . . 0.0 111.173 170.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.352 0.0 OUTLIER -93.5 92.65 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 125.455 2.55 . . . . 0.0 106.79 169.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -78.96 109.4 13.21 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 111.566 -2.561 . . . . 0.0 106.236 167.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.47 124.87 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 O-C-N 120.307 -1.496 . . . . 0.0 107.421 174.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.661 HD21 ' HG3' ' A' ' 78' ' ' ARG . 68.3 m-80 46.92 57.57 5.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.774 1.273 . . . . 0.0 110.169 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.23 4.75 51.57 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 113.56 -1.654 . . . . 0.0 114.439 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -131.03 121.47 25.09 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 120.82 2.31 . . . . 0.0 110.404 -167.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.99 100.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 126.691 1.996 . . . . 0.0 110.435 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.4 mt -138.48 108.12 6.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -170.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.409 ' CD ' ' H ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -137.13 38.41 2.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.888 2.075 . . . . 0.0 112.125 -163.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -143.18 158.88 43.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.616 1.566 . . . . 0.0 110.291 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.3 p -69.12 -33.19 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 121.177 -0.952 . . . . 0.0 111.796 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.08 -8.19 84.91 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 119.713 -0.493 . . . . 0.0 112.489 168.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.35 -55.64 4.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 116.862 -1.542 . . . . 0.0 109.24 170.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -138.93 145.86 27.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.402 0 CA-C-N 121.614 2.006 . . . . 0.0 111.774 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.2 mt -115.84 -98.57 0.44 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 163.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.05 -177.51 4.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.072 1.306 . . . . 0.0 114.145 -174.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.56 -48.71 71.73 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.068 0.947 . . . . 0.0 112.581 173.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -61.41 -20.31 62.92 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.996 1.319 . . . . 0.0 113.189 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -84.45 -19.33 33.58 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.151 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.661 ' HG3' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -96.2 -74.89 0.55 Allowed 'General case' 0 C--N 1.345 0.404 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.434 HD11 ' H ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.52 169.63 10.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.371 1.468 . . . . 0.0 111.129 172.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -23.24 -52.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.028 3.331 . . . . 0.0 115.839 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.53 56.28 0.01 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -168.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.9 -88.03 0.33 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.986 0.893 . . . . 0.0 111.851 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.434 ' H ' HD11 ' A' ' 79' ' ' LEU . 21.6 m-30 -131.56 -170.5 2.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -168.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.46 135.21 10.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.35 -0.844 . . . . 0.0 109.413 166.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -79.41 138.34 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 167.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.4 mm -113.22 92.74 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 126.323 1.849 . . . . 0.0 106.042 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 ttt-85 -97.78 74.63 2.37 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 -165.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.546 ' HB2' HH11 ' A' ' 88' ' ' ARG . 0.0 OUTLIER -88.3 105.14 17.36 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 130.499 3.519 . . . . 0.0 110.019 -169.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.23 -30.56 17.98 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.182 0.896 . . . . 0.0 114.524 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -23.58 31.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.721 1.609 . . . . 0.0 113.913 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -149.76 -89.91 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.42 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -151.94 -144.52 0.15 Allowed 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 122.424 1.107 . . . . 0.0 109.99 -175.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.42 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 3.6 m-30 -115.22 87.5 2.67 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.533 -162.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -78.49 161.92 26.72 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.87 134.9 54.85 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -172.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.7 mm -122.61 129.28 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -137.58 174.57 10.44 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 123.588 1.661 . . . . 0.0 111.061 171.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.71 166.05 13.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 124.738 1.215 . . . . 0.0 110.096 171.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 C-N-CA 129.075 2.95 . . . . 0.0 110.852 -168.684 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.591 0 CA-C-O 120.342 0.115 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.54 -51.01 63.06 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 120.467 -1.396 . . . . 0.0 111.47 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.34 81.08 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.402 0.439 . . . . 0.0 110.087 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.81 -34.31 66.78 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -174.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.9 mt -72.68 -52.14 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 126.261 1.824 . . . . 0.0 108.397 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -56.83 -47.24 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 118.598 0.635 . . . . 0.0 111.235 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -80.64 -22.54 40.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.581 0.628 . . . . 0.0 110.057 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.54 -24.67 58.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 125.241 1.4 . . . . 0.0 111.841 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -130.44 17.13 5.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.185 0.994 . . . . 0.0 110.596 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 -15.23 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.191 2.196 . . . . 0.0 112.47 169.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.1 -19.7 53.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.766 2.827 . . . . 0.0 111.392 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.08 161.54 51.08 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 176.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.16 172.26 16.58 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 N-CA-C 109.091 -1.157 . . . . 0.0 109.091 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 p -121.02 168.3 11.66 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 113.532 -1.667 . . . . 0.0 108.42 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -140.43 164.33 30.41 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.46 135.65 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -116.13 -179.23 3.6 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.75 0.786 . . . . 0.0 109.98 163.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -96.15 66.89 2.55 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.437 -0.79 . . . . 0.0 109.879 -171.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.56 -157.4 29.57 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.44 108.31 0.05 OUTLIER Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.295 1.426 . . . . 0.0 112.298 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -47.41 139.86 6.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.86 0.83 . . . . 0.0 112.192 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.95 136.54 10.86 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.722 -163.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.13 144.34 38.3 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.35 2.7 . . . . 0.0 112.388 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.377 1.1 pt? -55.8 -25.92 43.73 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 171.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.4 -56.6 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 119.58 1.082 . . . . 0.0 110.844 166.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -65.63 -41.88 92.16 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.188 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.81 -29.5 62.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 120.587 1.539 . . . . 0.0 109.517 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.74 -27.83 22.12 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 120.459 1.482 . . . . 0.0 109.482 -173.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.54 -49.86 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 t -60.98 -45.4 94.94 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.668 1.587 . . . . 0.0 108.685 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.87 -15.61 58.13 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.167 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.94 27.58 9.39 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 119.276 0.944 . . . . 0.0 111.268 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -45.77 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.51 102.83 2.91 Favored Pre-proline 0 C--N 1.347 0.49 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 164.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.94 -17.45 19.7 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.131 1.887 . . . . 0.0 113.067 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.0 t -90.81 109.14 20.34 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -56.96 -18.75 14.69 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -166.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -72.02 -53.84 11.72 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 120.91 1.687 . . . . 0.0 110.484 168.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -47.91 68.08 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.37 -57.25 8.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 124.403 1.065 . . . . 0.0 111.359 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -63.13 -26.93 69.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 116.251 -1.833 . . . . 0.0 112.229 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -69.74 -50.48 43.05 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 121.602 2.001 . . . . 0.0 110.982 163.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -9.55 3.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.725 1.21 . . . . 0.0 112.993 -174.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.9 mt -96.15 -67.74 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 C-N-CA 126.673 1.989 . . . . 0.0 109.071 164.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.62 -9.22 8.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 120.329 1.422 . . . . 0.0 112.54 -167.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.461 ' C ' ' H ' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -82.52 126.04 31.81 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 119.57 1.077 . . . . 0.0 110.971 168.152 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.46 9.55 0.23 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 169.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.461 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -80.11 -7.53 58.94 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 116.58 -1.676 . . . . 0.0 111.801 164.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.384 0.0 OUTLIER -91.75 90.13 3.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 125.621 2.629 . . . . 0.0 107.673 167.174 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -79.87 96.74 6.43 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 110.957 -2.838 . . . . 0.0 108.021 171.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.0 t -78.64 126.78 38.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m120 60.7 11.9 3.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.619 0.768 . . . . 0.0 111.834 -172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.97 18.32 56.26 Favored Glycine 0 CA--C 1.525 0.71 0 O-C-N 121.009 -1.057 . . . . 0.0 112.062 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -124.23 115.91 21.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.541 1.671 . . . . 0.0 107.793 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -51.71 105.78 0.12 Allowed 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 126.157 1.783 . . . . 0.0 107.5 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.9 mt -145.09 71.75 1.31 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -171.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.43 39.89 0.34 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.397 1.479 . . . . 0.0 111.192 -172.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -149.1 152.59 36.42 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -165.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.54 -29.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.363 2.265 . . . . 0.0 112.006 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.01 -34.88 90.4 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 164.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.86 -57.35 4.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 117.382 -1.294 . . . . 0.0 110.071 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.2 mp -136.12 139.49 45.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 CA-C-N 120.725 1.602 . . . . 0.0 112.402 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -112.13 -91.17 0.49 Allowed 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.72 -174.66 2.51 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.332 -1.48 . . . . 0.0 113.833 -170.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.08 -42.01 84.67 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -82.64 -0.42 47.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.641 1.109 . . . . 0.0 110.962 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -89.59 -3.49 58.26 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.837 -1.164 . . . . 0.0 110.357 164.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.79 -63.67 1.11 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 120.113 1.324 . . . . 0.0 111.092 177.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -168.79 2.16 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.378 1.071 . . . . 0.0 109.265 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -54.61 -17.66 3.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.298 1.439 . . . . 0.0 113.034 168.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.54 75.29 0.88 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 126.722 2.106 . . . . 0.0 112.343 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -145.01 -60.88 0.36 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.822 0.811 . . . . 0.0 111.865 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -137.58 -168.11 2.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.922 2.089 . . . . 0.0 107.912 -176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -160.62 131.71 5.59 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.56 1.944 . . . . 0.0 106.93 164.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.53 139.65 17.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 125.017 1.327 . . . . 0.0 107.99 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.8 mm -131.33 101.77 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 126.004 1.722 . . . . 0.0 106.528 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -100.65 95.57 6.77 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.62 121.07 29.59 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 172.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.9 98.57 0.71 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt 132.19 113.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 1 C-N-CA 134.458 5.103 . . . . 0.0 102.781 -163.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.431 0.0 OUTLIER 54.43 -127.61 2.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 116.665 -1.636 . . . . 0.0 109.031 -163.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.3 -143.55 0.16 Allowed 'General case' 0 C--O 1.243 0.725 0 CA-C-N 121.045 1.748 . . . . 0.0 113.213 -163.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -121.46 82.22 1.91 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.898 1.679 . . . . 0.0 109.851 -163.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -79.04 164.93 23.95 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.2 tt -134.41 129.1 34.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -164.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.72 135.16 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -171.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.2 ptt-85 -131.82 178.34 6.84 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.386 1.474 . . . . 0.0 111.853 166.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.61 161.82 18.59 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.462 1.105 . . . . 0.0 109.474 163.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.388 0 C-N-CA 126.197 1.799 . . . . 0.0 109.219 170.166 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.88 -39.14 73.0 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.747 -1.221 . . . . 0.0 112.146 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.22 -30.67 70.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 170.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -77.98 -32.86 51.56 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.904 0.881 . . . . 0.0 109.64 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 mt -64.96 -56.88 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 C-N-CA 126.155 1.782 . . . . 0.0 108.018 166.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -54.11 -50.45 66.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 120.309 1.413 . . . . 0.0 113.282 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -87.3 -12.61 46.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.095 0.861 . . . . 0.0 111.249 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.23 -44.02 94.45 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 164.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.417 ' CG ' ' CE2' ' A' ' 93' ' ' TYR . 10.4 m-85 -106.54 1.71 25.58 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -163.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -48.18 -12.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 19' ' ' PHE . 28.1 t70 -79.34 -12.74 59.92 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.78 1.632 . . . . 0.0 112.978 -177.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.417 ' CG2' ' HD2' ' A' ' 23' ' ' PRO . 10.5 p -160.36 160.69 26.15 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.659 1.984 . . . . 0.0 108.303 -177.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.417 ' HD2' ' CG2' ' A' ' 22' ' ' VAL . 89.9 Cg_endo -82.64 178.72 5.89 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.853 1.702 . . . . 0.0 111.761 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.5 179.0 4.15 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.01 1.724 . . . . 0.0 110.173 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 48.0 t80 -137.08 160.44 38.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.308 1.443 . . . . 0.0 108.69 164.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 t -139.27 129.64 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.388 1.875 . . . . 0.0 108.22 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.9 -168.33 1.59 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.476 0.58 . . . . 0.0 112.491 163.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.57 1.2 30.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -163.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.78 174.12 4.97 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.952 1.263 . . . . 0.0 112.244 -169.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.05 133.36 1.12 Allowed Glycine 0 CA--C 1.53 1.022 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -163.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -62.5 145.27 54.66 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -163.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 t -159.06 138.73 8.54 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 125.714 1.606 . . . . 0.0 106.876 -163.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.99 146.27 46.72 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.038 1.825 . . . . 0.0 111.203 -171.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.328 0.9 OUTLIER -45.92 -36.62 5.57 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.977 171.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.264 5.8 p -79.61 -9.28 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 120.602 -1.312 . . . . 0.0 114.194 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -96.18 -38.96 9.92 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.513 1.051 . . . . 0.0 109.498 163.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -78.83 -17.72 55.2 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 116.84 -1.552 . . . . 0.0 109.624 -172.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -27.07 43.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 121.146 1.793 . . . . 0.0 110.228 171.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.93 -44.34 28.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 126.342 1.857 . . . . 0.0 106.743 -174.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -69.88 -41.26 75.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 124.781 1.232 . . . . 0.0 108.679 172.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.64 -16.38 57.41 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.725 1.148 . . . . 0.0 112.858 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.3 33.33 8.8 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 166.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.36 -42.05 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.15 122.17 1.63 Allowed Pre-proline 0 C--N 1.348 0.509 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 163.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -84.34 -13.87 7.22 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.468 2.112 . . . . 0.0 112.758 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.8 m -89.63 101.6 14.29 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -164.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -47.05 -36.94 8.64 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 117.978 2.584 . . . . 0.0 117.978 -163.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -66.51 -47.03 74.24 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 121.991 2.178 . . . . 0.0 110.647 169.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -56.44 -50.89 70.36 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 119.366 0.985 . . . . 0.0 108.383 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.85 -54.95 16.23 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.933 1.293 . . . . 0.0 110.992 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -52.35 -48.7 65.38 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.919 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.07 -25.12 37.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.246 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -67.03 -16.52 64.4 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 126.709 2.004 . . . . 0.0 110.874 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.4 mt -109.14 -16.44 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 C-N-CA 126.098 1.759 . . . . 0.0 115.436 170.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -91.54 -8.09 48.47 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 120.801 1.637 . . . . 0.0 111.894 170.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.27 136.86 33.32 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 118.379 0.536 . . . . 0.0 109.962 174.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.19 10.04 0.44 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.459 -1.189 . . . . 0.0 114.47 168.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.9 -10.1 59.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.374 1.587 . . . . 0.0 112.369 171.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.419 0.0 OUTLIER -101.02 86.86 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 125.815 2.722 . . . . 0.0 106.981 178.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -79.09 95.19 5.49 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 110.678 -2.965 . . . . 0.0 106.701 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.433 HG13 HD21 ' A' ' 62' ' ' ASN . 22.3 t -79.12 142.6 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.433 HD21 HG13 ' A' ' 61' ' ' VAL . 2.7 p30 54.86 15.21 1.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.24 10.86 47.19 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 128.716 3.055 . . . . 0.0 113.225 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.84 131.52 14.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.466 1.633 . . . . 0.0 111.4 -163.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.21 109.1 0.39 Allowed 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 128.517 2.727 . . . . 0.0 109.805 -172.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.6 mt -139.18 71.01 1.37 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.337 0.971 . . . . 0.0 109.057 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.39 50.59 1.48 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.755 2.422 . . . . 0.0 112.442 -175.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -152.3 146.82 25.69 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.6 t -66.37 -30.47 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 127.47 2.308 . . . . 0.0 111.352 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.46 -2.36 90.6 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.557 1.075 . . . . 0.0 112.449 170.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.39 -60.63 1.84 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 117.398 -1.287 . . . . 0.0 109.322 164.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -135.24 138.12 49.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-N 120.587 1.54 . . . . 0.0 113.12 -172.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.1 mt -110.36 -96.62 0.41 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 163.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -94.9 -169.27 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.763 1.268 . . . . 0.0 113.631 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.34 78.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.94 1.296 . . . . 0.0 113.459 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -70.78 -14.61 62.49 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.017 0.826 . . . . 0.0 112.069 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -84.07 -2.11 56.1 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 171.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.76 -86.72 0.61 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 166.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 83' ' ' PHE . 0.5 OUTLIER -91.27 -166.56 1.6 Allowed 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 126.658 1.983 . . . . 0.0 110.284 -170.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -51.6 1.52 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 130.01 3.324 . . . . 0.0 116.18 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 79' ' ' LEU . . . 86.81 55.79 2.34 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 124.932 1.253 . . . . 0.0 110.54 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -135.26 -65.31 0.62 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 118.671 -0.681 . . . . 0.0 110.434 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.434 ' H ' HD12 ' A' ' 79' ' ' LEU . 96.6 m-85 -122.77 179.18 4.72 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 118.609 0.64 . . . . 0.0 109.439 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.93 136.24 26.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 163.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.251 33.0 t -108.74 131.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 116.26 -1.829 . . . . 0.0 106.969 -163.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 49.7 mm -133.27 106.29 9.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 120.93 1.695 . . . . 0.0 110.869 -169.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -97.43 99.21 10.63 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 164.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.6 ttp85 -86.78 112.78 22.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 120.785 1.629 . . . . 0.0 108.562 164.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.87 166.71 1.89 Allowed Glycine 0 CA--C 1.533 1.175 0 CA-C-O 121.864 0.702 . . . . 0.0 112.471 172.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.6 mptt 63.59 -56.79 0.2 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.563 1.945 . . . . 0.0 112.282 -165.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -94.41 0.07 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 121.268 1.849 . . . . 0.0 110.183 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.526 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -160.88 -179.29 7.44 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 124.422 2.058 . . . . 0.0 108.709 -172.269 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.526 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 90.0 t80 -79.43 157.78 27.47 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 111.569 -2.56 . . . . 0.0 106.667 163.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -145.57 160.31 41.83 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 128.521 2.728 . . . . 0.0 109.013 164.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.6 tp -117.86 137.49 52.75 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.468 1.507 . . . . 0.0 108.22 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.6 mm -121.44 136.51 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.555 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 8.8 ttt180 -138.43 -177.7 4.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 124.333 2.016 . . . . 0.0 109.168 164.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.555 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -120.78 161.59 21.21 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.006 -1.906 . . . . 0.0 108.873 163.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 0 C-N-CA 126.723 2.009 . . . . 0.0 111.873 -172.814 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.856 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.95 -44.66 54.19 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.14 0.976 . . . . 0.0 109.097 -171.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.14 77.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.399 0.437 . . . . 0.0 109.901 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -71.78 -41.83 67.87 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.4 mt -67.38 -51.96 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.65 0.78 . . . . 0.0 110.265 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.05 -45.11 87.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 119.673 1.124 . . . . 0.0 111.313 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.24 -35.32 66.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.23 97.5 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 126.743 2.116 . . . . 0.0 109.952 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 93' ' ' TYR . 11.8 m-85 -101.76 6.19 41.6 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.798 0.439 . . . . 0.0 111.29 -170.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -64.75 -2.99 2.83 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -79.14 -15.46 58.09 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 111.975 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.82 168.92 15.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 175.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -81.77 162.58 18.74 Favored 'Trans proline' 0 N--CA 1.437 -1.819 0 C-N-CA 121.512 1.475 . . . . 0.0 108.507 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 m -111.68 162.6 15.03 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -116.81 156.43 27.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.219 -0.926 . . . . 0.0 108.575 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.33 127.24 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.15 135.6 49.22 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.405 1.098 . . . . 0.0 108.687 163.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.91 61.9 3.97 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 170.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.37 171.02 32.87 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.811 1.196 . . . . 0.0 111.366 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.74 -150.72 26.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.349 1.452 . . . . 0.0 109.843 170.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HA ' ' CG2' ' A' ' 74' ' ' THR 0.278 0.0 OUTLIER -55.37 135.62 50.03 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.926 1.29 . . . . 0.0 113.53 -163.899 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -158.6 142.83 11.39 Favored Pre-proline 0 CA--C 1.518 -0.269 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -163.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -69.32 147.86 66.61 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.106 1.87 . . . . 0.0 111.957 -171.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.261 0.1 OUTLIER -39.37 -45.8 1.52 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.815 1.646 . . . . 0.0 113.421 170.256 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.02 -11.81 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.54 1.536 . . . . 0.0 113.218 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -91.06 -43.86 9.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.822 0.737 . . . . 0.0 109.278 165.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.05 -30.23 67.44 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.668 -168.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -36.58 62.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 120.129 1.331 . . . . 0.0 110.476 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.23 -43.28 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 C-N-CA 125.186 1.394 . . . . 0.0 107.566 -172.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.4 -40.08 81.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 126.415 1.886 . . . . 0.0 108.248 175.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.6 -20.56 50.2 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.799 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.55 17.17 11.58 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 119.085 0.857 . . . . 0.0 113.863 171.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -43.69 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 -171.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m -160.58 110.77 1.34 Allowed Pre-proline 0 N--CA 1.464 0.243 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.24 -20.96 6.84 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.467 2.111 . . . . 0.0 112.516 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -86.97 115.94 24.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -167.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -48.16 -36.77 14.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.972 1.309 . . . . 0.0 113.337 -172.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -67.04 -52.51 41.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.756 1.162 . . . . 0.0 111.152 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -56.26 -53.95 51.13 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.33 -54.61 10.63 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.409 1.884 . . . . 0.0 110.838 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.7 ttm-85 -50.23 -49.31 53.31 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 123.634 0.773 . . . . 0.0 110.771 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -80.99 -31.89 34.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.537 0.608 . . . . 0.0 112.482 -173.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.81 -21.96 63.67 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.514 1.525 . . . . 0.0 109.245 170.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.44 -43.22 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 116.254 -1.831 . . . . 0.0 112.766 169.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -73.98 -10.74 59.94 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 120.222 1.374 . . . . 0.0 111.226 -173.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 58' ' ' ALA . 3.9 m120 -84.95 144.33 28.4 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.52 25.44 0.48 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.772 1.177 . . . . 0.0 113.486 166.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -117.93 4.35 12.15 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 128.628 2.771 . . . . 0.0 109.471 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.327 0.0 OUTLIER -111.59 98.1 6.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 124.743 2.211 . . . . 0.0 107.573 163.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -81.07 100.39 8.98 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 112.687 -2.051 . . . . 0.0 107.776 171.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.2 t -78.91 128.25 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 61.43 0.93 0.49 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.932 1.293 . . . . 0.0 113.727 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.7 7.89 27.06 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 117.673 -1.626 . . . . 0.0 112.751 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.56 123.18 35.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.904 1.852 . . . . 0.0 108.555 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -50.37 102.29 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.927 2.091 . . . . 0.0 110.68 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.3 mt -141.81 110.1 5.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.443 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -138.33 44.61 2.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.541 2.736 . . . . 0.0 113.616 -163.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -143.32 154.62 43.96 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.003 -1.061 . . . . 0.0 111.785 167.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -64.09 134.72 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 122.975 1.369 . . . . 0.0 107.546 167.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.71 -6.57 46.25 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.006 -173.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.37 -46.59 32.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 163.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.04 146.23 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 124.646 1.179 . . . . 0.0 108.235 165.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.6 mt -124.17 -94.9 0.48 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 163.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.443 ' CG2' ' HA ' ' A' ' 31' ' ' ASP . 1.3 p -100.97 -173.89 2.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.774 1.624 . . . . 0.0 115.072 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.427 ' HA ' ' HG1' ' A' ' 84' ' ' THR . . . -50.4 -56.53 11.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.384 1.473 . . . . 0.0 114.075 171.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -67.23 -9.44 40.43 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.547 1.067 . . . . 0.0 113.166 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -89.64 -14.01 35.8 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.536 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.29 -66.6 0.93 Allowed 'General case' 0 C--N 1.338 0.095 0 O-C-N 119.85 -1.782 . . . . 0.0 108.027 174.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.04 -168.97 2.39 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 128.335 2.654 . . . . 0.0 110.907 -171.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -64.44 -5.66 5.76 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.146 1.379 . . . . 0.0 114.022 165.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.19 75.81 1.1 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.983 1.754 . . . . 0.0 113.612 -170.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.52 -81.74 0.28 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.839 0.856 . . . . 0.0 109.417 163.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -128.36 -162.63 1.2 Allowed 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 125.455 1.502 . . . . 0.0 110.076 -170.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.427 ' HG1' ' HA ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -154.39 121.15 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 119.205 -2.184 . . . . 0.0 107.151 168.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.02 143.99 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.1 mm -126.26 136.59 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 127.781 2.433 . . . . 0.0 106.293 172.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -127.43 84.4 2.25 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 164.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.6 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -84.37 91.93 7.91 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.844 2.057 . . . . 0.0 106.249 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -28.59 -63.82 0.11 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.367 2.413 . . . . 0.0 115.447 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.6 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 35.1 tttp -44.14 -37.85 3.35 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.707 2.403 . . . . 0.0 113.727 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -111.6 -117.63 0.3 Allowed 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 -170.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.13 -151.35 0.38 Allowed 'General case' 0 C--O 1.246 0.887 0 CA-C-O 122.662 1.22 . . . . 0.0 110.941 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.46 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 3.3 m-30 -110.83 104.14 12.73 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.951 2.5 . . . . 0.0 106.59 -165.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -113.05 165.86 11.96 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.593 1.157 . . . . 0.0 110.199 -173.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.1 tp -130.14 132.85 46.26 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.541 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.37 135.0 65.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -132.22 175.3 9.38 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.365 1.866 . . . . 0.0 109.633 170.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.78 168.35 10.83 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.898 0.879 . . . . 0.0 110.26 166.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.775 0 C-N-CA 125.259 1.423 . . . . 0.0 109.818 166.584 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.29 69.23 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 120.513 -1.367 . . . . 0.0 112.898 -167.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.57 -21.59 41.56 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.163 171.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.93 -40.77 78.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 mt -68.89 -56.59 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 116.873 -1.536 . . . . 0.0 109.198 173.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -52.96 -55.09 26.05 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 120.026 1.284 . . . . 0.0 111.373 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -83.26 -13.22 55.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.06 -1.025 . . . . 0.0 110.202 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.8 -27.99 63.79 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 118.222 -1.321 . . . . 0.0 111.771 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -126.93 4.35 6.56 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -171.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -59.82 0.32 0.15 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.5 -6.4 53.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.607 1.094 . . . . 0.0 109.761 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.22 160.25 64.88 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.876 2.07 . . . . 0.0 106.509 170.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.87 174.28 12.43 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.415 1.41 . . . . 0.0 110.429 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 p -110.33 174.21 5.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 112.396 -2.183 . . . . 0.0 109.096 175.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -140.19 158.39 44.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 164.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.68 128.33 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -110.61 156.09 21.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -81.27 51.08 1.54 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.248 1.019 . . . . 0.0 111.414 -172.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.93 -175.96 40.88 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 121.144 -0.972 . . . . 0.0 113.11 173.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.12 152.05 2.45 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 -163.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.01 162.09 22.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.17 164.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.0 t -154.18 127.7 4.34 Favored Pre-proline 0 CA--C 1.509 -0.631 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -167.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.95 148.03 44.67 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 122.358 2.039 . . . . 0.0 110.302 -175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.276 13.0 tp -39.29 -47.78 1.75 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.522 2.729 . . . . 0.0 112.042 173.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.0 -7.56 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.134 1.773 . . . . 0.0 114.849 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -103.32 -34.84 8.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.301 -1.333 . . . . 0.0 111.376 165.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.89 -30.12 44.75 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 120.675 1.58 . . . . 0.0 108.823 -170.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.2 -28.45 25.43 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 119.837 1.199 . . . . 0.0 108.656 -174.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 t -66.78 -52.36 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 t -66.56 -39.66 88.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.77 -16.53 57.06 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.345 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.38 21.93 12.32 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.179 0.899 . . . . 0.0 111.852 165.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 mp -78.55 -40.95 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 t -160.37 105.83 1.36 Allowed Pre-proline 0 C--N 1.346 0.437 0 CA-C-N 120.517 1.508 . . . . 0.0 108.101 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -83.32 -20.21 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.971 1.781 . . . . 0.0 113.799 -176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.7 t -85.61 103.41 14.41 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -56.63 -22.41 33.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -163.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -47.93 58.51 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 121.917 2.144 . . . . 0.0 110.006 169.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -56.73 -51.24 69.6 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.02 -50.88 63.36 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 125.144 1.378 . . . . 0.0 110.953 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -64.04 -32.7 74.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 116.712 -1.613 . . . . 0.0 111.314 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.56 -29.13 28.08 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.886 1.676 . . . . 0.0 112.891 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -65.88 -16.11 63.54 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.55 1.94 . . . . 0.0 112.036 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.1 mt -88.32 -61.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 C-N-CA 126.078 1.751 . . . . 0.0 108.0 163.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -16.26 61.69 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.488 1.04 . . . . 0.0 112.713 -164.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.2 m120 -85.14 138.69 32.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 119.023 0.829 . . . . 0.0 109.833 173.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.05 7.02 0.07 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.494 1.521 . . . . 0.0 114.851 171.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -78.45 -14.79 59.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.536 1.168 . . . . 0.0 110.434 175.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.39 0.0 OUTLIER -90.31 90.96 3.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 CA-C-O 125.972 2.796 . . . . 0.0 106.992 172.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -83.24 94.16 7.84 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 110.299 -3.137 . . . . 0.0 105.397 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.46 134.48 28.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 177.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.587 HD21 ' HG3' ' A' ' 78' ' ' ARG . 78.3 m-20 56.94 22.78 7.54 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.942 -1.099 . . . . 0.0 113.263 175.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.71 18.06 73.9 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.08 1.324 . . . . 0.0 113.617 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.38 119.93 21.35 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.674 2.39 . . . . 0.0 107.029 -164.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.27 108.88 0.99 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.02 -1.467 . . . . 0.0 108.048 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.1 mt -143.97 103.24 4.0 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-N 120.214 1.37 . . . . 0.0 107.742 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 25.73 8.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.576 1.151 . . . . 0.0 112.595 -172.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -131.29 137.06 48.66 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.034 -1.041 . . . . 0.0 112.509 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.38 -38.92 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 125.976 1.71 . . . . 0.0 110.402 166.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.53 -12.95 74.08 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.077 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.32 -36.84 13.62 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.198 0.999 . . . . 0.0 111.46 170.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.2 mt -142.0 121.9 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 120.068 1.304 . . . . 0.0 111.829 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.4 mt -111.15 -94.27 0.44 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 101.365 -3.568 . . . . 0.0 101.365 163.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.72 -172.72 2.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.24 -49.88 74.65 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.328 1.051 . . . . 0.0 112.26 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -14.08 62.81 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.458 0.703 . . . . 0.0 111.691 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -81.91 -18.73 42.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 118.484 -0.77 . . . . 0.0 109.481 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.587 ' HG3' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -112.3 -60.5 1.86 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 119.932 1.242 . . . . 0.0 110.507 -171.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.532 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -90.37 -177.02 4.98 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.521 1.528 . . . . 0.0 108.636 167.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -48.63 -36.71 16.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.795 164.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.26 93.63 0.53 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 124.737 1.16 . . . . 0.0 112.06 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -139.07 -64.44 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 164.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -134.9 -169.75 2.42 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.805 2.042 . . . . 0.0 107.354 -176.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.43 124.1 6.62 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 163.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -79.3 145.65 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.3 mm -129.06 91.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -91.4 81.83 5.42 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -78.7 102.86 8.27 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 168.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -43.98 -49.3 7.77 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.566 1.555 . . . . 0.0 113.022 -173.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.77 -0.28 3.97 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -132.42 -100.61 0.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 164.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -157.6 -164.67 1.6 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 121.056 1.753 . . . . 0.0 109.127 -178.157 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.404 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -91.48 82.49 5.36 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 130.937 3.695 . . . . 0.0 110.753 179.158 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -78.37 166.82 22.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.1 tp -130.07 140.62 50.81 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.677 -169.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.3 mm -134.99 127.64 48.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -170.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -136.62 172.46 12.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 122.519 1.152 . . . . 0.0 112.556 163.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.99 161.21 13.84 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.093 1.357 . . . . 0.0 110.78 165.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.851 0 C-N-CA 129.213 3.005 . . . . 0.0 106.374 165.461 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.86 -37.03 49.17 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.255 -0.903 . . . . 0.0 111.255 -165.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.76 88.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.806 0.812 . . . . 0.0 109.894 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.25 -43.19 61.56 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.358 1.063 . . . . 0.0 108.183 -167.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.0 mt -66.21 -50.5 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 117.617 -1.182 . . . . 0.0 108.909 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -58.09 -51.07 71.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.517 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -79.76 -22.98 42.54 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.304 0.502 . . . . 0.0 109.831 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.49 -41.27 99.31 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -127.75 13.47 6.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -164.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -53.81 -8.18 0.15 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.018 2.527 . . . . 0.0 113.312 165.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.43 -27.8 46.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 128.19 2.596 . . . . 0.0 112.452 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 p -131.05 173.05 6.33 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -173.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.09 177.47 8.84 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.719 1.613 . . . . 0.0 110.066 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 81.9 p -136.39 167.68 20.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.252 1.021 . . . . 0.0 108.659 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -134.93 155.34 50.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.48 129.91 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.209 1.404 . . . . 0.0 108.336 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.07 176.73 5.43 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 122.02 0.914 . . . . 0.0 112.809 167.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -79.01 32.15 0.21 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.456 2.302 . . . . 0.0 113.723 -163.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.18 -170.77 25.2 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.494 -1.379 . . . . 0.0 110.296 -165.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.85 138.14 2.59 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -174.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -68.84 147.78 51.23 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 117.957 0.878 . . . . 0.0 111.174 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.3 t -160.33 135.16 5.53 Favored Pre-proline 0 CA--C 1.519 -0.244 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -164.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.63 149.99 30.88 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.565 2.177 . . . . 0.0 112.311 -166.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.3 0.1 OUTLIER -46.81 -41.29 15.25 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.072 178.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 p -75.09 -10.73 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 128.685 2.794 . . . . 0.0 114.815 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -98.75 -43.79 6.65 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 166.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 pp -76.44 -19.91 57.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 116.79 -1.576 . . . . 0.0 109.682 -166.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.98 -33.27 51.5 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 120.836 1.653 . . . . 0.0 110.324 173.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.42 -50.64 44.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 126.003 1.721 . . . . 0.0 107.773 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -36.2 83.2 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 127.361 2.264 . . . . 0.0 110.51 174.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.65 -22.59 46.63 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.471 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.07 33.04 7.14 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 169.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.1 -52.72 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.2 m -145.54 99.95 4.43 Favored Pre-proline 0 C--N 1.344 0.364 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 -173.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.41 -17.82 12.72 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.382 2.054 . . . . 0.0 112.918 -168.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.3 t -90.94 109.28 20.5 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -52.38 -37.48 56.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 117.533 -1.223 . . . . 0.0 114.051 -168.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -46.52 80.27 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.397 1.908 . . . . 0.0 110.38 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -51.11 71.11 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.48 -47.2 66.67 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.992 1.717 . . . . 0.0 110.371 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -56.89 -47.87 79.49 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 117.434 -1.27 . . . . 0.0 111.358 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.68 -35.73 75.38 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.594 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.21 -12.68 21.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 124.267 1.027 . . . . 0.0 112.704 172.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.07 -29.39 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.669 1.988 . . . . 0.0 114.408 173.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -89.56 -9.66 49.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.062 1.345 . . . . 0.0 110.144 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.4 m120 -100.06 146.54 26.65 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.262 1.03 . . . . 0.0 110.847 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.77 11.54 0.26 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.32 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -84.6 -9.06 58.64 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 125.49 1.516 . . . . 0.0 110.583 171.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.315 0.0 OUTLIER -99.49 89.95 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 125.042 2.353 . . . . 0.0 107.36 171.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -83.46 95.91 8.41 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 111.681 -2.508 . . . . 0.0 106.34 170.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.9 p -78.75 134.75 27.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 103.629 -2.73 . . . . 0.0 103.629 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.451 HD22 ' CD2' ' A' ' 79' ' ' LEU . 1.9 m-80 59.75 19.78 8.56 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 120.713 1.597 . . . . 0.0 111.84 170.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.9 6.21 76.27 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.683 1.611 . . . . 0.0 114.298 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -130.8 116.92 18.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.622 1.711 . . . . 0.0 107.889 -164.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.18 106.16 0.35 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.571 1.548 . . . . 0.0 109.08 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 51.3 mt -140.43 104.12 4.7 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.87 68.9 1.11 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.849 1.26 . . . . 0.0 112.563 -172.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -157.54 153.27 26.69 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 120.673 -1.267 . . . . 0.0 109.205 167.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.03 -32.03 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.373 0.669 . . . . 0.0 109.872 164.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.16 -24.43 70.43 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.017 0.341 . . . . 0.0 113.847 172.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.82 -45.25 8.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.812 1.245 . . . . 0.0 111.023 -172.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 mt -141.76 129.31 21.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 119.462 1.028 . . . . 0.0 109.369 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.15 -93.83 0.43 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 101.177 -3.638 . . . . 0.0 101.177 163.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.27 -171.41 2.07 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -173.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.55 86.66 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.58 1.152 . . . . 0.0 112.288 174.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -17.74 64.77 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.806 0.73 . . . . 0.0 111.837 175.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -89.31 2.04 54.91 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 123.581 0.752 . . . . 0.0 109.729 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.97 -70.25 0.8 Allowed 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.791 1.178 . . . . 0.0 109.596 169.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.451 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -91.79 -170.86 2.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 129.195 2.998 . . . . 0.0 110.226 172.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -57.8 -7.17 0.65 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.391 2.277 . . . . 0.0 114.346 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.29 73.55 1.03 Allowed Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 124.286 0.946 . . . . 0.0 111.527 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.97 -66.02 0.53 Allowed 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -140.93 -175.4 4.29 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.564 1.946 . . . . 0.0 106.913 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.67 138.2 18.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 163.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.9 t -104.08 148.04 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.83 101.65 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 128.268 2.627 . . . . 0.0 105.531 -172.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -94.3 80.86 3.98 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.93 85.08 4.91 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 169.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -4.94 -88.82 0.0 OUTLIER Glycine 0 CA--C 1.525 0.659 1 C-N-CA 130.997 4.141 . . . . 0.0 116.033 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.49 -19.78 66.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.861 0.83 . . . . 0.0 112.138 -172.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -85.0 -111.63 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 166.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.38 -157.22 0.57 Allowed 'General case' 0 C--O 1.239 0.534 0 CA-C-N 120.276 1.398 . . . . 0.0 110.661 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -106.5 65.05 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 130.14 3.376 . . . . 0.0 111.087 -167.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -78.59 167.08 21.79 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 120.753 -1.217 . . . . 0.0 110.653 -170.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.5 tp -132.09 133.52 44.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.273 1.029 . . . . 0.0 108.946 -166.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.2 mm -135.61 124.81 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -166.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -138.53 174.07 10.92 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.754 1.264 . . . . 0.0 111.647 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.48 167.62 10.72 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.242 1.017 . . . . 0.0 109.798 164.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.525 0 C-N-CA 127.186 2.195 . . . . 0.0 110.295 178.523 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 122.782 1.277 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.2 -39.84 78.39 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 119.127 -2.233 . . . . 0.0 111.099 -175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.02 82.44 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -67.58 -37.61 82.85 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.8 mt -73.23 -50.75 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.81 1.644 . . . . 0.0 108.548 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.66 -46.54 89.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.15 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -71.26 -27.65 63.59 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.142 -0.974 . . . . 0.0 109.433 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.74 -41.32 42.85 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 126.28 1.895 . . . . 0.0 109.807 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -116.39 13.12 15.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.197 0.599 . . . . 0.0 111.208 -164.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -45.81 -25.65 0.54 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.745 2.418 . . . . 0.0 112.99 163.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.05 -12.08 59.96 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.755 2.422 . . . . 0.0 111.42 -174.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.51 169.9 12.74 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 127.257 2.223 . . . . 0.0 106.193 -174.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -76.42 176.66 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 CA-C-N 121.134 1.441 . . . . 0.0 109.503 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.5 p -129.64 165.8 21.06 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.254 164.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -133.47 158.76 42.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.763 1.225 . . . . 0.0 107.87 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.59 137.25 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -122.28 173.28 7.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 122.86 1.315 . . . . 0.0 110.956 163.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.46 37.14 0.33 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 127.833 2.453 . . . . 0.0 113.527 -163.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.7 -167.85 10.18 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -165.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.22 145.31 1.65 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -73.62 152.05 40.65 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.558 -0.966 . . . . 0.0 112.467 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.4 t -158.76 133.08 5.24 Favored Pre-proline 0 C--N 1.343 0.302 0 CA-C-O 117.693 -1.146 . . . . 0.0 109.394 -163.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -55.76 141.19 85.06 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.666 2.91 . . . . 0.0 112.058 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.364 0.4 OUTLIER -48.07 -36.38 12.99 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.779 165.166 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.423 ' HA ' ' CD1' ' A' ' 54' ' ' ILE 0.259 12.1 p -71.41 -15.44 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.464 1.506 . . . . 0.0 114.617 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -98.44 -44.04 6.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 118.785 0.72 . . . . 0.0 109.284 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -71.87 -25.94 62.15 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 116.887 -1.53 . . . . 0.0 109.133 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.32 -25.32 29.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 120.955 1.707 . . . . 0.0 110.469 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.07 -45.88 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.63 -45.36 90.61 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.66 1.584 . . . . 0.0 107.994 175.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.73 -18.61 53.99 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.139 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.92 33.87 7.13 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 119.071 0.851 . . . . 0.0 111.171 164.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.25 -49.31 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.42 107.44 2.76 Favored Pre-proline 0 C--N 1.345 0.399 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 172.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.55 -15.73 8.42 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.539 2.159 . . . . 0.0 113.04 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.8 t -82.65 119.05 23.8 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -56.04 -36.13 67.66 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 120.662 1.574 . . . . 0.0 114.459 -165.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.83 -56.17 24.39 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.288 1.404 . . . . 0.0 109.118 170.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -55.08 -49.06 72.62 Favored 'General case' 0 C--O 1.207 -1.179 0 O-C-N 124.218 0.949 . . . . 0.0 108.442 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.99 -58.72 4.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.336 1.454 . . . . 0.0 111.198 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -65.66 -26.57 67.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.672 -174.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -89.59 -29.11 19.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 120.094 1.315 . . . . 0.0 112.532 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.62 -20.08 65.39 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.771 1.629 . . . . 0.0 109.76 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.423 ' CD1' ' HA ' ' A' ' 35' ' ' VAL . 64.9 mt -82.99 -66.5 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-O 116.251 -1.833 . . . . 0.0 109.394 163.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -64.96 -5.85 7.13 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 119.864 1.211 . . . . 0.0 112.663 -164.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 58' ' ' ALA . 2.9 m120 -76.62 134.99 39.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.244 1.021 . . . . 0.0 113.166 164.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.27 34.3 0.66 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.145 1.831 . . . . 0.0 111.773 164.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -118.66 4.4 11.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.58 2.352 . . . . 0.0 111.161 167.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.328 0.0 OUTLIER -102.46 100.4 10.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 124.378 2.037 . . . . 0.0 106.585 163.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -88.94 98.98 12.05 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 112.928 -1.942 . . . . 0.0 107.631 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.3 t -79.36 135.16 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.461 HD22 ' CD2' ' A' ' 79' ' ' LEU . 1.6 m120 55.59 27.5 10.54 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.915 0.864 . . . . 0.0 109.87 -174.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.75 9.27 86.97 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 117.498 -1.723 . . . . 0.0 113.256 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 133.46 38.29 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.997 2.399 . . . . 0.0 109.411 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 109.75 0.65 Allowed 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 127.497 2.319 . . . . 0.0 109.403 -166.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.6 mt -145.28 110.82 5.35 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.75 27.76 8.71 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.997 2.519 . . . . 0.0 112.793 -163.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -142.18 156.91 45.36 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.939 -1.101 . . . . 0.0 113.76 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 p -69.63 -39.44 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.139 2.176 . . . . 0.0 110.882 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.2 -12.77 72.66 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 170.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.31 -58.35 3.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 116.267 -1.825 . . . . 0.0 109.991 167.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -139.66 137.78 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 121.601 2.001 . . . . 0.0 114.049 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.6 mt -108.05 -95.06 0.39 Allowed 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 163.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.9 -176.66 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 119.941 -1.724 . . . . 0.0 115.627 -164.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.44 -54.74 42.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.808 0.843 . . . . 0.0 111.04 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.63 -4.07 21.5 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.797 1.239 . . . . 0.0 113.329 175.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -88.53 -23.89 23.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.322 166.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.42 -65.12 1.07 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -171.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.461 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.88 -176.68 4.74 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.523 1.129 . . . . 0.0 108.262 174.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -54.3 -21.57 9.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.128 0.971 . . . . 0.0 112.362 170.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.73 85.53 0.81 Allowed Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 125.647 1.594 . . . . 0.0 112.829 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.2 mtp85 -141.28 -67.03 0.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 163.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -128.27 -168.11 1.86 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.786 1.234 . . . . 0.0 109.795 -170.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.16 130.88 12.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 163.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.78 136.59 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.7 mm -127.53 94.96 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 124.283 1.033 . . . . 0.0 108.316 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -91.28 83.26 5.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -78.89 99.16 6.65 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 170.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.71 159.76 4.26 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.0 tttt 71.98 -48.29 0.68 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.194 2.198 . . . . 0.0 109.686 -164.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -88.58 -153.65 0.26 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 164.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.53 -158.13 0.74 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 124.955 1.302 . . . . 0.0 110.912 -167.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -95.22 93.99 7.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.111 2.565 . . . . 0.0 107.886 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -78.55 164.92 24.28 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 120.478 -1.389 . . . . 0.0 107.779 168.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.3 tt -133.06 123.88 26.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 mm -116.49 132.55 65.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -136.5 179.92 6.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 122.322 1.058 . . . . 0.0 111.477 171.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.5 165.11 14.32 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 123.737 0.815 . . . . 0.0 111.328 165.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.369 0 C-N-CA 128.392 2.677 . . . . 0.0 110.075 -177.197 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.89 -49.27 47.71 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.226 -0.921 . . . . 0.0 111.901 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.77 74.44 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -39.37 65.26 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.6 mt -66.88 -51.53 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 124.755 1.222 . . . . 0.0 109.554 174.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -53.14 -59.11 4.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.829 0.74 . . . . 0.0 110.307 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -76.35 -19.37 58.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.698 -174.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.89 -40.47 74.42 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.431 ' C ' ' H ' ' A' ' 21' ' ' ASP . 58.6 m-85 -119.27 6.11 11.2 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -164.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -58.82 15.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.808 2.043 . . . . 0.0 114.963 163.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 19' ' ' PHE . 19.6 t70 -78.49 -25.08 45.61 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.71 -1.244 . . . . 0.0 109.802 164.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.94 160.22 62.5 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.395 1.878 . . . . 0.0 107.142 -176.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.23 179.21 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.086 1.857 . . . . 0.0 110.569 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.1 p -121.45 -178.37 3.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.325 1.05 . . . . 0.0 110.561 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -140.8 154.37 46.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 164.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.23 124.97 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 C-N-CA 124.954 1.302 . . . . 0.0 108.455 175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.22 170.99 7.78 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 122.556 1.17 . . . . 0.0 111.288 171.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -79.17 8.0 6.61 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 126.69 1.996 . . . . 0.0 113.865 -163.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.6 -179.52 49.07 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.698 1.618 . . . . 0.0 112.774 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.38 139.05 3.07 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -163.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -66.62 136.62 55.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.174 0.987 . . . . 0.0 111.333 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.7 t -144.93 136.54 12.79 Favored Pre-proline 0 C--O 1.225 -0.198 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -163.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.51 140.6 35.43 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 124.903 3.735 . . . . 0.0 114.816 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.254 0.0 OUTLIER -47.61 -45.02 27.18 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.821 0.819 . . . . 0.0 111.519 164.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.49 8.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 128.047 2.539 . . . . 0.0 113.548 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -120.55 -45.47 2.41 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.58 1.152 . . . . 0.0 108.089 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.92 -24.89 64.34 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 120.015 -1.678 . . . . 0.0 108.959 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -33.83 60.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.552 1.524 . . . . 0.0 110.296 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.97 -46.27 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 127.005 2.122 . . . . 0.0 108.536 -173.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 m -62.82 -45.65 91.64 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 128.34 2.656 . . . . 0.0 109.098 169.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.42 -11.91 59.98 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.409 1.004 . . . . 0.0 112.647 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.43 27.09 23.62 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 119.222 0.919 . . . . 0.0 112.096 167.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.99 -42.66 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.1 m -156.17 101.78 2.09 Favored Pre-proline 0 C--N 1.347 0.484 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 165.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.28 -14.69 13.09 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.379 2.053 . . . . 0.0 113.32 -171.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.8 t -81.87 108.62 15.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -50.1 -35.28 24.86 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -164.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.29 -47.35 67.89 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 121.137 1.789 . . . . 0.0 110.444 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -50.0 72.49 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.91 -48.0 60.71 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.946 1.699 . . . . 0.0 111.48 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -61.68 -40.79 96.2 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 115.961 -1.971 . . . . 0.0 110.478 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -25.11 48.69 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 116.332 -2.147 . . . . 0.0 112.861 173.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -18.79 65.56 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 117.666 -1.159 . . . . 0.0 112.093 174.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.38 -51.64 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 116.633 -1.651 . . . . 0.0 110.707 164.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -68.82 -13.48 62.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 120.821 1.646 . . . . 0.0 110.627 -164.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.44 ' C ' ' H ' ' A' ' 58' ' ' ALA . 9.5 m120 -85.76 132.58 34.1 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 118.317 0.508 . . . . 0.0 111.143 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.68 17.29 0.25 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.208 0.909 . . . . 0.0 114.129 169.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -94.17 -1.39 54.24 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 119.039 1.419 . . . . 0.0 111.006 164.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.286 0.0 OUTLIER -88.8 89.25 3.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 163.093 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -78.69 103.24 8.5 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 166.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.4 137.14 22.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 102.111 -3.292 . . . . 0.0 102.111 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.534 HD22 ' CD2' ' A' ' 79' ' ' LEU . 12.8 m-20 75.81 -54.43 0.62 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 127.192 2.197 . . . . 0.0 109.645 174.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.76 5.04 0.03 OUTLIER Glycine 0 CA--C 1.536 1.352 1 C-N-CA 131.969 4.604 . . . . 0.0 111.577 174.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -122.33 128.3 50.86 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.682 1.993 . . . . 0.0 108.362 -169.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 106.8 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.319 1.848 . . . . 0.0 109.145 -177.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.3 mt -144.23 110.51 5.49 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.421 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -121.63 16.51 11.16 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.507 2.323 . . . . 0.0 112.639 -169.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -118.98 141.08 48.99 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.468 1.507 . . . . 0.0 109.231 -172.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.47 -42.8 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.216 1.406 . . . . 0.0 110.39 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.9 -8.48 73.32 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.61 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.17 -45.06 12.39 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.736 0.768 . . . . 0.0 109.466 170.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.99 127.76 21.01 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-N 120.298 1.408 . . . . 0.0 112.657 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.7 mt -116.41 -92.64 0.51 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 102.241 -3.244 . . . . 0.0 102.241 163.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.66 -175.48 2.81 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.782 -1.199 . . . . 0.0 113.502 -175.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.45 -43.2 79.29 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -82.82 -6.0 59.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.81 1.186 . . . . 0.0 111.078 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -81.58 -11.39 59.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 121.768 -0.583 . . . . 0.0 109.61 165.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.2 -71.42 0.74 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.646 1.112 . . . . 0.0 109.505 -173.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.534 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.9 -168.4 2.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.884 2.473 . . . . 0.0 109.271 176.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -53.0 -9.88 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.396 1.878 . . . . 0.0 115.644 166.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.67 71.22 1.0 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.64 1.114 . . . . 0.0 113.021 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -141.35 -64.85 0.44 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.17 0.485 . . . . 0.0 110.614 173.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -133.82 -169.06 2.23 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.559 1.544 . . . . 0.0 107.953 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -158.08 155.79 29.87 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 164.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.72 150.61 23.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.9 mm -135.0 97.64 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -170.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -99.49 81.14 2.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.62 117.54 19.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 171.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.85 -49.68 12.6 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.038 1.304 . . . . 0.0 111.837 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -1.04 0.79 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.56 1.544 . . . . 0.0 115.001 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -146.92 -95.86 0.09 Allowed 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 121.448 1.931 . . . . 0.0 109.176 164.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.411 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -153.93 -163.1 1.56 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 120.53 1.514 . . . . 0.0 109.513 -171.275 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -107.41 75.64 1.03 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 127.949 2.499 . . . . 0.0 109.969 -170.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -78.45 165.05 24.23 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.965 -1.085 . . . . 0.0 109.568 -172.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.8 tp -115.63 134.67 54.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.111 1.365 . . . . 0.0 107.987 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.7 mm -128.62 133.5 66.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -174.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -139.25 174.49 10.46 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.948 1.356 . . . . 0.0 111.432 167.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.57 162.52 17.87 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.328 1.051 . . . . 0.0 110.199 164.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.408 0 C-N-CA 129.453 3.101 . . . . 0.0 108.276 175.887 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.223 -0.34 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.36 67.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 120.609 -1.307 . . . . 0.0 112.106 -169.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.63 76.27 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.132 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -74.4 -24.2 59.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.597 0.759 . . . . 0.0 110.251 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 mt -77.96 -57.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 125.732 1.613 . . . . 0.0 107.629 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -52.82 -45.34 67.25 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.93 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -91.19 -19.06 23.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.573 0.749 . . . . 0.0 111.346 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.51 -37.79 69.01 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 170.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.431 ' CD2' HG23 ' A' ' 85' ' ' VAL . 58.5 m-85 -120.61 15.45 11.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 119.581 -0.847 . . . . 0.0 110.497 -164.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -0.33 0.1 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.509 1.924 . . . . 0.0 115.297 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.82 -20.92 48.55 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.934 -1.104 . . . . 0.0 111.219 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.2 160.08 61.68 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.58 176.88 8.67 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 CA-C-N 120.626 1.259 . . . . 0.0 109.926 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.5 p -112.12 165.62 11.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.716 172.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -130.04 157.96 40.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.692 2.397 . . . . 0.0 106.956 169.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 4.1 p -135.21 136.12 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -127.42 -172.87 2.76 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 119.503 1.047 . . . . 0.0 112.533 163.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 6.78 8.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.577 1.551 . . . . 0.0 113.983 -163.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.54 -173.1 34.1 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.082 1.325 . . . . 0.0 111.26 -170.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.84 135.57 1.65 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.26 134.55 39.33 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.543 0.672 . . . . 0.0 112.692 -167.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 t -157.47 131.66 5.04 Favored Pre-proline 0 CA--C 1.515 -0.384 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -166.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.64 150.9 40.73 Favored 'Trans proline' 0 N--CA 1.437 -1.84 0 C-N-CA 122.529 2.153 . . . . 0.0 111.403 -167.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.299 0.0 OUTLIER -44.01 -42.09 5.83 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.568 174.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -79.76 -5.59 8.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 126.907 2.083 . . . . 0.0 115.342 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -105.06 -35.61 7.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.22 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.83 -21.03 57.69 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 120.914 1.688 . . . . 0.0 109.298 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -30.37 51.69 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 120.302 1.41 . . . . 0.0 110.27 173.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -74.35 -47.86 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -173.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -47.68 84.48 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.627 1.971 . . . . 0.0 109.482 171.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.82 -10.81 59.91 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.353 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.39 33.95 18.32 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 119.111 0.869 . . . . 0.0 111.068 166.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.56 -51.37 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 172.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -151.56 105.78 2.91 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 169.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -84.31 -12.67 7.84 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.811 2.341 . . . . 0.0 113.642 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -87.57 115.8 25.25 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -52.01 -34.85 44.71 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -165.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -62.95 -54.7 34.31 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.948 1.704 . . . . 0.0 109.039 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -48.31 78.86 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 117.172 -1.394 . . . . 0.0 108.482 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.31 -58.68 4.23 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 125.319 1.448 . . . . 0.0 111.104 175.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -67.35 -27.74 67.37 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 117.332 -1.318 . . . . 0.0 110.616 -170.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.07 -34.23 26.23 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 120.302 1.41 . . . . 0.0 112.234 172.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.65 -16.82 63.38 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.511 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -92.26 -53.59 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 116.054 -1.927 . . . . 0.0 111.728 166.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -71.61 -5.11 31.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 120.941 1.7 . . . . 0.0 112.076 -171.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.1 m120 -80.62 136.48 36.23 Favored 'General case' 0 N--CA 1.437 -1.118 0 O-C-N 121.373 -0.829 . . . . 0.0 112.462 173.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.72 33.87 0.86 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 124.486 1.041 . . . . 0.0 112.141 167.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -121.39 0.39 10.01 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 126.901 2.08 . . . . 0.0 111.509 168.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.315 0.0 OUTLIER -91.99 98.73 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 163.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -88.72 105.22 17.55 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.333 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 t -88.43 130.34 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.673 HD22 ' CD2' ' A' ' 79' ' ' LEU . 5.9 m-80 57.37 18.09 4.17 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.565 0.698 . . . . 0.0 111.577 -173.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.13 11.71 78.01 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 120.599 -1.313 . . . . 0.0 113.5 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -119.37 123.27 43.75 Favored 'General case' 0 C--O 1.228 -0.062 0 CA-C-N 119.735 1.768 . . . . 0.0 108.421 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 112.1 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.138 0.975 . . . . 0.0 108.854 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.8 mt -144.89 108.26 4.6 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -174.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.09 31.49 4.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 126.718 2.007 . . . . 0.0 113.891 -163.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -142.38 157.27 44.97 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.6 -0.687 . . . . 0.0 111.182 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.5 p -62.72 137.47 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 163.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.33 -8.41 46.97 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.645 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.17 -53.68 7.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 163.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -139.58 145.0 27.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 119.244 0.929 . . . . 0.0 110.137 170.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.5 mt -124.15 -91.32 0.55 Allowed 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 163.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.89 -175.56 3.0 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.729 -1.232 . . . . 0.0 113.548 -174.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 98' ' ' TYR . . . -58.57 -41.85 86.65 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.876 175.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -76.3 -7.47 55.0 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 123.727 0.642 . . . . 0.0 110.981 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -92.99 -4.8 51.99 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.927 1.291 . . . . 0.0 110.393 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.34 -65.17 1.18 Allowed 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.953 -1.717 . . . . 0.0 109.498 175.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.673 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.14 -172.68 3.57 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.475 1.51 . . . . 0.0 109.501 170.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -50.43 -17.87 0.55 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.712 2.005 . . . . 0.0 113.918 166.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.36 80.4 1.33 Allowed Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 125.435 1.493 . . . . 0.0 111.507 -174.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -143.62 -63.58 0.39 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 122.802 0.441 . . . . 0.0 111.548 163.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -131.46 -174.11 3.31 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.99 2.116 . . . . 0.0 108.172 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -160.73 164.12 31.84 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.839 1.656 . . . . 0.0 107.186 164.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG23 ' CD2' ' A' ' 19' ' ' PHE . 72.1 t -134.22 143.97 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 O-C-N 120.59 -1.319 . . . . 0.0 107.516 176.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.4 mm -125.06 98.38 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 127.774 2.429 . . . . 0.0 107.221 -172.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -96.13 84.62 3.83 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.401 ' HG3' ' H ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -82.14 114.08 20.43 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.77 1.78 0.7 Allowed Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 34.0 tptt -69.4 -46.23 67.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.58 1.69 . . . . 0.0 109.395 166.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -125.43 -90.27 0.55 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.801 1.24 . . . . 0.0 108.844 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.428 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.31 -159.88 1.02 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-N 119.671 1.123 . . . . 0.0 109.197 -163.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.428 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -99.46 83.84 2.88 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 130.826 3.65 . . . . 0.0 109.578 -176.166 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -78.46 158.97 28.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.131 -1.804 . . . . 0.0 106.131 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.9 tt -126.37 129.9 49.7 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -163.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.5 mm -120.82 122.53 68.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -168.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 11.5 ptt85 -128.63 171.89 11.73 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 124.044 1.878 . . . . 0.0 110.294 176.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.508 ' CE1' ' HB1' ' A' ' 75' ' ' ALA . 6.0 m-85 -143.56 158.47 43.63 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -164.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.796 0 C-N-CA 128.487 2.715 . . . . 0.0 111.127 169.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.72 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.44 -49.71 70.43 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 119.841 -1.787 . . . . 0.0 112.039 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.23 73.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.631 0.651 . . . . 0.0 111.033 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.31 -38.45 71.73 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 125.261 1.425 . . . . 0.0 109.158 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.4 mt -69.3 -45.96 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 126.518 1.927 . . . . 0.0 106.61 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -54.28 -57.91 9.41 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.463 175.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -71.85 -29.68 64.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.401 1.0 . . . . 0.0 109.94 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.54 -29.6 72.94 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 126.335 1.921 . . . . 0.0 110.414 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -117.11 -1.82 11.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.027 -173.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -59.02 -0.53 0.12 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.8 -13.35 59.86 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.844 1.202 . . . . 0.0 111.243 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 p -127.39 157.46 72.69 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 128.598 2.759 . . . . 0.0 105.785 167.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -87.08 176.66 4.29 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 121.313 1.342 . . . . 0.0 109.801 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.4 p -106.36 177.74 4.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.254 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -123.6 157.29 34.06 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 164.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 p -136.94 133.92 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 124.923 1.289 . . . . 0.0 108.347 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -123.72 -177.56 3.77 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.115 0.483 . . . . 0.0 111.743 163.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.78 39.43 0.95 Allowed 'General case' 0 C--N 1.318 -0.768 0 O-C-N 120.485 -1.384 . . . . 0.0 113.635 -163.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.67 -175.58 0.86 Allowed Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.903 -1.123 . . . . 0.0 112.788 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.18 131.83 0.23 Allowed Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.49 147.71 52.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -167.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 t -152.88 136.59 10.13 Favored Pre-proline 0 C--O 1.222 -0.382 0 C-N-CA 124.743 1.217 . . . . 0.0 108.345 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.451 ' HA ' ' CD2' ' A' ' 73' ' ' LEU . 61.3 Cg_endo -65.4 145.38 82.93 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.348 2.699 . . . . 0.0 111.394 -173.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.375 0.1 OUTLIER -43.22 -39.19 2.85 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 170.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.24 -13.0 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.963 1.305 . . . . 0.0 113.992 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -100.1 -32.79 10.75 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 120.119 1.327 . . . . 0.0 109.444 167.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.48 -30.79 64.85 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 121.829 2.104 . . . . 0.0 108.237 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.9 -31.4 59.18 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 120.658 1.572 . . . . 0.0 110.076 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.27 -46.09 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 126.402 1.881 . . . . 0.0 107.265 -176.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.2 t -65.69 -41.86 91.9 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 128.145 2.578 . . . . 0.0 107.776 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.77 -18.14 48.62 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.74 29.86 9.54 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 118.531 0.605 . . . . 0.0 111.776 168.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.81 -47.06 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 175.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.7 m -155.34 113.65 2.27 Favored Pre-proline 0 CA--C 1.517 -0.299 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.77 -17.17 7.29 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.41 2.074 . . . . 0.0 113.532 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.63 116.17 23.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -167.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -36.96 66.79 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -163.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -69.06 -42.71 75.91 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 120.15 1.341 . . . . 0.0 110.197 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -61.65 -51.99 66.18 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.52 -51.53 46.75 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.49 1.916 . . . . 0.0 110.0 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -53.56 -48.48 69.1 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.583 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -78.35 -32.11 48.91 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.69 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -62.78 -17.71 61.5 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.746 1.218 . . . . 0.0 111.001 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 mp -90.07 -55.92 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 117.193 -1.384 . . . . 0.0 112.599 169.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -73.18 -6.74 47.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.567 1.076 . . . . 0.0 111.416 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.2 m-80 -78.32 138.5 38.6 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.367 1.08 . . . . 0.0 112.041 169.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.31 46.07 2.43 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.055 164.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -126.26 11.01 7.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.979 2.912 . . . . 0.0 110.456 165.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.332 0.0 OUTLIER -111.25 91.9 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 162.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -82.85 122.1 27.8 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.02 -1.9 . . . . 0.0 107.618 174.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.519 ' C ' ' H ' ' A' ' 63' ' ' GLY . 25.1 t -115.28 135.83 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.11 -16.88 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.795 2.038 . . . . 0.0 114.205 -174.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 61' ' ' VAL . . . 152.19 -7.24 0.54 Allowed Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 126.683 2.087 . . . . 0.0 113.328 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.99 153.68 41.04 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 119.876 1.838 . . . . 0.0 110.651 -163.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.16 105.45 2.93 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.168 1.787 . . . . 0.0 110.066 -164.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 71.5 mt -134.36 102.73 5.45 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -173.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.482 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -128.86 38.61 3.92 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 128.151 2.58 . . . . 0.0 111.656 -163.685 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -139.66 146.83 40.17 Favored 'General case' 0 N--CA 1.457 -0.099 0 O-C-N 121.725 -0.609 . . . . 0.0 111.135 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.08 -37.01 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.382 0.673 . . . . 0.0 110.615 173.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.14 -12.8 83.24 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.418 -0.801 . . . . 0.0 112.779 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.5 -54.51 6.61 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.063 0.931 . . . . 0.0 109.177 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.1 mt -145.14 130.54 13.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 123.747 0.819 . . . . 0.0 109.367 -167.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.451 ' CD2' ' HA ' ' A' ' 33' ' ' PRO . 92.7 mt -122.26 -70.5 0.77 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 168.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.13 178.67 4.54 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.288 -1.507 . . . . 0.0 112.205 -177.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.52 -34.22 72.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -81.93 -12.17 58.53 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.535 0.607 . . . . 0.0 111.645 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -86.42 -1.24 57.39 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.219 1.408 . . . . 0.0 110.056 168.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.53 -79.1 0.58 Allowed 'General case' 0 C--N 1.341 0.216 0 O-C-N 120.109 -1.62 . . . . 0.0 106.875 175.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.59 -171.7 3.73 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 128.848 2.859 . . . . 0.0 108.735 176.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -48.99 -11.7 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 129.183 2.993 . . . . 0.0 115.664 163.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.21 82.35 1.59 Allowed Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 125.281 1.42 . . . . 0.0 111.728 -168.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.94 -81.56 0.34 Allowed 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 164.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -127.94 -162.19 1.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.429 1.491 . . . . 0.0 108.866 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -157.35 139.0 14.01 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 120.291 -1.506 . . . . 0.0 108.041 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.84 113.52 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -170.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.8 mm -95.72 139.71 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -128.12 82.89 2.11 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 163.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.425 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 1.3 tpm_? -79.0 95.12 5.41 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 172.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.25 -48.57 5.57 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 -171.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.425 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 20.5 tptm -68.21 -21.6 64.85 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.354 1.462 . . . . 0.0 113.859 -176.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -103.95 -98.67 0.31 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.4 OUTLIER -159.3 -162.64 1.08 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 123.001 1.381 . . . . 0.0 108.806 171.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.418 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 6.0 m-30 -78.48 147.23 34.0 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 163.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -144.15 174.05 11.21 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 128.646 2.778 . . . . 0.0 108.389 171.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.0 tp -135.33 137.03 42.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.187 1.795 . . . . 0.0 107.639 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 mm -130.69 131.85 64.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -173.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.5 ptt85 -139.22 173.1 11.91 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 123.46 1.6 . . . . 0.0 110.539 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.01 169.9 8.74 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.851 164.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.315 0 C-N-CA 128.491 2.716 . . . . 0.0 109.903 176.43 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.6 p . . . . . 0 C--O 1.215 -0.746 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.47 82.82 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 120.107 -1.62 . . . . 0.0 110.495 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.96 94.84 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 122.065 0.936 . . . . 0.0 109.693 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -75.32 -19.99 59.33 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.38 1.072 . . . . 0.0 110.268 -175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.0 mt -81.7 -55.47 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 127.569 2.348 . . . . 0.0 106.927 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -56.19 -44.14 79.12 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.17 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -31.17 50.23 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.67 0.668 . . . . 0.0 109.345 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.45 -35.5 81.85 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.477 ' C ' ' H ' ' A' ' 21' ' ' ASP . 58.5 m-85 -119.18 17.54 13.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.461 1.105 . . . . 0.0 110.077 -168.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -56.62 5.37 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.906 2.883 . . . . 0.0 113.468 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -78.48 -27.66 46.3 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.728 2.411 . . . . 0.0 110.221 175.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.95 166.65 27.73 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 126.454 1.902 . . . . 0.0 107.406 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.02 173.43 13.63 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 167.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.4 p -106.46 177.77 4.76 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.767 167.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -123.47 152.98 41.13 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 163.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.68 134.01 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -119.92 -178.08 3.56 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.487 0.66 . . . . 0.0 111.637 164.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -82.34 5.68 19.45 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.553 1.941 . . . . 0.0 115.624 -163.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.98 -175.16 20.47 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.908 1.718 . . . . 0.0 110.176 -165.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.78 155.41 28.7 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.349 11.2 p-10 -91.75 143.81 26.15 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.628 1.171 . . . . 0.0 111.551 163.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.2 t -159.48 136.33 6.71 Favored Pre-proline 0 C--O 1.225 -0.188 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -163.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.49 147.3 57.87 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.86 1.707 . . . . 0.0 112.068 -172.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.402 0.4 OUTLIER -49.59 -26.6 3.69 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.435 1.094 . . . . 0.0 113.899 177.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.18 -61.5 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.926 1.239 . . . . 0.0 111.249 168.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -66.16 -36.68 83.75 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.083 0.856 . . . . 0.0 109.528 -171.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 pp -80.52 -24.4 39.39 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 116.598 -1.667 . . . . 0.0 110.034 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.31 -37.81 60.59 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 121.833 2.106 . . . . 0.0 109.82 176.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 t -73.82 -43.35 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.3 t -63.7 -32.52 74.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.941 0.896 . . . . 0.0 109.936 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.33 -17.09 57.02 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.602 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.27 27.68 39.22 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -44.71 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 176.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -157.07 91.46 2.42 Favored Pre-proline 0 C--N 1.348 0.541 0 CA-C-N 120.571 1.532 . . . . 0.0 106.968 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.72 -15.45 21.48 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.476 2.118 . . . . 0.0 112.588 -164.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.59 105.03 17.06 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 -174.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -53.27 -22.59 7.24 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -166.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -60.36 3.73 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 120.314 1.415 . . . . 0.0 110.719 168.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -49.14 66.82 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 125.983 1.713 . . . . 0.0 107.058 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.59 -58.43 4.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.391 1.057 . . . . 0.0 111.566 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.2 mtt-85 -65.81 -24.28 66.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 115.688 -2.101 . . . . 0.0 112.49 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -77.87 -39.9 41.81 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 121.442 1.928 . . . . 0.0 111.746 167.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.62 -25.03 52.0 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.995 0.918 . . . . 0.0 111.23 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -83.59 -57.47 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 116.007 -1.949 . . . . 0.0 109.117 171.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -77.69 -5.77 51.63 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 124.879 1.362 . . . . 0.0 113.009 -163.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 58' ' ' ALA . 7.9 m120 -81.01 141.34 34.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.591 163.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 10.03 0.07 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.492 1.52 . . . . 0.0 113.341 163.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -78.34 -11.07 59.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.286 1.834 . . . . 0.0 110.085 172.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.422 ' HB ' ' HD3' ' A' ' 88' ' ' ARG 0.357 0.0 OUTLIER -102.74 92.77 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 124.855 2.264 . . . . 0.0 109.73 174.251 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -79.6 99.12 7.18 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 111.44 -2.618 . . . . 0.0 107.89 173.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 89.3 t -84.07 133.34 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.649 HD22 ' CD2' ' A' ' 79' ' ' LEU . 1.0 OUTLIER 60.92 14.76 5.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.699 0.4 . . . . 0.0 111.594 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.15 -1.84 57.72 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.083 1.325 . . . . 0.0 113.203 -174.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -131.73 123.63 28.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.791 1.795 . . . . 0.0 109.546 -164.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.46 111.25 0.35 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 127.836 2.454 . . . . 0.0 109.788 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.9 mt -145.87 102.25 3.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.06 40.7 2.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.478 1.911 . . . . 0.0 110.95 -165.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -148.23 153.49 38.8 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.282 -0.886 . . . . 0.0 111.866 -168.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.87 -41.43 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 126.518 1.927 . . . . 0.0 109.376 169.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.41 -0.99 50.01 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.902 -0.388 . . . . 0.0 112.686 172.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.81 -61.82 1.55 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.905 -1.045 . . . . 0.0 111.672 163.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.46 132.47 45.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 120.13 1.332 . . . . 0.0 113.149 -176.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.7 mt -99.6 -89.78 0.32 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 163.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 p -112.57 -168.8 1.37 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -173.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.26 -56.24 23.44 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.296 1.439 . . . . 0.0 114.577 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.26 -14.57 63.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.519 0.599 . . . . 0.0 111.781 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -80.8 -15.01 57.52 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 -82.09 0.54 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -178.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.649 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -89.91 174.47 7.66 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.568 1.547 . . . . 0.0 108.914 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -25.65 -51.12 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.285 3.034 . . . . 0.0 115.238 173.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.74 64.32 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.0 mmt-85 -140.82 -82.8 0.23 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.826 0.813 . . . . 0.0 109.727 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.409 ' H ' HD11 ' A' ' 79' ' ' LEU . 12.1 m-85 -130.29 -161.51 1.13 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.284 1.434 . . . . 0.0 110.361 -164.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.1 120.59 2.6 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.378 1.871 . . . . 0.0 108.899 167.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.3 t -78.95 134.04 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 173.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.4 mm -120.26 98.66 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 126.339 1.856 . . . . 0.0 106.274 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -92.84 82.25 4.69 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 171.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.422 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 15.8 tpp180 -84.04 96.24 8.82 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.274 2.63 . . . . 0.0 105.68 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.97 -24.16 33.66 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.395 0.521 . . . . 0.0 113.346 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -32.26 68.69 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.364 1.082 . . . . 0.0 112.638 171.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -135.96 -75.15 0.44 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.924 1.238 . . . . 0.0 112.037 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.54 -173.49 4.0 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 120.634 1.561 . . . . 0.0 109.465 -172.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -95.56 75.99 3.28 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.549 1.939 . . . . 0.0 110.393 174.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -78.57 171.62 14.85 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.947 -1.096 . . . . 0.0 110.567 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.2 tp -128.18 137.72 52.18 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.309 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.5 mm -131.28 132.92 62.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -175.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -149.36 174.31 12.58 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 123.387 1.565 . . . . 0.0 112.449 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.16 169.62 8.66 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.785 163.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.557 0 C-N-CA 130.948 3.699 . . . . 0.0 106.768 172.359 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.07 -53.0 52.43 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.634 1.174 . . . . 0.0 112.018 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.45 -26.85 66.6 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.1 0.25 . . . . 0.0 110.38 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.99 -43.67 70.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 mt -68.23 -53.47 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 118.2 -0.905 . . . . 0.0 108.82 177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -59.36 -50.58 73.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 118.236 -1.385 . . . . 0.0 111.695 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -69.36 -30.81 68.9 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 120.143 1.338 . . . . 0.0 109.065 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.21 -42.72 99.29 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.487 ' C ' ' H ' ' A' ' 21' ' ' ASP 0.258 40.6 m-85 -113.56 1.62 15.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -165.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -59.14 17.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.103 2.561 . . . . 0.0 114.258 163.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 19' ' ' PHE . 12.1 t0 -78.09 -37.5 46.31 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.284 2.233 . . . . 0.0 107.591 164.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.91 165.14 28.93 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.895 1.678 . . . . 0.0 106.6 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -80.68 177.84 7.63 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.45 2.1 . . . . 0.0 109.292 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 p -113.61 -177.93 3.25 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.837 -173.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -140.39 162.91 34.18 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.259 1.024 . . . . 0.0 108.541 167.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.3 p -143.34 138.43 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 125.294 1.438 . . . . 0.0 107.931 172.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.99 139.33 51.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.928 0.871 . . . . 0.0 109.558 163.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -81.35 73.11 8.4 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.89 153.97 24.11 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.209 -1.359 . . . . 0.0 113.182 -171.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.85 -157.15 15.65 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 163.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -60.97 140.32 57.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.582 0.353 . . . . 0.0 111.16 -174.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 t -155.06 137.1 9.76 Favored Pre-proline 0 C--O 1.223 -0.3 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -164.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -48.95 131.28 25.13 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.729 3.619 . . . . 0.0 112.559 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.33 0.7 OUTLIER -47.64 -36.27 10.67 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 168.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.23 -2.61 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.157 1.383 . . . . 0.0 113.605 -177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -98.85 -44.05 6.51 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 168.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.38 -20.73 56.88 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 116.499 -1.715 . . . . 0.0 109.944 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.4 -26.97 52.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 121.656 2.026 . . . . 0.0 110.777 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.68 -42.35 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 126.48 1.912 . . . . 0.0 106.862 -172.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.66 -48.91 77.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.185 2.194 . . . . 0.0 109.002 167.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.57 -15.96 57.96 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.74 -171.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.36 36.34 7.06 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 164.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.39 -56.37 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 102.423 -3.177 . . . . 0.0 102.423 171.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -150.75 103.91 3.04 Favored Pre-proline 0 C--N 1.342 0.259 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.66 -10.49 13.1 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.851 2.367 . . . . 0.0 113.7 -172.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.6 t -90.9 116.3 28.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -53.07 -36.1 60.29 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -54.18 48.97 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.16 1.345 . . . . 0.0 109.12 173.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -57.3 -52.41 65.45 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.79 -55.47 6.53 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.518 1.527 . . . . 0.0 111.127 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -58.18 -41.73 84.5 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.162 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.43 -37.95 68.47 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.633 1.106 . . . . 0.0 111.778 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.77 -15.27 27.84 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 126.274 1.829 . . . . 0.0 110.794 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.2 mt -117.03 -15.87 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 176.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -91.56 -5.94 53.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.675 1.58 . . . . 0.0 111.375 168.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -82.34 135.56 35.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 176.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.36 3.74 0.31 Allowed Glycine 0 CA--C 1.537 1.42 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.304 165.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -94.09 -0.71 55.2 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.683 1.593 . . . . 0.0 112.373 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.321 0.0 OUTLIER -102.87 96.92 5.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 124.913 2.292 . . . . 0.0 107.892 173.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -90.32 98.51 11.81 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 111.735 -2.484 . . . . 0.0 108.361 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.2 t -81.38 127.55 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 52.76 25.08 3.57 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.205 1.002 . . . . 0.0 112.062 -169.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.65 8.23 61.0 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.617 -1.657 . . . . 0.0 113.518 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -128.81 126.63 40.28 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.758 2.279 . . . . 0.0 109.288 -174.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.45 110.64 0.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.249 1.42 . . . . 0.0 108.781 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.7 mt -145.96 81.66 1.6 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -175.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.02 46.6 1.04 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.724 2.01 . . . . 0.0 112.088 -169.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -148.55 150.02 32.61 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.165 -1.584 . . . . 0.0 114.213 -174.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.4 p -63.29 -43.69 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 125.967 1.707 . . . . 0.0 111.852 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.38 -9.6 85.82 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 174.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.3 -56.32 4.43 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 116.215 -1.85 . . . . 0.0 108.263 167.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -138.31 138.41 43.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 CA-C-N 121.409 1.913 . . . . 0.0 113.726 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.6 mt -110.47 -88.02 0.51 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 101.777 -3.416 . . . . 0.0 101.777 163.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -102.49 -174.31 2.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 119.888 1.222 . . . . 0.0 113.689 -174.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB2' ' CE2' ' A' ' 98' ' ' TYR . . . -60.6 -47.13 87.59 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.63 -17.26 64.07 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.723 0.692 . . . . 0.0 111.87 175.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.61 -9.56 59.41 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.491 -0.756 . . . . 0.0 109.358 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.7 -75.07 0.63 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.334 0.97 . . . . 0.0 109.8 174.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.654 ' CD1' ' H ' ' A' ' 82' ' ' ARG . 1.3 pp -91.67 -170.17 2.51 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.787 1.235 . . . . 0.0 109.95 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -55.89 -26.82 49.09 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.51 69.81 0.16 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 127.374 2.416 . . . . 0.0 112.192 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.654 ' H ' ' CD1' ' A' ' 79' ' ' LEU . 90.3 mtt-85 -143.02 -45.63 0.3 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.513 ' H ' HD11 ' A' ' 79' ' ' LEU . 39.6 m-85 -157.94 -176.65 6.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.457 1.903 . . . . 0.0 109.348 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.49 124.4 9.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.259 -1.526 . . . . 0.0 107.014 163.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.23 147.59 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 166.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.5 mm -129.7 93.01 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 C-N-CA 125.504 1.522 . . . . 0.0 107.069 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -89.77 84.34 6.27 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.76 98.38 6.26 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 166.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -52.72 143.65 23.48 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 170.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.4 tptm 69.08 -0.31 2.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.226 2.61 . . . . 0.0 114.035 -169.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -117.47 -104.88 0.4 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 165.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.507 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.1 -171.91 4.04 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 119.831 1.196 . . . . 0.0 108.062 175.006 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.507 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 1.3 m-30 -114.1 82.88 1.78 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 126.743 2.017 . . . . 0.0 107.942 -173.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -79.45 169.14 18.5 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.386 0.674 . . . . 0.0 109.866 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.4 tp -130.74 135.73 48.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.244 1.018 . . . . 0.0 108.699 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 mt -134.53 134.69 54.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.504 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 9.4 ttt180 -135.24 -175.6 3.98 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 123.715 1.722 . . . . 0.0 112.067 171.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.504 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -122.73 158.59 29.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.188 165.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.399 0 C-N-CA 128.693 2.797 . . . . 0.0 107.921 172.469 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.336 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 tp -156.33 155.03 31.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -137.71 153.71 49.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.898 0.879 . . . . 0.0 108.757 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 p -149.6 162.72 39.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.359 1.464 . . . . 0.0 107.1 163.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.33 -153.8 25.48 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 107.444 -2.263 . . . . 0.0 107.444 -165.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.69 -66.61 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -91.7 26.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 122.358 1.075 . . . . 0.0 113.878 -168.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.61 -1.8 17.53 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -101.6 -20.32 15.09 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.687 1.595 . . . . 0.0 112.435 167.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -137.77 74.75 1.49 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.665 1.586 . . . . 0.0 110.742 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.51 -161.84 0.82 Allowed 'General case' 0 C--O 1.212 -0.909 0 O-C-N 120.811 -1.181 . . . . 0.0 111.557 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.95 -54.49 21.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 122.389 2.359 . . . . 0.0 112.162 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.43 -23.75 62.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.766 0.793 . . . . 0.0 109.394 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.58 -32.92 23.53 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -173.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 26.8 mt -71.49 -48.51 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 171.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -52.73 -58.52 6.6 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.63 0.65 . . . . 0.0 111.176 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -74.6 -24.71 58.92 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.642 1.11 . . . . 0.0 110.239 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.72 -40.26 97.29 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.551 ' C ' ' H ' ' A' ' 21' ' ' ASP . 45.9 m-85 -126.42 12.69 7.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -163.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.06 9.08 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 129.776 3.23 . . . . 0.0 113.68 163.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 19' ' ' PHE . 23.7 t70 -78.41 -38.22 42.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.752 2.421 . . . . 0.0 108.48 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.34 168.34 10.75 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.375 1.47 . . . . 0.0 109.58 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.92 178.11 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.13 1.887 . . . . 0.0 110.327 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 p -129.48 171.97 12.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.08 1.752 . . . . 0.0 109.874 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -137.67 166.56 23.66 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.863 1.265 . . . . 0.0 108.646 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 p -139.62 133.94 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.15 179.07 4.06 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 119.114 0.87 . . . . 0.0 109.961 163.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -78.75 15.82 0.99 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.536 1.534 . . . . 0.0 113.989 -163.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.8 -176.92 38.87 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -163.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.4 149.45 5.99 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -163.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.82 153.49 41.9 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.894 -0.768 . . . . 0.0 111.051 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -161.28 131.3 3.43 Favored Pre-proline 0 CA--C 1.509 -0.604 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -165.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -68.65 148.61 72.41 Favored 'Trans proline' 0 N--CA 1.436 -1.901 0 C-N-CA 121.69 1.593 . . . . 0.0 110.355 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.264 0.0 OUTLIER -44.85 -41.04 6.72 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.96 -1.473 . . . . 0.0 112.485 178.727 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.0 p -80.89 -7.75 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.92 2.088 . . . . 0.0 114.886 -175.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -104.53 -30.95 9.69 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 117.648 -1.168 . . . . 0.0 108.508 169.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -80.84 -20.2 42.92 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 121.593 1.997 . . . . 0.0 110.094 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -29.22 53.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 120.971 1.714 . . . . 0.0 109.866 173.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.63 -46.85 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.295 1.838 . . . . 0.0 107.033 -172.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.4 m -57.24 -52.55 64.88 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 129.939 3.295 . . . . 0.0 109.221 167.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.15 -10.27 59.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.028 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.51 29.69 15.81 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 122.842 1.246 . . . . 0.0 111.926 166.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mp -77.92 -51.05 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -156.85 99.47 2.02 Favored Pre-proline 0 C--N 1.344 0.364 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.75 -15.97 10.51 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.911 2.407 . . . . 0.0 113.617 -172.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.5 t -76.61 115.26 16.2 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -52.36 -37.61 56.63 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.183 1.356 . . . . 0.0 114.419 -164.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -54.44 43.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.099 0.863 . . . . 0.0 109.595 172.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -58.94 -47.77 83.88 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.736 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.27 -55.08 7.73 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.378 1.471 . . . . 0.0 110.383 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -65.0 -34.32 78.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 116.594 -1.67 . . . . 0.0 111.577 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.34 -36.36 58.28 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.777 1.626 . . . . 0.0 112.378 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -17.6 63.34 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.131 1.372 . . . . 0.0 110.543 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -92.32 -52.73 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 116.482 -1.723 . . . . 0.0 111.895 166.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -69.92 -6.5 33.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 120.488 1.495 . . . . 0.0 111.577 -170.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.515 ' C ' ' H ' ' A' ' 58' ' ' ALA . 4.3 m120 -79.9 139.77 36.98 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.2 26.29 0.44 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.025 1.774 . . . . 0.0 113.526 164.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -115.59 5.06 14.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.691 2.396 . . . . 0.0 111.403 170.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.319 0.0 OUTLIER -106.63 94.13 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 124.52 2.105 . . . . 0.0 106.065 163.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -79.99 106.73 12.23 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.026 168.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.7 t -83.81 124.61 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.622 HD21 ' HG3' ' A' ' 78' ' ' ARG . 63.4 m-20 53.5 27.39 6.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.96 -2.41 59.94 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.258 -1.301 . . . . 0.0 113.748 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -119.32 122.68 42.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.365 1.583 . . . . 0.0 107.151 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.46 109.0 0.49 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.1 mt -143.02 103.83 4.22 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 -171.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.461 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -127.91 45.3 2.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.867 2.067 . . . . 0.0 112.863 -163.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -154.42 154.12 32.7 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.975 0.91 . . . . 0.0 110.615 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 81.9 t -63.36 -38.19 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.785 1.234 . . . . 0.0 109.748 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.77 -2.21 60.49 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.83 -0.983 . . . . 0.0 113.061 171.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.33 -57.0 2.93 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.842 1.321 . . . . 0.0 111.391 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.458 ' HA ' ' CE1' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -141.28 148.17 21.56 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 121.164 1.802 . . . . 0.0 111.098 178.083 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 64.9 mt -112.38 -93.11 0.46 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 163.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 p -108.43 -170.24 1.64 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -169.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.12 73.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.755 1.222 . . . . 0.0 113.504 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.4 -17.95 64.94 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.107 0.963 . . . . 0.0 111.161 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.458 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 58.1 t-80 -86.48 -5.99 59.01 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.523 -0.736 . . . . 0.0 110.665 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.622 ' HG3' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -119.53 -64.99 1.21 Allowed 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.095 1.316 . . . . 0.0 110.512 178.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.59 178.38 7.41 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 164.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.75 -26.05 56.36 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.592 -0.693 . . . . 0.0 112.095 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.82 84.15 0.17 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 124.651 1.12 . . . . 0.0 113.299 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.12 -82.83 0.57 Allowed 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 167.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -119.55 -165.62 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.813 2.045 . . . . 0.0 108.171 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.18 138.64 12.7 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 163.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.7 t -83.99 139.27 17.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 166.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.9 mm -115.62 94.48 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.9 ttm-85 -91.46 75.13 5.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 -174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -78.98 92.59 4.97 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -51.19 -32.57 29.0 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.103 1.335 . . . . 0.0 113.425 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.402 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.26 -12.59 60.51 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.78 -1.424 . . . . 0.0 112.962 177.283 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -135.91 -97.55 0.23 Allowed 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 127.161 2.185 . . . . 0.0 105.864 -174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.485 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -159.17 -159.89 0.8 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 120.889 1.677 . . . . 0.0 109.415 174.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.485 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -110.23 75.9 0.96 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.058 2.143 . . . . 0.0 108.475 -167.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -78.23 164.56 24.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -171.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.0 tp -125.03 129.89 51.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.476 -164.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.6 mm -125.02 129.27 73.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -171.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.463 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 13.1 ttp180 -131.47 -177.15 4.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 124.064 1.888 . . . . 0.0 110.92 164.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.463 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -123.67 165.63 16.89 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 126.273 1.829 . . . . 0.0 110.743 173.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 127.148 2.179 . . . . 0.0 111.465 178.05 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.194 0.521 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.8 tp -121.83 -61.78 1.47 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 154.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -64.41 147.2 53.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.743 1.217 . . . . 0.0 110.659 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.2 m -73.96 -165.41 0.3 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.397 1.479 . . . . 0.0 110.529 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.77 -60.63 4.74 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -174.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.46 165.05 24.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 117.878 0.839 . . . . 0.0 108.993 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.471 ' H ' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -71.36 77.63 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.392 1.077 . . . . 0.0 111.077 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.06 -10.04 59.36 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.331 1.453 . . . . 0.0 111.98 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -77.72 -24.7 49.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 109.027 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -98.89 72.88 1.95 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.348 1.459 . . . . 0.0 107.296 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.01 172.56 13.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.02 -57.08 8.57 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 124.043 0.937 . . . . 0.0 111.225 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.85 -21.94 66.5 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.541 0.525 . . . . 0.0 110.706 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -82.74 -37.19 25.0 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.789 0.835 . . . . 0.0 109.624 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.4 mt -67.71 -45.07 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -55.47 -60.44 3.42 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.775 1.171 . . . . 0.0 110.541 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -75.89 -20.18 58.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.377 -0.827 . . . . 0.0 110.27 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.66 -38.44 90.03 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.435 ' C ' ' H ' ' A' ' 21' ' ' ASP . 51.7 m-85 -126.58 11.75 7.37 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.629 0.772 . . . . 0.0 112.841 -164.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -56.18 7.19 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.73 2.412 . . . . 0.0 115.322 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 19' ' ' PHE . 12.0 t70 -78.29 -34.78 48.6 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.243 1.417 . . . . 0.0 109.263 176.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.5 165.25 14.83 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 125.883 1.673 . . . . 0.0 108.251 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -68.98 177.72 4.78 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.801 1.667 . . . . 0.0 110.542 168.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 p -120.85 -177.59 3.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.999 1.72 . . . . 0.0 109.551 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -142.86 160.96 39.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.769 1.228 . . . . 0.0 109.362 164.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.9 p -143.88 136.35 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 C-N-CA 125.282 1.433 . . . . 0.0 108.271 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -118.8 179.05 4.26 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 119.123 0.874 . . . . 0.0 110.042 163.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -89.81 56.94 3.67 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 120.415 -1.428 . . . . 0.0 109.703 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.03 -158.94 19.75 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.723 0.678 . . . . 0.0 112.324 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.29 123.53 1.76 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.254 1.0 OUTLIER -59.91 130.47 46.89 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.203 1.501 . . . . 0.0 107.182 171.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -151.85 140.16 13.3 Favored Pre-proline 0 CA--C 1.507 -0.687 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -163.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -77.7 152.78 29.46 Favored 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 121.495 1.463 . . . . 0.0 110.689 -167.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.356 0.4 OUTLIER -47.15 -33.17 4.9 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.416 173.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.83 -15.51 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.476 ' CD ' ' HZ1' ' A' ' 47' ' ' LYS . 58.0 mm-40 -105.6 -42.04 5.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.1 -31.33 67.66 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 116.806 -1.569 . . . . 0.0 108.696 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -27.19 34.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 121.51 1.959 . . . . 0.0 109.562 -174.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -47.85 42.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 125.692 1.597 . . . . 0.0 107.976 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -34.79 78.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.313 0.645 . . . . 0.0 109.965 173.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.51 -14.32 59.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.237 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.46 27.88 21.22 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 164.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 mp -78.37 -45.93 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.7 108.14 2.17 Favored Pre-proline 0 C--N 1.343 0.316 0 CA-C-N 120.532 1.515 . . . . 0.0 106.945 167.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.45 -15.59 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.227 1.952 . . . . 0.0 112.183 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.0 m -88.19 105.85 17.8 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 -169.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' HZ1' ' CD ' ' A' ' 36' ' ' GLU . 20.9 tptt -52.18 -32.58 36.8 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -163.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -54.65 42.32 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.341 1.428 . . . . 0.0 109.619 169.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -57.39 -48.13 79.89 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 117.801 -1.095 . . . . 0.0 108.603 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.4 -61.61 1.83 Allowed 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 125.189 1.556 . . . . 0.0 110.14 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -62.84 -25.67 68.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 115.923 -1.989 . . . . 0.0 112.656 -174.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.68 -40.7 28.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 121.745 2.066 . . . . 0.0 112.988 168.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -62.96 -13.93 41.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.355 1.062 . . . . 0.0 111.41 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 66.1 mt -89.22 -64.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 C-N-CA 126.626 1.97 . . . . 0.0 109.04 163.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -61.89 -11.25 12.06 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.902 1.281 . . . . 0.0 112.21 -165.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 58' ' ' ALA . 5.1 m120 -82.45 131.37 35.22 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 118.824 0.738 . . . . 0.0 111.365 172.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.42 36.26 0.56 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 126.585 2.04 . . . . 0.0 111.716 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.537 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -117.18 -1.43 11.85 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 127.185 2.194 . . . . 0.0 111.027 165.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.339 0.0 OUTLIER -91.75 92.11 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 121.726 2.057 . . . . 0.0 106.501 163.562 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -80.66 100.8 8.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.924 -1.944 . . . . 0.0 108.101 171.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.8 t -80.2 128.88 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 175.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.484 HD22 ' CD2' ' A' ' 79' ' ' LEU 0.257 65.9 m-80 64.23 -6.63 0.26 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.65 4.6 26.45 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.137 1.351 . . . . 0.0 112.795 -169.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.87 119.33 32.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 108.56 0.78 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.344 1.458 . . . . 0.0 107.142 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.5 mt -141.4 88.17 2.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.89 25.05 3.34 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.996 1.318 . . . . 0.0 113.59 -173.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.66 154.77 46.53 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.54 -43.01 96.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 126.869 2.067 . . . . 0.0 110.803 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.6 -9.74 59.27 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.65 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.45 -47.49 7.41 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 117.562 -1.208 . . . . 0.0 112.24 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -140.09 135.04 37.11 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 CA-C-N 121.423 1.92 . . . . 0.0 113.308 178.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 80.5 mt -113.86 -97.3 0.44 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 163.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -97.87 -177.13 3.66 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.39 -1.444 . . . . 0.0 114.404 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.446 ' HB3' ' CE2' ' A' ' 98' ' ' TYR . . . -63.19 -37.78 88.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 120.967 -1.083 . . . . 0.0 113.119 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.55 -17.73 62.3 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.15 0.887 . . . . 0.0 111.11 174.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -81.22 -15.99 54.02 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.487 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.442 ' HG3' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -112.16 -59.58 1.98 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 120.223 1.374 . . . . 0.0 111.175 -173.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.484 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.08 -171.51 3.01 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.163 1.385 . . . . 0.0 110.265 166.288 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -53.61 -6.21 0.07 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 129.307 3.043 . . . . 0.0 114.725 163.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.85 79.89 1.48 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.954 1.264 . . . . 0.0 111.489 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 -63.61 0.55 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.306 0.642 . . . . 0.0 110.112 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -156.1 -169.58 3.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.022 2.929 . . . . 0.0 106.915 -175.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -154.5 152.67 30.38 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 119.605 -1.934 . . . . 0.0 107.07 163.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.9 p -115.7 151.43 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 C-N-CA 124.048 0.939 . . . . 0.0 109.337 171.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.8 mm -132.85 96.66 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 127.249 2.22 . . . . 0.0 108.011 -171.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -96.3 86.88 4.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -82.05 110.62 17.45 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.62 -20.17 45.26 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-N 120.123 1.329 . . . . 0.0 115.252 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -11.69 60.88 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.124 1.962 . . . . 0.0 111.228 171.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -148.59 -156.05 0.69 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.014 2.126 . . . . 0.0 107.453 -165.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -150.75 0.35 Allowed 'General case' 0 C--O 1.248 0.979 0 CA-C-O 122.883 1.325 . . . . 0.0 111.615 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.87 77.33 1.36 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.802 2.441 . . . . 0.0 109.018 -164.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -78.34 165.35 23.95 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.489 -0.757 . . . . 0.0 109.457 -170.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.2 tt -128.54 128.16 43.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -164.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.9 mp -127.08 135.64 63.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 124.369 1.068 . . . . 0.0 108.89 -169.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.515 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 9.4 ttt180 -139.29 -176.6 4.58 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 125.657 2.646 . . . . 0.0 114.335 167.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.515 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -115.86 161.04 19.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 112.451 -2.159 . . . . 0.0 107.866 163.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 C-N-CA 126.727 2.011 . . . . 0.0 107.462 -174.802 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.3 tp -143.61 148.0 35.2 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 165.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -59.85 -34.77 73.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.972 0.805 . . . . 0.0 111.784 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.7 m 58.69 -1.75 0.1 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.182 2.593 . . . . 0.0 117.132 171.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.97 -97.82 0.68 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 107.555 -2.218 . . . . 0.0 107.555 171.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -78.61 175.76 10.09 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -38.8 63.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 1 C-N-CA 134.021 4.928 . . . . 0.0 117.37 -175.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.35 -20.84 63.85 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 119.463 -2.023 . . . . 0.0 112.656 -166.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -79.32 -27.53 42.1 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 125.652 1.581 . . . . 0.0 110.933 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.11 79.46 9.59 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.71 169.26 18.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 170.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -57.38 12.97 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.804 1.641 . . . . 0.0 110.919 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.41 -20.87 65.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.833 0.288 . . . . 0.0 111.516 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.76 -38.89 27.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.848 1.259 . . . . 0.0 110.355 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.6 mt -69.19 -51.01 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.71 1.204 . . . . 0.0 107.951 172.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.92 -57.61 8.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.154 0.888 . . . . 0.0 110.517 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.99 -23.41 58.26 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.231 -0.918 . . . . 0.0 110.472 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.61 95.76 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -119.35 9.54 11.67 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -165.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -55.55 -9.57 0.52 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.645 2.378 . . . . 0.0 116.451 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.68 -29.34 45.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.678 1.591 . . . . 0.0 111.198 175.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -105.06 163.08 17.87 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -72.07 172.88 13.82 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 CA-C-O 122.855 1.106 . . . . 0.0 109.375 174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.8 p -120.55 171.85 8.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 113.197 -1.819 . . . . 0.0 108.073 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -137.11 152.91 50.54 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.94 134.66 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -125.86 152.58 45.33 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 122.599 1.19 . . . . 0.0 111.045 163.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -81.5 53.7 2.16 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 126.31 1.844 . . . . 0.0 110.965 -169.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.56 174.81 50.13 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.395 1.95 . . . . 0.0 114.015 166.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.75 149.07 16.15 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -75.18 151.87 38.47 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.13 0.49 . . . . 0.0 111.56 164.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.7 t -160.94 135.09 5.14 Favored Pre-proline 0 CA--C 1.513 -0.474 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -163.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -73.15 147.33 42.49 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 121.641 1.561 . . . . 0.0 111.16 -174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.336 0.3 OUTLIER -49.63 -30.05 8.25 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.675 175.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.4 p -74.04 -18.51 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -97.6 -46.69 5.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.075 -0.964 . . . . 0.0 108.424 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.6 -22.76 56.61 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 116.426 -1.749 . . . . 0.0 109.621 -168.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.98 -25.59 29.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 121.259 1.845 . . . . 0.0 109.9 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.7 -46.74 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -59.61 -40.63 88.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.663 1.985 . . . . 0.0 110.234 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.41 -17.73 56.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.481 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.51 34.67 6.88 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 163.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 mp -78.45 -53.14 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 174.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.13 95.63 2.35 Favored Pre-proline 0 C--N 1.349 0.549 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.11 -18.02 14.71 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.6 2.2 . . . . 0.0 113.128 -171.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.1 t -75.75 109.51 9.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -57.03 -27.84 61.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -163.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -49.39 66.69 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.726 1.603 . . . . 0.0 110.491 169.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -57.97 -50.46 73.3 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.26 -58.23 3.86 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 125.936 2.023 . . . . 0.0 109.703 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -58.7 -35.31 72.44 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 117.82 -1.086 . . . . 0.0 111.387 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -73.58 -45.83 50.87 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 118.103 -1.439 . . . . 0.0 112.089 170.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.22 -12.81 22.3 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.513 1.125 . . . . 0.0 111.7 -174.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 56.7 mt -89.41 -66.88 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 127.763 2.425 . . . . 0.0 109.07 164.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -71.58 -1.88 15.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.939 1.245 . . . . 0.0 113.331 -164.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.2 m120 -80.05 130.79 35.53 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.233 -0.917 . . . . 0.0 110.377 164.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.78 6.6 0.34 Allowed Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.967 -0.458 . . . . 0.0 114.025 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -81.78 -8.27 59.68 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 116.701 -1.618 . . . . 0.0 111.746 169.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.359 0.0 OUTLIER -92.77 92.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 125.569 2.604 . . . . 0.0 108.099 164.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -79.45 99.42 7.2 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 111.447 -2.615 . . . . 0.0 108.208 170.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 22.1 t -82.17 127.8 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.462 HD22 ' CD2' ' A' ' 79' ' ' LEU . 5.9 m-80 61.37 7.48 1.76 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.46 7.96 56.54 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.867 1.223 . . . . 0.0 113.077 -171.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -121.73 117.93 27.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 106.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.726 1.61 . . . . 0.0 109.114 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.6 mt -142.33 89.73 2.18 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -172.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.31 39.56 2.57 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.939 2.096 . . . . 0.0 112.755 -164.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -151.47 161.71 42.23 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.471 -1.393 . . . . 0.0 112.17 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.52 -26.37 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.149 1.38 . . . . 0.0 110.252 164.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.43 -14.28 74.5 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-O 119.417 -0.657 . . . . 0.0 113.344 167.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.53 -58.84 2.3 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.779 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -138.91 144.48 29.54 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 CA-C-N 121.143 1.792 . . . . 0.0 113.221 -177.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 74.2 mt -109.61 -93.14 0.43 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 101.355 -3.572 . . . . 0.0 101.355 163.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 p -108.79 -170.99 1.76 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.11 -44.49 83.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.496 1.119 . . . . 0.0 113.79 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.05 -15.89 62.57 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.238 0.926 . . . . 0.0 112.197 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -87.98 0.97 55.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.916 0.886 . . . . 0.0 109.762 173.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -79.58 0.59 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 167.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.462 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -91.09 -168.51 2.08 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.538 1.135 . . . . 0.0 109.848 176.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.01 0.05 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.869 2.867 . . . . 0.0 115.317 171.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.23 50.13 3.09 Favored Glycine 0 C--N 1.337 0.585 0 O-C-N 120.991 -1.068 . . . . 0.0 111.734 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -104.58 -65.92 1.0 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 172.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.44 ' H ' HD13 ' A' ' 79' ' ' LEU . 53.9 m-85 -145.3 -167.16 2.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.772 1.629 . . . . 0.0 107.153 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.89 140.95 13.77 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.923 1.238 . . . . 0.0 109.106 163.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 t -93.55 150.63 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.775 1.23 . . . . 0.0 108.568 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.2 mm -132.44 97.63 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 C-N-CA 126.767 2.027 . . . . 0.0 108.262 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -97.76 90.47 4.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.54 94.18 7.99 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.17 112.56 2.67 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt 137.53 -50.66 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 131.496 3.919 . . . . 0.0 107.773 -164.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.0 -110.51 0.35 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.04 -154.78 0.57 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-N 120.049 1.295 . . . . 0.0 109.173 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -115.0 78.85 1.2 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.971 2.508 . . . . 0.0 108.226 -164.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -78.14 169.41 18.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.049 -1.032 . . . . 0.0 109.078 -175.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.8 tp -127.02 131.38 51.01 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.775 -171.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.21 133.05 69.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 125.104 1.362 . . . . 0.0 107.37 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.498 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 7.8 ttt180 -145.39 -177.18 5.43 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 124.534 2.111 . . . . 0.0 111.783 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.498 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -126.12 159.33 33.16 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 112.636 -2.075 . . . . 0.0 111.59 164.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.476 0 C-N-CA 126.82 2.048 . . . . 0.0 106.1 165.415 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -53.09 126.1 19.57 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.44 1.096 . . . . 0.0 110.229 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -92.03 105.65 17.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.463 1.905 . . . . 0.0 108.18 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.3 m 52.12 -153.94 0.2 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.033 0.933 . . . . 0.0 110.14 -164.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.91 -140.16 11.34 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -175.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.54 -55.14 5.44 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.978 0.894 . . . . 0.0 108.942 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.535 ' H ' ' CD1' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -90.57 54.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 123.469 1.604 . . . . 0.0 107.531 -178.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.14 -12.6 41.37 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.944 1.298 . . . . 0.0 114.116 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -86.65 -22.64 26.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.299 1.44 . . . . 0.0 110.158 171.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -151.91 68.01 0.88 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.237 1.015 . . . . 0.0 108.623 -166.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.39 179.62 6.88 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 125.8 1.64 . . . . 0.0 109.389 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.98 81.01 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 119.988 -1.695 . . . . 0.0 113.515 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.29 -29.89 67.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.553 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -72.63 -36.5 68.05 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.2 mt -73.15 -52.25 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 127.101 2.161 . . . . 0.0 107.921 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.62 -47.06 87.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.953 -175.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -80.14 -27.11 39.11 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.815 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.86 -37.6 93.49 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 126.047 1.784 . . . . 0.0 109.975 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -123.56 12.28 9.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.12 -164.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -57.96 -9.01 1.16 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.42 -12.79 60.03 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.228 1.411 . . . . 0.0 111.726 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.23 168.53 11.41 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 120.617 -1.302 . . . . 0.0 108.888 167.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.09 174.67 12.44 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.678 1.585 . . . . 0.0 110.865 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -127.2 150.31 49.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.679 1.592 . . . . 0.0 109.0 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 38.2 t80 -134.96 159.5 41.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.505 1.048 . . . . 0.0 108.767 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.4 t -138.85 132.3 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 124.465 1.106 . . . . 0.0 108.623 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -113.23 -174.48 2.46 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 123.18 0.592 . . . . 0.0 110.501 163.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -87.96 8.79 24.69 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -163.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.55 176.35 32.65 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 120.907 -1.121 . . . . 0.0 110.859 -164.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.08 139.22 1.68 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -164.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.38 148.02 49.59 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.8 t -155.0 132.5 6.43 Favored Pre-proline 0 CA--C 1.51 -0.582 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -167.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.91 150.53 73.4 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.468 2.112 . . . . 0.0 110.975 -173.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.332 0.0 OUTLIER -49.82 -34.48 19.79 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.306 174.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -76.71 -14.88 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.531 1.932 . . . . 0.0 114.165 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -94.18 -40.1 10.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 120.278 1.399 . . . . 0.0 109.944 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.8 -24.46 58.65 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 116.89 -1.529 . . . . 0.0 108.989 -172.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.13 -33.84 65.76 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 121.068 1.758 . . . . 0.0 109.833 172.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.19 -48.82 30.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.14 1.776 . . . . 0.0 106.849 -169.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -65.73 -34.12 77.46 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.569 1.547 . . . . 0.0 110.023 170.654 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.36 -14.17 59.52 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 120.675 1.579 . . . . 0.0 111.353 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.7 21.61 33.52 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 164.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 mm -78.36 -39.92 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -171.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 m -157.3 95.58 2.11 Favored Pre-proline 0 C--N 1.342 0.244 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.71 -14.18 15.87 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.705 2.27 . . . . 0.0 113.649 -168.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 t -81.72 109.44 16.12 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . 0.261 48.8 mttt -59.2 -21.88 60.15 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -163.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -65.56 -55.2 19.02 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.487 1.494 . . . . 0.0 110.317 166.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -54.02 -50.41 66.71 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.52 -60.15 2.54 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 124.61 1.194 . . . . 0.0 110.976 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -68.53 -25.41 64.91 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 116.334 -1.793 . . . . 0.0 111.93 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -86.68 -25.35 24.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 121.239 1.836 . . . . 0.0 112.979 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.02 -31.86 69.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 125.496 1.518 . . . . 0.0 107.643 166.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 mp -77.43 -59.42 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 115.285 -2.293 . . . . 0.0 108.811 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -11.46 24.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.703 1.592 . . . . 0.0 112.659 -170.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.5 m-80 -81.22 137.99 35.83 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.851 1.31 . . . . 0.0 113.378 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.76 2.91 0.06 OUTLIER Glycine 0 CA--C 1.538 1.476 0 CA-C-N 113.034 -1.894 . . . . 0.0 114.999 164.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -79.43 -18.71 51.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 128.18 2.592 . . . . 0.0 112.436 172.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.356 0.0 OUTLIER -96.28 97.75 6.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 124.499 2.095 . . . . 0.0 108.896 178.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.13 93.46 9.58 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 111.185 -2.734 . . . . 0.0 105.158 175.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 p -78.63 136.93 22.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 103.056 -2.942 . . . . 0.0 103.056 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.459 HD22 ' CD2' ' A' ' 79' ' ' LEU . 1.8 m-80 57.41 23.05 8.55 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 119.258 0.935 . . . . 0.0 110.917 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.62 7.88 83.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.439 1.971 . . . . 0.0 114.206 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -134.98 125.25 26.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.337 1.568 . . . . 0.0 109.166 -166.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.79 117.48 3.69 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.841 0.856 . . . . 0.0 109.321 -173.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.1 mt -147.93 114.06 5.85 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 170.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.53 17.46 10.45 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.17 149.43 41.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.418 -0.801 . . . . 0.0 109.805 -174.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.06 -35.66 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 124.887 1.275 . . . . 0.0 109.962 174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.17 -17.37 69.97 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.248 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.5 -49.11 10.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.734 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.1 mt -138.74 129.19 33.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 120.069 1.304 . . . . 0.0 111.452 -174.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 84.6 mt -114.76 -95.2 0.47 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 103.247 -2.871 . . . . 0.0 103.247 163.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.21 -175.46 3.02 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.65 -1.281 . . . . 0.0 113.828 -173.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.86 -44.32 70.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.506 1.123 . . . . 0.0 113.261 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -75.05 -8.52 56.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.686 0.755 . . . . 0.0 111.386 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -93.31 -4.22 52.09 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.066 -1.021 . . . . 0.0 111.203 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -66.96 1.03 Allowed 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 120.863 -1.148 . . . . 0.0 108.786 175.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.459 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -89.54 -175.23 4.63 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 126.399 1.88 . . . . 0.0 107.699 173.467 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.94 -12.39 1.97 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.384 1.473 . . . . 0.0 113.889 166.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.85 79.17 0.96 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 125.517 1.532 . . . . 0.0 112.535 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -141.17 -49.17 0.41 Allowed 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 117.798 -1.096 . . . . 0.0 113.142 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -155.78 -170.57 3.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.945 2.498 . . . . 0.0 107.059 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.25 130.76 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 120.09 -1.631 . . . . 0.0 107.199 163.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.36 133.42 29.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.7 mm -111.05 106.85 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 167.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.48 79.47 2.11 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 176.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.1 ttm105 -85.1 109.97 18.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.29 -18.49 2.3 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.764 1.65 . . . . 0.0 114.756 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -47.01 -39.18 12.09 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.928 1.364 . . . . 0.0 111.793 169.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -142.27 -78.06 0.25 Allowed 'General case' 0 C--N 1.338 0.096 0 CA-C-O 117.976 -1.011 . . . . 0.0 108.435 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.36 -152.63 0.32 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.667 1.576 . . . . 0.0 111.997 -171.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.98 75.12 1.65 Allowed 'General case' 0 N--CA 1.47 0.529 1 C-N-CA 132.208 4.203 . . . . 0.0 113.298 -175.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.73 140.02 38.36 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 120.145 -1.597 . . . . 0.0 108.053 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.19 144.72 25.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.54 -175.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 mp -133.16 138.91 50.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 124.52 1.128 . . . . 0.0 108.622 173.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 ttm105 -136.43 -176.61 4.4 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.316 1.532 . . . . 0.0 111.781 163.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.23 163.06 13.71 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.92 1.688 . . . . 0.0 108.85 163.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 C-N-CA 127.487 2.315 . . . . 0.0 109.72 -175.22 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 49.6 tp -148.17 -52.31 0.18 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.163 0.985 . . . . 0.0 110.46 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -58.52 98.42 0.04 OUTLIER 'General case' 0 C--O 1.232 0.146 0 C-N-CA 127.09 2.156 . . . . 0.0 109.41 -172.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.3 p -150.68 54.36 0.89 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.647 0.779 . . . . 0.0 109.677 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.81 -90.99 1.14 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.85 -57.17 3.89 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 122.43 1.11 . . . . 0.0 110.25 -172.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -91.17 41.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 C-N-CA 125.346 1.458 . . . . 0.0 111.007 -174.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.49 -12.18 41.43 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -100.99 -20.17 15.53 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 126.011 1.724 . . . . 0.0 112.282 173.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . 0.334 1.6 pt? -130.51 73.44 1.54 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.396 1.079 . . . . 0.0 112.365 -175.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.25 175.43 10.21 Favored 'General case' 0 C--O 1.214 -0.765 0 C-N-CA 126.42 1.888 . . . . 0.0 108.139 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.54 -55.15 38.7 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 119.921 -1.737 . . . . 0.0 113.134 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.4 -23.17 60.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.65 -35.31 70.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.739 1.216 . . . . 0.0 109.467 175.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt -73.9 -53.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 C-N-CA 127.715 2.406 . . . . 0.0 106.892 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -55.13 -53.53 54.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.526 -1.225 . . . . 0.0 111.355 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -73.29 -31.22 63.92 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 120.38 1.445 . . . . 0.0 109.46 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.52 -34.43 89.45 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 125.335 1.445 . . . . 0.0 110.552 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -128.25 11.7 6.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.603 0.761 . . . . 0.0 111.813 -167.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -59.16 -5.55 0.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.053 2.141 . . . . 0.0 115.942 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.29 -28.82 47.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.793 -0.567 . . . . 0.0 110.295 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.21 170.46 6.5 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.0 177.32 7.9 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 CA-C-N 121.099 1.428 . . . . 0.0 109.231 173.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.4 p -125.46 145.56 50.03 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -108.93 156.24 19.93 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.942 1.297 . . . . 0.0 108.307 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.99 133.97 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 126.2 1.8 . . . . 0.0 107.936 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.63 -171.39 2.37 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 121.401 0.619 . . . . 0.0 111.093 163.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -100.08 13.58 33.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.844 1.657 . . . . 0.0 112.156 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.1 172.57 36.79 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.712 1.149 . . . . 0.0 113.375 -172.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.32 -85.39 1.87 Allowed Glycine 0 C--N 1.333 0.361 0 N-CA-C 106.686 -2.565 . . . . 0.0 106.686 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.33 150.08 21.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.251 1.42 . . . . 0.0 109.714 163.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -161.76 152.14 14.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 167.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.16 139.64 91.24 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.448 2.099 . . . . 0.0 113.168 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.293 0.9 OUTLIER -49.55 -32.65 12.95 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 169.172 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.407 ' HA ' HD11 ' A' ' 54' ' ' ILE . 5.7 p -74.59 -11.72 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 128.047 2.539 . . . . 0.0 115.086 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -103.03 -44.16 5.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.945 0.793 . . . . 0.0 109.224 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.05 -22.8 58.15 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 116.96 -1.495 . . . . 0.0 109.735 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.82 -23.26 27.25 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 120.706 1.594 . . . . 0.0 110.146 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -48.33 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.459 1.504 . . . . 0.0 107.243 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 t -68.63 -37.96 80.14 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.033 1.333 . . . . 0.0 109.31 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.83 -18.78 53.47 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.374 0.534 . . . . 0.0 112.052 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.23 33.36 6.59 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 118.819 0.736 . . . . 0.0 111.52 164.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.38 -49.89 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 172.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.35 107.46 3.35 Favored Pre-proline 0 C--N 1.349 0.553 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 169.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -81.36 -18.21 8.53 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.268 1.978 . . . . 0.0 113.255 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.5 t -86.4 106.34 17.37 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -58.82 -18.04 28.91 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -163.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.402 HH21 ' CD ' ' A' ' 52' ' ' GLU . 0.0 OUTLIER -73.33 -50.48 21.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 121.786 2.085 . . . . 0.0 110.47 167.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -42.96 70.13 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 116.468 -1.729 . . . . 0.0 107.31 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.63 -63.49 1.12 Allowed 'General case' 0 C--O 1.216 -0.681 0 CA-C-O 117.429 -1.272 . . . . 0.0 109.094 172.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.327 2.8 ttt-85 -60.2 -22.89 63.51 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 115.01 -2.424 . . . . 0.0 113.11 -170.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.402 ' CD ' HH21 ' A' ' 48' ' ' ARG . 0.0 OUTLIER -84.46 -29.88 25.71 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 121.664 2.029 . . . . 0.0 114.116 166.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.56 -20.32 64.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.95 1.25 . . . . 0.0 111.644 171.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.407 HD11 ' HA ' ' A' ' 35' ' ' VAL . 4.3 mp -87.22 -62.45 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 CA-C-O 116.833 -1.556 . . . . 0.0 108.356 163.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -64.32 -7.49 9.73 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 120.065 1.302 . . . . 0.0 111.607 -165.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 58' ' ' ALA . 4.1 m-80 -82.66 135.67 34.97 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.64 0.733 . . . . 0.0 111.838 173.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -74.2 40.26 1.05 Allowed Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.068 -1.423 . . . . 0.0 111.682 165.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -124.24 0.52 8.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 127.302 2.241 . . . . 0.0 111.146 164.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.323 0.0 OUTLIER -91.61 99.41 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 122.086 2.221 . . . . 0.0 106.385 163.63 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -86.84 115.06 24.01 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.666 1.987 . . . . 0.0 107.462 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' A' ' 63' ' ' GLY . 15.3 t -98.08 127.64 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 174.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.5 HD22 ' CD2' ' A' ' 79' ' ' LEU . 1.2 m-80 67.24 -14.06 0.2 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.862 1.265 . . . . 0.0 112.915 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 61' ' ' VAL . . . 128.44 -8.17 6.6 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.705 2.097 . . . . 0.0 111.66 -170.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -110.08 124.48 51.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 119.205 1.502 . . . . 0.0 107.338 -169.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.47 111.39 1.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.7 mt -146.4 89.17 1.83 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -171.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.19 35.09 1.2 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.156 1.783 . . . . 0.0 113.069 -171.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -140.26 144.04 36.26 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.269 -0.895 . . . . 0.0 112.361 -167.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.82 -36.57 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 126.49 1.916 . . . . 0.0 109.668 168.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.7 -16.11 69.58 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.607 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.7 -52.87 4.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 116.978 -1.486 . . . . 0.0 110.271 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp -138.13 138.98 42.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 121.376 1.898 . . . . 0.0 112.706 179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.97 -75.18 0.64 Allowed 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 102.367 -3.198 . . . . 0.0 102.367 163.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.419 ' HB ' ' H ' ' A' ' 75' ' ' ALA . 22.1 p -131.06 -142.21 0.23 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.419 ' H ' ' HB ' ' A' ' 74' ' ' THR . . . -89.06 -48.68 7.25 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 124.777 1.231 . . . . 0.0 111.768 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -8.15 55.15 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.038 0.923 . . . . 0.0 109.625 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -86.47 -9.31 56.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.337 1.455 . . . . 0.0 111.887 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.8 -71.9 0.67 Allowed 'General case' 0 C--N 1.34 0.156 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -170.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.5 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -91.22 -169.53 2.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 126.52 1.928 . . . . 0.0 110.028 172.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.01 -3.62 0.37 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.898 1.679 . . . . 0.0 113.674 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.52 78.46 1.41 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -133.77 -59.25 0.85 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.914 0.357 . . . . 0.0 111.471 167.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -148.95 -177.61 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.478 2.311 . . . . 0.0 106.283 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.76 153.88 43.71 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 163.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.8 t -124.48 134.43 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.0 mm -125.28 95.28 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.328 1.851 . . . . 0.0 107.528 -169.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -89.31 88.84 7.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.04 120.14 23.81 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 163.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.63 -22.18 59.01 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.729 1.157 . . . . 0.0 114.051 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -3.74 52.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.509 1.524 . . . . 0.0 111.879 173.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -144.15 -131.52 0.08 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -159.73 0.97 Allowed 'General case' 0 C--O 1.242 0.668 0 CA-C-N 120.64 1.564 . . . . 0.0 109.843 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.43 83.89 4.25 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 129.418 3.087 . . . . 0.0 110.441 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -78.39 164.24 24.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.22 129.94 44.0 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 -164.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.5 mm -126.98 123.0 61.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -163.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.538 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 6.4 ttt180 -134.33 -178.72 5.18 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 125.376 2.512 . . . . 0.0 115.34 171.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.538 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -137.99 143.15 40.51 Favored 'General case' 0 N--CA 1.427 -1.582 1 C-N-CA 131.837 4.055 . . . . 0.0 105.829 -172.975 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 125.819 1.648 . . . . 0.0 110.084 -175.384 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.4 mt -111.64 169.44 8.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.078 0.951 . . . . 0.0 108.972 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -106.73 136.78 45.94 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 167.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.7 m -134.05 -175.33 3.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.853 2.061 . . . . 0.0 106.67 163.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.89 -38.15 92.71 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 167.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -78.95 166.14 22.7 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.928 1.347 . . . . 0.0 108.602 166.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -67.48 82.92 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.688 1.595 . . . . 0.0 112.514 169.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.78 -6.7 48.58 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.61 -1.307 . . . . 0.0 110.439 163.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -78.8 -23.54 45.11 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.921 1.288 . . . . 0.0 111.007 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -86.62 66.09 9.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 165.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 168.12 20.17 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.81 -55.91 22.19 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 123.523 0.729 . . . . 0.0 111.833 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.64 -19.02 63.62 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.667 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.35 -41.87 46.72 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 123.868 0.867 . . . . 0.0 109.167 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.1 mt -72.74 -51.19 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -57.52 -46.99 83.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.334 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -78.07 -30.45 49.68 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.673 1.124 . . . . 0.0 110.194 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.55 -33.83 86.26 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -124.03 17.32 9.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.954 0.501 . . . . 0.0 112.083 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -14.16 16.98 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -78.99 -21.3 47.23 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.452 1.501 . . . . 0.0 111.716 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.95 161.61 29.95 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -175.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -83.23 172.79 10.36 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.245 1.296 . . . . 0.0 110.702 -169.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.8 p -127.09 170.57 12.22 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.068 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -139.03 154.89 48.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.277 1.431 . . . . 0.0 107.831 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 p -138.41 125.85 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 123.884 0.873 . . . . 0.0 109.931 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -117.49 -168.13 1.44 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 171.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -84.94 12.13 8.1 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 127.789 2.436 . . . . 0.0 116.022 -163.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.04 -177.39 8.6 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -164.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.78 133.39 1.61 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -168.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.08 149.76 40.25 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 117.575 0.688 . . . . 0.0 111.236 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -160.92 140.33 7.9 Favored Pre-proline 0 CA--C 1.51 -0.574 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -168.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.34 150.97 33.19 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 121.508 1.472 . . . . 0.0 110.973 -172.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.333 0.3 OUTLIER -48.46 -34.62 11.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.222 -1.353 . . . . 0.0 112.098 173.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.03 -29.89 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 117.786 -1.102 . . . . 0.0 113.68 178.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -91.68 -40.12 11.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.737 1.153 . . . . 0.0 109.389 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.59 -30.72 66.15 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 117.093 -1.432 . . . . 0.0 108.399 -174.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.11 -22.26 25.48 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 121.054 1.752 . . . . 0.0 110.333 -172.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.75 -50.97 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 171.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.82 -39.7 95.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.498 1.119 . . . . 0.0 108.621 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.09 47.11 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.915 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.07 33.88 7.5 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 166.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 mp -77.78 -43.47 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -148.44 109.6 3.63 Favored Pre-proline 0 C--O 1.224 -0.288 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 164.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.3 -15.71 11.24 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.548 2.165 . . . . 0.0 113.391 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.5 t -81.25 115.81 20.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -58.54 -30.01 66.79 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.62 1.555 . . . . 0.0 112.89 -168.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -52.33 24.47 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.637 173.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -54.79 -49.96 69.67 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.62 -58.45 3.82 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 126.375 1.87 . . . . 0.0 110.005 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 34.1 mtt85 -58.07 -33.79 69.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 117.045 -1.455 . . . . 0.0 113.218 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -80.77 -34.75 34.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.016 1.734 . . . . 0.0 112.926 173.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -15.6 62.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.452 1.501 . . . . 0.0 111.248 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 57.5 mt -86.65 -61.68 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 125.41 1.484 . . . . 0.0 108.86 163.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -72.98 -5.47 38.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -163.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.1 m-80 -81.01 131.81 35.33 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 163.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.31 2.98 0.08 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.856 0.741 . . . . 0.0 114.876 167.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.517 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -79.1 11.32 2.84 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.099 2.159 . . . . 0.0 111.451 169.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.38 0.0 OUTLIER -111.77 90.05 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 124.98 2.324 . . . . 0.0 104.735 163.349 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -78.9 96.69 5.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 111.36 -2.655 . . . . 0.0 104.807 172.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 p -78.49 134.58 27.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.614 HD22 ' CD2' ' A' ' 79' ' ' LEU . 1.8 m-20 60.11 14.36 4.41 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 122.004 2.183 . . . . 0.0 114.221 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.67 -4.77 69.38 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.535 1.541 . . . . 0.0 113.723 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -121.82 127.95 51.14 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.912 1.856 . . . . 0.0 108.521 -166.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 105.06 0.64 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.466 1.506 . . . . 0.0 108.302 -172.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.9 mt -140.09 100.89 4.03 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 120.234 1.379 . . . . 0.0 107.964 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.38 27.06 9.11 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.827 2.851 . . . . 0.0 110.559 -168.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -140.39 131.3 26.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.707 1.203 . . . . 0.0 112.138 -164.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 p -59.12 -36.39 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 126.568 1.947 . . . . 0.0 110.682 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.11 -19.49 68.11 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 119.283 -0.732 . . . . 0.0 112.771 173.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.23 -37.84 13.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.109 1.364 . . . . 0.0 114.486 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mt -142.41 123.58 11.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 120.729 1.604 . . . . 0.0 110.69 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.3 mt -107.26 -95.24 0.37 Allowed 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 102.676 -3.083 . . . . 0.0 102.676 163.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.42 -173.05 2.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.065 1.302 . . . . 0.0 114.346 -173.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.24 -41.07 87.86 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.253 -0.904 . . . . 0.0 112.395 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -65.17 -17.22 64.3 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.001 0.92 . . . . 0.0 112.734 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -93.73 4.14 54.38 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.984 1.714 . . . . 0.0 109.682 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.27 -61.34 1.09 Allowed 'General case' 0 C--N 1.35 0.592 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.938 170.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.614 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -91.07 -170.31 2.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.441 1.473 . . . . 0.0 109.101 169.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -43.8 -49.36 8.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.548 1.139 . . . . 0.0 109.664 163.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.05 81.68 0.11 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 125.604 1.574 . . . . 0.0 114.363 172.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -141.74 -46.1 0.36 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.269 0.534 . . . . 0.0 111.902 165.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -131.8 -177.52 4.47 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 125.502 1.521 . . . . 0.0 108.476 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -161.3 132.53 5.42 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.302 1.841 . . . . 0.0 106.72 163.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.25 145.4 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 170.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.4 mm -125.88 98.48 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 C-N-CA 126.442 1.897 . . . . 0.0 106.792 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -97.12 82.35 3.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.466 HH21 ' CB ' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -79.28 61.39 3.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.398 1.879 . . . . 0.0 109.309 -174.221 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 27.19 -82.7 0.0 OUTLIER Glycine 0 CA--C 1.527 0.784 0 C-N-CA 130.292 3.806 . . . . 0.0 116.598 171.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -51.74 -55.05 21.96 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.745 1.618 . . . . 0.0 109.97 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.24 176.9 8.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.894 1.678 . . . . 0.0 109.414 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.72 -146.07 0.08 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.707 1.242 . . . . 0.0 111.743 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -118.16 82.31 1.82 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.295 2.238 . . . . 0.0 109.506 -163.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -78.92 168.34 19.84 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.274 -0.891 . . . . 0.0 108.894 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.5 tp -121.9 131.38 54.0 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.766 -171.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.44 133.42 66.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -144.08 172.08 13.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.578 1.18 . . . . 0.0 109.989 171.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.86 163.29 21.56 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.611 1.164 . . . . 0.0 108.417 163.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.52 0 C-N-CA 127.017 2.127 . . . . 0.0 110.026 173.295 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 55.45 -175.21 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.897 0.879 . . . . 0.0 109.302 -150.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.94 -46.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.755 -1.216 . . . . 0.0 109.314 164.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.0 m -159.49 -179.99 8.41 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.372 2.269 . . . . 0.0 107.727 170.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.02 -132.87 3.92 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -78.75 -64.76 1.1 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pt -90.93 51.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 122.922 1.344 . . . . 0.0 111.363 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.47 -5.17 10.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.721 1.209 . . . . 0.0 111.534 171.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -106.23 -11.22 16.11 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 126.319 1.847 . . . . 0.0 109.815 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.76 84.52 0.82 Allowed 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 125.34 1.456 . . . . 0.0 110.088 -171.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 p -77.94 176.76 8.83 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.097 0.959 . . . . 0.0 109.593 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.5 -49.91 69.51 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 120.347 -1.471 . . . . 0.0 110.836 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 -28.8 65.97 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 118.55 -1.26 . . . . 0.0 109.906 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -79.38 -24.31 42.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.218 1.007 . . . . 0.0 110.146 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.0 mt -74.08 -54.76 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.837 1.655 . . . . 0.0 106.901 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -57.27 -48.59 78.5 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.812 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -81.22 -24.87 37.11 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.417 1.008 . . . . 0.0 110.437 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.43 -38.88 96.38 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -121.48 14.47 11.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 123.726 0.31 . . . . 0.0 111.468 -164.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -54.22 -11.64 0.52 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -78.36 -13.27 59.92 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.918 2.087 . . . . 0.0 110.413 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.446 ' CG1' ' HE2' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -127.92 155.45 77.6 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 126.26 1.824 . . . . 0.0 106.337 169.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.65 169.43 20.89 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.71 1.607 . . . . 0.0 110.463 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.8 p -104.25 175.63 5.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.637 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -136.75 160.31 39.23 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 163.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.43 132.12 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 171.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.98 172.61 6.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 164.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -100.08 57.74 0.98 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.655 -1.278 . . . . 0.0 111.681 -164.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.15 -171.63 9.91 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.98 148.19 2.22 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 -164.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -73.11 149.67 42.87 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.909 -0.759 . . . . 0.0 110.389 164.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.5 t -158.42 132.62 5.15 Favored Pre-proline 0 CA--C 1.505 -0.752 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -163.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -74.41 154.81 45.77 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 C-N-CA 121.715 1.61 . . . . 0.0 110.251 -173.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.397 0.6 OUTLIER -53.94 -29.99 44.69 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.482 176.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.6 p -70.25 -24.78 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -90.86 -43.77 9.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 120.31 1.414 . . . . 0.0 108.508 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -73.78 -28.31 61.6 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 116.943 -1.503 . . . . 0.0 109.49 -171.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.08 -31.29 25.4 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.713 1.597 . . . . 0.0 109.327 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 t -64.6 -51.5 66.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -66.62 -34.75 78.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.152 1.381 . . . . 0.0 109.998 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.4 -15.65 58.44 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.726 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.38 23.36 19.46 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 166.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.93 -43.37 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 m -156.34 101.12 2.07 Favored Pre-proline 0 C--N 1.349 0.562 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 171.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.62 -18.68 10.49 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 121.771 1.647 . . . . 0.0 113.431 -173.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.3 t -86.34 106.34 17.32 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -174.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -57.22 -22.19 39.22 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -164.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.55 -45.99 56.6 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 121.828 2.104 . . . . 0.0 111.095 169.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -51.81 67.84 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.59 -52.93 34.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 125.447 1.717 . . . . 0.0 110.586 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -57.08 -37.97 72.66 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 117.295 -1.336 . . . . 0.0 111.102 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -84.04 -24.89 30.27 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 116.736 -1.986 . . . . 0.0 113.296 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.449 ' CG ' ' HZ3' ' A' ' 90' ' ' LYS . 0.5 OUTLIER -62.16 -23.19 66.45 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 112.22 172.317 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.0 mt -84.95 -63.7 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 C-N-CA 126.211 1.804 . . . . 0.0 107.3 168.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.52 -5.13 10.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 119.916 1.235 . . . . 0.0 112.783 -164.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 58' ' ' ALA . 7.0 m120 -81.5 132.26 35.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 164.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.06 10.76 0.06 OUTLIER Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.246 1.403 . . . . 0.0 115.119 164.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -79.52 -12.67 59.86 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 116.253 -1.832 . . . . 0.0 112.964 165.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.491 ' HB ' ' CG ' ' A' ' 88' ' ' ARG 0.362 0.0 OUTLIER -99.74 87.79 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 125.881 2.753 . . . . 0.0 107.741 177.128 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -79.32 99.08 6.95 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 109.698 -3.41 . . . . 0.0 106.654 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.84 137.34 22.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.525 HD22 ' CD2' ' A' ' 79' ' ' LEU . 0.9 OUTLIER 60.19 4.56 0.67 Allowed 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 120.657 1.572 . . . . 0.0 113.132 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 -2.15 47.69 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.492 1.52 . . . . 0.0 114.035 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -124.18 129.07 50.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.852 1.826 . . . . 0.0 108.979 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.51 110.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.515 1.526 . . . . 0.0 108.386 -171.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 17.9 mt -141.22 70.42 1.35 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.128 0.966 . . . . 0.0 109.023 -174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.97 31.94 0.21 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -170.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -143.62 159.44 42.45 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.7 t -68.01 -27.42 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.971 2.509 . . . . 0.0 111.48 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.11 -7.57 85.09 Favored Glycine 0 C--N 1.333 0.401 0 O-C-N 121.393 -0.817 . . . . 0.0 112.552 168.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.44 -57.64 2.92 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 117.914 -1.041 . . . . 0.0 108.298 170.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp -136.17 137.34 48.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 120.596 1.544 . . . . 0.0 113.475 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.1 mt -108.12 -87.02 0.5 Allowed 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 100.571 -3.862 . . . . 0.0 100.571 163.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.48 -174.42 2.51 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 120.861 -1.15 . . . . 0.0 113.803 -169.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.0 -48.72 75.37 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -70.11 -15.34 62.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.175 0.898 . . . . 0.0 111.224 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -81.3 -10.34 59.59 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.928 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.21 -77.15 0.57 Allowed 'General case' 0 C--N 1.343 0.306 0 O-C-N 120.789 -1.194 . . . . 0.0 108.095 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.525 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -90.55 -171.51 3.09 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 125.66 1.584 . . . . 0.0 109.328 177.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -47.78 -26.27 1.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.72 2.008 . . . . 0.0 115.362 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.34 64.56 0.31 Allowed Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 126.01 1.767 . . . . 0.0 111.261 -169.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -133.27 -81.3 0.48 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -127.36 -166.39 1.6 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.845 1.258 . . . . 0.0 108.781 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.34 122.35 4.49 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 120.78 -1.2 . . . . 0.0 107.899 165.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.5 128.12 38.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.2 mm -116.24 98.03 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -92.37 85.62 5.43 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.491 ' CG ' ' HB ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -89.65 113.97 25.52 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 166.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.84 2.88 1.13 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.449 ' HZ3' ' CG ' ' A' ' 53' ' ' ASP . 6.6 ttpm? -58.2 -45.44 87.58 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.154 1.477 . . . . 0.0 109.573 164.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.446 ' HE2' ' CG1' ' A' ' 22' ' ' VAL . 61.7 tttt -131.76 -90.44 0.43 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HG3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -152.82 -152.39 0.42 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 120.878 1.672 . . . . 0.0 111.523 -167.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.404 ' CD1' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -94.68 79.5 3.76 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 129.897 3.279 . . . . 0.0 110.244 -176.746 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.4 144.38 35.95 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 119.95 -1.719 . . . . 0.0 107.219 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.1 tp -97.93 139.07 34.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -176.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.3 mm -126.6 135.71 62.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -135.37 174.01 11.09 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 122.655 1.217 . . . . 0.0 111.568 164.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.19 163.44 12.24 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 163.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.41 0 C-N-CA 127.671 2.388 . . . . 0.0 109.071 -176.932 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mt -67.93 126.35 29.17 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.541 1.064 . . . . 0.0 109.542 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.47 -172.33 3.26 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.897 1.679 . . . . 0.0 108.644 -174.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.95 -175.23 3.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.646 1.579 . . . . 0.0 107.833 167.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.9 -72.19 2.08 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -78.24 172.68 13.21 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.056 1.408 . . . . 0.0 109.154 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.4 pp -62.48 40.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 1 C-N-CA 131.82 4.048 . . . . 0.0 112.537 168.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.83 5.52 3.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 129.092 2.957 . . . . 0.0 111.286 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.6 -22.91 46.33 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.424 1.09 . . . . 0.0 109.57 164.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.3 94.41 8.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.152 1.781 . . . . 0.0 106.562 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.49 178.07 8.04 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.214 1.805 . . . . 0.0 108.594 176.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.82 -58.44 4.59 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.684 0.794 . . . . 0.0 111.139 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.13 -25.14 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.072 0.396 . . . . 0.0 111.026 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -73.73 -39.28 64.4 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.3 mt -70.31 -52.12 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.371 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.37 -48.22 82.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.494 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -72.12 -35.94 69.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.356 0.98 . . . . 0.0 109.155 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.79 -38.2 93.59 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -117.46 13.39 14.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.059 0.544 . . . . 0.0 110.458 -169.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -15.57 4.96 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.406 1.883 . . . . 0.0 113.939 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -78.04 -11.23 59.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 127.427 2.291 . . . . 0.0 111.598 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -133.76 172.84 6.63 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 167.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -76.85 -174.24 2.08 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.145 2.563 . . . . 0.0 110.111 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.4 p -135.35 175.45 9.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.594 1.157 . . . . 0.0 109.085 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -138.53 161.32 37.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.265 0.939 . . . . 0.0 109.075 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.8 t -138.81 139.64 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 124.713 1.205 . . . . 0.0 108.032 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.69 172.16 8.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.505 1.145 . . . . 0.0 112.705 163.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.19 33.08 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 128.641 2.776 . . . . 0.0 111.204 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.84 -170.87 31.95 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.543 -0.723 . . . . 0.0 112.058 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.78 145.54 2.98 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -164.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -67.98 148.16 51.45 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.306 0.574 . . . . 0.0 110.653 167.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.8 t -156.77 133.75 6.53 Favored Pre-proline 0 CA--C 1.511 -0.539 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -163.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -71.42 152.01 60.09 Favored 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 122.069 1.846 . . . . 0.0 110.989 -172.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.442 1.0 OUTLIER -51.69 -30.4 21.89 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.552 174.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.437 ' HA ' ' CD1' ' A' ' 54' ' ' ILE . 7.7 p -78.11 -14.87 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.512 1.525 . . . . 0.0 114.71 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.36 -49.05 6.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.114 0.87 . . . . 0.0 109.055 166.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.9 -23.88 60.77 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 117.381 -1.295 . . . . 0.0 109.051 -166.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.62 -33.4 60.52 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 120.822 1.646 . . . . 0.0 109.639 176.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -75.3 -46.86 37.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -175.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -38.07 89.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.542 1.937 . . . . 0.0 109.39 175.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.64 -24.08 45.47 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.108 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.17 23.12 11.68 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 124.096 0.855 . . . . 0.0 111.482 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.3 -39.66 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -174.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -145.15 113.6 4.86 Favored Pre-proline 0 C--O 1.225 -0.193 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.45 -15.08 5.37 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.778 2.319 . . . . 0.0 113.3 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -84.8 132.67 34.39 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -65.04 -35.48 81.3 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 119.583 1.083 . . . . 0.0 111.034 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -55.47 24.21 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 120.028 1.285 . . . . 0.0 108.945 177.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -49.3 76.71 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.033 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.13 -51.85 49.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.694 1.134 . . . . 0.0 112.366 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -60.0 -39.89 87.35 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 117.678 -1.153 . . . . 0.0 110.238 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.26 -32.05 49.44 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.777 1.172 . . . . 0.0 112.351 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -50.28 -39.81 46.46 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 35' ' ' VAL . 43.8 mt -84.85 -49.99 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 115.66 -2.114 . . . . 0.0 109.597 -174.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -66.99 -10.83 53.75 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 125.382 1.676 . . . . 0.0 111.489 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.2 m120 -83.52 137.3 33.93 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 174.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.66 0.42 0.45 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-N 115.067 -0.969 . . . . 0.0 114.419 164.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -78.95 -4.13 48.34 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.58 1.552 . . . . 0.0 111.617 172.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.445 HG13 ' NH2' ' A' ' 88' ' ' ARG 0.393 0.0 OUTLIER -106.78 92.43 2.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 CA-C-O 125.06 2.362 . . . . 0.0 109.125 171.546 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.97 93.59 7.58 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 109.913 -3.312 . . . . 0.0 105.067 169.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 p -78.31 127.33 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 102.375 -3.195 . . . . 0.0 102.375 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.64 HD22 ' CD2' ' A' ' 79' ' ' LEU . 1.2 m-80 76.34 -52.39 0.6 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.464 1.906 . . . . 0.0 110.499 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.45 3.89 0.02 OUTLIER Glycine 0 CA--C 1.533 1.182 1 C-N-CA 130.731 4.015 . . . . 0.0 111.063 170.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -112.82 116.25 29.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -163.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.08 105.74 0.93 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.9 mt -140.82 68.13 1.35 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.332 0.969 . . . . 0.0 109.547 -168.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.97 56.47 3.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.111 1.764 . . . . 0.0 112.535 -172.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -148.34 151.19 34.93 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.763 0.825 . . . . 0.0 112.928 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.32 -38.01 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.765 2.426 . . . . 0.0 110.699 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.14 -10.19 68.55 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 119.027 -0.874 . . . . 0.0 112.307 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.62 -55.6 3.8 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 117.213 -1.375 . . . . 0.0 109.664 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -136.25 134.53 50.02 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 CA-C-N 120.585 1.539 . . . . 0.0 113.613 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.3 mt -108.27 -86.41 0.51 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 163.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 p -115.57 -168.94 1.49 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.52 -45.33 93.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.634 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -70.2 -17.26 63.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.71 1.141 . . . . 0.0 110.93 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -82.7 0.16 44.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.464 1.106 . . . . 0.0 110.92 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 -62.97 0.9 Allowed 'General case' 0 C--N 1.345 0.379 0 O-C-N 120.785 -1.197 . . . . 0.0 110.033 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.64 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.06 -175.22 4.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.452 2.301 . . . . 0.0 109.528 172.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -52.81 -28.66 23.64 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.983 1.313 . . . . 0.0 112.852 172.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.46 73.47 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 126.355 1.931 . . . . 0.0 111.675 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -139.04 -79.23 0.33 Allowed 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 117.614 0.707 . . . . 0.0 109.403 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -126.71 -170.8 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.109 1.764 . . . . 0.0 109.13 -173.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.12 116.72 4.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 163.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.84 138.46 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 170.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 17.9 mm -123.1 104.63 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.788 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -92.67 83.92 4.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 170.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.445 ' NH2' HG13 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -78.48 82.22 4.76 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 169.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -49.28 -34.26 17.65 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.395 1.474 . . . . 0.0 111.932 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -69.39 15.19 0.07 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.709 1.204 . . . . 0.0 113.635 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -162.69 -82.96 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.855 2.462 . . . . 0.0 108.868 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.55 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -157.73 -169.21 2.78 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 123.364 1.554 . . . . 0.0 110.163 -176.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.55 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 12.0 m-30 -107.03 76.83 1.12 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.985 2.114 . . . . 0.0 111.704 -168.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -79.43 172.31 13.96 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.606 1.162 . . . . 0.0 112.129 -173.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.0 tp -140.66 137.53 33.63 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.377 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.15 141.83 45.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.716 1.606 . . . . 0.0 109.013 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.478 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 7.5 ttt180 -134.39 179.73 6.09 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 124.57 2.129 . . . . 0.0 109.392 163.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.478 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -121.25 162.14 20.74 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.257 163.458 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 125.169 1.388 . . . . 0.0 112.111 176.214 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mt 39.98 -5.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 2 C-N-CA 132.459 4.304 . . . . 0.0 121.964 164.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -130.71 -26.72 2.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.405 1.882 . . . . 0.0 110.601 169.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.3 t -166.22 -175.92 3.48 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.059 1.344 . . . . 0.0 108.704 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.45 -98.85 0.55 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 126.47 1.985 . . . . 0.0 109.642 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -72.71 0.36 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.455 ' H ' ' CD1' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -91.06 52.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.391 1.477 . . . . 0.0 110.856 -171.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.32 4.21 1.4 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.146 2.178 . . . . 0.0 112.993 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -116.63 -15.24 10.82 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 126.693 1.997 . . . . 0.0 110.086 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.96 70.25 0.87 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.789 0.835 . . . . 0.0 109.622 -174.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.51 177.18 8.74 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 125.618 1.567 . . . . 0.0 109.371 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.94 -51.61 68.49 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.081 -1.637 . . . . 0.0 112.438 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.89 -29.69 69.64 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.258 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.92 -31.96 61.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.78 2.032 . . . . 0.0 110.3 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 mt -76.38 -56.39 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 126.338 1.855 . . . . 0.0 106.38 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.27 -49.63 63.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.715 0.689 . . . . 0.0 112.519 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.84 -35.59 62.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.14 -40.61 95.91 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -115.58 16.49 16.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 124.035 0.491 . . . . 0.0 110.565 -165.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -55.79 -12.07 1.19 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -102.67 -2.51 28.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 129.25 3.02 . . . . 0.0 113.209 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.79 169.72 8.38 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -84.13 173.19 9.13 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 CA-C-N 121.189 1.46 . . . . 0.0 109.878 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.8 p -128.87 158.16 39.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.878 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 61.6 t80 -135.08 153.76 51.92 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 p -128.49 131.8 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.41 172.69 8.15 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 123.114 1.435 . . . . 0.0 113.523 164.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -80.92 37.98 0.44 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 128.162 2.585 . . . . 0.0 112.43 -164.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.21 -171.53 5.0 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.706 1.146 . . . . 0.0 113.703 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.71 137.04 0.76 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -167.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.17 137.0 57.35 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.378 1.089 . . . . 0.0 109.73 175.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.24 138.5 14.18 Favored Pre-proline 0 CA--C 1.514 -0.427 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -163.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -70.7 145.13 50.91 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.628 2.219 . . . . 0.0 110.776 -169.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.284 0.0 OUTLIER -47.35 -36.74 9.96 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.426 177.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.7 p -79.08 -15.88 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.707 2.003 . . . . 0.0 114.355 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -88.36 -44.23 10.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 120.088 1.313 . . . . 0.0 108.807 164.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -77.09 -18.18 58.18 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 116.847 -1.549 . . . . 0.0 109.888 -168.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.39 -34.69 63.37 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 121.144 1.793 . . . . 0.0 109.751 171.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.1 -49.14 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 C-N-CA 126.338 1.855 . . . . 0.0 106.054 -169.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 3.9 m -60.92 -40.89 94.88 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 128.53 2.732 . . . . 0.0 110.687 169.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.79 -11.09 59.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.904 1.229 . . . . 0.0 113.038 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.25 20.39 49.22 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.682 1.128 . . . . 0.0 112.199 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.86 -39.74 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.794 1.637 . . . . 0.0 106.836 -177.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.74 111.32 1.32 Allowed Pre-proline 0 C--N 1.344 0.358 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 167.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.11 -13.47 7.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.149 1.899 . . . . 0.0 112.414 -174.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 m -90.44 101.49 14.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 -164.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -41.44 -37.46 1.06 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -163.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.48 -54.06 33.75 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.226 1.376 . . . . 0.0 110.168 171.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -59.16 -42.05 89.8 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.728 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -51.49 -55.58 18.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 123.836 0.855 . . . . 0.0 110.415 175.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 mtt85 -55.2 -42.46 73.32 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.173 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -79.78 -33.5 40.49 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 119.989 1.268 . . . . 0.0 112.125 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.63 -29.43 68.01 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 116.592 -1.67 . . . . 0.0 107.636 171.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -81.74 -51.76 14.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-N 120.34 1.427 . . . . 0.0 110.848 174.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -69.6 -7.11 35.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.76 1.624 . . . . 0.0 111.458 -172.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.8 m-80 -81.07 134.95 35.75 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 171.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.59 8.25 0.2 Allowed Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.383 -1.232 . . . . 0.0 114.674 164.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.438 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -84.32 -16.22 43.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.213 1.507 . . . . 0.0 111.173 170.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.352 0.0 OUTLIER -93.5 92.65 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 125.455 2.55 . . . . 0.0 106.79 169.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -78.96 109.4 13.21 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 111.566 -2.561 . . . . 0.0 106.236 167.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.47 124.87 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 O-C-N 120.307 -1.496 . . . . 0.0 107.421 174.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.661 HD21 ' HG3' ' A' ' 78' ' ' ARG . 68.3 m-80 46.92 57.57 5.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.774 1.273 . . . . 0.0 110.169 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.23 4.75 51.57 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 113.56 -1.654 . . . . 0.0 114.439 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -131.03 121.47 25.09 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 120.82 2.31 . . . . 0.0 110.404 -167.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.99 100.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 126.691 1.996 . . . . 0.0 110.435 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.4 mt -138.48 108.12 6.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -170.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.409 ' CD ' ' H ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -137.13 38.41 2.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.888 2.075 . . . . 0.0 112.125 -163.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -143.18 158.88 43.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.616 1.566 . . . . 0.0 110.291 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.3 p -69.12 -33.19 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 121.177 -0.952 . . . . 0.0 111.796 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.08 -8.19 84.91 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 119.713 -0.493 . . . . 0.0 112.489 168.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.35 -55.64 4.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 116.862 -1.542 . . . . 0.0 109.24 170.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -138.93 145.86 27.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.402 0 CA-C-N 121.614 2.006 . . . . 0.0 111.774 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.2 mt -115.84 -98.57 0.44 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 163.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.05 -177.51 4.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.072 1.306 . . . . 0.0 114.145 -174.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.56 -48.71 71.73 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.068 0.947 . . . . 0.0 112.581 173.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -61.41 -20.31 62.92 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.996 1.319 . . . . 0.0 113.189 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -84.45 -19.33 33.58 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.151 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.661 ' HG3' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -96.2 -74.89 0.55 Allowed 'General case' 0 C--N 1.345 0.404 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.434 HD11 ' H ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.52 169.63 10.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.371 1.468 . . . . 0.0 111.129 172.954 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -23.24 -52.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.028 3.331 . . . . 0.0 115.839 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.53 56.28 0.01 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -168.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.9 -88.03 0.33 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.986 0.893 . . . . 0.0 111.851 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.434 ' H ' HD11 ' A' ' 79' ' ' LEU . 21.6 m-30 -131.56 -170.5 2.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -168.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.46 135.21 10.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.35 -0.844 . . . . 0.0 109.413 166.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -79.41 138.34 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 167.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.4 mm -113.22 92.74 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 126.323 1.849 . . . . 0.0 106.042 169.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 ttt-85 -97.78 74.63 2.37 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 -165.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.546 ' HB2' HH11 ' A' ' 88' ' ' ARG . 0.0 OUTLIER -88.3 105.14 17.36 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 130.499 3.519 . . . . 0.0 110.019 -169.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.23 -30.56 17.98 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.182 0.896 . . . . 0.0 114.524 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -23.58 31.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.721 1.609 . . . . 0.0 113.913 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -149.76 -89.91 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.42 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -151.94 -144.52 0.15 Allowed 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 122.424 1.107 . . . . 0.0 109.99 -175.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.42 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 3.6 m-30 -115.22 87.5 2.67 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.533 -162.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -78.49 161.92 26.72 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.87 134.9 54.85 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -172.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.7 mm -122.61 129.28 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -137.58 174.57 10.44 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 123.588 1.661 . . . . 0.0 111.061 171.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.71 166.05 13.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 124.738 1.215 . . . . 0.0 110.096 171.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 C-N-CA 129.075 2.95 . . . . 0.0 110.852 -168.684 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 120.476 0.179 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -148.42 171.96 15.21 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.53 1.932 . . . . 0.0 107.68 159.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -138.83 -97.1 0.17 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.9 t -156.99 -112.47 0.03 OUTLIER 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.09 -164.37 17.07 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 124.674 1.13 . . . . 0.0 110.965 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.22 -37.16 46.03 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 121.487 -1.008 . . . . 0.0 108.758 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.436 ' H ' ' CD1' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -91.58 53.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 124.402 1.081 . . . . 0.0 111.732 165.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.19 -10.49 10.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -98.07 -21.06 16.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.507 1.523 . . . . 0.0 111.207 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -155.0 72.93 0.85 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 121.34 0.591 . . . . 0.0 111.652 -164.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.41 -178.07 5.57 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 125.388 1.475 . . . . 0.0 110.951 173.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.54 -51.01 63.06 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 120.467 -1.396 . . . . 0.0 111.47 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.34 81.08 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.402 0.439 . . . . 0.0 110.087 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.81 -34.31 66.78 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -174.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.9 mt -72.68 -52.14 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 126.261 1.824 . . . . 0.0 108.397 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -56.83 -47.24 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 118.598 0.635 . . . . 0.0 111.235 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -80.64 -22.54 40.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.581 0.628 . . . . 0.0 110.057 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.54 -24.67 58.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 125.241 1.4 . . . . 0.0 111.841 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -130.44 17.13 5.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.185 0.994 . . . . 0.0 110.596 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 -15.23 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.191 2.196 . . . . 0.0 112.47 169.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.1 -19.7 53.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.766 2.827 . . . . 0.0 111.392 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.08 161.54 51.08 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 176.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.16 172.26 16.58 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 N-CA-C 109.091 -1.157 . . . . 0.0 109.091 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 p -121.02 168.3 11.66 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 113.532 -1.667 . . . . 0.0 108.42 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -140.43 164.33 30.41 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.46 135.65 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -116.13 -179.23 3.6 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.75 0.786 . . . . 0.0 109.98 163.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -96.15 66.89 2.55 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.437 -0.79 . . . . 0.0 109.879 -171.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.56 -157.4 29.57 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.44 108.31 0.05 OUTLIER Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.295 1.426 . . . . 0.0 112.298 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -47.41 139.86 6.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.86 0.83 . . . . 0.0 112.192 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.95 136.54 10.86 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.722 -163.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.13 144.34 38.3 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.35 2.7 . . . . 0.0 112.388 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.377 1.1 pt? -55.8 -25.92 43.73 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 171.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 p -57.4 -56.6 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 119.58 1.082 . . . . 0.0 110.844 166.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -65.63 -41.88 92.16 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.188 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.81 -29.5 62.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 120.587 1.539 . . . . 0.0 109.517 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.74 -27.83 22.12 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 120.459 1.482 . . . . 0.0 109.482 -173.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.54 -49.86 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 t -60.98 -45.4 94.94 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.668 1.587 . . . . 0.0 108.685 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.87 -15.61 58.13 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.167 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.94 27.58 9.39 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 119.276 0.944 . . . . 0.0 111.268 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -45.77 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.51 102.83 2.91 Favored Pre-proline 0 C--N 1.347 0.49 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 164.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.94 -17.45 19.7 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.131 1.887 . . . . 0.0 113.067 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.0 t -90.81 109.14 20.34 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -56.96 -18.75 14.69 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -166.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -72.02 -53.84 11.72 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 120.91 1.687 . . . . 0.0 110.484 168.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -47.91 68.08 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.37 -57.25 8.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 124.403 1.065 . . . . 0.0 111.359 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -63.13 -26.93 69.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 116.251 -1.833 . . . . 0.0 112.229 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -69.74 -50.48 43.05 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 121.602 2.001 . . . . 0.0 110.982 163.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.42 -9.55 3.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.725 1.21 . . . . 0.0 112.993 -174.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 38.9 mt -96.15 -67.74 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 C-N-CA 126.673 1.989 . . . . 0.0 109.071 164.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.62 -9.22 8.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 120.329 1.422 . . . . 0.0 112.54 -167.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.461 ' C ' ' H ' ' A' ' 58' ' ' ALA . 0.8 OUTLIER -82.52 126.04 31.81 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 119.57 1.077 . . . . 0.0 110.971 168.152 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.46 9.55 0.23 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 169.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.461 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -80.11 -7.53 58.94 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 116.58 -1.676 . . . . 0.0 111.801 164.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.384 0.0 OUTLIER -91.75 90.13 3.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 125.621 2.629 . . . . 0.0 107.673 167.174 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -79.87 96.74 6.43 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 110.957 -2.838 . . . . 0.0 108.021 171.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.0 t -78.64 126.78 38.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m120 60.7 11.9 3.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.619 0.768 . . . . 0.0 111.834 -172.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.97 18.32 56.26 Favored Glycine 0 CA--C 1.525 0.71 0 O-C-N 121.009 -1.057 . . . . 0.0 112.062 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -124.23 115.91 21.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.541 1.671 . . . . 0.0 107.793 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -51.71 105.78 0.12 Allowed 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 126.157 1.783 . . . . 0.0 107.5 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.9 mt -145.09 71.75 1.31 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -171.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.43 39.89 0.34 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.397 1.479 . . . . 0.0 111.192 -172.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -149.1 152.59 36.42 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -165.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.54 -29.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.363 2.265 . . . . 0.0 112.006 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.01 -34.88 90.4 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 164.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.86 -57.35 4.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 117.382 -1.294 . . . . 0.0 110.071 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.2 mp -136.12 139.49 45.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 CA-C-N 120.725 1.602 . . . . 0.0 112.402 -178.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -112.13 -91.17 0.49 Allowed 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.72 -174.66 2.51 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.332 -1.48 . . . . 0.0 113.833 -170.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.08 -42.01 84.67 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -82.64 -0.42 47.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.641 1.109 . . . . 0.0 110.962 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -89.59 -3.49 58.26 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.837 -1.164 . . . . 0.0 110.357 164.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.79 -63.67 1.11 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 120.113 1.324 . . . . 0.0 111.092 177.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.04 -168.79 2.16 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.378 1.071 . . . . 0.0 109.265 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -54.61 -17.66 3.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.298 1.439 . . . . 0.0 113.034 168.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.54 75.29 0.88 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 126.722 2.106 . . . . 0.0 112.343 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -145.01 -60.88 0.36 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.822 0.811 . . . . 0.0 111.865 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -137.58 -168.11 2.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.922 2.089 . . . . 0.0 107.912 -176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -160.62 131.71 5.59 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.56 1.944 . . . . 0.0 106.93 164.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.53 139.65 17.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 125.017 1.327 . . . . 0.0 107.99 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 18.8 mm -131.33 101.77 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 126.004 1.722 . . . . 0.0 106.528 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -100.65 95.57 6.77 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.62 121.07 29.59 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 172.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.9 98.57 0.71 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt 132.19 113.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 1 C-N-CA 134.458 5.103 . . . . 0.0 102.781 -163.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.431 0.0 OUTLIER 54.43 -127.61 2.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 116.665 -1.636 . . . . 0.0 109.031 -163.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.3 -143.55 0.16 Allowed 'General case' 0 C--O 1.243 0.725 0 CA-C-N 121.045 1.748 . . . . 0.0 113.213 -163.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -121.46 82.22 1.91 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.898 1.679 . . . . 0.0 109.851 -163.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -79.04 164.93 23.95 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.2 tt -134.41 129.1 34.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -164.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 mp -124.72 135.16 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -171.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.2 ptt-85 -131.82 178.34 6.84 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.386 1.474 . . . . 0.0 111.853 166.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.61 161.82 18.59 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.462 1.105 . . . . 0.0 109.474 163.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.388 0 C-N-CA 126.197 1.799 . . . . 0.0 109.219 170.166 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.3 164.39 29.96 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 156.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -73.0 63.5 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.644 2.377 . . . . 0.0 111.395 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.4 m -46.74 104.65 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 127.045 2.138 . . . . 0.0 112.042 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.56 -77.07 0.4 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.14 -57.8 3.55 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 124.217 1.007 . . . . 0.0 109.981 -175.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.46 53.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 122.806 1.288 . . . . 0.0 110.22 -167.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.91 -6.94 30.38 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.566 1.146 . . . . 0.0 113.314 -170.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -78.63 -38.11 40.51 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.828 1.251 . . . . 0.0 110.078 165.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.94 86.24 7.4 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.962 1.305 . . . . 0.0 109.09 -170.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.76 167.06 21.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 168.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.88 -39.14 73.0 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.747 -1.221 . . . . 0.0 112.146 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.22 -30.67 70.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 170.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -77.98 -32.86 51.56 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.904 0.881 . . . . 0.0 109.64 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 mt -64.96 -56.88 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 C-N-CA 126.155 1.782 . . . . 0.0 108.018 166.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -54.11 -50.45 66.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 120.309 1.413 . . . . 0.0 113.282 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -87.3 -12.61 46.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.095 0.861 . . . . 0.0 111.249 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.23 -44.02 94.45 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 164.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.417 ' CG ' ' CE2' ' A' ' 93' ' ' TYR . 10.4 m-85 -106.54 1.71 25.58 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -163.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -48.18 -12.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 19' ' ' PHE . 28.1 t70 -79.34 -12.74 59.92 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.78 1.632 . . . . 0.0 112.978 -177.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.417 ' CG2' ' HD2' ' A' ' 23' ' ' PRO . 10.5 p -160.36 160.69 26.15 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.659 1.984 . . . . 0.0 108.303 -177.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.417 ' HD2' ' CG2' ' A' ' 22' ' ' VAL . 89.9 Cg_endo -82.64 178.72 5.89 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.853 1.702 . . . . 0.0 111.761 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.5 179.0 4.15 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.01 1.724 . . . . 0.0 110.173 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 48.0 t80 -137.08 160.44 38.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.308 1.443 . . . . 0.0 108.69 164.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 t -139.27 129.64 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.388 1.875 . . . . 0.0 108.22 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.9 -168.33 1.59 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.476 0.58 . . . . 0.0 112.491 163.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.57 1.2 30.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -163.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.78 174.12 4.97 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.952 1.263 . . . . 0.0 112.244 -169.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.05 133.36 1.12 Allowed Glycine 0 CA--C 1.53 1.022 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -163.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -62.5 145.27 54.66 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -163.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 t -159.06 138.73 8.54 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 125.714 1.606 . . . . 0.0 106.876 -163.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.99 146.27 46.72 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.038 1.825 . . . . 0.0 111.203 -171.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.328 0.9 OUTLIER -45.92 -36.62 5.57 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.977 171.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.264 5.8 p -79.61 -9.28 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 120.602 -1.312 . . . . 0.0 114.194 -176.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -96.18 -38.96 9.92 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.513 1.051 . . . . 0.0 109.498 163.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -78.83 -17.72 55.2 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 116.84 -1.552 . . . . 0.0 109.624 -172.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.99 -27.07 43.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 121.146 1.793 . . . . 0.0 110.228 171.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.93 -44.34 28.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 126.342 1.857 . . . . 0.0 106.743 -174.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -69.88 -41.26 75.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 124.781 1.232 . . . . 0.0 108.679 172.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.64 -16.38 57.41 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.725 1.148 . . . . 0.0 112.858 -178.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.3 33.33 8.8 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 166.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.36 -42.05 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.15 122.17 1.63 Allowed Pre-proline 0 C--N 1.348 0.509 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 163.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -84.34 -13.87 7.22 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.468 2.112 . . . . 0.0 112.758 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.8 m -89.63 101.6 14.29 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -164.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -47.05 -36.94 8.64 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 117.978 2.584 . . . . 0.0 117.978 -163.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -66.51 -47.03 74.24 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 121.991 2.178 . . . . 0.0 110.647 169.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -56.44 -50.89 70.36 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 119.366 0.985 . . . . 0.0 108.383 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.85 -54.95 16.23 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.933 1.293 . . . . 0.0 110.992 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -52.35 -48.7 65.38 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.919 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.07 -25.12 37.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.246 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -67.03 -16.52 64.4 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 126.709 2.004 . . . . 0.0 110.874 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.4 mt -109.14 -16.44 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 C-N-CA 126.098 1.759 . . . . 0.0 115.436 170.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -91.54 -8.09 48.47 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 120.801 1.637 . . . . 0.0 111.894 170.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -85.27 136.86 33.32 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 118.379 0.536 . . . . 0.0 109.962 174.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.19 10.04 0.44 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.459 -1.189 . . . . 0.0 114.47 168.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.9 -10.1 59.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.374 1.587 . . . . 0.0 112.369 171.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.419 0.0 OUTLIER -101.02 86.86 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 125.815 2.722 . . . . 0.0 106.981 178.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -79.09 95.19 5.49 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 110.678 -2.965 . . . . 0.0 106.701 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.433 HG13 HD21 ' A' ' 62' ' ' ASN . 22.3 t -79.12 142.6 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.433 HD21 HG13 ' A' ' 61' ' ' VAL . 2.7 p30 54.86 15.21 1.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.24 10.86 47.19 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 128.716 3.055 . . . . 0.0 113.225 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.84 131.52 14.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.466 1.633 . . . . 0.0 111.4 -163.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.21 109.1 0.39 Allowed 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 128.517 2.727 . . . . 0.0 109.805 -172.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.6 mt -139.18 71.01 1.37 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.337 0.971 . . . . 0.0 109.057 178.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.39 50.59 1.48 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.755 2.422 . . . . 0.0 112.442 -175.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -152.3 146.82 25.69 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.6 t -66.37 -30.47 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 127.47 2.308 . . . . 0.0 111.352 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.46 -2.36 90.6 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.557 1.075 . . . . 0.0 112.449 170.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.39 -60.63 1.84 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 117.398 -1.287 . . . . 0.0 109.322 164.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -135.24 138.12 49.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-N 120.587 1.54 . . . . 0.0 113.12 -172.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.1 mt -110.36 -96.62 0.41 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 163.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -94.9 -169.27 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.763 1.268 . . . . 0.0 113.631 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.34 78.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.94 1.296 . . . . 0.0 113.459 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -70.78 -14.61 62.49 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.017 0.826 . . . . 0.0 112.069 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -84.07 -2.11 56.1 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 171.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.76 -86.72 0.61 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 166.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 83' ' ' PHE . 0.5 OUTLIER -91.27 -166.56 1.6 Allowed 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 126.658 1.983 . . . . 0.0 110.284 -170.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -51.6 1.52 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 130.01 3.324 . . . . 0.0 116.18 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 79' ' ' LEU . . . 86.81 55.79 2.34 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 124.932 1.253 . . . . 0.0 110.54 177.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -135.26 -65.31 0.62 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 118.671 -0.681 . . . . 0.0 110.434 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.434 ' H ' HD12 ' A' ' 79' ' ' LEU . 96.6 m-85 -122.77 179.18 4.72 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 118.609 0.64 . . . . 0.0 109.439 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.93 136.24 26.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 163.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.251 33.0 t -108.74 131.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 116.26 -1.829 . . . . 0.0 106.969 -163.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 49.7 mm -133.27 106.29 9.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 120.93 1.695 . . . . 0.0 110.869 -169.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -97.43 99.21 10.63 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 164.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.6 ttp85 -86.78 112.78 22.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 120.785 1.629 . . . . 0.0 108.562 164.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.87 166.71 1.89 Allowed Glycine 0 CA--C 1.533 1.175 0 CA-C-O 121.864 0.702 . . . . 0.0 112.471 172.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.6 mptt 63.59 -56.79 0.2 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.563 1.945 . . . . 0.0 112.282 -165.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -94.41 0.07 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 121.268 1.849 . . . . 0.0 110.183 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.526 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.2 OUTLIER -160.88 -179.29 7.44 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 124.422 2.058 . . . . 0.0 108.709 -172.269 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.526 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 90.0 t80 -79.43 157.78 27.47 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 111.569 -2.56 . . . . 0.0 106.667 163.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -145.57 160.31 41.83 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 128.521 2.728 . . . . 0.0 109.013 164.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.6 tp -117.86 137.49 52.75 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.468 1.507 . . . . 0.0 108.22 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.6 mm -121.44 136.51 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.555 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 8.8 ttt180 -138.43 -177.7 4.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 124.333 2.016 . . . . 0.0 109.168 164.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.555 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -120.78 161.59 21.21 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.006 -1.906 . . . . 0.0 108.873 163.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 0 C-N-CA 126.723 2.009 . . . . 0.0 111.873 -172.814 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' H3 ' ' CD ' ' A' ' 80' ' ' GLU . . . . . . . . 0 N--CA 1.474 0.767 0 CA-C-O 121.667 0.746 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.36 -149.44 0.3 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -178.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.74 100.9 3.85 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 163.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.4 m 55.08 -177.19 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.375 1.07 . . . . 0.0 112.153 -164.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.14 -89.02 0.89 Allowed Glycine 0 CA--C 1.526 0.768 0 O-C-N 120.492 -1.38 . . . . 0.0 110.3 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -79.24 171.72 14.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 122.16 0.981 . . . . 0.0 108.745 173.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 pp -53.88 93.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 128.04 2.536 . . . . 0.0 109.076 163.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.4 -17.83 25.2 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.063 -1.648 . . . . 0.0 115.15 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.05 -41.1 36.6 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 128.925 2.89 . . . . 0.0 108.546 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.57 101.04 9.72 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.41 162.43 13.49 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.488 -1.687 . . . . 0.0 107.401 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.95 -44.66 54.19 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.14 0.976 . . . . 0.0 109.097 -171.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.14 77.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.399 0.437 . . . . 0.0 109.901 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -71.78 -41.83 67.87 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.4 mt -67.38 -51.96 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.65 0.78 . . . . 0.0 110.265 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.05 -45.11 87.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 119.673 1.124 . . . . 0.0 111.313 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.24 -35.32 66.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.23 97.5 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 126.743 2.116 . . . . 0.0 109.952 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.46 ' CE2' ' HB3' ' A' ' 93' ' ' TYR . 11.8 m-85 -101.76 6.19 41.6 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.798 0.439 . . . . 0.0 111.29 -170.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -64.75 -2.99 2.83 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -79.14 -15.46 58.09 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 111.975 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.82 168.92 15.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 175.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -81.77 162.58 18.74 Favored 'Trans proline' 0 N--CA 1.437 -1.819 0 C-N-CA 121.512 1.475 . . . . 0.0 108.507 173.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 m -111.68 162.6 15.03 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -116.81 156.43 27.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.219 -0.926 . . . . 0.0 108.575 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.33 127.24 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -108.15 135.6 49.22 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.405 1.098 . . . . 0.0 108.687 163.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.91 61.9 3.97 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 170.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.37 171.02 32.87 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.811 1.196 . . . . 0.0 111.366 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.74 -150.72 26.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.349 1.452 . . . . 0.0 109.843 170.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.443 ' HA ' ' CG2' ' A' ' 74' ' ' THR 0.278 0.0 OUTLIER -55.37 135.62 50.03 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.926 1.29 . . . . 0.0 113.53 -163.899 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -158.6 142.83 11.39 Favored Pre-proline 0 CA--C 1.518 -0.269 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -163.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -69.32 147.86 66.61 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.106 1.87 . . . . 0.0 111.957 -171.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.261 0.1 OUTLIER -39.37 -45.8 1.52 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.815 1.646 . . . . 0.0 113.421 170.256 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.4 p -79.02 -11.81 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.54 1.536 . . . . 0.0 113.218 -175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -91.06 -43.86 9.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.822 0.737 . . . . 0.0 109.278 165.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.05 -30.23 67.44 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.668 -168.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.66 -36.58 62.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 120.129 1.331 . . . . 0.0 110.476 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.23 -43.28 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 C-N-CA 125.186 1.394 . . . . 0.0 107.566 -172.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.4 -40.08 81.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 126.415 1.886 . . . . 0.0 108.248 175.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.6 -20.56 50.2 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.799 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.55 17.17 11.58 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 119.085 0.857 . . . . 0.0 113.863 171.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -43.69 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 -171.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m -160.58 110.77 1.34 Allowed Pre-proline 0 N--CA 1.464 0.243 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.24 -20.96 6.84 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.467 2.111 . . . . 0.0 112.516 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -86.97 115.94 24.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -167.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -48.16 -36.77 14.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.972 1.309 . . . . 0.0 113.337 -172.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -67.04 -52.51 41.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.756 1.162 . . . . 0.0 111.152 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -56.26 -53.95 51.13 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.33 -54.61 10.63 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.409 1.884 . . . . 0.0 110.838 178.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.7 ttm-85 -50.23 -49.31 53.31 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 123.634 0.773 . . . . 0.0 110.771 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -80.99 -31.89 34.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.537 0.608 . . . . 0.0 112.482 -173.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.81 -21.96 63.67 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.514 1.525 . . . . 0.0 109.245 170.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.44 -43.22 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 116.254 -1.831 . . . . 0.0 112.766 169.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -73.98 -10.74 59.94 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 120.222 1.374 . . . . 0.0 111.226 -173.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 58' ' ' ALA . 3.9 m120 -84.95 144.33 28.4 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.52 25.44 0.48 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.772 1.177 . . . . 0.0 113.486 166.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -117.93 4.35 12.15 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 128.628 2.771 . . . . 0.0 109.471 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.327 0.0 OUTLIER -111.59 98.1 6.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 124.743 2.211 . . . . 0.0 107.573 163.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -81.07 100.39 8.98 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 112.687 -2.051 . . . . 0.0 107.776 171.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.2 t -78.91 128.25 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 61.43 0.93 0.49 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.932 1.293 . . . . 0.0 113.727 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.7 7.89 27.06 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 117.673 -1.626 . . . . 0.0 112.751 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.56 123.18 35.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.904 1.852 . . . . 0.0 108.555 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -50.37 102.29 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.927 2.091 . . . . 0.0 110.68 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.3 mt -141.81 110.1 5.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.443 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -138.33 44.61 2.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.541 2.736 . . . . 0.0 113.616 -163.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -143.32 154.62 43.96 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.003 -1.061 . . . . 0.0 111.785 167.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -64.09 134.72 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 122.975 1.369 . . . . 0.0 107.546 167.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.71 -6.57 46.25 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.006 -173.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.37 -46.59 32.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 163.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.04 146.23 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 124.646 1.179 . . . . 0.0 108.235 165.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.6 mt -124.17 -94.9 0.48 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 163.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.443 ' CG2' ' HA ' ' A' ' 31' ' ' ASP . 1.3 p -100.97 -173.89 2.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.774 1.624 . . . . 0.0 115.072 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.427 ' HA ' ' HG1' ' A' ' 84' ' ' THR . . . -50.4 -56.53 11.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.384 1.473 . . . . 0.0 114.075 171.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -67.23 -9.44 40.43 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.547 1.067 . . . . 0.0 113.166 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -89.64 -14.01 35.8 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.536 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.29 -66.6 0.93 Allowed 'General case' 0 C--N 1.338 0.095 0 O-C-N 119.85 -1.782 . . . . 0.0 108.027 174.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.04 -168.97 2.39 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 128.335 2.654 . . . . 0.0 110.907 -171.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.432 ' CD ' ' H3 ' ' A' ' 1' ' ' ALA . 4.2 pm0 -64.44 -5.66 5.76 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.146 1.379 . . . . 0.0 114.022 165.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.19 75.81 1.1 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.983 1.754 . . . . 0.0 113.612 -170.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.52 -81.74 0.28 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.839 0.856 . . . . 0.0 109.417 163.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -128.36 -162.63 1.2 Allowed 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 125.455 1.502 . . . . 0.0 110.076 -170.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.427 ' HG1' ' HA ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -154.39 121.15 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 119.205 -2.184 . . . . 0.0 107.151 168.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.02 143.99 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.1 mm -126.26 136.59 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 127.781 2.433 . . . . 0.0 106.293 172.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -127.43 84.4 2.25 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 164.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.6 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -84.37 91.93 7.91 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.844 2.057 . . . . 0.0 106.249 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -28.59 -63.82 0.11 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.367 2.413 . . . . 0.0 115.447 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.6 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 35.1 tttp -44.14 -37.85 3.35 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.707 2.403 . . . . 0.0 113.727 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -111.6 -117.63 0.3 Allowed 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 -170.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.13 -151.35 0.38 Allowed 'General case' 0 C--O 1.246 0.887 0 CA-C-O 122.662 1.22 . . . . 0.0 110.941 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.46 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 3.3 m-30 -110.83 104.14 12.73 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.951 2.5 . . . . 0.0 106.59 -165.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -113.05 165.86 11.96 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.593 1.157 . . . . 0.0 110.199 -173.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.1 tp -130.14 132.85 46.26 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.541 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.37 135.0 65.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -132.22 175.3 9.38 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.365 1.866 . . . . 0.0 109.633 170.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.78 168.35 10.83 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.898 0.879 . . . . 0.0 110.26 166.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.775 0 C-N-CA 125.259 1.423 . . . . 0.0 109.818 166.584 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tp -59.43 -52.71 64.42 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -139.08 135.52 34.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.183 2.193 . . . . 0.0 107.462 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.3 p -151.42 175.67 12.03 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.152 1.381 . . . . 0.0 108.17 163.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.52 -29.42 61.75 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 163.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -78.64 172.88 13.07 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.884 1.274 . . . . 0.0 109.233 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 pt -54.46 87.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 127.096 2.158 . . . . 0.0 111.269 164.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.83 -29.26 55.85 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 123.101 0.56 . . . . 0.0 112.191 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -78.47 -19.0 54.03 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.724 -175.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.23 72.04 2.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.73 176.14 9.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.29 69.23 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 120.513 -1.367 . . . . 0.0 112.898 -167.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.57 -21.59 41.56 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.163 171.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.93 -40.77 78.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 mt -68.89 -56.59 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 116.873 -1.536 . . . . 0.0 109.198 173.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -52.96 -55.09 26.05 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 120.026 1.284 . . . . 0.0 111.373 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -83.26 -13.22 55.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.06 -1.025 . . . . 0.0 110.202 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.8 -27.99 63.79 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 118.222 -1.321 . . . . 0.0 111.771 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -126.93 4.35 6.56 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -171.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -59.82 0.32 0.15 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.5 -6.4 53.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.607 1.094 . . . . 0.0 109.761 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.22 160.25 64.88 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.876 2.07 . . . . 0.0 106.509 170.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -78.87 174.28 12.43 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.415 1.41 . . . . 0.0 110.429 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 p -110.33 174.21 5.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 112.396 -2.183 . . . . 0.0 109.096 175.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -140.19 158.39 44.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 164.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.68 128.33 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -110.61 156.09 21.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -81.27 51.08 1.54 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.248 1.019 . . . . 0.0 111.414 -172.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.93 -175.96 40.88 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 121.144 -0.972 . . . . 0.0 113.11 173.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.12 152.05 2.45 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 -163.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.01 162.09 22.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.17 164.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.0 t -154.18 127.7 4.34 Favored Pre-proline 0 CA--C 1.509 -0.631 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -167.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.95 148.03 44.67 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 122.358 2.039 . . . . 0.0 110.302 -175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.276 13.0 tp -39.29 -47.78 1.75 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.522 2.729 . . . . 0.0 112.042 173.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.0 -7.56 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.134 1.773 . . . . 0.0 114.849 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -103.32 -34.84 8.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.301 -1.333 . . . . 0.0 111.376 165.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.89 -30.12 44.75 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 120.675 1.58 . . . . 0.0 108.823 -170.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.2 -28.45 25.43 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 119.837 1.199 . . . . 0.0 108.656 -174.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.1 t -66.78 -52.36 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 t -66.56 -39.66 88.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.77 -16.53 57.06 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.345 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.38 21.93 12.32 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.179 0.899 . . . . 0.0 111.852 165.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 mp -78.55 -40.95 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 t -160.37 105.83 1.36 Allowed Pre-proline 0 C--N 1.346 0.437 0 CA-C-N 120.517 1.508 . . . . 0.0 108.101 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -83.32 -20.21 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.971 1.781 . . . . 0.0 113.799 -176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.7 t -85.61 103.41 14.41 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -56.63 -22.41 33.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -163.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -47.93 58.51 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 121.917 2.144 . . . . 0.0 110.006 169.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -56.73 -51.24 69.6 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.02 -50.88 63.36 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 125.144 1.378 . . . . 0.0 110.953 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -64.04 -32.7 74.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 116.712 -1.613 . . . . 0.0 111.314 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.56 -29.13 28.08 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.886 1.676 . . . . 0.0 112.891 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -65.88 -16.11 63.54 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.55 1.94 . . . . 0.0 112.036 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 71.1 mt -88.32 -61.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 C-N-CA 126.078 1.751 . . . . 0.0 108.0 163.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -16.26 61.69 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.488 1.04 . . . . 0.0 112.713 -164.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.2 m120 -85.14 138.69 32.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 119.023 0.829 . . . . 0.0 109.833 173.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.05 7.02 0.07 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.494 1.521 . . . . 0.0 114.851 171.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -78.45 -14.79 59.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.536 1.168 . . . . 0.0 110.434 175.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.39 0.0 OUTLIER -90.31 90.96 3.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 CA-C-O 125.972 2.796 . . . . 0.0 106.992 172.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -83.24 94.16 7.84 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 110.299 -3.137 . . . . 0.0 105.397 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.46 134.48 28.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 177.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.587 HD21 ' HG3' ' A' ' 78' ' ' ARG . 78.3 m-20 56.94 22.78 7.54 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.942 -1.099 . . . . 0.0 113.263 175.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.71 18.06 73.9 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.08 1.324 . . . . 0.0 113.617 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.38 119.93 21.35 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.674 2.39 . . . . 0.0 107.029 -164.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.27 108.88 0.99 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.02 -1.467 . . . . 0.0 108.048 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.1 mt -143.97 103.24 4.0 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-N 120.214 1.37 . . . . 0.0 107.742 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 25.73 8.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.576 1.151 . . . . 0.0 112.595 -172.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -131.29 137.06 48.66 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.034 -1.041 . . . . 0.0 112.509 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.38 -38.92 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 125.976 1.71 . . . . 0.0 110.402 166.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.53 -12.95 74.08 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.077 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.32 -36.84 13.62 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.198 0.999 . . . . 0.0 111.46 170.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.2 mt -142.0 121.9 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 120.068 1.304 . . . . 0.0 111.829 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.4 mt -111.15 -94.27 0.44 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 101.365 -3.568 . . . . 0.0 101.365 163.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.72 -172.72 2.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.24 -49.88 74.65 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.328 1.051 . . . . 0.0 112.26 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -14.08 62.81 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.458 0.703 . . . . 0.0 111.691 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -81.91 -18.73 42.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 118.484 -0.77 . . . . 0.0 109.481 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.587 ' HG3' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -112.3 -60.5 1.86 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 119.932 1.242 . . . . 0.0 110.507 -171.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.532 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -90.37 -177.02 4.98 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.521 1.528 . . . . 0.0 108.636 167.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -48.63 -36.71 16.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.795 164.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.26 93.63 0.53 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 124.737 1.16 . . . . 0.0 112.06 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -139.07 -64.44 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 164.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -134.9 -169.75 2.42 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.805 2.042 . . . . 0.0 107.354 -176.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.43 124.1 6.62 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 163.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -79.3 145.65 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.3 mm -129.06 91.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -91.4 81.83 5.42 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -78.7 102.86 8.27 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 168.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -43.98 -49.3 7.77 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.566 1.555 . . . . 0.0 113.022 -173.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.77 -0.28 3.97 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -132.42 -100.61 0.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 164.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.1 OUTLIER -157.6 -164.67 1.6 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 121.056 1.753 . . . . 0.0 109.127 -178.157 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.404 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -91.48 82.49 5.36 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 130.937 3.695 . . . . 0.0 110.753 179.158 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -78.37 166.82 22.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.1 tp -130.07 140.62 50.81 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.677 -169.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 9.3 mm -134.99 127.64 48.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -170.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -136.62 172.46 12.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 122.519 1.152 . . . . 0.0 112.556 163.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.99 161.21 13.84 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.093 1.357 . . . . 0.0 110.78 165.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.851 0 C-N-CA 129.213 3.005 . . . . 0.0 106.374 165.461 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 tt -139.83 76.44 1.56 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.034 1.288 . . . . 0.0 107.831 159.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -140.81 162.56 35.14 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 128.047 2.539 . . . . 0.0 105.912 163.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.7 p -50.6 -34.43 25.92 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.141 1.776 . . . . 0.0 114.402 -166.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 46.29 -145.89 3.33 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.899 1.238 . . . . 0.0 114.349 164.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -85.54 -95.22 0.08 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 166.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.01 66.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 125.489 1.516 . . . . 0.0 109.973 -179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.48 -6.39 19.34 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.42 -0.8 . . . . 0.0 112.704 164.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -78.26 -12.01 59.97 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.854 1.262 . . . . 0.0 109.553 168.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.4 mp -123.5 64.6 1.02 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.225 1.81 . . . . 0.0 107.406 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.93 171.5 15.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 168.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.86 -37.03 49.17 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.255 -0.903 . . . . 0.0 111.255 -165.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.76 88.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.806 0.812 . . . . 0.0 109.894 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.25 -43.19 61.56 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.358 1.063 . . . . 0.0 108.183 -167.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.0 mt -66.21 -50.5 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 117.617 -1.182 . . . . 0.0 108.909 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -58.09 -51.07 71.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.517 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -79.76 -22.98 42.54 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.304 0.502 . . . . 0.0 109.831 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.49 -41.27 99.31 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -127.75 13.47 6.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -164.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -53.81 -8.18 0.15 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.018 2.527 . . . . 0.0 113.312 165.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.43 -27.8 46.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 128.19 2.596 . . . . 0.0 112.452 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.3 p -131.05 173.05 6.33 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -173.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.09 177.47 8.84 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.719 1.613 . . . . 0.0 110.066 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 81.9 p -136.39 167.68 20.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.252 1.021 . . . . 0.0 108.659 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -134.93 155.34 50.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.48 129.91 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.209 1.404 . . . . 0.0 108.336 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.07 176.73 5.43 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 122.02 0.914 . . . . 0.0 112.809 167.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -79.01 32.15 0.21 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.456 2.302 . . . . 0.0 113.723 -163.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.18 -170.77 25.2 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.494 -1.379 . . . . 0.0 110.296 -165.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.85 138.14 2.59 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -174.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -68.84 147.78 51.23 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 117.957 0.878 . . . . 0.0 111.174 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.3 t -160.33 135.16 5.53 Favored Pre-proline 0 CA--C 1.519 -0.244 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -164.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.63 149.99 30.88 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.565 2.177 . . . . 0.0 112.311 -166.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.3 0.1 OUTLIER -46.81 -41.29 15.25 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.072 178.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 p -75.09 -10.73 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 128.685 2.794 . . . . 0.0 114.815 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -98.75 -43.79 6.65 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 166.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 pp -76.44 -19.91 57.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 116.79 -1.576 . . . . 0.0 109.682 -166.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.98 -33.27 51.5 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 120.836 1.653 . . . . 0.0 110.324 173.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.42 -50.64 44.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 126.003 1.721 . . . . 0.0 107.773 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -36.2 83.2 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 127.361 2.264 . . . . 0.0 110.51 174.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.65 -22.59 46.63 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.471 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.07 33.04 7.14 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 169.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -78.1 -52.72 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.2 m -145.54 99.95 4.43 Favored Pre-proline 0 C--N 1.344 0.364 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 -173.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.41 -17.82 12.72 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.382 2.054 . . . . 0.0 112.918 -168.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.3 t -90.94 109.28 20.5 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -52.38 -37.48 56.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 117.533 -1.223 . . . . 0.0 114.051 -168.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -46.52 80.27 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.397 1.908 . . . . 0.0 110.38 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -51.11 71.11 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.48 -47.2 66.67 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.992 1.717 . . . . 0.0 110.371 177.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -56.89 -47.87 79.49 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 117.434 -1.27 . . . . 0.0 111.358 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.68 -35.73 75.38 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.594 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.21 -12.68 21.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 124.267 1.027 . . . . 0.0 112.704 172.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.07 -29.39 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.669 1.988 . . . . 0.0 114.408 173.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -89.56 -9.66 49.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.062 1.345 . . . . 0.0 110.144 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.4 m120 -100.06 146.54 26.65 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.262 1.03 . . . . 0.0 110.847 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.77 11.54 0.26 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.32 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -84.6 -9.06 58.64 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 125.49 1.516 . . . . 0.0 110.583 171.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.315 0.0 OUTLIER -99.49 89.95 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 125.042 2.353 . . . . 0.0 107.36 171.335 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -83.46 95.91 8.41 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 111.681 -2.508 . . . . 0.0 106.34 170.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.9 p -78.75 134.75 27.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 103.629 -2.73 . . . . 0.0 103.629 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.451 HD22 ' CD2' ' A' ' 79' ' ' LEU . 1.9 m-80 59.75 19.78 8.56 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 120.713 1.597 . . . . 0.0 111.84 170.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.9 6.21 76.27 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.683 1.611 . . . . 0.0 114.298 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -130.8 116.92 18.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.622 1.711 . . . . 0.0 107.889 -164.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.18 106.16 0.35 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.571 1.548 . . . . 0.0 109.08 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 51.3 mt -140.43 104.12 4.7 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.87 68.9 1.11 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.849 1.26 . . . . 0.0 112.563 -172.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -157.54 153.27 26.69 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 120.673 -1.267 . . . . 0.0 109.205 167.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.03 -32.03 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.373 0.669 . . . . 0.0 109.872 164.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.16 -24.43 70.43 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.017 0.341 . . . . 0.0 113.847 172.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.82 -45.25 8.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.812 1.245 . . . . 0.0 111.023 -172.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 2.2 mt -141.76 129.31 21.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 119.462 1.028 . . . . 0.0 109.369 -177.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.0 mt -110.15 -93.83 0.43 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 101.177 -3.638 . . . . 0.0 101.177 163.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.27 -171.41 2.07 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -173.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.55 86.66 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.58 1.152 . . . . 0.0 112.288 174.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -17.74 64.77 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.806 0.73 . . . . 0.0 111.837 175.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -89.31 2.04 54.91 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 123.581 0.752 . . . . 0.0 109.729 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.97 -70.25 0.8 Allowed 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.791 1.178 . . . . 0.0 109.596 169.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.451 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -91.79 -170.86 2.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 129.195 2.998 . . . . 0.0 110.226 172.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -57.8 -7.17 0.65 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.391 2.277 . . . . 0.0 114.346 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.29 73.55 1.03 Allowed Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 124.286 0.946 . . . . 0.0 111.527 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.97 -66.02 0.53 Allowed 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -140.93 -175.4 4.29 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.564 1.946 . . . . 0.0 106.913 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.67 138.2 18.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 163.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.9 t -104.08 148.04 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.83 101.65 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 128.268 2.627 . . . . 0.0 105.531 -172.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -94.3 80.86 3.98 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.93 85.08 4.91 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 169.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -4.94 -88.82 0.0 OUTLIER Glycine 0 CA--C 1.525 0.659 1 C-N-CA 130.997 4.141 . . . . 0.0 116.033 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.49 -19.78 66.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.861 0.83 . . . . 0.0 112.138 -172.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -85.0 -111.63 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 166.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.38 -157.22 0.57 Allowed 'General case' 0 C--O 1.239 0.534 0 CA-C-N 120.276 1.398 . . . . 0.0 110.661 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -106.5 65.05 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 130.14 3.376 . . . . 0.0 111.087 -167.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -78.59 167.08 21.79 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 120.753 -1.217 . . . . 0.0 110.653 -170.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.5 tp -132.09 133.52 44.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.273 1.029 . . . . 0.0 108.946 -166.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 36.2 mm -135.61 124.81 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -166.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -138.53 174.07 10.92 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.754 1.264 . . . . 0.0 111.647 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.48 167.62 10.72 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.242 1.017 . . . . 0.0 109.798 164.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.525 0 C-N-CA 127.186 2.195 . . . . 0.0 110.295 178.523 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.6 tp -147.88 158.96 44.3 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 164.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -76.05 -74.37 0.23 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 165.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t 55.75 178.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.179 1.392 . . . . 0.0 113.175 -164.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.36 -49.31 0.07 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 125.899 1.714 . . . . 0.0 109.42 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.82 -52.23 8.63 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 pt -90.96 30.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 122.107 0.956 . . . . 0.0 111.275 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.21 -2.62 4.48 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 120.859 -1.151 . . . . 0.0 112.135 173.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -98.44 -20.36 17.16 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.103 2.161 . . . . 0.0 109.341 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -151.43 78.59 1.27 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 127.458 2.303 . . . . 0.0 108.434 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.2 p -78.17 179.89 6.6 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 122.782 1.277 . . . . 0.0 109.397 -166.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.2 -39.84 78.39 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 119.127 -2.233 . . . . 0.0 111.099 -175.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.02 82.44 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -67.58 -37.61 82.85 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.8 mt -73.23 -50.75 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.81 1.644 . . . . 0.0 108.548 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.66 -46.54 89.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.15 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -71.26 -27.65 63.59 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.142 -0.974 . . . . 0.0 109.433 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.74 -41.32 42.85 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 126.28 1.895 . . . . 0.0 109.807 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -116.39 13.12 15.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.197 0.599 . . . . 0.0 111.208 -164.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -45.81 -25.65 0.54 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.745 2.418 . . . . 0.0 112.99 163.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.05 -12.08 59.96 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.755 2.422 . . . . 0.0 111.42 -174.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.51 169.9 12.74 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 127.257 2.223 . . . . 0.0 106.193 -174.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -76.42 176.66 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 CA-C-N 121.134 1.441 . . . . 0.0 109.503 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.5 p -129.64 165.8 21.06 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.254 164.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -133.47 158.76 42.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.763 1.225 . . . . 0.0 107.87 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.59 137.25 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -122.28 173.28 7.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 122.86 1.315 . . . . 0.0 110.956 163.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.46 37.14 0.33 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 127.833 2.453 . . . . 0.0 113.527 -163.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.7 -167.85 10.18 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -165.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.22 145.31 1.65 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -73.62 152.05 40.65 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.558 -0.966 . . . . 0.0 112.467 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.4 t -158.76 133.08 5.24 Favored Pre-proline 0 C--N 1.343 0.302 0 CA-C-O 117.693 -1.146 . . . . 0.0 109.394 -163.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -55.76 141.19 85.06 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.666 2.91 . . . . 0.0 112.058 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.364 0.4 OUTLIER -48.07 -36.38 12.99 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.779 165.166 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.423 ' HA ' ' CD1' ' A' ' 54' ' ' ILE 0.259 12.1 p -71.41 -15.44 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.464 1.506 . . . . 0.0 114.617 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -98.44 -44.04 6.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 118.785 0.72 . . . . 0.0 109.284 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -71.87 -25.94 62.15 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 116.887 -1.53 . . . . 0.0 109.133 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.32 -25.32 29.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 120.955 1.707 . . . . 0.0 110.469 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -76.07 -45.88 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.63 -45.36 90.61 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.66 1.584 . . . . 0.0 107.994 175.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.73 -18.61 53.99 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.139 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.92 33.87 7.13 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 119.071 0.851 . . . . 0.0 111.171 164.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.25 -49.31 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.42 107.44 2.76 Favored Pre-proline 0 C--N 1.345 0.399 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 172.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.55 -15.73 8.42 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.539 2.159 . . . . 0.0 113.04 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.8 t -82.65 119.05 23.8 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -56.04 -36.13 67.66 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 120.662 1.574 . . . . 0.0 114.459 -165.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.83 -56.17 24.39 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.288 1.404 . . . . 0.0 109.118 170.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -55.08 -49.06 72.62 Favored 'General case' 0 C--O 1.207 -1.179 0 O-C-N 124.218 0.949 . . . . 0.0 108.442 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.99 -58.72 4.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.336 1.454 . . . . 0.0 111.198 177.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -65.66 -26.57 67.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.672 -174.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -89.59 -29.11 19.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 120.094 1.315 . . . . 0.0 112.532 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.62 -20.08 65.39 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.771 1.629 . . . . 0.0 109.76 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.423 ' CD1' ' HA ' ' A' ' 35' ' ' VAL . 64.9 mt -82.99 -66.5 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-O 116.251 -1.833 . . . . 0.0 109.394 163.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -64.96 -5.85 7.13 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 119.864 1.211 . . . . 0.0 112.663 -164.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 58' ' ' ALA . 2.9 m120 -76.62 134.99 39.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.244 1.021 . . . . 0.0 113.166 164.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.27 34.3 0.66 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.145 1.831 . . . . 0.0 111.773 164.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.509 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -118.66 4.4 11.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.58 2.352 . . . . 0.0 111.161 167.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.328 0.0 OUTLIER -102.46 100.4 10.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 124.378 2.037 . . . . 0.0 106.585 163.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -88.94 98.98 12.05 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 112.928 -1.942 . . . . 0.0 107.631 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 40.3 t -79.36 135.16 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.461 HD22 ' CD2' ' A' ' 79' ' ' LEU . 1.6 m120 55.59 27.5 10.54 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.915 0.864 . . . . 0.0 109.87 -174.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.75 9.27 86.97 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 117.498 -1.723 . . . . 0.0 113.256 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 133.46 38.29 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.997 2.399 . . . . 0.0 109.411 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 109.75 0.65 Allowed 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 127.497 2.319 . . . . 0.0 109.403 -166.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.6 mt -145.28 110.82 5.35 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.75 27.76 8.71 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.997 2.519 . . . . 0.0 112.793 -163.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -142.18 156.91 45.36 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.939 -1.101 . . . . 0.0 113.76 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 p -69.63 -39.44 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.139 2.176 . . . . 0.0 110.882 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.2 -12.77 72.66 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 170.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.31 -58.35 3.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 116.267 -1.825 . . . . 0.0 109.991 167.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -139.66 137.78 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 121.601 2.001 . . . . 0.0 114.049 -176.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.6 mt -108.05 -95.06 0.39 Allowed 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 163.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.9 -176.66 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 119.941 -1.724 . . . . 0.0 115.627 -164.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.44 -54.74 42.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.808 0.843 . . . . 0.0 111.04 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.63 -4.07 21.5 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.797 1.239 . . . . 0.0 113.329 175.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -88.53 -23.89 23.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.322 166.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.42 -65.12 1.07 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -171.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.461 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.88 -176.68 4.74 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.523 1.129 . . . . 0.0 108.262 174.455 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -54.3 -21.57 9.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.128 0.971 . . . . 0.0 112.362 170.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.73 85.53 0.81 Allowed Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 125.647 1.594 . . . . 0.0 112.829 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.2 mtp85 -141.28 -67.03 0.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 163.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -128.27 -168.11 1.86 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.786 1.234 . . . . 0.0 109.795 -170.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.16 130.88 12.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 163.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.78 136.59 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.7 mm -127.53 94.96 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 124.283 1.033 . . . . 0.0 108.316 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -91.28 83.26 5.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -78.89 99.16 6.65 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 170.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.71 159.76 4.26 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.0 tttt 71.98 -48.29 0.68 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.194 2.198 . . . . 0.0 109.686 -164.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -88.58 -153.65 0.26 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 164.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.53 -158.13 0.74 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 124.955 1.302 . . . . 0.0 110.912 -167.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -95.22 93.99 7.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.111 2.565 . . . . 0.0 107.886 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -78.55 164.92 24.28 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 120.478 -1.389 . . . . 0.0 107.779 168.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.3 tt -133.06 123.88 26.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 mm -116.49 132.55 65.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -136.5 179.92 6.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 122.322 1.058 . . . . 0.0 111.477 171.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.5 165.11 14.32 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 123.737 0.815 . . . . 0.0 111.328 165.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.369 0 C-N-CA 128.392 2.677 . . . . 0.0 110.075 -177.197 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -153.37 106.97 3.01 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 102.652 -3.092 . . . . 0.0 102.652 169.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -56.2 -39.36 72.32 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.494 1.517 . . . . 0.0 113.948 -163.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.0 m -153.19 112.39 3.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 120.37 1.441 . . . . 0.0 108.882 174.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.22 -141.7 8.46 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 108.131 -1.987 . . . . 0.0 108.131 -176.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -78.75 164.52 24.48 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -169.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.44 90.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.717 1.207 . . . . 0.0 111.701 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.88 -3.13 58.56 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.61 1.164 . . . . 0.0 111.825 168.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -78.12 -25.26 47.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -84.3 64.16 8.16 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 164.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.76 167.89 20.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.89 -49.27 47.71 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.226 -0.921 . . . . 0.0 111.901 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.77 74.44 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -39.37 65.26 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.6 mt -66.88 -51.53 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 124.755 1.222 . . . . 0.0 109.554 174.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -53.14 -59.11 4.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.829 0.74 . . . . 0.0 110.307 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -76.35 -19.37 58.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.698 -174.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.89 -40.47 74.42 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.431 ' C ' ' H ' ' A' ' 21' ' ' ASP . 58.6 m-85 -119.27 6.11 11.2 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -164.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -58.82 15.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.808 2.043 . . . . 0.0 114.963 163.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 19' ' ' PHE . 19.6 t70 -78.49 -25.08 45.61 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.71 -1.244 . . . . 0.0 109.802 164.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.94 160.22 62.5 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.395 1.878 . . . . 0.0 107.142 -176.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.23 179.21 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.086 1.857 . . . . 0.0 110.569 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.1 p -121.45 -178.37 3.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.325 1.05 . . . . 0.0 110.561 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -140.8 154.37 46.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 164.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 p -135.23 124.97 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 C-N-CA 124.954 1.302 . . . . 0.0 108.455 175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.22 170.99 7.78 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 122.556 1.17 . . . . 0.0 111.288 171.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -79.17 8.0 6.61 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 126.69 1.996 . . . . 0.0 113.865 -163.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.6 -179.52 49.07 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.698 1.618 . . . . 0.0 112.774 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.38 139.05 3.07 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -163.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -66.62 136.62 55.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.174 0.987 . . . . 0.0 111.333 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.7 t -144.93 136.54 12.79 Favored Pre-proline 0 C--O 1.225 -0.198 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -163.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.51 140.6 35.43 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 124.903 3.735 . . . . 0.0 114.816 -176.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.254 0.0 OUTLIER -47.61 -45.02 27.18 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.821 0.819 . . . . 0.0 111.519 164.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.8 p -77.49 8.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 128.047 2.539 . . . . 0.0 113.548 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -120.55 -45.47 2.41 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.58 1.152 . . . . 0.0 108.089 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.92 -24.89 64.34 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 120.015 -1.678 . . . . 0.0 108.959 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -33.83 60.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.552 1.524 . . . . 0.0 110.296 177.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.97 -46.27 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 127.005 2.122 . . . . 0.0 108.536 -173.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 m -62.82 -45.65 91.64 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 128.34 2.656 . . . . 0.0 109.098 169.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.42 -11.91 59.98 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.409 1.004 . . . . 0.0 112.647 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.43 27.09 23.62 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 119.222 0.919 . . . . 0.0 112.096 167.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.99 -42.66 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.1 m -156.17 101.78 2.09 Favored Pre-proline 0 C--N 1.347 0.484 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 165.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.28 -14.69 13.09 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.379 2.053 . . . . 0.0 113.32 -171.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.8 t -81.87 108.62 15.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -50.1 -35.28 24.86 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -164.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.29 -47.35 67.89 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 121.137 1.789 . . . . 0.0 110.444 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -50.0 72.49 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.91 -48.0 60.71 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.946 1.699 . . . . 0.0 111.48 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -61.68 -40.79 96.2 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 115.961 -1.971 . . . . 0.0 110.478 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -25.11 48.69 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 116.332 -2.147 . . . . 0.0 112.861 173.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -18.79 65.56 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 117.666 -1.159 . . . . 0.0 112.093 174.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.38 -51.64 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 116.633 -1.651 . . . . 0.0 110.707 164.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -68.82 -13.48 62.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 120.821 1.646 . . . . 0.0 110.627 -164.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.44 ' C ' ' H ' ' A' ' 58' ' ' ALA . 9.5 m120 -85.76 132.58 34.1 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 118.317 0.508 . . . . 0.0 111.143 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.68 17.29 0.25 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.208 0.909 . . . . 0.0 114.129 169.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -94.17 -1.39 54.24 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 119.039 1.419 . . . . 0.0 111.006 164.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.286 0.0 OUTLIER -88.8 89.25 3.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 163.093 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -78.69 103.24 8.5 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 166.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.4 137.14 22.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 102.111 -3.292 . . . . 0.0 102.111 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.534 HD22 ' CD2' ' A' ' 79' ' ' LEU . 12.8 m-20 75.81 -54.43 0.62 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 127.192 2.197 . . . . 0.0 109.645 174.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 172.76 5.04 0.03 OUTLIER Glycine 0 CA--C 1.536 1.352 1 C-N-CA 131.969 4.604 . . . . 0.0 111.577 174.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.0 pm0 -122.33 128.3 50.86 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.682 1.993 . . . . 0.0 108.362 -169.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 106.8 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.319 1.848 . . . . 0.0 109.145 -177.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.3 mt -144.23 110.51 5.49 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.421 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -121.63 16.51 11.16 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.507 2.323 . . . . 0.0 112.639 -169.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -118.98 141.08 48.99 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.468 1.507 . . . . 0.0 109.231 -172.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 p -57.47 -42.8 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.216 1.406 . . . . 0.0 110.39 177.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.9 -8.48 73.32 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.61 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.17 -45.06 12.39 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.736 0.768 . . . . 0.0 109.466 170.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -140.99 127.76 21.01 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-N 120.298 1.408 . . . . 0.0 112.657 -178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 97.7 mt -116.41 -92.64 0.51 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 102.241 -3.244 . . . . 0.0 102.241 163.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.66 -175.48 2.81 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.782 -1.199 . . . . 0.0 113.502 -175.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.45 -43.2 79.29 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -82.82 -6.0 59.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.81 1.186 . . . . 0.0 111.078 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -81.58 -11.39 59.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 121.768 -0.583 . . . . 0.0 109.61 165.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.2 -71.42 0.74 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.646 1.112 . . . . 0.0 109.505 -173.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.534 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.9 -168.4 2.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.884 2.473 . . . . 0.0 109.271 176.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -53.0 -9.88 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.396 1.878 . . . . 0.0 115.644 166.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.67 71.22 1.0 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.64 1.114 . . . . 0.0 113.021 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -141.35 -64.85 0.44 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.17 0.485 . . . . 0.0 110.614 173.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -133.82 -169.06 2.23 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.559 1.544 . . . . 0.0 107.953 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -158.08 155.79 29.87 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 164.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.72 150.61 23.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.9 mm -135.0 97.64 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -170.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -99.49 81.14 2.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.62 117.54 19.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 171.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.85 -49.68 12.6 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.038 1.304 . . . . 0.0 111.837 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -1.04 0.79 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.56 1.544 . . . . 0.0 115.001 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -146.92 -95.86 0.09 Allowed 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 121.448 1.931 . . . . 0.0 109.176 164.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.411 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -153.93 -163.1 1.56 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 120.53 1.514 . . . . 0.0 109.513 -171.275 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -107.41 75.64 1.03 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 127.949 2.499 . . . . 0.0 109.969 -170.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -78.45 165.05 24.23 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.965 -1.085 . . . . 0.0 109.568 -172.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.8 tp -115.63 134.67 54.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.111 1.365 . . . . 0.0 107.987 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.7 mm -128.62 133.5 66.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -174.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -139.25 174.49 10.46 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.948 1.356 . . . . 0.0 111.432 167.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.57 162.52 17.87 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.328 1.051 . . . . 0.0 110.199 164.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.408 0 C-N-CA 129.453 3.101 . . . . 0.0 108.276 175.887 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 tt -156.64 96.04 1.6 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -108.94 158.52 17.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 166.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 p -124.62 173.13 8.71 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.626 0.771 . . . . 0.0 112.943 -163.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.69 -48.33 3.05 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 125.856 1.693 . . . . 0.0 109.573 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -78.96 -170.99 2.41 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.865 1.317 . . . . 0.0 109.917 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 7' ' ' ILE . 1.3 pp -54.2 64.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 131.697 3.999 . . . . 0.0 112.144 166.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.55 -3.98 34.2 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.329 1.852 . . . . 0.0 111.675 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.58 -21.87 47.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.617 1.167 . . . . 0.0 109.679 167.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mp -99.21 73.59 1.91 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 167.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.9 165.86 19.4 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 163.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.36 67.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 120.609 -1.307 . . . . 0.0 112.106 -169.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.63 76.27 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.132 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -74.4 -24.2 59.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.597 0.759 . . . . 0.0 110.251 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 mt -77.96 -57.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 125.732 1.613 . . . . 0.0 107.629 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -52.82 -45.34 67.25 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.93 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -91.19 -19.06 23.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.573 0.749 . . . . 0.0 111.346 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.51 -37.79 69.01 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 170.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.431 ' CD2' HG23 ' A' ' 85' ' ' VAL . 58.5 m-85 -120.61 15.45 11.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 119.581 -0.847 . . . . 0.0 110.497 -164.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -0.33 0.1 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.509 1.924 . . . . 0.0 115.297 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.82 -20.92 48.55 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.934 -1.104 . . . . 0.0 111.219 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.2 160.08 61.68 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 178.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -80.58 176.88 8.67 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 CA-C-N 120.626 1.259 . . . . 0.0 109.926 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.5 p -112.12 165.62 11.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.716 172.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -130.04 157.96 40.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.692 2.397 . . . . 0.0 106.956 169.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 4.1 p -135.21 136.12 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -127.42 -172.87 2.76 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 119.503 1.047 . . . . 0.0 112.533 163.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 6.78 8.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.577 1.551 . . . . 0.0 113.983 -163.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.54 -173.1 34.1 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.082 1.325 . . . . 0.0 111.26 -170.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.84 135.57 1.65 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.26 134.55 39.33 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.543 0.672 . . . . 0.0 112.692 -167.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 t -157.47 131.66 5.04 Favored Pre-proline 0 CA--C 1.515 -0.384 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -166.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.64 150.9 40.73 Favored 'Trans proline' 0 N--CA 1.437 -1.84 0 C-N-CA 122.529 2.153 . . . . 0.0 111.403 -167.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.299 0.0 OUTLIER -44.01 -42.09 5.83 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.568 174.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -79.76 -5.59 8.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 126.907 2.083 . . . . 0.0 115.342 -174.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -105.06 -35.61 7.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.22 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.83 -21.03 57.69 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 120.914 1.688 . . . . 0.0 109.298 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.72 -30.37 51.69 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 120.302 1.41 . . . . 0.0 110.27 173.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -74.35 -47.86 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -173.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -47.68 84.48 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.627 1.971 . . . . 0.0 109.482 171.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.82 -10.81 59.91 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.353 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.39 33.95 18.32 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 119.111 0.869 . . . . 0.0 111.068 166.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -78.56 -51.37 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 172.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -151.56 105.78 2.91 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 169.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -84.31 -12.67 7.84 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.811 2.341 . . . . 0.0 113.642 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -87.57 115.8 25.25 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -52.01 -34.85 44.71 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -165.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -62.95 -54.7 34.31 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.948 1.704 . . . . 0.0 109.039 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -48.31 78.86 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 117.172 -1.394 . . . . 0.0 108.482 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.31 -58.68 4.23 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 125.319 1.448 . . . . 0.0 111.104 175.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -67.35 -27.74 67.37 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 117.332 -1.318 . . . . 0.0 110.616 -170.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.07 -34.23 26.23 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 120.302 1.41 . . . . 0.0 112.234 172.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.65 -16.82 63.38 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.511 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -92.26 -53.59 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 116.054 -1.927 . . . . 0.0 111.728 166.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -71.61 -5.11 31.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 120.941 1.7 . . . . 0.0 112.076 -171.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.1 m120 -80.62 136.48 36.23 Favored 'General case' 0 N--CA 1.437 -1.118 0 O-C-N 121.373 -0.829 . . . . 0.0 112.462 173.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.72 33.87 0.86 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 124.486 1.041 . . . . 0.0 112.141 167.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.524 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -121.39 0.39 10.01 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 126.901 2.08 . . . . 0.0 111.509 168.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.315 0.0 OUTLIER -91.99 98.73 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 163.533 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -88.72 105.22 17.55 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.333 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 t -88.43 130.34 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.673 HD22 ' CD2' ' A' ' 79' ' ' LEU . 5.9 m-80 57.37 18.09 4.17 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.565 0.698 . . . . 0.0 111.577 -173.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.13 11.71 78.01 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 120.599 -1.313 . . . . 0.0 113.5 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -119.37 123.27 43.75 Favored 'General case' 0 C--O 1.228 -0.062 0 CA-C-N 119.735 1.768 . . . . 0.0 108.421 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 112.1 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.138 0.975 . . . . 0.0 108.854 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.8 mt -144.89 108.26 4.6 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -174.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.09 31.49 4.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 126.718 2.007 . . . . 0.0 113.891 -163.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -142.38 157.27 44.97 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.6 -0.687 . . . . 0.0 111.182 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.5 p -62.72 137.47 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 163.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.33 -8.41 46.97 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.645 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.17 -53.68 7.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 163.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -139.58 145.0 27.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 119.244 0.929 . . . . 0.0 110.137 170.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.5 mt -124.15 -91.32 0.55 Allowed 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 163.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.89 -175.56 3.0 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.729 -1.232 . . . . 0.0 113.548 -174.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.508 ' HB1' ' CE1' ' A' ' 98' ' ' TYR . . . -58.57 -41.85 86.65 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.876 175.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -76.3 -7.47 55.0 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 123.727 0.642 . . . . 0.0 110.981 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -92.99 -4.8 51.99 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.927 1.291 . . . . 0.0 110.393 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.34 -65.17 1.18 Allowed 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.953 -1.717 . . . . 0.0 109.498 175.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.673 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.14 -172.68 3.57 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.475 1.51 . . . . 0.0 109.501 170.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -50.43 -17.87 0.55 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.712 2.005 . . . . 0.0 113.918 166.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.36 80.4 1.33 Allowed Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 125.435 1.493 . . . . 0.0 111.507 -174.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -143.62 -63.58 0.39 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 122.802 0.441 . . . . 0.0 111.548 163.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -131.46 -174.11 3.31 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.99 2.116 . . . . 0.0 108.172 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -160.73 164.12 31.84 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.839 1.656 . . . . 0.0 107.186 164.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG23 ' CD2' ' A' ' 19' ' ' PHE . 72.1 t -134.22 143.97 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 O-C-N 120.59 -1.319 . . . . 0.0 107.516 176.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.4 mm -125.06 98.38 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 127.774 2.429 . . . . 0.0 107.221 -172.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -96.13 84.62 3.83 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.401 ' HG3' ' H ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -82.14 114.08 20.43 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.77 1.78 0.7 Allowed Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 34.0 tptt -69.4 -46.23 67.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.58 1.69 . . . . 0.0 109.395 166.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -125.43 -90.27 0.55 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.801 1.24 . . . . 0.0 108.844 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.428 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.31 -159.88 1.02 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-N 119.671 1.123 . . . . 0.0 109.197 -163.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.428 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -99.46 83.84 2.88 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 130.826 3.65 . . . . 0.0 109.578 -176.166 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -78.46 158.97 28.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.131 -1.804 . . . . 0.0 106.131 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.9 tt -126.37 129.9 49.7 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -163.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.5 mm -120.82 122.53 68.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -168.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 11.5 ptt85 -128.63 171.89 11.73 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 124.044 1.878 . . . . 0.0 110.294 176.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.508 ' CE1' ' HB1' ' A' ' 75' ' ' ALA . 6.0 m-85 -143.56 158.47 43.63 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -164.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.796 0 C-N-CA 128.487 2.715 . . . . 0.0 111.127 169.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.225 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.04 93.53 0.09 Allowed 'General case' 0 C--O 1.233 0.184 0 C-N-CA 126.14 1.776 . . . . 0.0 109.078 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.21 -162.72 0.93 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.063 1.345 . . . . 0.0 107.781 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.1 m 60.65 71.57 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.231 1.812 . . . . 0.0 110.863 -176.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.08 -23.88 66.48 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.69 166.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.29 -79.86 0.12 Allowed 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -90.97 72.01 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 123.435 1.588 . . . . 0.0 109.787 -171.304 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.02 8.07 0.81 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 125.362 1.465 . . . . 0.0 112.335 165.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -99.29 -13.83 19.5 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.564 1.146 . . . . 0.0 109.029 164.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.67 80.22 0.72 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.465 0.706 . . . . 0.0 110.14 -172.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.03 174.76 10.76 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 126.861 2.064 . . . . 0.0 107.371 -178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.44 -49.71 70.43 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 119.841 -1.787 . . . . 0.0 112.039 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.23 73.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.631 0.651 . . . . 0.0 111.033 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.31 -38.45 71.73 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 125.261 1.425 . . . . 0.0 109.158 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 27.4 mt -69.3 -45.96 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 126.518 1.927 . . . . 0.0 106.61 178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -54.28 -57.91 9.41 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.463 175.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -71.85 -29.68 64.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.401 1.0 . . . . 0.0 109.94 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.54 -29.6 72.94 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 126.335 1.921 . . . . 0.0 110.414 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -117.11 -1.82 11.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.027 -173.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -59.02 -0.53 0.12 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.8 -13.35 59.86 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.844 1.202 . . . . 0.0 111.243 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 p -127.39 157.46 72.69 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 128.598 2.759 . . . . 0.0 105.785 167.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -87.08 176.66 4.29 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 121.313 1.342 . . . . 0.0 109.801 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.4 p -106.36 177.74 4.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.254 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -123.6 157.29 34.06 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 164.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 p -136.94 133.92 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 124.923 1.289 . . . . 0.0 108.347 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -123.72 -177.56 3.77 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.115 0.483 . . . . 0.0 111.743 163.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.78 39.43 0.95 Allowed 'General case' 0 C--N 1.318 -0.768 0 O-C-N 120.485 -1.384 . . . . 0.0 113.635 -163.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.67 -175.58 0.86 Allowed Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.903 -1.123 . . . . 0.0 112.788 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.18 131.83 0.23 Allowed Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.49 147.71 52.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -167.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 t -152.88 136.59 10.13 Favored Pre-proline 0 C--O 1.222 -0.382 0 C-N-CA 124.743 1.217 . . . . 0.0 108.345 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.451 ' HA ' ' CD2' ' A' ' 73' ' ' LEU . 61.3 Cg_endo -65.4 145.38 82.93 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.348 2.699 . . . . 0.0 111.394 -173.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.375 0.1 OUTLIER -43.22 -39.19 2.85 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 170.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -77.24 -13.0 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.963 1.305 . . . . 0.0 113.992 -177.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -100.1 -32.79 10.75 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 120.119 1.327 . . . . 0.0 109.444 167.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.48 -30.79 64.85 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 121.829 2.104 . . . . 0.0 108.237 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.9 -31.4 59.18 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 120.658 1.572 . . . . 0.0 110.076 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.27 -46.09 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 126.402 1.881 . . . . 0.0 107.265 -176.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.2 t -65.69 -41.86 91.9 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 128.145 2.578 . . . . 0.0 107.776 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.77 -18.14 48.62 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.74 29.86 9.54 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 118.531 0.605 . . . . 0.0 111.776 168.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.81 -47.06 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 175.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.7 m -155.34 113.65 2.27 Favored Pre-proline 0 CA--C 1.517 -0.299 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.77 -17.17 7.29 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.41 2.074 . . . . 0.0 113.532 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.63 116.17 23.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -167.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -36.96 66.79 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -163.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -69.06 -42.71 75.91 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 120.15 1.341 . . . . 0.0 110.197 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -61.65 -51.99 66.18 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -50.52 -51.53 46.75 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.49 1.916 . . . . 0.0 110.0 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -53.56 -48.48 69.1 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.583 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -78.35 -32.11 48.91 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.69 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -62.78 -17.71 61.5 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.746 1.218 . . . . 0.0 111.001 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 1.2 mp -90.07 -55.92 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 117.193 -1.384 . . . . 0.0 112.599 169.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -73.18 -6.74 47.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.567 1.076 . . . . 0.0 111.416 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' A' ' 58' ' ' ALA . 1.2 m-80 -78.32 138.5 38.6 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.367 1.08 . . . . 0.0 112.041 169.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.31 46.07 2.43 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.055 164.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -126.26 11.01 7.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.979 2.912 . . . . 0.0 110.456 165.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.332 0.0 OUTLIER -111.25 91.9 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 162.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -82.85 122.1 27.8 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.02 -1.9 . . . . 0.0 107.618 174.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.519 ' C ' ' H ' ' A' ' 63' ' ' GLY . 25.1 t -115.28 135.83 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.11 -16.88 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.795 2.038 . . . . 0.0 114.205 -174.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.519 ' H ' ' C ' ' A' ' 61' ' ' VAL . . . 152.19 -7.24 0.54 Allowed Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 126.683 2.087 . . . . 0.0 113.328 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.99 153.68 41.04 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 119.876 1.838 . . . . 0.0 110.651 -163.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.16 105.45 2.93 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.168 1.787 . . . . 0.0 110.066 -164.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 71.5 mt -134.36 102.73 5.45 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -173.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.482 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -128.86 38.61 3.92 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 128.151 2.58 . . . . 0.0 111.656 -163.685 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -139.66 146.83 40.17 Favored 'General case' 0 N--CA 1.457 -0.099 0 O-C-N 121.725 -0.609 . . . . 0.0 111.135 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.08 -37.01 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.382 0.673 . . . . 0.0 110.615 173.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.14 -12.8 83.24 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.418 -0.801 . . . . 0.0 112.779 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.5 -54.51 6.61 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.063 0.931 . . . . 0.0 109.177 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.1 mt -145.14 130.54 13.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 123.747 0.819 . . . . 0.0 109.367 -167.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.451 ' CD2' ' HA ' ' A' ' 33' ' ' PRO . 92.7 mt -122.26 -70.5 0.77 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 168.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.13 178.67 4.54 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.288 -1.507 . . . . 0.0 112.205 -177.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.52 -34.22 72.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -81.93 -12.17 58.53 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.535 0.607 . . . . 0.0 111.645 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -86.42 -1.24 57.39 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.219 1.408 . . . . 0.0 110.056 168.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.53 -79.1 0.58 Allowed 'General case' 0 C--N 1.341 0.216 0 O-C-N 120.109 -1.62 . . . . 0.0 106.875 175.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.59 -171.7 3.73 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 128.848 2.859 . . . . 0.0 108.735 176.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -48.99 -11.7 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 129.183 2.993 . . . . 0.0 115.664 163.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.21 82.35 1.59 Allowed Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 125.281 1.42 . . . . 0.0 111.728 -168.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.94 -81.56 0.34 Allowed 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 164.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -127.94 -162.19 1.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.429 1.491 . . . . 0.0 108.866 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -157.35 139.0 14.01 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 120.291 -1.506 . . . . 0.0 108.041 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.84 113.52 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -170.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.8 mm -95.72 139.71 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -128.12 82.89 2.11 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 163.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.425 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 1.3 tpm_? -79.0 95.12 5.41 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 172.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.25 -48.57 5.57 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 -171.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.425 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 20.5 tptm -68.21 -21.6 64.85 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.354 1.462 . . . . 0.0 113.859 -176.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -103.95 -98.67 0.31 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.4 OUTLIER -159.3 -162.64 1.08 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 123.001 1.381 . . . . 0.0 108.806 171.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.418 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 6.0 m-30 -78.48 147.23 34.0 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 163.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -144.15 174.05 11.21 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 128.646 2.778 . . . . 0.0 108.389 171.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.0 tp -135.33 137.03 42.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.187 1.795 . . . . 0.0 107.639 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 mm -130.69 131.85 64.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -173.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.5 ptt85 -139.22 173.1 11.91 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 123.46 1.6 . . . . 0.0 110.539 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.01 169.9 8.74 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.851 164.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.315 0 C-N-CA 128.491 2.716 . . . . 0.0 109.903 176.43 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.536 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.03 -78.0 0.08 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 154.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -140.41 -166.2 2.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.35 1.46 . . . . 0.0 108.405 166.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.6 m -155.92 172.28 18.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.982 1.313 . . . . 0.0 109.174 172.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.17 -92.87 0.14 Allowed Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.71 -63.47 1.4 Allowed 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.577 1.179 . . . . 0.0 107.923 -176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.2 pt -91.62 49.57 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.0 1.32 . . . . 0.0 111.459 -173.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -17.27 63.13 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.551 -0.718 . . . . 0.0 112.655 -176.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.31 -17.04 26.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.162 1.785 . . . . 0.0 110.707 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -154.08 78.15 1.1 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.669 1.188 . . . . 0.0 109.848 -166.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.6 p -77.97 179.78 6.55 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 121.115 -0.991 . . . . 0.0 109.031 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.47 82.82 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 120.107 -1.62 . . . . 0.0 110.495 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.96 94.84 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 122.065 0.936 . . . . 0.0 109.693 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -75.32 -19.99 59.33 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.38 1.072 . . . . 0.0 110.268 -175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.0 mt -81.7 -55.47 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 127.569 2.348 . . . . 0.0 106.927 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -56.19 -44.14 79.12 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.17 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -31.17 50.23 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.67 0.668 . . . . 0.0 109.345 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.45 -35.5 81.85 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.477 ' C ' ' H ' ' A' ' 21' ' ' ASP . 58.5 m-85 -119.18 17.54 13.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.461 1.105 . . . . 0.0 110.077 -168.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -56.62 5.37 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.906 2.883 . . . . 0.0 113.468 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 19' ' ' PHE . 0.5 OUTLIER -78.48 -27.66 46.3 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.728 2.411 . . . . 0.0 110.221 175.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.95 166.65 27.73 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 126.454 1.902 . . . . 0.0 107.406 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.02 173.43 13.63 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 167.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.4 p -106.46 177.77 4.76 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.767 167.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -123.47 152.98 41.13 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 163.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.68 134.01 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -119.92 -178.08 3.56 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.487 0.66 . . . . 0.0 111.637 164.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -82.34 5.68 19.45 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.553 1.941 . . . . 0.0 115.624 -163.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.98 -175.16 20.47 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.908 1.718 . . . . 0.0 110.176 -165.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.78 155.41 28.7 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.349 11.2 p-10 -91.75 143.81 26.15 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.628 1.171 . . . . 0.0 111.551 163.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.2 t -159.48 136.33 6.71 Favored Pre-proline 0 C--O 1.225 -0.188 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -163.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.49 147.3 57.87 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.86 1.707 . . . . 0.0 112.068 -172.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.402 0.4 OUTLIER -49.59 -26.6 3.69 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.435 1.094 . . . . 0.0 113.899 177.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.6 p -63.18 -61.5 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.926 1.239 . . . . 0.0 111.249 168.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -66.16 -36.68 83.75 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.083 0.856 . . . . 0.0 109.528 -171.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 pp -80.52 -24.4 39.39 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 116.598 -1.667 . . . . 0.0 110.034 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.31 -37.81 60.59 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 121.833 2.106 . . . . 0.0 109.82 176.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 t -73.82 -43.35 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.3 t -63.7 -32.52 74.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.941 0.896 . . . . 0.0 109.936 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.33 -17.09 57.02 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.602 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.27 27.68 39.22 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -44.71 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 176.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -157.07 91.46 2.42 Favored Pre-proline 0 C--N 1.348 0.541 0 CA-C-N 120.571 1.532 . . . . 0.0 106.968 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.72 -15.45 21.48 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.476 2.118 . . . . 0.0 112.588 -164.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.59 105.03 17.06 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 -174.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -53.27 -22.59 7.24 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -166.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.04 -60.36 3.73 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 120.314 1.415 . . . . 0.0 110.719 168.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.0 -49.14 66.82 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 125.983 1.713 . . . . 0.0 107.058 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -48.59 -58.43 4.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.391 1.057 . . . . 0.0 111.566 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.2 mtt-85 -65.81 -24.28 66.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 115.688 -2.101 . . . . 0.0 112.49 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -77.87 -39.9 41.81 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 121.442 1.928 . . . . 0.0 111.746 167.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.62 -25.03 52.0 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.995 0.918 . . . . 0.0 111.23 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 70.3 mt -83.59 -57.47 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 116.007 -1.949 . . . . 0.0 109.117 171.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -77.69 -5.77 51.63 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 124.879 1.362 . . . . 0.0 113.009 -163.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 58' ' ' ALA . 7.9 m120 -81.01 141.34 34.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.591 163.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 10.03 0.07 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.492 1.52 . . . . 0.0 113.341 163.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -78.34 -11.07 59.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.286 1.834 . . . . 0.0 110.085 172.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.422 ' HB ' ' HD3' ' A' ' 88' ' ' ARG 0.357 0.0 OUTLIER -102.74 92.77 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 124.855 2.264 . . . . 0.0 109.73 174.251 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -79.6 99.12 7.18 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 111.44 -2.618 . . . . 0.0 107.89 173.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 89.3 t -84.07 133.34 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.649 HD22 ' CD2' ' A' ' 79' ' ' LEU . 1.0 OUTLIER 60.92 14.76 5.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.699 0.4 . . . . 0.0 111.594 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.15 -1.84 57.72 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.083 1.325 . . . . 0.0 113.203 -174.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -131.73 123.63 28.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.791 1.795 . . . . 0.0 109.546 -164.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.46 111.25 0.35 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 127.836 2.454 . . . . 0.0 109.788 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.9 mt -145.87 102.25 3.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.06 40.7 2.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.478 1.911 . . . . 0.0 110.95 -165.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -148.23 153.49 38.8 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.282 -0.886 . . . . 0.0 111.866 -168.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.87 -41.43 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 126.518 1.927 . . . . 0.0 109.376 169.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.41 -0.99 50.01 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.902 -0.388 . . . . 0.0 112.686 172.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.81 -61.82 1.55 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.905 -1.045 . . . . 0.0 111.672 163.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.46 132.47 45.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 120.13 1.332 . . . . 0.0 113.149 -176.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.7 mt -99.6 -89.78 0.32 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 163.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 p -112.57 -168.8 1.37 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -173.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.26 -56.24 23.44 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.296 1.439 . . . . 0.0 114.577 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.26 -14.57 63.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.519 0.599 . . . . 0.0 111.781 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -80.8 -15.01 57.52 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 -82.09 0.54 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -178.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.649 ' CD2' HD22 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -89.91 174.47 7.66 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.568 1.547 . . . . 0.0 108.914 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -25.65 -51.12 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.285 3.034 . . . . 0.0 115.238 173.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.74 64.32 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.0 mmt-85 -140.82 -82.8 0.23 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.826 0.813 . . . . 0.0 109.727 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.409 ' H ' HD11 ' A' ' 79' ' ' LEU . 12.1 m-85 -130.29 -161.51 1.13 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.284 1.434 . . . . 0.0 110.361 -164.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.1 120.59 2.6 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.378 1.871 . . . . 0.0 108.899 167.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.3 t -78.95 134.04 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 173.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.4 mm -120.26 98.66 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 126.339 1.856 . . . . 0.0 106.274 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -92.84 82.25 4.69 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 171.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.422 ' HD3' ' HB ' ' A' ' 59' ' ' ILE . 15.8 tpp180 -84.04 96.24 8.82 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.274 2.63 . . . . 0.0 105.68 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.97 -24.16 33.66 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.395 0.521 . . . . 0.0 113.346 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -32.26 68.69 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.364 1.082 . . . . 0.0 112.638 171.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -135.96 -75.15 0.44 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.924 1.238 . . . . 0.0 112.037 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.54 -173.49 4.0 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 120.634 1.561 . . . . 0.0 109.465 -172.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -95.56 75.99 3.28 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.549 1.939 . . . . 0.0 110.393 174.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -78.57 171.62 14.85 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.947 -1.096 . . . . 0.0 110.567 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 28.2 tp -128.18 137.72 52.18 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.309 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.5 mm -131.28 132.92 62.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -175.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 -149.36 174.31 12.58 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 123.387 1.565 . . . . 0.0 112.449 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.16 169.62 8.66 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.785 163.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.557 0 C-N-CA 130.948 3.699 . . . . 0.0 106.768 172.359 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.5 mp -74.34 148.42 41.34 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 170.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -144.71 -47.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.443 1.897 . . . . 0.0 107.932 172.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.4 m -69.19 170.84 9.35 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.715 0.769 . . . . 0.0 109.239 163.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.04 57.19 4.81 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 124.839 1.209 . . . . 0.0 111.031 -170.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -78.7 -177.95 5.68 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 pp -61.92 72.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 128.649 2.78 . . . . 0.0 113.065 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.47 62.16 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.453 1.501 . . . . 0.0 112.516 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -78.62 -19.6 52.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.093 0.957 . . . . 0.0 110.176 173.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.93 80.06 1.28 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.064 0.945 . . . . 0.0 109.502 -172.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.34 177.11 8.71 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.959 -1.088 . . . . 0.0 108.205 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.07 -53.0 52.43 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.634 1.174 . . . . 0.0 112.018 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.45 -26.85 66.6 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.1 0.25 . . . . 0.0 110.38 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.99 -43.67 70.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 mt -68.23 -53.47 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 118.2 -0.905 . . . . 0.0 108.82 177.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -59.36 -50.58 73.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 118.236 -1.385 . . . . 0.0 111.695 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -69.36 -30.81 68.9 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 120.143 1.338 . . . . 0.0 109.065 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.21 -42.72 99.29 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.487 ' C ' ' H ' ' A' ' 21' ' ' ASP 0.258 40.6 m-85 -113.56 1.62 15.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -165.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -59.14 17.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.103 2.561 . . . . 0.0 114.258 163.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 19' ' ' PHE . 12.1 t0 -78.09 -37.5 46.31 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.284 2.233 . . . . 0.0 107.591 164.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.91 165.14 28.93 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.895 1.678 . . . . 0.0 106.6 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -80.68 177.84 7.63 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.45 2.1 . . . . 0.0 109.292 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 p -113.61 -177.93 3.25 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.837 -173.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -140.39 162.91 34.18 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.259 1.024 . . . . 0.0 108.541 167.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.3 p -143.34 138.43 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 125.294 1.438 . . . . 0.0 107.931 172.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -117.99 139.33 51.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.928 0.871 . . . . 0.0 109.558 163.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -81.35 73.11 8.4 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.89 153.97 24.11 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.209 -1.359 . . . . 0.0 113.182 -171.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.85 -157.15 15.65 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 163.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -60.97 140.32 57.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.582 0.353 . . . . 0.0 111.16 -174.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 t -155.06 137.1 9.76 Favored Pre-proline 0 C--O 1.223 -0.3 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -164.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -48.95 131.28 25.13 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.729 3.619 . . . . 0.0 112.559 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.33 0.7 OUTLIER -47.64 -36.27 10.67 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 168.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.23 -2.61 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.157 1.383 . . . . 0.0 113.605 -177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -98.85 -44.05 6.51 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 168.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.38 -20.73 56.88 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 116.499 -1.715 . . . . 0.0 109.944 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.4 -26.97 52.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 121.656 2.026 . . . . 0.0 110.777 175.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.68 -42.35 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 126.48 1.912 . . . . 0.0 106.862 -172.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.66 -48.91 77.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.185 2.194 . . . . 0.0 109.002 167.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.57 -15.96 57.96 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.74 -171.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.36 36.34 7.06 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 164.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.39 -56.37 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 102.423 -3.177 . . . . 0.0 102.423 171.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -150.75 103.91 3.04 Favored Pre-proline 0 C--N 1.342 0.259 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.66 -10.49 13.1 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.851 2.367 . . . . 0.0 113.7 -172.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.6 t -90.9 116.3 28.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -53.07 -36.1 60.29 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -54.18 48.97 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.16 1.345 . . . . 0.0 109.12 173.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -57.3 -52.41 65.45 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -45.79 -55.47 6.53 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.518 1.527 . . . . 0.0 111.127 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -58.18 -41.73 84.5 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.162 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.43 -37.95 68.47 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.633 1.106 . . . . 0.0 111.778 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.77 -15.27 27.84 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 126.274 1.829 . . . . 0.0 110.794 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 2.2 mt -117.03 -15.87 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 176.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -91.56 -5.94 53.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.675 1.58 . . . . 0.0 111.375 168.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -82.34 135.56 35.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 176.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.36 3.74 0.31 Allowed Glycine 0 CA--C 1.537 1.42 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.304 165.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.471 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -94.09 -0.71 55.2 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.683 1.593 . . . . 0.0 112.373 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . 0.321 0.0 OUTLIER -102.87 96.92 5.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 124.913 2.292 . . . . 0.0 107.892 173.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -90.32 98.51 11.81 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 111.735 -2.484 . . . . 0.0 108.361 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.2 t -81.38 127.55 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 52.76 25.08 3.57 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.205 1.002 . . . . 0.0 112.062 -169.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.65 8.23 61.0 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.617 -1.657 . . . . 0.0 113.518 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -128.81 126.63 40.28 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.758 2.279 . . . . 0.0 109.288 -174.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.45 110.64 0.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.249 1.42 . . . . 0.0 108.781 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.7 mt -145.96 81.66 1.6 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -175.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.02 46.6 1.04 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.724 2.01 . . . . 0.0 112.088 -169.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -148.55 150.02 32.61 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.165 -1.584 . . . . 0.0 114.213 -174.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.4 p -63.29 -43.69 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 125.967 1.707 . . . . 0.0 111.852 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.38 -9.6 85.82 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 174.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.3 -56.32 4.43 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 116.215 -1.85 . . . . 0.0 108.263 167.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -138.31 138.41 43.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 CA-C-N 121.409 1.913 . . . . 0.0 113.726 177.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.6 mt -110.47 -88.02 0.51 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 101.777 -3.416 . . . . 0.0 101.777 163.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -102.49 -174.31 2.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 119.888 1.222 . . . . 0.0 113.689 -174.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB2' ' CE2' ' A' ' 98' ' ' TYR . . . -60.6 -47.13 87.59 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.63 -17.26 64.07 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.723 0.692 . . . . 0.0 111.87 175.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.61 -9.56 59.41 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.491 -0.756 . . . . 0.0 109.358 174.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.7 -75.07 0.63 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.334 0.97 . . . . 0.0 109.8 174.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.654 ' CD1' ' H ' ' A' ' 82' ' ' ARG . 1.3 pp -91.67 -170.17 2.51 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.787 1.235 . . . . 0.0 109.95 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -55.89 -26.82 49.09 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 127.51 69.81 0.16 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 127.374 2.416 . . . . 0.0 112.192 178.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.654 ' H ' ' CD1' ' A' ' 79' ' ' LEU . 90.3 mtt-85 -143.02 -45.63 0.3 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.513 ' H ' HD11 ' A' ' 79' ' ' LEU . 39.6 m-85 -157.94 -176.65 6.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.457 1.903 . . . . 0.0 109.348 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.49 124.4 9.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.259 -1.526 . . . . 0.0 107.014 163.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.23 147.59 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 166.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.5 mm -129.7 93.01 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 C-N-CA 125.504 1.522 . . . . 0.0 107.069 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -89.77 84.34 6.27 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.76 98.38 6.26 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 166.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -52.72 143.65 23.48 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 170.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.4 tptm 69.08 -0.31 2.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.226 2.61 . . . . 0.0 114.035 -169.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -117.47 -104.88 0.4 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 165.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.507 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.1 -171.91 4.04 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 119.831 1.196 . . . . 0.0 108.062 175.006 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.507 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 1.3 m-30 -114.1 82.88 1.78 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 126.743 2.017 . . . . 0.0 107.942 -173.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -79.45 169.14 18.5 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.386 0.674 . . . . 0.0 109.866 -175.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.4 tp -130.74 135.73 48.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.244 1.018 . . . . 0.0 108.699 -175.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 mt -134.53 134.69 54.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.504 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 9.4 ttt180 -135.24 -175.6 3.98 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 123.715 1.722 . . . . 0.0 112.067 171.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.504 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -122.73 158.59 29.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.188 165.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.399 0 C-N-CA 128.693 2.797 . . . . 0.0 107.921 172.469 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.212 -0.909 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.95 -54.49 21.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 122.389 2.359 . . . . 0.0 112.162 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.43 -23.75 62.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.766 0.793 . . . . 0.0 109.394 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.58 -32.92 23.53 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -173.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.476 ' CG2' HD13 ' A' ' 95' ' ' LEU . 26.8 mt -71.49 -48.51 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 171.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -52.73 -58.52 6.6 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.63 0.65 . . . . 0.0 111.176 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -74.6 -24.71 58.92 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.642 1.11 . . . . 0.0 110.239 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.72 -40.26 97.29 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.44 ' C ' ' H ' ' A' ' 21' ' ' ASP . 45.9 m-85 -126.42 12.69 7.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -163.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.06 9.08 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 129.776 3.23 . . . . 0.0 113.68 163.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 19' ' ' PHE . 23.7 t70 -78.41 -38.22 42.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.752 2.421 . . . . 0.0 108.48 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.34 168.34 10.75 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.375 1.47 . . . . 0.0 109.58 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.92 178.11 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.13 1.887 . . . . 0.0 110.327 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 p -129.48 171.97 12.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.08 1.752 . . . . 0.0 109.874 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -137.67 166.56 23.66 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.863 1.265 . . . . 0.0 108.646 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 p -139.62 133.94 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 179.07 4.06 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 119.114 0.87 . . . . 0.0 109.961 163.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -78.75 15.82 0.99 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.536 1.534 . . . . 0.0 113.989 -163.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.8 -176.92 38.87 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -163.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.4 149.45 5.99 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -163.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.82 153.49 41.9 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.894 -0.768 . . . . 0.0 111.051 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -161.28 131.3 3.43 Favored Pre-proline 0 CA--C 1.509 -0.604 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -165.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.551 ' HA ' HD23 ' A' ' 73' ' ' LEU . 90.0 Cg_endo -68.65 148.61 72.41 Favored 'Trans proline' 0 N--CA 1.436 -1.901 0 C-N-CA 121.69 1.593 . . . . 0.0 110.355 -174.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.779 HD22 HG13 ' A' ' 54' ' ' ILE 0.264 0.0 OUTLIER -44.85 -41.04 6.72 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.96 -1.473 . . . . 0.0 112.485 178.727 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.691 ' HA ' HD22 ' A' ' 38' ' ' LEU . 8.0 p -80.89 -7.75 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.92 2.088 . . . . 0.0 114.886 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.419 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 77.1 mm-40 -104.53 -30.95 9.69 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 117.648 -1.168 . . . . 0.0 108.508 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -80.84 -20.2 42.92 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 121.593 1.997 . . . . 0.0 110.094 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.713 HD13 ' CD1' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -77.36 -29.22 53.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 120.971 1.714 . . . . 0.0 109.866 173.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -75.63 -46.85 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.295 1.838 . . . . 0.0 107.033 -172.074 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.4 m -57.24 -52.55 64.88 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 129.939 3.295 . . . . 0.0 109.221 167.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.15 -10.27 59.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.028 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.51 29.69 15.81 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 122.842 1.246 . . . . 0.0 111.926 166.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.477 ' CG2' HD12 ' A' ' 38' ' ' LEU . 1.2 mp -77.92 -51.05 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 176.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -156.85 99.47 2.02 Favored Pre-proline 0 C--N 1.344 0.364 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.75 -15.97 10.51 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.911 2.407 . . . . 0.0 113.617 -172.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.5 t -76.61 115.26 16.2 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -52.36 -37.61 56.63 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.183 1.356 . . . . 0.0 114.419 -164.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -54.44 43.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.099 0.863 . . . . 0.0 109.595 172.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -58.94 -47.77 83.88 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.736 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.481 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -46.27 -55.08 7.73 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.378 1.471 . . . . 0.0 110.383 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.467 ' HG2' HG21 ' A' ' 35' ' ' VAL . 71.9 mtt-85 -65.0 -34.32 78.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 116.594 -1.67 . . . . 0.0 111.577 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.34 -36.36 58.28 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.777 1.626 . . . . 0.0 112.378 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -17.6 63.34 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.131 1.372 . . . . 0.0 110.543 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.779 HG13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -92.32 -52.73 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 116.482 -1.723 . . . . 0.0 111.895 166.396 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -69.92 -6.5 33.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 120.488 1.495 . . . . 0.0 111.577 -170.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.534 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.3 m120 -79.9 139.77 36.98 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.2 26.29 0.44 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.025 1.774 . . . . 0.0 113.526 164.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -115.59 5.06 14.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.691 2.396 . . . . 0.0 111.403 170.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.575 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.319 0.0 OUTLIER -106.63 94.13 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 124.52 2.105 . . . . 0.0 106.065 163.893 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 3.0 m-85 -79.99 106.73 12.23 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.026 168.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.554 HG21 HD13 ' A' ' 72' ' ' ILE . 10.7 t -83.81 124.61 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 173.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.648 HD22 ' HG3' ' A' ' 78' ' ' ARG . 63.4 m-20 53.5 27.39 6.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.96 -2.41 59.94 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.258 -1.301 . . . . 0.0 113.748 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -119.32 122.68 42.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.365 1.583 . . . . 0.0 107.151 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.46 109.0 0.49 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.63 ' HB3' HD11 ' A' ' 72' ' ' ILE . 83.1 mt -143.02 103.83 4.22 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 -171.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -127.91 45.3 2.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.867 2.067 . . . . 0.0 112.863 -163.641 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -154.42 154.12 32.7 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.975 0.91 . . . . 0.0 110.615 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 81.9 t -63.36 -38.19 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.785 1.234 . . . . 0.0 109.748 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.77 -2.21 60.49 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.83 -0.983 . . . . 0.0 113.061 171.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.33 -57.0 2.93 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.842 1.321 . . . . 0.0 111.391 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.63 HD11 ' HB3' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -141.28 148.17 21.56 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 121.164 1.802 . . . . 0.0 111.098 178.083 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' A' ' 33' ' ' PRO . 64.9 mt -112.38 -93.11 0.46 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 163.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 p -108.43 -170.24 1.64 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -169.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.12 73.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.755 1.222 . . . . 0.0 113.504 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.4 -17.95 64.94 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.107 0.963 . . . . 0.0 111.161 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 58.1 t-80 -86.48 -5.99 59.01 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.523 -0.736 . . . . 0.0 110.665 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.648 ' HG3' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -119.53 -64.99 1.21 Allowed 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.095 1.316 . . . . 0.0 110.512 178.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.59 178.38 7.41 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 164.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.75 -26.05 56.36 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.592 -0.693 . . . . 0.0 112.095 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.82 84.15 0.17 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 124.651 1.12 . . . . 0.0 113.299 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.12 -82.83 0.57 Allowed 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 167.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -119.55 -165.62 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.813 2.045 . . . . 0.0 108.171 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.18 138.64 12.7 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 163.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.7 t -83.99 139.27 17.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 166.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.9 mm -115.62 94.48 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' A' ' 60' ' ' TYR . 33.9 ttm-85 -91.46 75.13 5.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -78.98 92.59 4.97 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -51.19 -32.57 29.0 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.103 1.335 . . . . 0.0 113.425 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.26 -12.59 60.51 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.78 -1.424 . . . . 0.0 112.962 177.283 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -135.91 -97.55 0.23 Allowed 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 127.161 2.185 . . . . 0.0 105.864 -174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.445 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -159.17 -159.89 0.8 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 120.889 1.677 . . . . 0.0 109.415 174.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.445 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -110.23 75.9 0.96 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.058 2.143 . . . . 0.0 108.475 -167.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -78.23 164.56 24.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -171.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.476 HD13 ' CG2' ' A' ' 15' ' ' ILE . 18.0 tp -125.03 129.89 51.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.476 -164.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 95' ' ' LEU . 30.6 mm -125.02 129.27 73.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -171.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.473 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 13.1 ttp180 -131.47 -177.15 4.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 124.064 1.888 . . . . 0.0 110.92 164.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.473 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -123.67 165.63 16.89 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 126.273 1.829 . . . . 0.0 110.743 173.196 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 127.148 2.179 . . . . 0.0 111.465 178.05 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.02 -57.08 8.57 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 124.043 0.937 . . . . 0.0 111.225 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.85 -21.94 66.5 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.541 0.525 . . . . 0.0 110.706 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -82.74 -37.19 25.0 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.789 0.835 . . . . 0.0 109.624 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.4 mt -67.71 -45.07 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -55.47 -60.44 3.42 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.775 1.171 . . . . 0.0 110.541 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -75.89 -20.18 58.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.377 -0.827 . . . . 0.0 110.27 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.66 -38.44 90.03 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -126.58 11.75 7.37 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.629 0.772 . . . . 0.0 112.841 -164.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -56.18 7.19 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.73 2.412 . . . . 0.0 115.322 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -78.29 -34.78 48.6 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.243 1.417 . . . . 0.0 109.263 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.5 165.25 14.83 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 125.883 1.673 . . . . 0.0 108.251 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -68.98 177.72 4.78 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.801 1.667 . . . . 0.0 110.542 168.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 p -120.85 -177.59 3.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.999 1.72 . . . . 0.0 109.551 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -142.86 160.96 39.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.769 1.228 . . . . 0.0 109.362 164.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 9.9 p -143.88 136.35 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 C-N-CA 125.282 1.433 . . . . 0.0 108.271 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 98' ' ' TYR . 0.8 OUTLIER -118.8 179.05 4.26 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 119.123 0.874 . . . . 0.0 110.042 163.496 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -89.81 56.94 3.67 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 120.415 -1.428 . . . . 0.0 109.703 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.03 -158.94 19.75 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.723 0.678 . . . . 0.0 112.324 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.29 123.53 1.76 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.254 1.0 OUTLIER -59.91 130.47 46.89 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.203 1.501 . . . . 0.0 107.182 171.704 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -151.85 140.16 13.3 Favored Pre-proline 0 CA--C 1.507 -0.687 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -163.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.449 ' HA ' HD23 ' A' ' 73' ' ' LEU . 65.3 Cg_endo -77.7 152.78 29.46 Favored 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 121.495 1.463 . . . . 0.0 110.689 -167.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.356 0.4 OUTLIER -47.15 -33.17 4.9 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.416 173.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.704 ' HA ' HD11 ' A' ' 54' ' ' ILE . 11.5 p -72.83 -15.51 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 58.0 mm-40 -105.6 -42.04 5.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.1 -31.33 67.66 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 116.806 -1.569 . . . . 0.0 108.696 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -27.19 34.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 121.51 1.959 . . . . 0.0 109.562 -174.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -47.85 42.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 125.692 1.597 . . . . 0.0 107.976 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -34.79 78.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.313 0.645 . . . . 0.0 109.965 173.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.416 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.51 -14.32 59.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.237 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.46 27.88 21.22 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 164.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.1 mp -78.37 -45.93 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.7 108.14 2.17 Favored Pre-proline 0 C--N 1.343 0.316 0 CA-C-N 120.532 1.515 . . . . 0.0 106.945 167.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.45 -15.59 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.227 1.952 . . . . 0.0 112.183 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.0 m -88.19 105.85 17.8 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 -169.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 tptt -52.18 -32.58 36.8 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -163.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -54.65 42.32 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.341 1.428 . . . . 0.0 109.619 169.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -57.39 -48.13 79.89 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 117.801 -1.095 . . . . 0.0 108.603 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.4 -61.61 1.83 Allowed 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 125.189 1.556 . . . . 0.0 110.14 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.413 ' HA ' HD12 ' A' ' 54' ' ' ILE . 78.5 mtt-85 -62.84 -25.67 68.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 115.923 -1.989 . . . . 0.0 112.656 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.68 -40.7 28.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 121.745 2.066 . . . . 0.0 112.988 168.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' HA ' HH11 ' A' ' 88' ' ' ARG . 5.9 m-20 -62.96 -13.93 41.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.355 1.062 . . . . 0.0 111.41 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.704 HD11 ' HA ' ' A' ' 35' ' ' VAL . 66.1 mt -89.22 -64.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 C-N-CA 126.626 1.97 . . . . 0.0 109.04 163.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -61.89 -11.25 12.06 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.902 1.281 . . . . 0.0 112.21 -165.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 59' ' ' ILE . 5.1 m120 -82.45 131.37 35.22 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 118.824 0.738 . . . . 0.0 111.365 172.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.42 36.26 0.56 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 126.585 2.04 . . . . 0.0 111.716 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -117.18 -1.43 11.85 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 127.185 2.194 . . . . 0.0 111.027 165.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 56' ' ' ASN 0.339 0.0 OUTLIER -91.75 92.11 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 121.726 2.057 . . . . 0.0 106.501 163.562 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -80.66 100.8 8.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.924 -1.944 . . . . 0.0 108.101 171.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' A' ' 72' ' ' ILE . 15.8 t -80.2 128.88 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 175.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.416 ' HA ' ' CG1' ' A' ' 85' ' ' VAL 0.257 23.8 m120 64.23 -6.63 0.26 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.65 4.6 26.45 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.137 1.351 . . . . 0.0 112.795 -169.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.87 119.33 32.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 108.56 0.78 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.344 1.458 . . . . 0.0 107.142 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.487 ' CB ' HD11 ' A' ' 72' ' ' ILE . 80.5 mt -141.4 88.17 2.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.89 25.05 3.34 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.996 1.318 . . . . 0.0 113.59 -173.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.66 154.77 46.53 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.54 -43.01 96.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 126.869 2.067 . . . . 0.0 110.803 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.6 -9.74 59.27 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.65 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.45 -47.49 7.41 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 117.562 -1.208 . . . . 0.0 112.24 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.524 ' CD1' HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -140.09 135.04 37.11 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 CA-C-N 121.423 1.92 . . . . 0.0 113.308 178.283 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 33' ' ' PRO . 80.5 mt -113.86 -97.3 0.44 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 163.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -97.87 -177.13 3.66 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.39 -1.444 . . . . 0.0 114.404 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.446 ' HB3' ' CE2' ' A' ' 98' ' ' TYR . . . -63.19 -37.78 88.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 120.967 -1.083 . . . . 0.0 113.119 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.55 -17.73 62.3 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.15 0.887 . . . . 0.0 111.11 174.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -81.22 -15.99 54.02 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.487 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.16 -59.58 1.98 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 120.223 1.374 . . . . 0.0 111.175 -173.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -171.51 3.01 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.163 1.385 . . . . 0.0 110.265 166.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -53.61 -6.21 0.07 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 129.307 3.043 . . . . 0.0 114.725 163.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.85 79.89 1.48 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.954 1.264 . . . . 0.0 111.489 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 -63.61 0.55 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.306 0.642 . . . . 0.0 110.112 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -156.1 -169.58 3.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.022 2.929 . . . . 0.0 106.915 -175.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -154.5 152.67 30.38 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 119.605 -1.934 . . . . 0.0 107.07 163.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.416 ' CG1' ' HA ' ' A' ' 62' ' ' ASN . 9.9 p -115.7 151.43 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 C-N-CA 124.048 0.939 . . . . 0.0 109.337 171.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.48 HD12 HD11 ' A' ' 59' ' ' ILE . 27.8 mm -132.85 96.66 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 127.249 2.22 . . . . 0.0 108.011 -171.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -96.3 86.88 4.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.456 HH11 ' HA ' ' A' ' 53' ' ' ASP . 1.2 tpm_? -82.05 110.62 17.45 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 174.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.62 -20.17 45.26 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-N 120.123 1.329 . . . . 0.0 115.252 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -72.01 -11.69 60.88 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.124 1.962 . . . . 0.0 111.228 171.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -148.59 -156.05 0.69 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.014 2.126 . . . . 0.0 107.453 -165.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -150.75 0.35 Allowed 'General case' 0 C--O 1.248 0.979 0 CA-C-O 122.883 1.325 . . . . 0.0 111.615 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.87 77.33 1.36 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.802 2.441 . . . . 0.0 109.018 -164.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -78.34 165.35 23.95 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.489 -0.757 . . . . 0.0 109.457 -170.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.538 ' C ' HD12 ' A' ' 96' ' ' ILE . 1.2 tt -128.54 128.16 43.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -164.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.538 HD12 ' C ' ' A' ' 95' ' ' LEU . 1.9 mp -127.08 135.64 63.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 124.369 1.068 . . . . 0.0 108.89 -169.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 9.4 ttt180 -139.29 -176.6 4.58 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 125.657 2.646 . . . . 0.0 114.335 167.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.497 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -115.86 161.04 19.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 112.451 -2.159 . . . . 0.0 107.866 163.623 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 C-N-CA 126.727 2.011 . . . . 0.0 107.462 -174.802 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -57.38 12.97 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.804 1.641 . . . . 0.0 110.919 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.41 -20.87 65.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.833 0.288 . . . . 0.0 111.516 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.76 -38.89 27.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.848 1.259 . . . . 0.0 110.355 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.474 ' CG2' HD13 ' A' ' 95' ' ' LEU . 18.6 mt -69.19 -51.01 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.71 1.204 . . . . 0.0 107.951 172.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.92 -57.61 8.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.154 0.888 . . . . 0.0 110.517 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.99 -23.41 58.26 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.231 -0.918 . . . . 0.0 110.472 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.61 95.76 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -119.35 9.54 11.67 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -165.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -55.55 -9.57 0.52 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.645 2.378 . . . . 0.0 116.451 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.68 -29.34 45.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.678 1.591 . . . . 0.0 111.198 175.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.526 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -105.06 163.08 17.87 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -179.279 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.526 ' HD2' HG12 ' A' ' 22' ' ' VAL . 94.5 Cg_endo -72.07 172.88 13.82 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 CA-C-O 122.855 1.106 . . . . 0.0 109.375 174.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.8 p -120.55 171.85 8.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 113.197 -1.819 . . . . 0.0 108.073 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -137.11 152.91 50.54 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.94 134.66 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -125.86 152.58 45.33 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 122.599 1.19 . . . . 0.0 111.045 163.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -81.5 53.7 2.16 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 126.31 1.844 . . . . 0.0 110.965 -169.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.56 174.81 50.13 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.395 1.95 . . . . 0.0 114.015 166.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.75 149.07 16.15 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -75.18 151.87 38.47 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.13 0.49 . . . . 0.0 111.56 164.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.7 t -160.94 135.09 5.14 Favored Pre-proline 0 CA--C 1.513 -0.474 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -163.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HA ' HD23 ' A' ' 73' ' ' LEU . 84.5 Cg_endo -73.15 147.33 42.49 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 121.641 1.561 . . . . 0.0 111.16 -174.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.336 0.3 OUTLIER -49.63 -30.05 8.25 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.675 175.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.717 ' HA ' HD11 ' A' ' 54' ' ' ILE . 7.4 p -74.04 -18.51 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -97.6 -46.69 5.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.075 -0.964 . . . . 0.0 108.424 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.6 -22.76 56.61 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 116.426 -1.749 . . . . 0.0 109.621 -168.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.98 -25.59 29.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 121.259 1.845 . . . . 0.0 109.9 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 44' ' ' SER . 1.5 t -77.7 -46.74 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -59.61 -40.63 88.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.663 1.985 . . . . 0.0 110.234 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.409 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.41 -17.73 56.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.481 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.51 34.67 6.88 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 163.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.1 mp -78.45 -53.14 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.416 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -156.13 95.63 2.35 Favored Pre-proline 0 C--N 1.349 0.549 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.11 -18.02 14.71 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.6 2.2 . . . . 0.0 113.128 -171.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.1 t -75.75 109.51 9.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -57.03 -27.84 61.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -163.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -49.39 66.69 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.726 1.603 . . . . 0.0 110.491 169.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -57.97 -50.46 73.3 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.26 -58.23 3.86 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 125.936 2.023 . . . . 0.0 109.703 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -58.7 -35.31 72.44 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 117.82 -1.086 . . . . 0.0 111.387 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -73.58 -45.83 50.87 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 118.103 -1.439 . . . . 0.0 112.089 170.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.514 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.9 m-20 -62.22 -12.81 22.3 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.513 1.125 . . . . 0.0 111.7 -174.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.717 HD11 ' HA ' ' A' ' 35' ' ' VAL . 56.7 mt -89.41 -66.88 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 127.763 2.425 . . . . 0.0 109.07 164.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -71.58 -1.88 15.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.939 1.245 . . . . 0.0 113.331 -164.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.532 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.2 m120 -80.05 130.79 35.53 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.233 -0.917 . . . . 0.0 110.377 164.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.78 6.6 0.34 Allowed Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.967 -0.458 . . . . 0.0 114.025 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.78 -8.27 59.68 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 116.701 -1.618 . . . . 0.0 111.746 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 56' ' ' ASN 0.359 0.0 OUTLIER -92.77 92.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 125.569 2.604 . . . . 0.0 108.099 164.975 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -79.45 99.42 7.2 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 111.447 -2.615 . . . . 0.0 108.208 170.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.622 HG21 HD13 ' A' ' 72' ' ' ILE . 22.1 t -82.17 127.8 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 m120 61.37 7.48 1.76 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.46 7.96 56.54 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.867 1.223 . . . . 0.0 113.077 -171.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -121.73 117.93 27.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 106.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.726 1.61 . . . . 0.0 109.114 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' A' ' 72' ' ' ILE . 44.6 mt -142.33 89.73 2.18 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 1.0 OUTLIER -113.31 39.56 2.57 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.939 2.096 . . . . 0.0 112.755 -164.422 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -151.47 161.71 42.23 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.471 -1.393 . . . . 0.0 112.17 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.52 -26.37 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.149 1.38 . . . . 0.0 110.252 164.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.43 -14.28 74.5 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-O 119.417 -0.657 . . . . 0.0 113.344 167.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.53 -58.84 2.3 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.779 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -138.91 144.48 29.54 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 CA-C-N 121.143 1.792 . . . . 0.0 113.221 -177.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 33' ' ' PRO . 74.2 mt -109.61 -93.14 0.43 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 101.355 -3.572 . . . . 0.0 101.355 163.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 p -108.79 -170.99 1.76 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.11 -44.49 83.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.496 1.119 . . . . 0.0 113.79 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.05 -15.89 62.57 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.238 0.926 . . . . 0.0 112.197 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 51.7 t-80 -87.98 0.97 55.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.916 0.886 . . . . 0.0 109.762 173.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -79.58 0.59 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 167.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.607 HD11 ' H ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.09 -168.51 2.08 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.538 1.135 . . . . 0.0 109.848 176.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.01 0.05 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.869 2.867 . . . . 0.0 115.317 171.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.23 50.13 3.09 Favored Glycine 0 C--N 1.337 0.585 0 O-C-N 120.991 -1.068 . . . . 0.0 111.734 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -104.58 -65.92 1.0 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 172.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.607 ' H ' HD11 ' A' ' 79' ' ' LEU . 53.9 m-85 -145.3 -167.16 2.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.772 1.629 . . . . 0.0 107.153 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.89 140.95 13.77 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.923 1.238 . . . . 0.0 109.106 163.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 t -93.55 150.63 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.775 1.23 . . . . 0.0 108.568 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.469 HD13 HG22 ' A' ' 61' ' ' VAL . 22.2 mm -132.44 97.63 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 C-N-CA 126.767 2.027 . . . . 0.0 108.262 177.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -97.76 90.47 4.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.514 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER -83.54 94.18 7.99 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.17 112.56 2.67 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt 137.53 -50.66 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 131.496 3.919 . . . . 0.0 107.773 -164.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.0 -110.51 0.35 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.04 -154.78 0.57 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-N 120.049 1.295 . . . . 0.0 109.173 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -115.0 78.85 1.2 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.971 2.508 . . . . 0.0 108.226 -164.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.403 ' CD1' HG13 ' A' ' 43' ' ' ILE . 79.1 m-85 -78.14 169.41 18.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.049 -1.032 . . . . 0.0 109.078 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.474 HD13 ' CG2' ' A' ' 15' ' ' ILE . 16.8 tp -127.02 131.38 51.01 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.775 -171.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.21 133.05 69.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 125.104 1.362 . . . . 0.0 107.37 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.487 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 7.8 ttt180 -145.39 -177.18 5.43 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 124.534 2.111 . . . . 0.0 111.783 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.487 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -126.12 159.33 33.16 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 112.636 -2.075 . . . . 0.0 111.59 164.526 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.476 0 C-N-CA 126.82 2.048 . . . . 0.0 106.1 165.415 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.213 -0.849 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.98 81.01 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 119.988 -1.695 . . . . 0.0 113.515 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.29 -29.89 67.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.553 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -72.63 -36.5 68.05 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.2 mt -73.15 -52.25 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 127.101 2.161 . . . . 0.0 107.921 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.62 -47.06 87.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.953 -175.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -80.14 -27.11 39.11 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.815 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.86 -37.6 93.49 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 126.047 1.784 . . . . 0.0 109.975 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -123.56 12.28 9.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.12 -164.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -57.96 -9.01 1.16 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.42 -12.79 60.03 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.228 1.411 . . . . 0.0 111.726 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.23 168.53 11.41 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 120.617 -1.302 . . . . 0.0 108.888 167.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.09 174.67 12.44 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.678 1.585 . . . . 0.0 110.865 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -127.2 150.31 49.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.679 1.592 . . . . 0.0 109.0 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 38.2 t80 -134.96 159.5 41.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.505 1.048 . . . . 0.0 108.767 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.4 t -138.85 132.3 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 124.465 1.106 . . . . 0.0 108.623 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -113.23 -174.48 2.46 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 123.18 0.592 . . . . 0.0 110.501 163.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -87.96 8.79 24.69 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -163.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.55 176.35 32.65 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 120.907 -1.121 . . . . 0.0 110.859 -164.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.08 139.22 1.68 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -164.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.38 148.02 49.59 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.8 t -155.0 132.5 6.43 Favored Pre-proline 0 CA--C 1.51 -0.582 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -167.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HA ' HD23 ' A' ' 73' ' ' LEU . 71.9 Cg_endo -68.91 150.53 73.4 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.468 2.112 . . . . 0.0 110.975 -173.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.555 HD23 HD12 ' A' ' 72' ' ' ILE 0.332 0.0 OUTLIER -49.82 -34.48 19.79 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.306 174.985 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.487 ' HA ' HD22 ' A' ' 38' ' ' LEU . 3.1 p -76.71 -14.88 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.531 1.932 . . . . 0.0 114.165 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -94.18 -40.1 10.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 120.278 1.399 . . . . 0.0 109.944 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.8 -24.46 58.65 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 116.89 -1.529 . . . . 0.0 108.989 -172.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.581 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -73.13 -33.84 65.76 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 121.068 1.758 . . . . 0.0 109.833 172.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.494 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -75.19 -48.82 30.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.14 1.776 . . . . 0.0 106.849 -169.166 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -65.73 -34.12 77.46 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.569 1.547 . . . . 0.0 110.023 170.654 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.36 -14.17 59.52 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 120.675 1.579 . . . . 0.0 111.353 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.7 21.61 33.52 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 164.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.638 HG21 ' NH1' ' A' ' 88' ' ' ARG . 1.5 mm -78.36 -39.92 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -171.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 m -157.3 95.58 2.11 Favored Pre-proline 0 C--N 1.342 0.244 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.439 ' HA ' HG22 ' A' ' 39' ' ' VAL . 78.1 Cg_endo -77.71 -14.18 15.87 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.705 2.27 . . . . 0.0 113.649 -168.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 t -81.72 109.44 16.12 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 50' ' ' ALA 0.261 48.8 mttt -59.2 -21.88 60.15 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -163.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -65.56 -55.2 19.02 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.487 1.494 . . . . 0.0 110.317 166.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -54.02 -50.41 66.71 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.581 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -46.52 -60.15 2.54 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 124.61 1.194 . . . . 0.0 110.976 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -68.53 -25.41 64.91 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 116.334 -1.793 . . . . 0.0 111.93 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -86.68 -25.35 24.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 121.239 1.836 . . . . 0.0 112.979 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.02 -31.86 69.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 125.496 1.518 . . . . 0.0 107.643 166.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.5 HG13 HD22 ' A' ' 34' ' ' LEU . 1.1 mp -77.43 -59.42 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 115.285 -2.293 . . . . 0.0 108.811 172.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -11.46 24.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.703 1.592 . . . . 0.0 112.659 -170.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.502 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.3 m120 -81.22 137.99 35.83 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.851 1.31 . . . . 0.0 113.378 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.76 2.91 0.06 OUTLIER Glycine 0 CA--C 1.538 1.476 0 CA-C-N 113.034 -1.894 . . . . 0.0 114.999 164.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.461 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -79.43 -18.71 51.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 128.18 2.592 . . . . 0.0 112.436 172.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 56' ' ' ASN 0.356 0.0 OUTLIER -96.28 97.75 6.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 124.499 2.095 . . . . 0.0 108.896 178.63 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.13 93.46 9.58 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 111.185 -2.734 . . . . 0.0 105.158 175.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 p -78.63 136.93 22.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 103.056 -2.942 . . . . 0.0 103.056 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.45 HD22 HD22 ' A' ' 79' ' ' LEU . 2.1 m120 57.41 23.05 8.55 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 119.258 0.935 . . . . 0.0 110.917 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.62 7.88 83.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.439 1.971 . . . . 0.0 114.206 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -134.98 125.25 26.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.337 1.568 . . . . 0.0 109.166 -166.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.79 117.48 3.69 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.841 0.856 . . . . 0.0 109.321 -173.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.1 mt -147.93 114.06 5.85 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 170.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.53 17.46 10.45 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.17 149.43 41.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.418 -0.801 . . . . 0.0 109.805 -174.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.41 HG22 HD21 ' A' ' 73' ' ' LEU . 7.1 p -67.06 -35.66 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 124.887 1.275 . . . . 0.0 109.962 174.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.17 -17.37 69.97 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.248 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.5 -49.11 10.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.734 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.555 HD12 HD23 ' A' ' 34' ' ' LEU . 2.1 mt -138.74 129.19 33.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 120.069 1.304 . . . . 0.0 111.452 -174.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 33' ' ' PRO . 84.6 mt -114.76 -95.2 0.47 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 103.247 -2.871 . . . . 0.0 103.247 163.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.21 -175.46 3.02 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.65 -1.281 . . . . 0.0 113.828 -173.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.86 -44.32 70.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.506 1.123 . . . . 0.0 113.261 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -75.05 -8.52 56.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.686 0.755 . . . . 0.0 111.386 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -93.31 -4.22 52.09 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.066 -1.021 . . . . 0.0 111.203 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -66.96 1.03 Allowed 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 120.863 -1.148 . . . . 0.0 108.786 175.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.45 HD22 HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -89.54 -175.23 4.63 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 126.399 1.88 . . . . 0.0 107.699 173.467 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.94 -12.39 1.97 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.384 1.473 . . . . 0.0 113.889 166.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.85 79.17 0.96 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 125.517 1.532 . . . . 0.0 112.535 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -141.17 -49.17 0.41 Allowed 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 117.798 -1.096 . . . . 0.0 113.142 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -155.78 -170.57 3.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.945 2.498 . . . . 0.0 107.059 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.25 130.76 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 120.09 -1.631 . . . . 0.0 107.199 163.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.36 133.42 29.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 6.7 mm -111.05 106.85 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 167.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.48 79.47 2.11 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 176.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.638 ' NH1' HG21 ' A' ' 43' ' ' ILE . 30.1 ttm105 -85.1 109.97 18.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.29 -18.49 2.3 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.764 1.65 . . . . 0.0 114.756 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -47.01 -39.18 12.09 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.928 1.364 . . . . 0.0 111.793 169.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -142.27 -78.06 0.25 Allowed 'General case' 0 C--N 1.338 0.096 0 CA-C-O 117.976 -1.011 . . . . 0.0 108.435 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.36 -152.63 0.32 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.667 1.576 . . . . 0.0 111.997 -171.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -100.98 75.12 1.65 Allowed 'General case' 0 N--CA 1.47 0.529 1 C-N-CA 132.208 4.203 . . . . 0.0 113.298 -175.37 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.73 140.02 38.36 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 120.145 -1.597 . . . . 0.0 108.053 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -89.19 144.72 25.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.54 -175.2 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 95' ' ' LEU . 2.4 mp -133.16 138.91 50.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 124.52 1.128 . . . . 0.0 108.622 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 ttm105 -136.43 -176.61 4.4 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.316 1.532 . . . . 0.0 111.781 163.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.23 163.06 13.71 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.92 1.688 . . . . 0.0 108.85 163.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 C-N-CA 127.487 2.315 . . . . 0.0 109.72 -175.22 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.214 -0.765 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.54 -55.15 38.7 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 119.921 -1.737 . . . . 0.0 113.134 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.4 -23.17 60.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.65 -35.31 70.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.739 1.216 . . . . 0.0 109.467 175.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt -73.9 -53.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 C-N-CA 127.715 2.406 . . . . 0.0 106.892 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -55.13 -53.53 54.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.526 -1.225 . . . . 0.0 111.355 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -73.29 -31.22 63.92 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 120.38 1.445 . . . . 0.0 109.46 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.52 -34.43 89.45 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 125.335 1.445 . . . . 0.0 110.552 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -128.25 11.7 6.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.603 0.761 . . . . 0.0 111.813 -167.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -59.16 -5.55 0.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.053 2.141 . . . . 0.0 115.942 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.29 -28.82 47.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.793 -0.567 . . . . 0.0 110.295 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -101.21 170.46 6.5 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.03 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HD2' HG12 ' A' ' 22' ' ' VAL . 61.1 Cg_endo -73.0 177.32 7.9 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 CA-C-N 121.099 1.428 . . . . 0.0 109.231 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.4 p -125.46 145.56 50.03 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -108.93 156.24 19.93 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.942 1.297 . . . . 0.0 108.307 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.99 133.97 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 126.2 1.8 . . . . 0.0 107.936 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.63 -171.39 2.37 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 121.401 0.619 . . . . 0.0 111.093 163.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -100.08 13.58 33.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.844 1.657 . . . . 0.0 112.156 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.1 172.57 36.79 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.712 1.149 . . . . 0.0 113.375 -172.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.32 -85.39 1.87 Allowed Glycine 0 C--N 1.333 0.361 0 N-CA-C 106.686 -2.565 . . . . 0.0 106.686 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.33 150.08 21.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.251 1.42 . . . . 0.0 109.714 163.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.455 ' H ' HG23 ' A' ' 74' ' ' THR . 0.9 OUTLIER -161.76 152.14 14.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 167.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.16 139.64 91.24 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.448 2.099 . . . . 0.0 113.168 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.293 0.9 OUTLIER -49.55 -32.65 12.95 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 169.172 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.7 p -74.59 -11.72 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 128.047 2.539 . . . . 0.0 115.086 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -103.03 -44.16 5.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.945 0.793 . . . . 0.0 109.224 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.05 -22.8 58.15 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 116.96 -1.495 . . . . 0.0 109.735 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.651 HD21 HD11 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -85.82 -23.26 27.25 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 120.706 1.594 . . . . 0.0 110.146 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -48.33 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.459 1.504 . . . . 0.0 107.243 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 t -68.63 -37.96 80.14 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.033 1.333 . . . . 0.0 109.31 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.83 -18.78 53.47 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.374 0.534 . . . . 0.0 112.052 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.23 33.36 6.59 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 118.819 0.736 . . . . 0.0 111.52 164.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.38 -49.89 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 172.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.35 107.46 3.35 Favored Pre-proline 0 C--N 1.349 0.553 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 169.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -81.36 -18.21 8.53 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.268 1.978 . . . . 0.0 113.255 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.5 t -86.4 106.34 17.37 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -58.82 -18.04 28.91 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -163.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 -50.48 21.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 121.786 2.085 . . . . 0.0 110.47 167.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -42.96 70.13 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 116.468 -1.729 . . . . 0.0 107.31 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.594 ' O ' HD12 ' A' ' 54' ' ' ILE . . . -52.63 -63.49 1.12 Allowed 'General case' 0 C--O 1.216 -0.681 0 CA-C-O 117.429 -1.272 . . . . 0.0 109.094 172.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.327 2.8 ttt-85 -60.2 -22.89 63.51 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 115.01 -2.424 . . . . 0.0 113.11 -170.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -29.88 25.71 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 121.664 2.029 . . . . 0.0 114.116 166.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.432 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.2 m-20 -62.56 -20.32 64.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.95 1.25 . . . . 0.0 111.644 171.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.651 HD11 HD21 ' A' ' 38' ' ' LEU . 4.3 mp -87.22 -62.45 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 CA-C-O 116.833 -1.556 . . . . 0.0 108.356 163.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -64.32 -7.49 9.73 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 120.065 1.302 . . . . 0.0 111.607 -165.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.1 m-80 -82.66 135.67 34.97 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.64 0.733 . . . . 0.0 111.838 173.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.439 ' HA2' ' HG2' ' A' ' 65' ' ' ARG . . . -74.2 40.26 1.05 Allowed Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.068 -1.423 . . . . 0.0 111.682 165.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -124.24 0.52 8.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 127.302 2.241 . . . . 0.0 111.146 164.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 56' ' ' ASN 0.323 0.0 OUTLIER -91.61 99.41 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 122.086 2.221 . . . . 0.0 106.385 163.63 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -86.84 115.06 24.01 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.666 1.987 . . . . 0.0 107.462 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.802 HG21 HD13 ' A' ' 72' ' ' ILE . 15.3 t -98.08 127.64 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 174.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.471 HD21 ' CD2' ' A' ' 79' ' ' LEU . 1.2 m-80 67.24 -14.06 0.2 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.862 1.265 . . . . 0.0 112.915 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.44 -8.17 6.6 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.705 2.097 . . . . 0.0 111.66 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -110.08 124.48 51.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 119.205 1.502 . . . . 0.0 107.338 -169.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HG2' ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -60.47 111.39 1.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.597 ' HB3' HD11 ' A' ' 72' ' ' ILE . 76.7 mt -146.4 89.17 1.83 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -171.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.19 35.09 1.2 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.156 1.783 . . . . 0.0 113.069 -171.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -140.26 144.04 36.26 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.269 -0.895 . . . . 0.0 112.361 -167.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.82 -36.57 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 126.49 1.916 . . . . 0.0 109.668 168.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.7 -16.11 69.58 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.607 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.7 -52.87 4.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 116.978 -1.486 . . . . 0.0 110.271 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.802 HD13 HG21 ' A' ' 61' ' ' VAL . 1.1 mp -138.13 138.98 42.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 121.376 1.898 . . . . 0.0 112.706 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.97 -75.18 0.64 Allowed 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 102.367 -3.198 . . . . 0.0 102.367 163.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 32' ' ' VAL . 22.1 p -131.06 -142.21 0.23 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . . . -89.06 -48.68 7.25 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 124.777 1.231 . . . . 0.0 111.768 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -8.15 55.15 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.038 0.923 . . . . 0.0 109.625 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -86.47 -9.31 56.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.337 1.455 . . . . 0.0 111.887 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.409 ' HB3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -126.8 -71.9 0.67 Allowed 'General case' 0 C--N 1.34 0.156 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -170.182 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.471 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -91.22 -169.53 2.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 126.52 1.928 . . . . 0.0 110.028 172.641 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.01 -3.62 0.37 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.898 1.679 . . . . 0.0 113.674 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.52 78.46 1.41 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -133.77 -59.25 0.85 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.914 0.357 . . . . 0.0 111.471 167.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -148.95 -177.61 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.478 2.311 . . . . 0.0 106.283 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.76 153.88 43.71 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 163.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.8 t -124.48 134.43 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.493 HD13 HG22 ' A' ' 61' ' ' VAL . 26.0 mm -125.28 95.28 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.328 1.851 . . . . 0.0 107.528 -169.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -89.31 88.84 7.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.432 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -80.04 120.14 23.81 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 163.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.63 -22.18 59.01 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.729 1.157 . . . . 0.0 114.051 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -3.74 52.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.509 1.524 . . . . 0.0 111.879 173.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -144.15 -131.52 0.08 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -159.73 0.97 Allowed 'General case' 0 C--O 1.242 0.668 0 CA-C-N 120.64 1.564 . . . . 0.0 109.843 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.43 83.89 4.25 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 129.418 3.087 . . . . 0.0 110.441 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -78.39 164.24 24.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.22 129.94 44.0 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 -164.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.5 mm -126.98 123.0 61.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -163.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.571 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 6.4 ttt180 -134.33 -178.72 5.18 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 125.376 2.512 . . . . 0.0 115.34 171.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.571 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -137.99 143.15 40.51 Favored 'General case' 0 N--CA 1.427 -1.582 1 C-N-CA 131.837 4.055 . . . . 0.0 105.829 -172.975 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 125.819 1.648 . . . . 0.0 110.084 -175.384 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.41 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -62.81 -55.91 22.19 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 123.523 0.729 . . . . 0.0 111.833 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.64 -19.02 63.62 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.667 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.35 -41.87 46.72 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 123.868 0.867 . . . . 0.0 109.167 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.1 mt -72.74 -51.19 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -57.52 -46.99 83.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.334 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -78.07 -30.45 49.68 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.673 1.124 . . . . 0.0 110.194 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.55 -33.83 86.26 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -124.03 17.32 9.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.954 0.501 . . . . 0.0 112.083 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -14.16 16.98 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -78.99 -21.3 47.23 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.452 1.501 . . . . 0.0 111.716 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -115.95 161.61 29.95 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -175.124 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.433 ' HD2' HG12 ' A' ' 22' ' ' VAL . 29.8 Cg_endo -83.23 172.79 10.36 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.245 1.296 . . . . 0.0 110.702 -169.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.8 p -127.09 170.57 12.22 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.068 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -139.03 154.89 48.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.277 1.431 . . . . 0.0 107.831 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 3.6 p -138.41 125.85 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 123.884 0.873 . . . . 0.0 109.931 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.49 -168.13 1.44 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 171.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -84.94 12.13 8.1 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 127.789 2.436 . . . . 0.0 116.022 -163.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.04 -177.39 8.6 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -164.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.78 133.39 1.61 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -168.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.08 149.76 40.25 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 117.575 0.688 . . . . 0.0 111.236 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -160.92 140.33 7.9 Favored Pre-proline 0 CA--C 1.51 -0.574 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -168.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.422 ' HA ' HD23 ' A' ' 73' ' ' LEU . 98.6 Cg_endo -76.34 150.97 33.19 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 121.508 1.472 . . . . 0.0 110.973 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.333 0.3 OUTLIER -48.46 -34.62 11.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.222 -1.353 . . . . 0.0 112.098 173.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.807 ' HA ' HD11 ' A' ' 54' ' ' ILE . 9.9 p -67.03 -29.89 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 117.786 -1.102 . . . . 0.0 113.68 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -91.68 -40.12 11.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.737 1.153 . . . . 0.0 109.389 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.59 -30.72 66.15 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 117.093 -1.432 . . . . 0.0 108.399 -174.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.11 -22.26 25.48 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 121.054 1.752 . . . . 0.0 110.333 -172.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.75 -50.97 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 171.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.82 -39.7 95.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.498 1.119 . . . . 0.0 108.621 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.09 47.11 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.915 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.07 33.88 7.5 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 166.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.405 HG12 HG21 ' A' ' 86' ' ' ILE . 2.1 mp -77.78 -43.47 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 171.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -148.44 109.6 3.63 Favored Pre-proline 0 C--O 1.224 -0.288 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 164.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.3 -15.71 11.24 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.548 2.165 . . . . 0.0 113.391 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.5 t -81.25 115.81 20.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -58.54 -30.01 66.79 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.62 1.555 . . . . 0.0 112.89 -168.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -52.33 24.47 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.637 173.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -54.79 -49.96 69.67 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.62 -58.45 3.82 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 126.375 1.87 . . . . 0.0 110.005 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.464 ' HA ' HD12 ' A' ' 54' ' ' ILE . 34.1 mtt85 -58.07 -33.79 69.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 117.045 -1.455 . . . . 0.0 113.218 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -80.77 -34.75 34.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.016 1.734 . . . . 0.0 112.926 173.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -15.6 62.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.452 1.501 . . . . 0.0 111.248 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.807 HD11 ' HA ' ' A' ' 35' ' ' VAL . 57.5 mt -86.65 -61.68 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 125.41 1.484 . . . . 0.0 108.86 163.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -72.98 -5.47 38.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -163.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.52 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.1 m-80 -81.01 131.81 35.33 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 163.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.31 2.98 0.08 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.856 0.741 . . . . 0.0 114.876 167.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB1' HH21 ' A' ' 88' ' ' ARG . . . -79.1 11.32 2.84 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.099 2.159 . . . . 0.0 111.451 169.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 56' ' ' ASN 0.38 0.0 OUTLIER -111.77 90.05 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 124.98 2.324 . . . . 0.0 104.735 163.349 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.426 ' CE1' ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -78.9 96.69 5.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 111.36 -2.655 . . . . 0.0 104.807 172.248 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 p -78.49 134.58 27.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.11 14.36 4.41 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 122.004 2.183 . . . . 0.0 114.221 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.67 -4.77 69.38 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.535 1.541 . . . . 0.0 113.723 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -121.82 127.95 51.14 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.912 1.856 . . . . 0.0 108.521 -166.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 105.06 0.64 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.466 1.506 . . . . 0.0 108.302 -172.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.9 mt -140.09 100.89 4.03 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 120.234 1.379 . . . . 0.0 107.964 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -106.38 27.06 9.11 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.827 2.851 . . . . 0.0 110.559 -168.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -140.39 131.3 26.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.707 1.203 . . . . 0.0 112.138 -164.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 p -59.12 -36.39 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 126.568 1.947 . . . . 0.0 110.682 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.11 -19.49 68.11 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 119.283 -0.732 . . . . 0.0 112.771 173.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.23 -37.84 13.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.109 1.364 . . . . 0.0 114.486 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mt -142.41 123.58 11.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 120.729 1.604 . . . . 0.0 110.69 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' H ' ' CG ' ' A' ' 77' ' ' HIS . 70.3 mt -107.26 -95.24 0.37 Allowed 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 102.676 -3.083 . . . . 0.0 102.676 163.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.42 -173.05 2.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.065 1.302 . . . . 0.0 114.346 -173.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.24 -41.07 87.86 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.253 -0.904 . . . . 0.0 112.395 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -65.17 -17.22 64.3 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.001 0.92 . . . . 0.0 112.734 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.448 ' CG ' ' H ' ' A' ' 73' ' ' LEU . 42.5 t-80 -93.73 4.14 54.38 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.984 1.714 . . . . 0.0 109.682 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.27 -61.34 1.09 Allowed 'General case' 0 C--N 1.35 0.592 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.938 170.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' A' ' 84' ' ' THR . 0.1 OUTLIER -91.07 -170.31 2.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.441 1.473 . . . . 0.0 109.101 169.394 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -43.8 -49.36 8.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.548 1.139 . . . . 0.0 109.664 163.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.05 81.68 0.11 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 125.604 1.574 . . . . 0.0 114.363 172.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -141.74 -46.1 0.36 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.269 0.534 . . . . 0.0 111.902 165.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.41 ' CE1' ' HB1' ' A' ' 12' ' ' ALA . 83.6 m-85 -131.8 -177.52 4.47 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 125.502 1.521 . . . . 0.0 108.476 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.412 ' HA ' HD21 ' A' ' 79' ' ' LEU . 1.4 m -161.3 132.53 5.42 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.302 1.841 . . . . 0.0 106.72 163.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.25 145.4 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 170.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.405 HG21 HG12 ' A' ' 43' ' ' ILE . 15.4 mm -125.88 98.48 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 C-N-CA 126.442 1.897 . . . . 0.0 106.792 -176.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -97.12 82.35 3.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.479 HH21 ' HB1' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -79.28 61.39 3.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.398 1.879 . . . . 0.0 109.309 -174.221 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 27.19 -82.7 0.0 OUTLIER Glycine 0 CA--C 1.527 0.784 0 C-N-CA 130.292 3.806 . . . . 0.0 116.598 171.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -51.74 -55.05 21.96 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.745 1.618 . . . . 0.0 109.97 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.24 176.9 8.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.894 1.678 . . . . 0.0 109.414 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.527 ' HB3' HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -83.72 -146.07 0.08 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.707 1.242 . . . . 0.0 111.743 -176.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -118.16 82.31 1.82 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.295 2.238 . . . . 0.0 109.506 -163.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -78.92 168.34 19.84 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.274 -0.891 . . . . 0.0 108.894 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.5 tp -121.9 131.38 54.0 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.766 -171.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.44 133.42 66.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 15.0 ptt180 -144.08 172.08 13.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.578 1.18 . . . . 0.0 109.989 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.86 163.29 21.56 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.611 1.164 . . . . 0.0 108.417 163.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.52 0 C-N-CA 127.017 2.127 . . . . 0.0 110.026 173.295 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.218 -0.596 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.5 -49.91 69.51 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 120.347 -1.471 . . . . 0.0 110.836 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 -28.8 65.97 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 118.55 -1.26 . . . . 0.0 109.906 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -79.38 -24.31 42.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.218 1.007 . . . . 0.0 110.146 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.0 mt -74.08 -54.76 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.837 1.655 . . . . 0.0 106.901 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -57.27 -48.59 78.5 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.812 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -81.22 -24.87 37.11 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.417 1.008 . . . . 0.0 110.437 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.43 -38.88 96.38 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -121.48 14.47 11.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 123.726 0.31 . . . . 0.0 111.468 -164.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -54.22 -11.64 0.52 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -78.36 -13.27 59.92 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.918 2.087 . . . . 0.0 110.413 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.44 ' CG1' ' HE2' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -127.92 155.45 77.6 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 126.26 1.824 . . . . 0.0 106.337 169.496 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.65 169.43 20.89 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.71 1.607 . . . . 0.0 110.463 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.8 p -104.25 175.63 5.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.637 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -136.75 160.31 39.23 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 163.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 8.0 p -134.43 132.12 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 171.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.98 172.61 6.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 164.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -100.08 57.74 0.98 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.655 -1.278 . . . . 0.0 111.681 -164.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.15 -171.63 9.91 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.98 148.19 2.22 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 -164.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -73.11 149.67 42.87 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.909 -0.759 . . . . 0.0 110.389 164.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.5 t -158.42 132.62 5.15 Favored Pre-proline 0 CA--C 1.505 -0.752 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -163.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HA ' HD23 ' A' ' 73' ' ' LEU . 44.4 Cg_endo -74.41 154.81 45.77 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 C-N-CA 121.715 1.61 . . . . 0.0 110.251 -173.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.397 0.6 OUTLIER -53.94 -29.99 44.69 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.482 176.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.678 ' HA ' HD11 ' A' ' 54' ' ' ILE . 8.6 p -70.25 -24.78 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 174.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -90.86 -43.77 9.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 120.31 1.414 . . . . 0.0 108.508 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -73.78 -28.31 61.6 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 116.943 -1.503 . . . . 0.0 109.49 -171.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.08 -31.29 25.4 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.713 1.597 . . . . 0.0 109.327 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 t -64.6 -51.5 66.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -66.62 -34.75 78.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.152 1.381 . . . . 0.0 109.998 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.4 -15.65 58.44 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.726 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.38 23.36 19.46 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 166.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.93 -43.37 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 m -156.34 101.12 2.07 Favored Pre-proline 0 C--N 1.349 0.562 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 171.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.62 -18.68 10.49 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 121.771 1.647 . . . . 0.0 113.431 -173.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.3 t -86.34 106.34 17.32 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -174.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 75.2 mttt -57.22 -22.19 39.22 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -164.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.55 -45.99 56.6 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 121.828 2.104 . . . . 0.0 111.095 169.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -51.81 67.84 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -50.59 -52.93 34.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 125.447 1.717 . . . . 0.0 110.586 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -57.08 -37.97 72.66 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 117.295 -1.336 . . . . 0.0 111.102 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -84.04 -24.89 30.27 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 116.736 -1.986 . . . . 0.0 113.296 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.16 -23.19 66.45 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 112.22 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 35' ' ' VAL . 70.0 mt -84.95 -63.7 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 C-N-CA 126.211 1.804 . . . . 0.0 107.3 168.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.52 -5.13 10.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 119.916 1.235 . . . . 0.0 112.783 -164.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.628 ' O ' HG22 ' A' ' 59' ' ' ILE . 7.0 m120 -81.5 132.26 35.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 164.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.06 10.76 0.06 OUTLIER Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.246 1.403 . . . . 0.0 115.119 164.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.52 -12.67 59.86 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 116.253 -1.832 . . . . 0.0 112.964 165.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 56' ' ' ASN 0.362 0.0 OUTLIER -99.74 87.79 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 125.881 2.753 . . . . 0.0 107.741 177.128 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -79.32 99.08 6.95 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 109.698 -3.41 . . . . 0.0 106.654 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.84 137.34 22.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.5 HD21 ' CD2' ' A' ' 79' ' ' LEU . 0.9 OUTLIER 60.19 4.56 0.67 Allowed 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 120.657 1.572 . . . . 0.0 113.132 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 -2.15 47.69 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.492 1.52 . . . . 0.0 114.035 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -124.18 129.07 50.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.852 1.826 . . . . 0.0 108.979 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.51 110.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.515 1.526 . . . . 0.0 108.386 -171.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.479 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 17.9 mt -141.22 70.42 1.35 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.128 0.966 . . . . 0.0 109.023 -174.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -78.97 31.94 0.21 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -170.103 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -143.62 159.44 42.45 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.7 t -68.01 -27.42 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.971 2.509 . . . . 0.0 111.48 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.11 -7.57 85.09 Favored Glycine 0 C--N 1.333 0.401 0 O-C-N 121.393 -0.817 . . . . 0.0 112.552 168.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 66' ' ' LEU . . . -86.44 -57.64 2.92 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 117.914 -1.041 . . . . 0.0 108.298 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp -136.17 137.34 48.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 120.596 1.544 . . . . 0.0 113.475 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 33' ' ' PRO . 93.1 mt -108.12 -87.02 0.5 Allowed 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 100.571 -3.862 . . . . 0.0 100.571 163.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.48 -174.42 2.51 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 120.861 -1.15 . . . . 0.0 113.803 -169.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.0 -48.72 75.37 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -70.11 -15.34 62.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.175 0.898 . . . . 0.0 111.224 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -81.3 -10.34 59.59 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.928 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.21 -77.15 0.57 Allowed 'General case' 0 C--N 1.343 0.306 0 O-C-N 120.789 -1.194 . . . . 0.0 108.095 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.5 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -90.55 -171.51 3.09 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 125.66 1.584 . . . . 0.0 109.328 177.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -47.78 -26.27 1.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.72 2.008 . . . . 0.0 115.362 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.34 64.56 0.31 Allowed Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 126.01 1.767 . . . . 0.0 111.261 -169.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -133.27 -81.3 0.48 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -127.36 -166.39 1.6 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.845 1.258 . . . . 0.0 108.781 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.34 122.35 4.49 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 120.78 -1.2 . . . . 0.0 107.899 165.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.5 128.12 38.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.456 HD12 HD11 ' A' ' 59' ' ' ILE . 11.2 mm -116.24 98.03 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -92.37 85.62 5.43 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.528 ' CG ' ' HB ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -89.65 113.97 25.52 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 166.79 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.84 2.88 1.13 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -58.2 -45.44 87.58 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.154 1.477 . . . . 0.0 109.573 164.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HE2' ' CG1' ' A' ' 22' ' ' VAL . 61.7 tttt -131.76 -90.44 0.43 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.425 ' HG3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -152.82 -152.39 0.42 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 120.878 1.672 . . . . 0.0 111.523 -167.035 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.425 ' CD1' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -94.68 79.5 3.76 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 129.897 3.279 . . . . 0.0 110.244 -176.746 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.4 144.38 35.95 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 119.95 -1.719 . . . . 0.0 107.219 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.1 tp -97.93 139.07 34.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.3 mm -126.6 135.71 62.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 12.9 ptt180 -135.37 174.01 11.09 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 122.655 1.217 . . . . 0.0 111.568 164.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.19 163.44 12.24 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 163.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.41 0 C-N-CA 127.671 2.388 . . . . 0.0 109.071 -176.932 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.146 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.82 -58.44 4.59 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.684 0.794 . . . . 0.0 111.139 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.13 -25.14 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.072 0.396 . . . . 0.0 111.026 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -73.73 -39.28 64.4 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.3 mt -70.31 -52.12 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.371 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.37 -48.22 82.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.494 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -72.12 -35.94 69.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.356 0.98 . . . . 0.0 109.155 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.79 -38.2 93.59 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -117.46 13.39 14.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.059 0.544 . . . . 0.0 110.458 -169.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -15.57 4.96 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.406 1.883 . . . . 0.0 113.939 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -78.04 -11.23 59.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 127.427 2.291 . . . . 0.0 111.598 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.439 HG22 ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -133.76 172.84 6.63 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 167.033 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.439 ' HD2' HG22 ' A' ' 22' ' ' VAL . 71.1 Cg_endo -76.85 -174.24 2.08 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.145 2.563 . . . . 0.0 110.111 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.4 p -135.35 175.45 9.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.594 1.157 . . . . 0.0 109.085 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -138.53 161.32 37.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.265 0.939 . . . . 0.0 109.075 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.8 t -138.81 139.64 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 124.713 1.205 . . . . 0.0 108.032 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.69 172.16 8.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.505 1.145 . . . . 0.0 112.705 163.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.19 33.08 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 128.641 2.776 . . . . 0.0 111.204 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.84 -170.87 31.95 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.543 -0.723 . . . . 0.0 112.058 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.78 145.54 2.98 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -164.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -67.98 148.16 51.45 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.306 0.574 . . . . 0.0 110.653 167.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.8 t -156.77 133.75 6.53 Favored Pre-proline 0 CA--C 1.511 -0.539 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -163.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.519 ' HA ' HD23 ' A' ' 73' ' ' LEU . 89.9 Cg_endo -71.42 152.01 60.09 Favored 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 122.069 1.846 . . . . 0.0 110.989 -172.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.442 1.0 OUTLIER -51.69 -30.4 21.89 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.552 174.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.475 ' HA ' HD22 ' A' ' 38' ' ' LEU . 7.7 p -78.11 -14.87 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.512 1.525 . . . . 0.0 114.71 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.36 -49.05 6.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.114 0.87 . . . . 0.0 109.055 166.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.9 -23.88 60.77 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 117.381 -1.295 . . . . 0.0 109.051 -166.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.878 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -75.62 -33.4 60.52 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 120.822 1.646 . . . . 0.0 109.639 176.196 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.456 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -75.3 -46.86 37.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -175.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -38.07 89.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.542 1.937 . . . . 0.0 109.39 175.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.64 -24.08 45.47 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.108 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.17 23.12 11.68 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 124.096 0.855 . . . . 0.0 111.482 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.405 HG21 ' NH1' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -78.3 -39.66 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -174.505 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -145.15 113.6 4.86 Favored Pre-proline 0 C--O 1.225 -0.193 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.45 -15.08 5.37 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.778 2.319 . . . . 0.0 113.3 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -84.8 132.67 34.39 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -65.04 -35.48 81.3 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 119.583 1.083 . . . . 0.0 111.034 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -55.47 24.21 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 120.028 1.285 . . . . 0.0 108.945 177.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -49.3 76.71 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.033 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.878 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -51.13 -51.85 49.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.694 1.134 . . . . 0.0 112.366 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -60.0 -39.89 87.35 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 117.678 -1.153 . . . . 0.0 110.238 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.26 -32.05 49.44 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.777 1.172 . . . . 0.0 112.351 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -50.28 -39.81 46.46 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.561 HD11 HD22 ' A' ' 38' ' ' LEU . 43.8 mt -84.85 -49.99 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 115.66 -2.114 . . . . 0.0 109.597 -174.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -66.99 -10.83 53.75 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 125.382 1.676 . . . . 0.0 111.489 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.538 ' HB3' ' H ' ' A' ' 58' ' ' ALA . 1.2 m120 -83.52 137.3 33.93 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 174.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.66 0.42 0.45 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-N 115.067 -0.969 . . . . 0.0 114.419 164.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.538 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -78.95 -4.13 48.34 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.58 1.552 . . . . 0.0 111.617 172.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.475 HG13 ' NH2' ' A' ' 88' ' ' ARG 0.393 0.0 OUTLIER -106.78 92.43 2.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 CA-C-O 125.06 2.362 . . . . 0.0 109.125 171.546 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.97 93.59 7.58 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 109.913 -3.312 . . . . 0.0 105.067 169.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 p -78.31 127.33 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 102.375 -3.195 . . . . 0.0 102.375 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 76.34 -52.39 0.6 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.464 1.906 . . . . 0.0 110.499 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.45 3.89 0.02 OUTLIER Glycine 0 CA--C 1.533 1.182 1 C-N-CA 130.731 4.015 . . . . 0.0 111.063 170.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -112.82 116.25 29.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -163.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.08 105.74 0.93 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.9 mt -140.82 68.13 1.35 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.332 0.969 . . . . 0.0 109.547 -168.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.97 56.47 3.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.111 1.764 . . . . 0.0 112.535 -172.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -148.34 151.19 34.93 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.763 0.825 . . . . 0.0 112.928 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.32 -38.01 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.765 2.426 . . . . 0.0 110.699 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.14 -10.19 68.55 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 119.027 -0.874 . . . . 0.0 112.307 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.62 -55.6 3.8 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 117.213 -1.375 . . . . 0.0 109.664 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -136.25 134.53 50.02 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 CA-C-N 120.585 1.539 . . . . 0.0 113.613 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 33' ' ' PRO . 77.3 mt -108.27 -86.41 0.51 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 163.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 p -115.57 -168.94 1.49 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . . . -62.52 -45.33 93.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.634 -177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -70.2 -17.26 63.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.71 1.141 . . . . 0.0 110.93 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -82.7 0.16 44.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.464 1.106 . . . . 0.0 110.92 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 -62.97 0.9 Allowed 'General case' 0 C--N 1.345 0.379 0 O-C-N 120.785 -1.197 . . . . 0.0 110.033 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.06 -175.22 4.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.452 2.301 . . . . 0.0 109.528 172.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -52.81 -28.66 23.64 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.983 1.313 . . . . 0.0 112.852 172.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.46 73.47 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 126.355 1.931 . . . . 0.0 111.675 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -139.04 -79.23 0.33 Allowed 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 117.614 0.707 . . . . 0.0 109.403 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -126.71 -170.8 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.109 1.764 . . . . 0.0 109.13 -173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.12 116.72 4.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 163.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.84 138.46 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 170.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 17.9 mm -123.1 104.63 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.788 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -92.67 83.92 4.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 170.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HG2' HH11 ' A' ' 88' ' ' ARG . 0.0 OUTLIER -78.48 82.22 4.76 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 169.463 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -49.28 -34.26 17.65 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.395 1.474 . . . . 0.0 111.932 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -69.39 15.19 0.07 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.709 1.204 . . . . 0.0 113.635 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -162.69 -82.96 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.855 2.462 . . . . 0.0 108.868 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.608 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -157.73 -169.21 2.78 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 123.364 1.554 . . . . 0.0 110.163 -176.124 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.608 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 12.0 m-30 -107.03 76.83 1.12 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.985 2.114 . . . . 0.0 111.704 -168.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -79.43 172.31 13.96 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.606 1.162 . . . . 0.0 112.129 -173.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.0 tp -140.66 137.53 33.63 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.377 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.15 141.83 45.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.716 1.606 . . . . 0.0 109.013 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -134.39 179.73 6.09 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 124.57 2.129 . . . . 0.0 109.392 163.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -121.25 162.14 20.74 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.257 163.458 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 125.169 1.388 . . . . 0.0 112.111 176.214 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.218 -0.553 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.94 -51.61 68.49 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.081 -1.637 . . . . 0.0 112.438 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.89 -29.69 69.64 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.258 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.92 -31.96 61.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.78 2.032 . . . . 0.0 110.3 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 mt -76.38 -56.39 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 126.338 1.855 . . . . 0.0 106.38 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.27 -49.63 63.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.715 0.689 . . . . 0.0 112.519 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.84 -35.59 62.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.14 -40.61 95.91 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -115.58 16.49 16.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 124.035 0.491 . . . . 0.0 110.565 -165.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -55.79 -12.07 1.19 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -102.67 -2.51 28.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 129.25 3.02 . . . . 0.0 113.209 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -120.79 169.72 8.38 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.206 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.467 ' HD2' HG12 ' A' ' 22' ' ' VAL . 40.8 Cg_endo -84.13 173.19 9.13 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 CA-C-N 121.189 1.46 . . . . 0.0 109.878 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.8 p -128.87 158.16 39.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.878 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 61.6 t80 -135.08 153.76 51.92 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 p -128.49 131.8 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.41 172.69 8.15 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 123.114 1.435 . . . . 0.0 113.523 164.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -80.92 37.98 0.44 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 128.162 2.585 . . . . 0.0 112.43 -164.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.21 -171.53 5.0 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.706 1.146 . . . . 0.0 113.703 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.71 137.04 0.76 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -167.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.17 137.0 57.35 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.378 1.089 . . . . 0.0 109.73 175.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.24 138.5 14.18 Favored Pre-proline 0 CA--C 1.514 -0.427 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -163.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HA ' HD23 ' A' ' 73' ' ' LEU . 94.7 Cg_endo -70.7 145.13 50.91 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.628 2.219 . . . . 0.0 110.776 -169.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.754 HD22 HG13 ' A' ' 54' ' ' ILE 0.284 0.0 OUTLIER -47.35 -36.74 9.96 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.426 177.884 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.6 ' HA ' HD22 ' A' ' 38' ' ' LEU . 11.7 p -79.08 -15.88 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.707 2.003 . . . . 0.0 114.355 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -88.36 -44.23 10.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 120.088 1.313 . . . . 0.0 108.807 164.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -77.09 -18.18 58.18 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 116.847 -1.549 . . . . 0.0 109.888 -168.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.739 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -74.39 -34.69 63.37 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 121.144 1.793 . . . . 0.0 109.751 171.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.562 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -73.1 -49.14 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 C-N-CA 126.338 1.855 . . . . 0.0 106.054 -169.16 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 3.9 m -60.92 -40.89 94.88 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 128.53 2.732 . . . . 0.0 110.687 169.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.79 -11.09 59.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.904 1.229 . . . . 0.0 113.038 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.25 20.39 49.22 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.682 1.128 . . . . 0.0 112.199 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.506 HG21 ' NH1' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -77.86 -39.74 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.794 1.637 . . . . 0.0 106.836 -177.567 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.74 111.32 1.32 Allowed Pre-proline 0 C--N 1.344 0.358 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 167.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.11 -13.47 7.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.149 1.899 . . . . 0.0 112.414 -174.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 m -90.44 101.49 14.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 -164.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -41.44 -37.46 1.06 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -163.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.48 -54.06 33.75 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.226 1.376 . . . . 0.0 110.168 171.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -59.16 -42.05 89.8 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.728 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -51.49 -55.58 18.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 123.836 0.855 . . . . 0.0 110.415 175.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 mtt85 -55.2 -42.46 73.32 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.173 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -79.78 -33.5 40.49 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 119.989 1.268 . . . . 0.0 112.125 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.63 -29.43 68.01 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 116.592 -1.67 . . . . 0.0 107.636 171.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.754 HG13 HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -81.74 -51.76 14.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-N 120.34 1.427 . . . . 0.0 110.848 174.56 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -69.6 -7.11 35.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.76 1.624 . . . . 0.0 111.458 -172.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.553 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.8 m-80 -81.07 134.95 35.75 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 171.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.59 8.25 0.2 Allowed Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.383 -1.232 . . . . 0.0 114.674 164.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.475 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -84.32 -16.22 43.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.213 1.507 . . . . 0.0 111.173 170.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 56' ' ' ASN 0.352 0.0 OUTLIER -93.5 92.65 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 125.455 2.55 . . . . 0.0 106.79 169.615 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -78.96 109.4 13.21 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 111.566 -2.561 . . . . 0.0 106.236 167.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 72' ' ' ILE . 13.5 t -88.47 124.87 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 O-C-N 120.307 -1.496 . . . . 0.0 107.421 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.723 HD22 ' HG3' ' A' ' 78' ' ' ARG . 68.3 m-80 46.92 57.57 5.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.774 1.273 . . . . 0.0 110.169 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.23 4.75 51.57 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 113.56 -1.654 . . . . 0.0 114.439 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -131.03 121.47 25.09 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 120.82 2.31 . . . . 0.0 110.404 -167.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.99 100.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 126.691 1.996 . . . . 0.0 110.435 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.519 ' HB3' HD11 ' A' ' 72' ' ' ILE . 66.4 mt -138.48 108.12 6.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -170.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.13 38.41 2.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.888 2.075 . . . . 0.0 112.125 -163.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -143.18 158.88 43.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.616 1.566 . . . . 0.0 110.291 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.441 HG22 HD21 ' A' ' 73' ' ' LEU . 6.3 p -69.12 -33.19 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 121.177 -0.952 . . . . 0.0 111.796 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.08 -8.19 84.91 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 119.713 -0.493 . . . . 0.0 112.489 168.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.35 -55.64 4.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 116.862 -1.542 . . . . 0.0 109.24 170.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -138.93 145.86 27.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.402 0 CA-C-N 121.614 2.006 . . . . 0.0 111.774 177.201 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 33' ' ' PRO . 82.2 mt -115.84 -98.57 0.44 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 163.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.05 -177.51 4.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.072 1.306 . . . . 0.0 114.145 -174.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.56 -48.71 71.73 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.068 0.947 . . . . 0.0 112.581 173.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -61.41 -20.31 62.92 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.996 1.319 . . . . 0.0 113.189 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 60.1 t-80 -84.45 -19.33 33.58 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.151 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.723 ' HG3' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -96.2 -74.89 0.55 Allowed 'General case' 0 C--N 1.345 0.404 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.635 HD11 ' H ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.52 169.63 10.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.371 1.468 . . . . 0.0 111.129 172.954 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -23.24 -52.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.028 3.331 . . . . 0.0 115.839 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.53 56.28 0.01 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -168.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.9 -88.03 0.33 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.986 0.893 . . . . 0.0 111.851 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.635 ' H ' HD11 ' A' ' 79' ' ' LEU . 21.6 m-30 -131.56 -170.5 2.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -168.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.46 135.21 10.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.35 -0.844 . . . . 0.0 109.413 166.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -79.41 138.34 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 167.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 22.4 mm -113.22 92.74 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 126.323 1.849 . . . . 0.0 106.042 169.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 ttt-85 -97.78 74.63 2.37 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 -165.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.748 ' HB2' HH11 ' A' ' 88' ' ' ARG . 0.0 OUTLIER -88.3 105.14 17.36 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 130.499 3.519 . . . . 0.0 110.019 -169.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.23 -30.56 17.98 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.182 0.896 . . . . 0.0 114.524 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -23.58 31.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.721 1.609 . . . . 0.0 113.913 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -149.76 -89.91 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 -144.52 0.15 Allowed 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 122.424 1.107 . . . . 0.0 109.99 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 3.6 m-30 -115.22 87.5 2.67 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.533 -162.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -78.49 161.92 26.72 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.87 134.9 54.85 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -172.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.7 mm -122.61 129.28 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -137.58 174.57 10.44 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 123.588 1.661 . . . . 0.0 111.061 171.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.71 166.05 13.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 124.738 1.215 . . . . 0.0 110.096 171.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 C-N-CA 129.075 2.95 . . . . 0.0 110.852 -168.684 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.591 0 CA-C-O 120.342 0.115 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -65.54 -51.01 63.06 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 120.467 -1.396 . . . . 0.0 111.47 -170.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.34 81.08 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.402 0.439 . . . . 0.0 110.087 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.81 -34.31 66.78 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -174.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.9 mt -72.68 -52.14 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 126.261 1.824 . . . . 0.0 108.397 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -56.83 -47.24 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 118.598 0.635 . . . . 0.0 111.235 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -80.64 -22.54 40.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.581 0.628 . . . . 0.0 110.057 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.54 -24.67 58.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 125.241 1.4 . . . . 0.0 111.841 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -130.44 17.13 5.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.185 0.994 . . . . 0.0 110.596 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 -15.23 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.191 2.196 . . . . 0.0 112.47 169.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.1 -19.7 53.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.766 2.827 . . . . 0.0 111.392 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.597 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -126.08 161.54 51.08 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 176.804 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.597 ' HD2' HG12 ' A' ' 22' ' ' VAL . 44.4 Cg_endo -76.16 172.26 16.58 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 N-CA-C 109.091 -1.157 . . . . 0.0 109.091 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 p -121.02 168.3 11.66 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 113.532 -1.667 . . . . 0.0 108.42 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -140.43 164.33 30.41 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 9.5 p -139.46 135.65 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.13 -179.23 3.6 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.75 0.786 . . . . 0.0 109.98 163.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -96.15 66.89 2.55 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.437 -0.79 . . . . 0.0 109.879 -171.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.56 -157.4 29.57 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.44 108.31 0.05 OUTLIER Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.295 1.426 . . . . 0.0 112.298 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -47.41 139.86 6.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.86 0.83 . . . . 0.0 112.192 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.95 136.54 10.86 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.722 -163.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.13 144.34 38.3 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.35 2.7 . . . . 0.0 112.388 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.377 1.1 pt? -55.8 -25.92 43.73 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 171.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.716 ' HA ' HD11 ' A' ' 54' ' ' ILE . 7.6 p -57.4 -56.6 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 119.58 1.082 . . . . 0.0 110.844 166.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -65.63 -41.88 92.16 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.188 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.81 -29.5 62.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 120.587 1.539 . . . . 0.0 109.517 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.74 -27.83 22.12 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 120.459 1.482 . . . . 0.0 109.482 -173.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.54 -49.86 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 t -60.98 -45.4 94.94 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.668 1.587 . . . . 0.0 108.685 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.87 -15.61 58.13 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.167 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.94 27.58 9.39 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 119.276 0.944 . . . . 0.0 111.268 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -45.77 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.51 102.83 2.91 Favored Pre-proline 0 C--N 1.347 0.49 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 164.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.94 -17.45 19.7 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.131 1.887 . . . . 0.0 113.067 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.0 t -90.81 109.14 20.34 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 82.0 mttt -56.96 -18.75 14.69 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -166.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -72.02 -53.84 11.72 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 120.91 1.687 . . . . 0.0 110.484 168.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -47.91 68.08 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -50.37 -57.25 8.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 124.403 1.065 . . . . 0.0 111.359 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -63.13 -26.93 69.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 116.251 -1.833 . . . . 0.0 112.229 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -69.74 -50.48 43.05 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 121.602 2.001 . . . . 0.0 110.982 163.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.617 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.0 OUTLIER -60.42 -9.55 3.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.725 1.21 . . . . 0.0 112.993 -174.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.716 HD11 ' HA ' ' A' ' 35' ' ' VAL . 38.9 mt -96.15 -67.74 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 C-N-CA 126.673 1.989 . . . . 0.0 109.071 164.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.62 -9.22 8.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 120.329 1.422 . . . . 0.0 112.54 -167.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.609 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -82.52 126.04 31.81 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 119.57 1.077 . . . . 0.0 110.971 168.152 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.46 9.55 0.23 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 169.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.11 -7.53 58.94 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 116.58 -1.676 . . . . 0.0 111.801 164.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 56' ' ' ASN 0.384 0.0 OUTLIER -91.75 90.13 3.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 125.621 2.629 . . . . 0.0 107.673 167.174 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -79.87 96.74 6.43 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 110.957 -2.838 . . . . 0.0 108.021 171.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.875 HG21 HD13 ' A' ' 72' ' ' ILE . 31.0 t -78.64 126.78 38.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.413 HD21 HD21 ' A' ' 79' ' ' LEU . 1.8 m120 60.7 11.9 3.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.619 0.768 . . . . 0.0 111.834 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.97 18.32 56.26 Favored Glycine 0 CA--C 1.525 0.71 0 O-C-N 121.009 -1.057 . . . . 0.0 112.062 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -124.23 115.91 21.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.541 1.671 . . . . 0.0 107.793 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -51.71 105.78 0.12 Allowed 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 126.157 1.783 . . . . 0.0 107.5 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.566 ' HB3' HD11 ' A' ' 72' ' ' ILE . 65.9 mt -145.09 71.75 1.31 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -171.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.43 39.89 0.34 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.397 1.479 . . . . 0.0 111.192 -172.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -149.1 152.59 36.42 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -165.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.54 -29.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.363 2.265 . . . . 0.0 112.006 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.01 -34.88 90.4 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 164.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.86 -57.35 4.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 117.382 -1.294 . . . . 0.0 110.071 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.875 HD13 HG21 ' A' ' 61' ' ' VAL . 1.2 mp -136.12 139.49 45.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 CA-C-N 120.725 1.602 . . . . 0.0 112.402 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -112.13 -91.17 0.49 Allowed 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.72 -174.66 2.51 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.332 -1.48 . . . . 0.0 113.833 -170.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.08 -42.01 84.67 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -82.64 -0.42 47.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.641 1.109 . . . . 0.0 110.962 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -89.59 -3.49 58.26 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.837 -1.164 . . . . 0.0 110.357 164.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.462 ' HB3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -125.79 -63.67 1.11 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 120.113 1.324 . . . . 0.0 111.092 177.188 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -91.04 -168.79 2.16 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.378 1.071 . . . . 0.0 109.265 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -54.61 -17.66 3.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.298 1.439 . . . . 0.0 113.034 168.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.54 75.29 0.88 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 126.722 2.106 . . . . 0.0 112.343 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -145.01 -60.88 0.36 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.822 0.811 . . . . 0.0 111.865 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.432 ' CE1' ' HB1' ' A' ' 12' ' ' ALA . 75.4 m-85 -137.58 -168.11 2.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.922 2.089 . . . . 0.0 107.912 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -160.62 131.71 5.59 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.56 1.944 . . . . 0.0 106.93 164.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.53 139.65 17.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 125.017 1.327 . . . . 0.0 107.99 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.467 HD13 HG22 ' A' ' 61' ' ' VAL . 18.8 mm -131.33 101.77 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 126.004 1.722 . . . . 0.0 106.528 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -100.65 95.57 6.77 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.617 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -87.62 121.07 29.59 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 172.324 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.9 98.57 0.71 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt 132.19 113.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 1 C-N-CA 134.458 5.103 . . . . 0.0 102.781 -163.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.431 0.0 OUTLIER 54.43 -127.61 2.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 116.665 -1.636 . . . . 0.0 109.031 -163.592 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.444 ' HB3' HG11 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -139.3 -143.55 0.16 Allowed 'General case' 0 C--O 1.243 0.725 0 CA-C-N 121.045 1.748 . . . . 0.0 113.213 -163.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -121.46 82.22 1.91 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.898 1.679 . . . . 0.0 109.851 -163.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -79.04 164.93 23.95 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 96' ' ' ILE . 1.2 tt -134.41 129.1 34.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -164.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.437 HD13 HG13 ' A' ' 86' ' ' ILE . 3.5 mp -124.72 135.16 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -171.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 14.2 ptt-85 -131.82 178.34 6.84 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.386 1.474 . . . . 0.0 111.853 166.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.61 161.82 18.59 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.462 1.105 . . . . 0.0 109.474 163.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.388 0 C-N-CA 126.197 1.799 . . . . 0.0 109.219 170.166 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.88 -39.14 73.0 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.747 -1.221 . . . . 0.0 112.146 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.22 -30.67 70.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 170.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -77.98 -32.86 51.56 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.904 0.881 . . . . 0.0 109.64 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 mt -64.96 -56.88 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 C-N-CA 126.155 1.782 . . . . 0.0 108.018 166.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -54.11 -50.45 66.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 120.309 1.413 . . . . 0.0 113.282 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -87.3 -12.61 46.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.095 0.861 . . . . 0.0 111.249 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.23 -44.02 94.45 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 164.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.449 ' CD2' HD13 ' A' ' 95' ' ' LEU . 10.4 m-85 -106.54 1.71 25.58 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -163.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -48.18 -12.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.34 -12.74 59.92 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.78 1.632 . . . . 0.0 112.978 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.606 HG22 ' HD2' ' A' ' 23' ' ' PRO . 10.5 p -160.36 160.69 26.15 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.659 1.984 . . . . 0.0 108.303 -177.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.606 ' HD2' HG22 ' A' ' 22' ' ' VAL . 89.9 Cg_endo -82.64 178.72 5.89 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.853 1.702 . . . . 0.0 111.761 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.5 179.0 4.15 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.01 1.724 . . . . 0.0 110.173 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 48.0 t80 -137.08 160.44 38.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.308 1.443 . . . . 0.0 108.69 164.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 t -139.27 129.64 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.388 1.875 . . . . 0.0 108.22 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.9 -168.33 1.59 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.476 0.58 . . . . 0.0 112.491 163.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.57 1.2 30.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -163.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.78 174.12 4.97 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.952 1.263 . . . . 0.0 112.244 -169.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.05 133.36 1.12 Allowed Glycine 0 CA--C 1.53 1.022 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -163.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -62.5 145.27 54.66 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -163.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.401 HG13 ' HD2' ' A' ' 33' ' ' PRO . 4.7 t -159.06 138.73 8.54 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 125.714 1.606 . . . . 0.0 106.876 -163.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HA ' HD23 ' A' ' 73' ' ' LEU . 87.9 Cg_endo -71.99 146.27 46.72 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.038 1.825 . . . . 0.0 111.203 -171.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.418 ' HG ' HD13 ' A' ' 54' ' ' ILE 0.328 0.9 OUTLIER -45.92 -36.62 5.57 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.977 171.451 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.685 ' HA ' HD22 ' A' ' 38' ' ' LEU 0.264 5.8 p -79.61 -9.28 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 120.602 -1.312 . . . . 0.0 114.194 -176.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -96.18 -38.96 9.92 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.513 1.051 . . . . 0.0 109.498 163.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -78.83 -17.72 55.2 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 116.84 -1.552 . . . . 0.0 109.624 -172.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.685 HD22 ' HA ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -78.99 -27.07 43.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 121.146 1.793 . . . . 0.0 110.228 171.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.576 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -77.93 -44.34 28.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 126.342 1.857 . . . . 0.0 106.743 -174.192 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -69.88 -41.26 75.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 124.781 1.232 . . . . 0.0 108.679 172.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.64 -16.38 57.41 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.725 1.148 . . . . 0.0 112.858 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.3 33.33 8.8 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 166.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.2 mp -78.36 -42.05 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 172.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.15 122.17 1.63 Allowed Pre-proline 0 C--N 1.348 0.509 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 163.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -84.34 -13.87 7.22 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.468 2.112 . . . . 0.0 112.758 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.8 m -89.63 101.6 14.29 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -164.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -47.05 -36.94 8.64 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 117.978 2.584 . . . . 0.0 117.978 -163.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -66.51 -47.03 74.24 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 121.991 2.178 . . . . 0.0 110.647 169.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -56.44 -50.89 70.36 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 119.366 0.985 . . . . 0.0 108.383 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -49.85 -54.95 16.23 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.933 1.293 . . . . 0.0 110.992 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -52.35 -48.7 65.38 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.919 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.07 -25.12 37.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.246 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -67.03 -16.52 64.4 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 126.709 2.004 . . . . 0.0 110.874 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.553 ' HA ' HG21 ' A' ' 59' ' ' ILE . 1.4 mt -109.14 -16.44 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 C-N-CA 126.098 1.759 . . . . 0.0 115.436 170.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -91.54 -8.09 48.47 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 120.801 1.637 . . . . 0.0 111.894 170.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' O ' HG22 ' A' ' 59' ' ' ILE . 3.4 m-80 -85.27 136.86 33.32 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 118.379 0.536 . . . . 0.0 109.962 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.19 10.04 0.44 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.459 -1.189 . . . . 0.0 114.47 168.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.9 -10.1 59.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.374 1.587 . . . . 0.0 112.369 171.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.419 0.0 OUTLIER -101.02 86.86 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 125.815 2.722 . . . . 0.0 106.981 178.669 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -79.09 95.19 5.49 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 110.678 -2.965 . . . . 0.0 106.701 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.674 HG21 HD13 ' A' ' 72' ' ' ILE . 22.3 t -79.12 142.6 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.627 ' ND2' HH11 ' A' ' 78' ' ' ARG . 3.5 p-10 54.86 15.21 1.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.24 10.86 47.19 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 128.716 3.055 . . . . 0.0 113.225 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.84 131.52 14.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.466 1.633 . . . . 0.0 111.4 -163.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.21 109.1 0.39 Allowed 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 128.517 2.727 . . . . 0.0 109.805 -172.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.514 ' HB3' HD11 ' A' ' 72' ' ' ILE . 76.6 mt -139.18 71.01 1.37 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.337 0.971 . . . . 0.0 109.057 178.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.418 ' CD ' ' H ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -81.39 50.59 1.48 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.755 2.422 . . . . 0.0 112.442 -175.208 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -152.3 146.82 25.69 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.6 t -66.37 -30.47 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 127.47 2.308 . . . . 0.0 111.352 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.46 -2.36 90.6 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.557 1.075 . . . . 0.0 112.449 170.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.39 -60.63 1.84 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 117.398 -1.287 . . . . 0.0 109.322 164.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.674 HD13 HG21 ' A' ' 61' ' ' VAL . 1.4 mp -135.24 138.12 49.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-N 120.587 1.54 . . . . 0.0 113.12 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 33' ' ' PRO . 90.1 mt -110.36 -96.62 0.41 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 163.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -94.9 -169.27 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.763 1.268 . . . . 0.0 113.631 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.34 78.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.94 1.296 . . . . 0.0 113.459 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -70.78 -14.61 62.49 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.017 0.826 . . . . 0.0 112.069 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CG ' ' H ' ' A' ' 73' ' ' LEU . 52.3 t-80 -84.07 -2.11 56.1 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 171.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.627 HH11 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -115.76 -86.72 0.61 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 166.547 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.652 HD11 ' H ' ' A' ' 83' ' ' PHE . 0.5 OUTLIER -91.27 -166.56 1.6 Allowed 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 126.658 1.983 . . . . 0.0 110.284 -170.485 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -51.6 1.52 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 130.01 3.324 . . . . 0.0 116.18 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.81 55.79 2.34 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 124.932 1.253 . . . . 0.0 110.54 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -135.26 -65.31 0.62 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 118.671 -0.681 . . . . 0.0 110.434 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.652 ' H ' HD11 ' A' ' 79' ' ' LEU . 96.6 m-85 -122.77 179.18 4.72 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 118.609 0.64 . . . . 0.0 109.439 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.93 136.24 26.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 163.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 61' ' ' VAL 0.251 33.0 t -108.74 131.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 116.26 -1.829 . . . . 0.0 106.969 -163.464 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 59' ' ' ILE . 49.7 mm -133.27 106.29 9.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 120.93 1.695 . . . . 0.0 110.869 -169.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -97.43 99.21 10.63 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 164.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.6 ttp85 -86.78 112.78 22.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 120.785 1.629 . . . . 0.0 108.562 164.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.87 166.71 1.89 Allowed Glycine 0 CA--C 1.533 1.175 0 CA-C-O 121.864 0.702 . . . . 0.0 112.471 172.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.6 mptt 63.59 -56.79 0.2 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.563 1.945 . . . . 0.0 112.282 -165.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -94.41 0.07 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 121.268 1.849 . . . . 0.0 110.183 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.88 -179.29 7.44 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 124.422 2.058 . . . . 0.0 108.709 -172.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 90.0 t80 -79.43 157.78 27.47 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 111.569 -2.56 . . . . 0.0 106.667 163.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -145.57 160.31 41.83 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 128.521 2.728 . . . . 0.0 109.013 164.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.449 HD13 ' CD2' ' A' ' 19' ' ' PHE . 43.6 tp -117.86 137.49 52.75 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.468 1.507 . . . . 0.0 108.22 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.6 mm -121.44 136.51 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.478 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 8.8 ttt180 -138.43 -177.7 4.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 124.333 2.016 . . . . 0.0 109.168 164.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.478 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -120.78 161.59 21.21 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.006 -1.906 . . . . 0.0 108.873 163.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 0 C-N-CA 126.723 2.009 . . . . 0.0 111.873 -172.814 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.856 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.95 -44.66 54.19 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.14 0.976 . . . . 0.0 109.097 -171.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.14 77.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.399 0.437 . . . . 0.0 109.901 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -71.78 -41.83 67.87 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.4 mt -67.38 -51.96 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.65 0.78 . . . . 0.0 110.265 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.05 -45.11 87.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 119.673 1.124 . . . . 0.0 111.313 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.24 -35.32 66.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.23 97.5 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 126.743 2.116 . . . . 0.0 109.952 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.524 ' CZ ' HG13 ' A' ' 85' ' ' VAL . 11.8 m-85 -101.76 6.19 41.6 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.798 0.439 . . . . 0.0 111.29 -170.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -64.75 -2.99 2.83 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -79.14 -15.46 58.09 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 111.975 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.611 HG22 ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -132.82 168.92 15.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 175.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.611 ' HD2' HG22 ' A' ' 22' ' ' VAL . 33.9 Cg_endo -81.77 162.58 18.74 Favored 'Trans proline' 0 N--CA 1.437 -1.819 0 C-N-CA 121.512 1.475 . . . . 0.0 108.507 173.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 m -111.68 162.6 15.03 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -116.81 156.43 27.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.219 -0.926 . . . . 0.0 108.575 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 3.2 p -134.33 127.24 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.15 135.6 49.22 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.405 1.098 . . . . 0.0 108.687 163.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.91 61.9 3.97 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 170.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.37 171.02 32.87 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.811 1.196 . . . . 0.0 111.366 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.74 -150.72 26.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.349 1.452 . . . . 0.0 109.843 170.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HA ' ' CG2' ' A' ' 74' ' ' THR 0.278 0.0 OUTLIER -55.37 135.62 50.03 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.926 1.29 . . . . 0.0 113.53 -163.899 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -158.6 142.83 11.39 Favored Pre-proline 0 CA--C 1.518 -0.269 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -163.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HA ' HD23 ' A' ' 73' ' ' LEU . 33.1 Cg_endo -69.32 147.86 66.61 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.106 1.87 . . . . 0.0 111.957 -171.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.261 0.1 OUTLIER -39.37 -45.8 1.52 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.815 1.646 . . . . 0.0 113.421 170.256 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.555 ' HA ' HD22 ' A' ' 38' ' ' LEU . 8.4 p -79.02 -11.81 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.54 1.536 . . . . 0.0 113.218 -175.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -91.06 -43.86 9.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.822 0.737 . . . . 0.0 109.278 165.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.05 -30.23 67.44 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.668 -168.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.673 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -74.66 -36.58 62.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 120.129 1.331 . . . . 0.0 110.476 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.551 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -72.23 -43.28 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 C-N-CA 125.186 1.394 . . . . 0.0 107.566 -172.564 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.4 -40.08 81.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 126.415 1.886 . . . . 0.0 108.248 175.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.6 -20.56 50.2 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.799 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.55 17.17 11.58 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 119.085 0.857 . . . . 0.0 113.863 171.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -43.69 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 -171.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m -160.58 110.77 1.34 Allowed Pre-proline 0 N--CA 1.464 0.243 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.24 -20.96 6.84 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.467 2.111 . . . . 0.0 112.516 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -86.97 115.94 24.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -167.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -48.16 -36.77 14.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.972 1.309 . . . . 0.0 113.337 -172.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -67.04 -52.51 41.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.756 1.162 . . . . 0.0 111.152 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -56.26 -53.95 51.13 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.673 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -47.33 -54.61 10.63 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.409 1.884 . . . . 0.0 110.838 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.7 ttm-85 -50.23 -49.31 53.31 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 123.634 0.773 . . . . 0.0 110.771 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -80.99 -31.89 34.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.537 0.608 . . . . 0.0 112.482 -173.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.81 -21.96 63.67 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.514 1.525 . . . . 0.0 109.245 170.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.642 ' CD1' HD13 ' A' ' 38' ' ' LEU . 1.1 mp -91.44 -43.22 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 116.254 -1.831 . . . . 0.0 112.766 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -73.98 -10.74 59.94 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 120.222 1.374 . . . . 0.0 111.226 -173.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 58' ' ' ALA . 75.4 m-20 -84.95 144.33 28.4 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.52 25.44 0.48 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.772 1.177 . . . . 0.0 113.486 166.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.545 ' HB1' ' NH2' ' A' ' 88' ' ' ARG . . . -117.93 4.35 12.15 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 128.628 2.771 . . . . 0.0 109.471 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.461 HD11 HD12 ' A' ' 86' ' ' ILE 0.327 0.0 OUTLIER -111.59 98.1 6.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 124.743 2.211 . . . . 0.0 107.573 163.624 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -81.07 100.39 8.98 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 112.687 -2.051 . . . . 0.0 107.776 171.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.478 HG21 HD13 ' A' ' 72' ' ' ILE . 57.2 t -78.91 128.25 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.1 m120 61.43 0.93 0.49 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.932 1.293 . . . . 0.0 113.727 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.7 7.89 27.06 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 117.673 -1.626 . . . . 0.0 112.751 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.56 123.18 35.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.904 1.852 . . . . 0.0 108.555 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -50.37 102.29 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.927 2.091 . . . . 0.0 110.68 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.547 ' CB ' HD11 ' A' ' 72' ' ' ILE . 80.3 mt -141.81 110.1 5.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -175.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.33 44.61 2.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.541 2.736 . . . . 0.0 113.616 -163.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -143.32 154.62 43.96 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.003 -1.061 . . . . 0.0 111.785 167.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -64.09 134.72 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 122.975 1.369 . . . . 0.0 107.546 167.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.71 -6.57 46.25 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.006 -173.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.37 -46.59 32.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 163.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.547 HD11 ' CB ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -134.04 146.23 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 124.646 1.179 . . . . 0.0 108.235 165.568 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 33' ' ' PRO . 82.6 mt -124.17 -94.9 0.48 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 163.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.463 ' CG2' ' HA ' ' A' ' 31' ' ' ASP . 1.3 p -100.97 -173.89 2.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.774 1.624 . . . . 0.0 115.072 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . . . -50.4 -56.53 11.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.384 1.473 . . . . 0.0 114.075 171.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -67.23 -9.44 40.43 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.547 1.067 . . . . 0.0 113.166 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -89.64 -14.01 35.8 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.536 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.427 ' HA ' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -103.29 -66.6 0.93 Allowed 'General case' 0 C--N 1.338 0.095 0 O-C-N 119.85 -1.782 . . . . 0.0 108.027 174.421 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.496 HD12 ' H ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -88.04 -168.97 2.39 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 128.335 2.654 . . . . 0.0 110.907 -171.313 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -64.44 -5.66 5.76 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.146 1.379 . . . . 0.0 114.022 165.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.19 75.81 1.1 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.983 1.754 . . . . 0.0 113.612 -170.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.52 -81.74 0.28 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.839 0.856 . . . . 0.0 109.417 163.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.496 ' H ' HD12 ' A' ' 79' ' ' LEU . 5.7 m-85 -128.36 -162.63 1.2 Allowed 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 125.455 1.502 . . . . 0.0 110.076 -170.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.39 121.15 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 119.205 -2.184 . . . . 0.0 107.151 168.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.524 HG13 ' CZ ' ' A' ' 19' ' ' PHE . 2.3 t -79.02 143.99 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.461 HD12 HD11 ' A' ' 59' ' ' ILE . 26.1 mm -126.26 136.59 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 127.781 2.433 . . . . 0.0 106.293 172.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -127.43 84.4 2.25 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 164.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.6 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -84.37 91.93 7.91 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.844 2.057 . . . . 0.0 106.249 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -28.59 -63.82 0.11 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.367 2.413 . . . . 0.0 115.447 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.6 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 35.1 tttp -44.14 -37.85 3.35 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.707 2.403 . . . . 0.0 113.727 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -111.6 -117.63 0.3 Allowed 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 -170.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.13 -151.35 0.38 Allowed 'General case' 0 C--O 1.246 0.887 0 CA-C-O 122.662 1.22 . . . . 0.0 110.941 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.454 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 3.3 m-30 -110.83 104.14 12.73 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.951 2.5 . . . . 0.0 106.59 -165.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -113.05 165.86 11.96 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.593 1.157 . . . . 0.0 110.199 -173.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.1 tp -130.14 132.85 46.26 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.541 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.37 135.0 65.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 9.9 ptm180 -132.22 175.3 9.38 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.365 1.866 . . . . 0.0 109.633 170.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -118.78 168.35 10.83 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.898 0.879 . . . . 0.0 110.26 166.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.775 0 C-N-CA 125.259 1.423 . . . . 0.0 109.818 166.584 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.29 69.23 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 120.513 -1.367 . . . . 0.0 112.898 -167.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.57 -21.59 41.56 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.163 171.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.93 -40.77 78.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 mt -68.89 -56.59 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 116.873 -1.536 . . . . 0.0 109.198 173.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -52.96 -55.09 26.05 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 120.026 1.284 . . . . 0.0 111.373 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -83.26 -13.22 55.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.06 -1.025 . . . . 0.0 110.202 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.8 -27.99 63.79 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 118.222 -1.321 . . . . 0.0 111.771 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -126.93 4.35 6.56 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -171.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -59.82 0.32 0.15 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.5 -6.4 53.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.607 1.094 . . . . 0.0 109.761 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -129.22 160.25 64.88 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.876 2.07 . . . . 0.0 106.509 170.39 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.475 ' HD2' HG12 ' A' ' 22' ' ' VAL . 86.0 Cg_endo -78.87 174.28 12.43 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.415 1.41 . . . . 0.0 110.429 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 p -110.33 174.21 5.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 112.396 -2.183 . . . . 0.0 109.096 175.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -140.19 158.39 44.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 164.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.68 128.33 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -110.61 156.09 21.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -81.27 51.08 1.54 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.248 1.019 . . . . 0.0 111.414 -172.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.93 -175.96 40.88 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 121.144 -0.972 . . . . 0.0 113.11 173.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.12 152.05 2.45 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 -163.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.01 162.09 22.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.17 164.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.0 t -154.18 127.7 4.34 Favored Pre-proline 0 CA--C 1.509 -0.631 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -167.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.451 ' HA ' HD23 ' A' ' 73' ' ' LEU . 87.7 Cg_endo -72.95 148.03 44.67 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 122.358 2.039 . . . . 0.0 110.302 -175.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.276 13.0 tp -39.29 -47.78 1.75 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.522 2.729 . . . . 0.0 112.042 173.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.0 -7.56 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.134 1.773 . . . . 0.0 114.849 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -103.32 -34.84 8.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.301 -1.333 . . . . 0.0 111.376 165.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.89 -30.12 44.75 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 120.675 1.58 . . . . 0.0 108.823 -170.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.673 HD22 HD11 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -85.2 -28.45 25.43 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 119.837 1.199 . . . . 0.0 108.656 -174.7 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.441 ' N ' HD23 ' A' ' 38' ' ' LEU . 1.1 t -66.78 -52.36 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 t -66.56 -39.66 88.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.77 -16.53 57.06 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.345 -177.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.38 21.93 12.32 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.179 0.899 . . . . 0.0 111.852 165.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.1 mp -78.55 -40.95 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 t -160.37 105.83 1.36 Allowed Pre-proline 0 C--N 1.346 0.437 0 CA-C-N 120.517 1.508 . . . . 0.0 108.101 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -83.32 -20.21 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.971 1.781 . . . . 0.0 113.799 -176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.7 t -85.61 103.41 14.41 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 51.5 mttm -56.63 -22.41 33.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -163.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -47.93 58.51 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 121.917 2.144 . . . . 0.0 110.006 169.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -56.73 -51.24 69.6 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -53.02 -50.88 63.36 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 125.144 1.378 . . . . 0.0 110.953 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -64.04 -32.7 74.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 116.712 -1.613 . . . . 0.0 111.314 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.56 -29.13 28.08 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.886 1.676 . . . . 0.0 112.891 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -65.88 -16.11 63.54 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.55 1.94 . . . . 0.0 112.036 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.673 HD11 HD22 ' A' ' 38' ' ' LEU . 71.1 mt -88.32 -61.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 C-N-CA 126.078 1.751 . . . . 0.0 108.0 163.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -16.26 61.69 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.488 1.04 . . . . 0.0 112.713 -164.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.2 m120 -85.14 138.69 32.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 119.023 0.829 . . . . 0.0 109.833 173.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.05 7.02 0.07 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.494 1.521 . . . . 0.0 114.851 171.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.45 -14.79 59.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.536 1.168 . . . . 0.0 110.434 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.522 HG22 ' O ' ' A' ' 56' ' ' ASN 0.39 0.0 OUTLIER -90.31 90.96 3.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 CA-C-O 125.972 2.796 . . . . 0.0 106.992 172.605 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -83.24 94.16 7.84 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 110.299 -3.137 . . . . 0.0 105.397 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.454 HG23 HD13 ' A' ' 86' ' ' ILE . 9.4 p -78.46 134.48 28.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.629 HD22 ' HG3' ' A' ' 78' ' ' ARG . 78.3 m-20 56.94 22.78 7.54 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.942 -1.099 . . . . 0.0 113.263 175.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.71 18.06 73.9 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.08 1.324 . . . . 0.0 113.617 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.38 119.93 21.35 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.674 2.39 . . . . 0.0 107.029 -164.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.27 108.88 0.99 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.02 -1.467 . . . . 0.0 108.048 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.1 mt -143.97 103.24 4.0 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-N 120.214 1.37 . . . . 0.0 107.742 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 25.73 8.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.576 1.151 . . . . 0.0 112.595 -172.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -131.29 137.06 48.66 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.034 -1.041 . . . . 0.0 112.509 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.38 -38.92 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 125.976 1.71 . . . . 0.0 110.402 166.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.53 -12.95 74.08 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.077 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.32 -36.84 13.62 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.198 0.999 . . . . 0.0 111.46 170.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.2 mt -142.0 121.9 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 120.068 1.304 . . . . 0.0 111.829 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 33' ' ' PRO . 61.4 mt -111.15 -94.27 0.44 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 101.365 -3.568 . . . . 0.0 101.365 163.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.72 -172.72 2.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.24 -49.88 74.65 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.328 1.051 . . . . 0.0 112.26 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -14.08 62.81 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.458 0.703 . . . . 0.0 111.691 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -81.91 -18.73 42.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 118.484 -0.77 . . . . 0.0 109.481 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.629 ' HG3' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -112.3 -60.5 1.86 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 119.932 1.242 . . . . 0.0 110.507 -171.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.628 HD21 ' O ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -90.37 -177.02 4.98 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.521 1.528 . . . . 0.0 108.636 167.571 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -48.63 -36.71 16.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.795 164.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.26 93.63 0.53 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 124.737 1.16 . . . . 0.0 112.06 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -139.07 -64.44 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 164.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.628 ' O ' HD21 ' A' ' 79' ' ' LEU . 35.7 m-85 -134.9 -169.75 2.42 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.805 2.042 . . . . 0.0 107.354 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.43 124.1 6.62 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 163.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -79.3 145.65 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.454 HD13 HG23 ' A' ' 61' ' ' VAL . 20.3 mm -129.06 91.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -91.4 81.83 5.42 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -78.7 102.86 8.27 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 168.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -43.98 -49.3 7.77 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.566 1.555 . . . . 0.0 113.022 -173.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.77 -0.28 3.97 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -132.42 -100.61 0.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 164.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.6 -164.67 1.6 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 121.056 1.753 . . . . 0.0 109.127 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.48 82.49 5.36 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 130.937 3.695 . . . . 0.0 110.753 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -78.37 166.82 22.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.464 HD12 ' H ' ' A' ' 96' ' ' ILE . 40.1 tp -130.07 140.62 50.81 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.677 -169.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 95' ' ' LEU . 9.3 mm -134.99 127.64 48.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -170.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -136.62 172.46 12.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 122.519 1.152 . . . . 0.0 112.556 163.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.99 161.21 13.84 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.093 1.357 . . . . 0.0 110.78 165.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.851 0 C-N-CA 129.213 3.005 . . . . 0.0 106.374 165.461 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.86 -37.03 49.17 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.255 -0.903 . . . . 0.0 111.255 -165.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.76 88.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.806 0.812 . . . . 0.0 109.894 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.25 -43.19 61.56 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.358 1.063 . . . . 0.0 108.183 -167.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.0 mt -66.21 -50.5 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 117.617 -1.182 . . . . 0.0 108.909 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -58.09 -51.07 71.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.517 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -79.76 -22.98 42.54 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.304 0.502 . . . . 0.0 109.831 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.49 -41.27 99.31 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -127.75 13.47 6.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -164.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -53.81 -8.18 0.15 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.018 2.527 . . . . 0.0 113.312 165.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.43 -27.8 46.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 128.19 2.596 . . . . 0.0 112.452 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.624 HG22 ' HD2' ' A' ' 23' ' ' PRO . 1.3 p -131.05 173.05 6.33 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -173.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.624 ' HD2' HG22 ' A' ' 22' ' ' VAL . 66.7 Cg_endo -77.09 177.47 8.84 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.719 1.613 . . . . 0.0 110.066 -175.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 81.9 p -136.39 167.68 20.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.252 1.021 . . . . 0.0 108.659 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -134.93 155.34 50.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.48 129.91 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.209 1.404 . . . . 0.0 108.336 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.07 176.73 5.43 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 122.02 0.914 . . . . 0.0 112.809 167.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -79.01 32.15 0.21 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.456 2.302 . . . . 0.0 113.723 -163.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.18 -170.77 25.2 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.494 -1.379 . . . . 0.0 110.296 -165.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.85 138.14 2.59 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -174.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -68.84 147.78 51.23 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 117.957 0.878 . . . . 0.0 111.174 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.3 t -160.33 135.16 5.53 Favored Pre-proline 0 CA--C 1.519 -0.244 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -164.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.511 ' HA ' HD23 ' A' ' 73' ' ' LEU . 95.9 Cg_endo -76.63 149.99 30.88 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.565 2.177 . . . . 0.0 112.311 -166.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.789 HD22 HG13 ' A' ' 54' ' ' ILE 0.3 0.1 OUTLIER -46.81 -41.29 15.25 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.072 178.614 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 p -75.09 -10.73 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 128.685 2.794 . . . . 0.0 114.815 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -98.75 -43.79 6.65 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 166.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 pp -76.44 -19.91 57.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 116.79 -1.576 . . . . 0.0 109.682 -166.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.618 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -77.98 -33.27 51.5 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 120.836 1.653 . . . . 0.0 110.324 173.058 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.42 -50.64 44.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 126.003 1.721 . . . . 0.0 107.773 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -36.2 83.2 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 127.361 2.264 . . . . 0.0 110.51 174.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.65 -22.59 46.63 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.471 176.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.07 33.04 7.14 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 169.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -78.1 -52.72 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 176.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.2 m -145.54 99.95 4.43 Favored Pre-proline 0 C--N 1.344 0.364 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 -173.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.41 -17.82 12.72 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.382 2.054 . . . . 0.0 112.918 -168.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.3 t -90.94 109.28 20.5 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -52.38 -37.48 56.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 117.533 -1.223 . . . . 0.0 114.051 -168.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -46.52 80.27 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.397 1.908 . . . . 0.0 110.38 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -51.11 71.11 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -52.48 -47.2 66.67 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.992 1.717 . . . . 0.0 110.371 177.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -56.89 -47.87 79.49 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 117.434 -1.27 . . . . 0.0 111.358 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.68 -35.73 75.38 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.594 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.21 -12.68 21.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 124.267 1.027 . . . . 0.0 112.704 172.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.789 HG13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -107.07 -29.39 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.669 1.988 . . . . 0.0 114.408 173.601 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -89.56 -9.66 49.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.062 1.345 . . . . 0.0 110.144 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.459 ' O ' HG22 ' A' ' 59' ' ' ILE . 18.3 m-20 -100.06 146.54 26.65 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.262 1.03 . . . . 0.0 110.847 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.77 11.54 0.26 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.32 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.6 -9.06 58.64 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 125.49 1.516 . . . . 0.0 110.583 171.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.315 0.0 OUTLIER -99.49 89.95 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 125.042 2.353 . . . . 0.0 107.36 171.335 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -83.46 95.91 8.41 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 111.681 -2.508 . . . . 0.0 106.34 170.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.9 p -78.75 134.75 27.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 103.629 -2.73 . . . . 0.0 103.629 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 59.75 19.78 8.56 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 120.713 1.597 . . . . 0.0 111.84 170.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.9 6.21 76.27 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.683 1.611 . . . . 0.0 114.298 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -130.8 116.92 18.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.622 1.711 . . . . 0.0 107.889 -164.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.18 106.16 0.35 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.571 1.548 . . . . 0.0 109.08 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 51.3 mt -140.43 104.12 4.7 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.87 68.9 1.11 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.849 1.26 . . . . 0.0 112.563 -172.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -157.54 153.27 26.69 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 120.673 -1.267 . . . . 0.0 109.205 167.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.03 -32.03 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.373 0.669 . . . . 0.0 109.872 164.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.16 -24.43 70.43 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.017 0.341 . . . . 0.0 113.847 172.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.82 -45.25 8.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.812 1.245 . . . . 0.0 111.023 -172.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.534 HD12 HD23 ' A' ' 34' ' ' LEU . 2.2 mt -141.76 129.31 21.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 119.462 1.028 . . . . 0.0 109.369 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 33' ' ' PRO . 92.0 mt -110.15 -93.83 0.43 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 101.177 -3.638 . . . . 0.0 101.177 163.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.27 -171.41 2.07 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -173.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.55 86.66 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.58 1.152 . . . . 0.0 112.288 174.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -17.74 64.77 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.806 0.73 . . . . 0.0 111.837 175.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.444 ' CG ' ' H ' ' A' ' 73' ' ' LEU . 38.6 t-80 -89.31 2.04 54.91 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 123.581 0.752 . . . . 0.0 109.729 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.488 ' HB3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -119.97 -70.25 0.8 Allowed 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.791 1.178 . . . . 0.0 109.596 169.271 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.488 HD23 ' HB3' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -91.79 -170.86 2.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 129.195 2.998 . . . . 0.0 110.226 172.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -57.8 -7.17 0.65 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.391 2.277 . . . . 0.0 114.346 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.29 73.55 1.03 Allowed Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 124.286 0.946 . . . . 0.0 111.527 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.97 -66.02 0.53 Allowed 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -140.93 -175.4 4.29 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.564 1.946 . . . . 0.0 106.913 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.67 138.2 18.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 163.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.9 t -104.08 148.04 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.83 101.65 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 128.268 2.627 . . . . 0.0 105.531 -172.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -94.3 80.86 3.98 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.439 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -78.93 85.08 4.91 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 169.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -4.94 -88.82 0.0 OUTLIER Glycine 0 CA--C 1.525 0.659 1 C-N-CA 130.997 4.141 . . . . 0.0 116.033 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -65.49 -19.78 66.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.861 0.83 . . . . 0.0 112.138 -172.445 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -85.0 -111.63 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 166.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.38 -157.22 0.57 Allowed 'General case' 0 C--O 1.239 0.534 0 CA-C-N 120.276 1.398 . . . . 0.0 110.661 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -106.5 65.05 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 130.14 3.376 . . . . 0.0 111.087 -167.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -78.59 167.08 21.79 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 120.753 -1.217 . . . . 0.0 110.653 -170.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 96' ' ' ILE . 31.5 tp -132.09 133.52 44.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.273 1.029 . . . . 0.0 108.946 -166.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 95' ' ' LEU . 36.2 mm -135.61 124.81 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -166.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -138.53 174.07 10.92 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.754 1.264 . . . . 0.0 111.647 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.48 167.62 10.72 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.242 1.017 . . . . 0.0 109.798 164.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.525 0 C-N-CA 127.186 2.195 . . . . 0.0 110.295 178.523 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 122.782 1.277 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.2 -39.84 78.39 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 119.127 -2.233 . . . . 0.0 111.099 -175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.02 82.44 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -67.58 -37.61 82.85 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.8 mt -73.23 -50.75 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.81 1.644 . . . . 0.0 108.548 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.66 -46.54 89.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.15 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -71.26 -27.65 63.59 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.142 -0.974 . . . . 0.0 109.433 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.74 -41.32 42.85 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 126.28 1.895 . . . . 0.0 109.807 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -116.39 13.12 15.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.197 0.599 . . . . 0.0 111.208 -164.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -45.81 -25.65 0.54 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.745 2.418 . . . . 0.0 112.99 163.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.05 -12.08 59.96 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.755 2.422 . . . . 0.0 111.42 -174.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.564 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -133.51 169.9 12.74 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 127.257 2.223 . . . . 0.0 106.193 -174.675 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.564 ' HD2' HG12 ' A' ' 22' ' ' VAL . 43.6 Cg_endo -76.42 176.66 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 CA-C-N 121.134 1.441 . . . . 0.0 109.503 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.5 p -129.64 165.8 21.06 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.254 164.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -133.47 158.76 42.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.763 1.225 . . . . 0.0 107.87 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.59 137.25 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -122.28 173.28 7.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 122.86 1.315 . . . . 0.0 110.956 163.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.46 37.14 0.33 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 127.833 2.453 . . . . 0.0 113.527 -163.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.7 -167.85 10.18 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -165.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.22 145.31 1.65 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -73.62 152.05 40.65 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.558 -0.966 . . . . 0.0 112.467 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.4 t -158.76 133.08 5.24 Favored Pre-proline 0 C--N 1.343 0.302 0 CA-C-O 117.693 -1.146 . . . . 0.0 109.394 -163.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -55.76 141.19 85.06 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.666 2.91 . . . . 0.0 112.058 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.364 0.4 OUTLIER -48.07 -36.38 12.99 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.779 165.166 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.431 ' HA ' HD11 ' A' ' 54' ' ' ILE 0.259 12.1 p -71.41 -15.44 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.464 1.506 . . . . 0.0 114.617 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -98.44 -44.04 6.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 118.785 0.72 . . . . 0.0 109.284 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -71.87 -25.94 62.15 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 116.887 -1.53 . . . . 0.0 109.133 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.593 HD22 HD11 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -84.32 -25.32 29.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 120.955 1.707 . . . . 0.0 110.469 -177.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.434 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -76.07 -45.88 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.63 -45.36 90.61 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.66 1.584 . . . . 0.0 107.994 175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.73 -18.61 53.99 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.139 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.92 33.87 7.13 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 119.071 0.851 . . . . 0.0 111.171 164.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.25 -49.31 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.42 107.44 2.76 Favored Pre-proline 0 C--N 1.345 0.399 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 172.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.55 -15.73 8.42 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.539 2.159 . . . . 0.0 113.04 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.8 t -82.65 119.05 23.8 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -56.04 -36.13 67.66 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 120.662 1.574 . . . . 0.0 114.459 -165.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.83 -56.17 24.39 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.288 1.404 . . . . 0.0 109.118 170.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -55.08 -49.06 72.62 Favored 'General case' 0 C--O 1.207 -1.179 0 O-C-N 124.218 0.949 . . . . 0.0 108.442 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -47.99 -58.72 4.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.336 1.454 . . . . 0.0 111.198 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -65.66 -26.57 67.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.672 -174.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -89.59 -29.11 19.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 120.094 1.315 . . . . 0.0 112.532 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.62 -20.08 65.39 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.771 1.629 . . . . 0.0 109.76 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.593 HD11 HD22 ' A' ' 38' ' ' LEU . 64.9 mt -82.99 -66.5 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-O 116.251 -1.833 . . . . 0.0 109.394 163.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -64.96 -5.85 7.13 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 119.864 1.211 . . . . 0.0 112.663 -164.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 58' ' ' ALA . 2.9 m120 -76.62 134.99 39.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.244 1.021 . . . . 0.0 113.166 164.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.27 34.3 0.66 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.145 1.831 . . . . 0.0 111.773 164.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -118.66 4.4 11.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.58 2.352 . . . . 0.0 111.161 167.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.478 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.328 0.0 OUTLIER -102.46 100.4 10.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 124.378 2.037 . . . . 0.0 106.585 163.635 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -88.94 98.98 12.05 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 112.928 -1.942 . . . . 0.0 107.631 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.654 HG21 HD13 ' A' ' 72' ' ' ILE . 40.3 t -79.36 135.16 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.447 HD21 ' CD2' ' A' ' 79' ' ' LEU . 1.6 m120 55.59 27.5 10.54 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.915 0.864 . . . . 0.0 109.87 -174.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.75 9.27 86.97 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 117.498 -1.723 . . . . 0.0 113.256 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 133.46 38.29 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.997 2.399 . . . . 0.0 109.411 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 109.75 0.65 Allowed 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 127.497 2.319 . . . . 0.0 109.403 -166.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 72' ' ' ILE . 55.6 mt -145.28 110.82 5.35 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -118.75 27.76 8.71 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.997 2.519 . . . . 0.0 112.793 -163.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -142.18 156.91 45.36 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.939 -1.101 . . . . 0.0 113.76 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 p -69.63 -39.44 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.139 2.176 . . . . 0.0 110.882 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.2 -12.77 72.66 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 170.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.31 -58.35 3.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 116.267 -1.825 . . . . 0.0 109.991 167.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.654 HD13 HG21 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -139.66 137.78 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 121.601 2.001 . . . . 0.0 114.049 -176.171 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.6 mt -108.05 -95.06 0.39 Allowed 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 163.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.9 -176.66 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 119.941 -1.724 . . . . 0.0 115.627 -164.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.44 -54.74 42.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.808 0.843 . . . . 0.0 111.04 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.63 -4.07 21.5 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.797 1.239 . . . . 0.0 113.329 175.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 63.7 t-80 -88.53 -23.89 23.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.322 166.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.491 HH21 HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -105.42 -65.12 1.07 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -171.814 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -90.88 -176.68 4.74 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.523 1.129 . . . . 0.0 108.262 174.455 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -54.3 -21.57 9.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.128 0.971 . . . . 0.0 112.362 170.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.73 85.53 0.81 Allowed Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 125.647 1.594 . . . . 0.0 112.829 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.2 mtp85 -141.28 -67.03 0.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 163.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -128.27 -168.11 1.86 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.786 1.234 . . . . 0.0 109.795 -170.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.16 130.88 12.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 163.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.78 136.59 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.7 mm -127.53 94.96 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 124.283 1.033 . . . . 0.0 108.316 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -91.28 83.26 5.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -78.89 99.16 6.65 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 170.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.71 159.76 4.26 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.0 tttt 71.98 -48.29 0.68 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.194 2.198 . . . . 0.0 109.686 -164.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -88.58 -153.65 0.26 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 164.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.472 ' HB3' HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -120.53 -158.13 0.74 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 124.955 1.302 . . . . 0.0 110.912 -167.736 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -95.22 93.99 7.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.111 2.565 . . . . 0.0 107.886 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -78.55 164.92 24.28 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 120.478 -1.389 . . . . 0.0 107.779 168.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.3 tt -133.06 123.88 26.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 mm -116.49 132.55 65.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -136.5 179.92 6.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 122.322 1.058 . . . . 0.0 111.477 171.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.5 165.11 14.32 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 123.737 0.815 . . . . 0.0 111.328 165.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.369 0 C-N-CA 128.392 2.677 . . . . 0.0 110.075 -177.197 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.89 -49.27 47.71 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.226 -0.921 . . . . 0.0 111.901 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.77 74.44 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -39.37 65.26 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.6 mt -66.88 -51.53 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 124.755 1.222 . . . . 0.0 109.554 174.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -53.14 -59.11 4.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.829 0.74 . . . . 0.0 110.307 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -76.35 -19.37 58.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.698 -174.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.89 -40.47 74.42 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -119.27 6.11 11.2 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -164.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -58.82 15.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.808 2.043 . . . . 0.0 114.963 163.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.49 -25.08 45.61 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.71 -1.244 . . . . 0.0 109.802 164.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.435 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -127.94 160.22 62.5 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.395 1.878 . . . . 0.0 107.142 -176.705 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.435 ' HD2' HG12 ' A' ' 22' ' ' VAL . 96.3 Cg_endo -71.23 179.21 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.086 1.857 . . . . 0.0 110.569 172.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.1 p -121.45 -178.37 3.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.325 1.05 . . . . 0.0 110.561 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -140.8 154.37 46.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 164.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 4.2 p -135.23 124.97 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 C-N-CA 124.954 1.302 . . . . 0.0 108.455 175.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.22 170.99 7.78 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 122.556 1.17 . . . . 0.0 111.288 171.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -79.17 8.0 6.61 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 126.69 1.996 . . . . 0.0 113.865 -163.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.6 -179.52 49.07 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.698 1.618 . . . . 0.0 112.774 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.38 139.05 3.07 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -163.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -66.62 136.62 55.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.174 0.987 . . . . 0.0 111.333 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.7 t -144.93 136.54 12.79 Favored Pre-proline 0 C--O 1.225 -0.198 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -163.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HA ' HD23 ' A' ' 73' ' ' LEU . 88.8 Cg_exo -50.51 140.6 35.43 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 124.903 3.735 . . . . 0.0 114.816 -176.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.683 HD22 HG13 ' A' ' 54' ' ' ILE 0.254 0.0 OUTLIER -47.61 -45.02 27.18 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.821 0.819 . . . . 0.0 111.519 164.461 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.719 ' HA ' HD12 ' A' ' 38' ' ' LEU . 8.8 p -77.49 8.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 128.047 2.539 . . . . 0.0 113.548 -177.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -120.55 -45.47 2.41 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.58 1.152 . . . . 0.0 108.089 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.92 -24.89 64.34 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 120.015 -1.678 . . . . 0.0 108.959 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.719 HD12 ' HA ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -75.71 -33.83 60.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.552 1.524 . . . . 0.0 110.296 177.432 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.626 ' N ' HD13 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -72.97 -46.27 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 127.005 2.122 . . . . 0.0 108.536 -173.297 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 m -62.82 -45.65 91.64 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 128.34 2.656 . . . . 0.0 109.098 169.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.42 -11.91 59.98 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.409 1.004 . . . . 0.0 112.647 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.43 27.09 23.62 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 119.222 0.919 . . . . 0.0 112.096 167.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.99 -42.66 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.1 m -156.17 101.78 2.09 Favored Pre-proline 0 C--N 1.347 0.484 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 165.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.28 -14.69 13.09 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.379 2.053 . . . . 0.0 113.32 -171.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.8 t -81.87 108.62 15.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HE3' HG11 ' A' ' 39' ' ' VAL . 14.8 mptt -50.1 -35.28 24.86 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -164.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.29 -47.35 67.89 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 121.137 1.789 . . . . 0.0 110.444 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -50.0 72.49 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.608 ' HB1' HD11 ' A' ' 38' ' ' LEU . . . -50.91 -48.0 60.71 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.946 1.699 . . . . 0.0 111.48 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -61.68 -40.79 96.2 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 115.961 -1.971 . . . . 0.0 110.478 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -25.11 48.69 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 116.332 -2.147 . . . . 0.0 112.861 173.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.513 ' HA ' HH11 ' A' ' 88' ' ' ARG . 0.3 OUTLIER -66.65 -18.79 65.56 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 117.666 -1.159 . . . . 0.0 112.093 174.67 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.683 HG13 HD22 ' A' ' 34' ' ' LEU . 1.1 mp -92.38 -51.64 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 116.633 -1.651 . . . . 0.0 110.707 164.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -68.82 -13.48 62.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 120.821 1.646 . . . . 0.0 110.627 -164.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.652 ' O ' HG22 ' A' ' 59' ' ' ILE . 9.5 m120 -85.76 132.58 34.1 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 118.317 0.508 . . . . 0.0 111.143 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.68 17.29 0.25 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.208 0.909 . . . . 0.0 114.129 169.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.17 -1.39 54.24 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 119.039 1.419 . . . . 0.0 111.006 164.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 56' ' ' ASN 0.286 0.0 OUTLIER -88.8 89.25 3.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 163.093 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -78.69 103.24 8.5 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 166.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 66' ' ' LEU . 8.5 p -78.4 137.14 22.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 102.111 -3.292 . . . . 0.0 102.111 175.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.555 HD21 ' CD2' ' A' ' 79' ' ' LEU . 12.8 m-20 75.81 -54.43 0.62 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 127.192 2.197 . . . . 0.0 109.645 174.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' H ' ' H ' ' A' ' 64' ' ' GLU . . . 172.76 5.04 0.03 OUTLIER Glycine 0 CA--C 1.536 1.352 1 C-N-CA 131.969 4.604 . . . . 0.0 111.577 174.798 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.424 ' H ' ' H ' ' A' ' 63' ' ' GLY . 15.0 pm0 -122.33 128.3 50.86 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.682 1.993 . . . . 0.0 108.362 -169.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 106.8 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.319 1.848 . . . . 0.0 109.145 -177.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HB2' HG12 ' A' ' 61' ' ' VAL . 57.3 mt -144.23 110.51 5.49 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.63 16.51 11.16 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.507 2.323 . . . . 0.0 112.639 -169.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -118.98 141.08 48.99 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.468 1.507 . . . . 0.0 109.231 -172.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.482 HG22 HD21 ' A' ' 73' ' ' LEU . 9.8 p -57.47 -42.8 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.216 1.406 . . . . 0.0 110.39 177.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.9 -8.48 73.32 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.61 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.43 ' C ' HG13 ' A' ' 72' ' ' ILE . . . -85.17 -45.06 12.39 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.736 0.768 . . . . 0.0 109.466 170.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.621 HD12 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -140.99 127.76 21.01 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-N 120.298 1.408 . . . . 0.0 112.657 -178.858 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.482 HD21 HG22 ' A' ' 69' ' ' VAL . 97.7 mt -116.41 -92.64 0.51 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 102.241 -3.244 . . . . 0.0 102.241 163.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.66 -175.48 2.81 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.782 -1.199 . . . . 0.0 113.502 -175.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.45 -43.2 79.29 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -82.82 -6.0 59.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.81 1.186 . . . . 0.0 111.078 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -81.58 -11.39 59.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 121.768 -0.583 . . . . 0.0 109.61 165.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.409 ' HD3' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -117.2 -71.42 0.74 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.646 1.112 . . . . 0.0 109.505 -173.57 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.555 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.9 -168.4 2.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.884 2.473 . . . . 0.0 109.271 176.578 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -53.0 -9.88 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.396 1.878 . . . . 0.0 115.644 166.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.67 71.22 1.0 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.64 1.114 . . . . 0.0 113.021 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -141.35 -64.85 0.44 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.17 0.485 . . . . 0.0 110.614 173.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -133.82 -169.06 2.23 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.559 1.544 . . . . 0.0 107.953 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -158.08 155.79 29.87 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 164.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.72 150.61 23.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.9 mm -135.0 97.64 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -170.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -99.49 81.14 2.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.513 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -78.62 117.54 19.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 171.137 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.85 -49.68 12.6 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.038 1.304 . . . . 0.0 111.837 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -1.04 0.79 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.56 1.544 . . . . 0.0 115.001 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -146.92 -95.86 0.09 Allowed 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 121.448 1.931 . . . . 0.0 109.176 164.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -153.93 -163.1 1.56 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 120.53 1.514 . . . . 0.0 109.513 -171.275 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -107.41 75.64 1.03 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 127.949 2.499 . . . . 0.0 109.969 -170.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -78.45 165.05 24.23 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.965 -1.085 . . . . 0.0 109.568 -172.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.8 tp -115.63 134.67 54.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.111 1.365 . . . . 0.0 107.987 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.7 mm -128.62 133.5 66.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -174.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 8.1 ptt-85 -139.25 174.49 10.46 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.948 1.356 . . . . 0.0 111.432 167.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.57 162.52 17.87 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.328 1.051 . . . . 0.0 110.199 164.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.408 0 C-N-CA 129.453 3.101 . . . . 0.0 108.276 175.887 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.223 -0.34 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.36 67.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 120.609 -1.307 . . . . 0.0 112.106 -169.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.63 76.27 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.132 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -74.4 -24.2 59.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.597 0.759 . . . . 0.0 110.251 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 mt -77.96 -57.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 125.732 1.613 . . . . 0.0 107.629 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -52.82 -45.34 67.25 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.93 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -91.19 -19.06 23.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.573 0.749 . . . . 0.0 111.346 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.51 -37.79 69.01 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 170.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.561 ' CD2' HG21 ' A' ' 85' ' ' VAL . 58.5 m-85 -120.61 15.45 11.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 119.581 -0.847 . . . . 0.0 110.497 -164.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -0.33 0.1 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.509 1.924 . . . . 0.0 115.297 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.82 -20.92 48.55 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.934 -1.104 . . . . 0.0 111.219 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.415 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -127.2 160.08 61.68 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 178.112 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.415 ' HD2' HG12 ' A' ' 22' ' ' VAL . 39.6 Cg_endo -80.58 176.88 8.67 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 CA-C-N 120.626 1.259 . . . . 0.0 109.926 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.5 p -112.12 165.62 11.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.716 172.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -130.04 157.96 40.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.692 2.397 . . . . 0.0 106.956 169.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 4.1 p -135.21 136.12 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -127.42 -172.87 2.76 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 119.503 1.047 . . . . 0.0 112.533 163.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 6.78 8.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.577 1.551 . . . . 0.0 113.983 -163.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.54 -173.1 34.1 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.082 1.325 . . . . 0.0 111.26 -170.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.84 135.57 1.65 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.26 134.55 39.33 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.543 0.672 . . . . 0.0 112.692 -167.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 t -157.47 131.66 5.04 Favored Pre-proline 0 CA--C 1.515 -0.384 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -166.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.543 ' HA ' HD23 ' A' ' 73' ' ' LEU . 87.1 Cg_endo -74.64 150.9 40.73 Favored 'Trans proline' 0 N--CA 1.437 -1.84 0 C-N-CA 122.529 2.153 . . . . 0.0 111.403 -167.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.719 HD22 HG13 ' A' ' 54' ' ' ILE 0.299 0.0 OUTLIER -44.01 -42.09 5.83 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.568 174.149 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.66 ' HA ' HD22 ' A' ' 38' ' ' LEU . 1.4 p -79.76 -5.59 8.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 126.907 2.083 . . . . 0.0 115.342 -174.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -105.06 -35.61 7.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.22 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.83 -21.03 57.69 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 120.914 1.688 . . . . 0.0 109.298 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.705 HD13 ' CD1' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -77.72 -30.37 51.69 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 120.302 1.41 . . . . 0.0 110.27 173.437 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -74.35 -47.86 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -173.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -47.68 84.48 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.627 1.971 . . . . 0.0 109.482 171.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.417 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.82 -10.81 59.91 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.353 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.39 33.95 18.32 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 119.111 0.869 . . . . 0.0 111.068 166.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.484 ' CG2' HD12 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -78.56 -51.37 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 172.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -151.56 105.78 2.91 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 169.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -84.31 -12.67 7.84 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.811 2.341 . . . . 0.0 113.642 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -87.57 115.8 25.25 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -52.01 -34.85 44.71 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -165.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -62.95 -54.7 34.31 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.948 1.704 . . . . 0.0 109.039 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -48.31 78.86 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 117.172 -1.394 . . . . 0.0 108.482 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.545 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -48.31 -58.68 4.23 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 125.319 1.448 . . . . 0.0 111.104 175.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HG2' HG21 ' A' ' 35' ' ' VAL . 64.0 mtt180 -67.35 -27.74 67.37 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 117.332 -1.318 . . . . 0.0 110.616 -170.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.07 -34.23 26.23 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 120.302 1.41 . . . . 0.0 112.234 172.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.564 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.8 m-20 -64.65 -16.82 63.38 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.511 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.719 HG13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -92.26 -53.59 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 116.054 -1.927 . . . . 0.0 111.728 166.611 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -71.61 -5.11 31.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 120.941 1.7 . . . . 0.0 112.076 -171.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.543 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.1 m120 -80.62 136.48 36.23 Favored 'General case' 0 N--CA 1.437 -1.118 0 O-C-N 121.373 -0.829 . . . . 0.0 112.462 173.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.72 33.87 0.86 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 124.486 1.041 . . . . 0.0 112.141 167.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -121.39 0.39 10.01 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 126.901 2.08 . . . . 0.0 111.509 168.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 56' ' ' ASN 0.315 0.0 OUTLIER -91.99 98.73 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 163.533 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -88.72 105.22 17.55 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.333 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 72' ' ' ILE . 7.9 t -88.43 130.34 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.612 HD22 HD22 ' A' ' 79' ' ' LEU . 4.6 m120 57.37 18.09 4.17 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.565 0.698 . . . . 0.0 111.577 -173.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.13 11.71 78.01 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 120.599 -1.313 . . . . 0.0 113.5 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -119.37 123.27 43.75 Favored 'General case' 0 C--O 1.228 -0.062 0 CA-C-N 119.735 1.768 . . . . 0.0 108.421 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 112.1 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.138 0.975 . . . . 0.0 108.854 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.441 ' CB ' HD11 ' A' ' 72' ' ' ILE . 64.8 mt -144.89 108.26 4.6 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -174.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 2.2 pm0 -131.09 31.49 4.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 126.718 2.007 . . . . 0.0 113.891 -163.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -142.38 157.27 44.97 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.6 -0.687 . . . . 0.0 111.182 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.5 p -62.72 137.47 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 163.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.33 -8.41 46.97 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.645 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.17 -53.68 7.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 163.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.506 ' CD1' HG21 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -139.58 145.0 27.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 119.244 0.929 . . . . 0.0 110.137 170.221 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 33' ' ' PRO . 92.5 mt -124.15 -91.32 0.55 Allowed 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 163.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.89 -175.56 3.0 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.729 -1.232 . . . . 0.0 113.548 -174.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.627 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . . . -58.57 -41.85 86.65 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.876 175.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -76.3 -7.47 55.0 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 123.727 0.642 . . . . 0.0 110.981 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -92.99 -4.8 51.99 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.927 1.291 . . . . 0.0 110.393 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -120.34 -65.17 1.18 Allowed 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.953 -1.717 . . . . 0.0 109.498 175.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.612 HD22 HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.14 -172.68 3.57 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.475 1.51 . . . . 0.0 109.501 170.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -50.43 -17.87 0.55 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.712 2.005 . . . . 0.0 113.918 166.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.36 80.4 1.33 Allowed Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 125.435 1.493 . . . . 0.0 111.507 -174.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -143.62 -63.58 0.39 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 122.802 0.441 . . . . 0.0 111.548 163.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -131.46 -174.11 3.31 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.99 2.116 . . . . 0.0 108.172 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -160.73 164.12 31.84 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.839 1.656 . . . . 0.0 107.186 164.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 19' ' ' PHE . 72.1 t -134.22 143.97 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 O-C-N 120.59 -1.319 . . . . 0.0 107.516 176.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.488 HD13 HG22 ' A' ' 61' ' ' VAL . 25.4 mm -125.06 98.38 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 127.774 2.429 . . . . 0.0 107.221 -172.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -96.13 84.62 3.83 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.564 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -82.14 114.08 20.43 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.115 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.77 1.78 0.7 Allowed Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.459 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 34.0 tptt -69.4 -46.23 67.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.58 1.69 . . . . 0.0 109.395 166.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -125.43 -90.27 0.55 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.801 1.24 . . . . 0.0 108.844 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.433 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.31 -159.88 1.02 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-N 119.671 1.123 . . . . 0.0 109.197 -163.562 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.433 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -99.46 83.84 2.88 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 130.826 3.65 . . . . 0.0 109.578 -176.166 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -78.46 158.97 28.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.131 -1.804 . . . . 0.0 106.131 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.9 tt -126.37 129.9 49.7 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -163.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.5 mm -120.82 122.53 68.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -168.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 11.5 ptt85 -128.63 171.89 11.73 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 124.044 1.878 . . . . 0.0 110.294 176.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.627 ' CE1' ' HB2' ' A' ' 75' ' ' ALA . 6.0 m-85 -143.56 158.47 43.63 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -164.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.796 0 C-N-CA 128.487 2.715 . . . . 0.0 111.127 169.901 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.72 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.44 -49.71 70.43 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 119.841 -1.787 . . . . 0.0 112.039 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.23 73.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.631 0.651 . . . . 0.0 111.033 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.31 -38.45 71.73 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 125.261 1.425 . . . . 0.0 109.158 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.413 ' CG2' HD13 ' A' ' 95' ' ' LEU . 27.4 mt -69.3 -45.96 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 126.518 1.927 . . . . 0.0 106.61 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -54.28 -57.91 9.41 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.463 175.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -71.85 -29.68 64.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.401 1.0 . . . . 0.0 109.94 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.54 -29.6 72.94 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 126.335 1.921 . . . . 0.0 110.414 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -117.11 -1.82 11.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.027 -173.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -59.02 -0.53 0.12 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.8 -13.35 59.86 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.844 1.202 . . . . 0.0 111.243 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 p -127.39 157.46 72.69 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 128.598 2.759 . . . . 0.0 105.785 167.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -87.08 176.66 4.29 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 121.313 1.342 . . . . 0.0 109.801 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.4 p -106.36 177.74 4.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.254 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -123.6 157.29 34.06 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 164.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 p -136.94 133.92 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 124.923 1.289 . . . . 0.0 108.347 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -123.72 -177.56 3.77 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.115 0.483 . . . . 0.0 111.743 163.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.78 39.43 0.95 Allowed 'General case' 0 C--N 1.318 -0.768 0 O-C-N 120.485 -1.384 . . . . 0.0 113.635 -163.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.67 -175.58 0.86 Allowed Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.903 -1.123 . . . . 0.0 112.788 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.18 131.83 0.23 Allowed Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.49 147.71 52.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -167.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 t -152.88 136.59 10.13 Favored Pre-proline 0 C--O 1.222 -0.382 0 C-N-CA 124.743 1.217 . . . . 0.0 108.345 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.46 ' HA ' HD23 ' A' ' 73' ' ' LEU . 61.3 Cg_endo -65.4 145.38 82.93 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.348 2.699 . . . . 0.0 111.394 -173.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.428 HD22 HG13 ' A' ' 54' ' ' ILE 0.375 0.1 OUTLIER -43.22 -39.19 2.85 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 170.354 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.488 ' HA ' HD22 ' A' ' 38' ' ' LEU . 3.6 p -77.24 -13.0 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.963 1.305 . . . . 0.0 113.992 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -100.1 -32.79 10.75 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 120.119 1.327 . . . . 0.0 109.444 167.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.48 -30.79 64.85 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 121.829 2.104 . . . . 0.0 108.237 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.691 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -75.9 -31.4 59.18 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 120.658 1.572 . . . . 0.0 110.076 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.489 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -72.27 -46.09 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 126.402 1.881 . . . . 0.0 107.265 -176.536 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.2 t -65.69 -41.86 91.9 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 128.145 2.578 . . . . 0.0 107.776 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -80.77 -18.14 48.62 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.74 29.86 9.54 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 118.531 0.605 . . . . 0.0 111.776 168.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.471 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.4 mp -78.81 -47.06 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 175.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.7 m -155.34 113.65 2.27 Favored Pre-proline 0 CA--C 1.517 -0.299 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.77 -17.17 7.29 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.41 2.074 . . . . 0.0 113.532 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.63 116.17 23.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -167.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -36.96 66.79 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -163.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -69.06 -42.71 75.91 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 120.15 1.341 . . . . 0.0 110.197 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -61.65 -51.99 66.18 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.691 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -50.52 -51.53 46.75 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.49 1.916 . . . . 0.0 110.0 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -53.56 -48.48 69.1 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.583 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -78.35 -32.11 48.91 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.69 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -62.78 -17.71 61.5 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.746 1.218 . . . . 0.0 111.001 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.669 ' CD1' HD13 ' A' ' 38' ' ' LEU . 1.2 mp -90.07 -55.92 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 117.193 -1.384 . . . . 0.0 112.599 169.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -73.18 -6.74 47.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.567 1.076 . . . . 0.0 111.416 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.2 m-80 -78.32 138.5 38.6 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.367 1.08 . . . . 0.0 112.041 169.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.31 46.07 2.43 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.055 164.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -126.26 11.01 7.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.979 2.912 . . . . 0.0 110.456 165.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 56' ' ' ASN 0.332 0.0 OUTLIER -111.25 91.9 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 162.907 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -82.85 122.1 27.8 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.02 -1.9 . . . . 0.0 107.618 174.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.62 HG21 HD13 ' A' ' 72' ' ' ILE . 25.1 t -115.28 135.83 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER 61.11 -16.88 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.795 2.038 . . . . 0.0 114.205 -174.524 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 61' ' ' VAL . . . 152.19 -7.24 0.54 Allowed Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 126.683 2.087 . . . . 0.0 113.328 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.99 153.68 41.04 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 119.876 1.838 . . . . 0.0 110.651 -163.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.16 105.45 2.93 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.168 1.787 . . . . 0.0 110.066 -164.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.488 ' CB ' HD11 ' A' ' 72' ' ' ILE . 71.5 mt -134.36 102.73 5.45 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -173.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.86 38.61 3.92 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 128.151 2.58 . . . . 0.0 111.656 -163.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -139.66 146.83 40.17 Favored 'General case' 0 N--CA 1.457 -0.099 0 O-C-N 121.725 -0.609 . . . . 0.0 111.135 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.08 -37.01 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.382 0.673 . . . . 0.0 110.615 173.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.14 -12.8 83.24 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.418 -0.801 . . . . 0.0 112.779 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.434 ' C ' HG13 ' A' ' 72' ' ' ILE . . . -76.5 -54.51 6.61 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.063 0.931 . . . . 0.0 109.177 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.62 HD13 HG21 ' A' ' 61' ' ' VAL . 5.1 mt -145.14 130.54 13.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 123.747 0.819 . . . . 0.0 109.367 -167.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 33' ' ' PRO . 92.7 mt -122.26 -70.5 0.77 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 168.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.13 178.67 4.54 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.288 -1.507 . . . . 0.0 112.205 -177.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.52 -34.22 72.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -81.93 -12.17 58.53 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.535 0.607 . . . . 0.0 111.645 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -86.42 -1.24 57.39 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.219 1.408 . . . . 0.0 110.056 168.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -116.53 -79.1 0.58 Allowed 'General case' 0 C--N 1.341 0.216 0 O-C-N 120.109 -1.62 . . . . 0.0 106.875 175.037 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.59 -171.7 3.73 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 128.848 2.859 . . . . 0.0 108.735 176.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -48.99 -11.7 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 129.183 2.993 . . . . 0.0 115.664 163.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.21 82.35 1.59 Allowed Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 125.281 1.42 . . . . 0.0 111.728 -168.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.94 -81.56 0.34 Allowed 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 164.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -127.94 -162.19 1.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.429 1.491 . . . . 0.0 108.866 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -157.35 139.0 14.01 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 120.291 -1.506 . . . . 0.0 108.041 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.84 113.52 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -170.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.8 mm -95.72 139.71 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -128.12 82.89 2.11 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 163.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.411 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 1.3 tpm_? -79.0 95.12 5.41 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 172.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.25 -48.57 5.57 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 -171.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.411 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 20.5 tptm -68.21 -21.6 64.85 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.354 1.462 . . . . 0.0 113.859 -176.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -103.95 -98.67 0.31 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.504 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.4 OUTLIER -159.3 -162.64 1.08 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 123.001 1.381 . . . . 0.0 108.806 171.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.504 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 6.0 m-30 -78.48 147.23 34.0 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 163.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -144.15 174.05 11.21 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 128.646 2.778 . . . . 0.0 108.389 171.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.413 HD13 ' CG2' ' A' ' 15' ' ' ILE . 22.0 tp -135.33 137.03 42.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.187 1.795 . . . . 0.0 107.639 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 mm -130.69 131.85 64.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -173.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.5 ptt85 -139.22 173.1 11.91 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 123.46 1.6 . . . . 0.0 110.539 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.01 169.9 8.74 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.851 164.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.315 0 C-N-CA 128.491 2.716 . . . . 0.0 109.903 176.43 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.6 p . . . . . 0 C--O 1.215 -0.746 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.47 82.82 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 120.107 -1.62 . . . . 0.0 110.495 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.96 94.84 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 122.065 0.936 . . . . 0.0 109.693 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -75.32 -19.99 59.33 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.38 1.072 . . . . 0.0 110.268 -175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.0 mt -81.7 -55.47 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 127.569 2.348 . . . . 0.0 106.927 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -56.19 -44.14 79.12 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.17 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -31.17 50.23 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.67 0.668 . . . . 0.0 109.345 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.45 -35.5 81.85 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -119.18 17.54 13.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.461 1.105 . . . . 0.0 110.077 -168.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -56.62 5.37 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.906 2.883 . . . . 0.0 113.468 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.48 -27.66 46.3 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.728 2.411 . . . . 0.0 110.221 175.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.95 166.65 27.73 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 126.454 1.902 . . . . 0.0 107.406 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.02 173.43 13.63 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 167.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.4 p -106.46 177.77 4.76 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.767 167.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -123.47 152.98 41.13 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 163.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 7.7 p -139.68 134.01 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -119.92 -178.08 3.56 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.487 0.66 . . . . 0.0 111.637 164.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -82.34 5.68 19.45 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.553 1.941 . . . . 0.0 115.624 -163.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.98 -175.16 20.47 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.908 1.718 . . . . 0.0 110.176 -165.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.78 155.41 28.7 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.349 11.2 p-10 -91.75 143.81 26.15 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.628 1.171 . . . . 0.0 111.551 163.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.2 t -159.48 136.33 6.71 Favored Pre-proline 0 C--O 1.225 -0.188 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -163.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.425 ' HA ' HD23 ' A' ' 73' ' ' LEU . 72.3 Cg_endo -70.49 147.3 57.87 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.86 1.707 . . . . 0.0 112.068 -172.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.402 0.4 OUTLIER -49.59 -26.6 3.69 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.435 1.094 . . . . 0.0 113.899 177.426 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.592 ' HA ' HD11 ' A' ' 54' ' ' ILE . 14.6 p -63.18 -61.5 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.926 1.239 . . . . 0.0 111.249 168.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -66.16 -36.68 83.75 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.083 0.856 . . . . 0.0 109.528 -171.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 38' ' ' LEU . 1.3 pp -80.52 -24.4 39.39 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 116.598 -1.667 . . . . 0.0 110.034 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.416 HD22 ' NH1' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -75.31 -37.81 60.59 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 121.833 2.106 . . . . 0.0 109.82 176.172 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 t -73.82 -43.35 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.3 t -63.7 -32.52 74.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.941 0.896 . . . . 0.0 109.936 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.33 -17.09 57.02 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.602 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.27 27.68 39.22 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.471 HG21 ' HE ' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -78.58 -44.71 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 176.752 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -157.07 91.46 2.42 Favored Pre-proline 0 C--N 1.348 0.541 0 CA-C-N 120.571 1.532 . . . . 0.0 106.968 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.72 -15.45 21.48 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.476 2.118 . . . . 0.0 112.588 -164.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.59 105.03 17.06 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 -174.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 81.0 mttt -53.27 -22.59 7.24 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -166.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HD2' ' H ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -62.04 -60.36 3.73 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 120.314 1.415 . . . . 0.0 110.719 168.165 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.516 ' H ' ' HD2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -53.0 -49.14 66.82 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 125.983 1.713 . . . . 0.0 107.058 178.817 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -48.59 -58.43 4.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.391 1.057 . . . . 0.0 111.566 174.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.409 ' HA ' HD12 ' A' ' 54' ' ' ILE . 11.2 mtt-85 -65.81 -24.28 66.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 115.688 -2.101 . . . . 0.0 112.49 -175.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -77.87 -39.9 41.81 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 121.442 1.928 . . . . 0.0 111.746 167.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.62 -25.03 52.0 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.995 0.918 . . . . 0.0 111.23 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.592 HD11 ' HA ' ' A' ' 35' ' ' VAL . 70.3 mt -83.59 -57.47 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 116.007 -1.949 . . . . 0.0 109.117 171.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -77.69 -5.77 51.63 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 124.879 1.362 . . . . 0.0 113.009 -163.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.473 ' O ' HG22 ' A' ' 59' ' ' ILE . 7.9 m120 -81.01 141.34 34.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.591 163.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 10.03 0.07 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.492 1.52 . . . . 0.0 113.341 163.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -78.34 -11.07 59.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.286 1.834 . . . . 0.0 110.085 172.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 56' ' ' ASN 0.357 0.0 OUTLIER -102.74 92.77 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 124.855 2.264 . . . . 0.0 109.73 174.251 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -79.6 99.12 7.18 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 111.44 -2.618 . . . . 0.0 107.89 173.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.719 HG21 HD13 ' A' ' 72' ' ' ILE . 89.3 t -84.07 133.34 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.616 HD21 ' CD2' ' A' ' 79' ' ' LEU . 1.0 OUTLIER 60.92 14.76 5.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.699 0.4 . . . . 0.0 111.594 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.15 -1.84 57.72 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.083 1.325 . . . . 0.0 113.203 -174.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -131.73 123.63 28.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.791 1.795 . . . . 0.0 109.546 -164.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.46 111.25 0.35 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 127.836 2.454 . . . . 0.0 109.788 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HB3' HD11 ' A' ' 72' ' ' ILE . 18.9 mt -145.87 102.25 3.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -114.06 40.7 2.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.478 1.911 . . . . 0.0 110.95 -165.046 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -148.23 153.49 38.8 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.282 -0.886 . . . . 0.0 111.866 -168.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.87 -41.43 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 126.518 1.927 . . . . 0.0 109.376 169.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.41 -0.99 50.01 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.902 -0.388 . . . . 0.0 112.686 172.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.81 -61.82 1.55 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.905 -1.045 . . . . 0.0 111.672 163.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.719 HD13 HG21 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -137.46 132.47 45.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 120.13 1.332 . . . . 0.0 113.149 -176.036 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 33' ' ' PRO . 82.7 mt -99.6 -89.78 0.32 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 163.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 p -112.57 -168.8 1.37 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -173.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.26 -56.24 23.44 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.296 1.439 . . . . 0.0 114.577 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.26 -14.57 63.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.519 0.599 . . . . 0.0 111.781 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -80.8 -15.01 57.52 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 -82.09 0.54 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.616 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -89.91 174.47 7.66 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.568 1.547 . . . . 0.0 108.914 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -25.65 -51.12 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.285 3.034 . . . . 0.0 115.238 173.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.74 64.32 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.0 mmt-85 -140.82 -82.8 0.23 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.826 0.813 . . . . 0.0 109.727 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.444 ' H ' HD11 ' A' ' 79' ' ' LEU . 12.1 m-85 -130.29 -161.51 1.13 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.284 1.434 . . . . 0.0 110.361 -164.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.1 120.59 2.6 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.378 1.871 . . . . 0.0 108.899 167.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.3 t -78.95 134.04 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 173.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.4 mm -120.26 98.66 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 126.339 1.856 . . . . 0.0 106.274 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -92.84 82.25 4.69 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 171.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.471 ' HE ' HG21 ' A' ' 43' ' ' ILE . 15.8 tpp180 -84.04 96.24 8.82 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.274 2.63 . . . . 0.0 105.68 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.97 -24.16 33.66 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.395 0.521 . . . . 0.0 113.346 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -32.26 68.69 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.364 1.082 . . . . 0.0 112.638 171.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -135.96 -75.15 0.44 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.924 1.238 . . . . 0.0 112.037 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.54 -173.49 4.0 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 120.634 1.561 . . . . 0.0 109.465 -172.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -95.56 75.99 3.28 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.549 1.939 . . . . 0.0 110.393 174.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -78.57 171.62 14.85 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.947 -1.096 . . . . 0.0 110.567 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 83' ' ' PHE . 28.2 tp -128.18 137.72 52.18 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.309 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.5 mm -131.28 132.92 62.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -175.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 18.5 ptt180 -149.36 174.31 12.58 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 123.387 1.565 . . . . 0.0 112.449 177.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.16 169.62 8.66 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.785 163.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.557 0 C-N-CA 130.948 3.699 . . . . 0.0 106.768 172.359 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.07 -53.0 52.43 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.634 1.174 . . . . 0.0 112.018 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.45 -26.85 66.6 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.1 0.25 . . . . 0.0 110.38 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.99 -43.67 70.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 mt -68.23 -53.47 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 118.2 -0.905 . . . . 0.0 108.82 177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -59.36 -50.58 73.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 118.236 -1.385 . . . . 0.0 111.695 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -69.36 -30.81 68.9 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 120.143 1.338 . . . . 0.0 109.065 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.21 -42.72 99.29 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.258 40.6 m-85 -113.56 1.62 15.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -165.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -59.14 17.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.103 2.561 . . . . 0.0 114.258 163.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -78.09 -37.5 46.31 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.284 2.233 . . . . 0.0 107.591 164.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.829 HG22 ' HD2' ' A' ' 23' ' ' PRO . 4.3 p -125.91 165.14 28.93 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.895 1.678 . . . . 0.0 106.6 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.829 ' HD2' HG22 ' A' ' 22' ' ' VAL . 34.1 Cg_endo -80.68 177.84 7.63 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.45 2.1 . . . . 0.0 109.292 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 p -113.61 -177.93 3.25 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.837 -173.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -140.39 162.91 34.18 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.259 1.024 . . . . 0.0 108.541 167.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 9.3 p -143.34 138.43 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 125.294 1.438 . . . . 0.0 107.931 172.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -117.99 139.33 51.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.928 0.871 . . . . 0.0 109.558 163.622 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -81.35 73.11 8.4 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.89 153.97 24.11 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.209 -1.359 . . . . 0.0 113.182 -171.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.85 -157.15 15.65 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 163.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -60.97 140.32 57.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.582 0.353 . . . . 0.0 111.16 -174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 t -155.06 137.1 9.76 Favored Pre-proline 0 C--O 1.223 -0.3 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -164.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -48.95 131.28 25.13 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.729 3.619 . . . . 0.0 112.559 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.33 0.7 OUTLIER -47.64 -36.27 10.67 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 168.119 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.777 ' HA ' HD22 ' A' ' 38' ' ' LEU . 7.3 p -83.23 -2.61 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.157 1.383 . . . . 0.0 113.605 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -98.85 -44.05 6.51 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 168.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.38 -20.73 56.88 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 116.499 -1.715 . . . . 0.0 109.944 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.777 HD22 ' HA ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -77.4 -26.97 52.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 121.656 2.026 . . . . 0.0 110.777 175.246 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.57 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -79.68 -42.35 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 126.48 1.912 . . . . 0.0 106.862 -172.744 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.66 -48.91 77.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.185 2.194 . . . . 0.0 109.002 167.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.57 -15.96 57.96 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.74 -171.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.36 36.34 7.06 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 164.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.42 HG13 ' CD1' ' A' ' 94' ' ' TYR . 1.3 mp -78.39 -56.37 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 102.423 -3.177 . . . . 0.0 102.423 171.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -150.75 103.91 3.04 Favored Pre-proline 0 C--N 1.342 0.259 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.66 -10.49 13.1 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.851 2.367 . . . . 0.0 113.7 -172.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.6 t -90.9 116.3 28.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -53.07 -36.1 60.29 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -54.18 48.97 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.16 1.345 . . . . 0.0 109.12 173.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -57.3 -52.41 65.45 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.639 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -45.79 -55.47 6.53 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.518 1.527 . . . . 0.0 111.127 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -58.18 -41.73 84.5 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.162 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.43 -37.95 68.47 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.633 1.106 . . . . 0.0 111.778 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.77 -15.27 27.84 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 126.274 1.829 . . . . 0.0 110.794 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.738 ' HA ' HG21 ' A' ' 59' ' ' ILE . 2.2 mt -117.03 -15.87 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 176.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -91.56 -5.94 53.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.675 1.58 . . . . 0.0 111.375 168.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.659 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -82.34 135.56 35.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 176.426 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.36 3.74 0.31 Allowed Glycine 0 CA--C 1.537 1.42 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.304 165.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.43 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -94.09 -0.71 55.2 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.683 1.593 . . . . 0.0 112.373 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.738 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.321 0.0 OUTLIER -102.87 96.92 5.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 124.913 2.292 . . . . 0.0 107.892 173.931 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -90.32 98.51 11.81 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 111.735 -2.484 . . . . 0.0 108.361 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.802 HG21 HD13 ' A' ' 72' ' ' ILE . 5.2 t -81.38 127.55 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.403 HD21 ' HG ' ' A' ' 79' ' ' LEU . 90.1 m-20 52.76 25.08 3.57 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.205 1.002 . . . . 0.0 112.062 -169.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.65 8.23 61.0 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.617 -1.657 . . . . 0.0 113.518 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -128.81 126.63 40.28 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.758 2.279 . . . . 0.0 109.288 -174.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.45 110.64 0.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.249 1.42 . . . . 0.0 108.781 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.616 ' HB3' HD11 ' A' ' 72' ' ' ILE . 80.7 mt -145.96 81.66 1.6 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -175.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.02 46.6 1.04 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.724 2.01 . . . . 0.0 112.088 -169.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -148.55 150.02 32.61 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.165 -1.584 . . . . 0.0 114.213 -174.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.4 p -63.29 -43.69 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 125.967 1.707 . . . . 0.0 111.852 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.38 -9.6 85.82 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 174.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.3 -56.32 4.43 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 116.215 -1.85 . . . . 0.0 108.263 167.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.802 HD13 HG21 ' A' ' 61' ' ' VAL . 1.3 mp -138.31 138.41 43.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 CA-C-N 121.409 1.913 . . . . 0.0 113.726 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.6 mt -110.47 -88.02 0.51 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 101.777 -3.416 . . . . 0.0 101.777 163.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -102.49 -174.31 2.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 119.888 1.222 . . . . 0.0 113.689 -174.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.13 87.59 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.63 -17.26 64.07 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.723 0.692 . . . . 0.0 111.87 175.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.44 ' ND1' ' HA ' ' A' ' 72' ' ' ILE . 55.4 t-80 -78.61 -9.56 59.41 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.491 -0.756 . . . . 0.0 109.358 174.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.7 -75.07 0.63 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.334 0.97 . . . . 0.0 109.8 174.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.679 HD11 ' H ' ' A' ' 82' ' ' ARG . 1.3 pp -91.67 -170.17 2.51 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.787 1.235 . . . . 0.0 109.95 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -55.89 -26.82 49.09 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.428 ' H ' ' CD1' ' A' ' 79' ' ' LEU . . . 127.51 69.81 0.16 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 127.374 2.416 . . . . 0.0 112.192 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.679 ' H ' HD11 ' A' ' 79' ' ' LEU . 90.3 mtt-85 -143.02 -45.63 0.3 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.577 ' H ' HD11 ' A' ' 79' ' ' LEU . 39.6 m-85 -157.94 -176.65 6.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.457 1.903 . . . . 0.0 109.348 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.49 124.4 9.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.259 -1.526 . . . . 0.0 107.014 163.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.23 147.59 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 166.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 27.5 mm -129.7 93.01 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 C-N-CA 125.504 1.522 . . . . 0.0 107.069 173.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -89.77 84.34 6.27 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.76 98.38 6.26 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 166.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -52.72 143.65 23.48 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 170.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.4 tptm 69.08 -0.31 2.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.226 2.61 . . . . 0.0 114.035 -169.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -117.47 -104.88 0.4 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 165.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.1 -171.91 4.04 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 119.831 1.196 . . . . 0.0 108.062 175.006 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.529 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 1.3 m-30 -114.1 82.88 1.78 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 126.743 2.017 . . . . 0.0 107.942 -173.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.42 ' CD1' HG13 ' A' ' 43' ' ' ILE . 77.2 m-85 -79.45 169.14 18.5 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.386 0.674 . . . . 0.0 109.866 -175.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.525 HD11 ' CD1' ' A' ' 83' ' ' PHE . 33.4 tp -130.74 135.73 48.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.244 1.018 . . . . 0.0 108.699 -175.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 mt -134.53 134.69 54.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.489 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 9.4 ttt180 -135.24 -175.6 3.98 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 123.715 1.722 . . . . 0.0 112.067 171.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.489 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -122.73 158.59 29.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.188 165.548 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.399 0 C-N-CA 128.693 2.797 . . . . 0.0 107.921 172.469 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.336 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 tp -156.33 155.03 31.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -137.71 153.71 49.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.898 0.879 . . . . 0.0 108.757 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 p -149.6 162.72 39.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.359 1.464 . . . . 0.0 107.1 163.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.33 -153.8 25.48 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 107.444 -2.263 . . . . 0.0 107.444 -165.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.69 -66.61 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -91.7 26.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 122.358 1.075 . . . . 0.0 113.878 -168.113 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.61 -1.8 17.53 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -101.6 -20.32 15.09 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.687 1.595 . . . . 0.0 112.435 167.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -137.77 74.75 1.49 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.665 1.586 . . . . 0.0 110.742 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.51 -161.84 0.82 Allowed 'General case' 0 C--O 1.212 -0.909 0 O-C-N 120.811 -1.181 . . . . 0.0 111.557 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.95 -54.49 21.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 122.389 2.359 . . . . 0.0 112.162 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.43 -23.75 62.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.766 0.793 . . . . 0.0 109.394 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.58 -32.92 23.53 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -173.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.476 ' CG2' HD13 ' A' ' 95' ' ' LEU . 26.8 mt -71.49 -48.51 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 171.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -52.73 -58.52 6.6 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.63 0.65 . . . . 0.0 111.176 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -74.6 -24.71 58.92 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.642 1.11 . . . . 0.0 110.239 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.72 -40.26 97.29 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.44 ' C ' ' H ' ' A' ' 21' ' ' ASP . 45.9 m-85 -126.42 12.69 7.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -163.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.06 9.08 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 129.776 3.23 . . . . 0.0 113.68 163.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 19' ' ' PHE . 23.7 t70 -78.41 -38.22 42.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.752 2.421 . . . . 0.0 108.48 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.34 168.34 10.75 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.375 1.47 . . . . 0.0 109.58 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.92 178.11 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.13 1.887 . . . . 0.0 110.327 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 p -129.48 171.97 12.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.08 1.752 . . . . 0.0 109.874 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -137.67 166.56 23.66 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.863 1.265 . . . . 0.0 108.646 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 p -139.62 133.94 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.15 179.07 4.06 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 119.114 0.87 . . . . 0.0 109.961 163.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -78.75 15.82 0.99 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.536 1.534 . . . . 0.0 113.989 -163.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.8 -176.92 38.87 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -163.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.4 149.45 5.99 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -163.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.82 153.49 41.9 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.894 -0.768 . . . . 0.0 111.051 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -161.28 131.3 3.43 Favored Pre-proline 0 CA--C 1.509 -0.604 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -165.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.551 ' HA ' HD23 ' A' ' 73' ' ' LEU . 90.0 Cg_endo -68.65 148.61 72.41 Favored 'Trans proline' 0 N--CA 1.436 -1.901 0 C-N-CA 121.69 1.593 . . . . 0.0 110.355 -174.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.779 HD22 HG13 ' A' ' 54' ' ' ILE 0.264 0.0 OUTLIER -44.85 -41.04 6.72 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.96 -1.473 . . . . 0.0 112.485 178.727 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.691 ' HA ' HD22 ' A' ' 38' ' ' LEU . 8.0 p -80.89 -7.75 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.92 2.088 . . . . 0.0 114.886 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.419 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 77.1 mm-40 -104.53 -30.95 9.69 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 117.648 -1.168 . . . . 0.0 108.508 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -80.84 -20.2 42.92 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 121.593 1.997 . . . . 0.0 110.094 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.713 HD13 ' CD1' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -77.36 -29.22 53.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 120.971 1.714 . . . . 0.0 109.866 173.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -75.63 -46.85 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.295 1.838 . . . . 0.0 107.033 -172.074 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.4 m -57.24 -52.55 64.88 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 129.939 3.295 . . . . 0.0 109.221 167.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.15 -10.27 59.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.028 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.51 29.69 15.81 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 122.842 1.246 . . . . 0.0 111.926 166.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.477 ' CG2' HD12 ' A' ' 38' ' ' LEU . 1.2 mp -77.92 -51.05 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 176.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -156.85 99.47 2.02 Favored Pre-proline 0 C--N 1.344 0.364 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.75 -15.97 10.51 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.911 2.407 . . . . 0.0 113.617 -172.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.5 t -76.61 115.26 16.2 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -52.36 -37.61 56.63 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.183 1.356 . . . . 0.0 114.419 -164.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -54.44 43.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.099 0.863 . . . . 0.0 109.595 172.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -58.94 -47.77 83.88 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.736 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.481 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -46.27 -55.08 7.73 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.378 1.471 . . . . 0.0 110.383 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.467 ' HG2' HG21 ' A' ' 35' ' ' VAL . 71.9 mtt-85 -65.0 -34.32 78.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 116.594 -1.67 . . . . 0.0 111.577 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.34 -36.36 58.28 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.777 1.626 . . . . 0.0 112.378 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -17.6 63.34 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.131 1.372 . . . . 0.0 110.543 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.779 HG13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -92.32 -52.73 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 116.482 -1.723 . . . . 0.0 111.895 166.396 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -69.92 -6.5 33.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 120.488 1.495 . . . . 0.0 111.577 -170.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.534 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.3 m120 -79.9 139.77 36.98 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.2 26.29 0.44 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.025 1.774 . . . . 0.0 113.526 164.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -115.59 5.06 14.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.691 2.396 . . . . 0.0 111.403 170.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.575 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.319 0.0 OUTLIER -106.63 94.13 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 124.52 2.105 . . . . 0.0 106.065 163.893 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 3.0 m-85 -79.99 106.73 12.23 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.026 168.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.554 HG21 HD13 ' A' ' 72' ' ' ILE . 10.7 t -83.81 124.61 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 173.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.648 HD22 ' HG3' ' A' ' 78' ' ' ARG . 63.4 m-20 53.5 27.39 6.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.96 -2.41 59.94 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.258 -1.301 . . . . 0.0 113.748 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -119.32 122.68 42.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.365 1.583 . . . . 0.0 107.151 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.46 109.0 0.49 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.63 ' HB3' HD11 ' A' ' 72' ' ' ILE . 83.1 mt -143.02 103.83 4.22 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 -171.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -127.91 45.3 2.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.867 2.067 . . . . 0.0 112.863 -163.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -154.42 154.12 32.7 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.975 0.91 . . . . 0.0 110.615 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 81.9 t -63.36 -38.19 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.785 1.234 . . . . 0.0 109.748 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.77 -2.21 60.49 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.83 -0.983 . . . . 0.0 113.061 171.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.33 -57.0 2.93 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.842 1.321 . . . . 0.0 111.391 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.63 HD11 ' HB3' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -141.28 148.17 21.56 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 121.164 1.802 . . . . 0.0 111.098 178.083 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' A' ' 33' ' ' PRO . 64.9 mt -112.38 -93.11 0.46 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 163.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 p -108.43 -170.24 1.64 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -169.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.12 73.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.755 1.222 . . . . 0.0 113.504 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.4 -17.95 64.94 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.107 0.963 . . . . 0.0 111.161 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 58.1 t-80 -86.48 -5.99 59.01 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.523 -0.736 . . . . 0.0 110.665 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.648 ' HG3' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -119.53 -64.99 1.21 Allowed 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.095 1.316 . . . . 0.0 110.512 178.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.59 178.38 7.41 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 164.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.75 -26.05 56.36 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.592 -0.693 . . . . 0.0 112.095 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.82 84.15 0.17 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 124.651 1.12 . . . . 0.0 113.299 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.12 -82.83 0.57 Allowed 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 167.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -119.55 -165.62 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.813 2.045 . . . . 0.0 108.171 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.18 138.64 12.7 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 163.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.7 t -83.99 139.27 17.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 166.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.9 mm -115.62 94.48 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' A' ' 60' ' ' TYR . 33.9 ttm-85 -91.46 75.13 5.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -78.98 92.59 4.97 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -51.19 -32.57 29.0 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.103 1.335 . . . . 0.0 113.425 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.26 -12.59 60.51 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.78 -1.424 . . . . 0.0 112.962 177.283 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -135.91 -97.55 0.23 Allowed 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 127.161 2.185 . . . . 0.0 105.864 -174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.445 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -159.17 -159.89 0.8 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 120.889 1.677 . . . . 0.0 109.415 174.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.445 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -110.23 75.9 0.96 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.058 2.143 . . . . 0.0 108.475 -167.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -78.23 164.56 24.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -171.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.476 HD13 ' CG2' ' A' ' 15' ' ' ILE . 18.0 tp -125.03 129.89 51.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.476 -164.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 95' ' ' LEU . 30.6 mm -125.02 129.27 73.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -171.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.473 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 13.1 ttp180 -131.47 -177.15 4.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 124.064 1.888 . . . . 0.0 110.92 164.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.473 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -123.67 165.63 16.89 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 126.273 1.829 . . . . 0.0 110.743 173.196 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 127.148 2.179 . . . . 0.0 111.465 178.05 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.194 0.521 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.8 tp -121.83 -61.78 1.47 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 154.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -64.41 147.2 53.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.743 1.217 . . . . 0.0 110.659 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.2 m -73.96 -165.41 0.3 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.397 1.479 . . . . 0.0 110.529 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.77 -60.63 4.74 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -174.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.46 165.05 24.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 117.878 0.839 . . . . 0.0 108.993 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -71.36 77.63 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.392 1.077 . . . . 0.0 111.077 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.06 -10.04 59.36 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.331 1.453 . . . . 0.0 111.98 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -77.72 -24.7 49.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 109.027 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.621 ' HB3' HD11 ' A' ' 15' ' ' ILE . 1.6 mm? -98.89 72.88 1.95 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.348 1.459 . . . . 0.0 107.296 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.01 172.56 13.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.02 -57.08 8.57 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 124.043 0.937 . . . . 0.0 111.225 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.85 -21.94 66.5 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.541 0.525 . . . . 0.0 110.706 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -82.74 -37.19 25.0 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.789 0.835 . . . . 0.0 109.624 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.621 HD11 ' HB3' ' A' ' 10' ' ' LEU . 29.4 mt -67.71 -45.07 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -55.47 -60.44 3.42 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.775 1.171 . . . . 0.0 110.541 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -75.89 -20.18 58.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.377 -0.827 . . . . 0.0 110.27 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.66 -38.44 90.03 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -126.58 11.75 7.37 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.629 0.772 . . . . 0.0 112.841 -164.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -56.18 7.19 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.73 2.412 . . . . 0.0 115.322 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -78.29 -34.78 48.6 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.243 1.417 . . . . 0.0 109.263 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.5 165.25 14.83 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 125.883 1.673 . . . . 0.0 108.251 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -68.98 177.72 4.78 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.801 1.667 . . . . 0.0 110.542 168.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 p -120.85 -177.59 3.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.999 1.72 . . . . 0.0 109.551 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -142.86 160.96 39.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.769 1.228 . . . . 0.0 109.362 164.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 9.9 p -143.88 136.35 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 C-N-CA 125.282 1.433 . . . . 0.0 108.271 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 98' ' ' TYR . 0.8 OUTLIER -118.8 179.05 4.26 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 119.123 0.874 . . . . 0.0 110.042 163.496 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -89.81 56.94 3.67 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 120.415 -1.428 . . . . 0.0 109.703 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.03 -158.94 19.75 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.723 0.678 . . . . 0.0 112.324 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.29 123.53 1.76 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.254 1.0 OUTLIER -59.91 130.47 46.89 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.203 1.501 . . . . 0.0 107.182 171.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -151.85 140.16 13.3 Favored Pre-proline 0 CA--C 1.507 -0.687 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -163.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.449 ' HA ' HD23 ' A' ' 73' ' ' LEU . 65.3 Cg_endo -77.7 152.78 29.46 Favored 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 121.495 1.463 . . . . 0.0 110.689 -167.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.356 0.4 OUTLIER -47.15 -33.17 4.9 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.416 173.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.704 ' HA ' HD11 ' A' ' 54' ' ' ILE . 11.5 p -72.83 -15.51 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 58.0 mm-40 -105.6 -42.04 5.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.1 -31.33 67.66 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 116.806 -1.569 . . . . 0.0 108.696 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -27.19 34.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 121.51 1.959 . . . . 0.0 109.562 -174.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -47.85 42.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 125.692 1.597 . . . . 0.0 107.976 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -34.79 78.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.313 0.645 . . . . 0.0 109.965 173.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.416 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.51 -14.32 59.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.237 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.46 27.88 21.22 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 164.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.1 mp -78.37 -45.93 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.7 108.14 2.17 Favored Pre-proline 0 C--N 1.343 0.316 0 CA-C-N 120.532 1.515 . . . . 0.0 106.945 167.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.45 -15.59 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.227 1.952 . . . . 0.0 112.183 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.0 m -88.19 105.85 17.8 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 -169.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 tptt -52.18 -32.58 36.8 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -163.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -54.65 42.32 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.341 1.428 . . . . 0.0 109.619 169.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -57.39 -48.13 79.89 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 117.801 -1.095 . . . . 0.0 108.603 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.4 -61.61 1.83 Allowed 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 125.189 1.556 . . . . 0.0 110.14 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.413 ' HA ' HD12 ' A' ' 54' ' ' ILE . 78.5 mtt-85 -62.84 -25.67 68.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 115.923 -1.989 . . . . 0.0 112.656 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.68 -40.7 28.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 121.745 2.066 . . . . 0.0 112.988 168.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' HA ' HH11 ' A' ' 88' ' ' ARG . 5.9 m-20 -62.96 -13.93 41.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.355 1.062 . . . . 0.0 111.41 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.704 HD11 ' HA ' ' A' ' 35' ' ' VAL . 66.1 mt -89.22 -64.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 C-N-CA 126.626 1.97 . . . . 0.0 109.04 163.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -61.89 -11.25 12.06 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.902 1.281 . . . . 0.0 112.21 -165.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 59' ' ' ILE . 5.1 m120 -82.45 131.37 35.22 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 118.824 0.738 . . . . 0.0 111.365 172.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.42 36.26 0.56 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 126.585 2.04 . . . . 0.0 111.716 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -117.18 -1.43 11.85 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 127.185 2.194 . . . . 0.0 111.027 165.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 56' ' ' ASN 0.339 0.0 OUTLIER -91.75 92.11 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 121.726 2.057 . . . . 0.0 106.501 163.562 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -80.66 100.8 8.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.924 -1.944 . . . . 0.0 108.101 171.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' A' ' 72' ' ' ILE . 15.8 t -80.2 128.88 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 175.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.416 ' HA ' ' CG1' ' A' ' 85' ' ' VAL 0.257 23.8 m120 64.23 -6.63 0.26 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.65 4.6 26.45 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.137 1.351 . . . . 0.0 112.795 -169.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.87 119.33 32.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 108.56 0.78 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.344 1.458 . . . . 0.0 107.142 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.487 ' CB ' HD11 ' A' ' 72' ' ' ILE . 80.5 mt -141.4 88.17 2.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.89 25.05 3.34 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.996 1.318 . . . . 0.0 113.59 -173.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.66 154.77 46.53 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.54 -43.01 96.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 126.869 2.067 . . . . 0.0 110.803 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.6 -9.74 59.27 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.65 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.45 -47.49 7.41 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 117.562 -1.208 . . . . 0.0 112.24 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.524 ' CD1' HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -140.09 135.04 37.11 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 CA-C-N 121.423 1.92 . . . . 0.0 113.308 178.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 33' ' ' PRO . 80.5 mt -113.86 -97.3 0.44 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 163.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -97.87 -177.13 3.66 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.39 -1.444 . . . . 0.0 114.404 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.446 ' HB3' ' CE2' ' A' ' 98' ' ' TYR . . . -63.19 -37.78 88.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 120.967 -1.083 . . . . 0.0 113.119 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.55 -17.73 62.3 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.15 0.887 . . . . 0.0 111.11 174.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -81.22 -15.99 54.02 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.487 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.16 -59.58 1.98 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 120.223 1.374 . . . . 0.0 111.175 -173.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -171.51 3.01 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.163 1.385 . . . . 0.0 110.265 166.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -53.61 -6.21 0.07 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 129.307 3.043 . . . . 0.0 114.725 163.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.85 79.89 1.48 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.954 1.264 . . . . 0.0 111.489 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 -63.61 0.55 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.306 0.642 . . . . 0.0 110.112 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -156.1 -169.58 3.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.022 2.929 . . . . 0.0 106.915 -175.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -154.5 152.67 30.38 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 119.605 -1.934 . . . . 0.0 107.07 163.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.416 ' CG1' ' HA ' ' A' ' 62' ' ' ASN . 9.9 p -115.7 151.43 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 C-N-CA 124.048 0.939 . . . . 0.0 109.337 171.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.48 HD12 HD11 ' A' ' 59' ' ' ILE . 27.8 mm -132.85 96.66 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 127.249 2.22 . . . . 0.0 108.011 -171.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -96.3 86.88 4.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.456 HH11 ' HA ' ' A' ' 53' ' ' ASP . 1.2 tpm_? -82.05 110.62 17.45 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 174.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.62 -20.17 45.26 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-N 120.123 1.329 . . . . 0.0 115.252 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.411 ' HE3' ' HA ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -72.01 -11.69 60.88 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.124 1.962 . . . . 0.0 111.228 171.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -148.59 -156.05 0.69 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.014 2.126 . . . . 0.0 107.453 -165.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -150.75 0.35 Allowed 'General case' 0 C--O 1.248 0.979 0 CA-C-O 122.883 1.325 . . . . 0.0 111.615 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.87 77.33 1.36 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.802 2.441 . . . . 0.0 109.018 -164.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -78.34 165.35 23.95 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.489 -0.757 . . . . 0.0 109.457 -170.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.538 ' C ' HD12 ' A' ' 96' ' ' ILE . 1.2 tt -128.54 128.16 43.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -164.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.538 HD12 ' C ' ' A' ' 95' ' ' LEU . 1.9 mp -127.08 135.64 63.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 124.369 1.068 . . . . 0.0 108.89 -169.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 9.4 ttt180 -139.29 -176.6 4.58 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 125.657 2.646 . . . . 0.0 114.335 167.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.497 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -115.86 161.04 19.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 112.451 -2.159 . . . . 0.0 107.866 163.623 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 C-N-CA 126.727 2.011 . . . . 0.0 107.462 -174.802 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.3 tp -143.61 148.0 35.2 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 165.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -59.85 -34.77 73.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.972 0.805 . . . . 0.0 111.784 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.7 m 58.69 -1.75 0.1 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.182 2.593 . . . . 0.0 117.132 171.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.97 -97.82 0.68 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 107.555 -2.218 . . . . 0.0 107.555 171.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -78.61 175.76 10.09 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -38.8 63.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 1 C-N-CA 134.021 4.928 . . . . 0.0 117.37 -175.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.35 -20.84 63.85 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 119.463 -2.023 . . . . 0.0 112.656 -166.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -79.32 -27.53 42.1 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 125.652 1.581 . . . . 0.0 110.933 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.426 ' HB3' HD11 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -85.11 79.46 9.59 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.71 169.26 18.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 170.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -57.38 12.97 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.804 1.641 . . . . 0.0 110.919 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.41 -20.87 65.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.833 0.288 . . . . 0.0 111.516 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.76 -38.89 27.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.848 1.259 . . . . 0.0 110.355 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.474 ' CG2' HD13 ' A' ' 95' ' ' LEU . 18.6 mt -69.19 -51.01 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.71 1.204 . . . . 0.0 107.951 172.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.92 -57.61 8.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.154 0.888 . . . . 0.0 110.517 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.99 -23.41 58.26 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.231 -0.918 . . . . 0.0 110.472 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.61 95.76 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -119.35 9.54 11.67 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -165.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -55.55 -9.57 0.52 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.645 2.378 . . . . 0.0 116.451 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.68 -29.34 45.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.678 1.591 . . . . 0.0 111.198 175.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.526 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -105.06 163.08 17.87 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -179.279 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.526 ' HD2' HG12 ' A' ' 22' ' ' VAL . 94.5 Cg_endo -72.07 172.88 13.82 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 CA-C-O 122.855 1.106 . . . . 0.0 109.375 174.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.8 p -120.55 171.85 8.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 113.197 -1.819 . . . . 0.0 108.073 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -137.11 152.91 50.54 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.94 134.66 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -125.86 152.58 45.33 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 122.599 1.19 . . . . 0.0 111.045 163.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -81.5 53.7 2.16 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 126.31 1.844 . . . . 0.0 110.965 -169.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.56 174.81 50.13 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.395 1.95 . . . . 0.0 114.015 166.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.75 149.07 16.15 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -75.18 151.87 38.47 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.13 0.49 . . . . 0.0 111.56 164.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.7 t -160.94 135.09 5.14 Favored Pre-proline 0 CA--C 1.513 -0.474 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -163.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HA ' HD23 ' A' ' 73' ' ' LEU . 84.5 Cg_endo -73.15 147.33 42.49 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 121.641 1.561 . . . . 0.0 111.16 -174.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.336 0.3 OUTLIER -49.63 -30.05 8.25 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.675 175.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.717 ' HA ' HD11 ' A' ' 54' ' ' ILE . 7.4 p -74.04 -18.51 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -97.6 -46.69 5.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.075 -0.964 . . . . 0.0 108.424 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.6 -22.76 56.61 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 116.426 -1.749 . . . . 0.0 109.621 -168.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.98 -25.59 29.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 121.259 1.845 . . . . 0.0 109.9 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 44' ' ' SER . 1.5 t -77.7 -46.74 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -59.61 -40.63 88.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.663 1.985 . . . . 0.0 110.234 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.409 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.41 -17.73 56.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.481 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.51 34.67 6.88 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 163.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.1 mp -78.45 -53.14 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.416 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -156.13 95.63 2.35 Favored Pre-proline 0 C--N 1.349 0.549 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.11 -18.02 14.71 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.6 2.2 . . . . 0.0 113.128 -171.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.1 t -75.75 109.51 9.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -57.03 -27.84 61.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -163.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -49.39 66.69 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.726 1.603 . . . . 0.0 110.491 169.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -57.97 -50.46 73.3 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.26 -58.23 3.86 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 125.936 2.023 . . . . 0.0 109.703 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -58.7 -35.31 72.44 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 117.82 -1.086 . . . . 0.0 111.387 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -73.58 -45.83 50.87 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 118.103 -1.439 . . . . 0.0 112.089 170.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.514 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.9 m-20 -62.22 -12.81 22.3 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.513 1.125 . . . . 0.0 111.7 -174.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.717 HD11 ' HA ' ' A' ' 35' ' ' VAL . 56.7 mt -89.41 -66.88 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 127.763 2.425 . . . . 0.0 109.07 164.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -71.58 -1.88 15.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.939 1.245 . . . . 0.0 113.331 -164.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.532 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.2 m120 -80.05 130.79 35.53 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.233 -0.917 . . . . 0.0 110.377 164.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.78 6.6 0.34 Allowed Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.967 -0.458 . . . . 0.0 114.025 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.78 -8.27 59.68 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 116.701 -1.618 . . . . 0.0 111.746 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 56' ' ' ASN 0.359 0.0 OUTLIER -92.77 92.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 125.569 2.604 . . . . 0.0 108.099 164.975 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -79.45 99.42 7.2 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 111.447 -2.615 . . . . 0.0 108.208 170.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.622 HG21 HD13 ' A' ' 72' ' ' ILE . 22.1 t -82.17 127.8 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.2 m120 61.37 7.48 1.76 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.46 7.96 56.54 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.867 1.223 . . . . 0.0 113.077 -171.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -121.73 117.93 27.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 106.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.726 1.61 . . . . 0.0 109.114 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' A' ' 72' ' ' ILE . 44.6 mt -142.33 89.73 2.18 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 1.0 OUTLIER -113.31 39.56 2.57 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.939 2.096 . . . . 0.0 112.755 -164.422 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -151.47 161.71 42.23 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.471 -1.393 . . . . 0.0 112.17 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.52 -26.37 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.149 1.38 . . . . 0.0 110.252 164.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.43 -14.28 74.5 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-O 119.417 -0.657 . . . . 0.0 113.344 167.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.53 -58.84 2.3 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.779 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -138.91 144.48 29.54 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 CA-C-N 121.143 1.792 . . . . 0.0 113.221 -177.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 33' ' ' PRO . 74.2 mt -109.61 -93.14 0.43 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 101.355 -3.572 . . . . 0.0 101.355 163.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 p -108.79 -170.99 1.76 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.11 -44.49 83.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.496 1.119 . . . . 0.0 113.79 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.05 -15.89 62.57 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.238 0.926 . . . . 0.0 112.197 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 51.7 t-80 -87.98 0.97 55.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.916 0.886 . . . . 0.0 109.762 173.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -79.58 0.59 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 167.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.607 HD11 ' H ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.09 -168.51 2.08 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.538 1.135 . . . . 0.0 109.848 176.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.01 0.05 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.869 2.867 . . . . 0.0 115.317 171.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.23 50.13 3.09 Favored Glycine 0 C--N 1.337 0.585 0 O-C-N 120.991 -1.068 . . . . 0.0 111.734 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -104.58 -65.92 1.0 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 172.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.607 ' H ' HD11 ' A' ' 79' ' ' LEU . 53.9 m-85 -145.3 -167.16 2.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.772 1.629 . . . . 0.0 107.153 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.89 140.95 13.77 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.923 1.238 . . . . 0.0 109.106 163.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 t -93.55 150.63 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.775 1.23 . . . . 0.0 108.568 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.469 HD13 HG22 ' A' ' 61' ' ' VAL . 22.2 mm -132.44 97.63 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 C-N-CA 126.767 2.027 . . . . 0.0 108.262 177.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -97.76 90.47 4.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.514 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER -83.54 94.18 7.99 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.17 112.56 2.67 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt 137.53 -50.66 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 131.496 3.919 . . . . 0.0 107.773 -164.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.0 -110.51 0.35 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.04 -154.78 0.57 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-N 120.049 1.295 . . . . 0.0 109.173 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -115.0 78.85 1.2 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.971 2.508 . . . . 0.0 108.226 -164.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.403 ' CD1' HG13 ' A' ' 43' ' ' ILE . 79.1 m-85 -78.14 169.41 18.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.049 -1.032 . . . . 0.0 109.078 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.474 HD13 ' CG2' ' A' ' 15' ' ' ILE . 16.8 tp -127.02 131.38 51.01 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.775 -171.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.21 133.05 69.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 125.104 1.362 . . . . 0.0 107.37 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.487 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 7.8 ttt180 -145.39 -177.18 5.43 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 124.534 2.111 . . . . 0.0 111.783 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.487 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -126.12 159.33 33.16 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 112.636 -2.075 . . . . 0.0 111.59 164.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.476 0 C-N-CA 126.82 2.048 . . . . 0.0 106.1 165.415 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -53.09 126.1 19.57 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.44 1.096 . . . . 0.0 110.229 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -92.03 105.65 17.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.463 1.905 . . . . 0.0 108.18 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.3 m 52.12 -153.94 0.2 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.033 0.933 . . . . 0.0 110.14 -164.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.91 -140.16 11.34 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -175.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.54 -55.14 5.44 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.978 0.894 . . . . 0.0 108.942 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.72 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -90.57 54.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 123.469 1.604 . . . . 0.0 107.531 -178.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.14 -12.6 41.37 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.944 1.298 . . . . 0.0 114.116 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -86.65 -22.64 26.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.299 1.44 . . . . 0.0 110.158 171.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -151.91 68.01 0.88 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.237 1.015 . . . . 0.0 108.623 -166.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.39 179.62 6.88 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 125.8 1.64 . . . . 0.0 109.389 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.98 81.01 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 119.988 -1.695 . . . . 0.0 113.515 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.29 -29.89 67.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.553 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -72.63 -36.5 68.05 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.2 mt -73.15 -52.25 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 127.101 2.161 . . . . 0.0 107.921 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.62 -47.06 87.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.953 -175.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -80.14 -27.11 39.11 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.815 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.86 -37.6 93.49 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 126.047 1.784 . . . . 0.0 109.975 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -123.56 12.28 9.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.12 -164.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -57.96 -9.01 1.16 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.42 -12.79 60.03 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.228 1.411 . . . . 0.0 111.726 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.23 168.53 11.41 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 120.617 -1.302 . . . . 0.0 108.888 167.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.09 174.67 12.44 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.678 1.585 . . . . 0.0 110.865 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -127.2 150.31 49.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.679 1.592 . . . . 0.0 109.0 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 38.2 t80 -134.96 159.5 41.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.505 1.048 . . . . 0.0 108.767 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.4 t -138.85 132.3 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 124.465 1.106 . . . . 0.0 108.623 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -113.23 -174.48 2.46 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 123.18 0.592 . . . . 0.0 110.501 163.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -87.96 8.79 24.69 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -163.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.55 176.35 32.65 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 120.907 -1.121 . . . . 0.0 110.859 -164.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.08 139.22 1.68 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -164.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.38 148.02 49.59 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.8 t -155.0 132.5 6.43 Favored Pre-proline 0 CA--C 1.51 -0.582 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -167.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HA ' HD23 ' A' ' 73' ' ' LEU . 71.9 Cg_endo -68.91 150.53 73.4 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.468 2.112 . . . . 0.0 110.975 -173.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.555 HD23 HD12 ' A' ' 72' ' ' ILE 0.332 0.0 OUTLIER -49.82 -34.48 19.79 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.306 174.985 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.487 ' HA ' HD22 ' A' ' 38' ' ' LEU . 3.1 p -76.71 -14.88 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.531 1.932 . . . . 0.0 114.165 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -94.18 -40.1 10.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 120.278 1.399 . . . . 0.0 109.944 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.8 -24.46 58.65 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 116.89 -1.529 . . . . 0.0 108.989 -172.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.581 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -73.13 -33.84 65.76 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 121.068 1.758 . . . . 0.0 109.833 172.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.494 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -75.19 -48.82 30.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.14 1.776 . . . . 0.0 106.849 -169.166 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -65.73 -34.12 77.46 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.569 1.547 . . . . 0.0 110.023 170.654 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.36 -14.17 59.52 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 120.675 1.579 . . . . 0.0 111.353 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.7 21.61 33.52 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 164.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.638 HG21 ' NH1' ' A' ' 88' ' ' ARG . 1.5 mm -78.36 -39.92 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -171.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 m -157.3 95.58 2.11 Favored Pre-proline 0 C--N 1.342 0.244 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.439 ' HA ' HG22 ' A' ' 39' ' ' VAL . 78.1 Cg_endo -77.71 -14.18 15.87 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.705 2.27 . . . . 0.0 113.649 -168.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 t -81.72 109.44 16.12 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 50' ' ' ALA 0.261 48.8 mttt -59.2 -21.88 60.15 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -163.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -65.56 -55.2 19.02 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.487 1.494 . . . . 0.0 110.317 166.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -54.02 -50.41 66.71 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.581 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -46.52 -60.15 2.54 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 124.61 1.194 . . . . 0.0 110.976 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -68.53 -25.41 64.91 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 116.334 -1.793 . . . . 0.0 111.93 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -86.68 -25.35 24.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 121.239 1.836 . . . . 0.0 112.979 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.02 -31.86 69.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 125.496 1.518 . . . . 0.0 107.643 166.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.5 HG13 HD22 ' A' ' 34' ' ' LEU . 1.1 mp -77.43 -59.42 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 115.285 -2.293 . . . . 0.0 108.811 172.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -11.46 24.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.703 1.592 . . . . 0.0 112.659 -170.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.502 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.3 m120 -81.22 137.99 35.83 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.851 1.31 . . . . 0.0 113.378 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.76 2.91 0.06 OUTLIER Glycine 0 CA--C 1.538 1.476 0 CA-C-N 113.034 -1.894 . . . . 0.0 114.999 164.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.461 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -79.43 -18.71 51.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 128.18 2.592 . . . . 0.0 112.436 172.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 56' ' ' ASN 0.356 0.0 OUTLIER -96.28 97.75 6.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 124.499 2.095 . . . . 0.0 108.896 178.63 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.13 93.46 9.58 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 111.185 -2.734 . . . . 0.0 105.158 175.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 p -78.63 136.93 22.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 103.056 -2.942 . . . . 0.0 103.056 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.402 HD21 HD21 ' A' ' 79' ' ' LEU . 1.8 m-80 57.41 23.05 8.55 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 119.258 0.935 . . . . 0.0 110.917 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.62 7.88 83.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.439 1.971 . . . . 0.0 114.206 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -134.98 125.25 26.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.337 1.568 . . . . 0.0 109.166 -166.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.79 117.48 3.69 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.841 0.856 . . . . 0.0 109.321 -173.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.1 mt -147.93 114.06 5.85 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 170.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.53 17.46 10.45 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.17 149.43 41.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.418 -0.801 . . . . 0.0 109.805 -174.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.41 HG22 HD21 ' A' ' 73' ' ' LEU . 7.1 p -67.06 -35.66 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 124.887 1.275 . . . . 0.0 109.962 174.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.17 -17.37 69.97 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.248 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.5 -49.11 10.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.734 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.555 HD12 HD23 ' A' ' 34' ' ' LEU . 2.1 mt -138.74 129.19 33.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 120.069 1.304 . . . . 0.0 111.452 -174.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 33' ' ' PRO . 84.6 mt -114.76 -95.2 0.47 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 103.247 -2.871 . . . . 0.0 103.247 163.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.21 -175.46 3.02 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.65 -1.281 . . . . 0.0 113.828 -173.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.86 -44.32 70.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.506 1.123 . . . . 0.0 113.261 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -75.05 -8.52 56.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.686 0.755 . . . . 0.0 111.386 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -93.31 -4.22 52.09 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.066 -1.021 . . . . 0.0 111.203 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -66.96 1.03 Allowed 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 120.863 -1.148 . . . . 0.0 108.786 175.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.557 HD22 HG21 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -89.54 -175.23 4.63 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 126.399 1.88 . . . . 0.0 107.699 173.467 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.94 -12.39 1.97 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.384 1.473 . . . . 0.0 113.889 166.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.85 79.17 0.96 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 125.517 1.532 . . . . 0.0 112.535 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -141.17 -49.17 0.41 Allowed 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 117.798 -1.096 . . . . 0.0 113.142 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -155.78 -170.57 3.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.945 2.498 . . . . 0.0 107.059 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.25 130.76 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 120.09 -1.631 . . . . 0.0 107.199 163.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.36 133.42 29.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 6.7 mm -111.05 106.85 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 167.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.48 79.47 2.11 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 176.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.638 ' NH1' HG21 ' A' ' 43' ' ' ILE . 30.1 ttm105 -85.1 109.97 18.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.29 -18.49 2.3 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.764 1.65 . . . . 0.0 114.756 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -47.01 -39.18 12.09 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.928 1.364 . . . . 0.0 111.793 169.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -142.27 -78.06 0.25 Allowed 'General case' 0 C--N 1.338 0.096 0 CA-C-O 117.976 -1.011 . . . . 0.0 108.435 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.36 -152.63 0.32 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.667 1.576 . . . . 0.0 111.997 -171.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -100.98 75.12 1.65 Allowed 'General case' 0 N--CA 1.47 0.529 1 C-N-CA 132.208 4.203 . . . . 0.0 113.298 -175.37 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.73 140.02 38.36 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 120.145 -1.597 . . . . 0.0 108.053 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -89.19 144.72 25.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.54 -175.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 95' ' ' LEU . 2.4 mp -133.16 138.91 50.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 124.52 1.128 . . . . 0.0 108.622 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 ttm105 -136.43 -176.61 4.4 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.316 1.532 . . . . 0.0 111.781 163.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.23 163.06 13.71 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.92 1.688 . . . . 0.0 108.85 163.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 C-N-CA 127.487 2.315 . . . . 0.0 109.72 -175.22 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 49.6 tp -148.17 -52.31 0.18 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.163 0.985 . . . . 0.0 110.46 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -58.52 98.42 0.04 OUTLIER 'General case' 0 C--O 1.232 0.146 0 C-N-CA 127.09 2.156 . . . . 0.0 109.41 -172.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.3 p -150.68 54.36 0.89 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.647 0.779 . . . . 0.0 109.677 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.81 -90.99 1.14 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.85 -57.17 3.89 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 122.43 1.11 . . . . 0.0 110.25 -172.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.455 HG21 ' HB3' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -91.17 41.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 C-N-CA 125.346 1.458 . . . . 0.0 111.007 -174.052 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.49 -12.18 41.43 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -100.99 -20.17 15.53 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 126.011 1.724 . . . . 0.0 112.282 173.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.603 HD11 ' HA ' ' A' ' 62' ' ' ASN 0.334 1.6 pt? -130.51 73.44 1.54 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.396 1.079 . . . . 0.0 112.365 -175.32 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.25 175.43 10.21 Favored 'General case' 0 C--O 1.214 -0.765 0 C-N-CA 126.42 1.888 . . . . 0.0 108.139 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.54 -55.15 38.7 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 119.921 -1.737 . . . . 0.0 113.134 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.4 -23.17 60.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.65 -35.31 70.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.739 1.216 . . . . 0.0 109.467 175.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt -73.9 -53.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 C-N-CA 127.715 2.406 . . . . 0.0 106.892 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -55.13 -53.53 54.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.526 -1.225 . . . . 0.0 111.355 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -73.29 -31.22 63.92 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 120.38 1.445 . . . . 0.0 109.46 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.52 -34.43 89.45 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 125.335 1.445 . . . . 0.0 110.552 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -128.25 11.7 6.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.603 0.761 . . . . 0.0 111.813 -167.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -59.16 -5.55 0.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.053 2.141 . . . . 0.0 115.942 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.29 -28.82 47.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.793 -0.567 . . . . 0.0 110.295 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -101.21 170.46 6.5 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HD2' HG12 ' A' ' 22' ' ' VAL . 61.1 Cg_endo -73.0 177.32 7.9 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 CA-C-N 121.099 1.428 . . . . 0.0 109.231 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.4 p -125.46 145.56 50.03 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -108.93 156.24 19.93 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.942 1.297 . . . . 0.0 108.307 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.99 133.97 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 126.2 1.8 . . . . 0.0 107.936 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.63 -171.39 2.37 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 121.401 0.619 . . . . 0.0 111.093 163.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -100.08 13.58 33.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.844 1.657 . . . . 0.0 112.156 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -91.1 172.57 36.79 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.712 1.149 . . . . 0.0 113.375 -172.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.32 -85.39 1.87 Allowed Glycine 0 C--N 1.333 0.361 0 N-CA-C 106.686 -2.565 . . . . 0.0 106.686 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.33 150.08 21.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.251 1.42 . . . . 0.0 109.714 163.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.455 ' H ' HG23 ' A' ' 74' ' ' THR . 0.9 OUTLIER -161.76 152.14 14.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 167.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.16 139.64 91.24 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.448 2.099 . . . . 0.0 113.168 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.293 0.9 OUTLIER -49.55 -32.65 12.95 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 169.172 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.7 p -74.59 -11.72 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 128.047 2.539 . . . . 0.0 115.086 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -103.03 -44.16 5.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.945 0.793 . . . . 0.0 109.224 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.05 -22.8 58.15 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 116.96 -1.495 . . . . 0.0 109.735 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.651 HD21 HD11 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -85.82 -23.26 27.25 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 120.706 1.594 . . . . 0.0 110.146 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -48.33 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.459 1.504 . . . . 0.0 107.243 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 t -68.63 -37.96 80.14 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.033 1.333 . . . . 0.0 109.31 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.83 -18.78 53.47 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.374 0.534 . . . . 0.0 112.052 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.23 33.36 6.59 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 118.819 0.736 . . . . 0.0 111.52 164.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.38 -49.89 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 172.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.35 107.46 3.35 Favored Pre-proline 0 C--N 1.349 0.553 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 169.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -81.36 -18.21 8.53 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.268 1.978 . . . . 0.0 113.255 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.5 t -86.4 106.34 17.37 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -58.82 -18.04 28.91 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -163.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 -50.48 21.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 121.786 2.085 . . . . 0.0 110.47 167.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -42.96 70.13 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 116.468 -1.729 . . . . 0.0 107.31 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.594 ' O ' HD12 ' A' ' 54' ' ' ILE . . . -52.63 -63.49 1.12 Allowed 'General case' 0 C--O 1.216 -0.681 0 CA-C-O 117.429 -1.272 . . . . 0.0 109.094 172.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.327 2.8 ttt-85 -60.2 -22.89 63.51 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 115.01 -2.424 . . . . 0.0 113.11 -170.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -29.88 25.71 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 121.664 2.029 . . . . 0.0 114.116 166.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.432 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.2 m-20 -62.56 -20.32 64.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.95 1.25 . . . . 0.0 111.644 171.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.651 HD11 HD21 ' A' ' 38' ' ' LEU . 4.3 mp -87.22 -62.45 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 CA-C-O 116.833 -1.556 . . . . 0.0 108.356 163.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -64.32 -7.49 9.73 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 120.065 1.302 . . . . 0.0 111.607 -165.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.1 m-80 -82.66 135.67 34.97 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.64 0.733 . . . . 0.0 111.838 173.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.439 ' HA2' ' HG2' ' A' ' 65' ' ' ARG . . . -74.2 40.26 1.05 Allowed Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.068 -1.423 . . . . 0.0 111.682 165.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -124.24 0.52 8.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 127.302 2.241 . . . . 0.0 111.146 164.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 56' ' ' ASN 0.323 0.0 OUTLIER -91.61 99.41 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 122.086 2.221 . . . . 0.0 106.385 163.63 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -86.84 115.06 24.01 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.666 1.987 . . . . 0.0 107.462 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.802 HG21 HD13 ' A' ' 72' ' ' ILE . 15.3 t -98.08 127.64 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 174.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.603 ' HA ' HD11 ' A' ' 10' ' ' LEU . 1.2 m-80 67.24 -14.06 0.2 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.862 1.265 . . . . 0.0 112.915 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.44 -8.17 6.6 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.705 2.097 . . . . 0.0 111.66 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -110.08 124.48 51.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 119.205 1.502 . . . . 0.0 107.338 -169.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HG2' ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -60.47 111.39 1.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.597 ' HB3' HD11 ' A' ' 72' ' ' ILE . 76.7 mt -146.4 89.17 1.83 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -171.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.19 35.09 1.2 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.156 1.783 . . . . 0.0 113.069 -171.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -140.26 144.04 36.26 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.269 -0.895 . . . . 0.0 112.361 -167.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.82 -36.57 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 126.49 1.916 . . . . 0.0 109.668 168.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.7 -16.11 69.58 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.607 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.7 -52.87 4.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 116.978 -1.486 . . . . 0.0 110.271 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.802 HD13 HG21 ' A' ' 61' ' ' VAL . 1.1 mp -138.13 138.98 42.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 121.376 1.898 . . . . 0.0 112.706 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.97 -75.18 0.64 Allowed 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 102.367 -3.198 . . . . 0.0 102.367 163.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 32' ' ' VAL . 22.1 p -131.06 -142.21 0.23 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . . . -89.06 -48.68 7.25 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 124.777 1.231 . . . . 0.0 111.768 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -8.15 55.15 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.038 0.923 . . . . 0.0 109.625 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -86.47 -9.31 56.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.337 1.455 . . . . 0.0 111.887 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.409 ' HB3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -126.8 -71.9 0.67 Allowed 'General case' 0 C--N 1.34 0.156 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -170.182 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.471 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -91.22 -169.53 2.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 126.52 1.928 . . . . 0.0 110.028 172.641 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.01 -3.62 0.37 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.898 1.679 . . . . 0.0 113.674 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.52 78.46 1.41 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -133.77 -59.25 0.85 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.914 0.357 . . . . 0.0 111.471 167.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -148.95 -177.61 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.478 2.311 . . . . 0.0 106.283 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.76 153.88 43.71 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 163.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.8 t -124.48 134.43 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.493 HD13 HG22 ' A' ' 61' ' ' VAL . 26.0 mm -125.28 95.28 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.328 1.851 . . . . 0.0 107.528 -169.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -89.31 88.84 7.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.432 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -80.04 120.14 23.81 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 163.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.63 -22.18 59.01 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.729 1.157 . . . . 0.0 114.051 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -3.74 52.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.509 1.524 . . . . 0.0 111.879 173.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -144.15 -131.52 0.08 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -159.73 0.97 Allowed 'General case' 0 C--O 1.242 0.668 0 CA-C-N 120.64 1.564 . . . . 0.0 109.843 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.43 83.89 4.25 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 129.418 3.087 . . . . 0.0 110.441 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -78.39 164.24 24.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.22 129.94 44.0 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 -164.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.5 mm -126.98 123.0 61.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -163.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.571 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 6.4 ttt180 -134.33 -178.72 5.18 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 125.376 2.512 . . . . 0.0 115.34 171.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.571 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -137.99 143.15 40.51 Favored 'General case' 0 N--CA 1.427 -1.582 1 C-N-CA 131.837 4.055 . . . . 0.0 105.829 -172.975 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 125.819 1.648 . . . . 0.0 110.084 -175.384 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.4 mt -111.64 169.44 8.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.078 0.951 . . . . 0.0 108.972 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -106.73 136.78 45.94 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 167.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.7 m -134.05 -175.33 3.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.853 2.061 . . . . 0.0 106.67 163.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.89 -38.15 92.71 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 167.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -78.95 166.14 22.7 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.928 1.347 . . . . 0.0 108.602 166.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -67.48 82.92 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.688 1.595 . . . . 0.0 112.514 169.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.78 -6.7 48.58 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.61 -1.307 . . . . 0.0 110.439 163.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -78.8 -23.54 45.11 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.921 1.288 . . . . 0.0 111.007 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.542 ' HB3' HD11 ' A' ' 15' ' ' ILE . 1.3 mm? -86.62 66.09 9.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 165.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 168.12 20.17 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.41 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -62.81 -55.91 22.19 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 123.523 0.729 . . . . 0.0 111.833 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.64 -19.02 63.62 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.667 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.35 -41.87 46.72 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 123.868 0.867 . . . . 0.0 109.167 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 10' ' ' LEU . 10.1 mt -72.74 -51.19 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -57.52 -46.99 83.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.334 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -78.07 -30.45 49.68 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.673 1.124 . . . . 0.0 110.194 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.55 -33.83 86.26 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -124.03 17.32 9.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.954 0.501 . . . . 0.0 112.083 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -14.16 16.98 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -78.99 -21.3 47.23 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.452 1.501 . . . . 0.0 111.716 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -115.95 161.61 29.95 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -175.124 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.433 ' HD2' HG12 ' A' ' 22' ' ' VAL . 29.8 Cg_endo -83.23 172.79 10.36 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.245 1.296 . . . . 0.0 110.702 -169.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.8 p -127.09 170.57 12.22 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.068 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -139.03 154.89 48.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.277 1.431 . . . . 0.0 107.831 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 3.6 p -138.41 125.85 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 123.884 0.873 . . . . 0.0 109.931 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -117.49 -168.13 1.44 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 171.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -84.94 12.13 8.1 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 127.789 2.436 . . . . 0.0 116.022 -163.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.04 -177.39 8.6 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -164.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.78 133.39 1.61 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -168.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.08 149.76 40.25 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 117.575 0.688 . . . . 0.0 111.236 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -160.92 140.33 7.9 Favored Pre-proline 0 CA--C 1.51 -0.574 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -168.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.422 ' HA ' HD23 ' A' ' 73' ' ' LEU . 98.6 Cg_endo -76.34 150.97 33.19 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 121.508 1.472 . . . . 0.0 110.973 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.333 0.3 OUTLIER -48.46 -34.62 11.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.222 -1.353 . . . . 0.0 112.098 173.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.807 ' HA ' HD11 ' A' ' 54' ' ' ILE . 9.9 p -67.03 -29.89 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 117.786 -1.102 . . . . 0.0 113.68 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -91.68 -40.12 11.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.737 1.153 . . . . 0.0 109.389 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.59 -30.72 66.15 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 117.093 -1.432 . . . . 0.0 108.399 -174.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.11 -22.26 25.48 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 121.054 1.752 . . . . 0.0 110.333 -172.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.75 -50.97 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 171.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.82 -39.7 95.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.498 1.119 . . . . 0.0 108.621 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.09 47.11 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.915 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.07 33.88 7.5 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 166.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.405 HG12 HG21 ' A' ' 86' ' ' ILE . 2.1 mp -77.78 -43.47 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 171.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -148.44 109.6 3.63 Favored Pre-proline 0 C--O 1.224 -0.288 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 164.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.3 -15.71 11.24 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.548 2.165 . . . . 0.0 113.391 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.5 t -81.25 115.81 20.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -58.54 -30.01 66.79 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.62 1.555 . . . . 0.0 112.89 -168.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -52.33 24.47 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.637 173.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -54.79 -49.96 69.67 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.62 -58.45 3.82 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 126.375 1.87 . . . . 0.0 110.005 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.464 ' HA ' HD12 ' A' ' 54' ' ' ILE . 34.1 mtt85 -58.07 -33.79 69.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 117.045 -1.455 . . . . 0.0 113.218 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -80.77 -34.75 34.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.016 1.734 . . . . 0.0 112.926 173.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -15.6 62.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.452 1.501 . . . . 0.0 111.248 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.807 HD11 ' HA ' ' A' ' 35' ' ' VAL . 57.5 mt -86.65 -61.68 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 125.41 1.484 . . . . 0.0 108.86 163.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -72.98 -5.47 38.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -163.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.52 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.1 m-80 -81.01 131.81 35.33 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 163.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.31 2.98 0.08 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.856 0.741 . . . . 0.0 114.876 167.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB1' HH21 ' A' ' 88' ' ' ARG . . . -79.1 11.32 2.84 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.099 2.159 . . . . 0.0 111.451 169.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 56' ' ' ASN 0.38 0.0 OUTLIER -111.77 90.05 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 124.98 2.324 . . . . 0.0 104.735 163.349 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.426 ' CE1' ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -78.9 96.69 5.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 111.36 -2.655 . . . . 0.0 104.807 172.248 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 p -78.49 134.58 27.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.11 14.36 4.41 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 122.004 2.183 . . . . 0.0 114.221 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.67 -4.77 69.38 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.535 1.541 . . . . 0.0 113.723 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -121.82 127.95 51.14 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.912 1.856 . . . . 0.0 108.521 -166.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 105.06 0.64 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.466 1.506 . . . . 0.0 108.302 -172.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.9 mt -140.09 100.89 4.03 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 120.234 1.379 . . . . 0.0 107.964 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -106.38 27.06 9.11 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.827 2.851 . . . . 0.0 110.559 -168.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -140.39 131.3 26.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.707 1.203 . . . . 0.0 112.138 -164.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 p -59.12 -36.39 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 126.568 1.947 . . . . 0.0 110.682 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.11 -19.49 68.11 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 119.283 -0.732 . . . . 0.0 112.771 173.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.23 -37.84 13.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.109 1.364 . . . . 0.0 114.486 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mt -142.41 123.58 11.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 120.729 1.604 . . . . 0.0 110.69 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' H ' ' CG ' ' A' ' 77' ' ' HIS . 70.3 mt -107.26 -95.24 0.37 Allowed 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 102.676 -3.083 . . . . 0.0 102.676 163.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.42 -173.05 2.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.065 1.302 . . . . 0.0 114.346 -173.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.24 -41.07 87.86 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.253 -0.904 . . . . 0.0 112.395 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -65.17 -17.22 64.3 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.001 0.92 . . . . 0.0 112.734 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.448 ' CG ' ' H ' ' A' ' 73' ' ' LEU . 42.5 t-80 -93.73 4.14 54.38 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.984 1.714 . . . . 0.0 109.682 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.27 -61.34 1.09 Allowed 'General case' 0 C--N 1.35 0.592 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.938 170.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' A' ' 84' ' ' THR . 0.1 OUTLIER -91.07 -170.31 2.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.441 1.473 . . . . 0.0 109.101 169.394 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -43.8 -49.36 8.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.548 1.139 . . . . 0.0 109.664 163.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.05 81.68 0.11 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 125.604 1.574 . . . . 0.0 114.363 172.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -141.74 -46.1 0.36 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.269 0.534 . . . . 0.0 111.902 165.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.41 ' CE1' ' HB1' ' A' ' 12' ' ' ALA . 83.6 m-85 -131.8 -177.52 4.47 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 125.502 1.521 . . . . 0.0 108.476 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.412 ' HA ' HD21 ' A' ' 79' ' ' LEU . 1.4 m -161.3 132.53 5.42 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.302 1.841 . . . . 0.0 106.72 163.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.25 145.4 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 170.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.405 HG21 HG12 ' A' ' 43' ' ' ILE . 15.4 mm -125.88 98.48 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 C-N-CA 126.442 1.897 . . . . 0.0 106.792 -176.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -97.12 82.35 3.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.479 HH21 ' HB1' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -79.28 61.39 3.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.398 1.879 . . . . 0.0 109.309 -174.221 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 27.19 -82.7 0.0 OUTLIER Glycine 0 CA--C 1.527 0.784 0 C-N-CA 130.292 3.806 . . . . 0.0 116.598 171.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -51.74 -55.05 21.96 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.745 1.618 . . . . 0.0 109.97 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.24 176.9 8.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.894 1.678 . . . . 0.0 109.414 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.527 ' HB3' HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -83.72 -146.07 0.08 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.707 1.242 . . . . 0.0 111.743 -176.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -118.16 82.31 1.82 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.295 2.238 . . . . 0.0 109.506 -163.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -78.92 168.34 19.84 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.274 -0.891 . . . . 0.0 108.894 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.5 tp -121.9 131.38 54.0 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.766 -171.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.44 133.42 66.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 15.0 ptt180 -144.08 172.08 13.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.578 1.18 . . . . 0.0 109.989 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.86 163.29 21.56 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.611 1.164 . . . . 0.0 108.417 163.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.52 0 C-N-CA 127.017 2.127 . . . . 0.0 110.026 173.295 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 55.45 -175.21 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.897 0.879 . . . . 0.0 109.302 -150.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.94 -46.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.755 -1.216 . . . . 0.0 109.314 164.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.0 m -159.49 -179.99 8.41 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.372 2.269 . . . . 0.0 107.727 170.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.02 -132.87 3.92 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -78.75 -64.76 1.1 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pt -90.93 51.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 122.922 1.344 . . . . 0.0 111.363 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.47 -5.17 10.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.721 1.209 . . . . 0.0 111.534 171.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -106.23 -11.22 16.11 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 126.319 1.847 . . . . 0.0 109.815 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.449 HD12 HG21 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -158.76 84.52 0.82 Allowed 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 125.34 1.456 . . . . 0.0 110.088 -171.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 p -77.94 176.76 8.83 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.097 0.959 . . . . 0.0 109.593 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.5 -49.91 69.51 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 120.347 -1.471 . . . . 0.0 110.836 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 -28.8 65.97 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 118.55 -1.26 . . . . 0.0 109.906 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -79.38 -24.31 42.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.218 1.007 . . . . 0.0 110.146 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.0 mt -74.08 -54.76 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.837 1.655 . . . . 0.0 106.901 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -57.27 -48.59 78.5 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.812 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -81.22 -24.87 37.11 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.417 1.008 . . . . 0.0 110.437 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.43 -38.88 96.38 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -121.48 14.47 11.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 123.726 0.31 . . . . 0.0 111.468 -164.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -54.22 -11.64 0.52 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -78.36 -13.27 59.92 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.918 2.087 . . . . 0.0 110.413 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.44 ' CG1' ' HE2' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -127.92 155.45 77.6 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 126.26 1.824 . . . . 0.0 106.337 169.496 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.65 169.43 20.89 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.71 1.607 . . . . 0.0 110.463 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.8 p -104.25 175.63 5.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.637 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -136.75 160.31 39.23 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 163.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 8.0 p -134.43 132.12 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 171.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.98 172.61 6.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 164.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -100.08 57.74 0.98 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.655 -1.278 . . . . 0.0 111.681 -164.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.15 -171.63 9.91 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.98 148.19 2.22 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 -164.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -73.11 149.67 42.87 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.909 -0.759 . . . . 0.0 110.389 164.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.5 t -158.42 132.62 5.15 Favored Pre-proline 0 CA--C 1.505 -0.752 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -163.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HA ' HD23 ' A' ' 73' ' ' LEU . 44.4 Cg_endo -74.41 154.81 45.77 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 C-N-CA 121.715 1.61 . . . . 0.0 110.251 -173.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.397 0.6 OUTLIER -53.94 -29.99 44.69 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.482 176.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.678 ' HA ' HD11 ' A' ' 54' ' ' ILE . 8.6 p -70.25 -24.78 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 174.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -90.86 -43.77 9.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 120.31 1.414 . . . . 0.0 108.508 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -73.78 -28.31 61.6 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 116.943 -1.503 . . . . 0.0 109.49 -171.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.08 -31.29 25.4 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.713 1.597 . . . . 0.0 109.327 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 t -64.6 -51.5 66.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -66.62 -34.75 78.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.152 1.381 . . . . 0.0 109.998 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.4 -15.65 58.44 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.726 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.38 23.36 19.46 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 166.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.93 -43.37 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 m -156.34 101.12 2.07 Favored Pre-proline 0 C--N 1.349 0.562 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 171.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.62 -18.68 10.49 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 121.771 1.647 . . . . 0.0 113.431 -173.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.3 t -86.34 106.34 17.32 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -174.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 75.2 mttt -57.22 -22.19 39.22 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -164.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.55 -45.99 56.6 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 121.828 2.104 . . . . 0.0 111.095 169.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -51.81 67.84 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -50.59 -52.93 34.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 125.447 1.717 . . . . 0.0 110.586 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -57.08 -37.97 72.66 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 117.295 -1.336 . . . . 0.0 111.102 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -84.04 -24.89 30.27 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 116.736 -1.986 . . . . 0.0 113.296 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.16 -23.19 66.45 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 112.22 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 35' ' ' VAL . 70.0 mt -84.95 -63.7 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 C-N-CA 126.211 1.804 . . . . 0.0 107.3 168.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.52 -5.13 10.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 119.916 1.235 . . . . 0.0 112.783 -164.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.628 ' O ' HG22 ' A' ' 59' ' ' ILE . 7.0 m120 -81.5 132.26 35.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 164.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.06 10.76 0.06 OUTLIER Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.246 1.403 . . . . 0.0 115.119 164.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.52 -12.67 59.86 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 116.253 -1.832 . . . . 0.0 112.964 165.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 56' ' ' ASN 0.362 0.0 OUTLIER -99.74 87.79 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 125.881 2.753 . . . . 0.0 107.741 177.128 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -79.32 99.08 6.95 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 109.698 -3.41 . . . . 0.0 106.654 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.84 137.34 22.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.5 HD21 ' CD2' ' A' ' 79' ' ' LEU . 0.9 OUTLIER 60.19 4.56 0.67 Allowed 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 120.657 1.572 . . . . 0.0 113.132 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 -2.15 47.69 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.492 1.52 . . . . 0.0 114.035 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -124.18 129.07 50.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.852 1.826 . . . . 0.0 108.979 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.51 110.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.515 1.526 . . . . 0.0 108.386 -171.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.479 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 17.9 mt -141.22 70.42 1.35 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.128 0.966 . . . . 0.0 109.023 -174.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -78.97 31.94 0.21 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -170.103 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -143.62 159.44 42.45 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.7 t -68.01 -27.42 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.971 2.509 . . . . 0.0 111.48 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.11 -7.57 85.09 Favored Glycine 0 C--N 1.333 0.401 0 O-C-N 121.393 -0.817 . . . . 0.0 112.552 168.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 66' ' ' LEU . . . -86.44 -57.64 2.92 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 117.914 -1.041 . . . . 0.0 108.298 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp -136.17 137.34 48.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 120.596 1.544 . . . . 0.0 113.475 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 33' ' ' PRO . 93.1 mt -108.12 -87.02 0.5 Allowed 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 100.571 -3.862 . . . . 0.0 100.571 163.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.48 -174.42 2.51 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 120.861 -1.15 . . . . 0.0 113.803 -169.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.0 -48.72 75.37 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -70.11 -15.34 62.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.175 0.898 . . . . 0.0 111.224 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -81.3 -10.34 59.59 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.928 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.21 -77.15 0.57 Allowed 'General case' 0 C--N 1.343 0.306 0 O-C-N 120.789 -1.194 . . . . 0.0 108.095 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.5 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -90.55 -171.51 3.09 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 125.66 1.584 . . . . 0.0 109.328 177.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -47.78 -26.27 1.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.72 2.008 . . . . 0.0 115.362 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.34 64.56 0.31 Allowed Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 126.01 1.767 . . . . 0.0 111.261 -169.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -133.27 -81.3 0.48 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -127.36 -166.39 1.6 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.845 1.258 . . . . 0.0 108.781 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.34 122.35 4.49 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 120.78 -1.2 . . . . 0.0 107.899 165.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.449 HG21 HD12 ' A' ' 10' ' ' LEU . 39.2 t -79.5 128.12 38.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.456 HD12 HD11 ' A' ' 59' ' ' ILE . 11.2 mm -116.24 98.03 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -92.37 85.62 5.43 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.528 ' CG ' ' HB ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -89.65 113.97 25.52 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 166.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.84 2.88 1.13 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -58.2 -45.44 87.58 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.154 1.477 . . . . 0.0 109.573 164.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HE2' ' CG1' ' A' ' 22' ' ' VAL . 61.7 tttt -131.76 -90.44 0.43 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.425 ' HG3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -152.82 -152.39 0.42 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 120.878 1.672 . . . . 0.0 111.523 -167.035 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.425 ' CD1' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -94.68 79.5 3.76 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 129.897 3.279 . . . . 0.0 110.244 -176.746 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.4 144.38 35.95 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 119.95 -1.719 . . . . 0.0 107.219 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.1 tp -97.93 139.07 34.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -176.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.3 mm -126.6 135.71 62.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 12.9 ptt180 -135.37 174.01 11.09 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 122.655 1.217 . . . . 0.0 111.568 164.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.19 163.44 12.24 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 163.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.41 0 C-N-CA 127.671 2.388 . . . . 0.0 109.071 -176.932 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mt -67.93 126.35 29.17 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.541 1.064 . . . . 0.0 109.542 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.47 -172.33 3.26 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.897 1.679 . . . . 0.0 108.644 -174.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.95 -175.23 3.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.646 1.579 . . . . 0.0 107.833 167.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.9 -72.19 2.08 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -78.24 172.68 13.21 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.056 1.408 . . . . 0.0 109.154 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 7' ' ' ILE . 1.4 pp -62.48 40.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 1 C-N-CA 131.82 4.048 . . . . 0.0 112.537 168.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.83 5.52 3.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 129.092 2.957 . . . . 0.0 111.286 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.6 -22.91 46.33 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.424 1.09 . . . . 0.0 109.57 164.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.3 94.41 8.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.152 1.781 . . . . 0.0 106.562 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.49 178.07 8.04 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.214 1.805 . . . . 0.0 108.594 176.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.82 -58.44 4.59 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.684 0.794 . . . . 0.0 111.139 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.13 -25.14 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.072 0.396 . . . . 0.0 111.026 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -73.73 -39.28 64.4 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.3 mt -70.31 -52.12 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.371 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.37 -48.22 82.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.494 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -72.12 -35.94 69.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.356 0.98 . . . . 0.0 109.155 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.79 -38.2 93.59 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -117.46 13.39 14.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.059 0.544 . . . . 0.0 110.458 -169.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -15.57 4.96 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.406 1.883 . . . . 0.0 113.939 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -78.04 -11.23 59.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 127.427 2.291 . . . . 0.0 111.598 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.439 HG22 ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -133.76 172.84 6.63 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 167.033 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.439 ' HD2' HG22 ' A' ' 22' ' ' VAL . 71.1 Cg_endo -76.85 -174.24 2.08 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.145 2.563 . . . . 0.0 110.111 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.4 p -135.35 175.45 9.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.594 1.157 . . . . 0.0 109.085 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -138.53 161.32 37.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.265 0.939 . . . . 0.0 109.075 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.8 t -138.81 139.64 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 124.713 1.205 . . . . 0.0 108.032 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.69 172.16 8.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.505 1.145 . . . . 0.0 112.705 163.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.19 33.08 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 128.641 2.776 . . . . 0.0 111.204 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.84 -170.87 31.95 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.543 -0.723 . . . . 0.0 112.058 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.78 145.54 2.98 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -164.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -67.98 148.16 51.45 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.306 0.574 . . . . 0.0 110.653 167.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.8 t -156.77 133.75 6.53 Favored Pre-proline 0 CA--C 1.511 -0.539 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -163.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.519 ' HA ' HD23 ' A' ' 73' ' ' LEU . 89.9 Cg_endo -71.42 152.01 60.09 Favored 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 122.069 1.846 . . . . 0.0 110.989 -172.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.442 1.0 OUTLIER -51.69 -30.4 21.89 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.552 174.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.475 ' HA ' HD22 ' A' ' 38' ' ' LEU . 7.7 p -78.11 -14.87 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.512 1.525 . . . . 0.0 114.71 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.36 -49.05 6.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.114 0.87 . . . . 0.0 109.055 166.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.9 -23.88 60.77 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 117.381 -1.295 . . . . 0.0 109.051 -166.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.878 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -75.62 -33.4 60.52 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 120.822 1.646 . . . . 0.0 109.639 176.196 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.456 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -75.3 -46.86 37.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -175.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -38.07 89.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.542 1.937 . . . . 0.0 109.39 175.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.64 -24.08 45.47 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.108 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.17 23.12 11.68 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 124.096 0.855 . . . . 0.0 111.482 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.405 HG21 ' NH1' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -78.3 -39.66 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -174.505 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -145.15 113.6 4.86 Favored Pre-proline 0 C--O 1.225 -0.193 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.45 -15.08 5.37 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.778 2.319 . . . . 0.0 113.3 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -84.8 132.67 34.39 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -65.04 -35.48 81.3 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 119.583 1.083 . . . . 0.0 111.034 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -55.47 24.21 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 120.028 1.285 . . . . 0.0 108.945 177.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -49.3 76.71 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.033 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.878 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -51.13 -51.85 49.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.694 1.134 . . . . 0.0 112.366 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -60.0 -39.89 87.35 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 117.678 -1.153 . . . . 0.0 110.238 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.26 -32.05 49.44 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.777 1.172 . . . . 0.0 112.351 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -50.28 -39.81 46.46 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.561 HD11 HD22 ' A' ' 38' ' ' LEU . 43.8 mt -84.85 -49.99 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 115.66 -2.114 . . . . 0.0 109.597 -174.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -66.99 -10.83 53.75 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 125.382 1.676 . . . . 0.0 111.489 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.538 ' HB3' ' H ' ' A' ' 58' ' ' ALA . 1.2 m120 -83.52 137.3 33.93 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 174.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.66 0.42 0.45 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-N 115.067 -0.969 . . . . 0.0 114.419 164.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.538 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -78.95 -4.13 48.34 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.58 1.552 . . . . 0.0 111.617 172.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.475 HG13 ' NH2' ' A' ' 88' ' ' ARG 0.393 0.0 OUTLIER -106.78 92.43 2.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 CA-C-O 125.06 2.362 . . . . 0.0 109.125 171.546 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.97 93.59 7.58 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 109.913 -3.312 . . . . 0.0 105.067 169.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 p -78.31 127.33 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 102.375 -3.195 . . . . 0.0 102.375 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 76.34 -52.39 0.6 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.464 1.906 . . . . 0.0 110.499 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.45 3.89 0.02 OUTLIER Glycine 0 CA--C 1.533 1.182 1 C-N-CA 130.731 4.015 . . . . 0.0 111.063 170.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -112.82 116.25 29.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -163.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.08 105.74 0.93 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.9 mt -140.82 68.13 1.35 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.332 0.969 . . . . 0.0 109.547 -168.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.97 56.47 3.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.111 1.764 . . . . 0.0 112.535 -172.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -148.34 151.19 34.93 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.763 0.825 . . . . 0.0 112.928 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.32 -38.01 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.765 2.426 . . . . 0.0 110.699 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.14 -10.19 68.55 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 119.027 -0.874 . . . . 0.0 112.307 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.62 -55.6 3.8 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 117.213 -1.375 . . . . 0.0 109.664 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -136.25 134.53 50.02 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 CA-C-N 120.585 1.539 . . . . 0.0 113.613 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 33' ' ' PRO . 77.3 mt -108.27 -86.41 0.51 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 163.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 p -115.57 -168.94 1.49 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . . . -62.52 -45.33 93.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.634 -177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -70.2 -17.26 63.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.71 1.141 . . . . 0.0 110.93 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -82.7 0.16 44.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.464 1.106 . . . . 0.0 110.92 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 -62.97 0.9 Allowed 'General case' 0 C--N 1.345 0.379 0 O-C-N 120.785 -1.197 . . . . 0.0 110.033 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.06 -175.22 4.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.452 2.301 . . . . 0.0 109.528 172.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -52.81 -28.66 23.64 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.983 1.313 . . . . 0.0 112.852 172.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.46 73.47 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 126.355 1.931 . . . . 0.0 111.675 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -139.04 -79.23 0.33 Allowed 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 117.614 0.707 . . . . 0.0 109.403 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -126.71 -170.8 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.109 1.764 . . . . 0.0 109.13 -173.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.12 116.72 4.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 163.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.84 138.46 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 170.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 17.9 mm -123.1 104.63 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.788 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -92.67 83.92 4.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 170.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HG2' HH11 ' A' ' 88' ' ' ARG . 0.0 OUTLIER -78.48 82.22 4.76 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 169.463 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -49.28 -34.26 17.65 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.395 1.474 . . . . 0.0 111.932 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -69.39 15.19 0.07 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.709 1.204 . . . . 0.0 113.635 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -162.69 -82.96 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.855 2.462 . . . . 0.0 108.868 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.608 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -157.73 -169.21 2.78 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 123.364 1.554 . . . . 0.0 110.163 -176.124 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.608 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 12.0 m-30 -107.03 76.83 1.12 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.985 2.114 . . . . 0.0 111.704 -168.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -79.43 172.31 13.96 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.606 1.162 . . . . 0.0 112.129 -173.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.0 tp -140.66 137.53 33.63 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.377 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.15 141.83 45.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.716 1.606 . . . . 0.0 109.013 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -134.39 179.73 6.09 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 124.57 2.129 . . . . 0.0 109.392 163.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -121.25 162.14 20.74 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.257 163.458 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 125.169 1.388 . . . . 0.0 112.111 176.214 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mt 39.98 -5.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 2 C-N-CA 132.459 4.304 . . . . 0.0 121.964 164.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -130.71 -26.72 2.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.405 1.882 . . . . 0.0 110.601 169.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.3 t -166.22 -175.92 3.48 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.059 1.344 . . . . 0.0 108.704 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.45 -98.85 0.55 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 126.47 1.985 . . . . 0.0 109.642 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -72.71 0.36 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.639 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -91.06 52.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.391 1.477 . . . . 0.0 110.856 -171.294 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.32 4.21 1.4 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.146 2.178 . . . . 0.0 112.993 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -116.63 -15.24 10.82 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 126.693 1.997 . . . . 0.0 110.086 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.96 70.25 0.87 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.789 0.835 . . . . 0.0 109.622 -174.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.51 177.18 8.74 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 125.618 1.567 . . . . 0.0 109.371 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.94 -51.61 68.49 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.081 -1.637 . . . . 0.0 112.438 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.89 -29.69 69.64 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.258 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.92 -31.96 61.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.78 2.032 . . . . 0.0 110.3 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 mt -76.38 -56.39 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 126.338 1.855 . . . . 0.0 106.38 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.27 -49.63 63.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.715 0.689 . . . . 0.0 112.519 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.84 -35.59 62.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.14 -40.61 95.91 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -115.58 16.49 16.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 124.035 0.491 . . . . 0.0 110.565 -165.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -55.79 -12.07 1.19 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -102.67 -2.51 28.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 129.25 3.02 . . . . 0.0 113.209 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -120.79 169.72 8.38 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.206 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.467 ' HD2' HG12 ' A' ' 22' ' ' VAL . 40.8 Cg_endo -84.13 173.19 9.13 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 CA-C-N 121.189 1.46 . . . . 0.0 109.878 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.8 p -128.87 158.16 39.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.878 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 61.6 t80 -135.08 153.76 51.92 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 p -128.49 131.8 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.41 172.69 8.15 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 123.114 1.435 . . . . 0.0 113.523 164.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -80.92 37.98 0.44 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 128.162 2.585 . . . . 0.0 112.43 -164.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.21 -171.53 5.0 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.706 1.146 . . . . 0.0 113.703 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.71 137.04 0.76 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -167.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.17 137.0 57.35 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.378 1.089 . . . . 0.0 109.73 175.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.24 138.5 14.18 Favored Pre-proline 0 CA--C 1.514 -0.427 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -163.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HA ' HD23 ' A' ' 73' ' ' LEU . 94.7 Cg_endo -70.7 145.13 50.91 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.628 2.219 . . . . 0.0 110.776 -169.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.754 HD22 HG13 ' A' ' 54' ' ' ILE 0.284 0.0 OUTLIER -47.35 -36.74 9.96 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.426 177.884 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.6 ' HA ' HD22 ' A' ' 38' ' ' LEU . 11.7 p -79.08 -15.88 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.707 2.003 . . . . 0.0 114.355 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -88.36 -44.23 10.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 120.088 1.313 . . . . 0.0 108.807 164.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -77.09 -18.18 58.18 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 116.847 -1.549 . . . . 0.0 109.888 -168.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.739 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -74.39 -34.69 63.37 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 121.144 1.793 . . . . 0.0 109.751 171.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.562 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -73.1 -49.14 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 C-N-CA 126.338 1.855 . . . . 0.0 106.054 -169.16 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 3.9 m -60.92 -40.89 94.88 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 128.53 2.732 . . . . 0.0 110.687 169.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.79 -11.09 59.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.904 1.229 . . . . 0.0 113.038 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.25 20.39 49.22 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.682 1.128 . . . . 0.0 112.199 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.506 HG21 ' NH1' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -77.86 -39.74 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.794 1.637 . . . . 0.0 106.836 -177.567 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.74 111.32 1.32 Allowed Pre-proline 0 C--N 1.344 0.358 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 167.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.11 -13.47 7.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.149 1.899 . . . . 0.0 112.414 -174.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 m -90.44 101.49 14.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 -164.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -41.44 -37.46 1.06 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -163.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.48 -54.06 33.75 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.226 1.376 . . . . 0.0 110.168 171.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -59.16 -42.05 89.8 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.728 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -51.49 -55.58 18.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 123.836 0.855 . . . . 0.0 110.415 175.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 mtt85 -55.2 -42.46 73.32 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.173 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -79.78 -33.5 40.49 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 119.989 1.268 . . . . 0.0 112.125 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.63 -29.43 68.01 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 116.592 -1.67 . . . . 0.0 107.636 171.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.754 HG13 HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -81.74 -51.76 14.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-N 120.34 1.427 . . . . 0.0 110.848 174.56 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -69.6 -7.11 35.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.76 1.624 . . . . 0.0 111.458 -172.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.553 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.8 m-80 -81.07 134.95 35.75 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 171.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.59 8.25 0.2 Allowed Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.383 -1.232 . . . . 0.0 114.674 164.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.475 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -84.32 -16.22 43.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.213 1.507 . . . . 0.0 111.173 170.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 56' ' ' ASN 0.352 0.0 OUTLIER -93.5 92.65 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 125.455 2.55 . . . . 0.0 106.79 169.615 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -78.96 109.4 13.21 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 111.566 -2.561 . . . . 0.0 106.236 167.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 72' ' ' ILE . 13.5 t -88.47 124.87 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 O-C-N 120.307 -1.496 . . . . 0.0 107.421 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.723 HD22 ' HG3' ' A' ' 78' ' ' ARG . 68.3 m-80 46.92 57.57 5.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.774 1.273 . . . . 0.0 110.169 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.23 4.75 51.57 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 113.56 -1.654 . . . . 0.0 114.439 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -131.03 121.47 25.09 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 120.82 2.31 . . . . 0.0 110.404 -167.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.99 100.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 126.691 1.996 . . . . 0.0 110.435 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.519 ' HB3' HD11 ' A' ' 72' ' ' ILE . 66.4 mt -138.48 108.12 6.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -170.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.13 38.41 2.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.888 2.075 . . . . 0.0 112.125 -163.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -143.18 158.88 43.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.616 1.566 . . . . 0.0 110.291 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.441 HG22 HD21 ' A' ' 73' ' ' LEU . 6.3 p -69.12 -33.19 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 121.177 -0.952 . . . . 0.0 111.796 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.08 -8.19 84.91 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 119.713 -0.493 . . . . 0.0 112.489 168.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.35 -55.64 4.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 116.862 -1.542 . . . . 0.0 109.24 170.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -138.93 145.86 27.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.402 0 CA-C-N 121.614 2.006 . . . . 0.0 111.774 177.201 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 33' ' ' PRO . 82.2 mt -115.84 -98.57 0.44 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 163.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.05 -177.51 4.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.072 1.306 . . . . 0.0 114.145 -174.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.56 -48.71 71.73 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.068 0.947 . . . . 0.0 112.581 173.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -61.41 -20.31 62.92 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.996 1.319 . . . . 0.0 113.189 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 60.1 t-80 -84.45 -19.33 33.58 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.151 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.723 ' HG3' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -96.2 -74.89 0.55 Allowed 'General case' 0 C--N 1.345 0.404 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.635 HD11 ' H ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.52 169.63 10.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.371 1.468 . . . . 0.0 111.129 172.954 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -23.24 -52.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.028 3.331 . . . . 0.0 115.839 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.53 56.28 0.01 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -168.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.9 -88.03 0.33 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.986 0.893 . . . . 0.0 111.851 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.635 ' H ' HD11 ' A' ' 79' ' ' LEU . 21.6 m-30 -131.56 -170.5 2.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -168.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.46 135.21 10.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.35 -0.844 . . . . 0.0 109.413 166.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -79.41 138.34 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 167.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 22.4 mm -113.22 92.74 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 126.323 1.849 . . . . 0.0 106.042 169.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 ttt-85 -97.78 74.63 2.37 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 -165.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.748 ' HB2' HH11 ' A' ' 88' ' ' ARG . 0.0 OUTLIER -88.3 105.14 17.36 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 130.499 3.519 . . . . 0.0 110.019 -169.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.23 -30.56 17.98 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.182 0.896 . . . . 0.0 114.524 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -23.58 31.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.721 1.609 . . . . 0.0 113.913 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -149.76 -89.91 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 -144.52 0.15 Allowed 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 122.424 1.107 . . . . 0.0 109.99 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 3.6 m-30 -115.22 87.5 2.67 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.533 -162.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -78.49 161.92 26.72 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.87 134.9 54.85 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -172.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.7 mm -122.61 129.28 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -137.58 174.57 10.44 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 123.588 1.661 . . . . 0.0 111.061 171.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.71 166.05 13.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 124.738 1.215 . . . . 0.0 110.096 171.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 C-N-CA 129.075 2.95 . . . . 0.0 110.852 -168.684 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 120.476 0.179 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -148.42 171.96 15.21 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.53 1.932 . . . . 0.0 107.68 159.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -138.83 -97.1 0.17 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.9 t -156.99 -112.47 0.03 OUTLIER 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.09 -164.37 17.07 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 124.674 1.13 . . . . 0.0 110.965 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.22 -37.16 46.03 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 121.487 -1.008 . . . . 0.0 108.758 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -91.58 53.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 124.402 1.081 . . . . 0.0 111.732 165.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.19 -10.49 10.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -98.07 -21.06 16.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.507 1.523 . . . . 0.0 111.207 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -155.0 72.93 0.85 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 121.34 0.591 . . . . 0.0 111.652 -164.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.41 -178.07 5.57 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 125.388 1.475 . . . . 0.0 110.951 173.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -65.54 -51.01 63.06 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 120.467 -1.396 . . . . 0.0 111.47 -170.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.34 81.08 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.402 0.439 . . . . 0.0 110.087 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.81 -34.31 66.78 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -174.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.9 mt -72.68 -52.14 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 126.261 1.824 . . . . 0.0 108.397 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -56.83 -47.24 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 118.598 0.635 . . . . 0.0 111.235 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -80.64 -22.54 40.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.581 0.628 . . . . 0.0 110.057 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.54 -24.67 58.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 125.241 1.4 . . . . 0.0 111.841 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -130.44 17.13 5.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.185 0.994 . . . . 0.0 110.596 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 -15.23 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.191 2.196 . . . . 0.0 112.47 169.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.1 -19.7 53.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.766 2.827 . . . . 0.0 111.392 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.597 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -126.08 161.54 51.08 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 176.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.597 ' HD2' HG12 ' A' ' 22' ' ' VAL . 44.4 Cg_endo -76.16 172.26 16.58 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 N-CA-C 109.091 -1.157 . . . . 0.0 109.091 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 p -121.02 168.3 11.66 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 113.532 -1.667 . . . . 0.0 108.42 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -140.43 164.33 30.41 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 9.5 p -139.46 135.65 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.13 -179.23 3.6 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.75 0.786 . . . . 0.0 109.98 163.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -96.15 66.89 2.55 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.437 -0.79 . . . . 0.0 109.879 -171.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.56 -157.4 29.57 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.44 108.31 0.05 OUTLIER Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.295 1.426 . . . . 0.0 112.298 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -47.41 139.86 6.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.86 0.83 . . . . 0.0 112.192 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.95 136.54 10.86 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.722 -163.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.13 144.34 38.3 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.35 2.7 . . . . 0.0 112.388 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.377 1.1 pt? -55.8 -25.92 43.73 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 171.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.716 ' HA ' HD11 ' A' ' 54' ' ' ILE . 7.6 p -57.4 -56.6 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 119.58 1.082 . . . . 0.0 110.844 166.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -65.63 -41.88 92.16 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.188 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.81 -29.5 62.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 120.587 1.539 . . . . 0.0 109.517 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.74 -27.83 22.12 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 120.459 1.482 . . . . 0.0 109.482 -173.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.54 -49.86 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 t -60.98 -45.4 94.94 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.668 1.587 . . . . 0.0 108.685 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.87 -15.61 58.13 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.167 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.94 27.58 9.39 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 119.276 0.944 . . . . 0.0 111.268 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -45.77 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.51 102.83 2.91 Favored Pre-proline 0 C--N 1.347 0.49 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 164.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.94 -17.45 19.7 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.131 1.887 . . . . 0.0 113.067 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.0 t -90.81 109.14 20.34 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 82.0 mttt -56.96 -18.75 14.69 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -166.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -72.02 -53.84 11.72 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 120.91 1.687 . . . . 0.0 110.484 168.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -47.91 68.08 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -50.37 -57.25 8.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 124.403 1.065 . . . . 0.0 111.359 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -63.13 -26.93 69.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 116.251 -1.833 . . . . 0.0 112.229 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -69.74 -50.48 43.05 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 121.602 2.001 . . . . 0.0 110.982 163.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.617 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.0 OUTLIER -60.42 -9.55 3.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.725 1.21 . . . . 0.0 112.993 -174.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.716 HD11 ' HA ' ' A' ' 35' ' ' VAL . 38.9 mt -96.15 -67.74 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 C-N-CA 126.673 1.989 . . . . 0.0 109.071 164.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.62 -9.22 8.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 120.329 1.422 . . . . 0.0 112.54 -167.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.609 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -82.52 126.04 31.81 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 119.57 1.077 . . . . 0.0 110.971 168.152 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.46 9.55 0.23 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 169.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.11 -7.53 58.94 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 116.58 -1.676 . . . . 0.0 111.801 164.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 56' ' ' ASN 0.384 0.0 OUTLIER -91.75 90.13 3.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 125.621 2.629 . . . . 0.0 107.673 167.174 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -79.87 96.74 6.43 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 110.957 -2.838 . . . . 0.0 108.021 171.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.875 HG21 HD13 ' A' ' 72' ' ' ILE . 31.0 t -78.64 126.78 38.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.413 HD21 HD21 ' A' ' 79' ' ' LEU . 1.8 m120 60.7 11.9 3.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.619 0.768 . . . . 0.0 111.834 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.97 18.32 56.26 Favored Glycine 0 CA--C 1.525 0.71 0 O-C-N 121.009 -1.057 . . . . 0.0 112.062 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -124.23 115.91 21.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.541 1.671 . . . . 0.0 107.793 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -51.71 105.78 0.12 Allowed 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 126.157 1.783 . . . . 0.0 107.5 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.566 ' HB3' HD11 ' A' ' 72' ' ' ILE . 65.9 mt -145.09 71.75 1.31 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -171.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.43 39.89 0.34 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.397 1.479 . . . . 0.0 111.192 -172.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -149.1 152.59 36.42 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -165.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.54 -29.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.363 2.265 . . . . 0.0 112.006 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.01 -34.88 90.4 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 164.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.86 -57.35 4.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 117.382 -1.294 . . . . 0.0 110.071 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.875 HD13 HG21 ' A' ' 61' ' ' VAL . 1.2 mp -136.12 139.49 45.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 CA-C-N 120.725 1.602 . . . . 0.0 112.402 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -112.13 -91.17 0.49 Allowed 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.72 -174.66 2.51 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.332 -1.48 . . . . 0.0 113.833 -170.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.08 -42.01 84.67 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -82.64 -0.42 47.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.641 1.109 . . . . 0.0 110.962 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -89.59 -3.49 58.26 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.837 -1.164 . . . . 0.0 110.357 164.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.462 ' HB3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -125.79 -63.67 1.11 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 120.113 1.324 . . . . 0.0 111.092 177.188 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -91.04 -168.79 2.16 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.378 1.071 . . . . 0.0 109.265 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -54.61 -17.66 3.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.298 1.439 . . . . 0.0 113.034 168.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.54 75.29 0.88 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 126.722 2.106 . . . . 0.0 112.343 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -145.01 -60.88 0.36 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.822 0.811 . . . . 0.0 111.865 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.432 ' CE1' ' HB1' ' A' ' 12' ' ' ALA . 75.4 m-85 -137.58 -168.11 2.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.922 2.089 . . . . 0.0 107.912 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -160.62 131.71 5.59 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.56 1.944 . . . . 0.0 106.93 164.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.53 139.65 17.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 125.017 1.327 . . . . 0.0 107.99 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.467 HD13 HG22 ' A' ' 61' ' ' VAL . 18.8 mm -131.33 101.77 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 126.004 1.722 . . . . 0.0 106.528 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -100.65 95.57 6.77 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.617 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -87.62 121.07 29.59 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 172.324 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.9 98.57 0.71 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt 132.19 113.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 1 C-N-CA 134.458 5.103 . . . . 0.0 102.781 -163.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.431 0.0 OUTLIER 54.43 -127.61 2.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 116.665 -1.636 . . . . 0.0 109.031 -163.592 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.444 ' HB3' HG11 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -139.3 -143.55 0.16 Allowed 'General case' 0 C--O 1.243 0.725 0 CA-C-N 121.045 1.748 . . . . 0.0 113.213 -163.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -121.46 82.22 1.91 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.898 1.679 . . . . 0.0 109.851 -163.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -79.04 164.93 23.95 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 96' ' ' ILE . 1.2 tt -134.41 129.1 34.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -164.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.437 HD13 HG13 ' A' ' 86' ' ' ILE . 3.5 mp -124.72 135.16 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -171.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 14.2 ptt-85 -131.82 178.34 6.84 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.386 1.474 . . . . 0.0 111.853 166.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.61 161.82 18.59 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.462 1.105 . . . . 0.0 109.474 163.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.388 0 C-N-CA 126.197 1.799 . . . . 0.0 109.219 170.166 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.3 164.39 29.96 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 156.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -73.0 63.5 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.644 2.377 . . . . 0.0 111.395 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.4 m -46.74 104.65 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 127.045 2.138 . . . . 0.0 112.042 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.56 -77.07 0.4 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.14 -57.8 3.55 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 124.217 1.007 . . . . 0.0 109.981 -175.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.46 53.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 122.806 1.288 . . . . 0.0 110.22 -167.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.91 -6.94 30.38 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.566 1.146 . . . . 0.0 113.314 -170.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -78.63 -38.11 40.51 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.828 1.251 . . . . 0.0 110.078 165.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.94 86.24 7.4 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.962 1.305 . . . . 0.0 109.09 -170.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.76 167.06 21.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 168.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.88 -39.14 73.0 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.747 -1.221 . . . . 0.0 112.146 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.22 -30.67 70.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 170.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -77.98 -32.86 51.56 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.904 0.881 . . . . 0.0 109.64 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 mt -64.96 -56.88 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 C-N-CA 126.155 1.782 . . . . 0.0 108.018 166.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -54.11 -50.45 66.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 120.309 1.413 . . . . 0.0 113.282 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -87.3 -12.61 46.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.095 0.861 . . . . 0.0 111.249 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.23 -44.02 94.45 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 164.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.449 ' CD2' HD13 ' A' ' 95' ' ' LEU . 10.4 m-85 -106.54 1.71 25.58 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -163.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -48.18 -12.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.34 -12.74 59.92 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.78 1.632 . . . . 0.0 112.978 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.606 HG22 ' HD2' ' A' ' 23' ' ' PRO . 10.5 p -160.36 160.69 26.15 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.659 1.984 . . . . 0.0 108.303 -177.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.606 ' HD2' HG22 ' A' ' 22' ' ' VAL . 89.9 Cg_endo -82.64 178.72 5.89 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.853 1.702 . . . . 0.0 111.761 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.5 179.0 4.15 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.01 1.724 . . . . 0.0 110.173 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 48.0 t80 -137.08 160.44 38.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.308 1.443 . . . . 0.0 108.69 164.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 t -139.27 129.64 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.388 1.875 . . . . 0.0 108.22 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.9 -168.33 1.59 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.476 0.58 . . . . 0.0 112.491 163.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.57 1.2 30.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -163.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.78 174.12 4.97 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.952 1.263 . . . . 0.0 112.244 -169.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.05 133.36 1.12 Allowed Glycine 0 CA--C 1.53 1.022 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -163.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -62.5 145.27 54.66 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -163.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.401 HG13 ' HD2' ' A' ' 33' ' ' PRO . 4.7 t -159.06 138.73 8.54 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 125.714 1.606 . . . . 0.0 106.876 -163.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HA ' HD23 ' A' ' 73' ' ' LEU . 87.9 Cg_endo -71.99 146.27 46.72 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.038 1.825 . . . . 0.0 111.203 -171.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.418 ' HG ' HD13 ' A' ' 54' ' ' ILE 0.328 0.9 OUTLIER -45.92 -36.62 5.57 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.977 171.451 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.685 ' HA ' HD22 ' A' ' 38' ' ' LEU 0.264 5.8 p -79.61 -9.28 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 120.602 -1.312 . . . . 0.0 114.194 -176.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -96.18 -38.96 9.92 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.513 1.051 . . . . 0.0 109.498 163.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -78.83 -17.72 55.2 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 116.84 -1.552 . . . . 0.0 109.624 -172.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.685 HD22 ' HA ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -78.99 -27.07 43.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 121.146 1.793 . . . . 0.0 110.228 171.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.576 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -77.93 -44.34 28.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 126.342 1.857 . . . . 0.0 106.743 -174.192 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -69.88 -41.26 75.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 124.781 1.232 . . . . 0.0 108.679 172.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.64 -16.38 57.41 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.725 1.148 . . . . 0.0 112.858 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.3 33.33 8.8 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 166.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.2 mp -78.36 -42.05 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 172.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.15 122.17 1.63 Allowed Pre-proline 0 C--N 1.348 0.509 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 163.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -84.34 -13.87 7.22 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.468 2.112 . . . . 0.0 112.758 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.8 m -89.63 101.6 14.29 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -164.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -47.05 -36.94 8.64 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 117.978 2.584 . . . . 0.0 117.978 -163.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -66.51 -47.03 74.24 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 121.991 2.178 . . . . 0.0 110.647 169.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -56.44 -50.89 70.36 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 119.366 0.985 . . . . 0.0 108.383 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -49.85 -54.95 16.23 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.933 1.293 . . . . 0.0 110.992 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -52.35 -48.7 65.38 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.919 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.07 -25.12 37.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.246 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -67.03 -16.52 64.4 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 126.709 2.004 . . . . 0.0 110.874 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.553 ' HA ' HG21 ' A' ' 59' ' ' ILE . 1.4 mt -109.14 -16.44 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 C-N-CA 126.098 1.759 . . . . 0.0 115.436 170.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -91.54 -8.09 48.47 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 120.801 1.637 . . . . 0.0 111.894 170.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' O ' HG22 ' A' ' 59' ' ' ILE . 3.4 m-80 -85.27 136.86 33.32 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 118.379 0.536 . . . . 0.0 109.962 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.19 10.04 0.44 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.459 -1.189 . . . . 0.0 114.47 168.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.9 -10.1 59.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.374 1.587 . . . . 0.0 112.369 171.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.419 0.0 OUTLIER -101.02 86.86 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 125.815 2.722 . . . . 0.0 106.981 178.669 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -79.09 95.19 5.49 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 110.678 -2.965 . . . . 0.0 106.701 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.674 HG21 HD13 ' A' ' 72' ' ' ILE . 22.3 t -79.12 142.6 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.627 ' ND2' HH11 ' A' ' 78' ' ' ARG . 3.5 p-10 54.86 15.21 1.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.24 10.86 47.19 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 128.716 3.055 . . . . 0.0 113.225 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.84 131.52 14.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.466 1.633 . . . . 0.0 111.4 -163.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.21 109.1 0.39 Allowed 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 128.517 2.727 . . . . 0.0 109.805 -172.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.514 ' HB3' HD11 ' A' ' 72' ' ' ILE . 76.6 mt -139.18 71.01 1.37 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.337 0.971 . . . . 0.0 109.057 178.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.418 ' CD ' ' H ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -81.39 50.59 1.48 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.755 2.422 . . . . 0.0 112.442 -175.208 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -152.3 146.82 25.69 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.6 t -66.37 -30.47 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 127.47 2.308 . . . . 0.0 111.352 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.46 -2.36 90.6 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.557 1.075 . . . . 0.0 112.449 170.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.39 -60.63 1.84 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 117.398 -1.287 . . . . 0.0 109.322 164.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.674 HD13 HG21 ' A' ' 61' ' ' VAL . 1.4 mp -135.24 138.12 49.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-N 120.587 1.54 . . . . 0.0 113.12 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 33' ' ' PRO . 90.1 mt -110.36 -96.62 0.41 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 163.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -94.9 -169.27 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.763 1.268 . . . . 0.0 113.631 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.34 78.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.94 1.296 . . . . 0.0 113.459 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -70.78 -14.61 62.49 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.017 0.826 . . . . 0.0 112.069 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CG ' ' H ' ' A' ' 73' ' ' LEU . 52.3 t-80 -84.07 -2.11 56.1 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 171.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.627 HH11 ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -115.76 -86.72 0.61 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 166.547 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.652 HD11 ' H ' ' A' ' 83' ' ' PHE . 0.5 OUTLIER -91.27 -166.56 1.6 Allowed 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 126.658 1.983 . . . . 0.0 110.284 -170.485 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -51.6 1.52 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 130.01 3.324 . . . . 0.0 116.18 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.81 55.79 2.34 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 124.932 1.253 . . . . 0.0 110.54 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -135.26 -65.31 0.62 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 118.671 -0.681 . . . . 0.0 110.434 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.652 ' H ' HD11 ' A' ' 79' ' ' LEU . 96.6 m-85 -122.77 179.18 4.72 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 118.609 0.64 . . . . 0.0 109.439 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.93 136.24 26.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 163.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 61' ' ' VAL 0.251 33.0 t -108.74 131.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 116.26 -1.829 . . . . 0.0 106.969 -163.464 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 59' ' ' ILE . 49.7 mm -133.27 106.29 9.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 120.93 1.695 . . . . 0.0 110.869 -169.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -97.43 99.21 10.63 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 164.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.6 ttp85 -86.78 112.78 22.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 120.785 1.629 . . . . 0.0 108.562 164.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.87 166.71 1.89 Allowed Glycine 0 CA--C 1.533 1.175 0 CA-C-O 121.864 0.702 . . . . 0.0 112.471 172.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.6 mptt 63.59 -56.79 0.2 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.563 1.945 . . . . 0.0 112.282 -165.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -94.41 0.07 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 121.268 1.849 . . . . 0.0 110.183 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.88 -179.29 7.44 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 124.422 2.058 . . . . 0.0 108.709 -172.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 90.0 t80 -79.43 157.78 27.47 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 111.569 -2.56 . . . . 0.0 106.667 163.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -145.57 160.31 41.83 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 128.521 2.728 . . . . 0.0 109.013 164.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.449 HD13 ' CD2' ' A' ' 19' ' ' PHE . 43.6 tp -117.86 137.49 52.75 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.468 1.507 . . . . 0.0 108.22 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.6 mm -121.44 136.51 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.478 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 8.8 ttt180 -138.43 -177.7 4.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 124.333 2.016 . . . . 0.0 109.168 164.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.478 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -120.78 161.59 21.21 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.006 -1.906 . . . . 0.0 108.873 163.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 0 C-N-CA 126.723 2.009 . . . . 0.0 111.873 -172.814 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.767 0 CA-C-O 121.667 0.746 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.36 -149.44 0.3 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -178.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.74 100.9 3.85 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 163.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.4 m 55.08 -177.19 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.375 1.07 . . . . 0.0 112.153 -164.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.14 -89.02 0.89 Allowed Glycine 0 CA--C 1.526 0.768 0 O-C-N 120.492 -1.38 . . . . 0.0 110.3 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -79.24 171.72 14.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 122.16 0.981 . . . . 0.0 108.745 173.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.507 ' CD1' HD22 ' A' ' 79' ' ' LEU . 2.0 pp -53.88 93.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 128.04 2.536 . . . . 0.0 109.076 163.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.4 -17.83 25.2 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.063 -1.648 . . . . 0.0 115.15 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.05 -41.1 36.6 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 128.925 2.89 . . . . 0.0 108.546 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.645 ' HB3' HD11 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -81.57 101.04 9.72 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.41 162.43 13.49 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.488 -1.687 . . . . 0.0 107.401 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.95 -44.66 54.19 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.14 0.976 . . . . 0.0 109.097 -171.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.14 77.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.399 0.437 . . . . 0.0 109.901 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -71.78 -41.83 67.87 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.645 HD11 ' HB3' ' A' ' 10' ' ' LEU . 49.4 mt -67.38 -51.96 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.65 0.78 . . . . 0.0 110.265 177.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.05 -45.11 87.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 119.673 1.124 . . . . 0.0 111.313 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.24 -35.32 66.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.23 97.5 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 126.743 2.116 . . . . 0.0 109.952 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.524 ' CZ ' HG13 ' A' ' 85' ' ' VAL . 11.8 m-85 -101.76 6.19 41.6 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.798 0.439 . . . . 0.0 111.29 -170.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -64.75 -2.99 2.83 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -79.14 -15.46 58.09 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 111.975 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.611 HG22 ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -132.82 168.92 15.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 175.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.611 ' HD2' HG22 ' A' ' 22' ' ' VAL . 33.9 Cg_endo -81.77 162.58 18.74 Favored 'Trans proline' 0 N--CA 1.437 -1.819 0 C-N-CA 121.512 1.475 . . . . 0.0 108.507 173.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 m -111.68 162.6 15.03 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -116.81 156.43 27.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.219 -0.926 . . . . 0.0 108.575 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 3.2 p -134.33 127.24 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -108.15 135.6 49.22 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.405 1.098 . . . . 0.0 108.687 163.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.91 61.9 3.97 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 170.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.37 171.02 32.87 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.811 1.196 . . . . 0.0 111.366 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.74 -150.72 26.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.349 1.452 . . . . 0.0 109.843 170.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HA ' ' CG2' ' A' ' 74' ' ' THR 0.278 0.0 OUTLIER -55.37 135.62 50.03 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.926 1.29 . . . . 0.0 113.53 -163.899 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -158.6 142.83 11.39 Favored Pre-proline 0 CA--C 1.518 -0.269 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -163.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HA ' HD23 ' A' ' 73' ' ' LEU . 33.1 Cg_endo -69.32 147.86 66.61 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.106 1.87 . . . . 0.0 111.957 -171.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.261 0.1 OUTLIER -39.37 -45.8 1.52 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.815 1.646 . . . . 0.0 113.421 170.256 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.555 ' HA ' HD22 ' A' ' 38' ' ' LEU . 8.4 p -79.02 -11.81 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.54 1.536 . . . . 0.0 113.218 -175.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -91.06 -43.86 9.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.822 0.737 . . . . 0.0 109.278 165.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.05 -30.23 67.44 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.668 -168.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.673 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -74.66 -36.58 62.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 120.129 1.331 . . . . 0.0 110.476 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.551 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -72.23 -43.28 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 C-N-CA 125.186 1.394 . . . . 0.0 107.566 -172.564 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.4 -40.08 81.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 126.415 1.886 . . . . 0.0 108.248 175.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.6 -20.56 50.2 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.799 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.55 17.17 11.58 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 119.085 0.857 . . . . 0.0 113.863 171.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -43.69 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 -171.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m -160.58 110.77 1.34 Allowed Pre-proline 0 N--CA 1.464 0.243 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.24 -20.96 6.84 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.467 2.111 . . . . 0.0 112.516 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -86.97 115.94 24.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -167.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -48.16 -36.77 14.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.972 1.309 . . . . 0.0 113.337 -172.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -67.04 -52.51 41.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.756 1.162 . . . . 0.0 111.152 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -56.26 -53.95 51.13 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.673 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -47.33 -54.61 10.63 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.409 1.884 . . . . 0.0 110.838 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.7 ttm-85 -50.23 -49.31 53.31 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 123.634 0.773 . . . . 0.0 110.771 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -80.99 -31.89 34.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.537 0.608 . . . . 0.0 112.482 -173.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.81 -21.96 63.67 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.514 1.525 . . . . 0.0 109.245 170.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.642 ' CD1' HD13 ' A' ' 38' ' ' LEU . 1.1 mp -91.44 -43.22 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 116.254 -1.831 . . . . 0.0 112.766 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -73.98 -10.74 59.94 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 120.222 1.374 . . . . 0.0 111.226 -173.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 58' ' ' ALA . 75.4 m-20 -84.95 144.33 28.4 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.52 25.44 0.48 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.772 1.177 . . . . 0.0 113.486 166.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.545 ' HB1' ' NH2' ' A' ' 88' ' ' ARG . . . -117.93 4.35 12.15 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 128.628 2.771 . . . . 0.0 109.471 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.461 HD11 HD12 ' A' ' 86' ' ' ILE 0.327 0.0 OUTLIER -111.59 98.1 6.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 124.743 2.211 . . . . 0.0 107.573 163.624 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -81.07 100.39 8.98 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 112.687 -2.051 . . . . 0.0 107.776 171.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.478 HG21 HD13 ' A' ' 72' ' ' ILE . 57.2 t -78.91 128.25 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 61.43 0.93 0.49 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.932 1.293 . . . . 0.0 113.727 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.7 7.89 27.06 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 117.673 -1.626 . . . . 0.0 112.751 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.56 123.18 35.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.904 1.852 . . . . 0.0 108.555 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -50.37 102.29 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.927 2.091 . . . . 0.0 110.68 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.547 ' CB ' HD11 ' A' ' 72' ' ' ILE . 80.3 mt -141.81 110.1 5.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -175.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.33 44.61 2.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.541 2.736 . . . . 0.0 113.616 -163.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -143.32 154.62 43.96 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.003 -1.061 . . . . 0.0 111.785 167.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -64.09 134.72 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 122.975 1.369 . . . . 0.0 107.546 167.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.71 -6.57 46.25 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.006 -173.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.37 -46.59 32.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 163.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.547 HD11 ' CB ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -134.04 146.23 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 124.646 1.179 . . . . 0.0 108.235 165.568 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 33' ' ' PRO . 82.6 mt -124.17 -94.9 0.48 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 163.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.463 ' CG2' ' HA ' ' A' ' 31' ' ' ASP . 1.3 p -100.97 -173.89 2.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.774 1.624 . . . . 0.0 115.072 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . . . -50.4 -56.53 11.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.384 1.473 . . . . 0.0 114.075 171.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -67.23 -9.44 40.43 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.547 1.067 . . . . 0.0 113.166 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -89.64 -14.01 35.8 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.536 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.427 ' HA ' HH11 ' A' ' 78' ' ' ARG . 0.0 OUTLIER -103.29 -66.6 0.93 Allowed 'General case' 0 C--N 1.338 0.095 0 O-C-N 119.85 -1.782 . . . . 0.0 108.027 174.421 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.507 HD22 ' CD1' ' A' ' 7' ' ' ILE . 0.9 OUTLIER -88.04 -168.97 2.39 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 128.335 2.654 . . . . 0.0 110.907 -171.313 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -64.44 -5.66 5.76 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.146 1.379 . . . . 0.0 114.022 165.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.19 75.81 1.1 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.983 1.754 . . . . 0.0 113.612 -170.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.52 -81.74 0.28 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.839 0.856 . . . . 0.0 109.417 163.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.496 ' H ' HD12 ' A' ' 79' ' ' LEU . 5.7 m-85 -128.36 -162.63 1.2 Allowed 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 125.455 1.502 . . . . 0.0 110.076 -170.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.39 121.15 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 119.205 -2.184 . . . . 0.0 107.151 168.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.524 HG13 ' CZ ' ' A' ' 19' ' ' PHE . 2.3 t -79.02 143.99 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.461 HD12 HD11 ' A' ' 59' ' ' ILE . 26.1 mm -126.26 136.59 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 127.781 2.433 . . . . 0.0 106.293 172.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -127.43 84.4 2.25 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 164.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.6 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -84.37 91.93 7.91 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.844 2.057 . . . . 0.0 106.249 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -28.59 -63.82 0.11 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.367 2.413 . . . . 0.0 115.447 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.6 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 35.1 tttp -44.14 -37.85 3.35 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.707 2.403 . . . . 0.0 113.727 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -111.6 -117.63 0.3 Allowed 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 -170.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.13 -151.35 0.38 Allowed 'General case' 0 C--O 1.246 0.887 0 CA-C-O 122.662 1.22 . . . . 0.0 110.941 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.454 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 3.3 m-30 -110.83 104.14 12.73 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.951 2.5 . . . . 0.0 106.59 -165.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -113.05 165.86 11.96 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.593 1.157 . . . . 0.0 110.199 -173.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.1 tp -130.14 132.85 46.26 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.541 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.37 135.0 65.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 9.9 ptm180 -132.22 175.3 9.38 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.365 1.866 . . . . 0.0 109.633 170.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -118.78 168.35 10.83 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.898 0.879 . . . . 0.0 110.26 166.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.775 0 C-N-CA 125.259 1.423 . . . . 0.0 109.818 166.584 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.444 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tp -59.43 -52.71 64.42 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -139.08 135.52 34.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.183 2.193 . . . . 0.0 107.462 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 8' ' ' ALA . 7.3 p -151.42 175.67 12.03 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.152 1.381 . . . . 0.0 108.17 163.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.52 -29.42 61.75 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 163.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -78.64 172.88 13.07 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.884 1.274 . . . . 0.0 109.233 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.736 HD11 HD22 ' A' ' 79' ' ' LEU . 3.0 pt -54.46 87.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 127.096 2.158 . . . . 0.0 111.269 164.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB2' ' OG ' ' A' ' 4' ' ' SER . . . -76.83 -29.26 55.85 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 123.101 0.56 . . . . 0.0 112.191 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -78.47 -19.0 54.03 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.724 -175.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' A' ' 7' ' ' ILE . 2.6 mm? -96.23 72.04 2.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.73 176.14 9.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.29 69.23 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 120.513 -1.367 . . . . 0.0 112.898 -167.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.57 -21.59 41.56 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.163 171.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.93 -40.77 78.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' A' ' 10' ' ' LEU . 8.9 mt -68.89 -56.59 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 116.873 -1.536 . . . . 0.0 109.198 173.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -52.96 -55.09 26.05 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 120.026 1.284 . . . . 0.0 111.373 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -83.26 -13.22 55.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.06 -1.025 . . . . 0.0 110.202 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.8 -27.99 63.79 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 118.222 -1.321 . . . . 0.0 111.771 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -126.93 4.35 6.56 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -171.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -59.82 0.32 0.15 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.5 -6.4 53.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.607 1.094 . . . . 0.0 109.761 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -129.22 160.25 64.88 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.876 2.07 . . . . 0.0 106.509 170.39 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.475 ' HD2' HG12 ' A' ' 22' ' ' VAL . 86.0 Cg_endo -78.87 174.28 12.43 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.415 1.41 . . . . 0.0 110.429 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 p -110.33 174.21 5.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 112.396 -2.183 . . . . 0.0 109.096 175.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -140.19 158.39 44.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 164.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.68 128.33 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -110.61 156.09 21.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -81.27 51.08 1.54 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.248 1.019 . . . . 0.0 111.414 -172.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.93 -175.96 40.88 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 121.144 -0.972 . . . . 0.0 113.11 173.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.12 152.05 2.45 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 -163.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.01 162.09 22.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.17 164.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.0 t -154.18 127.7 4.34 Favored Pre-proline 0 CA--C 1.509 -0.631 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -167.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.451 ' HA ' HD23 ' A' ' 73' ' ' LEU . 87.7 Cg_endo -72.95 148.03 44.67 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 122.358 2.039 . . . . 0.0 110.302 -175.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.276 13.0 tp -39.29 -47.78 1.75 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.522 2.729 . . . . 0.0 112.042 173.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.0 -7.56 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.134 1.773 . . . . 0.0 114.849 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -103.32 -34.84 8.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.301 -1.333 . . . . 0.0 111.376 165.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.89 -30.12 44.75 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 120.675 1.58 . . . . 0.0 108.823 -170.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.673 HD22 HD11 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -85.2 -28.45 25.43 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 119.837 1.199 . . . . 0.0 108.656 -174.7 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.441 ' N ' HD23 ' A' ' 38' ' ' LEU . 1.1 t -66.78 -52.36 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 t -66.56 -39.66 88.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.77 -16.53 57.06 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.345 -177.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.38 21.93 12.32 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.179 0.899 . . . . 0.0 111.852 165.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.1 mp -78.55 -40.95 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 t -160.37 105.83 1.36 Allowed Pre-proline 0 C--N 1.346 0.437 0 CA-C-N 120.517 1.508 . . . . 0.0 108.101 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -83.32 -20.21 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.971 1.781 . . . . 0.0 113.799 -176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.7 t -85.61 103.41 14.41 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 51.5 mttm -56.63 -22.41 33.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -163.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -47.93 58.51 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 121.917 2.144 . . . . 0.0 110.006 169.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -56.73 -51.24 69.6 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -53.02 -50.88 63.36 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 125.144 1.378 . . . . 0.0 110.953 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -64.04 -32.7 74.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 116.712 -1.613 . . . . 0.0 111.314 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.56 -29.13 28.08 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.886 1.676 . . . . 0.0 112.891 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -65.88 -16.11 63.54 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.55 1.94 . . . . 0.0 112.036 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.673 HD11 HD22 ' A' ' 38' ' ' LEU . 71.1 mt -88.32 -61.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 C-N-CA 126.078 1.751 . . . . 0.0 108.0 163.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -16.26 61.69 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.488 1.04 . . . . 0.0 112.713 -164.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.2 m120 -85.14 138.69 32.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 119.023 0.829 . . . . 0.0 109.833 173.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.05 7.02 0.07 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.494 1.521 . . . . 0.0 114.851 171.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.45 -14.79 59.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.536 1.168 . . . . 0.0 110.434 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.522 HG22 ' O ' ' A' ' 56' ' ' ASN 0.39 0.0 OUTLIER -90.31 90.96 3.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 CA-C-O 125.972 2.796 . . . . 0.0 106.992 172.605 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -83.24 94.16 7.84 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 110.299 -3.137 . . . . 0.0 105.397 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.454 HG23 HD13 ' A' ' 86' ' ' ILE . 9.4 p -78.46 134.48 28.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.629 HD22 ' HG3' ' A' ' 78' ' ' ARG . 78.3 m-20 56.94 22.78 7.54 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.942 -1.099 . . . . 0.0 113.263 175.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.71 18.06 73.9 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.08 1.324 . . . . 0.0 113.617 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.38 119.93 21.35 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.674 2.39 . . . . 0.0 107.029 -164.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.27 108.88 0.99 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.02 -1.467 . . . . 0.0 108.048 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.1 mt -143.97 103.24 4.0 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-N 120.214 1.37 . . . . 0.0 107.742 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 25.73 8.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.576 1.151 . . . . 0.0 112.595 -172.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -131.29 137.06 48.66 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.034 -1.041 . . . . 0.0 112.509 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.38 -38.92 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 125.976 1.71 . . . . 0.0 110.402 166.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.53 -12.95 74.08 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.077 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.32 -36.84 13.62 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.198 0.999 . . . . 0.0 111.46 170.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.2 mt -142.0 121.9 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 120.068 1.304 . . . . 0.0 111.829 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 33' ' ' PRO . 61.4 mt -111.15 -94.27 0.44 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 101.365 -3.568 . . . . 0.0 101.365 163.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.72 -172.72 2.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.24 -49.88 74.65 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.328 1.051 . . . . 0.0 112.26 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -14.08 62.81 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.458 0.703 . . . . 0.0 111.691 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -81.91 -18.73 42.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 118.484 -0.77 . . . . 0.0 109.481 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.629 ' HG3' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -112.3 -60.5 1.86 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 119.932 1.242 . . . . 0.0 110.507 -171.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.736 HD22 HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -90.37 -177.02 4.98 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.521 1.528 . . . . 0.0 108.636 167.571 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -48.63 -36.71 16.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.795 164.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.26 93.63 0.53 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 124.737 1.16 . . . . 0.0 112.06 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -139.07 -64.44 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 164.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.628 ' O ' HD21 ' A' ' 79' ' ' LEU . 35.7 m-85 -134.9 -169.75 2.42 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.805 2.042 . . . . 0.0 107.354 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.43 124.1 6.62 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 163.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -79.3 145.65 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.454 HD13 HG23 ' A' ' 61' ' ' VAL . 20.3 mm -129.06 91.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -91.4 81.83 5.42 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -78.7 102.86 8.27 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 168.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -43.98 -49.3 7.77 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.566 1.555 . . . . 0.0 113.022 -173.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.458 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.77 -0.28 3.97 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -132.42 -100.61 0.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 164.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.6 -164.67 1.6 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 121.056 1.753 . . . . 0.0 109.127 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.48 82.49 5.36 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 130.937 3.695 . . . . 0.0 110.753 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -78.37 166.82 22.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.464 HD12 ' H ' ' A' ' 96' ' ' ILE . 40.1 tp -130.07 140.62 50.81 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.677 -169.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 95' ' ' LEU . 9.3 mm -134.99 127.64 48.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -170.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -136.62 172.46 12.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 122.519 1.152 . . . . 0.0 112.556 163.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.99 161.21 13.84 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.093 1.357 . . . . 0.0 110.78 165.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.851 0 C-N-CA 129.213 3.005 . . . . 0.0 106.374 165.461 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 tt -139.83 76.44 1.56 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.034 1.288 . . . . 0.0 107.831 159.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -140.81 162.56 35.14 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 128.047 2.539 . . . . 0.0 105.912 163.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.7 p -50.6 -34.43 25.92 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.141 1.776 . . . . 0.0 114.402 -166.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 46.29 -145.89 3.33 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.899 1.238 . . . . 0.0 114.349 164.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.537 ' HB3' HD13 ' A' ' 7' ' ' ILE . 1.6 m-20 -85.54 -95.22 0.08 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 166.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -91.01 66.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 125.489 1.516 . . . . 0.0 109.973 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.48 -6.39 19.34 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.42 -0.8 . . . . 0.0 112.704 164.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -78.26 -12.01 59.97 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.854 1.262 . . . . 0.0 109.553 168.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.842 ' HB3' HD11 ' A' ' 15' ' ' ILE . 2.4 mp -123.5 64.6 1.02 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.225 1.81 . . . . 0.0 107.406 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.93 171.5 15.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 168.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.86 -37.03 49.17 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.255 -0.903 . . . . 0.0 111.255 -165.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.76 88.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.806 0.812 . . . . 0.0 109.894 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.25 -43.19 61.56 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.358 1.063 . . . . 0.0 108.183 -167.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.842 HD11 ' HB3' ' A' ' 10' ' ' LEU . 42.0 mt -66.21 -50.5 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 117.617 -1.182 . . . . 0.0 108.909 174.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -58.09 -51.07 71.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.517 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -79.76 -22.98 42.54 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.304 0.502 . . . . 0.0 109.831 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.49 -41.27 99.31 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -127.75 13.47 6.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -164.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -53.81 -8.18 0.15 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.018 2.527 . . . . 0.0 113.312 165.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.43 -27.8 46.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 128.19 2.596 . . . . 0.0 112.452 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.624 HG22 ' HD2' ' A' ' 23' ' ' PRO . 1.3 p -131.05 173.05 6.33 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -173.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.624 ' HD2' HG22 ' A' ' 22' ' ' VAL . 66.7 Cg_endo -77.09 177.47 8.84 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.719 1.613 . . . . 0.0 110.066 -175.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 81.9 p -136.39 167.68 20.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.252 1.021 . . . . 0.0 108.659 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -134.93 155.34 50.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.48 129.91 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.209 1.404 . . . . 0.0 108.336 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.07 176.73 5.43 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 122.02 0.914 . . . . 0.0 112.809 167.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -79.01 32.15 0.21 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.456 2.302 . . . . 0.0 113.723 -163.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.18 -170.77 25.2 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.494 -1.379 . . . . 0.0 110.296 -165.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.85 138.14 2.59 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -174.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -68.84 147.78 51.23 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 117.957 0.878 . . . . 0.0 111.174 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.3 t -160.33 135.16 5.53 Favored Pre-proline 0 CA--C 1.519 -0.244 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -164.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.511 ' HA ' HD23 ' A' ' 73' ' ' LEU . 95.9 Cg_endo -76.63 149.99 30.88 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.565 2.177 . . . . 0.0 112.311 -166.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.789 HD22 HG13 ' A' ' 54' ' ' ILE 0.3 0.1 OUTLIER -46.81 -41.29 15.25 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.072 178.614 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 p -75.09 -10.73 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 128.685 2.794 . . . . 0.0 114.815 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -98.75 -43.79 6.65 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 166.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 pp -76.44 -19.91 57.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 116.79 -1.576 . . . . 0.0 109.682 -166.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.618 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -77.98 -33.27 51.5 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 120.836 1.653 . . . . 0.0 110.324 173.058 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.42 -50.64 44.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 126.003 1.721 . . . . 0.0 107.773 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -36.2 83.2 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 127.361 2.264 . . . . 0.0 110.51 174.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.65 -22.59 46.63 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.471 176.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.07 33.04 7.14 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 169.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -78.1 -52.72 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 176.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.2 m -145.54 99.95 4.43 Favored Pre-proline 0 C--N 1.344 0.364 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 -173.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.41 -17.82 12.72 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.382 2.054 . . . . 0.0 112.918 -168.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.3 t -90.94 109.28 20.5 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -52.38 -37.48 56.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 117.533 -1.223 . . . . 0.0 114.051 -168.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -46.52 80.27 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.397 1.908 . . . . 0.0 110.38 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -51.11 71.11 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -52.48 -47.2 66.67 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.992 1.717 . . . . 0.0 110.371 177.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -56.89 -47.87 79.49 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 117.434 -1.27 . . . . 0.0 111.358 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.68 -35.73 75.38 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.594 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.21 -12.68 21.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 124.267 1.027 . . . . 0.0 112.704 172.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.789 HG13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -107.07 -29.39 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.669 1.988 . . . . 0.0 114.408 173.601 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -89.56 -9.66 49.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.062 1.345 . . . . 0.0 110.144 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.459 ' O ' HG22 ' A' ' 59' ' ' ILE . 18.3 m-20 -100.06 146.54 26.65 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.262 1.03 . . . . 0.0 110.847 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.77 11.54 0.26 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.32 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.6 -9.06 58.64 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 125.49 1.516 . . . . 0.0 110.583 171.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.315 0.0 OUTLIER -99.49 89.95 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 125.042 2.353 . . . . 0.0 107.36 171.335 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -83.46 95.91 8.41 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 111.681 -2.508 . . . . 0.0 106.34 170.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.9 p -78.75 134.75 27.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 103.629 -2.73 . . . . 0.0 103.629 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 59.75 19.78 8.56 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 120.713 1.597 . . . . 0.0 111.84 170.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.9 6.21 76.27 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.683 1.611 . . . . 0.0 114.298 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -130.8 116.92 18.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.622 1.711 . . . . 0.0 107.889 -164.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.18 106.16 0.35 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.571 1.548 . . . . 0.0 109.08 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 51.3 mt -140.43 104.12 4.7 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.87 68.9 1.11 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.849 1.26 . . . . 0.0 112.563 -172.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -157.54 153.27 26.69 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 120.673 -1.267 . . . . 0.0 109.205 167.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.03 -32.03 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.373 0.669 . . . . 0.0 109.872 164.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.16 -24.43 70.43 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.017 0.341 . . . . 0.0 113.847 172.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.82 -45.25 8.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.812 1.245 . . . . 0.0 111.023 -172.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.534 HD12 HD23 ' A' ' 34' ' ' LEU . 2.2 mt -141.76 129.31 21.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 119.462 1.028 . . . . 0.0 109.369 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 33' ' ' PRO . 92.0 mt -110.15 -93.83 0.43 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 101.177 -3.638 . . . . 0.0 101.177 163.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.27 -171.41 2.07 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -173.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.55 86.66 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.58 1.152 . . . . 0.0 112.288 174.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -17.74 64.77 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.806 0.73 . . . . 0.0 111.837 175.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.444 ' CG ' ' H ' ' A' ' 73' ' ' LEU . 38.6 t-80 -89.31 2.04 54.91 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 123.581 0.752 . . . . 0.0 109.729 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.488 ' HB3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -119.97 -70.25 0.8 Allowed 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.791 1.178 . . . . 0.0 109.596 169.271 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.662 ' HA ' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -91.79 -170.86 2.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 129.195 2.998 . . . . 0.0 110.226 172.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -57.8 -7.17 0.65 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.391 2.277 . . . . 0.0 114.346 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.29 73.55 1.03 Allowed Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 124.286 0.946 . . . . 0.0 111.527 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.97 -66.02 0.53 Allowed 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -140.93 -175.4 4.29 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.564 1.946 . . . . 0.0 106.913 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.67 138.2 18.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 163.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.9 t -104.08 148.04 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.83 101.65 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 128.268 2.627 . . . . 0.0 105.531 -172.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -94.3 80.86 3.98 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.439 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -78.93 85.08 4.91 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 169.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -4.94 -88.82 0.0 OUTLIER Glycine 0 CA--C 1.525 0.659 1 C-N-CA 130.997 4.141 . . . . 0.0 116.033 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -65.49 -19.78 66.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.861 0.83 . . . . 0.0 112.138 -172.445 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -85.0 -111.63 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 166.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.38 -157.22 0.57 Allowed 'General case' 0 C--O 1.239 0.534 0 CA-C-N 120.276 1.398 . . . . 0.0 110.661 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -106.5 65.05 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 130.14 3.376 . . . . 0.0 111.087 -167.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -78.59 167.08 21.79 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 120.753 -1.217 . . . . 0.0 110.653 -170.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 96' ' ' ILE . 31.5 tp -132.09 133.52 44.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.273 1.029 . . . . 0.0 108.946 -166.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 95' ' ' LEU . 36.2 mm -135.61 124.81 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -166.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -138.53 174.07 10.92 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.754 1.264 . . . . 0.0 111.647 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.48 167.62 10.72 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.242 1.017 . . . . 0.0 109.798 164.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.525 0 C-N-CA 127.186 2.195 . . . . 0.0 110.295 178.523 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.6 tp -147.88 158.96 44.3 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 164.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -76.05 -74.37 0.23 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 165.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t 55.75 178.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.179 1.392 . . . . 0.0 113.175 -164.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.36 -49.31 0.07 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 125.899 1.714 . . . . 0.0 109.42 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.82 -52.23 8.63 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.701 HD13 HD13 ' A' ' 79' ' ' LEU . 4.7 pt -90.96 30.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 122.107 0.956 . . . . 0.0 111.275 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.21 -2.62 4.48 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 120.859 -1.151 . . . . 0.0 112.135 173.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -98.44 -20.36 17.16 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.103 2.161 . . . . 0.0 109.341 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -151.43 78.59 1.27 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 127.458 2.303 . . . . 0.0 108.434 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.2 p -78.17 179.89 6.6 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 122.782 1.277 . . . . 0.0 109.397 -166.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.2 -39.84 78.39 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 119.127 -2.233 . . . . 0.0 111.099 -175.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.02 82.44 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -67.58 -37.61 82.85 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.8 mt -73.23 -50.75 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.81 1.644 . . . . 0.0 108.548 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.66 -46.54 89.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.15 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -71.26 -27.65 63.59 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.142 -0.974 . . . . 0.0 109.433 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.74 -41.32 42.85 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 126.28 1.895 . . . . 0.0 109.807 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -116.39 13.12 15.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.197 0.599 . . . . 0.0 111.208 -164.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -45.81 -25.65 0.54 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.745 2.418 . . . . 0.0 112.99 163.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.05 -12.08 59.96 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.755 2.422 . . . . 0.0 111.42 -174.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.564 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -133.51 169.9 12.74 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 127.257 2.223 . . . . 0.0 106.193 -174.675 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.564 ' HD2' HG12 ' A' ' 22' ' ' VAL . 43.6 Cg_endo -76.42 176.66 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 CA-C-N 121.134 1.441 . . . . 0.0 109.503 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.5 p -129.64 165.8 21.06 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.254 164.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -133.47 158.76 42.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.763 1.225 . . . . 0.0 107.87 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.59 137.25 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -122.28 173.28 7.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 122.86 1.315 . . . . 0.0 110.956 163.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.46 37.14 0.33 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 127.833 2.453 . . . . 0.0 113.527 -163.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.7 -167.85 10.18 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -165.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.22 145.31 1.65 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -73.62 152.05 40.65 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.558 -0.966 . . . . 0.0 112.467 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.4 t -158.76 133.08 5.24 Favored Pre-proline 0 C--N 1.343 0.302 0 CA-C-O 117.693 -1.146 . . . . 0.0 109.394 -163.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -55.76 141.19 85.06 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.666 2.91 . . . . 0.0 112.058 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.364 0.4 OUTLIER -48.07 -36.38 12.99 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.779 165.166 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.431 ' HA ' HD11 ' A' ' 54' ' ' ILE 0.259 12.1 p -71.41 -15.44 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.464 1.506 . . . . 0.0 114.617 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -98.44 -44.04 6.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 118.785 0.72 . . . . 0.0 109.284 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -71.87 -25.94 62.15 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 116.887 -1.53 . . . . 0.0 109.133 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.593 HD22 HD11 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -84.32 -25.32 29.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 120.955 1.707 . . . . 0.0 110.469 -177.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.434 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -76.07 -45.88 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.63 -45.36 90.61 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.66 1.584 . . . . 0.0 107.994 175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.73 -18.61 53.99 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.139 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.92 33.87 7.13 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 119.071 0.851 . . . . 0.0 111.171 164.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.25 -49.31 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.42 107.44 2.76 Favored Pre-proline 0 C--N 1.345 0.399 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 172.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.55 -15.73 8.42 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.539 2.159 . . . . 0.0 113.04 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.8 t -82.65 119.05 23.8 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -56.04 -36.13 67.66 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 120.662 1.574 . . . . 0.0 114.459 -165.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.83 -56.17 24.39 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.288 1.404 . . . . 0.0 109.118 170.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -55.08 -49.06 72.62 Favored 'General case' 0 C--O 1.207 -1.179 0 O-C-N 124.218 0.949 . . . . 0.0 108.442 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -47.99 -58.72 4.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.336 1.454 . . . . 0.0 111.198 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -65.66 -26.57 67.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.672 -174.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -89.59 -29.11 19.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 120.094 1.315 . . . . 0.0 112.532 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.62 -20.08 65.39 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.771 1.629 . . . . 0.0 109.76 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.593 HD11 HD22 ' A' ' 38' ' ' LEU . 64.9 mt -82.99 -66.5 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-O 116.251 -1.833 . . . . 0.0 109.394 163.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -64.96 -5.85 7.13 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 119.864 1.211 . . . . 0.0 112.663 -164.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 58' ' ' ALA . 2.9 m120 -76.62 134.99 39.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.244 1.021 . . . . 0.0 113.166 164.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.27 34.3 0.66 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.145 1.831 . . . . 0.0 111.773 164.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -118.66 4.4 11.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.58 2.352 . . . . 0.0 111.161 167.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.478 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.328 0.0 OUTLIER -102.46 100.4 10.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 124.378 2.037 . . . . 0.0 106.585 163.635 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -88.94 98.98 12.05 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 112.928 -1.942 . . . . 0.0 107.631 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.654 HG21 HD13 ' A' ' 72' ' ' ILE . 40.3 t -79.36 135.16 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.447 HD21 ' CD2' ' A' ' 79' ' ' LEU . 1.6 m120 55.59 27.5 10.54 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.915 0.864 . . . . 0.0 109.87 -174.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.75 9.27 86.97 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 117.498 -1.723 . . . . 0.0 113.256 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 133.46 38.29 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.997 2.399 . . . . 0.0 109.411 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 109.75 0.65 Allowed 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 127.497 2.319 . . . . 0.0 109.403 -166.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 72' ' ' ILE . 55.6 mt -145.28 110.82 5.35 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -118.75 27.76 8.71 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.997 2.519 . . . . 0.0 112.793 -163.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -142.18 156.91 45.36 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.939 -1.101 . . . . 0.0 113.76 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 p -69.63 -39.44 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.139 2.176 . . . . 0.0 110.882 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.2 -12.77 72.66 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 170.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.31 -58.35 3.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 116.267 -1.825 . . . . 0.0 109.991 167.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.654 HD13 HG21 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -139.66 137.78 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 121.601 2.001 . . . . 0.0 114.049 -176.171 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.6 mt -108.05 -95.06 0.39 Allowed 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 163.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.9 -176.66 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 119.941 -1.724 . . . . 0.0 115.627 -164.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.44 -54.74 42.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.808 0.843 . . . . 0.0 111.04 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.63 -4.07 21.5 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.797 1.239 . . . . 0.0 113.329 175.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 63.7 t-80 -88.53 -23.89 23.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.322 166.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.491 HH21 HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -105.42 -65.12 1.07 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -171.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.701 HD13 HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -90.88 -176.68 4.74 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.523 1.129 . . . . 0.0 108.262 174.455 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -54.3 -21.57 9.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.128 0.971 . . . . 0.0 112.362 170.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.73 85.53 0.81 Allowed Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 125.647 1.594 . . . . 0.0 112.829 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.2 mtp85 -141.28 -67.03 0.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 163.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -128.27 -168.11 1.86 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.786 1.234 . . . . 0.0 109.795 -170.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.16 130.88 12.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 163.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.78 136.59 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.7 mm -127.53 94.96 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 124.283 1.033 . . . . 0.0 108.316 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -91.28 83.26 5.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -78.89 99.16 6.65 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 170.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.71 159.76 4.26 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.0 tttt 71.98 -48.29 0.68 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.194 2.198 . . . . 0.0 109.686 -164.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -88.58 -153.65 0.26 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 164.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.472 ' HB3' HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -120.53 -158.13 0.74 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 124.955 1.302 . . . . 0.0 110.912 -167.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -95.22 93.99 7.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.111 2.565 . . . . 0.0 107.886 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -78.55 164.92 24.28 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 120.478 -1.389 . . . . 0.0 107.779 168.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.3 tt -133.06 123.88 26.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 mm -116.49 132.55 65.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -136.5 179.92 6.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 122.322 1.058 . . . . 0.0 111.477 171.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.5 165.11 14.32 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 123.737 0.815 . . . . 0.0 111.328 165.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.369 0 C-N-CA 128.392 2.677 . . . . 0.0 110.075 -177.197 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -153.37 106.97 3.01 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 102.652 -3.092 . . . . 0.0 102.652 169.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -56.2 -39.36 72.32 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.494 1.517 . . . . 0.0 113.948 -163.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.0 m -153.19 112.39 3.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 120.37 1.441 . . . . 0.0 108.882 174.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.22 -141.7 8.46 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 108.131 -1.987 . . . . 0.0 108.131 -176.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -78.75 164.52 24.48 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -169.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.44 90.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.717 1.207 . . . . 0.0 111.701 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.88 -3.13 58.56 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.61 1.164 . . . . 0.0 111.825 168.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -78.12 -25.26 47.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.595 ' HB3' HD11 ' A' ' 15' ' ' ILE . 2.6 mm? -84.3 64.16 8.16 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 164.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.76 167.89 20.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.89 -49.27 47.71 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.226 -0.921 . . . . 0.0 111.901 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.77 74.44 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -39.37 65.26 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.595 HD11 ' HB3' ' A' ' 10' ' ' LEU . 12.6 mt -66.88 -51.53 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 124.755 1.222 . . . . 0.0 109.554 174.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -53.14 -59.11 4.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.829 0.74 . . . . 0.0 110.307 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -76.35 -19.37 58.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.698 -174.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.89 -40.47 74.42 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -119.27 6.11 11.2 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -164.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -58.82 15.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.808 2.043 . . . . 0.0 114.963 163.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.49 -25.08 45.61 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.71 -1.244 . . . . 0.0 109.802 164.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.435 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -127.94 160.22 62.5 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.395 1.878 . . . . 0.0 107.142 -176.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.435 ' HD2' HG12 ' A' ' 22' ' ' VAL . 96.3 Cg_endo -71.23 179.21 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.086 1.857 . . . . 0.0 110.569 172.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.1 p -121.45 -178.37 3.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.325 1.05 . . . . 0.0 110.561 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -140.8 154.37 46.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 164.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 4.2 p -135.23 124.97 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 C-N-CA 124.954 1.302 . . . . 0.0 108.455 175.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -112.22 170.99 7.78 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 122.556 1.17 . . . . 0.0 111.288 171.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -79.17 8.0 6.61 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 126.69 1.996 . . . . 0.0 113.865 -163.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.6 -179.52 49.07 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.698 1.618 . . . . 0.0 112.774 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.38 139.05 3.07 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -163.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -66.62 136.62 55.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.174 0.987 . . . . 0.0 111.333 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.7 t -144.93 136.54 12.79 Favored Pre-proline 0 C--O 1.225 -0.198 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -163.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HA ' HD23 ' A' ' 73' ' ' LEU . 88.8 Cg_exo -50.51 140.6 35.43 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 124.903 3.735 . . . . 0.0 114.816 -176.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.683 HD22 HG13 ' A' ' 54' ' ' ILE 0.254 0.0 OUTLIER -47.61 -45.02 27.18 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.821 0.819 . . . . 0.0 111.519 164.461 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.719 ' HA ' HD12 ' A' ' 38' ' ' LEU . 8.8 p -77.49 8.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 128.047 2.539 . . . . 0.0 113.548 -177.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -120.55 -45.47 2.41 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.58 1.152 . . . . 0.0 108.089 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.92 -24.89 64.34 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 120.015 -1.678 . . . . 0.0 108.959 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.719 HD12 ' HA ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -75.71 -33.83 60.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.552 1.524 . . . . 0.0 110.296 177.432 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.626 ' N ' HD13 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -72.97 -46.27 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 127.005 2.122 . . . . 0.0 108.536 -173.297 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 m -62.82 -45.65 91.64 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 128.34 2.656 . . . . 0.0 109.098 169.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.42 -11.91 59.98 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.409 1.004 . . . . 0.0 112.647 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.43 27.09 23.62 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 119.222 0.919 . . . . 0.0 112.096 167.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.99 -42.66 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.1 m -156.17 101.78 2.09 Favored Pre-proline 0 C--N 1.347 0.484 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 165.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.28 -14.69 13.09 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.379 2.053 . . . . 0.0 113.32 -171.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.8 t -81.87 108.62 15.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HE3' HG11 ' A' ' 39' ' ' VAL . 14.8 mptt -50.1 -35.28 24.86 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -164.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.29 -47.35 67.89 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 121.137 1.789 . . . . 0.0 110.444 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -50.0 72.49 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.608 ' HB1' HD11 ' A' ' 38' ' ' LEU . . . -50.91 -48.0 60.71 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.946 1.699 . . . . 0.0 111.48 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -61.68 -40.79 96.2 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 115.961 -1.971 . . . . 0.0 110.478 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -25.11 48.69 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 116.332 -2.147 . . . . 0.0 112.861 173.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.513 ' HA ' HH11 ' A' ' 88' ' ' ARG . 0.3 OUTLIER -66.65 -18.79 65.56 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 117.666 -1.159 . . . . 0.0 112.093 174.67 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.683 HG13 HD22 ' A' ' 34' ' ' LEU . 1.1 mp -92.38 -51.64 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 116.633 -1.651 . . . . 0.0 110.707 164.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -68.82 -13.48 62.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 120.821 1.646 . . . . 0.0 110.627 -164.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.652 ' O ' HG22 ' A' ' 59' ' ' ILE . 9.5 m120 -85.76 132.58 34.1 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 118.317 0.508 . . . . 0.0 111.143 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.68 17.29 0.25 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.208 0.909 . . . . 0.0 114.129 169.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.17 -1.39 54.24 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 119.039 1.419 . . . . 0.0 111.006 164.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 56' ' ' ASN 0.286 0.0 OUTLIER -88.8 89.25 3.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 163.093 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -78.69 103.24 8.5 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 166.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 66' ' ' LEU . 8.5 p -78.4 137.14 22.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 102.111 -3.292 . . . . 0.0 102.111 175.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.555 HD21 ' CD2' ' A' ' 79' ' ' LEU . 12.8 m-20 75.81 -54.43 0.62 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 127.192 2.197 . . . . 0.0 109.645 174.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' H ' ' H ' ' A' ' 64' ' ' GLU . . . 172.76 5.04 0.03 OUTLIER Glycine 0 CA--C 1.536 1.352 1 C-N-CA 131.969 4.604 . . . . 0.0 111.577 174.798 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' H ' ' H ' ' A' ' 63' ' ' GLY . 15.0 pm0 -122.33 128.3 50.86 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.682 1.993 . . . . 0.0 108.362 -169.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 106.8 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.319 1.848 . . . . 0.0 109.145 -177.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HB2' HG12 ' A' ' 61' ' ' VAL . 57.3 mt -144.23 110.51 5.49 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.63 16.51 11.16 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.507 2.323 . . . . 0.0 112.639 -169.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -118.98 141.08 48.99 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.468 1.507 . . . . 0.0 109.231 -172.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.482 HG22 HD21 ' A' ' 73' ' ' LEU . 9.8 p -57.47 -42.8 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.216 1.406 . . . . 0.0 110.39 177.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.9 -8.48 73.32 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.61 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.43 ' C ' HG13 ' A' ' 72' ' ' ILE . . . -85.17 -45.06 12.39 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.736 0.768 . . . . 0.0 109.466 170.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.621 HD12 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -140.99 127.76 21.01 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-N 120.298 1.408 . . . . 0.0 112.657 -178.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.482 HD21 HG22 ' A' ' 69' ' ' VAL . 97.7 mt -116.41 -92.64 0.51 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 102.241 -3.244 . . . . 0.0 102.241 163.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.66 -175.48 2.81 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.782 -1.199 . . . . 0.0 113.502 -175.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.45 -43.2 79.29 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -82.82 -6.0 59.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.81 1.186 . . . . 0.0 111.078 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -81.58 -11.39 59.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 121.768 -0.583 . . . . 0.0 109.61 165.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.409 ' HD3' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -117.2 -71.42 0.74 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.646 1.112 . . . . 0.0 109.505 -173.57 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.555 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.9 -168.4 2.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.884 2.473 . . . . 0.0 109.271 176.578 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -53.0 -9.88 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.396 1.878 . . . . 0.0 115.644 166.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.67 71.22 1.0 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.64 1.114 . . . . 0.0 113.021 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -141.35 -64.85 0.44 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.17 0.485 . . . . 0.0 110.614 173.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -133.82 -169.06 2.23 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.559 1.544 . . . . 0.0 107.953 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -158.08 155.79 29.87 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 164.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.72 150.61 23.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.9 mm -135.0 97.64 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -170.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -99.49 81.14 2.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.513 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -78.62 117.54 19.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 171.137 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.85 -49.68 12.6 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.038 1.304 . . . . 0.0 111.837 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -1.04 0.79 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.56 1.544 . . . . 0.0 115.001 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -146.92 -95.86 0.09 Allowed 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 121.448 1.931 . . . . 0.0 109.176 164.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -153.93 -163.1 1.56 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 120.53 1.514 . . . . 0.0 109.513 -171.275 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -107.41 75.64 1.03 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 127.949 2.499 . . . . 0.0 109.969 -170.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -78.45 165.05 24.23 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.965 -1.085 . . . . 0.0 109.568 -172.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.8 tp -115.63 134.67 54.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.111 1.365 . . . . 0.0 107.987 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.7 mm -128.62 133.5 66.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -174.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 8.1 ptt-85 -139.25 174.49 10.46 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.948 1.356 . . . . 0.0 111.432 167.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.57 162.52 17.87 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.328 1.051 . . . . 0.0 110.199 164.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.408 0 C-N-CA 129.453 3.101 . . . . 0.0 108.276 175.887 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 tt -156.64 96.04 1.6 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -108.94 158.52 17.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 166.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 p -124.62 173.13 8.71 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.626 0.771 . . . . 0.0 112.943 -163.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.69 -48.33 3.05 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 125.856 1.693 . . . . 0.0 109.573 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -78.96 -170.99 2.41 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.865 1.317 . . . . 0.0 109.917 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.427 HG21 ' HB3' ' A' ' 62' ' ' ASN . 1.3 pp -54.2 64.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 131.697 3.999 . . . . 0.0 112.144 166.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.55 -3.98 34.2 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.329 1.852 . . . . 0.0 111.675 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.58 -21.87 47.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.617 1.167 . . . . 0.0 109.679 167.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.742 ' HB3' HD11 ' A' ' 15' ' ' ILE . 2.7 mp -99.21 73.59 1.91 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 167.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.9 165.86 19.4 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 163.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.36 67.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 120.609 -1.307 . . . . 0.0 112.106 -169.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.63 76.27 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.132 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -74.4 -24.2 59.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.597 0.759 . . . . 0.0 110.251 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 10' ' ' LEU . 8.9 mt -77.96 -57.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 125.732 1.613 . . . . 0.0 107.629 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -52.82 -45.34 67.25 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.93 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -91.19 -19.06 23.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.573 0.749 . . . . 0.0 111.346 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.51 -37.79 69.01 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 170.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.561 ' CD2' HG21 ' A' ' 85' ' ' VAL . 58.5 m-85 -120.61 15.45 11.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 119.581 -0.847 . . . . 0.0 110.497 -164.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -0.33 0.1 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.509 1.924 . . . . 0.0 115.297 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.82 -20.92 48.55 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.934 -1.104 . . . . 0.0 111.219 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.415 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -127.2 160.08 61.68 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 178.112 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.415 ' HD2' HG12 ' A' ' 22' ' ' VAL . 39.6 Cg_endo -80.58 176.88 8.67 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 CA-C-N 120.626 1.259 . . . . 0.0 109.926 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.5 p -112.12 165.62 11.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.716 172.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -130.04 157.96 40.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.692 2.397 . . . . 0.0 106.956 169.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 4.1 p -135.21 136.12 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -127.42 -172.87 2.76 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 119.503 1.047 . . . . 0.0 112.533 163.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 6.78 8.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.577 1.551 . . . . 0.0 113.983 -163.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.54 -173.1 34.1 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.082 1.325 . . . . 0.0 111.26 -170.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.84 135.57 1.65 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.26 134.55 39.33 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.543 0.672 . . . . 0.0 112.692 -167.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 t -157.47 131.66 5.04 Favored Pre-proline 0 CA--C 1.515 -0.384 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -166.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.543 ' HA ' HD23 ' A' ' 73' ' ' LEU . 87.1 Cg_endo -74.64 150.9 40.73 Favored 'Trans proline' 0 N--CA 1.437 -1.84 0 C-N-CA 122.529 2.153 . . . . 0.0 111.403 -167.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.719 HD22 HG13 ' A' ' 54' ' ' ILE 0.299 0.0 OUTLIER -44.01 -42.09 5.83 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.568 174.149 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.66 ' HA ' HD22 ' A' ' 38' ' ' LEU . 1.4 p -79.76 -5.59 8.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 126.907 2.083 . . . . 0.0 115.342 -174.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -105.06 -35.61 7.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.22 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.83 -21.03 57.69 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 120.914 1.688 . . . . 0.0 109.298 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.705 HD13 ' CD1' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -77.72 -30.37 51.69 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 120.302 1.41 . . . . 0.0 110.27 173.437 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -74.35 -47.86 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -173.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -47.68 84.48 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.627 1.971 . . . . 0.0 109.482 171.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.417 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.82 -10.81 59.91 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.353 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.39 33.95 18.32 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 119.111 0.869 . . . . 0.0 111.068 166.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.484 ' CG2' HD12 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -78.56 -51.37 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 172.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -151.56 105.78 2.91 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 169.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -84.31 -12.67 7.84 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.811 2.341 . . . . 0.0 113.642 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -87.57 115.8 25.25 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -52.01 -34.85 44.71 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -165.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -62.95 -54.7 34.31 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.948 1.704 . . . . 0.0 109.039 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -48.31 78.86 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 117.172 -1.394 . . . . 0.0 108.482 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.545 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -48.31 -58.68 4.23 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 125.319 1.448 . . . . 0.0 111.104 175.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HG2' HG21 ' A' ' 35' ' ' VAL . 64.0 mtt180 -67.35 -27.74 67.37 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 117.332 -1.318 . . . . 0.0 110.616 -170.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.07 -34.23 26.23 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 120.302 1.41 . . . . 0.0 112.234 172.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.564 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.8 m-20 -64.65 -16.82 63.38 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.511 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.719 HG13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -92.26 -53.59 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 116.054 -1.927 . . . . 0.0 111.728 166.611 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -71.61 -5.11 31.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 120.941 1.7 . . . . 0.0 112.076 -171.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.543 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.1 m120 -80.62 136.48 36.23 Favored 'General case' 0 N--CA 1.437 -1.118 0 O-C-N 121.373 -0.829 . . . . 0.0 112.462 173.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.72 33.87 0.86 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 124.486 1.041 . . . . 0.0 112.141 167.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -121.39 0.39 10.01 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 126.901 2.08 . . . . 0.0 111.509 168.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 56' ' ' ASN 0.315 0.0 OUTLIER -91.99 98.73 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 163.533 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -88.72 105.22 17.55 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.333 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 72' ' ' ILE . 7.9 t -88.43 130.34 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.538 HD21 ' CD2' ' A' ' 79' ' ' LEU . 5.9 m-80 57.37 18.09 4.17 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.565 0.698 . . . . 0.0 111.577 -173.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.13 11.71 78.01 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 120.599 -1.313 . . . . 0.0 113.5 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -119.37 123.27 43.75 Favored 'General case' 0 C--O 1.228 -0.062 0 CA-C-N 119.735 1.768 . . . . 0.0 108.421 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 112.1 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.138 0.975 . . . . 0.0 108.854 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.441 ' CB ' HD11 ' A' ' 72' ' ' ILE . 64.8 mt -144.89 108.26 4.6 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -174.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 2.2 pm0 -131.09 31.49 4.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 126.718 2.007 . . . . 0.0 113.891 -163.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -142.38 157.27 44.97 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.6 -0.687 . . . . 0.0 111.182 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.5 p -62.72 137.47 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 163.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.33 -8.41 46.97 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.645 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.17 -53.68 7.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 163.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.506 ' CD1' HG21 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -139.58 145.0 27.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 119.244 0.929 . . . . 0.0 110.137 170.221 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 33' ' ' PRO . 92.5 mt -124.15 -91.32 0.55 Allowed 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 163.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.89 -175.56 3.0 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.729 -1.232 . . . . 0.0 113.548 -174.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.627 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . . . -58.57 -41.85 86.65 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.876 175.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -76.3 -7.47 55.0 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 123.727 0.642 . . . . 0.0 110.981 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -92.99 -4.8 51.99 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.927 1.291 . . . . 0.0 110.393 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -120.34 -65.17 1.18 Allowed 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.953 -1.717 . . . . 0.0 109.498 175.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.538 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.14 -172.68 3.57 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.475 1.51 . . . . 0.0 109.501 170.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -50.43 -17.87 0.55 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.712 2.005 . . . . 0.0 113.918 166.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.36 80.4 1.33 Allowed Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 125.435 1.493 . . . . 0.0 111.507 -174.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -143.62 -63.58 0.39 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 122.802 0.441 . . . . 0.0 111.548 163.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -131.46 -174.11 3.31 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.99 2.116 . . . . 0.0 108.172 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -160.73 164.12 31.84 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.839 1.656 . . . . 0.0 107.186 164.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 19' ' ' PHE . 72.1 t -134.22 143.97 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 O-C-N 120.59 -1.319 . . . . 0.0 107.516 176.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.488 HD13 HG22 ' A' ' 61' ' ' VAL . 25.4 mm -125.06 98.38 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 127.774 2.429 . . . . 0.0 107.221 -172.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -96.13 84.62 3.83 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.564 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -82.14 114.08 20.43 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.115 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.77 1.78 0.7 Allowed Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.459 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 34.0 tptt -69.4 -46.23 67.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.58 1.69 . . . . 0.0 109.395 166.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -125.43 -90.27 0.55 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.801 1.24 . . . . 0.0 108.844 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.433 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.31 -159.88 1.02 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-N 119.671 1.123 . . . . 0.0 109.197 -163.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.433 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -99.46 83.84 2.88 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 130.826 3.65 . . . . 0.0 109.578 -176.166 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -78.46 158.97 28.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.131 -1.804 . . . . 0.0 106.131 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.9 tt -126.37 129.9 49.7 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -163.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.5 mm -120.82 122.53 68.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -168.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 11.5 ptt85 -128.63 171.89 11.73 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 124.044 1.878 . . . . 0.0 110.294 176.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.627 ' CE1' ' HB2' ' A' ' 75' ' ' ALA . 6.0 m-85 -143.56 158.47 43.63 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -164.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.796 0 C-N-CA 128.487 2.715 . . . . 0.0 111.127 169.901 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.225 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.04 93.53 0.09 Allowed 'General case' 0 C--O 1.233 0.184 0 C-N-CA 126.14 1.776 . . . . 0.0 109.078 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.21 -162.72 0.93 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.063 1.345 . . . . 0.0 107.781 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.416 ' HB2' HG23 ' A' ' 11' ' ' THR . 8.1 m 60.65 71.57 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.231 1.812 . . . . 0.0 110.863 -176.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.08 -23.88 66.48 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.69 166.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.29 -79.86 0.12 Allowed 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.79 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -90.97 72.01 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 123.435 1.588 . . . . 0.0 109.787 -171.304 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.02 8.07 0.81 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 125.362 1.465 . . . . 0.0 112.335 165.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -99.29 -13.83 19.5 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.564 1.146 . . . . 0.0 109.029 164.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.67 80.22 0.72 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.465 0.706 . . . . 0.0 110.14 -172.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.416 HG23 ' HB2' ' A' ' 4' ' ' SER . 0.2 OUTLIER -78.03 174.76 10.76 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 126.861 2.064 . . . . 0.0 107.371 -178.173 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.44 -49.71 70.43 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 119.841 -1.787 . . . . 0.0 112.039 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.23 73.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.631 0.651 . . . . 0.0 111.033 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.31 -38.45 71.73 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 125.261 1.425 . . . . 0.0 109.158 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.413 ' CG2' HD13 ' A' ' 95' ' ' LEU . 27.4 mt -69.3 -45.96 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 126.518 1.927 . . . . 0.0 106.61 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -54.28 -57.91 9.41 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.463 175.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -71.85 -29.68 64.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.401 1.0 . . . . 0.0 109.94 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.54 -29.6 72.94 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 126.335 1.921 . . . . 0.0 110.414 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -117.11 -1.82 11.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.027 -173.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -59.02 -0.53 0.12 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.8 -13.35 59.86 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.844 1.202 . . . . 0.0 111.243 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 p -127.39 157.46 72.69 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 128.598 2.759 . . . . 0.0 105.785 167.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -87.08 176.66 4.29 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 121.313 1.342 . . . . 0.0 109.801 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.4 p -106.36 177.74 4.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.254 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -123.6 157.29 34.06 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 164.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 p -136.94 133.92 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 124.923 1.289 . . . . 0.0 108.347 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -123.72 -177.56 3.77 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.115 0.483 . . . . 0.0 111.743 163.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.78 39.43 0.95 Allowed 'General case' 0 C--N 1.318 -0.768 0 O-C-N 120.485 -1.384 . . . . 0.0 113.635 -163.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.67 -175.58 0.86 Allowed Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.903 -1.123 . . . . 0.0 112.788 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.18 131.83 0.23 Allowed Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.49 147.71 52.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -167.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 t -152.88 136.59 10.13 Favored Pre-proline 0 C--O 1.222 -0.382 0 C-N-CA 124.743 1.217 . . . . 0.0 108.345 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.46 ' HA ' HD23 ' A' ' 73' ' ' LEU . 61.3 Cg_endo -65.4 145.38 82.93 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.348 2.699 . . . . 0.0 111.394 -173.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.428 HD22 HG13 ' A' ' 54' ' ' ILE 0.375 0.1 OUTLIER -43.22 -39.19 2.85 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 170.354 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.488 ' HA ' HD22 ' A' ' 38' ' ' LEU . 3.6 p -77.24 -13.0 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.963 1.305 . . . . 0.0 113.992 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -100.1 -32.79 10.75 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 120.119 1.327 . . . . 0.0 109.444 167.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.48 -30.79 64.85 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 121.829 2.104 . . . . 0.0 108.237 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.691 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -75.9 -31.4 59.18 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 120.658 1.572 . . . . 0.0 110.076 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.489 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -72.27 -46.09 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 126.402 1.881 . . . . 0.0 107.265 -176.536 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.2 t -65.69 -41.86 91.9 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 128.145 2.578 . . . . 0.0 107.776 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -80.77 -18.14 48.62 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.74 29.86 9.54 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 118.531 0.605 . . . . 0.0 111.776 168.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.471 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.4 mp -78.81 -47.06 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 175.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.7 m -155.34 113.65 2.27 Favored Pre-proline 0 CA--C 1.517 -0.299 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.77 -17.17 7.29 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.41 2.074 . . . . 0.0 113.532 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.63 116.17 23.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -167.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -36.96 66.79 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -163.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -69.06 -42.71 75.91 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 120.15 1.341 . . . . 0.0 110.197 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -61.65 -51.99 66.18 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.691 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -50.52 -51.53 46.75 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.49 1.916 . . . . 0.0 110.0 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -53.56 -48.48 69.1 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.583 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -78.35 -32.11 48.91 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.69 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -62.78 -17.71 61.5 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.746 1.218 . . . . 0.0 111.001 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.669 ' CD1' HD13 ' A' ' 38' ' ' LEU . 1.2 mp -90.07 -55.92 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 117.193 -1.384 . . . . 0.0 112.599 169.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -73.18 -6.74 47.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.567 1.076 . . . . 0.0 111.416 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.2 m-80 -78.32 138.5 38.6 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.367 1.08 . . . . 0.0 112.041 169.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.31 46.07 2.43 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.055 164.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -126.26 11.01 7.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.979 2.912 . . . . 0.0 110.456 165.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 56' ' ' ASN 0.332 0.0 OUTLIER -111.25 91.9 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 162.907 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -82.85 122.1 27.8 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.02 -1.9 . . . . 0.0 107.618 174.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.62 HG21 HD13 ' A' ' 72' ' ' ILE . 25.1 t -115.28 135.83 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER 61.11 -16.88 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.795 2.038 . . . . 0.0 114.205 -174.524 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 61' ' ' VAL . . . 152.19 -7.24 0.54 Allowed Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 126.683 2.087 . . . . 0.0 113.328 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.99 153.68 41.04 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 119.876 1.838 . . . . 0.0 110.651 -163.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.16 105.45 2.93 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.168 1.787 . . . . 0.0 110.066 -164.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' CB ' HD11 ' A' ' 72' ' ' ILE . 71.5 mt -134.36 102.73 5.45 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -173.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.86 38.61 3.92 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 128.151 2.58 . . . . 0.0 111.656 -163.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -139.66 146.83 40.17 Favored 'General case' 0 N--CA 1.457 -0.099 0 O-C-N 121.725 -0.609 . . . . 0.0 111.135 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.08 -37.01 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.382 0.673 . . . . 0.0 110.615 173.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.14 -12.8 83.24 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.418 -0.801 . . . . 0.0 112.779 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.434 ' C ' HG13 ' A' ' 72' ' ' ILE . . . -76.5 -54.51 6.61 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.063 0.931 . . . . 0.0 109.177 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.62 HD13 HG21 ' A' ' 61' ' ' VAL . 5.1 mt -145.14 130.54 13.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 123.747 0.819 . . . . 0.0 109.367 -167.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 33' ' ' PRO . 92.7 mt -122.26 -70.5 0.77 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 168.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.13 178.67 4.54 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.288 -1.507 . . . . 0.0 112.205 -177.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.52 -34.22 72.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -81.93 -12.17 58.53 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.535 0.607 . . . . 0.0 111.645 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -86.42 -1.24 57.39 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.219 1.408 . . . . 0.0 110.056 168.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -116.53 -79.1 0.58 Allowed 'General case' 0 C--N 1.341 0.216 0 O-C-N 120.109 -1.62 . . . . 0.0 106.875 175.037 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.59 -171.7 3.73 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 128.848 2.859 . . . . 0.0 108.735 176.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -48.99 -11.7 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 129.183 2.993 . . . . 0.0 115.664 163.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.21 82.35 1.59 Allowed Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 125.281 1.42 . . . . 0.0 111.728 -168.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.94 -81.56 0.34 Allowed 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 164.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -127.94 -162.19 1.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.429 1.491 . . . . 0.0 108.866 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -157.35 139.0 14.01 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 120.291 -1.506 . . . . 0.0 108.041 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.84 113.52 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -170.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.8 mm -95.72 139.71 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -128.12 82.89 2.11 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 163.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.411 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 1.3 tpm_? -79.0 95.12 5.41 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 172.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.25 -48.57 5.57 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 -171.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.411 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 20.5 tptm -68.21 -21.6 64.85 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.354 1.462 . . . . 0.0 113.859 -176.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -103.95 -98.67 0.31 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.504 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.4 OUTLIER -159.3 -162.64 1.08 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 123.001 1.381 . . . . 0.0 108.806 171.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.504 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 6.0 m-30 -78.48 147.23 34.0 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 163.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -144.15 174.05 11.21 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 128.646 2.778 . . . . 0.0 108.389 171.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.413 HD13 ' CG2' ' A' ' 15' ' ' ILE . 22.0 tp -135.33 137.03 42.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.187 1.795 . . . . 0.0 107.639 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 mm -130.69 131.85 64.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -173.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.5 ptt85 -139.22 173.1 11.91 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 123.46 1.6 . . . . 0.0 110.539 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.01 169.9 8.74 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.851 164.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.315 0 C-N-CA 128.491 2.716 . . . . 0.0 109.903 176.43 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.536 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.03 -78.0 0.08 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 154.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -140.41 -166.2 2.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.35 1.46 . . . . 0.0 108.405 166.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.6 m -155.92 172.28 18.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.982 1.313 . . . . 0.0 109.174 172.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.17 -92.87 0.14 Allowed Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.71 -63.47 1.4 Allowed 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.577 1.179 . . . . 0.0 107.923 -176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.457 HD13 HD13 ' A' ' 79' ' ' LEU . 15.2 pt -91.62 49.57 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.0 1.32 . . . . 0.0 111.459 -173.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -17.27 63.13 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.551 -0.718 . . . . 0.0 112.655 -176.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.31 -17.04 26.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.162 1.785 . . . . 0.0 110.707 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.435 HD12 HG21 ' A' ' 85' ' ' VAL . 1.7 pt? -154.08 78.15 1.1 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.669 1.188 . . . . 0.0 109.848 -166.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.6 p -77.97 179.78 6.55 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 121.115 -0.991 . . . . 0.0 109.031 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.47 82.82 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 120.107 -1.62 . . . . 0.0 110.495 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.96 94.84 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 122.065 0.936 . . . . 0.0 109.693 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -75.32 -19.99 59.33 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.38 1.072 . . . . 0.0 110.268 -175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.0 mt -81.7 -55.47 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 127.569 2.348 . . . . 0.0 106.927 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -56.19 -44.14 79.12 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.17 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -31.17 50.23 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.67 0.668 . . . . 0.0 109.345 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.45 -35.5 81.85 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -119.18 17.54 13.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.461 1.105 . . . . 0.0 110.077 -168.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -56.62 5.37 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.906 2.883 . . . . 0.0 113.468 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.48 -27.66 46.3 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.728 2.411 . . . . 0.0 110.221 175.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.95 166.65 27.73 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 126.454 1.902 . . . . 0.0 107.406 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.02 173.43 13.63 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 167.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.4 p -106.46 177.77 4.76 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.767 167.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -123.47 152.98 41.13 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 163.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 7.7 p -139.68 134.01 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -119.92 -178.08 3.56 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.487 0.66 . . . . 0.0 111.637 164.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -82.34 5.68 19.45 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.553 1.941 . . . . 0.0 115.624 -163.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.98 -175.16 20.47 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.908 1.718 . . . . 0.0 110.176 -165.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.78 155.41 28.7 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.349 11.2 p-10 -91.75 143.81 26.15 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.628 1.171 . . . . 0.0 111.551 163.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.2 t -159.48 136.33 6.71 Favored Pre-proline 0 C--O 1.225 -0.188 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -163.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.425 ' HA ' HD23 ' A' ' 73' ' ' LEU . 72.3 Cg_endo -70.49 147.3 57.87 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.86 1.707 . . . . 0.0 112.068 -172.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.402 0.4 OUTLIER -49.59 -26.6 3.69 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.435 1.094 . . . . 0.0 113.899 177.426 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.592 ' HA ' HD11 ' A' ' 54' ' ' ILE . 14.6 p -63.18 -61.5 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.926 1.239 . . . . 0.0 111.249 168.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -66.16 -36.68 83.75 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.083 0.856 . . . . 0.0 109.528 -171.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 38' ' ' LEU . 1.3 pp -80.52 -24.4 39.39 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 116.598 -1.667 . . . . 0.0 110.034 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.416 HD22 ' NH1' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -75.31 -37.81 60.59 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 121.833 2.106 . . . . 0.0 109.82 176.172 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 t -73.82 -43.35 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.3 t -63.7 -32.52 74.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.941 0.896 . . . . 0.0 109.936 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.33 -17.09 57.02 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.602 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.27 27.68 39.22 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.471 HG21 ' HE ' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -78.58 -44.71 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 176.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -157.07 91.46 2.42 Favored Pre-proline 0 C--N 1.348 0.541 0 CA-C-N 120.571 1.532 . . . . 0.0 106.968 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.72 -15.45 21.48 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.476 2.118 . . . . 0.0 112.588 -164.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.59 105.03 17.06 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 -174.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 81.0 mttt -53.27 -22.59 7.24 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -166.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HD2' ' H ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -62.04 -60.36 3.73 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 120.314 1.415 . . . . 0.0 110.719 168.165 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.516 ' H ' ' HD2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -53.0 -49.14 66.82 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 125.983 1.713 . . . . 0.0 107.058 178.817 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -48.59 -58.43 4.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.391 1.057 . . . . 0.0 111.566 174.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.409 ' HA ' HD12 ' A' ' 54' ' ' ILE . 11.2 mtt-85 -65.81 -24.28 66.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 115.688 -2.101 . . . . 0.0 112.49 -175.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -77.87 -39.9 41.81 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 121.442 1.928 . . . . 0.0 111.746 167.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.62 -25.03 52.0 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.995 0.918 . . . . 0.0 111.23 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.592 HD11 ' HA ' ' A' ' 35' ' ' VAL . 70.3 mt -83.59 -57.47 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 116.007 -1.949 . . . . 0.0 109.117 171.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -77.69 -5.77 51.63 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 124.879 1.362 . . . . 0.0 113.009 -163.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.473 ' O ' HG22 ' A' ' 59' ' ' ILE . 7.9 m120 -81.01 141.34 34.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.591 163.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 10.03 0.07 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.492 1.52 . . . . 0.0 113.341 163.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -78.34 -11.07 59.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.286 1.834 . . . . 0.0 110.085 172.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 56' ' ' ASN 0.357 0.0 OUTLIER -102.74 92.77 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 124.855 2.264 . . . . 0.0 109.73 174.251 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -79.6 99.12 7.18 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 111.44 -2.618 . . . . 0.0 107.89 173.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.719 HG21 HD13 ' A' ' 72' ' ' ILE . 89.3 t -84.07 133.34 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.616 HD21 ' CD2' ' A' ' 79' ' ' LEU . 1.0 OUTLIER 60.92 14.76 5.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.699 0.4 . . . . 0.0 111.594 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.15 -1.84 57.72 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.083 1.325 . . . . 0.0 113.203 -174.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -131.73 123.63 28.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.791 1.795 . . . . 0.0 109.546 -164.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.46 111.25 0.35 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 127.836 2.454 . . . . 0.0 109.788 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HB3' HD11 ' A' ' 72' ' ' ILE . 18.9 mt -145.87 102.25 3.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -114.06 40.7 2.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.478 1.911 . . . . 0.0 110.95 -165.046 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -148.23 153.49 38.8 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.282 -0.886 . . . . 0.0 111.866 -168.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.87 -41.43 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 126.518 1.927 . . . . 0.0 109.376 169.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.41 -0.99 50.01 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.902 -0.388 . . . . 0.0 112.686 172.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.81 -61.82 1.55 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.905 -1.045 . . . . 0.0 111.672 163.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.719 HD13 HG21 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -137.46 132.47 45.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 120.13 1.332 . . . . 0.0 113.149 -176.036 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 33' ' ' PRO . 82.7 mt -99.6 -89.78 0.32 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 163.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 p -112.57 -168.8 1.37 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -173.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.26 -56.24 23.44 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.296 1.439 . . . . 0.0 114.577 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.26 -14.57 63.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.519 0.599 . . . . 0.0 111.781 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -80.8 -15.01 57.52 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 -82.09 0.54 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -178.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.616 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -89.91 174.47 7.66 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.568 1.547 . . . . 0.0 108.914 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -25.65 -51.12 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.285 3.034 . . . . 0.0 115.238 173.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.74 64.32 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.0 mmt-85 -140.82 -82.8 0.23 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.826 0.813 . . . . 0.0 109.727 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.444 ' H ' HD11 ' A' ' 79' ' ' LEU . 12.1 m-85 -130.29 -161.51 1.13 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.284 1.434 . . . . 0.0 110.361 -164.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.1 120.59 2.6 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.378 1.871 . . . . 0.0 108.899 167.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.435 HG21 HD12 ' A' ' 10' ' ' LEU . 63.3 t -78.95 134.04 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 173.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.4 mm -120.26 98.66 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 126.339 1.856 . . . . 0.0 106.274 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -92.84 82.25 4.69 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 171.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.471 ' HE ' HG21 ' A' ' 43' ' ' ILE . 15.8 tpp180 -84.04 96.24 8.82 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.274 2.63 . . . . 0.0 105.68 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.97 -24.16 33.66 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.395 0.521 . . . . 0.0 113.346 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -32.26 68.69 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.364 1.082 . . . . 0.0 112.638 171.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -135.96 -75.15 0.44 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.924 1.238 . . . . 0.0 112.037 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.54 -173.49 4.0 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 120.634 1.561 . . . . 0.0 109.465 -172.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -95.56 75.99 3.28 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.549 1.939 . . . . 0.0 110.393 174.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -78.57 171.62 14.85 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.947 -1.096 . . . . 0.0 110.567 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 83' ' ' PHE . 28.2 tp -128.18 137.72 52.18 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.309 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.5 mm -131.28 132.92 62.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -175.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 18.5 ptt180 -149.36 174.31 12.58 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 123.387 1.565 . . . . 0.0 112.449 177.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.16 169.62 8.66 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.785 163.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.557 0 C-N-CA 130.948 3.699 . . . . 0.0 106.768 172.359 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.5 mp -74.34 148.42 41.34 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 170.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -144.71 -47.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.443 1.897 . . . . 0.0 107.932 172.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.4 m -69.19 170.84 9.35 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.715 0.769 . . . . 0.0 109.239 163.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.04 57.19 4.81 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 124.839 1.209 . . . . 0.0 111.031 -170.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -78.7 -177.95 5.68 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 79' ' ' LEU . 2.0 pp -61.92 72.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 128.649 2.78 . . . . 0.0 113.065 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.47 62.16 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.453 1.501 . . . . 0.0 112.516 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -78.62 -19.6 52.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.093 0.957 . . . . 0.0 110.176 173.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.93 80.06 1.28 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.064 0.945 . . . . 0.0 109.502 -172.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.34 177.11 8.71 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.959 -1.088 . . . . 0.0 108.205 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.07 -53.0 52.43 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.634 1.174 . . . . 0.0 112.018 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.45 -26.85 66.6 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.1 0.25 . . . . 0.0 110.38 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.99 -43.67 70.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 mt -68.23 -53.47 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 118.2 -0.905 . . . . 0.0 108.82 177.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -59.36 -50.58 73.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 118.236 -1.385 . . . . 0.0 111.695 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -69.36 -30.81 68.9 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 120.143 1.338 . . . . 0.0 109.065 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.21 -42.72 99.29 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.258 40.6 m-85 -113.56 1.62 15.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -165.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -59.14 17.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.103 2.561 . . . . 0.0 114.258 163.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -78.09 -37.5 46.31 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.284 2.233 . . . . 0.0 107.591 164.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.829 HG22 ' HD2' ' A' ' 23' ' ' PRO . 4.3 p -125.91 165.14 28.93 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.895 1.678 . . . . 0.0 106.6 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.829 ' HD2' HG22 ' A' ' 22' ' ' VAL . 34.1 Cg_endo -80.68 177.84 7.63 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.45 2.1 . . . . 0.0 109.292 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 p -113.61 -177.93 3.25 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.837 -173.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -140.39 162.91 34.18 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.259 1.024 . . . . 0.0 108.541 167.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 9.3 p -143.34 138.43 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 125.294 1.438 . . . . 0.0 107.931 172.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 98' ' ' TYR . 0.0 OUTLIER -117.99 139.33 51.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.928 0.871 . . . . 0.0 109.558 163.622 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -81.35 73.11 8.4 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.89 153.97 24.11 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.209 -1.359 . . . . 0.0 113.182 -171.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.85 -157.15 15.65 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 163.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -60.97 140.32 57.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.582 0.353 . . . . 0.0 111.16 -174.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 t -155.06 137.1 9.76 Favored Pre-proline 0 C--O 1.223 -0.3 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -164.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -48.95 131.28 25.13 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.729 3.619 . . . . 0.0 112.559 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.33 0.7 OUTLIER -47.64 -36.27 10.67 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 168.119 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.777 ' HA ' HD22 ' A' ' 38' ' ' LEU . 7.3 p -83.23 -2.61 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.157 1.383 . . . . 0.0 113.605 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -98.85 -44.05 6.51 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 168.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.38 -20.73 56.88 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 116.499 -1.715 . . . . 0.0 109.944 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.777 HD22 ' HA ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -77.4 -26.97 52.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 121.656 2.026 . . . . 0.0 110.777 175.246 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.57 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -79.68 -42.35 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 126.48 1.912 . . . . 0.0 106.862 -172.744 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.66 -48.91 77.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.185 2.194 . . . . 0.0 109.002 167.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.57 -15.96 57.96 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.74 -171.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.36 36.34 7.06 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 164.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.42 HG13 ' CD1' ' A' ' 94' ' ' TYR . 1.3 mp -78.39 -56.37 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 102.423 -3.177 . . . . 0.0 102.423 171.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -150.75 103.91 3.04 Favored Pre-proline 0 C--N 1.342 0.259 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.66 -10.49 13.1 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.851 2.367 . . . . 0.0 113.7 -172.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.6 t -90.9 116.3 28.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -53.07 -36.1 60.29 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -54.18 48.97 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.16 1.345 . . . . 0.0 109.12 173.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -57.3 -52.41 65.45 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.639 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -45.79 -55.47 6.53 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.518 1.527 . . . . 0.0 111.127 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -58.18 -41.73 84.5 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.162 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.43 -37.95 68.47 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.633 1.106 . . . . 0.0 111.778 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.77 -15.27 27.84 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 126.274 1.829 . . . . 0.0 110.794 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.738 ' HA ' HG21 ' A' ' 59' ' ' ILE . 2.2 mt -117.03 -15.87 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 176.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -91.56 -5.94 53.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.675 1.58 . . . . 0.0 111.375 168.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.659 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -82.34 135.56 35.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 176.426 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.36 3.74 0.31 Allowed Glycine 0 CA--C 1.537 1.42 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.304 165.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.43 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -94.09 -0.71 55.2 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.683 1.593 . . . . 0.0 112.373 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.738 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.321 0.0 OUTLIER -102.87 96.92 5.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 124.913 2.292 . . . . 0.0 107.892 173.931 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -90.32 98.51 11.81 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 111.735 -2.484 . . . . 0.0 108.361 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.802 HG21 HD13 ' A' ' 72' ' ' ILE . 5.2 t -81.38 127.55 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.403 HD21 ' HG ' ' A' ' 79' ' ' LEU . 90.1 m-20 52.76 25.08 3.57 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.205 1.002 . . . . 0.0 112.062 -169.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.65 8.23 61.0 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.617 -1.657 . . . . 0.0 113.518 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -128.81 126.63 40.28 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.758 2.279 . . . . 0.0 109.288 -174.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.45 110.64 0.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.249 1.42 . . . . 0.0 108.781 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.616 ' HB3' HD11 ' A' ' 72' ' ' ILE . 80.7 mt -145.96 81.66 1.6 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -175.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.02 46.6 1.04 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.724 2.01 . . . . 0.0 112.088 -169.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -148.55 150.02 32.61 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.165 -1.584 . . . . 0.0 114.213 -174.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.4 p -63.29 -43.69 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 125.967 1.707 . . . . 0.0 111.852 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.38 -9.6 85.82 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 174.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.3 -56.32 4.43 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 116.215 -1.85 . . . . 0.0 108.263 167.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.802 HD13 HG21 ' A' ' 61' ' ' VAL . 1.3 mp -138.31 138.41 43.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 CA-C-N 121.409 1.913 . . . . 0.0 113.726 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.6 mt -110.47 -88.02 0.51 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 101.777 -3.416 . . . . 0.0 101.777 163.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -102.49 -174.31 2.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 119.888 1.222 . . . . 0.0 113.689 -174.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.13 87.59 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.63 -17.26 64.07 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.723 0.692 . . . . 0.0 111.87 175.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.44 ' ND1' ' HA ' ' A' ' 72' ' ' ILE . 55.4 t-80 -78.61 -9.56 59.41 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.491 -0.756 . . . . 0.0 109.358 174.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.7 -75.07 0.63 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.334 0.97 . . . . 0.0 109.8 174.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.679 HD11 ' H ' ' A' ' 82' ' ' ARG . 1.3 pp -91.67 -170.17 2.51 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.787 1.235 . . . . 0.0 109.95 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -55.89 -26.82 49.09 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.428 ' H ' ' CD1' ' A' ' 79' ' ' LEU . . . 127.51 69.81 0.16 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 127.374 2.416 . . . . 0.0 112.192 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.679 ' H ' HD11 ' A' ' 79' ' ' LEU . 90.3 mtt-85 -143.02 -45.63 0.3 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.577 ' H ' HD11 ' A' ' 79' ' ' LEU . 39.6 m-85 -157.94 -176.65 6.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.457 1.903 . . . . 0.0 109.348 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.49 124.4 9.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.259 -1.526 . . . . 0.0 107.014 163.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.23 147.59 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 166.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 27.5 mm -129.7 93.01 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 C-N-CA 125.504 1.522 . . . . 0.0 107.069 173.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -89.77 84.34 6.27 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.76 98.38 6.26 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 166.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -52.72 143.65 23.48 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 170.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.4 tptm 69.08 -0.31 2.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.226 2.61 . . . . 0.0 114.035 -169.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -117.47 -104.88 0.4 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 165.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.1 -171.91 4.04 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 119.831 1.196 . . . . 0.0 108.062 175.006 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.529 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 1.3 m-30 -114.1 82.88 1.78 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 126.743 2.017 . . . . 0.0 107.942 -173.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.42 ' CD1' HG13 ' A' ' 43' ' ' ILE . 77.2 m-85 -79.45 169.14 18.5 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.386 0.674 . . . . 0.0 109.866 -175.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.525 HD11 ' CD1' ' A' ' 83' ' ' PHE . 33.4 tp -130.74 135.73 48.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.244 1.018 . . . . 0.0 108.699 -175.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 mt -134.53 134.69 54.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.489 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 9.4 ttt180 -135.24 -175.6 3.98 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 123.715 1.722 . . . . 0.0 112.067 171.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.489 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -122.73 158.59 29.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.188 165.548 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.399 0 C-N-CA 128.693 2.797 . . . . 0.0 107.921 172.469 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.212 -0.909 0 CA-C-O 118.489 -0.767 . . . . 0.0 111.557 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.95 -54.49 21.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 122.389 2.359 . . . . 0.0 112.162 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.43 -23.75 62.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.766 0.793 . . . . 0.0 109.394 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.58 -32.92 23.53 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -173.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.476 ' CG2' HD13 ' A' ' 95' ' ' LEU . 26.8 mt -71.49 -48.51 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 171.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -52.73 -58.52 6.6 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.63 0.65 . . . . 0.0 111.176 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -74.6 -24.71 58.92 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.642 1.11 . . . . 0.0 110.239 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.72 -40.26 97.29 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.44 ' C ' ' H ' ' A' ' 21' ' ' ASP . 45.9 m-85 -126.42 12.69 7.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -163.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.06 9.08 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 129.776 3.23 . . . . 0.0 113.68 163.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 19' ' ' PHE . 23.7 t70 -78.41 -38.22 42.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.752 2.421 . . . . 0.0 108.48 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.34 168.34 10.75 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.375 1.47 . . . . 0.0 109.58 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.92 178.11 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.13 1.887 . . . . 0.0 110.327 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 p -129.48 171.97 12.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.08 1.752 . . . . 0.0 109.874 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -137.67 166.56 23.66 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.863 1.265 . . . . 0.0 108.646 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 p -139.62 133.94 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.15 179.07 4.06 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 119.114 0.87 . . . . 0.0 109.961 163.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -78.75 15.82 0.99 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.536 1.534 . . . . 0.0 113.989 -163.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.8 -176.92 38.87 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -163.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.4 149.45 5.99 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -163.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.82 153.49 41.9 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.894 -0.768 . . . . 0.0 111.051 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -161.28 131.3 3.43 Favored Pre-proline 0 CA--C 1.509 -0.604 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -165.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.551 ' HA ' HD23 ' A' ' 73' ' ' LEU . 90.0 Cg_endo -68.65 148.61 72.41 Favored 'Trans proline' 0 N--CA 1.436 -1.901 0 C-N-CA 121.69 1.593 . . . . 0.0 110.355 -174.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.779 HD22 HG13 ' A' ' 54' ' ' ILE 0.264 0.0 OUTLIER -44.85 -41.04 6.72 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.96 -1.473 . . . . 0.0 112.485 178.727 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.691 ' HA ' HD22 ' A' ' 38' ' ' LEU . 8.0 p -80.89 -7.75 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.92 2.088 . . . . 0.0 114.886 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.419 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 77.1 mm-40 -104.53 -30.95 9.69 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 117.648 -1.168 . . . . 0.0 108.508 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -80.84 -20.2 42.92 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 121.593 1.997 . . . . 0.0 110.094 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.713 HD13 ' CD1' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -77.36 -29.22 53.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 120.971 1.714 . . . . 0.0 109.866 173.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -75.63 -46.85 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.295 1.838 . . . . 0.0 107.033 -172.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.4 m -57.24 -52.55 64.88 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 129.939 3.295 . . . . 0.0 109.221 167.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.15 -10.27 59.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.028 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.51 29.69 15.81 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 122.842 1.246 . . . . 0.0 111.926 166.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.477 ' CG2' HD12 ' A' ' 38' ' ' LEU . 1.2 mp -77.92 -51.05 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 176.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -156.85 99.47 2.02 Favored Pre-proline 0 C--N 1.344 0.364 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.75 -15.97 10.51 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.911 2.407 . . . . 0.0 113.617 -172.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.5 t -76.61 115.26 16.2 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -52.36 -37.61 56.63 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.183 1.356 . . . . 0.0 114.419 -164.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -54.44 43.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.099 0.863 . . . . 0.0 109.595 172.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -58.94 -47.77 83.88 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.736 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.481 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -46.27 -55.08 7.73 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.378 1.471 . . . . 0.0 110.383 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.467 ' HG2' HG21 ' A' ' 35' ' ' VAL . 71.9 mtt-85 -65.0 -34.32 78.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 116.594 -1.67 . . . . 0.0 111.577 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.34 -36.36 58.28 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.777 1.626 . . . . 0.0 112.378 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -17.6 63.34 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.131 1.372 . . . . 0.0 110.543 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.779 HG13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -92.32 -52.73 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 116.482 -1.723 . . . . 0.0 111.895 166.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -69.92 -6.5 33.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 120.488 1.495 . . . . 0.0 111.577 -170.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.534 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.3 m120 -79.9 139.77 36.98 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.2 26.29 0.44 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.025 1.774 . . . . 0.0 113.526 164.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -115.59 5.06 14.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.691 2.396 . . . . 0.0 111.403 170.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.575 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.319 0.0 OUTLIER -106.63 94.13 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 124.52 2.105 . . . . 0.0 106.065 163.893 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 3.0 m-85 -79.99 106.73 12.23 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.026 168.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.554 HG21 HD13 ' A' ' 72' ' ' ILE . 10.7 t -83.81 124.61 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 173.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.648 HD22 ' HG3' ' A' ' 78' ' ' ARG . 63.4 m-20 53.5 27.39 6.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.96 -2.41 59.94 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.258 -1.301 . . . . 0.0 113.748 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -119.32 122.68 42.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.365 1.583 . . . . 0.0 107.151 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.46 109.0 0.49 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.63 ' HB3' HD11 ' A' ' 72' ' ' ILE . 83.1 mt -143.02 103.83 4.22 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 -171.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -127.91 45.3 2.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.867 2.067 . . . . 0.0 112.863 -163.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -154.42 154.12 32.7 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.975 0.91 . . . . 0.0 110.615 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 81.9 t -63.36 -38.19 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.785 1.234 . . . . 0.0 109.748 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.77 -2.21 60.49 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.83 -0.983 . . . . 0.0 113.061 171.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.33 -57.0 2.93 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.842 1.321 . . . . 0.0 111.391 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.63 HD11 ' HB3' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -141.28 148.17 21.56 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 121.164 1.802 . . . . 0.0 111.098 178.083 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' A' ' 33' ' ' PRO . 64.9 mt -112.38 -93.11 0.46 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 163.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 p -108.43 -170.24 1.64 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -169.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.12 73.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.755 1.222 . . . . 0.0 113.504 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.4 -17.95 64.94 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.107 0.963 . . . . 0.0 111.161 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 58.1 t-80 -86.48 -5.99 59.01 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.523 -0.736 . . . . 0.0 110.665 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.648 ' HG3' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -119.53 -64.99 1.21 Allowed 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.095 1.316 . . . . 0.0 110.512 178.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.59 178.38 7.41 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 164.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.75 -26.05 56.36 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.592 -0.693 . . . . 0.0 112.095 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.82 84.15 0.17 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 124.651 1.12 . . . . 0.0 113.299 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.12 -82.83 0.57 Allowed 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 167.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -119.55 -165.62 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.813 2.045 . . . . 0.0 108.171 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.18 138.64 12.7 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 163.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.7 t -83.99 139.27 17.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 166.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.9 mm -115.62 94.48 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' A' ' 60' ' ' TYR . 33.9 ttm-85 -91.46 75.13 5.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -78.98 92.59 4.97 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -51.19 -32.57 29.0 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.103 1.335 . . . . 0.0 113.425 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.422 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.26 -12.59 60.51 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.78 -1.424 . . . . 0.0 112.962 177.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -135.91 -97.55 0.23 Allowed 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 127.161 2.185 . . . . 0.0 105.864 -174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.445 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -159.17 -159.89 0.8 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 120.889 1.677 . . . . 0.0 109.415 174.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.445 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -110.23 75.9 0.96 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.058 2.143 . . . . 0.0 108.475 -167.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -78.23 164.56 24.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -171.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.476 HD13 ' CG2' ' A' ' 15' ' ' ILE . 18.0 tp -125.03 129.89 51.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.476 -164.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 95' ' ' LEU . 30.6 mm -125.02 129.27 73.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -171.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.473 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 13.1 ttp180 -131.47 -177.15 4.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 124.064 1.888 . . . . 0.0 110.92 164.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.473 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -123.67 165.63 16.89 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 126.273 1.829 . . . . 0.0 110.743 173.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 127.148 2.179 . . . . 0.0 111.465 178.05 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.02 -57.08 8.57 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 124.043 0.937 . . . . 0.0 111.225 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.85 -21.94 66.5 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.541 0.525 . . . . 0.0 110.706 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -82.74 -37.19 25.0 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.789 0.835 . . . . 0.0 109.624 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.4 mt -67.71 -45.07 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -55.47 -60.44 3.42 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.775 1.171 . . . . 0.0 110.541 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -75.89 -20.18 58.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.377 -0.827 . . . . 0.0 110.27 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.66 -38.44 90.03 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -126.58 11.75 7.37 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.629 0.772 . . . . 0.0 112.841 -164.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -56.18 7.19 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.73 2.412 . . . . 0.0 115.322 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -78.29 -34.78 48.6 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.243 1.417 . . . . 0.0 109.263 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.5 165.25 14.83 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 125.883 1.673 . . . . 0.0 108.251 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -68.98 177.72 4.78 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.801 1.667 . . . . 0.0 110.542 168.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 p -120.85 -177.59 3.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.999 1.72 . . . . 0.0 109.551 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -142.86 160.96 39.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.769 1.228 . . . . 0.0 109.362 164.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 9.9 p -143.88 136.35 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 C-N-CA 125.282 1.433 . . . . 0.0 108.271 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 98' ' ' TYR . 0.8 OUTLIER -118.8 179.05 4.26 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 119.123 0.874 . . . . 0.0 110.042 163.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -89.81 56.94 3.67 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 120.415 -1.428 . . . . 0.0 109.703 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.03 -158.94 19.75 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.723 0.678 . . . . 0.0 112.324 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.29 123.53 1.76 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.254 1.0 OUTLIER -59.91 130.47 46.89 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.203 1.501 . . . . 0.0 107.182 171.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -151.85 140.16 13.3 Favored Pre-proline 0 CA--C 1.507 -0.687 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -163.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.449 ' HA ' HD23 ' A' ' 73' ' ' LEU . 65.3 Cg_endo -77.7 152.78 29.46 Favored 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 121.495 1.463 . . . . 0.0 110.689 -167.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.356 0.4 OUTLIER -47.15 -33.17 4.9 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.416 173.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.704 ' HA ' HD11 ' A' ' 54' ' ' ILE . 11.5 p -72.83 -15.51 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 58.0 mm-40 -105.6 -42.04 5.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.1 -31.33 67.66 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 116.806 -1.569 . . . . 0.0 108.696 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -27.19 34.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 121.51 1.959 . . . . 0.0 109.562 -174.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -47.85 42.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 125.692 1.597 . . . . 0.0 107.976 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -34.79 78.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.313 0.645 . . . . 0.0 109.965 173.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.416 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.51 -14.32 59.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.237 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.46 27.88 21.22 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 164.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.1 mp -78.37 -45.93 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.7 108.14 2.17 Favored Pre-proline 0 C--N 1.343 0.316 0 CA-C-N 120.532 1.515 . . . . 0.0 106.945 167.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.45 -15.59 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.227 1.952 . . . . 0.0 112.183 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.0 m -88.19 105.85 17.8 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 -169.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 tptt -52.18 -32.58 36.8 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -163.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -54.65 42.32 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.341 1.428 . . . . 0.0 109.619 169.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -57.39 -48.13 79.89 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 117.801 -1.095 . . . . 0.0 108.603 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.4 -61.61 1.83 Allowed 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 125.189 1.556 . . . . 0.0 110.14 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.413 ' HA ' HD12 ' A' ' 54' ' ' ILE . 78.5 mtt-85 -62.84 -25.67 68.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 115.923 -1.989 . . . . 0.0 112.656 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.68 -40.7 28.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 121.745 2.066 . . . . 0.0 112.988 168.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.456 ' HA ' HH11 ' A' ' 88' ' ' ARG . 5.9 m-20 -62.96 -13.93 41.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.355 1.062 . . . . 0.0 111.41 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.704 HD11 ' HA ' ' A' ' 35' ' ' VAL . 66.1 mt -89.22 -64.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 C-N-CA 126.626 1.97 . . . . 0.0 109.04 163.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -61.89 -11.25 12.06 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.902 1.281 . . . . 0.0 112.21 -165.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 59' ' ' ILE . 5.1 m120 -82.45 131.37 35.22 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 118.824 0.738 . . . . 0.0 111.365 172.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.42 36.26 0.56 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 126.585 2.04 . . . . 0.0 111.716 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -117.18 -1.43 11.85 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 127.185 2.194 . . . . 0.0 111.027 165.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 56' ' ' ASN 0.339 0.0 OUTLIER -91.75 92.11 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 121.726 2.057 . . . . 0.0 106.501 163.562 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -80.66 100.8 8.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.924 -1.944 . . . . 0.0 108.101 171.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' A' ' 72' ' ' ILE . 15.8 t -80.2 128.88 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 175.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.434 HD22 ' HG3' ' A' ' 78' ' ' ARG 0.257 65.9 m-80 64.23 -6.63 0.26 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.65 4.6 26.45 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.137 1.351 . . . . 0.0 112.795 -169.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.87 119.33 32.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 108.56 0.78 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.344 1.458 . . . . 0.0 107.142 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.487 ' CB ' HD11 ' A' ' 72' ' ' ILE . 80.5 mt -141.4 88.17 2.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.89 25.05 3.34 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.996 1.318 . . . . 0.0 113.59 -173.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.66 154.77 46.53 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.54 -43.01 96.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 126.869 2.067 . . . . 0.0 110.803 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.6 -9.74 59.27 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.65 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.45 -47.49 7.41 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 117.562 -1.208 . . . . 0.0 112.24 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.524 ' CD1' HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -140.09 135.04 37.11 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 CA-C-N 121.423 1.92 . . . . 0.0 113.308 178.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 33' ' ' PRO . 80.5 mt -113.86 -97.3 0.44 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 163.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -97.87 -177.13 3.66 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.39 -1.444 . . . . 0.0 114.404 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.446 ' HB3' ' CE2' ' A' ' 98' ' ' TYR . . . -63.19 -37.78 88.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 120.967 -1.083 . . . . 0.0 113.119 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.55 -17.73 62.3 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.15 0.887 . . . . 0.0 111.11 174.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -81.22 -15.99 54.02 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.487 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.434 ' HG3' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -112.16 -59.58 1.98 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 120.223 1.374 . . . . 0.0 111.175 -173.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -171.51 3.01 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.163 1.385 . . . . 0.0 110.265 166.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -53.61 -6.21 0.07 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 129.307 3.043 . . . . 0.0 114.725 163.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.85 79.89 1.48 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.954 1.264 . . . . 0.0 111.489 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 -63.61 0.55 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.306 0.642 . . . . 0.0 110.112 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -156.1 -169.58 3.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.022 2.929 . . . . 0.0 106.915 -175.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -154.5 152.67 30.38 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 119.605 -1.934 . . . . 0.0 107.07 163.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.416 ' CG1' ' HA ' ' A' ' 62' ' ' ASN . 9.9 p -115.7 151.43 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 C-N-CA 124.048 0.939 . . . . 0.0 109.337 171.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.48 HD12 HD11 ' A' ' 59' ' ' ILE . 27.8 mm -132.85 96.66 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 127.249 2.22 . . . . 0.0 108.011 -171.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -96.3 86.88 4.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.456 HH11 ' HA ' ' A' ' 53' ' ' ASP . 1.2 tpm_? -82.05 110.62 17.45 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 174.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.62 -20.17 45.26 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-N 120.123 1.329 . . . . 0.0 115.252 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.411 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -72.01 -11.69 60.88 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.124 1.962 . . . . 0.0 111.228 171.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -148.59 -156.05 0.69 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.014 2.126 . . . . 0.0 107.453 -165.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -150.75 0.35 Allowed 'General case' 0 C--O 1.248 0.979 0 CA-C-O 122.883 1.325 . . . . 0.0 111.615 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.87 77.33 1.36 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.802 2.441 . . . . 0.0 109.018 -164.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -78.34 165.35 23.95 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.489 -0.757 . . . . 0.0 109.457 -170.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.538 ' C ' HD12 ' A' ' 96' ' ' ILE . 1.2 tt -128.54 128.16 43.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -164.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.538 HD12 ' C ' ' A' ' 95' ' ' LEU . 1.9 mp -127.08 135.64 63.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 124.369 1.068 . . . . 0.0 108.89 -169.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 9.4 ttt180 -139.29 -176.6 4.58 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 125.657 2.646 . . . . 0.0 114.335 167.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.497 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -115.86 161.04 19.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 112.451 -2.159 . . . . 0.0 107.866 163.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 C-N-CA 126.727 2.011 . . . . 0.0 107.462 -174.802 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -57.38 12.97 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.804 1.641 . . . . 0.0 110.919 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.41 -20.87 65.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.833 0.288 . . . . 0.0 111.516 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.76 -38.89 27.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.848 1.259 . . . . 0.0 110.355 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.474 ' CG2' HD13 ' A' ' 95' ' ' LEU . 18.6 mt -69.19 -51.01 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.71 1.204 . . . . 0.0 107.951 172.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.92 -57.61 8.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.154 0.888 . . . . 0.0 110.517 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.99 -23.41 58.26 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.231 -0.918 . . . . 0.0 110.472 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.61 95.76 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -119.35 9.54 11.67 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -165.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -55.55 -9.57 0.52 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.645 2.378 . . . . 0.0 116.451 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.68 -29.34 45.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.678 1.591 . . . . 0.0 111.198 175.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.526 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -105.06 163.08 17.87 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -179.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.526 ' HD2' HG12 ' A' ' 22' ' ' VAL . 94.5 Cg_endo -72.07 172.88 13.82 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 CA-C-O 122.855 1.106 . . . . 0.0 109.375 174.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.8 p -120.55 171.85 8.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 113.197 -1.819 . . . . 0.0 108.073 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -137.11 152.91 50.54 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.94 134.66 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -125.86 152.58 45.33 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 122.599 1.19 . . . . 0.0 111.045 163.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -81.5 53.7 2.16 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 126.31 1.844 . . . . 0.0 110.965 -169.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.56 174.81 50.13 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.395 1.95 . . . . 0.0 114.015 166.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.75 149.07 16.15 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -75.18 151.87 38.47 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.13 0.49 . . . . 0.0 111.56 164.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.7 t -160.94 135.09 5.14 Favored Pre-proline 0 CA--C 1.513 -0.474 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -163.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HA ' HD23 ' A' ' 73' ' ' LEU . 84.5 Cg_endo -73.15 147.33 42.49 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 121.641 1.561 . . . . 0.0 111.16 -174.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.336 0.3 OUTLIER -49.63 -30.05 8.25 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.675 175.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.717 ' HA ' HD11 ' A' ' 54' ' ' ILE . 7.4 p -74.04 -18.51 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -97.6 -46.69 5.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.075 -0.964 . . . . 0.0 108.424 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.6 -22.76 56.61 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 116.426 -1.749 . . . . 0.0 109.621 -168.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.98 -25.59 29.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 121.259 1.845 . . . . 0.0 109.9 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 44' ' ' SER . 1.5 t -77.7 -46.74 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -59.61 -40.63 88.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.663 1.985 . . . . 0.0 110.234 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.409 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.41 -17.73 56.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.481 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.51 34.67 6.88 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 163.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.1 mp -78.45 -53.14 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.416 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -156.13 95.63 2.35 Favored Pre-proline 0 C--N 1.349 0.549 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.11 -18.02 14.71 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.6 2.2 . . . . 0.0 113.128 -171.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.1 t -75.75 109.51 9.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -57.03 -27.84 61.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -163.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -49.39 66.69 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.726 1.603 . . . . 0.0 110.491 169.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -57.97 -50.46 73.3 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.26 -58.23 3.86 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 125.936 2.023 . . . . 0.0 109.703 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -58.7 -35.31 72.44 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 117.82 -1.086 . . . . 0.0 111.387 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -73.58 -45.83 50.87 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 118.103 -1.439 . . . . 0.0 112.089 170.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.514 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.9 m-20 -62.22 -12.81 22.3 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.513 1.125 . . . . 0.0 111.7 -174.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.717 HD11 ' HA ' ' A' ' 35' ' ' VAL . 56.7 mt -89.41 -66.88 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 127.763 2.425 . . . . 0.0 109.07 164.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -71.58 -1.88 15.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.939 1.245 . . . . 0.0 113.331 -164.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.532 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.2 m120 -80.05 130.79 35.53 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.233 -0.917 . . . . 0.0 110.377 164.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.78 6.6 0.34 Allowed Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.967 -0.458 . . . . 0.0 114.025 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.78 -8.27 59.68 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 116.701 -1.618 . . . . 0.0 111.746 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 56' ' ' ASN 0.359 0.0 OUTLIER -92.77 92.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 125.569 2.604 . . . . 0.0 108.099 164.975 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -79.45 99.42 7.2 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 111.447 -2.615 . . . . 0.0 108.208 170.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.622 HG21 HD13 ' A' ' 72' ' ' ILE . 22.1 t -82.17 127.8 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 84' ' ' THR . 5.9 m-80 61.37 7.48 1.76 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.46 7.96 56.54 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.867 1.223 . . . . 0.0 113.077 -171.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -121.73 117.93 27.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 106.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.726 1.61 . . . . 0.0 109.114 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' A' ' 72' ' ' ILE . 44.6 mt -142.33 89.73 2.18 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 1.0 OUTLIER -113.31 39.56 2.57 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.939 2.096 . . . . 0.0 112.755 -164.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -151.47 161.71 42.23 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.471 -1.393 . . . . 0.0 112.17 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.52 -26.37 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.149 1.38 . . . . 0.0 110.252 164.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.43 -14.28 74.5 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-O 119.417 -0.657 . . . . 0.0 113.344 167.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.53 -58.84 2.3 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.779 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -138.91 144.48 29.54 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 CA-C-N 121.143 1.792 . . . . 0.0 113.221 -177.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 33' ' ' PRO . 74.2 mt -109.61 -93.14 0.43 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 101.355 -3.572 . . . . 0.0 101.355 163.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 p -108.79 -170.99 1.76 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.11 -44.49 83.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.496 1.119 . . . . 0.0 113.79 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.05 -15.89 62.57 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.238 0.926 . . . . 0.0 112.197 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 51.7 t-80 -87.98 0.97 55.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.916 0.886 . . . . 0.0 109.762 173.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -79.58 0.59 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 167.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.607 HD11 ' H ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.09 -168.51 2.08 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.538 1.135 . . . . 0.0 109.848 176.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.01 0.05 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.869 2.867 . . . . 0.0 115.317 171.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.23 50.13 3.09 Favored Glycine 0 C--N 1.337 0.585 0 O-C-N 120.991 -1.068 . . . . 0.0 111.734 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -104.58 -65.92 1.0 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 172.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.607 ' H ' HD11 ' A' ' 79' ' ' LEU . 53.9 m-85 -145.3 -167.16 2.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.772 1.629 . . . . 0.0 107.153 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.461 ' HA ' HD21 ' A' ' 62' ' ' ASN . 1.0 OUTLIER -158.89 140.95 13.77 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.923 1.238 . . . . 0.0 109.106 163.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 t -93.55 150.63 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.775 1.23 . . . . 0.0 108.568 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.469 HD13 HG22 ' A' ' 61' ' ' VAL . 22.2 mm -132.44 97.63 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 C-N-CA 126.767 2.027 . . . . 0.0 108.262 177.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -97.76 90.47 4.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.514 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER -83.54 94.18 7.99 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.17 112.56 2.67 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt 137.53 -50.66 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 131.496 3.919 . . . . 0.0 107.773 -164.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.0 -110.51 0.35 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.04 -154.78 0.57 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-N 120.049 1.295 . . . . 0.0 109.173 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -115.0 78.85 1.2 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.971 2.508 . . . . 0.0 108.226 -164.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.403 ' CD1' HG13 ' A' ' 43' ' ' ILE . 79.1 m-85 -78.14 169.41 18.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.049 -1.032 . . . . 0.0 109.078 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.474 HD13 ' CG2' ' A' ' 15' ' ' ILE . 16.8 tp -127.02 131.38 51.01 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.775 -171.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.21 133.05 69.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 125.104 1.362 . . . . 0.0 107.37 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.487 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 7.8 ttt180 -145.39 -177.18 5.43 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 124.534 2.111 . . . . 0.0 111.783 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.487 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -126.12 159.33 33.16 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 112.636 -2.075 . . . . 0.0 111.59 164.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.476 0 C-N-CA 126.82 2.048 . . . . 0.0 106.1 165.415 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.213 -0.849 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.98 81.01 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 119.988 -1.695 . . . . 0.0 113.515 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.29 -29.89 67.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.553 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -72.63 -36.5 68.05 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.2 mt -73.15 -52.25 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 127.101 2.161 . . . . 0.0 107.921 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.62 -47.06 87.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.953 -175.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -80.14 -27.11 39.11 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.815 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.86 -37.6 93.49 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 126.047 1.784 . . . . 0.0 109.975 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -123.56 12.28 9.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.12 -164.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -57.96 -9.01 1.16 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.42 -12.79 60.03 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.228 1.411 . . . . 0.0 111.726 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.23 168.53 11.41 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 120.617 -1.302 . . . . 0.0 108.888 167.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.09 174.67 12.44 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.678 1.585 . . . . 0.0 110.865 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -127.2 150.31 49.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.679 1.592 . . . . 0.0 109.0 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 38.2 t80 -134.96 159.5 41.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.505 1.048 . . . . 0.0 108.767 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.4 t -138.85 132.3 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 124.465 1.106 . . . . 0.0 108.623 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -113.23 -174.48 2.46 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 123.18 0.592 . . . . 0.0 110.501 163.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -87.96 8.79 24.69 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -163.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.55 176.35 32.65 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 120.907 -1.121 . . . . 0.0 110.859 -164.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.08 139.22 1.68 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -164.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.38 148.02 49.59 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.8 t -155.0 132.5 6.43 Favored Pre-proline 0 CA--C 1.51 -0.582 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -167.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HA ' HD23 ' A' ' 73' ' ' LEU . 71.9 Cg_endo -68.91 150.53 73.4 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.468 2.112 . . . . 0.0 110.975 -173.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.555 HD23 HD12 ' A' ' 72' ' ' ILE 0.332 0.0 OUTLIER -49.82 -34.48 19.79 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.306 174.985 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.487 ' HA ' HD22 ' A' ' 38' ' ' LEU . 3.1 p -76.71 -14.88 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.531 1.932 . . . . 0.0 114.165 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -94.18 -40.1 10.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 120.278 1.399 . . . . 0.0 109.944 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.8 -24.46 58.65 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 116.89 -1.529 . . . . 0.0 108.989 -172.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.581 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -73.13 -33.84 65.76 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 121.068 1.758 . . . . 0.0 109.833 172.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.494 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -75.19 -48.82 30.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.14 1.776 . . . . 0.0 106.849 -169.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -65.73 -34.12 77.46 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.569 1.547 . . . . 0.0 110.023 170.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.36 -14.17 59.52 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 120.675 1.579 . . . . 0.0 111.353 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.7 21.61 33.52 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 164.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.638 HG21 ' NH1' ' A' ' 88' ' ' ARG . 1.5 mm -78.36 -39.92 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -171.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 m -157.3 95.58 2.11 Favored Pre-proline 0 C--N 1.342 0.244 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.439 ' HA ' HG22 ' A' ' 39' ' ' VAL . 78.1 Cg_endo -77.71 -14.18 15.87 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.705 2.27 . . . . 0.0 113.649 -168.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 t -81.72 109.44 16.12 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 50' ' ' ALA 0.261 48.8 mttt -59.2 -21.88 60.15 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -163.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -65.56 -55.2 19.02 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.487 1.494 . . . . 0.0 110.317 166.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -54.02 -50.41 66.71 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.581 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -46.52 -60.15 2.54 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 124.61 1.194 . . . . 0.0 110.976 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -68.53 -25.41 64.91 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 116.334 -1.793 . . . . 0.0 111.93 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -86.68 -25.35 24.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 121.239 1.836 . . . . 0.0 112.979 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.02 -31.86 69.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 125.496 1.518 . . . . 0.0 107.643 166.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.5 HG13 HD22 ' A' ' 34' ' ' LEU . 1.1 mp -77.43 -59.42 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 115.285 -2.293 . . . . 0.0 108.811 172.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -11.46 24.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.703 1.592 . . . . 0.0 112.659 -170.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.502 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.5 m-80 -81.22 137.99 35.83 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.851 1.31 . . . . 0.0 113.378 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.76 2.91 0.06 OUTLIER Glycine 0 CA--C 1.538 1.476 0 CA-C-N 113.034 -1.894 . . . . 0.0 114.999 164.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.461 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -79.43 -18.71 51.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 128.18 2.592 . . . . 0.0 112.436 172.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 56' ' ' ASN 0.356 0.0 OUTLIER -96.28 97.75 6.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 124.499 2.095 . . . . 0.0 108.896 178.63 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.13 93.46 9.58 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 111.185 -2.734 . . . . 0.0 105.158 175.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 p -78.63 136.93 22.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 103.056 -2.942 . . . . 0.0 103.056 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.402 HD21 HD21 ' A' ' 79' ' ' LEU . 1.8 m-80 57.41 23.05 8.55 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 119.258 0.935 . . . . 0.0 110.917 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.62 7.88 83.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.439 1.971 . . . . 0.0 114.206 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -134.98 125.25 26.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.337 1.568 . . . . 0.0 109.166 -166.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.79 117.48 3.69 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.841 0.856 . . . . 0.0 109.321 -173.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.1 mt -147.93 114.06 5.85 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 170.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.53 17.46 10.45 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.17 149.43 41.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.418 -0.801 . . . . 0.0 109.805 -174.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.41 HG22 HD21 ' A' ' 73' ' ' LEU . 7.1 p -67.06 -35.66 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 124.887 1.275 . . . . 0.0 109.962 174.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.17 -17.37 69.97 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.248 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.5 -49.11 10.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.734 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.555 HD12 HD23 ' A' ' 34' ' ' LEU . 2.1 mt -138.74 129.19 33.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 120.069 1.304 . . . . 0.0 111.452 -174.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 33' ' ' PRO . 84.6 mt -114.76 -95.2 0.47 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 103.247 -2.871 . . . . 0.0 103.247 163.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.21 -175.46 3.02 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.65 -1.281 . . . . 0.0 113.828 -173.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.86 -44.32 70.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.506 1.123 . . . . 0.0 113.261 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -75.05 -8.52 56.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.686 0.755 . . . . 0.0 111.386 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -93.31 -4.22 52.09 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.066 -1.021 . . . . 0.0 111.203 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -66.96 1.03 Allowed 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 120.863 -1.148 . . . . 0.0 108.786 175.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.402 HD21 HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -89.54 -175.23 4.63 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 126.399 1.88 . . . . 0.0 107.699 173.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.94 -12.39 1.97 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.384 1.473 . . . . 0.0 113.889 166.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.85 79.17 0.96 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 125.517 1.532 . . . . 0.0 112.535 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -141.17 -49.17 0.41 Allowed 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 117.798 -1.096 . . . . 0.0 113.142 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -155.78 -170.57 3.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.945 2.498 . . . . 0.0 107.059 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.25 130.76 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 120.09 -1.631 . . . . 0.0 107.199 163.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.36 133.42 29.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 6.7 mm -111.05 106.85 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 167.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.48 79.47 2.11 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 176.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.638 ' NH1' HG21 ' A' ' 43' ' ' ILE . 30.1 ttm105 -85.1 109.97 18.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.29 -18.49 2.3 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.764 1.65 . . . . 0.0 114.756 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -47.01 -39.18 12.09 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.928 1.364 . . . . 0.0 111.793 169.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -142.27 -78.06 0.25 Allowed 'General case' 0 C--N 1.338 0.096 0 CA-C-O 117.976 -1.011 . . . . 0.0 108.435 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.36 -152.63 0.32 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.667 1.576 . . . . 0.0 111.997 -171.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -100.98 75.12 1.65 Allowed 'General case' 0 N--CA 1.47 0.529 1 C-N-CA 132.208 4.203 . . . . 0.0 113.298 -175.37 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.73 140.02 38.36 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 120.145 -1.597 . . . . 0.0 108.053 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -89.19 144.72 25.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.54 -175.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 95' ' ' LEU . 2.4 mp -133.16 138.91 50.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 124.52 1.128 . . . . 0.0 108.622 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 ttm105 -136.43 -176.61 4.4 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.316 1.532 . . . . 0.0 111.781 163.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.23 163.06 13.71 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.92 1.688 . . . . 0.0 108.85 163.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 C-N-CA 127.487 2.315 . . . . 0.0 109.72 -175.22 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.214 -0.765 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.54 -55.15 38.7 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 119.921 -1.737 . . . . 0.0 113.134 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.4 -23.17 60.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.65 -35.31 70.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.739 1.216 . . . . 0.0 109.467 175.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt -73.9 -53.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 C-N-CA 127.715 2.406 . . . . 0.0 106.892 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -55.13 -53.53 54.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.526 -1.225 . . . . 0.0 111.355 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -73.29 -31.22 63.92 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 120.38 1.445 . . . . 0.0 109.46 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.52 -34.43 89.45 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 125.335 1.445 . . . . 0.0 110.552 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -128.25 11.7 6.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.603 0.761 . . . . 0.0 111.813 -167.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -59.16 -5.55 0.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.053 2.141 . . . . 0.0 115.942 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.29 -28.82 47.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.793 -0.567 . . . . 0.0 110.295 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.489 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -101.21 170.46 6.5 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HD2' HG12 ' A' ' 22' ' ' VAL . 61.1 Cg_endo -73.0 177.32 7.9 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 CA-C-N 121.099 1.428 . . . . 0.0 109.231 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.4 p -125.46 145.56 50.03 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -108.93 156.24 19.93 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.942 1.297 . . . . 0.0 108.307 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.99 133.97 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 126.2 1.8 . . . . 0.0 107.936 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.402 ' CD2' ' H ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -125.63 -171.39 2.37 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 121.401 0.619 . . . . 0.0 111.093 163.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -100.08 13.58 33.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.844 1.657 . . . . 0.0 112.156 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.402 ' H ' ' CD2' ' A' ' 27' ' ' HIS . . . -91.1 172.57 36.79 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.712 1.149 . . . . 0.0 113.375 -172.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.32 -85.39 1.87 Allowed Glycine 0 C--N 1.333 0.361 0 N-CA-C 106.686 -2.565 . . . . 0.0 106.686 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.33 150.08 21.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.251 1.42 . . . . 0.0 109.714 163.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.455 ' H ' HG23 ' A' ' 74' ' ' THR . 0.9 OUTLIER -161.76 152.14 14.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 167.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.16 139.64 91.24 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.448 2.099 . . . . 0.0 113.168 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.293 0.9 OUTLIER -49.55 -32.65 12.95 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 169.172 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.7 p -74.59 -11.72 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 128.047 2.539 . . . . 0.0 115.086 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -103.03 -44.16 5.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.945 0.793 . . . . 0.0 109.224 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.05 -22.8 58.15 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 116.96 -1.495 . . . . 0.0 109.735 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.651 HD21 HD11 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -85.82 -23.26 27.25 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 120.706 1.594 . . . . 0.0 110.146 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -48.33 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.459 1.504 . . . . 0.0 107.243 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 t -68.63 -37.96 80.14 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.033 1.333 . . . . 0.0 109.31 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.83 -18.78 53.47 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.374 0.534 . . . . 0.0 112.052 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.23 33.36 6.59 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 118.819 0.736 . . . . 0.0 111.52 164.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.38 -49.89 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 172.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.35 107.46 3.35 Favored Pre-proline 0 C--N 1.349 0.553 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 169.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -81.36 -18.21 8.53 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.268 1.978 . . . . 0.0 113.255 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.5 t -86.4 106.34 17.37 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -58.82 -18.04 28.91 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -163.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 -50.48 21.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 121.786 2.085 . . . . 0.0 110.47 167.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -42.96 70.13 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 116.468 -1.729 . . . . 0.0 107.31 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.594 ' O ' HD12 ' A' ' 54' ' ' ILE . . . -52.63 -63.49 1.12 Allowed 'General case' 0 C--O 1.216 -0.681 0 CA-C-O 117.429 -1.272 . . . . 0.0 109.094 172.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.327 2.8 ttt-85 -60.2 -22.89 63.51 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 115.01 -2.424 . . . . 0.0 113.11 -170.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -29.88 25.71 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 121.664 2.029 . . . . 0.0 114.116 166.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.432 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.2 m-20 -62.56 -20.32 64.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.95 1.25 . . . . 0.0 111.644 171.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.651 HD11 HD21 ' A' ' 38' ' ' LEU . 4.3 mp -87.22 -62.45 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 CA-C-O 116.833 -1.556 . . . . 0.0 108.356 163.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -64.32 -7.49 9.73 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 120.065 1.302 . . . . 0.0 111.607 -165.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.1 m-80 -82.66 135.67 34.97 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.64 0.733 . . . . 0.0 111.838 173.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.439 ' HA2' ' HG2' ' A' ' 65' ' ' ARG . . . -74.2 40.26 1.05 Allowed Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.068 -1.423 . . . . 0.0 111.682 165.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -124.24 0.52 8.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 127.302 2.241 . . . . 0.0 111.146 164.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 56' ' ' ASN 0.323 0.0 OUTLIER -91.61 99.41 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 122.086 2.221 . . . . 0.0 106.385 163.63 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -86.84 115.06 24.01 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.666 1.987 . . . . 0.0 107.462 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.802 HG21 HD13 ' A' ' 72' ' ' ILE . 15.3 t -98.08 127.64 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 174.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.471 HD21 ' CD2' ' A' ' 79' ' ' LEU . 1.2 m-80 67.24 -14.06 0.2 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.862 1.265 . . . . 0.0 112.915 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.44 -8.17 6.6 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.705 2.097 . . . . 0.0 111.66 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -110.08 124.48 51.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 119.205 1.502 . . . . 0.0 107.338 -169.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HG2' ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -60.47 111.39 1.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.597 ' HB3' HD11 ' A' ' 72' ' ' ILE . 76.7 mt -146.4 89.17 1.83 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -171.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.19 35.09 1.2 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.156 1.783 . . . . 0.0 113.069 -171.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -140.26 144.04 36.26 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.269 -0.895 . . . . 0.0 112.361 -167.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.82 -36.57 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 126.49 1.916 . . . . 0.0 109.668 168.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.7 -16.11 69.58 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.607 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.7 -52.87 4.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 116.978 -1.486 . . . . 0.0 110.271 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.802 HD13 HG21 ' A' ' 61' ' ' VAL . 1.1 mp -138.13 138.98 42.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 121.376 1.898 . . . . 0.0 112.706 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.97 -75.18 0.64 Allowed 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 102.367 -3.198 . . . . 0.0 102.367 163.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 32' ' ' VAL . 22.1 p -131.06 -142.21 0.23 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . . . -89.06 -48.68 7.25 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 124.777 1.231 . . . . 0.0 111.768 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -8.15 55.15 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.038 0.923 . . . . 0.0 109.625 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -86.47 -9.31 56.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.337 1.455 . . . . 0.0 111.887 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.409 ' HB3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -126.8 -71.9 0.67 Allowed 'General case' 0 C--N 1.34 0.156 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -170.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.471 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -91.22 -169.53 2.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 126.52 1.928 . . . . 0.0 110.028 172.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.01 -3.62 0.37 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.898 1.679 . . . . 0.0 113.674 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.52 78.46 1.41 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -133.77 -59.25 0.85 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.914 0.357 . . . . 0.0 111.471 167.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -148.95 -177.61 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.478 2.311 . . . . 0.0 106.283 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.76 153.88 43.71 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 163.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.8 t -124.48 134.43 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.493 HD13 HG22 ' A' ' 61' ' ' VAL . 26.0 mm -125.28 95.28 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.328 1.851 . . . . 0.0 107.528 -169.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -89.31 88.84 7.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.432 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -80.04 120.14 23.81 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 163.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.63 -22.18 59.01 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.729 1.157 . . . . 0.0 114.051 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -3.74 52.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.509 1.524 . . . . 0.0 111.879 173.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -144.15 -131.52 0.08 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -159.73 0.97 Allowed 'General case' 0 C--O 1.242 0.668 0 CA-C-N 120.64 1.564 . . . . 0.0 109.843 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.43 83.89 4.25 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 129.418 3.087 . . . . 0.0 110.441 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -78.39 164.24 24.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.22 129.94 44.0 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 -164.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.5 mm -126.98 123.0 61.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -163.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.571 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 6.4 ttt180 -134.33 -178.72 5.18 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 125.376 2.512 . . . . 0.0 115.34 171.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.571 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -137.99 143.15 40.51 Favored 'General case' 0 N--CA 1.427 -1.582 1 C-N-CA 131.837 4.055 . . . . 0.0 105.829 -172.975 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 125.819 1.648 . . . . 0.0 110.084 -175.384 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.44 -0.967 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.41 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -62.81 -55.91 22.19 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 123.523 0.729 . . . . 0.0 111.833 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.64 -19.02 63.62 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.667 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.35 -41.87 46.72 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 123.868 0.867 . . . . 0.0 109.167 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.1 mt -72.74 -51.19 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -57.52 -46.99 83.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.334 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -78.07 -30.45 49.68 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.673 1.124 . . . . 0.0 110.194 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.55 -33.83 86.26 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -124.03 17.32 9.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.954 0.501 . . . . 0.0 112.083 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -14.16 16.98 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -78.99 -21.3 47.23 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.452 1.501 . . . . 0.0 111.716 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -115.95 161.61 29.95 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -175.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.433 ' HD2' HG12 ' A' ' 22' ' ' VAL . 29.8 Cg_endo -83.23 172.79 10.36 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.245 1.296 . . . . 0.0 110.702 -169.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.8 p -127.09 170.57 12.22 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.068 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -139.03 154.89 48.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.277 1.431 . . . . 0.0 107.831 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 3.6 p -138.41 125.85 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 123.884 0.873 . . . . 0.0 109.931 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -117.49 -168.13 1.44 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 171.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -84.94 12.13 8.1 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 127.789 2.436 . . . . 0.0 116.022 -163.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.04 -177.39 8.6 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -164.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.78 133.39 1.61 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -168.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.08 149.76 40.25 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 117.575 0.688 . . . . 0.0 111.236 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -160.92 140.33 7.9 Favored Pre-proline 0 CA--C 1.51 -0.574 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -168.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.422 ' HA ' HD23 ' A' ' 73' ' ' LEU . 98.6 Cg_endo -76.34 150.97 33.19 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 121.508 1.472 . . . . 0.0 110.973 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.333 0.3 OUTLIER -48.46 -34.62 11.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.222 -1.353 . . . . 0.0 112.098 173.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.807 ' HA ' HD11 ' A' ' 54' ' ' ILE . 9.9 p -67.03 -29.89 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 117.786 -1.102 . . . . 0.0 113.68 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -91.68 -40.12 11.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.737 1.153 . . . . 0.0 109.389 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.59 -30.72 66.15 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 117.093 -1.432 . . . . 0.0 108.399 -174.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.11 -22.26 25.48 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 121.054 1.752 . . . . 0.0 110.333 -172.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.75 -50.97 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 171.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.82 -39.7 95.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.498 1.119 . . . . 0.0 108.621 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.09 47.11 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.915 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.07 33.88 7.5 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 166.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.405 HG12 HG21 ' A' ' 86' ' ' ILE . 2.1 mp -77.78 -43.47 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 171.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -148.44 109.6 3.63 Favored Pre-proline 0 C--O 1.224 -0.288 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 164.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.3 -15.71 11.24 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.548 2.165 . . . . 0.0 113.391 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.5 t -81.25 115.81 20.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -58.54 -30.01 66.79 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.62 1.555 . . . . 0.0 112.89 -168.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -52.33 24.47 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.637 173.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -54.79 -49.96 69.67 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.62 -58.45 3.82 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 126.375 1.87 . . . . 0.0 110.005 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.464 ' HA ' HD12 ' A' ' 54' ' ' ILE . 34.1 mtt85 -58.07 -33.79 69.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 117.045 -1.455 . . . . 0.0 113.218 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -80.77 -34.75 34.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.016 1.734 . . . . 0.0 112.926 173.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -15.6 62.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.452 1.501 . . . . 0.0 111.248 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.807 HD11 ' HA ' ' A' ' 35' ' ' VAL . 57.5 mt -86.65 -61.68 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 125.41 1.484 . . . . 0.0 108.86 163.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -72.98 -5.47 38.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -163.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.52 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.1 m-80 -81.01 131.81 35.33 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 163.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.31 2.98 0.08 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.856 0.741 . . . . 0.0 114.876 167.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB1' HH21 ' A' ' 88' ' ' ARG . . . -79.1 11.32 2.84 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.099 2.159 . . . . 0.0 111.451 169.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 56' ' ' ASN 0.38 0.0 OUTLIER -111.77 90.05 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 124.98 2.324 . . . . 0.0 104.735 163.349 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.426 ' CE1' ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -78.9 96.69 5.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 111.36 -2.655 . . . . 0.0 104.807 172.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 p -78.49 134.58 27.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.729 HD21 HD22 ' A' ' 79' ' ' LEU . 1.8 m-20 60.11 14.36 4.41 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 122.004 2.183 . . . . 0.0 114.221 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.67 -4.77 69.38 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.535 1.541 . . . . 0.0 113.723 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -121.82 127.95 51.14 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.912 1.856 . . . . 0.0 108.521 -166.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 105.06 0.64 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.466 1.506 . . . . 0.0 108.302 -172.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.9 mt -140.09 100.89 4.03 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 120.234 1.379 . . . . 0.0 107.964 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -106.38 27.06 9.11 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.827 2.851 . . . . 0.0 110.559 -168.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -140.39 131.3 26.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.707 1.203 . . . . 0.0 112.138 -164.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 p -59.12 -36.39 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 126.568 1.947 . . . . 0.0 110.682 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.11 -19.49 68.11 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 119.283 -0.732 . . . . 0.0 112.771 173.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.23 -37.84 13.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.109 1.364 . . . . 0.0 114.486 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mt -142.41 123.58 11.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 120.729 1.604 . . . . 0.0 110.69 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.448 ' H ' ' CG ' ' A' ' 77' ' ' HIS . 70.3 mt -107.26 -95.24 0.37 Allowed 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 102.676 -3.083 . . . . 0.0 102.676 163.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.42 -173.05 2.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.065 1.302 . . . . 0.0 114.346 -173.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.24 -41.07 87.86 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.253 -0.904 . . . . 0.0 112.395 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -65.17 -17.22 64.3 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.001 0.92 . . . . 0.0 112.734 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.448 ' CG ' ' H ' ' A' ' 73' ' ' LEU . 42.5 t-80 -93.73 4.14 54.38 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.984 1.714 . . . . 0.0 109.682 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.27 -61.34 1.09 Allowed 'General case' 0 C--N 1.35 0.592 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.938 170.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.729 HD22 HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -91.07 -170.31 2.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.441 1.473 . . . . 0.0 109.101 169.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -43.8 -49.36 8.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.548 1.139 . . . . 0.0 109.664 163.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.05 81.68 0.11 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 125.604 1.574 . . . . 0.0 114.363 172.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -141.74 -46.1 0.36 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.269 0.534 . . . . 0.0 111.902 165.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.41 ' CE1' ' HB1' ' A' ' 12' ' ' ALA . 83.6 m-85 -131.8 -177.52 4.47 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 125.502 1.521 . . . . 0.0 108.476 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.412 ' HA ' HD21 ' A' ' 79' ' ' LEU . 1.4 m -161.3 132.53 5.42 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.302 1.841 . . . . 0.0 106.72 163.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.25 145.4 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 170.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.405 HG21 HG12 ' A' ' 43' ' ' ILE . 15.4 mm -125.88 98.48 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 C-N-CA 126.442 1.897 . . . . 0.0 106.792 -176.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -97.12 82.35 3.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.479 HH21 ' HB1' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -79.28 61.39 3.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.398 1.879 . . . . 0.0 109.309 -174.221 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 27.19 -82.7 0.0 OUTLIER Glycine 0 CA--C 1.527 0.784 0 C-N-CA 130.292 3.806 . . . . 0.0 116.598 171.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -51.74 -55.05 21.96 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.745 1.618 . . . . 0.0 109.97 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.24 176.9 8.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.894 1.678 . . . . 0.0 109.414 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.527 ' HB3' HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -83.72 -146.07 0.08 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.707 1.242 . . . . 0.0 111.743 -176.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -118.16 82.31 1.82 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.295 2.238 . . . . 0.0 109.506 -163.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -78.92 168.34 19.84 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.274 -0.891 . . . . 0.0 108.894 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.5 tp -121.9 131.38 54.0 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.766 -171.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.44 133.42 66.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 15.0 ptt180 -144.08 172.08 13.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.578 1.18 . . . . 0.0 109.989 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.86 163.29 21.56 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.611 1.164 . . . . 0.0 108.417 163.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.52 0 C-N-CA 127.017 2.127 . . . . 0.0 110.026 173.295 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 p . . . . . 0 C--O 1.218 -0.596 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.5 -49.91 69.51 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 120.347 -1.471 . . . . 0.0 110.836 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 -28.8 65.97 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 118.55 -1.26 . . . . 0.0 109.906 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -79.38 -24.31 42.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.218 1.007 . . . . 0.0 110.146 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.0 mt -74.08 -54.76 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.837 1.655 . . . . 0.0 106.901 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -57.27 -48.59 78.5 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.812 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -81.22 -24.87 37.11 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.417 1.008 . . . . 0.0 110.437 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.43 -38.88 96.38 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -121.48 14.47 11.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 123.726 0.31 . . . . 0.0 111.468 -164.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -54.22 -11.64 0.52 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -78.36 -13.27 59.92 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.918 2.087 . . . . 0.0 110.413 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.44 ' CG1' ' HE2' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -127.92 155.45 77.6 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 126.26 1.824 . . . . 0.0 106.337 169.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.65 169.43 20.89 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.71 1.607 . . . . 0.0 110.463 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.8 p -104.25 175.63 5.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.637 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -136.75 160.31 39.23 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 163.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 8.0 p -134.43 132.12 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 171.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.98 172.61 6.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 164.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -100.08 57.74 0.98 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.655 -1.278 . . . . 0.0 111.681 -164.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.15 -171.63 9.91 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.98 148.19 2.22 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 -164.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -73.11 149.67 42.87 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.909 -0.759 . . . . 0.0 110.389 164.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.5 t -158.42 132.62 5.15 Favored Pre-proline 0 CA--C 1.505 -0.752 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -163.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HA ' HD23 ' A' ' 73' ' ' LEU . 44.4 Cg_endo -74.41 154.81 45.77 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 C-N-CA 121.715 1.61 . . . . 0.0 110.251 -173.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.397 0.6 OUTLIER -53.94 -29.99 44.69 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.482 176.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.678 ' HA ' HD11 ' A' ' 54' ' ' ILE . 8.6 p -70.25 -24.78 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 174.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -90.86 -43.77 9.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 120.31 1.414 . . . . 0.0 108.508 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -73.78 -28.31 61.6 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 116.943 -1.503 . . . . 0.0 109.49 -171.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.08 -31.29 25.4 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.713 1.597 . . . . 0.0 109.327 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 t -64.6 -51.5 66.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -66.62 -34.75 78.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.152 1.381 . . . . 0.0 109.998 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.4 -15.65 58.44 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.726 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.38 23.36 19.46 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 166.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.93 -43.37 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 m -156.34 101.12 2.07 Favored Pre-proline 0 C--N 1.349 0.562 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 171.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.62 -18.68 10.49 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 121.771 1.647 . . . . 0.0 113.431 -173.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.3 t -86.34 106.34 17.32 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -174.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 75.2 mttt -57.22 -22.19 39.22 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -164.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.55 -45.99 56.6 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 121.828 2.104 . . . . 0.0 111.095 169.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -51.81 67.84 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -50.59 -52.93 34.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 125.447 1.717 . . . . 0.0 110.586 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -57.08 -37.97 72.66 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 117.295 -1.336 . . . . 0.0 111.102 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -84.04 -24.89 30.27 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 116.736 -1.986 . . . . 0.0 113.296 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.16 -23.19 66.45 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 112.22 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 35' ' ' VAL . 70.0 mt -84.95 -63.7 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 C-N-CA 126.211 1.804 . . . . 0.0 107.3 168.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.52 -5.13 10.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 119.916 1.235 . . . . 0.0 112.783 -164.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.628 ' O ' HG22 ' A' ' 59' ' ' ILE . 7.0 m120 -81.5 132.26 35.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 164.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.06 10.76 0.06 OUTLIER Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.246 1.403 . . . . 0.0 115.119 164.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.52 -12.67 59.86 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 116.253 -1.832 . . . . 0.0 112.964 165.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 56' ' ' ASN 0.362 0.0 OUTLIER -99.74 87.79 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 125.881 2.753 . . . . 0.0 107.741 177.128 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -79.32 99.08 6.95 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 109.698 -3.41 . . . . 0.0 106.654 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.84 137.34 22.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.5 HD21 ' CD2' ' A' ' 79' ' ' LEU . 0.9 OUTLIER 60.19 4.56 0.67 Allowed 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 120.657 1.572 . . . . 0.0 113.132 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 -2.15 47.69 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.492 1.52 . . . . 0.0 114.035 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -124.18 129.07 50.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.852 1.826 . . . . 0.0 108.979 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.51 110.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.515 1.526 . . . . 0.0 108.386 -171.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.479 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 17.9 mt -141.22 70.42 1.35 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.128 0.966 . . . . 0.0 109.023 -174.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -78.97 31.94 0.21 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -170.103 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -143.62 159.44 42.45 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.7 t -68.01 -27.42 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.971 2.509 . . . . 0.0 111.48 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.11 -7.57 85.09 Favored Glycine 0 C--N 1.333 0.401 0 O-C-N 121.393 -0.817 . . . . 0.0 112.552 168.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 66' ' ' LEU . . . -86.44 -57.64 2.92 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 117.914 -1.041 . . . . 0.0 108.298 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp -136.17 137.34 48.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 120.596 1.544 . . . . 0.0 113.475 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 33' ' ' PRO . 93.1 mt -108.12 -87.02 0.5 Allowed 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 100.571 -3.862 . . . . 0.0 100.571 163.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.48 -174.42 2.51 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 120.861 -1.15 . . . . 0.0 113.803 -169.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.0 -48.72 75.37 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -70.11 -15.34 62.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.175 0.898 . . . . 0.0 111.224 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -81.3 -10.34 59.59 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.928 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.21 -77.15 0.57 Allowed 'General case' 0 C--N 1.343 0.306 0 O-C-N 120.789 -1.194 . . . . 0.0 108.095 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.5 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -90.55 -171.51 3.09 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 125.66 1.584 . . . . 0.0 109.328 177.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -47.78 -26.27 1.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.72 2.008 . . . . 0.0 115.362 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.34 64.56 0.31 Allowed Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 126.01 1.767 . . . . 0.0 111.261 -169.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -133.27 -81.3 0.48 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -127.36 -166.39 1.6 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.845 1.258 . . . . 0.0 108.781 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.34 122.35 4.49 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 120.78 -1.2 . . . . 0.0 107.899 165.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.5 128.12 38.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.456 HD12 HD11 ' A' ' 59' ' ' ILE . 11.2 mm -116.24 98.03 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -92.37 85.62 5.43 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.528 ' CG ' ' HB ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -89.65 113.97 25.52 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 166.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.84 2.88 1.13 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -58.2 -45.44 87.58 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.154 1.477 . . . . 0.0 109.573 164.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HE2' ' CG1' ' A' ' 22' ' ' VAL . 61.7 tttt -131.76 -90.44 0.43 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.425 ' HG3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -152.82 -152.39 0.42 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 120.878 1.672 . . . . 0.0 111.523 -167.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.425 ' CD1' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -94.68 79.5 3.76 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 129.897 3.279 . . . . 0.0 110.244 -176.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.4 144.38 35.95 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 119.95 -1.719 . . . . 0.0 107.219 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.1 tp -97.93 139.07 34.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.3 mm -126.6 135.71 62.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 12.9 ptt180 -135.37 174.01 11.09 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 122.655 1.217 . . . . 0.0 111.568 164.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.19 163.44 12.24 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 163.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.41 0 C-N-CA 127.671 2.388 . . . . 0.0 109.071 -176.932 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.226 -0.146 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.82 -58.44 4.59 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.684 0.794 . . . . 0.0 111.139 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.13 -25.14 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.072 0.396 . . . . 0.0 111.026 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -73.73 -39.28 64.4 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.3 mt -70.31 -52.12 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.371 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.37 -48.22 82.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.494 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -72.12 -35.94 69.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.356 0.98 . . . . 0.0 109.155 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.79 -38.2 93.59 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -117.46 13.39 14.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.059 0.544 . . . . 0.0 110.458 -169.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -15.57 4.96 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.406 1.883 . . . . 0.0 113.939 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -78.04 -11.23 59.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 127.427 2.291 . . . . 0.0 111.598 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.439 HG22 ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -133.76 172.84 6.63 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 167.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.439 ' HD2' HG22 ' A' ' 22' ' ' VAL . 71.1 Cg_endo -76.85 -174.24 2.08 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.145 2.563 . . . . 0.0 110.111 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.4 p -135.35 175.45 9.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.594 1.157 . . . . 0.0 109.085 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -138.53 161.32 37.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.265 0.939 . . . . 0.0 109.075 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.8 t -138.81 139.64 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 124.713 1.205 . . . . 0.0 108.032 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.69 172.16 8.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.505 1.145 . . . . 0.0 112.705 163.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.19 33.08 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 128.641 2.776 . . . . 0.0 111.204 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.84 -170.87 31.95 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.543 -0.723 . . . . 0.0 112.058 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.78 145.54 2.98 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -164.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -67.98 148.16 51.45 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.306 0.574 . . . . 0.0 110.653 167.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.8 t -156.77 133.75 6.53 Favored Pre-proline 0 CA--C 1.511 -0.539 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -163.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.519 ' HA ' HD23 ' A' ' 73' ' ' LEU . 89.9 Cg_endo -71.42 152.01 60.09 Favored 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 122.069 1.846 . . . . 0.0 110.989 -172.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.442 1.0 OUTLIER -51.69 -30.4 21.89 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.552 174.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.475 ' HA ' HD22 ' A' ' 38' ' ' LEU . 7.7 p -78.11 -14.87 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.512 1.525 . . . . 0.0 114.71 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.36 -49.05 6.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.114 0.87 . . . . 0.0 109.055 166.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.9 -23.88 60.77 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 117.381 -1.295 . . . . 0.0 109.051 -166.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.878 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -75.62 -33.4 60.52 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 120.822 1.646 . . . . 0.0 109.639 176.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.456 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -75.3 -46.86 37.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -175.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -38.07 89.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.542 1.937 . . . . 0.0 109.39 175.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.64 -24.08 45.47 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.108 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.17 23.12 11.68 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 124.096 0.855 . . . . 0.0 111.482 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.405 HG21 ' NH1' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -78.3 -39.66 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -174.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -145.15 113.6 4.86 Favored Pre-proline 0 C--O 1.225 -0.193 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.45 -15.08 5.37 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.778 2.319 . . . . 0.0 113.3 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -84.8 132.67 34.39 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -65.04 -35.48 81.3 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 119.583 1.083 . . . . 0.0 111.034 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -55.47 24.21 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 120.028 1.285 . . . . 0.0 108.945 177.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -49.3 76.71 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.033 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.878 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -51.13 -51.85 49.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.694 1.134 . . . . 0.0 112.366 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -60.0 -39.89 87.35 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 117.678 -1.153 . . . . 0.0 110.238 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.26 -32.05 49.44 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.777 1.172 . . . . 0.0 112.351 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -50.28 -39.81 46.46 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.561 HD11 HD22 ' A' ' 38' ' ' LEU . 43.8 mt -84.85 -49.99 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 115.66 -2.114 . . . . 0.0 109.597 -174.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -66.99 -10.83 53.75 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 125.382 1.676 . . . . 0.0 111.489 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.538 ' HB3' ' H ' ' A' ' 58' ' ' ALA . 1.2 m120 -83.52 137.3 33.93 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 174.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.66 0.42 0.45 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-N 115.067 -0.969 . . . . 0.0 114.419 164.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.538 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -78.95 -4.13 48.34 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.58 1.552 . . . . 0.0 111.617 172.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.475 HG13 ' NH2' ' A' ' 88' ' ' ARG 0.393 0.0 OUTLIER -106.78 92.43 2.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 CA-C-O 125.06 2.362 . . . . 0.0 109.125 171.546 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.97 93.59 7.58 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 109.913 -3.312 . . . . 0.0 105.067 169.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 p -78.31 127.33 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 102.375 -3.195 . . . . 0.0 102.375 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.474 HD21 ' CD2' ' A' ' 79' ' ' LEU . 1.2 m-80 76.34 -52.39 0.6 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.464 1.906 . . . . 0.0 110.499 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.45 3.89 0.02 OUTLIER Glycine 0 CA--C 1.533 1.182 1 C-N-CA 130.731 4.015 . . . . 0.0 111.063 170.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -112.82 116.25 29.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -163.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.08 105.74 0.93 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.9 mt -140.82 68.13 1.35 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.332 0.969 . . . . 0.0 109.547 -168.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.97 56.47 3.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.111 1.764 . . . . 0.0 112.535 -172.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -148.34 151.19 34.93 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.763 0.825 . . . . 0.0 112.928 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.32 -38.01 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.765 2.426 . . . . 0.0 110.699 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.14 -10.19 68.55 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 119.027 -0.874 . . . . 0.0 112.307 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.62 -55.6 3.8 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 117.213 -1.375 . . . . 0.0 109.664 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -136.25 134.53 50.02 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 CA-C-N 120.585 1.539 . . . . 0.0 113.613 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 33' ' ' PRO . 77.3 mt -108.27 -86.41 0.51 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 163.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 p -115.57 -168.94 1.49 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . . . -62.52 -45.33 93.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.634 -177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -70.2 -17.26 63.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.71 1.141 . . . . 0.0 110.93 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -82.7 0.16 44.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.464 1.106 . . . . 0.0 110.92 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 -62.97 0.9 Allowed 'General case' 0 C--N 1.345 0.379 0 O-C-N 120.785 -1.197 . . . . 0.0 110.033 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.474 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.06 -175.22 4.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.452 2.301 . . . . 0.0 109.528 172.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -52.81 -28.66 23.64 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.983 1.313 . . . . 0.0 112.852 172.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.46 73.47 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 126.355 1.931 . . . . 0.0 111.675 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -139.04 -79.23 0.33 Allowed 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 117.614 0.707 . . . . 0.0 109.403 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -126.71 -170.8 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.109 1.764 . . . . 0.0 109.13 -173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.12 116.72 4.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 163.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.84 138.46 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 170.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 17.9 mm -123.1 104.63 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.788 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -92.67 83.92 4.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 170.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HG2' HH11 ' A' ' 88' ' ' ARG . 0.0 OUTLIER -78.48 82.22 4.76 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 169.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -49.28 -34.26 17.65 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.395 1.474 . . . . 0.0 111.932 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -69.39 15.19 0.07 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.709 1.204 . . . . 0.0 113.635 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -162.69 -82.96 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.855 2.462 . . . . 0.0 108.868 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.608 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -157.73 -169.21 2.78 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 123.364 1.554 . . . . 0.0 110.163 -176.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.608 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 12.0 m-30 -107.03 76.83 1.12 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.985 2.114 . . . . 0.0 111.704 -168.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -79.43 172.31 13.96 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.606 1.162 . . . . 0.0 112.129 -173.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.0 tp -140.66 137.53 33.63 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.377 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.15 141.83 45.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.716 1.606 . . . . 0.0 109.013 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -134.39 179.73 6.09 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 124.57 2.129 . . . . 0.0 109.392 163.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -121.25 162.14 20.74 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.257 163.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 125.169 1.388 . . . . 0.0 112.111 176.214 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.218 -0.553 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.94 -51.61 68.49 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.081 -1.637 . . . . 0.0 112.438 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.89 -29.69 69.64 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.258 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.92 -31.96 61.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.78 2.032 . . . . 0.0 110.3 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 mt -76.38 -56.39 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 126.338 1.855 . . . . 0.0 106.38 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.27 -49.63 63.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.715 0.689 . . . . 0.0 112.519 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.84 -35.59 62.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.14 -40.61 95.91 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -115.58 16.49 16.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 124.035 0.491 . . . . 0.0 110.565 -165.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -55.79 -12.07 1.19 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -102.67 -2.51 28.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 129.25 3.02 . . . . 0.0 113.209 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.467 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -120.79 169.72 8.38 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.467 ' HD2' HG12 ' A' ' 22' ' ' VAL . 40.8 Cg_endo -84.13 173.19 9.13 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 CA-C-N 121.189 1.46 . . . . 0.0 109.878 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.8 p -128.87 158.16 39.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.878 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 61.6 t80 -135.08 153.76 51.92 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 p -128.49 131.8 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.41 172.69 8.15 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 123.114 1.435 . . . . 0.0 113.523 164.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -80.92 37.98 0.44 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 128.162 2.585 . . . . 0.0 112.43 -164.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.21 -171.53 5.0 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.706 1.146 . . . . 0.0 113.703 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.71 137.04 0.76 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -167.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.17 137.0 57.35 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.378 1.089 . . . . 0.0 109.73 175.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.24 138.5 14.18 Favored Pre-proline 0 CA--C 1.514 -0.427 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -163.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HA ' HD23 ' A' ' 73' ' ' LEU . 94.7 Cg_endo -70.7 145.13 50.91 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.628 2.219 . . . . 0.0 110.776 -169.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.754 HD22 HG13 ' A' ' 54' ' ' ILE 0.284 0.0 OUTLIER -47.35 -36.74 9.96 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.426 177.884 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.6 ' HA ' HD22 ' A' ' 38' ' ' LEU . 11.7 p -79.08 -15.88 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.707 2.003 . . . . 0.0 114.355 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -88.36 -44.23 10.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 120.088 1.313 . . . . 0.0 108.807 164.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -77.09 -18.18 58.18 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 116.847 -1.549 . . . . 0.0 109.888 -168.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.739 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -74.39 -34.69 63.37 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 121.144 1.793 . . . . 0.0 109.751 171.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.562 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -73.1 -49.14 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 C-N-CA 126.338 1.855 . . . . 0.0 106.054 -169.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 3.9 m -60.92 -40.89 94.88 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 128.53 2.732 . . . . 0.0 110.687 169.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.79 -11.09 59.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.904 1.229 . . . . 0.0 113.038 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.25 20.39 49.22 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.682 1.128 . . . . 0.0 112.199 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.506 HG21 ' NH1' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -77.86 -39.74 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.794 1.637 . . . . 0.0 106.836 -177.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.74 111.32 1.32 Allowed Pre-proline 0 C--N 1.344 0.358 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 167.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.11 -13.47 7.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.149 1.899 . . . . 0.0 112.414 -174.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 m -90.44 101.49 14.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 -164.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -41.44 -37.46 1.06 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -163.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.48 -54.06 33.75 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.226 1.376 . . . . 0.0 110.168 171.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -59.16 -42.05 89.8 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.728 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -51.49 -55.58 18.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 123.836 0.855 . . . . 0.0 110.415 175.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 mtt85 -55.2 -42.46 73.32 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.173 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -79.78 -33.5 40.49 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 119.989 1.268 . . . . 0.0 112.125 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.63 -29.43 68.01 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 116.592 -1.67 . . . . 0.0 107.636 171.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.754 HG13 HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -81.74 -51.76 14.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-N 120.34 1.427 . . . . 0.0 110.848 174.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -69.6 -7.11 35.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.76 1.624 . . . . 0.0 111.458 -172.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.553 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.8 m-80 -81.07 134.95 35.75 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 171.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.59 8.25 0.2 Allowed Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.383 -1.232 . . . . 0.0 114.674 164.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.475 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -84.32 -16.22 43.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.213 1.507 . . . . 0.0 111.173 170.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 56' ' ' ASN 0.352 0.0 OUTLIER -93.5 92.65 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 125.455 2.55 . . . . 0.0 106.79 169.615 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -78.96 109.4 13.21 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 111.566 -2.561 . . . . 0.0 106.236 167.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 72' ' ' ILE . 13.5 t -88.47 124.87 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 O-C-N 120.307 -1.496 . . . . 0.0 107.421 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.723 HD22 ' HG3' ' A' ' 78' ' ' ARG . 68.3 m-80 46.92 57.57 5.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.774 1.273 . . . . 0.0 110.169 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.23 4.75 51.57 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 113.56 -1.654 . . . . 0.0 114.439 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -131.03 121.47 25.09 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 120.82 2.31 . . . . 0.0 110.404 -167.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.99 100.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 126.691 1.996 . . . . 0.0 110.435 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.519 ' HB3' HD11 ' A' ' 72' ' ' ILE . 66.4 mt -138.48 108.12 6.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -170.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.13 38.41 2.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.888 2.075 . . . . 0.0 112.125 -163.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -143.18 158.88 43.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.616 1.566 . . . . 0.0 110.291 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.441 HG22 HD21 ' A' ' 73' ' ' LEU . 6.3 p -69.12 -33.19 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 121.177 -0.952 . . . . 0.0 111.796 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.08 -8.19 84.91 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 119.713 -0.493 . . . . 0.0 112.489 168.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.35 -55.64 4.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 116.862 -1.542 . . . . 0.0 109.24 170.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -138.93 145.86 27.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.402 0 CA-C-N 121.614 2.006 . . . . 0.0 111.774 177.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 33' ' ' PRO . 82.2 mt -115.84 -98.57 0.44 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 163.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.05 -177.51 4.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.072 1.306 . . . . 0.0 114.145 -174.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.56 -48.71 71.73 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.068 0.947 . . . . 0.0 112.581 173.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -61.41 -20.31 62.92 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.996 1.319 . . . . 0.0 113.189 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 60.1 t-80 -84.45 -19.33 33.58 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.151 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.723 ' HG3' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -96.2 -74.89 0.55 Allowed 'General case' 0 C--N 1.345 0.404 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.635 HD11 ' H ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.52 169.63 10.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.371 1.468 . . . . 0.0 111.129 172.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -23.24 -52.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.028 3.331 . . . . 0.0 115.839 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.53 56.28 0.01 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -168.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.9 -88.03 0.33 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.986 0.893 . . . . 0.0 111.851 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.635 ' H ' HD11 ' A' ' 79' ' ' LEU . 21.6 m-30 -131.56 -170.5 2.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -168.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.46 135.21 10.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.35 -0.844 . . . . 0.0 109.413 166.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -79.41 138.34 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 167.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 22.4 mm -113.22 92.74 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 126.323 1.849 . . . . 0.0 106.042 169.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 ttt-85 -97.78 74.63 2.37 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 -165.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.748 HH11 ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -88.3 105.14 17.36 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 130.499 3.519 . . . . 0.0 110.019 -169.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.23 -30.56 17.98 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.182 0.896 . . . . 0.0 114.524 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -23.58 31.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.721 1.609 . . . . 0.0 113.913 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -149.76 -89.91 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 -144.52 0.15 Allowed 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 122.424 1.107 . . . . 0.0 109.99 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 3.6 m-30 -115.22 87.5 2.67 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.533 -162.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -78.49 161.92 26.72 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.87 134.9 54.85 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -172.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.7 mm -122.61 129.28 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -137.58 174.57 10.44 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 123.588 1.661 . . . . 0.0 111.061 171.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.71 166.05 13.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 124.738 1.215 . . . . 0.0 110.096 171.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 C-N-CA 129.075 2.95 . . . . 0.0 110.852 -168.684 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.218 -0.591 0 CA-C-O 120.342 0.115 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -65.54 -51.01 63.06 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 120.467 -1.396 . . . . 0.0 111.47 -170.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.34 81.08 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.402 0.439 . . . . 0.0 110.087 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.81 -34.31 66.78 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -174.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.9 mt -72.68 -52.14 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 126.261 1.824 . . . . 0.0 108.397 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -56.83 -47.24 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 118.598 0.635 . . . . 0.0 111.235 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -80.64 -22.54 40.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.581 0.628 . . . . 0.0 110.057 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.54 -24.67 58.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 125.241 1.4 . . . . 0.0 111.841 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -130.44 17.13 5.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.185 0.994 . . . . 0.0 110.596 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 -15.23 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.191 2.196 . . . . 0.0 112.47 169.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.1 -19.7 53.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.766 2.827 . . . . 0.0 111.392 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.597 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -126.08 161.54 51.08 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 176.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.597 ' HD2' HG12 ' A' ' 22' ' ' VAL . 44.4 Cg_endo -76.16 172.26 16.58 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 N-CA-C 109.091 -1.157 . . . . 0.0 109.091 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 p -121.02 168.3 11.66 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 113.532 -1.667 . . . . 0.0 108.42 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -140.43 164.33 30.41 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 9.5 p -139.46 135.65 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -116.13 -179.23 3.6 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.75 0.786 . . . . 0.0 109.98 163.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -96.15 66.89 2.55 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.437 -0.79 . . . . 0.0 109.879 -171.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.56 -157.4 29.57 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.44 108.31 0.05 OUTLIER Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.295 1.426 . . . . 0.0 112.298 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -47.41 139.86 6.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.86 0.83 . . . . 0.0 112.192 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.95 136.54 10.86 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.722 -163.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.13 144.34 38.3 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.35 2.7 . . . . 0.0 112.388 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.377 1.1 pt? -55.8 -25.92 43.73 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 171.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.716 ' HA ' HD11 ' A' ' 54' ' ' ILE . 7.6 p -57.4 -56.6 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 119.58 1.082 . . . . 0.0 110.844 166.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -65.63 -41.88 92.16 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.188 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.81 -29.5 62.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 120.587 1.539 . . . . 0.0 109.517 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.74 -27.83 22.12 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 120.459 1.482 . . . . 0.0 109.482 -173.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.54 -49.86 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 t -60.98 -45.4 94.94 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.668 1.587 . . . . 0.0 108.685 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.87 -15.61 58.13 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.167 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.94 27.58 9.39 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 119.276 0.944 . . . . 0.0 111.268 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -45.77 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.51 102.83 2.91 Favored Pre-proline 0 C--N 1.347 0.49 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 164.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.94 -17.45 19.7 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.131 1.887 . . . . 0.0 113.067 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.0 t -90.81 109.14 20.34 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 82.0 mttt -56.96 -18.75 14.69 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -166.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -72.02 -53.84 11.72 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 120.91 1.687 . . . . 0.0 110.484 168.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -47.91 68.08 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -50.37 -57.25 8.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 124.403 1.065 . . . . 0.0 111.359 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -63.13 -26.93 69.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 116.251 -1.833 . . . . 0.0 112.229 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -69.74 -50.48 43.05 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 121.602 2.001 . . . . 0.0 110.982 163.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.617 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.0 OUTLIER -60.42 -9.55 3.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.725 1.21 . . . . 0.0 112.993 -174.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.716 HD11 ' HA ' ' A' ' 35' ' ' VAL . 38.9 mt -96.15 -67.74 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 C-N-CA 126.673 1.989 . . . . 0.0 109.071 164.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.62 -9.22 8.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 120.329 1.422 . . . . 0.0 112.54 -167.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.609 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -82.52 126.04 31.81 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 119.57 1.077 . . . . 0.0 110.971 168.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.46 9.55 0.23 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 169.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.11 -7.53 58.94 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 116.58 -1.676 . . . . 0.0 111.801 164.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 56' ' ' ASN 0.384 0.0 OUTLIER -91.75 90.13 3.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 125.621 2.629 . . . . 0.0 107.673 167.174 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -79.87 96.74 6.43 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 110.957 -2.838 . . . . 0.0 108.021 171.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.875 HG21 HD13 ' A' ' 72' ' ' ILE . 31.0 t -78.64 126.78 38.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.413 HD21 HD21 ' A' ' 79' ' ' LEU . 1.8 m120 60.7 11.9 3.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.619 0.768 . . . . 0.0 111.834 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.97 18.32 56.26 Favored Glycine 0 CA--C 1.525 0.71 0 O-C-N 121.009 -1.057 . . . . 0.0 112.062 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -124.23 115.91 21.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.541 1.671 . . . . 0.0 107.793 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -51.71 105.78 0.12 Allowed 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 126.157 1.783 . . . . 0.0 107.5 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.566 ' HB3' HD11 ' A' ' 72' ' ' ILE . 65.9 mt -145.09 71.75 1.31 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -171.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.43 39.89 0.34 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.397 1.479 . . . . 0.0 111.192 -172.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -149.1 152.59 36.42 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -165.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.54 -29.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.363 2.265 . . . . 0.0 112.006 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.01 -34.88 90.4 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 164.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.86 -57.35 4.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 117.382 -1.294 . . . . 0.0 110.071 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.875 HD13 HG21 ' A' ' 61' ' ' VAL . 1.2 mp -136.12 139.49 45.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 CA-C-N 120.725 1.602 . . . . 0.0 112.402 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -112.13 -91.17 0.49 Allowed 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.72 -174.66 2.51 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.332 -1.48 . . . . 0.0 113.833 -170.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.08 -42.01 84.67 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -82.64 -0.42 47.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.641 1.109 . . . . 0.0 110.962 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -89.59 -3.49 58.26 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.837 -1.164 . . . . 0.0 110.357 164.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.462 ' HB3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -125.79 -63.67 1.11 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 120.113 1.324 . . . . 0.0 111.092 177.188 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -91.04 -168.79 2.16 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.378 1.071 . . . . 0.0 109.265 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -54.61 -17.66 3.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.298 1.439 . . . . 0.0 113.034 168.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.54 75.29 0.88 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 126.722 2.106 . . . . 0.0 112.343 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -145.01 -60.88 0.36 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.822 0.811 . . . . 0.0 111.865 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.432 ' CE1' ' HB1' ' A' ' 12' ' ' ALA . 75.4 m-85 -137.58 -168.11 2.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.922 2.089 . . . . 0.0 107.912 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -160.62 131.71 5.59 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.56 1.944 . . . . 0.0 106.93 164.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.53 139.65 17.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 125.017 1.327 . . . . 0.0 107.99 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.467 HD13 HG22 ' A' ' 61' ' ' VAL . 18.8 mm -131.33 101.77 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 126.004 1.722 . . . . 0.0 106.528 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -100.65 95.57 6.77 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.617 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -87.62 121.07 29.59 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 172.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.9 98.57 0.71 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt 132.19 113.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 1 C-N-CA 134.458 5.103 . . . . 0.0 102.781 -163.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.431 0.0 OUTLIER 54.43 -127.61 2.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 116.665 -1.636 . . . . 0.0 109.031 -163.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.444 ' HB3' HG11 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -139.3 -143.55 0.16 Allowed 'General case' 0 C--O 1.243 0.725 0 CA-C-N 121.045 1.748 . . . . 0.0 113.213 -163.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -121.46 82.22 1.91 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.898 1.679 . . . . 0.0 109.851 -163.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -79.04 164.93 23.95 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 96' ' ' ILE . 1.2 tt -134.41 129.1 34.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -164.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.437 HD13 HG13 ' A' ' 86' ' ' ILE . 3.5 mp -124.72 135.16 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -171.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 14.2 ptt-85 -131.82 178.34 6.84 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.386 1.474 . . . . 0.0 111.853 166.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.61 161.82 18.59 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.462 1.105 . . . . 0.0 109.474 163.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.388 0 C-N-CA 126.197 1.799 . . . . 0.0 109.219 170.166 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.637 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.88 -39.14 73.0 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.747 -1.221 . . . . 0.0 112.146 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.22 -30.67 70.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 170.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -77.98 -32.86 51.56 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.904 0.881 . . . . 0.0 109.64 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 mt -64.96 -56.88 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 C-N-CA 126.155 1.782 . . . . 0.0 108.018 166.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -54.11 -50.45 66.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 120.309 1.413 . . . . 0.0 113.282 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -87.3 -12.61 46.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.095 0.861 . . . . 0.0 111.249 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.23 -44.02 94.45 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 164.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.449 ' CD2' HD13 ' A' ' 95' ' ' LEU . 10.4 m-85 -106.54 1.71 25.58 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -163.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -48.18 -12.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.34 -12.74 59.92 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.78 1.632 . . . . 0.0 112.978 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.606 HG22 ' HD2' ' A' ' 23' ' ' PRO . 10.5 p -160.36 160.69 26.15 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.659 1.984 . . . . 0.0 108.303 -177.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.606 ' HD2' HG22 ' A' ' 22' ' ' VAL . 89.9 Cg_endo -82.64 178.72 5.89 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.853 1.702 . . . . 0.0 111.761 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.5 179.0 4.15 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.01 1.724 . . . . 0.0 110.173 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 48.0 t80 -137.08 160.44 38.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.308 1.443 . . . . 0.0 108.69 164.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 t -139.27 129.64 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.388 1.875 . . . . 0.0 108.22 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.9 -168.33 1.59 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.476 0.58 . . . . 0.0 112.491 163.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.57 1.2 30.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -163.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.78 174.12 4.97 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.952 1.263 . . . . 0.0 112.244 -169.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.05 133.36 1.12 Allowed Glycine 0 CA--C 1.53 1.022 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -163.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -62.5 145.27 54.66 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -163.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.401 HG13 ' HD2' ' A' ' 33' ' ' PRO . 4.7 t -159.06 138.73 8.54 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 125.714 1.606 . . . . 0.0 106.876 -163.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HA ' HD23 ' A' ' 73' ' ' LEU . 87.9 Cg_endo -71.99 146.27 46.72 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.038 1.825 . . . . 0.0 111.203 -171.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.418 ' HG ' HD13 ' A' ' 54' ' ' ILE 0.328 0.9 OUTLIER -45.92 -36.62 5.57 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.977 171.451 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.685 ' HA ' HD22 ' A' ' 38' ' ' LEU 0.264 5.8 p -79.61 -9.28 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 120.602 -1.312 . . . . 0.0 114.194 -176.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -96.18 -38.96 9.92 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.513 1.051 . . . . 0.0 109.498 163.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -78.83 -17.72 55.2 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 116.84 -1.552 . . . . 0.0 109.624 -172.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.685 HD22 ' HA ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -78.99 -27.07 43.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 121.146 1.793 . . . . 0.0 110.228 171.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.576 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -77.93 -44.34 28.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 126.342 1.857 . . . . 0.0 106.743 -174.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -69.88 -41.26 75.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 124.781 1.232 . . . . 0.0 108.679 172.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.64 -16.38 57.41 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.725 1.148 . . . . 0.0 112.858 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.3 33.33 8.8 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 166.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.2 mp -78.36 -42.05 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 172.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.15 122.17 1.63 Allowed Pre-proline 0 C--N 1.348 0.509 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 163.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -84.34 -13.87 7.22 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.468 2.112 . . . . 0.0 112.758 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.8 m -89.63 101.6 14.29 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -164.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -47.05 -36.94 8.64 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 117.978 2.584 . . . . 0.0 117.978 -163.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -66.51 -47.03 74.24 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 121.991 2.178 . . . . 0.0 110.647 169.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -56.44 -50.89 70.36 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 119.366 0.985 . . . . 0.0 108.383 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -49.85 -54.95 16.23 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.933 1.293 . . . . 0.0 110.992 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -52.35 -48.7 65.38 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.919 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.07 -25.12 37.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.246 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -67.03 -16.52 64.4 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 126.709 2.004 . . . . 0.0 110.874 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.553 ' HA ' HG21 ' A' ' 59' ' ' ILE . 1.4 mt -109.14 -16.44 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 C-N-CA 126.098 1.759 . . . . 0.0 115.436 170.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -91.54 -8.09 48.47 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 120.801 1.637 . . . . 0.0 111.894 170.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' O ' HG22 ' A' ' 59' ' ' ILE . 3.4 m-80 -85.27 136.86 33.32 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 118.379 0.536 . . . . 0.0 109.962 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.19 10.04 0.44 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.459 -1.189 . . . . 0.0 114.47 168.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.9 -10.1 59.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.374 1.587 . . . . 0.0 112.369 171.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.419 0.0 OUTLIER -101.02 86.86 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 125.815 2.722 . . . . 0.0 106.981 178.669 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -79.09 95.19 5.49 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 110.678 -2.965 . . . . 0.0 106.701 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.674 HG21 HD13 ' A' ' 72' ' ' ILE . 22.3 t -79.12 142.6 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.64 HD22 HG12 ' A' ' 61' ' ' VAL . 2.7 p30 54.86 15.21 1.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.24 10.86 47.19 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 128.716 3.055 . . . . 0.0 113.225 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.84 131.52 14.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.466 1.633 . . . . 0.0 111.4 -163.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.21 109.1 0.39 Allowed 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 128.517 2.727 . . . . 0.0 109.805 -172.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.514 ' HB3' HD11 ' A' ' 72' ' ' ILE . 76.6 mt -139.18 71.01 1.37 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.337 0.971 . . . . 0.0 109.057 178.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.418 ' CD ' ' H ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -81.39 50.59 1.48 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.755 2.422 . . . . 0.0 112.442 -175.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -152.3 146.82 25.69 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.6 t -66.37 -30.47 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 127.47 2.308 . . . . 0.0 111.352 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.46 -2.36 90.6 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.557 1.075 . . . . 0.0 112.449 170.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.39 -60.63 1.84 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 117.398 -1.287 . . . . 0.0 109.322 164.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.674 HD13 HG21 ' A' ' 61' ' ' VAL . 1.4 mp -135.24 138.12 49.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-N 120.587 1.54 . . . . 0.0 113.12 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 33' ' ' PRO . 90.1 mt -110.36 -96.62 0.41 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 163.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -94.9 -169.27 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.763 1.268 . . . . 0.0 113.631 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.34 78.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.94 1.296 . . . . 0.0 113.459 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -70.78 -14.61 62.49 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.017 0.826 . . . . 0.0 112.069 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CG ' ' H ' ' A' ' 73' ' ' LEU . 52.3 t-80 -84.07 -2.11 56.1 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 171.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.471 ' HA ' ' HE ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -115.76 -86.72 0.61 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 166.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.652 HD11 ' H ' ' A' ' 83' ' ' PHE . 0.5 OUTLIER -91.27 -166.56 1.6 Allowed 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 126.658 1.983 . . . . 0.0 110.284 -170.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -51.6 1.52 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 130.01 3.324 . . . . 0.0 116.18 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.81 55.79 2.34 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 124.932 1.253 . . . . 0.0 110.54 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -135.26 -65.31 0.62 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 118.671 -0.681 . . . . 0.0 110.434 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.652 ' H ' HD11 ' A' ' 79' ' ' LEU . 96.6 m-85 -122.77 179.18 4.72 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 118.609 0.64 . . . . 0.0 109.439 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.93 136.24 26.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 163.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 61' ' ' VAL 0.251 33.0 t -108.74 131.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 116.26 -1.829 . . . . 0.0 106.969 -163.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 59' ' ' ILE . 49.7 mm -133.27 106.29 9.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 120.93 1.695 . . . . 0.0 110.869 -169.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -97.43 99.21 10.63 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 164.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.6 ttp85 -86.78 112.78 22.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 120.785 1.629 . . . . 0.0 108.562 164.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.87 166.71 1.89 Allowed Glycine 0 CA--C 1.533 1.175 0 CA-C-O 121.864 0.702 . . . . 0.0 112.471 172.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.6 mptt 63.59 -56.79 0.2 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.563 1.945 . . . . 0.0 112.282 -165.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -94.41 0.07 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 121.268 1.849 . . . . 0.0 110.183 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.88 -179.29 7.44 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 124.422 2.058 . . . . 0.0 108.709 -172.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 90.0 t80 -79.43 157.78 27.47 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 111.569 -2.56 . . . . 0.0 106.667 163.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -145.57 160.31 41.83 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 128.521 2.728 . . . . 0.0 109.013 164.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.449 HD13 ' CD2' ' A' ' 19' ' ' PHE . 43.6 tp -117.86 137.49 52.75 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.468 1.507 . . . . 0.0 108.22 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.6 mm -121.44 136.51 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.478 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 8.8 ttt180 -138.43 -177.7 4.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 124.333 2.016 . . . . 0.0 109.168 164.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.478 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -120.78 161.59 21.21 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.006 -1.906 . . . . 0.0 108.873 163.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 0 C-N-CA 126.723 2.009 . . . . 0.0 111.873 -172.814 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.856 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.95 -44.66 54.19 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.14 0.976 . . . . 0.0 109.097 -171.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.14 77.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.399 0.437 . . . . 0.0 109.901 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -71.78 -41.83 67.87 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 49.4 mt -67.38 -51.96 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.65 0.78 . . . . 0.0 110.265 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.05 -45.11 87.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 119.673 1.124 . . . . 0.0 111.313 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.24 -35.32 66.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.23 97.5 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 126.743 2.116 . . . . 0.0 109.952 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.524 ' CZ ' HG13 ' A' ' 85' ' ' VAL . 11.8 m-85 -101.76 6.19 41.6 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.798 0.439 . . . . 0.0 111.29 -170.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -64.75 -2.99 2.83 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -79.14 -15.46 58.09 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 111.975 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.611 HG22 ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -132.82 168.92 15.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 175.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.611 ' HD2' HG22 ' A' ' 22' ' ' VAL . 33.9 Cg_endo -81.77 162.58 18.74 Favored 'Trans proline' 0 N--CA 1.437 -1.819 0 C-N-CA 121.512 1.475 . . . . 0.0 108.507 173.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 m -111.68 162.6 15.03 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -116.81 156.43 27.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.219 -0.926 . . . . 0.0 108.575 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 3.2 p -134.33 127.24 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.413 ' CD2' ' H ' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -108.15 135.6 49.22 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.405 1.098 . . . . 0.0 108.687 163.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.91 61.9 3.97 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 170.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.37 171.02 32.87 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.811 1.196 . . . . 0.0 111.366 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.74 -150.72 26.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.349 1.452 . . . . 0.0 109.843 170.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HA ' ' CG2' ' A' ' 74' ' ' THR 0.278 0.0 OUTLIER -55.37 135.62 50.03 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.926 1.29 . . . . 0.0 113.53 -163.899 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -158.6 142.83 11.39 Favored Pre-proline 0 CA--C 1.518 -0.269 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -163.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HA ' HD23 ' A' ' 73' ' ' LEU . 33.1 Cg_endo -69.32 147.86 66.61 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.106 1.87 . . . . 0.0 111.957 -171.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.261 0.1 OUTLIER -39.37 -45.8 1.52 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.815 1.646 . . . . 0.0 113.421 170.256 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.555 ' HA ' HD22 ' A' ' 38' ' ' LEU . 8.4 p -79.02 -11.81 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.54 1.536 . . . . 0.0 113.218 -175.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -91.06 -43.86 9.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.822 0.737 . . . . 0.0 109.278 165.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.05 -30.23 67.44 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.668 -168.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.673 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -74.66 -36.58 62.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 120.129 1.331 . . . . 0.0 110.476 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.551 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -72.23 -43.28 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 C-N-CA 125.186 1.394 . . . . 0.0 107.566 -172.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.4 -40.08 81.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 126.415 1.886 . . . . 0.0 108.248 175.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.6 -20.56 50.2 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.799 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.55 17.17 11.58 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 119.085 0.857 . . . . 0.0 113.863 171.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -43.69 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 -171.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m -160.58 110.77 1.34 Allowed Pre-proline 0 N--CA 1.464 0.243 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.24 -20.96 6.84 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.467 2.111 . . . . 0.0 112.516 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -86.97 115.94 24.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -167.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -48.16 -36.77 14.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.972 1.309 . . . . 0.0 113.337 -172.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -67.04 -52.51 41.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.756 1.162 . . . . 0.0 111.152 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -56.26 -53.95 51.13 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.673 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -47.33 -54.61 10.63 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.409 1.884 . . . . 0.0 110.838 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.7 ttm-85 -50.23 -49.31 53.31 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 123.634 0.773 . . . . 0.0 110.771 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -80.99 -31.89 34.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.537 0.608 . . . . 0.0 112.482 -173.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.81 -21.96 63.67 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.514 1.525 . . . . 0.0 109.245 170.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.642 ' CD1' HD13 ' A' ' 38' ' ' LEU . 1.1 mp -91.44 -43.22 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 116.254 -1.831 . . . . 0.0 112.766 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -73.98 -10.74 59.94 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 120.222 1.374 . . . . 0.0 111.226 -173.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 58' ' ' ALA . 3.9 m120 -84.95 144.33 28.4 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.52 25.44 0.48 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.772 1.177 . . . . 0.0 113.486 166.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.545 ' HB1' ' NH2' ' A' ' 88' ' ' ARG . . . -117.93 4.35 12.15 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 128.628 2.771 . . . . 0.0 109.471 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.461 HD11 HD12 ' A' ' 86' ' ' ILE 0.327 0.0 OUTLIER -111.59 98.1 6.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 124.743 2.211 . . . . 0.0 107.573 163.624 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -81.07 100.39 8.98 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 112.687 -2.051 . . . . 0.0 107.776 171.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.478 HG21 HD13 ' A' ' 72' ' ' ILE . 57.2 t -78.91 128.25 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 61.43 0.93 0.49 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.932 1.293 . . . . 0.0 113.727 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.7 7.89 27.06 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 117.673 -1.626 . . . . 0.0 112.751 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.56 123.18 35.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.904 1.852 . . . . 0.0 108.555 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -50.37 102.29 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.927 2.091 . . . . 0.0 110.68 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.547 ' CB ' HD11 ' A' ' 72' ' ' ILE . 80.3 mt -141.81 110.1 5.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -175.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.33 44.61 2.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.541 2.736 . . . . 0.0 113.616 -163.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -143.32 154.62 43.96 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.003 -1.061 . . . . 0.0 111.785 167.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -64.09 134.72 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 122.975 1.369 . . . . 0.0 107.546 167.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.71 -6.57 46.25 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.006 -173.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.37 -46.59 32.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 163.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.547 HD11 ' CB ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -134.04 146.23 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 124.646 1.179 . . . . 0.0 108.235 165.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 33' ' ' PRO . 82.6 mt -124.17 -94.9 0.48 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 163.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.463 ' CG2' ' HA ' ' A' ' 31' ' ' ASP . 1.3 p -100.97 -173.89 2.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.774 1.624 . . . . 0.0 115.072 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . . . -50.4 -56.53 11.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.384 1.473 . . . . 0.0 114.075 171.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -67.23 -9.44 40.43 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.547 1.067 . . . . 0.0 113.166 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -89.64 -14.01 35.8 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.536 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.427 HH11 ' HA ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -103.29 -66.6 0.93 Allowed 'General case' 0 C--N 1.338 0.095 0 O-C-N 119.85 -1.782 . . . . 0.0 108.027 174.421 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.496 HD12 ' H ' ' A' ' 83' ' ' PHE . 0.9 OUTLIER -88.04 -168.97 2.39 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 128.335 2.654 . . . . 0.0 110.907 -171.313 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -64.44 -5.66 5.76 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.146 1.379 . . . . 0.0 114.022 165.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.19 75.81 1.1 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.983 1.754 . . . . 0.0 113.612 -170.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.52 -81.74 0.28 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.839 0.856 . . . . 0.0 109.417 163.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.496 ' H ' HD12 ' A' ' 79' ' ' LEU . 5.7 m-85 -128.36 -162.63 1.2 Allowed 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 125.455 1.502 . . . . 0.0 110.076 -170.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.39 121.15 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 119.205 -2.184 . . . . 0.0 107.151 168.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.524 HG13 ' CZ ' ' A' ' 19' ' ' PHE . 2.3 t -79.02 143.99 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.461 HD12 HD11 ' A' ' 59' ' ' ILE . 26.1 mm -126.26 136.59 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 127.781 2.433 . . . . 0.0 106.293 172.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -127.43 84.4 2.25 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 164.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.6 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -84.37 91.93 7.91 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.844 2.057 . . . . 0.0 106.249 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -28.59 -63.82 0.11 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.367 2.413 . . . . 0.0 115.447 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.6 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 35.1 tttp -44.14 -37.85 3.35 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.707 2.403 . . . . 0.0 113.727 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -111.6 -117.63 0.3 Allowed 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 -170.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.13 -151.35 0.38 Allowed 'General case' 0 C--O 1.246 0.887 0 CA-C-O 122.662 1.22 . . . . 0.0 110.941 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.454 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 3.3 m-30 -110.83 104.14 12.73 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.951 2.5 . . . . 0.0 106.59 -165.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -113.05 165.86 11.96 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.593 1.157 . . . . 0.0 110.199 -173.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.1 tp -130.14 132.85 46.26 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.541 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.37 135.0 65.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 9.9 ptm180 -132.22 175.3 9.38 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.365 1.866 . . . . 0.0 109.633 170.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -118.78 168.35 10.83 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.898 0.879 . . . . 0.0 110.26 166.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.775 0 C-N-CA 125.259 1.423 . . . . 0.0 109.818 166.584 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.29 69.23 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 120.513 -1.367 . . . . 0.0 112.898 -167.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.57 -21.59 41.56 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.163 171.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.93 -40.77 78.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 mt -68.89 -56.59 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 116.873 -1.536 . . . . 0.0 109.198 173.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -52.96 -55.09 26.05 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 120.026 1.284 . . . . 0.0 111.373 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -83.26 -13.22 55.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.06 -1.025 . . . . 0.0 110.202 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.8 -27.99 63.79 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 118.222 -1.321 . . . . 0.0 111.771 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -126.93 4.35 6.56 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -171.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -59.82 0.32 0.15 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.5 -6.4 53.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.607 1.094 . . . . 0.0 109.761 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -129.22 160.25 64.88 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.876 2.07 . . . . 0.0 106.509 170.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.475 ' HD2' HG12 ' A' ' 22' ' ' VAL . 86.0 Cg_endo -78.87 174.28 12.43 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.415 1.41 . . . . 0.0 110.429 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 p -110.33 174.21 5.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 112.396 -2.183 . . . . 0.0 109.096 175.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -140.19 158.39 44.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 164.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.68 128.33 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -110.61 156.09 21.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -81.27 51.08 1.54 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.248 1.019 . . . . 0.0 111.414 -172.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.93 -175.96 40.88 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 121.144 -0.972 . . . . 0.0 113.11 173.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.12 152.05 2.45 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 -163.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.01 162.09 22.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.17 164.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.0 t -154.18 127.7 4.34 Favored Pre-proline 0 CA--C 1.509 -0.631 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -167.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.451 ' HA ' HD23 ' A' ' 73' ' ' LEU . 87.7 Cg_endo -72.95 148.03 44.67 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 122.358 2.039 . . . . 0.0 110.302 -175.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.276 13.0 tp -39.29 -47.78 1.75 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.522 2.729 . . . . 0.0 112.042 173.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.0 -7.56 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.134 1.773 . . . . 0.0 114.849 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -103.32 -34.84 8.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.301 -1.333 . . . . 0.0 111.376 165.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.89 -30.12 44.75 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 120.675 1.58 . . . . 0.0 108.823 -170.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.673 HD22 HD11 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -85.2 -28.45 25.43 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 119.837 1.199 . . . . 0.0 108.656 -174.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.441 ' N ' HD23 ' A' ' 38' ' ' LEU . 1.1 t -66.78 -52.36 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 t -66.56 -39.66 88.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.77 -16.53 57.06 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.345 -177.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.38 21.93 12.32 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.179 0.899 . . . . 0.0 111.852 165.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.1 mp -78.55 -40.95 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 t -160.37 105.83 1.36 Allowed Pre-proline 0 C--N 1.346 0.437 0 CA-C-N 120.517 1.508 . . . . 0.0 108.101 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -83.32 -20.21 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.971 1.781 . . . . 0.0 113.799 -176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.7 t -85.61 103.41 14.41 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 51.5 mttm -56.63 -22.41 33.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -163.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -47.93 58.51 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 121.917 2.144 . . . . 0.0 110.006 169.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -56.73 -51.24 69.6 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -53.02 -50.88 63.36 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 125.144 1.378 . . . . 0.0 110.953 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -64.04 -32.7 74.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 116.712 -1.613 . . . . 0.0 111.314 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.56 -29.13 28.08 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.886 1.676 . . . . 0.0 112.891 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -65.88 -16.11 63.54 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.55 1.94 . . . . 0.0 112.036 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.673 HD11 HD22 ' A' ' 38' ' ' LEU . 71.1 mt -88.32 -61.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 C-N-CA 126.078 1.751 . . . . 0.0 108.0 163.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -16.26 61.69 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.488 1.04 . . . . 0.0 112.713 -164.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.2 m120 -85.14 138.69 32.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 119.023 0.829 . . . . 0.0 109.833 173.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.05 7.02 0.07 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.494 1.521 . . . . 0.0 114.851 171.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.45 -14.79 59.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.536 1.168 . . . . 0.0 110.434 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.522 HG22 ' O ' ' A' ' 56' ' ' ASN 0.39 0.0 OUTLIER -90.31 90.96 3.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 CA-C-O 125.972 2.796 . . . . 0.0 106.992 172.605 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -83.24 94.16 7.84 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 110.299 -3.137 . . . . 0.0 105.397 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.454 HG23 HD13 ' A' ' 86' ' ' ILE . 9.4 p -78.46 134.48 28.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.629 HD22 ' HG3' ' A' ' 78' ' ' ARG . 78.3 m-20 56.94 22.78 7.54 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.942 -1.099 . . . . 0.0 113.263 175.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.71 18.06 73.9 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.08 1.324 . . . . 0.0 113.617 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.38 119.93 21.35 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.674 2.39 . . . . 0.0 107.029 -164.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.27 108.88 0.99 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.02 -1.467 . . . . 0.0 108.048 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.1 mt -143.97 103.24 4.0 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-N 120.214 1.37 . . . . 0.0 107.742 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 25.73 8.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.576 1.151 . . . . 0.0 112.595 -172.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -131.29 137.06 48.66 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.034 -1.041 . . . . 0.0 112.509 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.38 -38.92 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 125.976 1.71 . . . . 0.0 110.402 166.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.53 -12.95 74.08 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.077 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.32 -36.84 13.62 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.198 0.999 . . . . 0.0 111.46 170.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.2 mt -142.0 121.9 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 120.068 1.304 . . . . 0.0 111.829 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 33' ' ' PRO . 61.4 mt -111.15 -94.27 0.44 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 101.365 -3.568 . . . . 0.0 101.365 163.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.72 -172.72 2.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.24 -49.88 74.65 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.328 1.051 . . . . 0.0 112.26 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -14.08 62.81 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.458 0.703 . . . . 0.0 111.691 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -81.91 -18.73 42.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 118.484 -0.77 . . . . 0.0 109.481 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.629 ' HG3' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -112.3 -60.5 1.86 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 119.932 1.242 . . . . 0.0 110.507 -171.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.628 HD21 ' O ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -90.37 -177.02 4.98 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.521 1.528 . . . . 0.0 108.636 167.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -48.63 -36.71 16.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.795 164.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.26 93.63 0.53 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 124.737 1.16 . . . . 0.0 112.06 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -139.07 -64.44 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 164.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.628 ' O ' HD21 ' A' ' 79' ' ' LEU . 35.7 m-85 -134.9 -169.75 2.42 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.805 2.042 . . . . 0.0 107.354 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.43 124.1 6.62 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 163.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -79.3 145.65 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.454 HD13 HG23 ' A' ' 61' ' ' VAL . 20.3 mm -129.06 91.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -91.4 81.83 5.42 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -78.7 102.86 8.27 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 168.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -43.98 -49.3 7.77 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.566 1.555 . . . . 0.0 113.022 -173.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.458 ' HA ' ' HE2' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.77 -0.28 3.97 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -132.42 -100.61 0.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 164.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.6 -164.67 1.6 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 121.056 1.753 . . . . 0.0 109.127 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.48 82.49 5.36 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 130.937 3.695 . . . . 0.0 110.753 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -78.37 166.82 22.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.464 HD12 ' H ' ' A' ' 96' ' ' ILE . 40.1 tp -130.07 140.62 50.81 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.677 -169.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 95' ' ' LEU . 9.3 mm -134.99 127.64 48.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -170.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -136.62 172.46 12.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 122.519 1.152 . . . . 0.0 112.556 163.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.99 161.21 13.84 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.093 1.357 . . . . 0.0 110.78 165.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.851 0 C-N-CA 129.213 3.005 . . . . 0.0 106.374 165.461 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.86 -37.03 49.17 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.255 -0.903 . . . . 0.0 111.255 -165.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.76 88.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.806 0.812 . . . . 0.0 109.894 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.25 -43.19 61.56 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.358 1.063 . . . . 0.0 108.183 -167.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 42.0 mt -66.21 -50.5 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 117.617 -1.182 . . . . 0.0 108.909 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -58.09 -51.07 71.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.517 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -79.76 -22.98 42.54 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.304 0.502 . . . . 0.0 109.831 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.49 -41.27 99.31 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -127.75 13.47 6.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -164.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -53.81 -8.18 0.15 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.018 2.527 . . . . 0.0 113.312 165.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.43 -27.8 46.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 128.19 2.596 . . . . 0.0 112.452 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.624 HG22 ' HD2' ' A' ' 23' ' ' PRO . 1.3 p -131.05 173.05 6.33 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -173.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.624 ' HD2' HG22 ' A' ' 22' ' ' VAL . 66.7 Cg_endo -77.09 177.47 8.84 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.719 1.613 . . . . 0.0 110.066 -175.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 81.9 p -136.39 167.68 20.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.252 1.021 . . . . 0.0 108.659 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -134.93 155.34 50.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.48 129.91 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.209 1.404 . . . . 0.0 108.336 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.07 176.73 5.43 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 122.02 0.914 . . . . 0.0 112.809 167.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -79.01 32.15 0.21 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.456 2.302 . . . . 0.0 113.723 -163.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.18 -170.77 25.2 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.494 -1.379 . . . . 0.0 110.296 -165.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.85 138.14 2.59 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -174.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -68.84 147.78 51.23 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 117.957 0.878 . . . . 0.0 111.174 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.3 t -160.33 135.16 5.53 Favored Pre-proline 0 CA--C 1.519 -0.244 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -164.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.511 ' HA ' HD23 ' A' ' 73' ' ' LEU . 95.9 Cg_endo -76.63 149.99 30.88 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.565 2.177 . . . . 0.0 112.311 -166.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.789 HD22 HG13 ' A' ' 54' ' ' ILE 0.3 0.1 OUTLIER -46.81 -41.29 15.25 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.072 178.614 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 p -75.09 -10.73 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 128.685 2.794 . . . . 0.0 114.815 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -98.75 -43.79 6.65 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 166.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 pp -76.44 -19.91 57.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 116.79 -1.576 . . . . 0.0 109.682 -166.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.618 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -77.98 -33.27 51.5 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 120.836 1.653 . . . . 0.0 110.324 173.058 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.42 -50.64 44.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 126.003 1.721 . . . . 0.0 107.773 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -36.2 83.2 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 127.361 2.264 . . . . 0.0 110.51 174.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.65 -22.59 46.63 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.471 176.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.07 33.04 7.14 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 169.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -78.1 -52.72 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 176.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.2 m -145.54 99.95 4.43 Favored Pre-proline 0 C--N 1.344 0.364 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 -173.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.41 -17.82 12.72 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.382 2.054 . . . . 0.0 112.918 -168.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.3 t -90.94 109.28 20.5 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -52.38 -37.48 56.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 117.533 -1.223 . . . . 0.0 114.051 -168.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -46.52 80.27 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.397 1.908 . . . . 0.0 110.38 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -51.11 71.11 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -52.48 -47.2 66.67 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.992 1.717 . . . . 0.0 110.371 177.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -56.89 -47.87 79.49 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 117.434 -1.27 . . . . 0.0 111.358 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.68 -35.73 75.38 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.594 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.21 -12.68 21.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 124.267 1.027 . . . . 0.0 112.704 172.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.789 HG13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -107.07 -29.39 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.669 1.988 . . . . 0.0 114.408 173.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -89.56 -9.66 49.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.062 1.345 . . . . 0.0 110.144 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.459 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.4 m120 -100.06 146.54 26.65 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.262 1.03 . . . . 0.0 110.847 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.77 11.54 0.26 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.32 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.6 -9.06 58.64 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 125.49 1.516 . . . . 0.0 110.583 171.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.315 0.0 OUTLIER -99.49 89.95 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 125.042 2.353 . . . . 0.0 107.36 171.335 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -83.46 95.91 8.41 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 111.681 -2.508 . . . . 0.0 106.34 170.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.9 p -78.75 134.75 27.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 103.629 -2.73 . . . . 0.0 103.629 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 59.75 19.78 8.56 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 120.713 1.597 . . . . 0.0 111.84 170.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.9 6.21 76.27 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.683 1.611 . . . . 0.0 114.298 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -130.8 116.92 18.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.622 1.711 . . . . 0.0 107.889 -164.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.18 106.16 0.35 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.571 1.548 . . . . 0.0 109.08 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 51.3 mt -140.43 104.12 4.7 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.87 68.9 1.11 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.849 1.26 . . . . 0.0 112.563 -172.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -157.54 153.27 26.69 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 120.673 -1.267 . . . . 0.0 109.205 167.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.03 -32.03 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.373 0.669 . . . . 0.0 109.872 164.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.16 -24.43 70.43 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.017 0.341 . . . . 0.0 113.847 172.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.82 -45.25 8.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.812 1.245 . . . . 0.0 111.023 -172.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.534 HD12 HD23 ' A' ' 34' ' ' LEU . 2.2 mt -141.76 129.31 21.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 119.462 1.028 . . . . 0.0 109.369 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 33' ' ' PRO . 92.0 mt -110.15 -93.83 0.43 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 101.177 -3.638 . . . . 0.0 101.177 163.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.27 -171.41 2.07 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -173.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.55 86.66 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.58 1.152 . . . . 0.0 112.288 174.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -17.74 64.77 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.806 0.73 . . . . 0.0 111.837 175.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.444 ' CG ' ' H ' ' A' ' 73' ' ' LEU . 38.6 t-80 -89.31 2.04 54.91 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 123.581 0.752 . . . . 0.0 109.729 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.488 ' HB3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -119.97 -70.25 0.8 Allowed 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.791 1.178 . . . . 0.0 109.596 169.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.488 HD23 ' HB3' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -91.79 -170.86 2.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 129.195 2.998 . . . . 0.0 110.226 172.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -57.8 -7.17 0.65 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.391 2.277 . . . . 0.0 114.346 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.29 73.55 1.03 Allowed Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 124.286 0.946 . . . . 0.0 111.527 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.97 -66.02 0.53 Allowed 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -140.93 -175.4 4.29 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.564 1.946 . . . . 0.0 106.913 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.67 138.2 18.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 163.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.9 t -104.08 148.04 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.83 101.65 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 128.268 2.627 . . . . 0.0 105.531 -172.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -94.3 80.86 3.98 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.439 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -78.93 85.08 4.91 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 169.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -4.94 -88.82 0.0 OUTLIER Glycine 0 CA--C 1.525 0.659 1 C-N-CA 130.997 4.141 . . . . 0.0 116.033 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.439 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -65.49 -19.78 66.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.861 0.83 . . . . 0.0 112.138 -172.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -85.0 -111.63 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 166.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.38 -157.22 0.57 Allowed 'General case' 0 C--O 1.239 0.534 0 CA-C-N 120.276 1.398 . . . . 0.0 110.661 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -106.5 65.05 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 130.14 3.376 . . . . 0.0 111.087 -167.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -78.59 167.08 21.79 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 120.753 -1.217 . . . . 0.0 110.653 -170.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 96' ' ' ILE . 31.5 tp -132.09 133.52 44.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.273 1.029 . . . . 0.0 108.946 -166.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 95' ' ' LEU . 36.2 mm -135.61 124.81 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -166.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -138.53 174.07 10.92 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.754 1.264 . . . . 0.0 111.647 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.48 167.62 10.72 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.242 1.017 . . . . 0.0 109.798 164.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.525 0 C-N-CA 127.186 2.195 . . . . 0.0 110.295 178.523 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 C--O 1.219 -0.539 0 CA-C-O 122.782 1.277 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.2 -39.84 78.39 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 119.127 -2.233 . . . . 0.0 111.099 -175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.02 82.44 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -67.58 -37.61 82.85 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.8 mt -73.23 -50.75 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.81 1.644 . . . . 0.0 108.548 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.66 -46.54 89.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.15 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -71.26 -27.65 63.59 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.142 -0.974 . . . . 0.0 109.433 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.74 -41.32 42.85 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 126.28 1.895 . . . . 0.0 109.807 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -116.39 13.12 15.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.197 0.599 . . . . 0.0 111.208 -164.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -45.81 -25.65 0.54 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.745 2.418 . . . . 0.0 112.99 163.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.05 -12.08 59.96 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.755 2.422 . . . . 0.0 111.42 -174.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.564 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -133.51 169.9 12.74 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 127.257 2.223 . . . . 0.0 106.193 -174.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.564 ' HD2' HG12 ' A' ' 22' ' ' VAL . 43.6 Cg_endo -76.42 176.66 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 CA-C-N 121.134 1.441 . . . . 0.0 109.503 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.5 p -129.64 165.8 21.06 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.254 164.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -133.47 158.76 42.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.763 1.225 . . . . 0.0 107.87 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.59 137.25 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -122.28 173.28 7.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 122.86 1.315 . . . . 0.0 110.956 163.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.46 37.14 0.33 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 127.833 2.453 . . . . 0.0 113.527 -163.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.7 -167.85 10.18 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -165.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.22 145.31 1.65 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -73.62 152.05 40.65 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.558 -0.966 . . . . 0.0 112.467 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.4 t -158.76 133.08 5.24 Favored Pre-proline 0 C--N 1.343 0.302 0 CA-C-O 117.693 -1.146 . . . . 0.0 109.394 -163.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -55.76 141.19 85.06 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.666 2.91 . . . . 0.0 112.058 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.364 0.4 OUTLIER -48.07 -36.38 12.99 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.779 165.166 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.431 ' HA ' HD11 ' A' ' 54' ' ' ILE 0.259 12.1 p -71.41 -15.44 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.464 1.506 . . . . 0.0 114.617 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -98.44 -44.04 6.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 118.785 0.72 . . . . 0.0 109.284 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -71.87 -25.94 62.15 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 116.887 -1.53 . . . . 0.0 109.133 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.593 HD22 HD11 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -84.32 -25.32 29.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 120.955 1.707 . . . . 0.0 110.469 -177.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.434 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -76.07 -45.88 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.63 -45.36 90.61 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.66 1.584 . . . . 0.0 107.994 175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.73 -18.61 53.99 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.139 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.92 33.87 7.13 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 119.071 0.851 . . . . 0.0 111.171 164.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.25 -49.31 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.42 107.44 2.76 Favored Pre-proline 0 C--N 1.345 0.399 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 172.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.55 -15.73 8.42 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.539 2.159 . . . . 0.0 113.04 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.8 t -82.65 119.05 23.8 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -56.04 -36.13 67.66 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 120.662 1.574 . . . . 0.0 114.459 -165.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.83 -56.17 24.39 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.288 1.404 . . . . 0.0 109.118 170.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -55.08 -49.06 72.62 Favored 'General case' 0 C--O 1.207 -1.179 0 O-C-N 124.218 0.949 . . . . 0.0 108.442 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -47.99 -58.72 4.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.336 1.454 . . . . 0.0 111.198 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -65.66 -26.57 67.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.672 -174.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -89.59 -29.11 19.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 120.094 1.315 . . . . 0.0 112.532 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.62 -20.08 65.39 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.771 1.629 . . . . 0.0 109.76 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.593 HD11 HD22 ' A' ' 38' ' ' LEU . 64.9 mt -82.99 -66.5 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-O 116.251 -1.833 . . . . 0.0 109.394 163.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -64.96 -5.85 7.13 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 119.864 1.211 . . . . 0.0 112.663 -164.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 58' ' ' ALA . 2.9 m120 -76.62 134.99 39.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.244 1.021 . . . . 0.0 113.166 164.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.27 34.3 0.66 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.145 1.831 . . . . 0.0 111.773 164.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -118.66 4.4 11.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.58 2.352 . . . . 0.0 111.161 167.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.478 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.328 0.0 OUTLIER -102.46 100.4 10.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 124.378 2.037 . . . . 0.0 106.585 163.635 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -88.94 98.98 12.05 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 112.928 -1.942 . . . . 0.0 107.631 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.654 HG21 HD13 ' A' ' 72' ' ' ILE . 40.3 t -79.36 135.16 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.447 HD21 ' CD2' ' A' ' 79' ' ' LEU . 1.6 m120 55.59 27.5 10.54 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.915 0.864 . . . . 0.0 109.87 -174.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.75 9.27 86.97 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 117.498 -1.723 . . . . 0.0 113.256 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 133.46 38.29 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.997 2.399 . . . . 0.0 109.411 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 109.75 0.65 Allowed 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 127.497 2.319 . . . . 0.0 109.403 -166.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 72' ' ' ILE . 55.6 mt -145.28 110.82 5.35 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -118.75 27.76 8.71 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.997 2.519 . . . . 0.0 112.793 -163.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -142.18 156.91 45.36 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.939 -1.101 . . . . 0.0 113.76 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 p -69.63 -39.44 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.139 2.176 . . . . 0.0 110.882 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.2 -12.77 72.66 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 170.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.31 -58.35 3.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 116.267 -1.825 . . . . 0.0 109.991 167.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.654 HD13 HG21 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -139.66 137.78 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 121.601 2.001 . . . . 0.0 114.049 -176.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.6 mt -108.05 -95.06 0.39 Allowed 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 163.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.9 -176.66 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 119.941 -1.724 . . . . 0.0 115.627 -164.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.44 -54.74 42.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.808 0.843 . . . . 0.0 111.04 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.63 -4.07 21.5 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.797 1.239 . . . . 0.0 113.329 175.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 63.7 t-80 -88.53 -23.89 23.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.322 166.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.491 HH21 HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -105.42 -65.12 1.07 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -171.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -90.88 -176.68 4.74 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.523 1.129 . . . . 0.0 108.262 174.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -54.3 -21.57 9.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.128 0.971 . . . . 0.0 112.362 170.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.73 85.53 0.81 Allowed Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 125.647 1.594 . . . . 0.0 112.829 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.2 mtp85 -141.28 -67.03 0.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 163.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -128.27 -168.11 1.86 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.786 1.234 . . . . 0.0 109.795 -170.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.16 130.88 12.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 163.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.78 136.59 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.7 mm -127.53 94.96 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 124.283 1.033 . . . . 0.0 108.316 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -91.28 83.26 5.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -78.89 99.16 6.65 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 170.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.71 159.76 4.26 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.0 tttt 71.98 -48.29 0.68 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.194 2.198 . . . . 0.0 109.686 -164.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -88.58 -153.65 0.26 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 164.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.472 ' HB3' HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -120.53 -158.13 0.74 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 124.955 1.302 . . . . 0.0 110.912 -167.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -95.22 93.99 7.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.111 2.565 . . . . 0.0 107.886 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -78.55 164.92 24.28 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 120.478 -1.389 . . . . 0.0 107.779 168.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.3 tt -133.06 123.88 26.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 mm -116.49 132.55 65.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -136.5 179.92 6.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 122.322 1.058 . . . . 0.0 111.477 171.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.5 165.11 14.32 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 123.737 0.815 . . . . 0.0 111.328 165.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.369 0 C-N-CA 128.392 2.677 . . . . 0.0 110.075 -177.197 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.89 -49.27 47.71 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.226 -0.921 . . . . 0.0 111.901 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.77 74.44 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -39.37 65.26 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.6 mt -66.88 -51.53 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 124.755 1.222 . . . . 0.0 109.554 174.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -53.14 -59.11 4.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.829 0.74 . . . . 0.0 110.307 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -76.35 -19.37 58.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.698 -174.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.89 -40.47 74.42 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -119.27 6.11 11.2 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -164.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -58.82 15.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.808 2.043 . . . . 0.0 114.963 163.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.49 -25.08 45.61 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.71 -1.244 . . . . 0.0 109.802 164.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.435 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -127.94 160.22 62.5 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.395 1.878 . . . . 0.0 107.142 -176.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.435 ' HD2' HG12 ' A' ' 22' ' ' VAL . 96.3 Cg_endo -71.23 179.21 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.086 1.857 . . . . 0.0 110.569 172.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.1 p -121.45 -178.37 3.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.325 1.05 . . . . 0.0 110.561 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -140.8 154.37 46.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 164.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 4.2 p -135.23 124.97 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 C-N-CA 124.954 1.302 . . . . 0.0 108.455 175.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.22 170.99 7.78 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 122.556 1.17 . . . . 0.0 111.288 171.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -79.17 8.0 6.61 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 126.69 1.996 . . . . 0.0 113.865 -163.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.6 -179.52 49.07 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.698 1.618 . . . . 0.0 112.774 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.38 139.05 3.07 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -163.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -66.62 136.62 55.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.174 0.987 . . . . 0.0 111.333 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.7 t -144.93 136.54 12.79 Favored Pre-proline 0 C--O 1.225 -0.198 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -163.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HA ' HD23 ' A' ' 73' ' ' LEU . 88.8 Cg_exo -50.51 140.6 35.43 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 124.903 3.735 . . . . 0.0 114.816 -176.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.683 HD22 HG13 ' A' ' 54' ' ' ILE 0.254 0.0 OUTLIER -47.61 -45.02 27.18 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.821 0.819 . . . . 0.0 111.519 164.461 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.719 ' HA ' HD12 ' A' ' 38' ' ' LEU . 8.8 p -77.49 8.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 128.047 2.539 . . . . 0.0 113.548 -177.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -120.55 -45.47 2.41 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.58 1.152 . . . . 0.0 108.089 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.92 -24.89 64.34 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 120.015 -1.678 . . . . 0.0 108.959 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.719 HD12 ' HA ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -75.71 -33.83 60.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.552 1.524 . . . . 0.0 110.296 177.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.626 ' N ' HD13 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -72.97 -46.27 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 127.005 2.122 . . . . 0.0 108.536 -173.297 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 m -62.82 -45.65 91.64 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 128.34 2.656 . . . . 0.0 109.098 169.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.42 -11.91 59.98 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.409 1.004 . . . . 0.0 112.647 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.43 27.09 23.62 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 119.222 0.919 . . . . 0.0 112.096 167.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.99 -42.66 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.1 m -156.17 101.78 2.09 Favored Pre-proline 0 C--N 1.347 0.484 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 165.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.28 -14.69 13.09 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.379 2.053 . . . . 0.0 113.32 -171.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.8 t -81.87 108.62 15.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HE3' HG11 ' A' ' 39' ' ' VAL . 14.8 mptt -50.1 -35.28 24.86 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -164.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.29 -47.35 67.89 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 121.137 1.789 . . . . 0.0 110.444 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -50.0 72.49 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.608 ' HB1' HD11 ' A' ' 38' ' ' LEU . . . -50.91 -48.0 60.71 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.946 1.699 . . . . 0.0 111.48 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -61.68 -40.79 96.2 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 115.961 -1.971 . . . . 0.0 110.478 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -25.11 48.69 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 116.332 -2.147 . . . . 0.0 112.861 173.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.513 ' HA ' HH11 ' A' ' 88' ' ' ARG . 0.3 OUTLIER -66.65 -18.79 65.56 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 117.666 -1.159 . . . . 0.0 112.093 174.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.683 HG13 HD22 ' A' ' 34' ' ' LEU . 1.1 mp -92.38 -51.64 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 116.633 -1.651 . . . . 0.0 110.707 164.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -68.82 -13.48 62.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 120.821 1.646 . . . . 0.0 110.627 -164.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.652 ' O ' HG22 ' A' ' 59' ' ' ILE . 9.5 m120 -85.76 132.58 34.1 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 118.317 0.508 . . . . 0.0 111.143 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.68 17.29 0.25 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.208 0.909 . . . . 0.0 114.129 169.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.17 -1.39 54.24 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 119.039 1.419 . . . . 0.0 111.006 164.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 56' ' ' ASN 0.286 0.0 OUTLIER -88.8 89.25 3.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 163.093 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -78.69 103.24 8.5 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 166.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 66' ' ' LEU . 8.5 p -78.4 137.14 22.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 102.111 -3.292 . . . . 0.0 102.111 175.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.555 HD21 ' CD2' ' A' ' 79' ' ' LEU . 12.8 m-20 75.81 -54.43 0.62 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 127.192 2.197 . . . . 0.0 109.645 174.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' H ' ' H ' ' A' ' 64' ' ' GLU . . . 172.76 5.04 0.03 OUTLIER Glycine 0 CA--C 1.536 1.352 1 C-N-CA 131.969 4.604 . . . . 0.0 111.577 174.798 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.424 ' H ' ' H ' ' A' ' 63' ' ' GLY . 15.0 pm0 -122.33 128.3 50.86 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.682 1.993 . . . . 0.0 108.362 -169.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 106.8 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.319 1.848 . . . . 0.0 109.145 -177.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HB2' HG12 ' A' ' 61' ' ' VAL . 57.3 mt -144.23 110.51 5.49 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.426 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -121.63 16.51 11.16 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.507 2.323 . . . . 0.0 112.639 -169.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -118.98 141.08 48.99 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.468 1.507 . . . . 0.0 109.231 -172.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.482 HG22 HD21 ' A' ' 73' ' ' LEU . 9.8 p -57.47 -42.8 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.216 1.406 . . . . 0.0 110.39 177.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.9 -8.48 73.32 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.61 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.43 ' C ' HG13 ' A' ' 72' ' ' ILE . . . -85.17 -45.06 12.39 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.736 0.768 . . . . 0.0 109.466 170.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.621 HD12 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -140.99 127.76 21.01 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-N 120.298 1.408 . . . . 0.0 112.657 -178.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.482 HD21 HG22 ' A' ' 69' ' ' VAL . 97.7 mt -116.41 -92.64 0.51 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 102.241 -3.244 . . . . 0.0 102.241 163.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.66 -175.48 2.81 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.782 -1.199 . . . . 0.0 113.502 -175.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.45 -43.2 79.29 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -82.82 -6.0 59.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.81 1.186 . . . . 0.0 111.078 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -81.58 -11.39 59.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 121.768 -0.583 . . . . 0.0 109.61 165.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.409 ' HD3' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -117.2 -71.42 0.74 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.646 1.112 . . . . 0.0 109.505 -173.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.555 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.9 -168.4 2.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.884 2.473 . . . . 0.0 109.271 176.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -53.0 -9.88 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.396 1.878 . . . . 0.0 115.644 166.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.67 71.22 1.0 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.64 1.114 . . . . 0.0 113.021 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -141.35 -64.85 0.44 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.17 0.485 . . . . 0.0 110.614 173.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -133.82 -169.06 2.23 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.559 1.544 . . . . 0.0 107.953 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -158.08 155.79 29.87 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 164.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.72 150.61 23.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.9 mm -135.0 97.64 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -170.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -99.49 81.14 2.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.513 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -78.62 117.54 19.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 171.137 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.85 -49.68 12.6 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.038 1.304 . . . . 0.0 111.837 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -1.04 0.79 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.56 1.544 . . . . 0.0 115.001 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -146.92 -95.86 0.09 Allowed 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 121.448 1.931 . . . . 0.0 109.176 164.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -153.93 -163.1 1.56 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 120.53 1.514 . . . . 0.0 109.513 -171.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -107.41 75.64 1.03 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 127.949 2.499 . . . . 0.0 109.969 -170.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -78.45 165.05 24.23 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.965 -1.085 . . . . 0.0 109.568 -172.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.8 tp -115.63 134.67 54.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.111 1.365 . . . . 0.0 107.987 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.7 mm -128.62 133.5 66.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -174.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 8.1 ptt-85 -139.25 174.49 10.46 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.948 1.356 . . . . 0.0 111.432 167.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.57 162.52 17.87 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.328 1.051 . . . . 0.0 110.199 164.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.408 0 C-N-CA 129.453 3.101 . . . . 0.0 108.276 175.887 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.223 -0.34 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.36 67.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 120.609 -1.307 . . . . 0.0 112.106 -169.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.63 76.27 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.132 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -74.4 -24.2 59.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.597 0.759 . . . . 0.0 110.251 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.9 mt -77.96 -57.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 125.732 1.613 . . . . 0.0 107.629 175.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -52.82 -45.34 67.25 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.93 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -91.19 -19.06 23.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.573 0.749 . . . . 0.0 111.346 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.51 -37.79 69.01 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 170.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.561 ' CD2' HG21 ' A' ' 85' ' ' VAL . 58.5 m-85 -120.61 15.45 11.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 119.581 -0.847 . . . . 0.0 110.497 -164.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -0.33 0.1 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.509 1.924 . . . . 0.0 115.297 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.82 -20.92 48.55 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.934 -1.104 . . . . 0.0 111.219 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.415 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -127.2 160.08 61.68 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 178.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.415 ' HD2' HG12 ' A' ' 22' ' ' VAL . 39.6 Cg_endo -80.58 176.88 8.67 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 CA-C-N 120.626 1.259 . . . . 0.0 109.926 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.5 p -112.12 165.62 11.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.716 172.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -130.04 157.96 40.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.692 2.397 . . . . 0.0 106.956 169.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 4.1 p -135.21 136.12 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -127.42 -172.87 2.76 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 119.503 1.047 . . . . 0.0 112.533 163.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 6.78 8.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.577 1.551 . . . . 0.0 113.983 -163.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.54 -173.1 34.1 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.082 1.325 . . . . 0.0 111.26 -170.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.84 135.57 1.65 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.26 134.55 39.33 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.543 0.672 . . . . 0.0 112.692 -167.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 t -157.47 131.66 5.04 Favored Pre-proline 0 CA--C 1.515 -0.384 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -166.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.543 ' HA ' HD23 ' A' ' 73' ' ' LEU . 87.1 Cg_endo -74.64 150.9 40.73 Favored 'Trans proline' 0 N--CA 1.437 -1.84 0 C-N-CA 122.529 2.153 . . . . 0.0 111.403 -167.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.719 HD22 HG13 ' A' ' 54' ' ' ILE 0.299 0.0 OUTLIER -44.01 -42.09 5.83 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.568 174.149 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.66 ' HA ' HD22 ' A' ' 38' ' ' LEU . 1.4 p -79.76 -5.59 8.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 126.907 2.083 . . . . 0.0 115.342 -174.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -105.06 -35.61 7.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.22 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.83 -21.03 57.69 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 120.914 1.688 . . . . 0.0 109.298 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.705 HD13 ' CD1' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -77.72 -30.37 51.69 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 120.302 1.41 . . . . 0.0 110.27 173.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.583 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -74.35 -47.86 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -173.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -47.68 84.48 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.627 1.971 . . . . 0.0 109.482 171.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.417 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.82 -10.81 59.91 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.353 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.39 33.95 18.32 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 119.111 0.869 . . . . 0.0 111.068 166.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.484 ' CG2' HD12 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -78.56 -51.37 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 172.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -151.56 105.78 2.91 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 169.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -84.31 -12.67 7.84 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.811 2.341 . . . . 0.0 113.642 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -87.57 115.8 25.25 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -52.01 -34.85 44.71 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -165.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -62.95 -54.7 34.31 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.948 1.704 . . . . 0.0 109.039 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -48.31 78.86 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 117.172 -1.394 . . . . 0.0 108.482 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.545 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -48.31 -58.68 4.23 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 125.319 1.448 . . . . 0.0 111.104 175.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HG2' HG21 ' A' ' 35' ' ' VAL . 64.0 mtt180 -67.35 -27.74 67.37 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 117.332 -1.318 . . . . 0.0 110.616 -170.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.07 -34.23 26.23 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 120.302 1.41 . . . . 0.0 112.234 172.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.564 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.8 m-20 -64.65 -16.82 63.38 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.511 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.719 HG13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -92.26 -53.59 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 116.054 -1.927 . . . . 0.0 111.728 166.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -71.61 -5.11 31.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 120.941 1.7 . . . . 0.0 112.076 -171.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.543 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.1 m120 -80.62 136.48 36.23 Favored 'General case' 0 N--CA 1.437 -1.118 0 O-C-N 121.373 -0.829 . . . . 0.0 112.462 173.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.72 33.87 0.86 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 124.486 1.041 . . . . 0.0 112.141 167.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -121.39 0.39 10.01 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 126.901 2.08 . . . . 0.0 111.509 168.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 56' ' ' ASN 0.315 0.0 OUTLIER -91.99 98.73 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 163.533 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -88.72 105.22 17.55 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.333 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 72' ' ' ILE . 7.9 t -88.43 130.34 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.538 HD21 ' CD2' ' A' ' 79' ' ' LEU . 5.9 m-80 57.37 18.09 4.17 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.565 0.698 . . . . 0.0 111.577 -173.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.13 11.71 78.01 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 120.599 -1.313 . . . . 0.0 113.5 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -119.37 123.27 43.75 Favored 'General case' 0 C--O 1.228 -0.062 0 CA-C-N 119.735 1.768 . . . . 0.0 108.421 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 112.1 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.138 0.975 . . . . 0.0 108.854 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.441 ' CB ' HD11 ' A' ' 72' ' ' ILE . 64.8 mt -144.89 108.26 4.6 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -174.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -131.09 31.49 4.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 126.718 2.007 . . . . 0.0 113.891 -163.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -142.38 157.27 44.97 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.6 -0.687 . . . . 0.0 111.182 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.5 p -62.72 137.47 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 163.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.33 -8.41 46.97 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.645 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.17 -53.68 7.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 163.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.506 ' CD1' HG21 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -139.58 145.0 27.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 119.244 0.929 . . . . 0.0 110.137 170.221 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 33' ' ' PRO . 92.5 mt -124.15 -91.32 0.55 Allowed 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 163.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.89 -175.56 3.0 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.729 -1.232 . . . . 0.0 113.548 -174.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.627 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . . . -58.57 -41.85 86.65 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.876 175.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -76.3 -7.47 55.0 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 123.727 0.642 . . . . 0.0 110.981 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -92.99 -4.8 51.99 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.927 1.291 . . . . 0.0 110.393 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -120.34 -65.17 1.18 Allowed 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.953 -1.717 . . . . 0.0 109.498 175.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.538 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.14 -172.68 3.57 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.475 1.51 . . . . 0.0 109.501 170.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -50.43 -17.87 0.55 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.712 2.005 . . . . 0.0 113.918 166.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.36 80.4 1.33 Allowed Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 125.435 1.493 . . . . 0.0 111.507 -174.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -143.62 -63.58 0.39 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 122.802 0.441 . . . . 0.0 111.548 163.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -131.46 -174.11 3.31 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.99 2.116 . . . . 0.0 108.172 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -160.73 164.12 31.84 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.839 1.656 . . . . 0.0 107.186 164.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 19' ' ' PHE . 72.1 t -134.22 143.97 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 O-C-N 120.59 -1.319 . . . . 0.0 107.516 176.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.488 HD13 HG22 ' A' ' 61' ' ' VAL . 25.4 mm -125.06 98.38 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 127.774 2.429 . . . . 0.0 107.221 -172.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -96.13 84.62 3.83 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.564 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -82.14 114.08 20.43 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.77 1.78 0.7 Allowed Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.459 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 34.0 tptt -69.4 -46.23 67.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.58 1.69 . . . . 0.0 109.395 166.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -125.43 -90.27 0.55 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.801 1.24 . . . . 0.0 108.844 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.433 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.31 -159.88 1.02 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-N 119.671 1.123 . . . . 0.0 109.197 -163.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.433 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -99.46 83.84 2.88 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 130.826 3.65 . . . . 0.0 109.578 -176.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -78.46 158.97 28.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.131 -1.804 . . . . 0.0 106.131 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.9 tt -126.37 129.9 49.7 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -163.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.5 mm -120.82 122.53 68.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -168.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 11.5 ptt85 -128.63 171.89 11.73 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 124.044 1.878 . . . . 0.0 110.294 176.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.627 ' CE1' ' HB2' ' A' ' 75' ' ' ALA . 6.0 m-85 -143.56 158.47 43.63 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -164.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.796 0 C-N-CA 128.487 2.715 . . . . 0.0 111.127 169.901 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.215 -0.72 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.44 -49.71 70.43 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 119.841 -1.787 . . . . 0.0 112.039 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.23 73.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.631 0.651 . . . . 0.0 111.033 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.31 -38.45 71.73 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 125.261 1.425 . . . . 0.0 109.158 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.413 ' CG2' HD13 ' A' ' 95' ' ' LEU . 27.4 mt -69.3 -45.96 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 126.518 1.927 . . . . 0.0 106.61 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -54.28 -57.91 9.41 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.463 175.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -71.85 -29.68 64.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.401 1.0 . . . . 0.0 109.94 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.54 -29.6 72.94 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 126.335 1.921 . . . . 0.0 110.414 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -117.11 -1.82 11.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.027 -173.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -59.02 -0.53 0.12 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.8 -13.35 59.86 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.844 1.202 . . . . 0.0 111.243 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 p -127.39 157.46 72.69 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 128.598 2.759 . . . . 0.0 105.785 167.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -87.08 176.66 4.29 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 121.313 1.342 . . . . 0.0 109.801 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.4 p -106.36 177.74 4.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.254 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -123.6 157.29 34.06 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 164.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 p -136.94 133.92 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 124.923 1.289 . . . . 0.0 108.347 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -123.72 -177.56 3.77 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.115 0.483 . . . . 0.0 111.743 163.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.78 39.43 0.95 Allowed 'General case' 0 C--N 1.318 -0.768 0 O-C-N 120.485 -1.384 . . . . 0.0 113.635 -163.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.67 -175.58 0.86 Allowed Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.903 -1.123 . . . . 0.0 112.788 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.18 131.83 0.23 Allowed Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.49 147.71 52.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -167.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 t -152.88 136.59 10.13 Favored Pre-proline 0 C--O 1.222 -0.382 0 C-N-CA 124.743 1.217 . . . . 0.0 108.345 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.46 ' HA ' HD23 ' A' ' 73' ' ' LEU . 61.3 Cg_endo -65.4 145.38 82.93 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.348 2.699 . . . . 0.0 111.394 -173.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.428 HD22 HG13 ' A' ' 54' ' ' ILE 0.375 0.1 OUTLIER -43.22 -39.19 2.85 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 170.354 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.488 ' HA ' HD22 ' A' ' 38' ' ' LEU . 3.6 p -77.24 -13.0 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.963 1.305 . . . . 0.0 113.992 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -100.1 -32.79 10.75 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 120.119 1.327 . . . . 0.0 109.444 167.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.48 -30.79 64.85 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 121.829 2.104 . . . . 0.0 108.237 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.691 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -75.9 -31.4 59.18 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 120.658 1.572 . . . . 0.0 110.076 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.489 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -72.27 -46.09 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 126.402 1.881 . . . . 0.0 107.265 -176.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.2 t -65.69 -41.86 91.9 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 128.145 2.578 . . . . 0.0 107.776 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -80.77 -18.14 48.62 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.74 29.86 9.54 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 118.531 0.605 . . . . 0.0 111.776 168.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.471 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.4 mp -78.81 -47.06 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 175.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.7 m -155.34 113.65 2.27 Favored Pre-proline 0 CA--C 1.517 -0.299 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.77 -17.17 7.29 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.41 2.074 . . . . 0.0 113.532 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.63 116.17 23.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -167.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -36.96 66.79 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -163.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -69.06 -42.71 75.91 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 120.15 1.341 . . . . 0.0 110.197 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -61.65 -51.99 66.18 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.691 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -50.52 -51.53 46.75 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.49 1.916 . . . . 0.0 110.0 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -53.56 -48.48 69.1 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.583 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -78.35 -32.11 48.91 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.69 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -62.78 -17.71 61.5 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.746 1.218 . . . . 0.0 111.001 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.669 ' CD1' HD13 ' A' ' 38' ' ' LEU . 1.2 mp -90.07 -55.92 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 117.193 -1.384 . . . . 0.0 112.599 169.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -73.18 -6.74 47.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.567 1.076 . . . . 0.0 111.416 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.2 m-80 -78.32 138.5 38.6 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.367 1.08 . . . . 0.0 112.041 169.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.31 46.07 2.43 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.055 164.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -126.26 11.01 7.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.979 2.912 . . . . 0.0 110.456 165.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 56' ' ' ASN 0.332 0.0 OUTLIER -111.25 91.9 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 162.907 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -82.85 122.1 27.8 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.02 -1.9 . . . . 0.0 107.618 174.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.62 HG21 HD13 ' A' ' 72' ' ' ILE . 25.1 t -115.28 135.83 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER 61.11 -16.88 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.795 2.038 . . . . 0.0 114.205 -174.524 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 61' ' ' VAL . . . 152.19 -7.24 0.54 Allowed Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 126.683 2.087 . . . . 0.0 113.328 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.99 153.68 41.04 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 119.876 1.838 . . . . 0.0 110.651 -163.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.16 105.45 2.93 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.168 1.787 . . . . 0.0 110.066 -164.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.488 ' CB ' HD11 ' A' ' 72' ' ' ILE . 71.5 mt -134.36 102.73 5.45 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -173.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.86 38.61 3.92 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 128.151 2.58 . . . . 0.0 111.656 -163.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -139.66 146.83 40.17 Favored 'General case' 0 N--CA 1.457 -0.099 0 O-C-N 121.725 -0.609 . . . . 0.0 111.135 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.08 -37.01 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.382 0.673 . . . . 0.0 110.615 173.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.14 -12.8 83.24 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.418 -0.801 . . . . 0.0 112.779 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.434 ' C ' HG13 ' A' ' 72' ' ' ILE . . . -76.5 -54.51 6.61 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.063 0.931 . . . . 0.0 109.177 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.62 HD13 HG21 ' A' ' 61' ' ' VAL . 5.1 mt -145.14 130.54 13.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 123.747 0.819 . . . . 0.0 109.367 -167.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 33' ' ' PRO . 92.7 mt -122.26 -70.5 0.77 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 168.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.13 178.67 4.54 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.288 -1.507 . . . . 0.0 112.205 -177.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.52 -34.22 72.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -81.93 -12.17 58.53 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.535 0.607 . . . . 0.0 111.645 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -86.42 -1.24 57.39 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.219 1.408 . . . . 0.0 110.056 168.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -116.53 -79.1 0.58 Allowed 'General case' 0 C--N 1.341 0.216 0 O-C-N 120.109 -1.62 . . . . 0.0 106.875 175.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.59 -171.7 3.73 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 128.848 2.859 . . . . 0.0 108.735 176.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -48.99 -11.7 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 129.183 2.993 . . . . 0.0 115.664 163.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.21 82.35 1.59 Allowed Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 125.281 1.42 . . . . 0.0 111.728 -168.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.94 -81.56 0.34 Allowed 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 164.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -127.94 -162.19 1.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.429 1.491 . . . . 0.0 108.866 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -157.35 139.0 14.01 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 120.291 -1.506 . . . . 0.0 108.041 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.84 113.52 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -170.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.8 mm -95.72 139.71 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -128.12 82.89 2.11 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 163.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.411 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 1.3 tpm_? -79.0 95.12 5.41 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 172.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.25 -48.57 5.57 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 -171.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.411 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 20.5 tptm -68.21 -21.6 64.85 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.354 1.462 . . . . 0.0 113.859 -176.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -103.95 -98.67 0.31 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.504 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.4 OUTLIER -159.3 -162.64 1.08 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 123.001 1.381 . . . . 0.0 108.806 171.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.504 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 6.0 m-30 -78.48 147.23 34.0 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 163.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -144.15 174.05 11.21 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 128.646 2.778 . . . . 0.0 108.389 171.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.413 HD13 ' CG2' ' A' ' 15' ' ' ILE . 22.0 tp -135.33 137.03 42.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.187 1.795 . . . . 0.0 107.639 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 mm -130.69 131.85 64.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -173.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.5 ptt85 -139.22 173.1 11.91 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 123.46 1.6 . . . . 0.0 110.539 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.01 169.9 8.74 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.851 164.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.315 0 C-N-CA 128.491 2.716 . . . . 0.0 109.903 176.43 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.6 p . . . . . 0 C--O 1.215 -0.746 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.47 82.82 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 120.107 -1.62 . . . . 0.0 110.495 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.96 94.84 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 122.065 0.936 . . . . 0.0 109.693 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -75.32 -19.99 59.33 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.38 1.072 . . . . 0.0 110.268 -175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.0 mt -81.7 -55.47 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 127.569 2.348 . . . . 0.0 106.927 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -56.19 -44.14 79.12 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.17 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -31.17 50.23 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.67 0.668 . . . . 0.0 109.345 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.45 -35.5 81.85 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -119.18 17.54 13.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.461 1.105 . . . . 0.0 110.077 -168.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -56.62 5.37 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.906 2.883 . . . . 0.0 113.468 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.48 -27.66 46.3 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.728 2.411 . . . . 0.0 110.221 175.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.95 166.65 27.73 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 126.454 1.902 . . . . 0.0 107.406 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.02 173.43 13.63 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 167.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.4 p -106.46 177.77 4.76 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.767 167.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -123.47 152.98 41.13 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 163.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 7.7 p -139.68 134.01 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -119.92 -178.08 3.56 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.487 0.66 . . . . 0.0 111.637 164.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -82.34 5.68 19.45 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.553 1.941 . . . . 0.0 115.624 -163.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.98 -175.16 20.47 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.908 1.718 . . . . 0.0 110.176 -165.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.78 155.41 28.7 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.349 11.2 p-10 -91.75 143.81 26.15 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.628 1.171 . . . . 0.0 111.551 163.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.2 t -159.48 136.33 6.71 Favored Pre-proline 0 C--O 1.225 -0.188 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -163.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.425 ' HA ' HD23 ' A' ' 73' ' ' LEU . 72.3 Cg_endo -70.49 147.3 57.87 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.86 1.707 . . . . 0.0 112.068 -172.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.402 0.4 OUTLIER -49.59 -26.6 3.69 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.435 1.094 . . . . 0.0 113.899 177.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.592 ' HA ' HD11 ' A' ' 54' ' ' ILE . 14.6 p -63.18 -61.5 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.926 1.239 . . . . 0.0 111.249 168.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -66.16 -36.68 83.75 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.083 0.856 . . . . 0.0 109.528 -171.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 38' ' ' LEU . 1.3 pp -80.52 -24.4 39.39 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 116.598 -1.667 . . . . 0.0 110.034 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.416 HD22 ' NH1' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -75.31 -37.81 60.59 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 121.833 2.106 . . . . 0.0 109.82 176.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 t -73.82 -43.35 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.3 t -63.7 -32.52 74.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.941 0.896 . . . . 0.0 109.936 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.33 -17.09 57.02 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.602 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.27 27.68 39.22 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.471 HG21 ' HE ' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -78.58 -44.71 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 176.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -157.07 91.46 2.42 Favored Pre-proline 0 C--N 1.348 0.541 0 CA-C-N 120.571 1.532 . . . . 0.0 106.968 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.72 -15.45 21.48 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.476 2.118 . . . . 0.0 112.588 -164.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.59 105.03 17.06 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 -174.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 81.0 mttt -53.27 -22.59 7.24 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -166.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HD2' ' H ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -62.04 -60.36 3.73 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 120.314 1.415 . . . . 0.0 110.719 168.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.516 ' H ' ' HD2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -53.0 -49.14 66.82 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 125.983 1.713 . . . . 0.0 107.058 178.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -48.59 -58.43 4.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.391 1.057 . . . . 0.0 111.566 174.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.409 ' HA ' HD12 ' A' ' 54' ' ' ILE . 11.2 mtt-85 -65.81 -24.28 66.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 115.688 -2.101 . . . . 0.0 112.49 -175.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -77.87 -39.9 41.81 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 121.442 1.928 . . . . 0.0 111.746 167.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.62 -25.03 52.0 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.995 0.918 . . . . 0.0 111.23 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.592 HD11 ' HA ' ' A' ' 35' ' ' VAL . 70.3 mt -83.59 -57.47 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 116.007 -1.949 . . . . 0.0 109.117 171.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -77.69 -5.77 51.63 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 124.879 1.362 . . . . 0.0 113.009 -163.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.473 ' O ' HG22 ' A' ' 59' ' ' ILE . 7.9 m120 -81.01 141.34 34.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.591 163.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 10.03 0.07 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.492 1.52 . . . . 0.0 113.341 163.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -78.34 -11.07 59.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.286 1.834 . . . . 0.0 110.085 172.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 56' ' ' ASN 0.357 0.0 OUTLIER -102.74 92.77 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 124.855 2.264 . . . . 0.0 109.73 174.251 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -79.6 99.12 7.18 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 111.44 -2.618 . . . . 0.0 107.89 173.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.719 HG21 HD13 ' A' ' 72' ' ' ILE . 89.3 t -84.07 133.34 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.616 HD21 ' CD2' ' A' ' 79' ' ' LEU . 1.0 OUTLIER 60.92 14.76 5.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.699 0.4 . . . . 0.0 111.594 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.15 -1.84 57.72 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.083 1.325 . . . . 0.0 113.203 -174.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -131.73 123.63 28.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.791 1.795 . . . . 0.0 109.546 -164.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.46 111.25 0.35 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 127.836 2.454 . . . . 0.0 109.788 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HB3' HD11 ' A' ' 72' ' ' ILE . 18.9 mt -145.87 102.25 3.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -114.06 40.7 2.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.478 1.911 . . . . 0.0 110.95 -165.046 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -148.23 153.49 38.8 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.282 -0.886 . . . . 0.0 111.866 -168.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.87 -41.43 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 126.518 1.927 . . . . 0.0 109.376 169.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.41 -0.99 50.01 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.902 -0.388 . . . . 0.0 112.686 172.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.81 -61.82 1.55 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.905 -1.045 . . . . 0.0 111.672 163.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.719 HD13 HG21 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -137.46 132.47 45.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 120.13 1.332 . . . . 0.0 113.149 -176.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 33' ' ' PRO . 82.7 mt -99.6 -89.78 0.32 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 163.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 p -112.57 -168.8 1.37 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -173.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.26 -56.24 23.44 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.296 1.439 . . . . 0.0 114.577 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.26 -14.57 63.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.519 0.599 . . . . 0.0 111.781 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -80.8 -15.01 57.52 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 -82.09 0.54 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.616 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -89.91 174.47 7.66 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.568 1.547 . . . . 0.0 108.914 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -25.65 -51.12 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.285 3.034 . . . . 0.0 115.238 173.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.74 64.32 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.0 mmt-85 -140.82 -82.8 0.23 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.826 0.813 . . . . 0.0 109.727 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.444 ' H ' HD11 ' A' ' 79' ' ' LEU . 12.1 m-85 -130.29 -161.51 1.13 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.284 1.434 . . . . 0.0 110.361 -164.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.1 120.59 2.6 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.378 1.871 . . . . 0.0 108.899 167.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 63.3 t -78.95 134.04 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 173.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.4 mm -120.26 98.66 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 126.339 1.856 . . . . 0.0 106.274 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -92.84 82.25 4.69 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 171.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.471 ' HE ' HG21 ' A' ' 43' ' ' ILE . 15.8 tpp180 -84.04 96.24 8.82 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.274 2.63 . . . . 0.0 105.68 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.97 -24.16 33.66 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.395 0.521 . . . . 0.0 113.346 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -32.26 68.69 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.364 1.082 . . . . 0.0 112.638 171.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -135.96 -75.15 0.44 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.924 1.238 . . . . 0.0 112.037 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.54 -173.49 4.0 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 120.634 1.561 . . . . 0.0 109.465 -172.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -95.56 75.99 3.28 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.549 1.939 . . . . 0.0 110.393 174.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -78.57 171.62 14.85 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.947 -1.096 . . . . 0.0 110.567 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 83' ' ' PHE . 28.2 tp -128.18 137.72 52.18 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.309 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.5 mm -131.28 132.92 62.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -175.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 18.5 ptt180 -149.36 174.31 12.58 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 123.387 1.565 . . . . 0.0 112.449 177.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.16 169.62 8.66 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.785 163.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.557 0 C-N-CA 130.948 3.699 . . . . 0.0 106.768 172.359 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.467 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.07 -53.0 52.43 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.634 1.174 . . . . 0.0 112.018 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.45 -26.85 66.6 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.1 0.25 . . . . 0.0 110.38 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.99 -43.67 70.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 mt -68.23 -53.47 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 118.2 -0.905 . . . . 0.0 108.82 177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -59.36 -50.58 73.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 118.236 -1.385 . . . . 0.0 111.695 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -69.36 -30.81 68.9 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 120.143 1.338 . . . . 0.0 109.065 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.21 -42.72 99.29 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.258 40.6 m-85 -113.56 1.62 15.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -165.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -59.14 17.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.103 2.561 . . . . 0.0 114.258 163.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -78.09 -37.5 46.31 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.284 2.233 . . . . 0.0 107.591 164.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.829 HG22 ' HD2' ' A' ' 23' ' ' PRO . 4.3 p -125.91 165.14 28.93 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.895 1.678 . . . . 0.0 106.6 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.829 ' HD2' HG22 ' A' ' 22' ' ' VAL . 34.1 Cg_endo -80.68 177.84 7.63 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.45 2.1 . . . . 0.0 109.292 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 p -113.61 -177.93 3.25 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.837 -173.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -140.39 162.91 34.18 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.259 1.024 . . . . 0.0 108.541 167.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 9.3 p -143.34 138.43 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 125.294 1.438 . . . . 0.0 107.931 172.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -117.99 139.33 51.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.928 0.871 . . . . 0.0 109.558 163.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -81.35 73.11 8.4 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.89 153.97 24.11 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.209 -1.359 . . . . 0.0 113.182 -171.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.85 -157.15 15.65 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 163.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -60.97 140.32 57.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.582 0.353 . . . . 0.0 111.16 -174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 t -155.06 137.1 9.76 Favored Pre-proline 0 C--O 1.223 -0.3 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -164.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -48.95 131.28 25.13 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.729 3.619 . . . . 0.0 112.559 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.33 0.7 OUTLIER -47.64 -36.27 10.67 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 168.119 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.777 ' HA ' HD22 ' A' ' 38' ' ' LEU . 7.3 p -83.23 -2.61 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.157 1.383 . . . . 0.0 113.605 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -98.85 -44.05 6.51 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 168.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.38 -20.73 56.88 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 116.499 -1.715 . . . . 0.0 109.944 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.777 HD22 ' HA ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -77.4 -26.97 52.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 121.656 2.026 . . . . 0.0 110.777 175.246 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.57 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -79.68 -42.35 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 126.48 1.912 . . . . 0.0 106.862 -172.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.66 -48.91 77.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.185 2.194 . . . . 0.0 109.002 167.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.57 -15.96 57.96 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.74 -171.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.36 36.34 7.06 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 164.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.42 HG13 ' CD1' ' A' ' 94' ' ' TYR . 1.3 mp -78.39 -56.37 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 102.423 -3.177 . . . . 0.0 102.423 171.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -150.75 103.91 3.04 Favored Pre-proline 0 C--N 1.342 0.259 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.66 -10.49 13.1 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.851 2.367 . . . . 0.0 113.7 -172.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.6 t -90.9 116.3 28.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -53.07 -36.1 60.29 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -54.18 48.97 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.16 1.345 . . . . 0.0 109.12 173.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -57.3 -52.41 65.45 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.639 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -45.79 -55.47 6.53 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.518 1.527 . . . . 0.0 111.127 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -58.18 -41.73 84.5 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.162 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.43 -37.95 68.47 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.633 1.106 . . . . 0.0 111.778 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.77 -15.27 27.84 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 126.274 1.829 . . . . 0.0 110.794 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.738 ' HA ' HG21 ' A' ' 59' ' ' ILE . 2.2 mt -117.03 -15.87 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 176.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -91.56 -5.94 53.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.675 1.58 . . . . 0.0 111.375 168.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.659 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -82.34 135.56 35.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 176.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.36 3.74 0.31 Allowed Glycine 0 CA--C 1.537 1.42 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.304 165.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.43 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -94.09 -0.71 55.2 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.683 1.593 . . . . 0.0 112.373 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.738 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.321 0.0 OUTLIER -102.87 96.92 5.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 124.913 2.292 . . . . 0.0 107.892 173.931 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -90.32 98.51 11.81 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 111.735 -2.484 . . . . 0.0 108.361 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.802 HG21 HD13 ' A' ' 72' ' ' ILE . 5.2 t -81.38 127.55 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.403 HD21 ' HG ' ' A' ' 79' ' ' LEU . 90.1 m-20 52.76 25.08 3.57 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.205 1.002 . . . . 0.0 112.062 -169.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.65 8.23 61.0 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.617 -1.657 . . . . 0.0 113.518 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -128.81 126.63 40.28 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.758 2.279 . . . . 0.0 109.288 -174.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.45 110.64 0.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.249 1.42 . . . . 0.0 108.781 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.616 ' HB3' HD11 ' A' ' 72' ' ' ILE . 80.7 mt -145.96 81.66 1.6 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -175.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.02 46.6 1.04 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.724 2.01 . . . . 0.0 112.088 -169.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -148.55 150.02 32.61 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.165 -1.584 . . . . 0.0 114.213 -174.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.4 p -63.29 -43.69 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 125.967 1.707 . . . . 0.0 111.852 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.38 -9.6 85.82 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 174.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.3 -56.32 4.43 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 116.215 -1.85 . . . . 0.0 108.263 167.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.802 HD13 HG21 ' A' ' 61' ' ' VAL . 1.3 mp -138.31 138.41 43.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 CA-C-N 121.409 1.913 . . . . 0.0 113.726 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.6 mt -110.47 -88.02 0.51 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 101.777 -3.416 . . . . 0.0 101.777 163.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -102.49 -174.31 2.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 119.888 1.222 . . . . 0.0 113.689 -174.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.13 87.59 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.63 -17.26 64.07 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.723 0.692 . . . . 0.0 111.87 175.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.44 ' ND1' ' HA ' ' A' ' 72' ' ' ILE . 55.4 t-80 -78.61 -9.56 59.41 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.491 -0.756 . . . . 0.0 109.358 174.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.7 -75.07 0.63 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.334 0.97 . . . . 0.0 109.8 174.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.679 HD11 ' H ' ' A' ' 82' ' ' ARG . 1.3 pp -91.67 -170.17 2.51 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.787 1.235 . . . . 0.0 109.95 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -55.89 -26.82 49.09 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.428 ' H ' ' CD1' ' A' ' 79' ' ' LEU . . . 127.51 69.81 0.16 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 127.374 2.416 . . . . 0.0 112.192 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.679 ' H ' HD11 ' A' ' 79' ' ' LEU . 90.3 mtt-85 -143.02 -45.63 0.3 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.577 ' H ' HD11 ' A' ' 79' ' ' LEU . 39.6 m-85 -157.94 -176.65 6.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.457 1.903 . . . . 0.0 109.348 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.49 124.4 9.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.259 -1.526 . . . . 0.0 107.014 163.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.23 147.59 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 166.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 27.5 mm -129.7 93.01 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 C-N-CA 125.504 1.522 . . . . 0.0 107.069 173.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -89.77 84.34 6.27 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.76 98.38 6.26 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 166.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -52.72 143.65 23.48 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 170.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.4 tptm 69.08 -0.31 2.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.226 2.61 . . . . 0.0 114.035 -169.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -117.47 -104.88 0.4 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 165.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.1 -171.91 4.04 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 119.831 1.196 . . . . 0.0 108.062 175.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.529 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 1.3 m-30 -114.1 82.88 1.78 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 126.743 2.017 . . . . 0.0 107.942 -173.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.42 ' CD1' HG13 ' A' ' 43' ' ' ILE . 77.2 m-85 -79.45 169.14 18.5 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.386 0.674 . . . . 0.0 109.866 -175.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.525 HD11 ' CD1' ' A' ' 83' ' ' PHE . 33.4 tp -130.74 135.73 48.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.244 1.018 . . . . 0.0 108.699 -175.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 mt -134.53 134.69 54.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.489 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 9.4 ttt180 -135.24 -175.6 3.98 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 123.715 1.722 . . . . 0.0 112.067 171.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.489 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -122.73 158.59 29.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.188 165.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.399 0 C-N-CA 128.693 2.797 . . . . 0.0 107.921 172.469 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.336 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 7.2 tp -156.33 155.03 31.54 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -137.71 153.71 49.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.898 0.879 . . . . 0.0 108.757 173.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.8 p -149.6 162.72 39.63 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.359 1.464 . . . . 0.0 107.1 163.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 148.33 -153.8 25.48 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 107.444 -2.263 . . . . 0.0 107.444 -165.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.69 -66.61 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . 0.265 0.1 OUTLIER -91.7 26.7 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 122.358 1.075 . . . . 0.0 113.878 -168.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.61 -1.8 17.53 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -101.6 -20.32 15.09 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.687 1.595 . . . . 0.0 112.435 167.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -137.77 74.75 1.49 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.665 1.586 . . . . 0.0 110.742 -178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.51 -161.84 0.82 Allowed 'General case' 0 C--O 1.212 -0.909 0 O-C-N 120.811 -1.181 . . . . 0.0 111.557 -178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.95 -54.49 21.43 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 122.389 2.359 . . . . 0.0 112.162 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.43 -23.75 62.79 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.766 0.793 . . . . 0.0 109.394 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.58 -32.92 23.53 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -173.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.476 ' CG2' HD13 ' A' ' 95' ' ' LEU . 26.8 mt -71.49 -48.51 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 171.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -52.73 -58.52 6.6 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 118.63 0.65 . . . . 0.0 111.176 178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -74.6 -24.71 58.92 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.642 1.11 . . . . 0.0 110.239 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.72 -40.26 97.29 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.44 ' C ' ' H ' ' A' ' 21' ' ' ASP . 45.9 m-85 -126.42 12.69 7.57 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -163.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.06 9.08 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 129.776 3.23 . . . . 0.0 113.68 163.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 19' ' ' PHE . 23.7 t70 -78.41 -38.22 42.08 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.752 2.421 . . . . 0.0 108.48 173.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.34 168.34 10.75 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 125.375 1.47 . . . . 0.0 109.58 -177.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.92 178.11 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.13 1.887 . . . . 0.0 110.327 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 32.7 p -129.48 171.97 12.01 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 126.08 1.752 . . . . 0.0 109.874 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -137.67 166.56 23.66 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.863 1.265 . . . . 0.0 108.646 176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 p -139.62 133.94 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -114.15 179.07 4.06 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 119.114 0.87 . . . . 0.0 109.961 163.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -78.75 15.82 0.99 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.536 1.534 . . . . 0.0 113.989 -163.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.8 -176.92 38.87 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 -163.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.4 149.45 5.99 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -163.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -71.82 153.49 41.9 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 121.894 -0.768 . . . . 0.0 111.051 170.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -161.28 131.3 3.43 Favored Pre-proline 0 CA--C 1.509 -0.604 0 N-CA-C 104.511 -2.403 . . . . 0.0 104.511 -165.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.551 ' HA ' HD23 ' A' ' 73' ' ' LEU . 90.0 Cg_endo -68.65 148.61 72.41 Favored 'Trans proline' 0 N--CA 1.436 -1.901 0 C-N-CA 121.69 1.593 . . . . 0.0 110.355 -174.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.779 HD22 HG13 ' A' ' 54' ' ' ILE 0.264 0.0 OUTLIER -44.85 -41.04 6.72 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 113.96 -1.473 . . . . 0.0 112.485 178.727 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.691 ' HA ' HD22 ' A' ' 38' ' ' LEU . 8.0 p -80.89 -7.75 10.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 126.92 2.088 . . . . 0.0 114.886 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.419 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 77.1 mm-40 -104.53 -30.95 9.69 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 117.648 -1.168 . . . . 0.0 108.508 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -80.84 -20.2 42.92 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 121.593 1.997 . . . . 0.0 110.094 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.713 HD13 ' CD1' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -77.36 -29.22 53.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 120.971 1.714 . . . . 0.0 109.866 173.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -75.63 -46.85 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 126.295 1.838 . . . . 0.0 107.033 -172.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.4 m -57.24 -52.55 64.88 Favored 'General case' 0 N--CA 1.426 -1.658 0 C-N-CA 129.939 3.295 . . . . 0.0 109.221 167.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.15 -10.27 59.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 119.215 -0.994 . . . . 0.0 113.028 -173.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.51 29.69 15.81 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 122.842 1.246 . . . . 0.0 111.926 166.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.477 ' CG2' HD12 ' A' ' 38' ' ' LEU . 1.2 mp -77.92 -51.05 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 176.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.3 m -156.85 99.47 2.02 Favored Pre-proline 0 C--N 1.344 0.364 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 172.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.75 -15.97 10.51 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.911 2.407 . . . . 0.0 113.617 -172.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.5 t -76.61 115.26 16.2 Favored 'General case' 0 C--O 1.222 -0.363 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.8 tptt -52.36 -37.61 56.63 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.183 1.356 . . . . 0.0 114.419 -164.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.3 -54.44 43.95 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.099 0.863 . . . . 0.0 109.595 172.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 tp60 -58.94 -47.77 83.88 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-O 118.008 -0.996 . . . . 0.0 108.736 -175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.481 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -46.27 -55.08 7.73 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.378 1.471 . . . . 0.0 110.383 176.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.467 ' HG2' HG21 ' A' ' 35' ' ' VAL . 71.9 mtt-85 -65.0 -34.32 78.15 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-O 116.594 -1.67 . . . . 0.0 111.577 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.34 -36.36 58.28 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 120.777 1.626 . . . . 0.0 112.378 171.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.88 -17.6 63.34 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 125.131 1.372 . . . . 0.0 110.543 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.779 HG13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -92.32 -52.73 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 CA-C-O 116.482 -1.723 . . . . 0.0 111.895 166.396 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -69.92 -6.5 33.33 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 120.488 1.495 . . . . 0.0 111.577 -170.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.534 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.3 m120 -79.9 139.77 36.98 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 113.901 1.075 . . . . 0.0 113.901 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.2 26.29 0.44 Allowed Glycine 0 CA--C 1.534 1.257 0 C-N-CA 126.025 1.774 . . . . 0.0 113.526 164.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.424 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -115.59 5.06 14.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.691 2.396 . . . . 0.0 111.403 170.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.575 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.319 0.0 OUTLIER -106.63 94.13 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 124.52 2.105 . . . . 0.0 106.065 163.893 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.422 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 3.0 m-85 -79.99 106.73 12.23 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.026 168.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.554 HG21 HD13 ' A' ' 72' ' ' ILE . 10.7 t -83.81 124.61 39.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 173.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.648 HD22 ' HG3' ' A' ' 78' ' ' ARG . 63.4 m-20 53.5 27.39 6.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.96 -2.41 59.94 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-O 118.258 -1.301 . . . . 0.0 113.748 176.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -119.32 122.68 42.39 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 119.365 1.583 . . . . 0.0 107.151 -175.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.46 109.0 0.49 Allowed 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.63 ' HB3' HD11 ' A' ' 72' ' ' ILE . 83.1 mt -143.02 103.83 4.22 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 -171.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -127.91 45.3 2.77 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 126.867 2.067 . . . . 0.0 112.863 -163.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -154.42 154.12 32.7 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.975 0.91 . . . . 0.0 110.615 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 81.9 t -63.36 -38.19 81.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.785 1.234 . . . . 0.0 109.748 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -73.77 -2.21 60.49 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-O 118.83 -0.983 . . . . 0.0 113.061 171.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.33 -57.0 2.93 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.842 1.321 . . . . 0.0 111.391 170.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.63 HD11 ' HB3' ' A' ' 66' ' ' LEU . 0.3 OUTLIER -141.28 148.17 21.56 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 CA-C-N 121.164 1.802 . . . . 0.0 111.098 178.083 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.551 HD23 ' HA ' ' A' ' 33' ' ' PRO . 64.9 mt -112.38 -93.11 0.46 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 163.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 p -108.43 -170.24 1.64 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -169.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.12 73.67 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.755 1.222 . . . . 0.0 113.504 176.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -65.4 -17.95 64.94 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.107 0.963 . . . . 0.0 111.161 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.492 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 58.1 t-80 -86.48 -5.99 59.01 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.523 -0.736 . . . . 0.0 110.665 175.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.648 ' HG3' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -119.53 -64.99 1.21 Allowed 'General case' 0 C--N 1.343 0.319 0 CA-C-N 120.095 1.316 . . . . 0.0 110.512 178.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.59 178.38 7.41 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 164.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -56.75 -26.05 56.36 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.592 -0.693 . . . . 0.0 112.095 172.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.82 84.15 0.17 Allowed Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 124.651 1.12 . . . . 0.0 113.299 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.12 -82.83 0.57 Allowed 'General case' 0 C--O 1.223 -0.292 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 167.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -119.55 -165.62 1.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.813 2.045 . . . . 0.0 108.171 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -158.18 138.64 12.7 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 163.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.7 t -83.99 139.27 17.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 166.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.9 mm -115.62 94.48 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.833 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' A' ' 60' ' ' TYR . 33.9 ttm-85 -91.46 75.13 5.99 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.64 -2.355 . . . . 0.0 104.64 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -78.98 92.59 4.97 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 104.736 -2.32 . . . . 0.0 104.736 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -51.19 -32.57 29.0 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.103 1.335 . . . . 0.0 113.425 -175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.422 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.26 -12.59 60.51 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.78 -1.424 . . . . 0.0 112.962 177.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -135.91 -97.55 0.23 Allowed 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 127.161 2.185 . . . . 0.0 105.864 -174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.445 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -159.17 -159.89 0.8 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 120.889 1.677 . . . . 0.0 109.415 174.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.445 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -110.23 75.9 0.96 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 127.058 2.143 . . . . 0.0 108.475 -167.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -78.23 164.56 24.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 -171.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.476 HD13 ' CG2' ' A' ' 15' ' ' ILE . 18.0 tp -125.03 129.89 51.21 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 113.935 -1.484 . . . . 0.0 108.476 -164.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 95' ' ' LEU . 30.6 mm -125.02 129.27 73.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -171.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.473 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 13.1 ttp180 -131.47 -177.15 4.28 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 124.064 1.888 . . . . 0.0 110.92 164.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.473 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -123.67 165.63 16.89 Favored 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 126.273 1.829 . . . . 0.0 110.743 173.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 127.148 2.179 . . . . 0.0 111.465 178.05 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.43 0 CA-C-O 121.194 0.521 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 36.8 tp -121.83 -61.78 1.47 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 154.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -64.41 147.2 53.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.743 1.217 . . . . 0.0 110.659 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.2 m -73.96 -165.41 0.3 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.397 1.479 . . . . 0.0 110.529 170.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 81.77 -60.63 4.74 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -174.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.46 165.05 24.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 117.878 0.839 . . . . 0.0 108.993 -171.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -71.36 77.63 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.392 1.077 . . . . 0.0 111.077 179.458 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.06 -10.04 59.36 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 125.331 1.453 . . . . 0.0 111.98 175.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -77.72 -24.7 49.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 109.027 172.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.621 ' HB3' HD11 ' A' ' 15' ' ' ILE . 1.6 mm? -98.89 72.88 1.95 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 125.348 1.459 . . . . 0.0 107.296 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.01 172.56 13.64 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.02 -57.08 8.57 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 124.043 0.937 . . . . 0.0 111.225 -176.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.85 -21.94 66.5 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 123.541 0.525 . . . . 0.0 110.706 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -82.74 -37.19 25.0 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.789 0.835 . . . . 0.0 109.624 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.621 HD11 ' HB3' ' A' ' 10' ' ' LEU . 29.4 mt -67.71 -45.07 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -55.47 -60.44 3.42 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.775 1.171 . . . . 0.0 110.541 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -75.89 -20.18 58.25 Favored 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 121.377 -0.827 . . . . 0.0 110.27 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.66 -38.44 90.03 Favored Glycine 0 N--CA 1.437 -1.246 0 N-CA-C 110.594 -1.003 . . . . 0.0 110.594 175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -126.58 11.75 7.37 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.629 0.772 . . . . 0.0 112.841 -164.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -56.18 7.19 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.73 2.412 . . . . 0.0 115.322 168.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -78.29 -34.78 48.6 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.243 1.417 . . . . 0.0 109.263 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.5 165.25 14.83 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 125.883 1.673 . . . . 0.0 108.251 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -68.98 177.72 4.78 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 121.801 1.667 . . . . 0.0 110.542 168.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.0 p -120.85 -177.59 3.52 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.999 1.72 . . . . 0.0 109.551 -173.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -142.86 160.96 39.33 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.769 1.228 . . . . 0.0 109.362 164.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 9.9 p -143.88 136.35 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 C-N-CA 125.282 1.433 . . . . 0.0 108.271 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.437 ' O ' ' HA ' ' A' ' 98' ' ' TYR . 0.8 OUTLIER -118.8 179.05 4.26 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 119.123 0.874 . . . . 0.0 110.042 163.496 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -89.81 56.94 3.67 Favored 'General case' 0 C--N 1.315 -0.913 0 O-C-N 120.415 -1.428 . . . . 0.0 109.703 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.03 -158.94 19.75 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 123.723 0.678 . . . . 0.0 112.324 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.29 123.53 1.76 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 107.906 -2.078 . . . . 0.0 107.906 -175.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.254 1.0 OUTLIER -59.91 130.47 46.89 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.203 1.501 . . . . 0.0 107.182 171.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -151.85 140.16 13.3 Favored Pre-proline 0 CA--C 1.507 -0.687 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -163.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.449 ' HA ' HD23 ' A' ' 73' ' ' LEU . 65.3 Cg_endo -77.7 152.78 29.46 Favored 'Trans proline' 0 N--CA 1.435 -1.97 0 C-N-CA 121.495 1.463 . . . . 0.0 110.689 -167.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.356 0.4 OUTLIER -47.15 -33.17 4.9 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 113.585 -1.643 . . . . 0.0 112.416 173.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.704 ' HA ' HD11 ' A' ' 54' ' ' ILE . 11.5 p -72.83 -15.51 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.905 1.817 . . . . 0.0 115.905 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HG2' ' HG2' ' A' ' 33' ' ' PRO . 58.0 mm-40 -105.6 -42.04 5.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.1 -31.33 67.66 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-O 116.806 -1.569 . . . . 0.0 108.696 -176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.46 -27.19 34.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 121.51 1.959 . . . . 0.0 109.562 -174.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.78 -47.85 42.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 C-N-CA 125.692 1.597 . . . . 0.0 107.976 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -34.79 78.79 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 123.313 0.645 . . . . 0.0 109.965 173.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.416 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.51 -14.32 59.41 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.237 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.46 27.88 21.22 Favored Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 164.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.416 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.1 mp -78.37 -45.93 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 175.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.7 108.14 2.17 Favored Pre-proline 0 C--N 1.343 0.316 0 CA-C-N 120.532 1.515 . . . . 0.0 106.945 167.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.45 -15.59 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.227 1.952 . . . . 0.0 112.183 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.0 m -88.19 105.85 17.8 Favored 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 -169.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 tptt -52.18 -32.58 36.8 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 -163.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.98 -54.65 42.32 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.341 1.428 . . . . 0.0 109.619 169.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -57.39 -48.13 79.89 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 117.801 -1.095 . . . . 0.0 108.603 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.4 -61.61 1.83 Allowed 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 125.189 1.556 . . . . 0.0 110.14 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.413 ' HA ' HD12 ' A' ' 54' ' ' ILE . 78.5 mtt-85 -62.84 -25.67 68.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 115.923 -1.989 . . . . 0.0 112.656 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -79.68 -40.7 28.45 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 121.745 2.066 . . . . 0.0 112.988 168.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.456 ' HA ' HH11 ' A' ' 88' ' ' ARG . 5.9 m-20 -62.96 -13.93 41.07 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.355 1.062 . . . . 0.0 111.41 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.704 HD11 ' HA ' ' A' ' 35' ' ' VAL . 66.1 mt -89.22 -64.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.589 0 C-N-CA 126.626 1.97 . . . . 0.0 109.04 163.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -61.89 -11.25 12.06 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.902 1.281 . . . . 0.0 112.21 -165.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.539 ' O ' HG22 ' A' ' 59' ' ' ILE . 5.1 m120 -82.45 131.37 35.22 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 118.824 0.738 . . . . 0.0 111.365 172.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.42 36.26 0.56 Allowed Glycine 0 CA--C 1.528 0.863 0 C-N-CA 126.585 2.04 . . . . 0.0 111.716 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.476 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -117.18 -1.43 11.85 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 127.185 2.194 . . . . 0.0 111.027 165.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 56' ' ' ASN 0.339 0.0 OUTLIER -91.75 92.11 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 121.726 2.057 . . . . 0.0 106.501 163.562 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -80.66 100.8 8.87 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 112.924 -1.944 . . . . 0.0 108.101 171.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.524 HG21 ' CD1' ' A' ' 72' ' ' ILE . 15.8 t -80.2 128.88 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 175.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.434 HD22 ' HG3' ' A' ' 78' ' ' ARG 0.257 65.9 m-80 64.23 -6.63 0.26 Allowed 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.65 4.6 26.45 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 125.137 1.351 . . . . 0.0 112.795 -169.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.87 119.33 32.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 -174.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.89 108.56 0.78 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.344 1.458 . . . . 0.0 107.142 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.487 ' CB ' HD11 ' A' ' 72' ' ' ILE . 80.5 mt -141.4 88.17 2.13 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.89 25.05 3.34 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.996 1.318 . . . . 0.0 113.59 -173.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -140.66 154.77 46.53 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.54 -43.01 96.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 126.869 2.067 . . . . 0.0 110.803 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.6 -9.74 59.27 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-O 119.525 -0.597 . . . . 0.0 112.65 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.45 -47.49 7.41 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 117.562 -1.208 . . . . 0.0 112.24 170.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.524 ' CD1' HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -140.09 135.04 37.11 Favored 'Isoleucine or valine' 0 C--N 1.345 0.41 0 CA-C-N 121.423 1.92 . . . . 0.0 113.308 178.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 33' ' ' PRO . 80.5 mt -113.86 -97.3 0.44 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.376 -2.824 . . . . 0.0 103.376 163.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -97.87 -177.13 3.66 Favored 'General case' 0 N--CA 1.465 0.304 0 O-C-N 120.39 -1.444 . . . . 0.0 114.404 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.446 ' HB3' ' CE2' ' A' ' 98' ' ' TYR . . . -63.19 -37.78 88.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 120.967 -1.083 . . . . 0.0 113.119 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.55 -17.73 62.3 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.15 0.887 . . . . 0.0 111.11 174.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -81.22 -15.99 54.02 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.487 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.434 ' HG3' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -112.16 -59.58 1.98 Allowed 'General case' 0 C--N 1.347 0.487 0 CA-C-N 120.223 1.374 . . . . 0.0 111.175 -173.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.08 -171.51 3.01 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 125.163 1.385 . . . . 0.0 110.265 166.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -53.61 -6.21 0.07 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 129.307 3.043 . . . . 0.0 114.725 163.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.85 79.89 1.48 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 124.954 1.264 . . . . 0.0 111.489 -173.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 -63.61 0.55 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.306 0.642 . . . . 0.0 110.112 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -156.1 -169.58 3.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.022 2.929 . . . . 0.0 106.915 -175.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -154.5 152.67 30.38 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 119.605 -1.934 . . . . 0.0 107.07 163.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.416 ' CG1' ' HA ' ' A' ' 62' ' ' ASN . 9.9 p -115.7 151.43 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.095 0 C-N-CA 124.048 0.939 . . . . 0.0 109.337 171.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.48 HD12 HD11 ' A' ' 59' ' ' ILE . 27.8 mm -132.85 96.66 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 127.249 2.22 . . . . 0.0 108.011 -171.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 mtt180 -96.3 86.88 4.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.456 HH11 ' HA ' ' A' ' 53' ' ' ASP . 1.2 tpm_? -82.05 110.62 17.45 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 174.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -58.62 -20.17 45.26 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-N 120.123 1.329 . . . . 0.0 115.252 -177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.411 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -72.01 -11.69 60.88 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.124 1.962 . . . . 0.0 111.228 171.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.4 tppt? -148.59 -156.05 0.69 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.014 2.126 . . . . 0.0 107.453 -165.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.68 -150.75 0.35 Allowed 'General case' 0 C--O 1.248 0.979 0 CA-C-O 122.883 1.325 . . . . 0.0 111.615 176.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.87 77.33 1.36 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.802 2.441 . . . . 0.0 109.018 -164.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -78.34 165.35 23.95 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 121.489 -0.757 . . . . 0.0 109.457 -170.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.538 ' C ' HD12 ' A' ' 96' ' ' ILE . 1.2 tt -128.54 128.16 43.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -164.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.538 HD12 ' C ' ' A' ' 95' ' ' LEU . 1.9 mp -127.08 135.64 63.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 C-N-CA 124.369 1.068 . . . . 0.0 108.89 -169.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.497 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 9.4 ttt180 -139.29 -176.6 4.58 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 125.657 2.646 . . . . 0.0 114.335 167.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.497 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -115.86 161.04 19.36 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 112.451 -2.159 . . . . 0.0 107.866 163.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.67 0 C-N-CA 126.727 2.011 . . . . 0.0 107.462 -174.802 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 32.3 tp -143.61 148.0 35.2 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 165.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -59.85 -34.77 73.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.972 0.805 . . . . 0.0 111.784 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.7 m 58.69 -1.75 0.1 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 128.182 2.593 . . . . 0.0 117.132 171.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -84.97 -97.82 0.68 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 107.555 -2.218 . . . . 0.0 107.555 171.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -78.61 175.76 10.09 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 174.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -38.8 63.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 1 C-N-CA 134.021 4.928 . . . . 0.0 117.37 -175.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.35 -20.84 63.85 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 119.463 -2.023 . . . . 0.0 112.656 -166.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -79.32 -27.53 42.1 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 125.652 1.581 . . . . 0.0 110.933 174.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.426 ' HB3' HD11 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -85.11 79.46 9.59 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.71 169.26 18.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 170.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.54 -57.38 12.97 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 125.804 1.641 . . . . 0.0 110.919 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.41 -20.87 65.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.833 0.288 . . . . 0.0 111.516 177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.76 -38.89 27.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.848 1.259 . . . . 0.0 110.355 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.474 ' CG2' HD13 ' A' ' 95' ' ' LEU . 18.6 mt -69.19 -51.01 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 124.71 1.204 . . . . 0.0 107.951 172.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -51.92 -57.61 8.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 119.154 0.888 . . . . 0.0 110.517 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.99 -23.41 58.26 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.231 -0.918 . . . . 0.0 110.472 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.77 -40.61 95.76 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 178.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -119.35 9.54 11.67 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -165.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -55.55 -9.57 0.52 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.645 2.378 . . . . 0.0 116.451 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.68 -29.34 45.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.678 1.591 . . . . 0.0 111.198 175.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.526 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -105.06 163.08 17.87 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -179.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.526 ' HD2' HG12 ' A' ' 22' ' ' VAL . 94.5 Cg_endo -72.07 172.88 13.82 Favored 'Trans proline' 0 N--CA 1.44 -1.643 0 CA-C-O 122.855 1.106 . . . . 0.0 109.375 174.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 52.8 p -120.55 171.85 8.27 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 113.197 -1.819 . . . . 0.0 108.073 172.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -137.11 152.91 50.54 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.0 p -136.94 134.66 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 98' ' ' TYR . 0.4 OUTLIER -125.86 152.58 45.33 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 122.599 1.19 . . . . 0.0 111.045 163.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -81.5 53.7 2.16 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 126.31 1.844 . . . . 0.0 110.965 -169.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.56 174.81 50.13 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.395 1.95 . . . . 0.0 114.015 166.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.75 149.07 16.15 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -75.18 151.87 38.47 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.13 0.49 . . . . 0.0 111.56 164.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.7 t -160.94 135.09 5.14 Favored Pre-proline 0 CA--C 1.513 -0.474 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -163.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HA ' HD23 ' A' ' 73' ' ' LEU . 84.5 Cg_endo -73.15 147.33 42.49 Favored 'Trans proline' 0 N--CA 1.44 -1.633 0 C-N-CA 121.641 1.561 . . . . 0.0 111.16 -174.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.336 0.3 OUTLIER -49.63 -30.05 8.25 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.675 175.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.717 ' HA ' HD11 ' A' ' 54' ' ' ILE . 7.4 p -74.04 -18.51 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -97.6 -46.69 5.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.075 -0.964 . . . . 0.0 108.424 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 pp -75.6 -22.76 56.61 Favored 'General case' 0 CA--C 1.505 -0.758 0 CA-C-O 116.426 -1.749 . . . . 0.0 109.621 -168.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.98 -25.59 29.89 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 121.259 1.845 . . . . 0.0 109.9 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 44' ' ' SER . 1.5 t -77.7 -46.74 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.3 m -59.61 -40.63 88.13 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 126.663 1.985 . . . . 0.0 110.234 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.409 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.41 -17.73 56.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.481 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.51 34.67 6.88 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 110.651 -0.98 . . . . 0.0 110.651 163.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.409 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.1 mp -78.45 -53.14 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 103.12 -2.919 . . . . 0.0 103.12 174.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.416 ' O ' HG22 ' A' ' 39' ' ' VAL . 0.4 OUTLIER -156.13 95.63 2.35 Favored Pre-proline 0 C--N 1.349 0.549 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 178.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.11 -18.02 14.71 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 122.6 2.2 . . . . 0.0 113.128 -171.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 35.1 t -75.75 109.51 9.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 -175.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -57.03 -27.84 61.99 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -163.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.52 -49.39 66.69 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.726 1.603 . . . . 0.0 110.491 169.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -57.97 -50.46 73.3 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.26 -58.23 3.86 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 125.936 2.023 . . . . 0.0 109.703 176.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -58.7 -35.31 72.44 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 117.82 -1.086 . . . . 0.0 111.387 -174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -73.58 -45.83 50.87 Favored 'General case' 0 CA--C 1.509 -0.627 0 C-N-CA 118.103 -1.439 . . . . 0.0 112.089 170.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.514 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.9 m-20 -62.22 -12.81 22.3 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.513 1.125 . . . . 0.0 111.7 -174.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.717 HD11 ' HA ' ' A' ' 35' ' ' VAL . 56.7 mt -89.41 -66.88 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 127.763 2.425 . . . . 0.0 109.07 164.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -71.58 -1.88 15.07 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 119.939 1.245 . . . . 0.0 113.331 -164.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.532 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.2 m120 -80.05 130.79 35.53 Favored 'General case' 0 N--CA 1.441 -0.915 0 O-C-N 121.233 -0.917 . . . . 0.0 110.377 164.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.78 6.6 0.34 Allowed Glycine 0 CA--C 1.534 1.228 0 O-C-N 121.967 -0.458 . . . . 0.0 114.025 167.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.78 -8.27 59.68 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-O 116.701 -1.618 . . . . 0.0 111.746 169.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 56' ' ' ASN 0.359 0.0 OUTLIER -92.77 92.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-O 125.569 2.604 . . . . 0.0 108.099 164.975 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -79.45 99.42 7.2 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 111.447 -2.615 . . . . 0.0 108.208 170.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.622 HG21 HD13 ' A' ' 72' ' ' ILE . 22.1 t -82.17 127.8 39.3 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 175.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.461 HD21 ' HA ' ' A' ' 84' ' ' THR . 5.9 m-80 61.37 7.48 1.76 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -176.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.46 7.96 56.54 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.867 1.223 . . . . 0.0 113.077 -171.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -121.73 117.93 27.82 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.44 106.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.726 1.61 . . . . 0.0 109.114 177.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.651 ' HB3' HD11 ' A' ' 72' ' ' ILE . 44.6 mt -142.33 89.73 2.18 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 1.0 OUTLIER -113.31 39.56 2.57 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.939 2.096 . . . . 0.0 112.755 -164.422 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -151.47 161.71 42.23 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.471 -1.393 . . . . 0.0 112.17 175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.5 p -65.52 -26.37 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 125.149 1.38 . . . . 0.0 110.252 164.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.43 -14.28 74.5 Favored Glycine 0 C--N 1.334 0.459 0 CA-C-O 119.417 -0.657 . . . . 0.0 113.344 167.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.53 -58.84 2.3 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 117.581 -1.2 . . . . 0.0 110.779 175.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.651 HD11 ' HB3' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -138.91 144.48 29.54 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 CA-C-N 121.143 1.792 . . . . 0.0 113.221 -177.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 33' ' ' PRO . 74.2 mt -109.61 -93.14 0.43 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 101.355 -3.572 . . . . 0.0 101.355 163.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.2 p -108.79 -170.99 1.76 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -172.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.11 -44.49 83.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.496 1.119 . . . . 0.0 113.79 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -71.05 -15.89 62.57 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 119.238 0.926 . . . . 0.0 112.197 174.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 51.7 t-80 -87.98 0.97 55.25 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 123.916 0.886 . . . . 0.0 109.762 173.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -79.58 0.59 Allowed 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 106.35 -1.722 . . . . 0.0 106.35 167.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.607 HD11 ' H ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.09 -168.51 2.08 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.538 1.135 . . . . 0.0 109.848 176.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.01 0.05 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 128.869 2.867 . . . . 0.0 115.317 171.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.23 50.13 3.09 Favored Glycine 0 C--N 1.337 0.585 0 O-C-N 120.991 -1.068 . . . . 0.0 111.734 178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -104.58 -65.92 1.0 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 172.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.607 ' H ' HD11 ' A' ' 79' ' ' LEU . 53.9 m-85 -145.3 -167.16 2.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.772 1.629 . . . . 0.0 107.153 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.461 ' HA ' HD21 ' A' ' 62' ' ' ASN . 1.0 OUTLIER -158.89 140.95 13.77 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 119.923 1.238 . . . . 0.0 109.106 163.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 t -93.55 150.63 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.775 1.23 . . . . 0.0 108.568 176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.469 HD13 HG22 ' A' ' 61' ' ' VAL . 22.2 mm -132.44 97.63 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 C-N-CA 126.767 2.027 . . . . 0.0 108.262 177.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -97.76 90.47 4.98 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.514 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER -83.54 94.18 7.99 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 169.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.17 112.56 2.67 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 169.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt 137.53 -50.66 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 131.496 3.919 . . . . 0.0 107.773 -164.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.0 -110.51 0.35 Allowed 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -148.04 -154.78 0.57 Allowed 'General case' 0 C--O 1.242 0.678 0 CA-C-N 120.049 1.295 . . . . 0.0 109.173 -174.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -115.0 78.85 1.2 Allowed 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.971 2.508 . . . . 0.0 108.226 -164.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.403 ' CD1' HG13 ' A' ' 43' ' ' ILE . 79.1 m-85 -78.14 169.41 18.32 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 121.049 -1.032 . . . . 0.0 109.078 -175.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.474 HD13 ' CG2' ' A' ' 15' ' ' ILE . 16.8 tp -127.02 131.38 51.01 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.775 -171.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.1 mm -122.21 133.05 69.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 125.104 1.362 . . . . 0.0 107.37 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.487 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 7.8 ttt180 -145.39 -177.18 5.43 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 124.534 2.111 . . . . 0.0 111.783 169.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.487 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.1 OUTLIER -126.12 159.33 33.16 Favored 'General case' 0 N--CA 1.415 -2.216 0 CA-C-N 112.636 -2.075 . . . . 0.0 111.59 164.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.476 0 C-N-CA 126.82 2.048 . . . . 0.0 106.1 165.415 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.32 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -53.09 126.1 19.57 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.44 1.096 . . . . 0.0 110.229 -178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -92.03 105.65 17.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.463 1.905 . . . . 0.0 108.18 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.3 m 52.12 -153.94 0.2 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.033 0.933 . . . . 0.0 110.14 -164.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.91 -140.16 11.34 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -175.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.54 -55.14 5.44 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-O 121.978 0.894 . . . . 0.0 108.942 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.72 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -90.57 54.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.567 0 CA-C-O 123.469 1.604 . . . . 0.0 107.531 -178.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.14 -12.6 41.37 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.944 1.298 . . . . 0.0 114.116 -176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -86.65 -22.64 26.02 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.299 1.44 . . . . 0.0 110.158 171.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -151.91 68.01 0.88 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.237 1.015 . . . . 0.0 108.623 -166.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.39 179.62 6.88 Favored 'General case' 0 C--O 1.213 -0.849 0 C-N-CA 125.8 1.64 . . . . 0.0 109.389 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.98 81.01 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 119.988 -1.695 . . . . 0.0 113.515 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.29 -29.89 67.86 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.553 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -72.63 -36.5 68.05 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.2 mt -73.15 -52.25 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 C-N-CA 127.101 2.161 . . . . 0.0 107.921 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -60.62 -47.06 87.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 118.146 -0.93 . . . . 0.0 109.953 -175.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -80.14 -27.11 39.11 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 119.143 -1.023 . . . . 0.0 109.815 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.86 -37.6 93.49 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 126.047 1.784 . . . . 0.0 109.975 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -123.56 12.28 9.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.12 -164.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -57.96 -9.01 1.16 Allowed 'General case' 0 C--N 1.339 0.138 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.42 -12.79 60.03 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.228 1.411 . . . . 0.0 111.726 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.23 168.53 11.41 Favored Pre-proline 0 CA--C 1.54 0.573 0 O-C-N 120.617 -1.302 . . . . 0.0 108.888 167.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.09 174.67 12.44 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 121.678 1.585 . . . . 0.0 110.865 -175.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -127.2 150.31 49.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.679 1.592 . . . . 0.0 109.0 -174.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 38.2 t80 -134.96 159.5 41.28 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 119.505 1.048 . . . . 0.0 108.767 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.4 t -138.85 132.3 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 124.465 1.106 . . . . 0.0 108.623 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -113.23 -174.48 2.46 Favored 'General case' 0 C--O 1.219 -0.53 0 C-N-CA 123.18 0.592 . . . . 0.0 110.501 163.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -87.96 8.79 24.69 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -163.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.55 176.35 32.65 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 120.907 -1.121 . . . . 0.0 110.859 -164.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.08 139.22 1.68 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 -164.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.38 148.02 49.59 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -170.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.8 t -155.0 132.5 6.43 Favored Pre-proline 0 CA--C 1.51 -0.582 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 -167.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HA ' HD23 ' A' ' 73' ' ' LEU . 71.9 Cg_endo -68.91 150.53 73.4 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.468 2.112 . . . . 0.0 110.975 -173.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.555 HD23 HD12 ' A' ' 72' ' ' ILE 0.332 0.0 OUTLIER -49.82 -34.48 19.79 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.306 174.985 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.487 ' HA ' HD22 ' A' ' 38' ' ' LEU . 3.1 p -76.71 -14.88 14.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 126.531 1.932 . . . . 0.0 114.165 179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -94.18 -40.1 10.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 120.278 1.399 . . . . 0.0 109.944 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -74.8 -24.46 58.65 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 116.89 -1.529 . . . . 0.0 108.989 -172.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.581 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -73.13 -33.84 65.76 Favored 'General case' 0 N--CA 1.434 -1.268 0 CA-C-N 121.068 1.758 . . . . 0.0 109.833 172.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.494 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -75.19 -48.82 30.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 126.14 1.776 . . . . 0.0 106.849 -169.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -65.73 -34.12 77.46 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 125.569 1.547 . . . . 0.0 110.023 170.654 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.36 -14.17 59.52 Favored 'General case' 0 C--N 1.35 0.628 0 CA-C-N 120.675 1.579 . . . . 0.0 111.353 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.7 21.61 33.52 Favored Glycine 0 C--N 1.332 0.33 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 164.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.638 HG21 ' NH1' ' A' ' 88' ' ' ARG . 1.5 mm -78.36 -39.92 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -171.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 m -157.3 95.58 2.11 Favored Pre-proline 0 C--N 1.342 0.244 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 173.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.439 ' HA ' HG22 ' A' ' 39' ' ' VAL . 78.1 Cg_endo -77.71 -14.18 15.87 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.705 2.27 . . . . 0.0 113.649 -168.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.5 t -81.72 109.44 16.12 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 -173.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 50' ' ' ALA 0.261 48.8 mttt -59.2 -21.88 60.15 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 -163.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 -65.56 -55.2 19.02 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 120.487 1.494 . . . . 0.0 110.317 166.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -54.02 -50.41 66.71 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 177.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.581 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -46.52 -60.15 2.54 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 124.61 1.194 . . . . 0.0 110.976 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 -68.53 -25.41 64.91 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 116.334 -1.793 . . . . 0.0 111.93 -173.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -86.68 -25.35 24.86 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 121.239 1.836 . . . . 0.0 112.979 175.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.02 -31.86 69.21 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 125.496 1.518 . . . . 0.0 107.643 166.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.5 HG13 HD22 ' A' ' 34' ' ' LEU . 1.1 mp -77.43 -59.42 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.403 0 CA-C-O 115.285 -2.293 . . . . 0.0 108.811 172.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -63.52 -11.46 24.36 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 120.703 1.592 . . . . 0.0 112.659 -170.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.502 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.5 m-80 -81.22 137.99 35.83 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-O 122.851 1.31 . . . . 0.0 113.378 176.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -56.76 2.91 0.06 OUTLIER Glycine 0 CA--C 1.538 1.476 0 CA-C-N 113.034 -1.894 . . . . 0.0 114.999 164.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.461 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -79.43 -18.71 51.64 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 128.18 2.592 . . . . 0.0 112.436 172.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 56' ' ' ASN 0.356 0.0 OUTLIER -96.28 97.75 6.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 124.499 2.095 . . . . 0.0 108.896 178.63 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.13 93.46 9.58 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 111.185 -2.734 . . . . 0.0 105.158 175.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 p -78.63 136.93 22.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 103.056 -2.942 . . . . 0.0 103.056 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.402 HD21 HD21 ' A' ' 79' ' ' LEU . 1.8 m-80 57.41 23.05 8.55 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 119.258 0.935 . . . . 0.0 110.917 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.62 7.88 83.76 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 126.439 1.971 . . . . 0.0 114.206 -179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -134.98 125.25 26.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 119.337 1.568 . . . . 0.0 109.166 -166.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.79 117.48 3.69 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 123.841 0.856 . . . . 0.0 109.321 -173.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 32.1 mt -147.93 114.06 5.85 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 170.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.53 17.46 10.45 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.17 149.43 41.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 121.418 -0.801 . . . . 0.0 109.805 -174.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.41 HG22 HD21 ' A' ' 73' ' ' LEU . 7.1 p -67.06 -35.66 75.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 124.887 1.275 . . . . 0.0 109.962 174.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.17 -17.37 69.97 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.759 -0.467 . . . . 0.0 113.248 169.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.5 -49.11 10.28 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.734 174.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.555 HD12 HD23 ' A' ' 34' ' ' LEU . 2.1 mt -138.74 129.19 33.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 120.069 1.304 . . . . 0.0 111.452 -174.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 33' ' ' PRO . 84.6 mt -114.76 -95.2 0.47 Allowed 'General case' 0 N--CA 1.431 -1.398 0 N-CA-C 103.247 -2.871 . . . . 0.0 103.247 163.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.21 -175.46 3.02 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.65 -1.281 . . . . 0.0 113.828 -173.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.86 -44.32 70.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.506 1.123 . . . . 0.0 113.261 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -75.05 -8.52 56.75 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.686 0.755 . . . . 0.0 111.386 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -93.31 -4.22 52.09 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.066 -1.021 . . . . 0.0 111.203 170.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.44 -66.96 1.03 Allowed 'General case' 0 CA--C 1.519 -0.212 0 O-C-N 120.863 -1.148 . . . . 0.0 108.786 175.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.557 HD22 HG21 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -89.54 -175.23 4.63 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 126.399 1.88 . . . . 0.0 107.699 173.467 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -56.94 -12.39 1.97 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.384 1.473 . . . . 0.0 113.889 166.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 111.85 79.17 0.96 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 125.517 1.532 . . . . 0.0 112.535 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -141.17 -49.17 0.41 Allowed 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 117.798 -1.096 . . . . 0.0 113.142 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -155.78 -170.57 3.46 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.945 2.498 . . . . 0.0 107.059 -174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.25 130.76 7.97 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 120.09 -1.631 . . . . 0.0 107.199 163.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.36 133.42 29.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 168.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 6.7 mm -111.05 106.85 21.55 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.421 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 167.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -100.48 79.47 2.11 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 104.776 -2.305 . . . . 0.0 104.776 176.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.638 ' NH1' HG21 ' A' ' 43' ' ' ILE . 30.1 ttm105 -85.1 109.97 18.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 174.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.29 -18.49 2.3 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.764 1.65 . . . . 0.0 114.756 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -47.01 -39.18 12.09 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.928 1.364 . . . . 0.0 111.793 169.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -142.27 -78.06 0.25 Allowed 'General case' 0 C--N 1.338 0.096 0 CA-C-O 117.976 -1.011 . . . . 0.0 108.435 175.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.36 -152.63 0.32 Allowed 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 120.667 1.576 . . . . 0.0 111.997 -171.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 0.1 OUTLIER -100.98 75.12 1.65 Allowed 'General case' 0 N--CA 1.47 0.529 1 C-N-CA 132.208 4.203 . . . . 0.0 113.298 -175.37 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.73 140.02 38.36 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 120.145 -1.597 . . . . 0.0 108.053 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 96' ' ' ILE . 0.4 OUTLIER -89.19 144.72 25.91 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.54 -175.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.408 HD12 ' C ' ' A' ' 95' ' ' LEU . 2.4 mp -133.16 138.91 50.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 124.52 1.128 . . . . 0.0 108.622 173.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 6.5 ttm105 -136.43 -176.61 4.4 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.316 1.532 . . . . 0.0 111.781 163.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.23 163.06 13.71 Favored 'General case' 0 N--CA 1.433 -1.292 0 C-N-CA 125.92 1.688 . . . . 0.0 108.85 163.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 0 C-N-CA 127.487 2.315 . . . . 0.0 109.72 -175.22 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 119.695 -0.193 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 49.6 tp -148.17 -52.31 0.18 Allowed 'General case' 0 N--CA 1.463 0.187 0 C-N-CA 124.163 0.985 . . . . 0.0 110.46 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -58.52 98.42 0.04 OUTLIER 'General case' 0 C--O 1.232 0.146 0 C-N-CA 127.09 2.156 . . . . 0.0 109.41 -172.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.3 p -150.68 54.36 0.89 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.647 0.779 . . . . 0.0 109.677 -169.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -88.81 -90.99 1.14 Allowed Glycine 0 C--N 1.335 0.482 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 173.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.85 -57.17 3.89 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-O 122.43 1.11 . . . . 0.0 110.25 -172.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.455 HG21 ' HB3' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -91.17 41.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.843 0 C-N-CA 125.346 1.458 . . . . 0.0 111.007 -174.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.49 -12.18 41.43 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -100.99 -20.17 15.53 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 126.011 1.724 . . . . 0.0 112.282 173.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.603 HD11 ' HA ' ' A' ' 62' ' ' ASN 0.334 1.6 pt? -130.51 73.44 1.54 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.396 1.079 . . . . 0.0 112.365 -175.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.25 175.43 10.21 Favored 'General case' 0 C--O 1.214 -0.765 0 C-N-CA 126.42 1.888 . . . . 0.0 108.139 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.54 -55.15 38.7 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 119.921 -1.737 . . . . 0.0 113.134 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.4 -23.17 60.12 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.65 -35.31 70.32 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.739 1.216 . . . . 0.0 109.467 175.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 mt -73.9 -53.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 C-N-CA 127.715 2.406 . . . . 0.0 106.892 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -55.13 -53.53 54.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 117.526 -1.225 . . . . 0.0 111.355 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -73.29 -31.22 63.92 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 120.38 1.445 . . . . 0.0 109.46 -177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.52 -34.43 89.45 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 125.335 1.445 . . . . 0.0 110.552 -175.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -128.25 11.7 6.46 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.603 0.761 . . . . 0.0 111.813 -167.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -59.16 -5.55 0.71 Allowed 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 127.053 2.141 . . . . 0.0 115.942 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -78.29 -28.82 47.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.793 -0.567 . . . . 0.0 110.295 177.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.489 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -101.21 170.46 6.5 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 173.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.489 ' HD2' HG12 ' A' ' 22' ' ' VAL . 61.1 Cg_endo -73.0 177.32 7.9 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 CA-C-N 121.099 1.428 . . . . 0.0 109.231 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.4 p -125.46 145.56 50.03 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 171.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -108.93 156.24 19.93 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.942 1.297 . . . . 0.0 108.307 178.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.99 133.97 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 126.2 1.8 . . . . 0.0 107.936 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.402 ' CD2' ' H ' ' A' ' 29' ' ' GLY . 0.8 OUTLIER -125.63 -171.39 2.37 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 121.401 0.619 . . . . 0.0 111.093 163.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -100.08 13.58 33.6 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.844 1.657 . . . . 0.0 112.156 -175.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.402 ' H ' ' CD2' ' A' ' 27' ' ' HIS . . . -91.1 172.57 36.79 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.712 1.149 . . . . 0.0 113.375 -172.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -102.32 -85.39 1.87 Allowed Glycine 0 C--N 1.333 0.361 0 N-CA-C 106.686 -2.565 . . . . 0.0 106.686 169.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.33 150.08 21.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 125.251 1.42 . . . . 0.0 109.714 163.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.455 ' H ' HG23 ' A' ' 74' ' ' THR . 0.9 OUTLIER -161.76 152.14 14.51 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 167.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -58.16 139.64 91.24 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.448 2.099 . . . . 0.0 113.168 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.293 0.9 OUTLIER -49.55 -32.65 12.95 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 169.172 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.7 p -74.59 -11.72 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 128.047 2.539 . . . . 0.0 115.086 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -103.03 -44.16 5.3 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.945 0.793 . . . . 0.0 109.224 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.05 -22.8 58.15 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 116.96 -1.495 . . . . 0.0 109.735 -171.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.651 HD21 HD11 ' A' ' 54' ' ' ILE . 0.3 OUTLIER -85.82 -23.26 27.25 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 120.706 1.594 . . . . 0.0 110.146 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -48.33 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 125.459 1.504 . . . . 0.0 107.243 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 t -68.63 -37.96 80.14 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.033 1.333 . . . . 0.0 109.31 178.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.83 -18.78 53.47 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.374 0.534 . . . . 0.0 112.052 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.23 33.36 6.59 Favored Glycine 0 C--N 1.335 0.5 0 CA-C-N 118.819 0.736 . . . . 0.0 111.52 164.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 mp -78.38 -49.89 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 104.077 -2.564 . . . . 0.0 104.077 172.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -149.35 107.46 3.35 Favored Pre-proline 0 C--N 1.349 0.553 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 169.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -81.36 -18.21 8.53 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.268 1.978 . . . . 0.0 113.255 -176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.5 t -86.4 106.34 17.37 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 104.416 -2.438 . . . . 0.0 104.416 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -58.82 -18.04 28.91 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -163.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.33 -50.48 21.84 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 121.786 2.085 . . . . 0.0 110.47 167.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -42.96 70.13 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-O 116.468 -1.729 . . . . 0.0 107.31 173.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.594 ' O ' HD12 ' A' ' 54' ' ' ILE . . . -52.63 -63.49 1.12 Allowed 'General case' 0 C--O 1.216 -0.681 0 CA-C-O 117.429 -1.272 . . . . 0.0 109.094 172.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . 0.327 2.8 ttt-85 -60.2 -22.89 63.51 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 115.01 -2.424 . . . . 0.0 113.11 -170.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.46 -29.88 25.71 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 121.664 2.029 . . . . 0.0 114.116 166.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.432 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.2 m-20 -62.56 -20.32 64.57 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 119.95 1.25 . . . . 0.0 111.644 171.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.651 HD11 HD21 ' A' ' 38' ' ' LEU . 4.3 mp -87.22 -62.45 1.53 Allowed 'Isoleucine or valine' 0 C--O 1.21 -1.015 0 CA-C-O 116.833 -1.556 . . . . 0.0 108.356 163.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -64.32 -7.49 9.73 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 120.065 1.302 . . . . 0.0 111.607 -165.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.481 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.1 m-80 -82.66 135.67 34.97 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.64 0.733 . . . . 0.0 111.838 173.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.439 ' HA2' ' HG2' ' A' ' 65' ' ' ARG . . . -74.2 40.26 1.05 Allowed Glycine 0 N--CA 1.435 -1.429 0 CA-C-N 114.068 -1.423 . . . . 0.0 111.682 165.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -124.24 0.52 8.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 C-N-CA 127.302 2.241 . . . . 0.0 111.146 164.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 56' ' ' ASN 0.323 0.0 OUTLIER -91.61 99.41 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 122.086 2.221 . . . . 0.0 106.385 163.63 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -86.84 115.06 24.01 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 126.666 1.987 . . . . 0.0 107.462 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.802 HG21 HD13 ' A' ' 72' ' ' ILE . 15.3 t -98.08 127.64 50.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.609 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 174.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.603 ' HA ' HD11 ' A' ' 10' ' ' LEU . 1.2 m-80 67.24 -14.06 0.2 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.862 1.265 . . . . 0.0 112.915 -173.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.44 -8.17 6.6 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 126.705 2.097 . . . . 0.0 111.66 -170.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -110.08 124.48 51.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 119.205 1.502 . . . . 0.0 107.338 -169.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HG2' ' HA2' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -60.47 111.39 1.56 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.597 ' HB3' HD11 ' A' ' 72' ' ' ILE . 76.7 mt -146.4 89.17 1.83 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -171.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.19 35.09 1.2 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.156 1.783 . . . . 0.0 113.069 -171.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -140.26 144.04 36.26 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.269 -0.895 . . . . 0.0 112.361 -167.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 13.0 p -66.82 -36.57 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 126.49 1.916 . . . . 0.0 109.668 168.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -68.7 -16.11 69.58 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-O 119.268 -0.74 . . . . 0.0 112.607 173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.7 -52.87 4.66 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 116.978 -1.486 . . . . 0.0 110.271 175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.802 HD13 HG21 ' A' ' 61' ' ' VAL . 1.1 mp -138.13 138.98 42.96 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 121.376 1.898 . . . . 0.0 112.706 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.8 mt -106.97 -75.18 0.64 Allowed 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 102.367 -3.198 . . . . 0.0 102.367 163.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.455 HG23 ' H ' ' A' ' 32' ' ' VAL . 22.1 p -131.06 -142.21 0.23 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . . . -89.06 -48.68 7.25 Favored 'General case' 0 CA--C 1.498 -1.021 0 C-N-CA 124.777 1.231 . . . . 0.0 111.768 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.15 -8.15 55.15 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 122.038 0.923 . . . . 0.0 109.625 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -86.47 -9.31 56.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.337 1.455 . . . . 0.0 111.887 168.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.409 ' HB3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -126.8 -71.9 0.67 Allowed 'General case' 0 C--N 1.34 0.156 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 -170.182 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.471 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -91.22 -169.53 2.36 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 126.52 1.928 . . . . 0.0 110.028 172.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -59.01 -3.62 0.37 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.898 1.679 . . . . 0.0 113.674 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 94.52 78.46 1.41 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -133.77 -59.25 0.85 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.914 0.357 . . . . 0.0 111.471 167.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -148.95 -177.61 5.9 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.478 2.311 . . . . 0.0 106.283 -176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.76 153.88 43.71 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 163.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.8 t -124.48 134.43 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.493 HD13 HG22 ' A' ' 61' ' ' VAL . 26.0 mm -125.28 95.28 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.328 1.851 . . . . 0.0 107.528 -169.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -89.31 88.84 7.65 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.432 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -80.04 120.14 23.81 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 163.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.63 -22.18 59.01 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.729 1.157 . . . . 0.0 114.051 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -3.74 52.88 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.509 1.524 . . . . 0.0 111.879 173.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -144.15 -131.52 0.08 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 175.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.27 -159.73 0.97 Allowed 'General case' 0 C--O 1.242 0.668 0 CA-C-N 120.64 1.564 . . . . 0.0 109.843 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.43 83.89 4.25 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 129.418 3.087 . . . . 0.0 110.441 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -78.39 164.24 24.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 174.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.22 129.94 44.0 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 -164.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.5 mm -126.98 123.0 61.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -163.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.571 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 6.4 ttt180 -134.33 -178.72 5.18 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-O 125.376 2.512 . . . . 0.0 115.34 171.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.571 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -137.99 143.15 40.51 Favored 'General case' 0 N--CA 1.427 -1.582 1 C-N-CA 131.837 4.055 . . . . 0.0 105.829 -172.975 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.814 0 C-N-CA 125.819 1.648 . . . . 0.0 110.084 -175.384 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.609 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.4 mt -111.64 169.44 8.82 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.078 0.951 . . . . 0.0 108.972 174.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -106.73 136.78 45.94 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 167.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.7 m -134.05 -175.33 3.82 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.853 2.061 . . . . 0.0 106.67 163.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -66.89 -38.15 92.71 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 167.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -78.95 166.14 22.7 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 122.928 1.347 . . . . 0.0 108.602 166.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.436 HG12 HD22 ' A' ' 62' ' ' ASN . 0.7 OUTLIER -67.48 82.92 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 125.688 1.595 . . . . 0.0 112.514 169.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -73.78 -6.7 48.58 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.61 -1.307 . . . . 0.0 110.439 163.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -78.8 -23.54 45.11 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.921 1.288 . . . . 0.0 111.007 170.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.542 ' HB3' HD11 ' A' ' 15' ' ' ILE . 1.3 mm? -86.62 66.09 9.32 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 165.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.84 168.12 20.17 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.41 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -62.81 -55.91 22.19 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 123.523 0.729 . . . . 0.0 111.833 -174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.64 -19.02 63.62 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.667 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.35 -41.87 46.72 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 123.868 0.867 . . . . 0.0 109.167 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' A' ' 10' ' ' LEU . 10.1 mt -72.74 -51.19 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 175.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -57.52 -46.99 83.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.334 -176.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -78.07 -30.45 49.68 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 119.673 1.124 . . . . 0.0 110.194 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.55 -33.83 86.26 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -124.03 17.32 9.26 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.954 0.501 . . . . 0.0 112.083 -171.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.33 -14.16 16.98 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -178.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -78.99 -21.3 47.23 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.452 1.501 . . . . 0.0 111.716 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.527 HG11 ' HB3' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -115.95 161.61 29.95 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -175.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.433 ' HD2' HG12 ' A' ' 22' ' ' VAL . 29.8 Cg_endo -83.23 172.79 10.36 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.245 1.296 . . . . 0.0 110.702 -169.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 78.8 p -127.09 170.57 12.22 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 114.631 -1.168 . . . . 0.0 111.068 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -139.03 154.89 48.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.277 1.431 . . . . 0.0 107.831 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 3.6 p -138.41 125.85 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 C-N-CA 123.884 0.873 . . . . 0.0 109.931 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -117.49 -168.13 1.44 Allowed 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 171.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -84.94 12.13 8.1 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 127.789 2.436 . . . . 0.0 116.022 -163.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.04 -177.39 8.6 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -164.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.78 133.39 1.61 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -168.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.08 149.76 40.25 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 117.575 0.688 . . . . 0.0 111.236 -174.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -160.92 140.33 7.9 Favored Pre-proline 0 CA--C 1.51 -0.574 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 -168.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.422 ' HA ' HD23 ' A' ' 73' ' ' LEU . 98.6 Cg_endo -76.34 150.97 33.19 Favored 'Trans proline' 0 N--CA 1.435 -1.926 0 C-N-CA 121.508 1.472 . . . . 0.0 110.973 -172.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.333 0.3 OUTLIER -48.46 -34.62 11.4 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.222 -1.353 . . . . 0.0 112.098 173.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.807 ' HA ' HD11 ' A' ' 54' ' ' ILE . 9.9 p -67.03 -29.89 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 117.786 -1.102 . . . . 0.0 113.68 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.2 mm-40 -91.68 -40.12 11.46 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.737 1.153 . . . . 0.0 109.389 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.59 -30.72 66.15 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 117.093 -1.432 . . . . 0.0 108.399 -174.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.11 -22.26 25.48 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 121.054 1.752 . . . . 0.0 110.333 -172.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.75 -50.97 26.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 171.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.82 -39.7 95.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.498 1.119 . . . . 0.0 108.621 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.09 47.11 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.915 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.07 33.88 7.5 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 166.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.405 HG12 HG21 ' A' ' 86' ' ' ILE . 2.1 mp -77.78 -43.47 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 171.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -148.44 109.6 3.63 Favored Pre-proline 0 C--O 1.224 -0.288 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 164.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.3 -15.71 11.24 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.548 2.165 . . . . 0.0 113.391 -176.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.5 t -81.25 115.81 20.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.2 tttp -58.54 -30.01 66.79 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.62 1.555 . . . . 0.0 112.89 -168.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -52.33 24.47 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.052 -1.03 . . . . 0.0 109.637 173.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.7 tp60 -54.79 -49.96 69.67 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -46.62 -58.45 3.82 Favored 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 126.375 1.87 . . . . 0.0 110.005 176.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.464 ' HA ' HD12 ' A' ' 54' ' ' ILE . 34.1 mtt85 -58.07 -33.79 69.43 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 117.045 -1.455 . . . . 0.0 113.218 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -80.77 -34.75 34.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.016 1.734 . . . . 0.0 112.926 173.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.85 -15.6 62.08 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.452 1.501 . . . . 0.0 111.248 176.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.807 HD11 ' HA ' ' A' ' 35' ' ' VAL . 57.5 mt -86.65 -61.68 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 C-N-CA 125.41 1.484 . . . . 0.0 108.86 163.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -72.98 -5.47 38.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 -163.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.52 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.1 m-80 -81.01 131.81 35.33 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 163.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -57.31 2.98 0.08 OUTLIER Glycine 0 CA--C 1.535 1.337 0 C-N-CA 123.856 0.741 . . . . 0.0 114.876 167.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.479 ' HB1' HH21 ' A' ' 88' ' ' ARG . . . -79.1 11.32 2.84 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.099 2.159 . . . . 0.0 111.451 169.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 56' ' ' ASN 0.38 0.0 OUTLIER -111.77 90.05 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-O 124.98 2.324 . . . . 0.0 104.735 163.349 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.426 ' CE1' ' HA ' ' A' ' 58' ' ' ALA . 0.3 OUTLIER -78.9 96.69 5.76 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 111.36 -2.655 . . . . 0.0 104.807 172.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 p -78.49 134.58 27.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 103.347 -2.834 . . . . 0.0 103.347 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.729 HD21 HD22 ' A' ' 79' ' ' LEU . 1.8 m-20 60.11 14.36 4.41 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 122.004 2.183 . . . . 0.0 114.221 173.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.67 -4.77 69.38 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.535 1.541 . . . . 0.0 113.723 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -121.82 127.95 51.14 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.912 1.856 . . . . 0.0 108.521 -166.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 105.06 0.64 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 125.466 1.506 . . . . 0.0 108.302 -172.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 58.9 mt -140.09 100.89 4.03 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 120.234 1.379 . . . . 0.0 107.964 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -106.38 27.06 9.11 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.827 2.851 . . . . 0.0 110.559 -168.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -140.39 131.3 26.03 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.707 1.203 . . . . 0.0 112.138 -164.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 p -59.12 -36.39 62.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 126.568 1.947 . . . . 0.0 110.682 167.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -66.11 -19.49 68.11 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 119.283 -0.732 . . . . 0.0 112.771 173.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.23 -37.84 13.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.109 1.364 . . . . 0.0 114.486 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mt -142.41 123.58 11.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 120.729 1.604 . . . . 0.0 110.69 -173.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.448 ' H ' ' CG ' ' A' ' 77' ' ' HIS . 70.3 mt -107.26 -95.24 0.37 Allowed 'General case' 0 N--CA 1.433 -1.294 0 N-CA-C 102.676 -3.083 . . . . 0.0 102.676 163.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.42 -173.05 2.46 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.065 1.302 . . . . 0.0 114.346 -173.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.24 -41.07 87.86 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 121.253 -0.904 . . . . 0.0 112.395 176.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -65.17 -17.22 64.3 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.001 0.92 . . . . 0.0 112.734 174.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.448 ' CG ' ' H ' ' A' ' 73' ' ' LEU . 42.5 t-80 -93.73 4.14 54.38 Favored 'General case' 0 N--CA 1.442 -0.874 0 C-N-CA 125.984 1.714 . . . . 0.0 109.682 176.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -128.27 -61.34 1.09 Allowed 'General case' 0 C--N 1.35 0.592 0 CA-C-O 118.248 -0.882 . . . . 0.0 111.938 170.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.729 HD22 HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -91.07 -170.31 2.62 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 120.441 1.473 . . . . 0.0 109.101 169.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 25.7 pt-20 -43.8 -49.36 8.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.548 1.139 . . . . 0.0 109.664 163.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.05 81.68 0.11 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 125.604 1.574 . . . . 0.0 114.363 172.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -141.74 -46.1 0.36 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 117.269 0.534 . . . . 0.0 111.902 165.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.41 ' CE1' ' HB1' ' A' ' 12' ' ' ALA . 83.6 m-85 -131.8 -177.52 4.47 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 125.502 1.521 . . . . 0.0 108.476 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.412 ' HA ' HD21 ' A' ' 79' ' ' LEU . 1.4 m -161.3 132.53 5.42 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.302 1.841 . . . . 0.0 106.72 163.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.25 145.4 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 170.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.405 HG21 HG12 ' A' ' 43' ' ' ILE . 15.4 mm -125.88 98.48 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.558 0 C-N-CA 126.442 1.897 . . . . 0.0 106.792 -176.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.4 mtt180 -97.12 82.35 3.18 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.479 HH21 ' HB1' ' A' ' 58' ' ' ALA . 0.7 OUTLIER -79.28 61.39 3.36 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.398 1.879 . . . . 0.0 109.309 -174.221 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 27.19 -82.7 0.0 OUTLIER Glycine 0 CA--C 1.527 0.784 0 C-N-CA 130.292 3.806 . . . . 0.0 116.598 171.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -51.74 -55.05 21.96 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 125.745 1.618 . . . . 0.0 109.97 175.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.24 176.9 8.8 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.894 1.678 . . . . 0.0 109.414 170.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.527 ' HB3' HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -83.72 -146.07 0.08 Allowed 'General case' 0 C--O 1.242 0.66 0 CA-C-O 122.707 1.242 . . . . 0.0 111.743 -176.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -118.16 82.31 1.82 Allowed 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.295 2.238 . . . . 0.0 109.506 -163.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -78.92 168.34 19.84 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.274 -0.891 . . . . 0.0 108.894 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.5 tp -121.9 131.38 54.0 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.766 -171.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.44 133.42 66.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 15.0 ptt180 -144.08 172.08 13.38 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 122.578 1.18 . . . . 0.0 109.989 171.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.86 163.29 21.56 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 124.611 1.164 . . . . 0.0 108.417 163.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.52 0 C-N-CA 127.017 2.127 . . . . 0.0 110.026 173.295 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 55.45 -175.21 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.897 0.879 . . . . 0.0 109.302 -150.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.94 -46.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 O-C-N 120.755 -1.216 . . . . 0.0 109.314 164.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 61.0 m -159.49 -179.99 8.41 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.372 2.269 . . . . 0.0 107.727 170.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.02 -132.87 3.92 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -172.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -78.75 -64.76 1.1 Allowed 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.3 pt -90.93 51.24 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 122.922 1.344 . . . . 0.0 111.363 -175.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.47 -5.17 10.15 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 124.721 1.209 . . . . 0.0 111.534 171.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -106.23 -11.22 16.11 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 126.319 1.847 . . . . 0.0 109.815 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.449 HD12 HG21 ' A' ' 85' ' ' VAL . 0.9 OUTLIER -158.76 84.52 0.82 Allowed 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 125.34 1.456 . . . . 0.0 110.088 -171.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.4 p -77.94 176.76 8.83 Favored 'General case' 0 C--O 1.218 -0.596 0 C-N-CA 124.097 0.959 . . . . 0.0 109.593 -175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.5 -49.91 69.51 Favored 'General case' 0 CA--C 1.511 -0.526 0 O-C-N 120.347 -1.471 . . . . 0.0 110.836 -174.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 -28.8 65.97 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 118.55 -1.26 . . . . 0.0 109.906 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -79.38 -24.31 42.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.218 1.007 . . . . 0.0 110.146 -177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.0 mt -74.08 -54.76 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 C-N-CA 125.837 1.655 . . . . 0.0 106.901 171.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -57.27 -48.59 78.5 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.812 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -81.22 -24.87 37.11 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 119.417 1.008 . . . . 0.0 110.437 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.43 -38.88 96.38 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -121.48 14.47 11.11 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 123.726 0.31 . . . . 0.0 111.468 -164.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.7 ttmt -54.22 -11.64 0.52 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -78.36 -13.27 59.92 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 126.918 2.087 . . . . 0.0 110.413 -174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.44 ' CG1' ' HE2' ' A' ' 91' ' ' LYS . 0.1 OUTLIER -127.92 155.45 77.6 Favored Pre-proline 0 N--CA 1.441 -0.881 0 C-N-CA 126.26 1.824 . . . . 0.0 106.337 169.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.65 169.43 20.89 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.71 1.607 . . . . 0.0 110.463 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.8 p -104.25 175.63 5.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.637 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -136.75 160.31 39.23 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 163.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 8.0 p -134.43 132.12 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 171.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -108.98 172.61 6.74 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 164.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -100.08 57.74 0.98 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.655 -1.278 . . . . 0.0 111.681 -164.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 62.15 -171.63 9.91 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 111.983 -0.447 . . . . 0.0 111.983 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.98 148.19 2.22 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 107.322 -2.311 . . . . 0.0 107.322 -164.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -73.11 149.67 42.87 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 121.909 -0.759 . . . . 0.0 110.389 164.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.5 t -158.42 132.62 5.15 Favored Pre-proline 0 CA--C 1.505 -0.752 0 N-CA-C 105.204 -2.147 . . . . 0.0 105.204 -163.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.462 ' HA ' HD23 ' A' ' 73' ' ' LEU . 44.4 Cg_endo -74.41 154.81 45.77 Favored 'Trans proline' 0 N--CA 1.438 -1.789 0 C-N-CA 121.715 1.61 . . . . 0.0 110.251 -173.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.397 0.6 OUTLIER -53.94 -29.99 44.69 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.482 176.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.678 ' HA ' HD11 ' A' ' 54' ' ' ILE . 8.6 p -70.25 -24.78 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 174.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -90.86 -43.77 9.82 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 120.31 1.414 . . . . 0.0 108.508 175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -73.78 -28.31 61.6 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 116.943 -1.503 . . . . 0.0 109.49 -171.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.08 -31.29 25.4 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 120.713 1.597 . . . . 0.0 109.327 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.8 t -64.6 -51.5 66.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -66.62 -34.75 78.57 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.152 1.381 . . . . 0.0 109.998 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.4 -15.65 58.44 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.726 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.38 23.36 19.46 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 166.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.93 -43.37 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 m -156.34 101.12 2.07 Favored Pre-proline 0 C--N 1.349 0.562 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 171.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.62 -18.68 10.49 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 121.771 1.647 . . . . 0.0 113.431 -173.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.3 t -86.34 106.34 17.32 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 105.796 -1.927 . . . . 0.0 105.796 -174.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.485 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 75.2 mttt -57.22 -22.19 39.22 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 115.915 1.82 . . . . 0.0 115.915 -164.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.55 -45.99 56.6 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 121.828 2.104 . . . . 0.0 111.095 169.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -57.27 -51.81 67.84 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -50.59 -52.93 34.65 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 125.447 1.717 . . . . 0.0 110.586 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ttm180 -57.08 -37.97 72.66 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 117.295 -1.336 . . . . 0.0 111.102 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -84.04 -24.89 30.27 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 116.736 -1.986 . . . . 0.0 113.296 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.16 -23.19 66.45 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 112.22 172.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.678 HD11 ' HA ' ' A' ' 35' ' ' VAL . 70.0 mt -84.95 -63.7 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 C-N-CA 126.211 1.804 . . . . 0.0 107.3 168.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -66.52 -5.13 10.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 119.916 1.235 . . . . 0.0 112.783 -164.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.628 ' O ' HG22 ' A' ' 59' ' ' ILE . 7.0 m120 -81.5 132.26 35.31 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 164.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.06 10.76 0.06 OUTLIER Glycine 0 CA--C 1.536 1.395 0 C-N-CA 125.246 1.403 . . . . 0.0 115.119 164.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.52 -12.67 59.86 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 116.253 -1.832 . . . . 0.0 112.964 165.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 56' ' ' ASN 0.362 0.0 OUTLIER -99.74 87.79 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.518 0 CA-C-O 125.881 2.753 . . . . 0.0 107.741 177.128 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -79.32 99.08 6.95 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 109.698 -3.41 . . . . 0.0 106.654 173.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 p -78.84 137.34 22.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.5 HD21 ' CD2' ' A' ' 79' ' ' LEU . 0.9 OUTLIER 60.19 4.56 0.67 Allowed 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 120.657 1.572 . . . . 0.0 113.132 177.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 -2.15 47.69 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.492 1.52 . . . . 0.0 114.035 -171.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -124.18 129.07 50.18 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 119.852 1.826 . . . . 0.0 108.979 -171.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.51 110.35 1.94 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.515 1.526 . . . . 0.0 108.386 -171.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.479 ' HB3' ' HB1' ' A' ' 71' ' ' ALA . 17.9 mt -141.22 70.42 1.35 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 122.128 0.966 . . . . 0.0 109.023 -174.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -78.97 31.94 0.21 Allowed 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 -170.103 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -143.62 159.44 42.45 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.7 t -68.01 -27.42 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.971 2.509 . . . . 0.0 111.48 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -84.11 -7.57 85.09 Favored Glycine 0 C--N 1.333 0.401 0 O-C-N 121.393 -0.817 . . . . 0.0 112.552 168.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HB1' ' HB3' ' A' ' 66' ' ' LEU . . . -86.44 -57.64 2.92 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 117.914 -1.041 . . . . 0.0 108.298 170.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp -136.17 137.34 48.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 120.596 1.544 . . . . 0.0 113.475 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 33' ' ' PRO . 93.1 mt -108.12 -87.02 0.5 Allowed 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 100.571 -3.862 . . . . 0.0 100.571 163.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.48 -174.42 2.51 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 120.861 -1.15 . . . . 0.0 113.803 -169.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.0 -48.72 75.37 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -70.11 -15.34 62.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.175 0.898 . . . . 0.0 111.224 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -81.3 -10.34 59.59 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.249 -0.907 . . . . 0.0 109.928 172.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.21 -77.15 0.57 Allowed 'General case' 0 C--N 1.343 0.306 0 O-C-N 120.789 -1.194 . . . . 0.0 108.095 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.5 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -90.55 -171.51 3.09 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 125.66 1.584 . . . . 0.0 109.328 177.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -47.78 -26.27 1.55 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.72 2.008 . . . . 0.0 115.362 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.34 64.56 0.31 Allowed Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 126.01 1.767 . . . . 0.0 111.261 -169.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.5 mmt85 -133.27 -81.3 0.48 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -127.36 -166.39 1.6 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.845 1.258 . . . . 0.0 108.781 -168.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.34 122.35 4.49 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 120.78 -1.2 . . . . 0.0 107.899 165.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.449 HG21 HD12 ' A' ' 10' ' ' LEU . 39.2 t -79.5 128.12 38.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 172.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.456 HD12 HD11 ' A' ' 59' ' ' ILE . 11.2 mm -116.24 98.03 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 176.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -92.37 85.62 5.43 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 176.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.528 ' CG ' ' HB ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -89.65 113.97 25.52 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 166.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.84 2.88 1.13 Allowed Glycine 0 CA--C 1.537 1.444 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -58.2 -45.44 87.58 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.154 1.477 . . . . 0.0 109.573 164.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.44 ' HE2' ' CG1' ' A' ' 22' ' ' VAL . 61.7 tttt -131.76 -90.44 0.43 Allowed 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 173.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.425 ' HG3' ' CD1' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -152.82 -152.39 0.42 Allowed 'General case' 0 C--O 1.241 0.653 0 CA-C-N 120.878 1.672 . . . . 0.0 111.523 -167.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.425 ' CD1' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -94.68 79.5 3.76 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 129.897 3.279 . . . . 0.0 110.244 -176.746 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.4 144.38 35.95 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 119.95 -1.719 . . . . 0.0 107.219 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 52.1 tp -97.93 139.07 34.31 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -176.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 11.3 mm -126.6 135.71 62.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 12.9 ptt180 -135.37 174.01 11.09 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 122.655 1.217 . . . . 0.0 111.568 164.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.19 163.44 12.24 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 163.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.41 0 C-N-CA 127.671 2.388 . . . . 0.0 109.071 -176.932 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mt -67.93 126.35 29.17 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.541 1.064 . . . . 0.0 109.542 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.47 -172.33 3.26 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 125.897 1.679 . . . . 0.0 108.644 -174.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.95 -175.23 3.9 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.646 1.579 . . . . 0.0 107.833 167.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.9 -72.19 2.08 Favored Glycine 0 C--N 1.335 0.526 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -78.24 172.68 13.21 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 123.056 1.408 . . . . 0.0 109.154 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.403 HG13 ' H ' ' A' ' 7' ' ' ILE . 1.4 pp -62.48 40.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.63 1 C-N-CA 131.82 4.048 . . . . 0.0 112.537 168.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.83 5.52 3.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 129.092 2.957 . . . . 0.0 111.286 173.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -78.6 -22.91 46.33 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 124.424 1.09 . . . . 0.0 109.57 164.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.3 94.41 8.74 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.152 1.781 . . . . 0.0 106.562 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.49 178.07 8.04 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.214 1.805 . . . . 0.0 108.594 176.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.82 -58.44 4.59 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.684 0.794 . . . . 0.0 111.139 176.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.13 -25.14 66.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 118.072 0.396 . . . . 0.0 111.026 177.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -73.73 -39.28 64.4 Favored 'General case' 0 C--O 1.22 -0.464 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.3 mt -70.31 -52.12 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-O 118.572 -0.727 . . . . 0.0 109.371 175.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -59.37 -48.22 82.45 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 117.862 -1.535 . . . . 0.0 111.494 -175.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -72.12 -35.94 69.27 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.356 0.98 . . . . 0.0 109.155 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.79 -38.2 93.59 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -175.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -117.46 13.39 14.42 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 123.059 0.544 . . . . 0.0 110.458 -169.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -15.57 4.96 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.406 1.883 . . . . 0.0 113.939 176.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -78.04 -11.23 59.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 127.427 2.291 . . . . 0.0 111.598 -175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.439 HG22 ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -133.76 172.84 6.63 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 167.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.439 ' HD2' HG22 ' A' ' 22' ' ' VAL . 71.1 Cg_endo -76.85 -174.24 2.08 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.145 2.563 . . . . 0.0 110.111 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.4 p -135.35 175.45 9.57 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.594 1.157 . . . . 0.0 109.085 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -138.53 161.32 37.35 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 119.265 0.939 . . . . 0.0 109.075 174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.8 t -138.81 139.64 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 124.713 1.205 . . . . 0.0 108.032 176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.69 172.16 8.62 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 122.505 1.145 . . . . 0.0 112.705 163.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -79.19 33.08 0.22 Allowed 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 128.641 2.776 . . . . 0.0 111.204 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.84 -170.87 31.95 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.543 -0.723 . . . . 0.0 112.058 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.78 145.54 2.98 Favored Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 107.854 -2.098 . . . . 0.0 107.854 -164.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -67.98 148.16 51.45 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.306 0.574 . . . . 0.0 110.653 167.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 39.8 t -156.77 133.75 6.53 Favored Pre-proline 0 CA--C 1.511 -0.539 0 N-CA-C 105.99 -1.855 . . . . 0.0 105.99 -163.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.519 ' HA ' HD23 ' A' ' 73' ' ' LEU . 89.9 Cg_endo -71.42 152.01 60.09 Favored 'Trans proline' 0 N--CA 1.441 -1.559 0 C-N-CA 122.069 1.846 . . . . 0.0 110.989 -172.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.442 1.0 OUTLIER -51.69 -30.4 21.89 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.552 174.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.475 ' HA ' HD22 ' A' ' 38' ' ' LEU . 7.7 p -78.11 -14.87 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.512 1.525 . . . . 0.0 114.71 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -91.36 -49.05 6.56 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 119.114 0.87 . . . . 0.0 109.055 166.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 pp -72.9 -23.88 60.77 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 117.381 -1.295 . . . . 0.0 109.051 -166.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.878 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -75.62 -33.4 60.52 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 120.822 1.646 . . . . 0.0 109.639 176.196 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.456 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -75.3 -46.86 37.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -175.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.37 -38.07 89.72 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.542 1.937 . . . . 0.0 109.39 175.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.64 -24.08 45.47 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.108 177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.17 23.12 11.68 Favored Glycine 0 CA--C 1.522 0.51 0 C-N-CA 124.096 0.855 . . . . 0.0 111.482 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.405 HG21 ' NH1' ' A' ' 88' ' ' ARG . 0.2 OUTLIER -78.3 -39.66 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 -174.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -145.15 113.6 4.86 Favored Pre-proline 0 C--O 1.225 -0.193 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 166.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.45 -15.08 5.37 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 122.778 2.319 . . . . 0.0 113.3 -176.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 t -84.8 132.67 34.39 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 175.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -65.04 -35.48 81.3 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-N 119.583 1.083 . . . . 0.0 111.034 176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -55.47 24.21 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 120.028 1.285 . . . . 0.0 108.945 177.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -49.3 76.71 Favored 'General case' 0 C--O 1.213 -0.858 0 CA-C-O 117.082 -1.437 . . . . 0.0 108.033 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.878 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -51.13 -51.85 49.58 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 119.694 1.134 . . . . 0.0 112.366 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -60.0 -39.89 87.35 Favored 'General case' 0 CA--C 1.511 -0.52 0 CA-C-O 117.678 -1.153 . . . . 0.0 110.238 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.26 -32.05 49.44 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 119.777 1.172 . . . . 0.0 112.351 177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -50.28 -39.81 46.46 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 168.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.561 HD11 HD22 ' A' ' 38' ' ' LEU . 43.8 mt -84.85 -49.99 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 115.66 -2.114 . . . . 0.0 109.597 -174.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -66.99 -10.83 53.75 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 125.382 1.676 . . . . 0.0 111.489 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.538 ' HB3' ' H ' ' A' ' 58' ' ' ALA . 1.2 m120 -83.52 137.3 33.93 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 174.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.66 0.42 0.45 Allowed Glycine 0 CA--C 1.533 1.177 0 CA-C-N 115.067 -0.969 . . . . 0.0 114.419 164.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.538 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -78.95 -4.13 48.34 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.58 1.552 . . . . 0.0 111.617 172.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.475 HG13 ' NH2' ' A' ' 88' ' ' ARG 0.393 0.0 OUTLIER -106.78 92.43 2.1 Favored 'Isoleucine or valine' 0 C--O 1.247 0.932 0 CA-C-O 125.06 2.362 . . . . 0.0 109.125 171.546 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -82.97 93.59 7.58 Favored 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 109.913 -3.312 . . . . 0.0 105.067 169.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 p -78.31 127.33 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 102.375 -3.195 . . . . 0.0 102.375 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.474 HD21 ' CD2' ' A' ' 79' ' ' LEU . 1.2 m-80 76.34 -52.39 0.6 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.464 1.906 . . . . 0.0 110.499 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.45 3.89 0.02 OUTLIER Glycine 0 CA--C 1.533 1.182 1 C-N-CA 130.731 4.015 . . . . 0.0 111.063 170.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -112.82 116.25 29.75 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -163.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.08 105.74 0.93 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 -175.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.9 mt -140.82 68.13 1.35 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.332 0.969 . . . . 0.0 109.547 -168.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.97 56.47 3.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.111 1.764 . . . . 0.0 112.535 -172.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -148.34 151.19 34.93 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.763 0.825 . . . . 0.0 112.928 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.32 -38.01 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 127.765 2.426 . . . . 0.0 110.699 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.14 -10.19 68.55 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-O 119.027 -0.874 . . . . 0.0 112.307 173.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.62 -55.6 3.8 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 117.213 -1.375 . . . . 0.0 109.664 170.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.3 mp -136.25 134.53 50.02 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 CA-C-N 120.585 1.539 . . . . 0.0 113.613 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 33' ' ' PRO . 77.3 mt -108.27 -86.41 0.51 Allowed 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 102.177 -3.268 . . . . 0.0 102.177 163.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 p -115.57 -168.94 1.49 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -169.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . . . -62.52 -45.33 93.45 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.634 -177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -70.2 -17.26 63.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 119.71 1.141 . . . . 0.0 110.93 175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -82.7 0.16 44.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.464 1.106 . . . . 0.0 110.92 173.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.45 -62.97 0.9 Allowed 'General case' 0 C--N 1.345 0.379 0 O-C-N 120.785 -1.197 . . . . 0.0 110.033 177.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.474 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -91.06 -175.22 4.24 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.452 2.301 . . . . 0.0 109.528 172.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -52.81 -28.66 23.64 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.983 1.313 . . . . 0.0 112.852 172.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.46 73.47 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.182 0 C-N-CA 126.355 1.931 . . . . 0.0 111.675 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.7 mtt-85 -139.04 -79.23 0.33 Allowed 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 117.614 0.707 . . . . 0.0 109.403 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -126.71 -170.8 2.27 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 126.109 1.764 . . . . 0.0 109.13 -173.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -153.12 116.72 4.71 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 163.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.84 138.46 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 170.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 17.9 mm -123.1 104.63 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.788 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.2 mtt180 -92.67 83.92 4.94 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 104.777 -2.305 . . . . 0.0 104.777 170.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.525 ' HG2' HH11 ' A' ' 88' ' ' ARG . 0.0 OUTLIER -78.48 82.22 4.76 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 103.084 -2.932 . . . . 0.0 103.084 169.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -49.28 -34.26 17.65 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.395 1.474 . . . . 0.0 111.932 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -69.39 15.19 0.07 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.709 1.204 . . . . 0.0 113.635 172.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 28.3 ttpt -162.69 -82.96 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.855 2.462 . . . . 0.0 108.868 163.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.608 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -157.73 -169.21 2.78 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 123.364 1.554 . . . . 0.0 110.163 -176.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.608 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 12.0 m-30 -107.03 76.83 1.12 Allowed 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 126.985 2.114 . . . . 0.0 111.704 -168.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -79.43 172.31 13.96 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.606 1.162 . . . . 0.0 112.129 -173.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.0 tp -140.66 137.53 33.63 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.377 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.15 141.83 45.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 125.716 1.606 . . . . 0.0 109.013 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -134.39 179.73 6.09 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 124.57 2.129 . . . . 0.0 109.392 163.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.405 ' CZ ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -121.25 162.14 20.74 Favored 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 112.73 -2.032 . . . . 0.0 107.257 163.458 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.474 0 C-N-CA 125.169 1.388 . . . . 0.0 112.111 176.214 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.313 0 CA-C-O 118.445 -0.788 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.0 mt 39.98 -5.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 2 C-N-CA 132.459 4.304 . . . . 0.0 121.964 164.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -130.71 -26.72 2.19 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 126.405 1.882 . . . . 0.0 110.601 169.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.3 t -166.22 -175.92 3.48 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.059 1.344 . . . . 0.0 108.704 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 125.45 -98.85 0.55 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 126.47 1.985 . . . . 0.0 109.642 175.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -72.71 0.36 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 177.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.639 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -91.06 52.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.391 1.477 . . . . 0.0 110.856 -171.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.32 4.21 1.4 Allowed 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 127.146 2.178 . . . . 0.0 112.993 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -116.63 -15.24 10.82 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 126.693 1.997 . . . . 0.0 110.086 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -152.96 70.25 0.87 Allowed 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.789 0.835 . . . . 0.0 109.622 -174.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.51 177.18 8.74 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 125.618 1.567 . . . . 0.0 109.371 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.94 -51.61 68.49 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.081 -1.637 . . . . 0.0 112.438 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.89 -29.69 69.64 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.258 178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.92 -31.96 61.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.78 2.032 . . . . 0.0 110.3 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.0 mt -76.38 -56.39 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 C-N-CA 126.338 1.855 . . . . 0.0 106.38 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.27 -49.63 63.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 118.715 0.689 . . . . 0.0 112.519 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.84 -35.59 62.39 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.14 -40.61 95.91 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -115.58 16.49 16.52 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 124.035 0.491 . . . . 0.0 110.565 -165.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 pttp -55.79 -12.07 1.19 Allowed 'General case' 0 C--N 1.34 0.18 0 N-CA-C 116.291 1.96 . . . . 0.0 116.291 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -102.67 -2.51 28.13 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 129.25 3.02 . . . . 0.0 113.209 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.467 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -120.79 169.72 8.38 Favored Pre-proline 0 CA--C 1.546 0.812 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.467 ' HD2' HG12 ' A' ' 22' ' ' VAL . 40.8 Cg_endo -84.13 173.19 9.13 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 CA-C-N 121.189 1.46 . . . . 0.0 109.878 -178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.8 p -128.87 158.16 39.52 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 114.05 -1.432 . . . . 0.0 108.878 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 61.6 t80 -135.08 153.76 51.92 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 173.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.0 p -128.49 131.8 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -122.41 172.69 8.15 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 123.114 1.435 . . . . 0.0 113.523 164.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 68.1 mt-10 -80.92 37.98 0.44 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 128.162 2.585 . . . . 0.0 112.43 -164.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 59.21 -171.53 5.0 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.706 1.146 . . . . 0.0 113.703 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.71 137.04 0.76 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 -167.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -65.17 137.0 57.35 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 118.378 1.089 . . . . 0.0 109.73 175.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.8 t -145.24 138.5 14.18 Favored Pre-proline 0 CA--C 1.514 -0.427 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 -163.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.518 ' HA ' HD23 ' A' ' 73' ' ' LEU . 94.7 Cg_endo -70.7 145.13 50.91 Favored 'Trans proline' 0 N--CA 1.441 -1.61 0 C-N-CA 122.628 2.219 . . . . 0.0 110.776 -169.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.754 HD22 HG13 ' A' ' 54' ' ' ILE 0.284 0.0 OUTLIER -47.35 -36.74 9.96 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.882 -1.054 . . . . 0.0 112.426 177.884 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.6 ' HA ' HD22 ' A' ' 38' ' ' LEU . 11.7 p -79.08 -15.88 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 126.707 2.003 . . . . 0.0 114.355 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -88.36 -44.23 10.93 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 120.088 1.313 . . . . 0.0 108.807 164.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -77.09 -18.18 58.18 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 116.847 -1.549 . . . . 0.0 109.888 -168.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.739 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -74.39 -34.69 63.37 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 121.144 1.793 . . . . 0.0 109.751 171.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.562 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -73.1 -49.14 40.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 C-N-CA 126.338 1.855 . . . . 0.0 106.054 -169.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 3.9 m -60.92 -40.89 94.88 Favored 'General case' 0 N--CA 1.425 -1.713 0 C-N-CA 128.53 2.732 . . . . 0.0 110.687 169.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.79 -11.09 59.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.904 1.229 . . . . 0.0 113.038 177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.25 20.39 49.22 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-N 119.682 1.128 . . . . 0.0 112.199 171.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.506 HG21 ' NH1' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -77.86 -39.74 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.794 1.637 . . . . 0.0 106.836 -177.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.74 111.32 1.32 Allowed Pre-proline 0 C--N 1.344 0.358 0 N-CA-C 104.297 -2.483 . . . . 0.0 104.297 167.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.11 -13.47 7.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.149 1.899 . . . . 0.0 112.414 -174.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 m -90.44 101.49 14.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 -164.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -41.44 -37.46 1.06 Allowed 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 117.157 2.281 . . . . 0.0 117.157 -163.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.48 -54.06 33.75 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 120.226 1.376 . . . . 0.0 110.168 171.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -59.16 -42.05 89.8 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 118.935 -0.555 . . . . 0.0 109.728 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.739 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -51.49 -55.58 18.15 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 123.836 0.855 . . . . 0.0 110.415 175.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.1 mtt85 -55.2 -42.46 73.32 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.173 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -79.78 -33.5 40.49 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 119.989 1.268 . . . . 0.0 112.125 -177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.63 -29.43 68.01 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 116.592 -1.67 . . . . 0.0 107.636 171.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.754 HG13 HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -81.74 -51.76 14.72 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.797 0 CA-C-N 120.34 1.427 . . . . 0.0 110.848 174.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -69.6 -7.11 35.89 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.76 1.624 . . . . 0.0 111.458 -172.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.553 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.8 m-80 -81.07 134.95 35.75 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 171.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -62.59 8.25 0.2 Allowed Glycine 0 CA--C 1.533 1.192 0 CA-C-O 118.383 -1.232 . . . . 0.0 114.674 164.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.475 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -84.32 -16.22 43.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 119.213 1.507 . . . . 0.0 111.173 170.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 56' ' ' ASN 0.352 0.0 OUTLIER -93.5 92.65 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-O 125.455 2.55 . . . . 0.0 106.79 169.615 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -78.96 109.4 13.21 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 111.566 -2.561 . . . . 0.0 106.236 167.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 72' ' ' ILE . 13.5 t -88.47 124.87 41.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.726 0 O-C-N 120.307 -1.496 . . . . 0.0 107.421 174.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.723 HD22 ' HG3' ' A' ' 78' ' ' ARG . 68.3 m-80 46.92 57.57 5.53 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 122.774 1.273 . . . . 0.0 110.169 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.23 4.75 51.57 Favored Glycine 0 CA--C 1.531 1.032 0 CA-C-N 113.56 -1.654 . . . . 0.0 114.439 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.0 tt0 -131.03 121.47 25.09 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 120.82 2.31 . . . . 0.0 110.404 -167.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.99 100.39 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 126.691 1.996 . . . . 0.0 110.435 -177.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.519 ' HB3' HD11 ' A' ' 72' ' ' ILE . 66.4 mt -138.48 108.12 6.23 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 105.313 -2.106 . . . . 0.0 105.313 -170.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.13 38.41 2.53 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.888 2.075 . . . . 0.0 112.125 -163.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -143.18 158.88 43.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.616 1.566 . . . . 0.0 110.291 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.441 HG22 HD21 ' A' ' 73' ' ' LEU . 6.3 p -69.12 -33.19 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 O-C-N 121.177 -0.952 . . . . 0.0 111.796 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.08 -8.19 84.91 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-O 119.713 -0.493 . . . . 0.0 112.489 168.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.35 -55.64 4.21 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 116.862 -1.542 . . . . 0.0 109.24 170.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.519 HD11 ' HB3' ' A' ' 66' ' ' LEU . 0.8 OUTLIER -138.93 145.86 27.02 Favored 'Isoleucine or valine' 0 C--N 1.345 0.402 0 CA-C-N 121.614 2.006 . . . . 0.0 111.774 177.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 33' ' ' PRO . 82.2 mt -115.84 -98.57 0.44 Allowed 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 163.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.05 -177.51 4.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.072 1.306 . . . . 0.0 114.145 -174.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -54.56 -48.71 71.73 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.068 0.947 . . . . 0.0 112.581 173.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -61.41 -20.31 62.92 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.996 1.319 . . . . 0.0 113.189 175.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 60.1 t-80 -84.45 -19.33 33.58 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.151 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.723 ' HG3' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -96.2 -74.89 0.55 Allowed 'General case' 0 C--N 1.345 0.404 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.635 HD11 ' H ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -91.52 169.63 10.6 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.371 1.468 . . . . 0.0 111.129 172.954 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -23.24 -52.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.028 3.331 . . . . 0.0 115.839 175.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 154.53 56.28 0.01 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 -168.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.9 -88.03 0.33 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 117.986 0.893 . . . . 0.0 111.851 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.635 ' H ' HD11 ' A' ' 79' ' ' LEU . 21.6 m-30 -131.56 -170.5 2.4 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -168.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -157.46 135.21 10.71 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.35 -0.844 . . . . 0.0 109.413 166.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 t -79.41 138.34 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 167.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 22.4 mm -113.22 92.74 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 C-N-CA 126.323 1.849 . . . . 0.0 106.042 169.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.9 ttt-85 -97.78 74.63 2.37 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 -165.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.748 HH11 ' HB2' ' A' ' 88' ' ' ARG . 0.0 OUTLIER -88.3 105.14 17.36 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 130.499 3.519 . . . . 0.0 110.019 -169.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -50.23 -30.56 17.98 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 124.182 0.896 . . . . 0.0 114.524 178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -23.58 31.71 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.721 1.609 . . . . 0.0 113.913 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -149.76 -89.91 0.07 Allowed 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.94 -144.52 0.15 Allowed 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 122.424 1.107 . . . . 0.0 109.99 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 3.6 m-30 -115.22 87.5 2.67 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 114.057 -1.429 . . . . 0.0 109.533 -162.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -78.49 161.92 26.72 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.87 134.9 54.85 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -172.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.7 mm -122.61 129.28 75.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.5 ptt180 -137.58 174.57 10.44 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 123.588 1.661 . . . . 0.0 111.061 171.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.71 166.05 13.72 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 124.738 1.215 . . . . 0.0 110.096 171.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.47 0 C-N-CA 129.075 2.95 . . . . 0.0 110.852 -168.684 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.384 0 CA-C-O 120.476 0.179 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -148.42 171.96 15.21 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 126.53 1.932 . . . . 0.0 107.68 159.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -138.83 -97.1 0.17 Allowed 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 169.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.9 t -156.99 -112.47 0.03 OUTLIER 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.09 -164.37 17.07 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 124.674 1.13 . . . . 0.0 110.965 172.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.22 -37.16 46.03 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 121.487 -1.008 . . . . 0.0 108.758 178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.1 OUTLIER -91.58 53.39 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 C-N-CA 124.402 1.081 . . . . 0.0 111.732 165.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.19 -10.49 10.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -98.07 -21.06 16.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.507 1.523 . . . . 0.0 111.207 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -155.0 72.93 0.85 Allowed 'General case' 0 C--O 1.226 -0.159 0 CA-C-O 121.34 0.591 . . . . 0.0 111.652 -164.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.41 -178.07 5.57 Favored 'General case' 0 C--O 1.218 -0.591 0 C-N-CA 125.388 1.475 . . . . 0.0 110.951 173.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.432 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -65.54 -51.01 63.06 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 120.467 -1.396 . . . . 0.0 111.47 -170.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.34 81.08 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 123.402 0.439 . . . . 0.0 110.087 175.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -72.81 -34.31 66.78 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -174.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.9 mt -72.68 -52.14 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 126.261 1.824 . . . . 0.0 108.397 177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -56.83 -47.24 80.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 118.598 0.635 . . . . 0.0 111.235 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -80.64 -22.54 40.44 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 118.581 0.628 . . . . 0.0 110.057 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -80.54 -24.67 58.28 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 125.241 1.4 . . . . 0.0 111.841 -177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -130.44 17.13 5.41 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.185 0.994 . . . . 0.0 110.596 -173.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.72 -15.23 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 127.191 2.196 . . . . 0.0 112.47 169.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.1 -19.7 53.63 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.766 2.827 . . . . 0.0 111.392 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.597 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -126.08 161.54 51.08 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 176.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.597 ' HD2' HG12 ' A' ' 22' ' ' VAL . 44.4 Cg_endo -76.16 172.26 16.58 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 N-CA-C 109.091 -1.157 . . . . 0.0 109.091 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.1 p -121.02 168.3 11.66 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 113.532 -1.667 . . . . 0.0 108.42 178.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -140.43 164.33 30.41 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 9.5 p -139.46 135.65 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -116.13 -179.23 3.6 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 121.75 0.786 . . . . 0.0 109.98 163.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -96.15 66.89 2.55 Favored 'General case' 0 C--N 1.322 -0.619 0 O-C-N 121.437 -0.79 . . . . 0.0 109.879 -171.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.56 -157.4 29.57 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.44 108.31 0.05 OUTLIER Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.295 1.426 . . . . 0.0 112.298 167.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -47.41 139.86 6.21 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 117.86 0.83 . . . . 0.0 112.192 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -149.95 136.54 10.86 Favored Pre-proline 0 CA--C 1.516 -0.352 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.722 -163.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.13 144.34 38.3 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 123.35 2.7 . . . . 0.0 112.388 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.377 1.1 pt? -55.8 -25.92 43.73 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 171.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.716 ' HA ' HD11 ' A' ' 54' ' ' ILE . 7.6 p -57.4 -56.6 14.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 119.58 1.082 . . . . 0.0 110.844 166.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -65.63 -41.88 92.16 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.188 -173.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -73.81 -29.5 62.2 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-N 120.587 1.539 . . . . 0.0 109.517 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.74 -27.83 22.12 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 120.459 1.482 . . . . 0.0 109.482 -173.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 t -69.54 -49.86 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 169.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 3.7 t -60.98 -45.4 94.94 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.668 1.587 . . . . 0.0 108.685 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.87 -15.61 58.13 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 119.695 -0.802 . . . . 0.0 112.167 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.94 27.58 9.39 Favored Glycine 0 C--N 1.335 0.501 0 CA-C-N 119.276 0.944 . . . . 0.0 111.268 164.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -45.77 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 103.127 -2.916 . . . . 0.0 103.127 176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -151.51 102.83 2.91 Favored Pre-proline 0 C--N 1.347 0.49 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 164.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.94 -17.45 19.7 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.131 1.887 . . . . 0.0 113.067 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.0 t -90.81 109.14 20.34 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.525 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 82.0 mttt -56.96 -18.75 14.69 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -166.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -72.02 -53.84 11.72 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-N 120.91 1.687 . . . . 0.0 110.484 168.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -47.91 68.08 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.525 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -50.37 -57.25 8.39 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 124.403 1.065 . . . . 0.0 111.359 177.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -63.13 -26.93 69.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 116.251 -1.833 . . . . 0.0 112.229 -176.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -69.74 -50.48 43.05 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 121.602 2.001 . . . . 0.0 110.982 163.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.617 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.0 OUTLIER -60.42 -9.55 3.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.725 1.21 . . . . 0.0 112.993 -174.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.716 HD11 ' HA ' ' A' ' 35' ' ' VAL . 38.9 mt -96.15 -67.74 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 C-N-CA 126.673 1.989 . . . . 0.0 109.071 164.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.62 -9.22 8.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 120.329 1.422 . . . . 0.0 112.54 -167.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.609 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.8 OUTLIER -82.52 126.04 31.81 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 119.57 1.077 . . . . 0.0 110.971 168.152 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -63.46 9.55 0.23 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 169.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.11 -7.53 58.94 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 116.58 -1.676 . . . . 0.0 111.801 164.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 56' ' ' ASN 0.384 0.0 OUTLIER -91.75 90.13 3.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 CA-C-O 125.621 2.629 . . . . 0.0 107.673 167.174 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -79.87 96.74 6.43 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 110.957 -2.838 . . . . 0.0 108.021 171.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.875 HG21 HD13 ' A' ' 72' ' ' ILE . 31.0 t -78.64 126.78 38.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 175.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.413 HD21 HD21 ' A' ' 79' ' ' LEU . 1.8 m120 60.7 11.9 3.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.619 0.768 . . . . 0.0 111.834 -172.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.97 18.32 56.26 Favored Glycine 0 CA--C 1.525 0.71 0 O-C-N 121.009 -1.057 . . . . 0.0 112.062 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -124.23 115.91 21.84 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 119.541 1.671 . . . . 0.0 107.793 178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -51.71 105.78 0.12 Allowed 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 126.157 1.783 . . . . 0.0 107.5 178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.566 ' HB3' HD11 ' A' ' 72' ' ' ILE . 65.9 mt -145.09 71.75 1.31 Allowed 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 -171.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.43 39.89 0.34 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.397 1.479 . . . . 0.0 111.192 -172.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -149.1 152.59 36.42 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 115.655 1.724 . . . . 0.0 115.655 -165.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.54 -29.9 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 127.363 2.265 . . . . 0.0 112.006 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.01 -34.88 90.4 Favored Glycine 0 CA--C 1.52 0.405 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 164.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.86 -57.35 4.4 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 117.382 -1.294 . . . . 0.0 110.071 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.875 HD13 HG21 ' A' ' 61' ' ' VAL . 1.2 mp -136.12 139.49 45.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.444 0 CA-C-N 120.725 1.602 . . . . 0.0 112.402 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.2 mt -112.13 -91.17 0.49 Allowed 'General case' 0 N--CA 1.435 -1.204 0 N-CA-C 102.942 -2.984 . . . . 0.0 102.942 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.72 -174.66 2.51 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.332 -1.48 . . . . 0.0 113.833 -170.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.08 -42.01 84.67 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -82.64 -0.42 47.07 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 119.641 1.109 . . . . 0.0 110.962 176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -89.59 -3.49 58.26 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 120.837 -1.164 . . . . 0.0 110.357 164.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.462 ' HB3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -125.79 -63.67 1.11 Allowed 'General case' 0 C--N 1.346 0.444 0 CA-C-N 120.113 1.324 . . . . 0.0 111.092 177.188 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.462 HD23 ' HB3' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -91.04 -168.79 2.16 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 124.378 1.071 . . . . 0.0 109.265 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -54.61 -17.66 3.57 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.298 1.439 . . . . 0.0 113.034 168.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 108.54 75.29 0.88 Allowed Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 126.722 2.106 . . . . 0.0 112.343 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 92.1 mtt-85 -145.01 -60.88 0.36 Allowed 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 117.822 0.811 . . . . 0.0 111.865 178.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.432 ' CE1' ' HB1' ' A' ' 12' ' ' ALA . 75.4 m-85 -137.58 -168.11 2.26 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.922 2.089 . . . . 0.0 107.912 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.6 m -160.62 131.71 5.59 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.56 1.944 . . . . 0.0 106.93 164.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.53 139.65 17.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 125.017 1.327 . . . . 0.0 107.99 168.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.467 HD13 HG22 ' A' ' 61' ' ' VAL . 18.8 mm -131.33 101.77 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 C-N-CA 126.004 1.722 . . . . 0.0 106.528 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -100.65 95.57 6.77 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.617 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -87.62 121.07 29.59 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 172.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.9 98.57 0.71 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 164.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt 132.19 113.8 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 1 C-N-CA 134.458 5.103 . . . . 0.0 102.781 -163.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . 0.431 0.0 OUTLIER 54.43 -127.61 2.3 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 116.665 -1.636 . . . . 0.0 109.031 -163.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.444 ' HB3' HG11 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -139.3 -143.55 0.16 Allowed 'General case' 0 C--O 1.243 0.725 0 CA-C-N 121.045 1.748 . . . . 0.0 113.213 -163.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -121.46 82.22 1.91 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 125.898 1.679 . . . . 0.0 109.851 -163.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -79.04 164.93 23.95 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -174.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.409 ' C ' HD12 ' A' ' 96' ' ' ILE . 1.2 tt -134.41 129.1 34.82 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 -164.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.437 HD13 HG13 ' A' ' 86' ' ' ILE . 3.5 mp -124.72 135.16 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 -171.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 14.2 ptt-85 -131.82 178.34 6.84 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.386 1.474 . . . . 0.0 111.853 166.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.61 161.82 18.59 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.462 1.105 . . . . 0.0 109.474 163.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.388 0 C-N-CA 126.197 1.799 . . . . 0.0 109.219 170.166 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 tt -139.3 164.39 29.96 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 156.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -73.0 63.5 0.66 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.644 2.377 . . . . 0.0 111.395 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.4 m -46.74 104.65 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 127.045 2.138 . . . . 0.0 112.042 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.56 -77.07 0.4 Allowed Glycine 0 C--N 1.335 0.493 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.14 -57.8 3.55 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 124.217 1.007 . . . . 0.0 109.981 -175.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.46 53.21 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 122.806 1.288 . . . . 0.0 110.22 -167.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.91 -6.94 30.38 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.566 1.146 . . . . 0.0 113.314 -170.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -78.63 -38.11 40.51 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.828 1.251 . . . . 0.0 110.078 165.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -84.94 86.24 7.4 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.962 1.305 . . . . 0.0 109.09 -170.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.76 167.06 21.74 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 168.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.88 -39.14 73.0 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.747 -1.221 . . . . 0.0 112.146 -176.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.22 -30.67 70.65 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 170.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -77.98 -32.86 51.56 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 123.904 0.881 . . . . 0.0 109.64 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.6 mt -64.96 -56.88 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 C-N-CA 126.155 1.782 . . . . 0.0 108.018 166.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -54.11 -50.45 66.85 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 120.309 1.413 . . . . 0.0 113.282 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -87.3 -12.61 46.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 119.095 0.861 . . . . 0.0 111.249 -176.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.23 -44.02 94.45 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 108.062 -2.015 . . . . 0.0 108.062 164.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.449 ' CD2' HD13 ' A' ' 95' ' ' LEU . 10.4 m-85 -106.54 1.71 25.58 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -163.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -48.18 -12.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 171.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.34 -12.74 59.92 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 125.78 1.632 . . . . 0.0 112.978 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.606 HG22 ' HD2' ' A' ' 23' ' ' PRO . 10.5 p -160.36 160.69 26.15 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.659 1.984 . . . . 0.0 108.303 -177.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.606 ' HD2' HG22 ' A' ' 22' ' ' VAL . 89.9 Cg_endo -82.64 178.72 5.89 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.853 1.702 . . . . 0.0 111.761 -176.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -111.5 179.0 4.15 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 126.01 1.724 . . . . 0.0 110.173 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 40' ' ' SER . 48.0 t80 -137.08 160.44 38.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.308 1.443 . . . . 0.0 108.69 164.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 t -139.27 129.64 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 126.388 1.875 . . . . 0.0 108.22 -177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.9 -168.33 1.59 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 118.476 0.58 . . . . 0.0 112.491 163.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.57 1.2 30.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -163.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.78 174.12 4.97 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.952 1.263 . . . . 0.0 112.244 -169.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.05 133.36 1.12 Allowed Glycine 0 CA--C 1.53 1.022 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -163.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -62.5 145.27 54.66 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -163.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.401 HG13 ' HD2' ' A' ' 33' ' ' PRO . 4.7 t -159.06 138.73 8.54 Favored Pre-proline 0 N--CA 1.469 0.521 0 C-N-CA 125.714 1.606 . . . . 0.0 106.876 -163.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.456 ' HA ' HD23 ' A' ' 73' ' ' LEU . 87.9 Cg_endo -71.99 146.27 46.72 Favored 'Trans proline' 0 N--CA 1.441 -1.57 0 C-N-CA 122.038 1.825 . . . . 0.0 111.203 -171.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.418 ' HG ' HD13 ' A' ' 54' ' ' ILE 0.328 0.9 OUTLIER -45.92 -36.62 5.57 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.369 -1.287 . . . . 0.0 110.977 171.451 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.685 ' HA ' HD22 ' A' ' 38' ' ' LEU 0.264 5.8 p -79.61 -9.28 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 O-C-N 120.602 -1.312 . . . . 0.0 114.194 -176.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -96.18 -38.96 9.92 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.513 1.051 . . . . 0.0 109.498 163.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -78.83 -17.72 55.2 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 116.84 -1.552 . . . . 0.0 109.624 -172.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.685 HD22 ' HA ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -78.99 -27.07 43.34 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 121.146 1.793 . . . . 0.0 110.228 171.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.576 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -77.93 -44.34 28.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 126.342 1.857 . . . . 0.0 106.743 -174.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -69.88 -41.26 75.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 124.781 1.232 . . . . 0.0 108.679 172.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.64 -16.38 57.41 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.725 1.148 . . . . 0.0 112.858 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.3 33.33 8.8 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 166.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.2 mp -78.36 -42.05 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 172.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -161.15 122.17 1.63 Allowed Pre-proline 0 C--N 1.348 0.509 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 163.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -84.34 -13.87 7.22 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.468 2.112 . . . . 0.0 112.758 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.8 m -89.63 101.6 14.29 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -164.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -47.05 -36.94 8.64 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 117.978 2.584 . . . . 0.0 117.978 -163.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.0 tpp180 -66.51 -47.03 74.24 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 121.991 2.178 . . . . 0.0 110.647 169.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -56.44 -50.89 70.36 Favored 'General case' 0 C--O 1.211 -0.938 0 CA-C-N 119.366 0.985 . . . . 0.0 108.383 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.665 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -49.85 -54.95 16.23 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.933 1.293 . . . . 0.0 110.992 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -52.35 -48.7 65.38 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 118.063 -0.97 . . . . 0.0 110.919 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -81.07 -25.12 37.31 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 119.44 -0.904 . . . . 0.0 112.246 -173.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -67.03 -16.52 64.4 Favored 'General case' 0 N--CA 1.434 -1.235 0 C-N-CA 126.709 2.004 . . . . 0.0 110.874 169.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.553 ' HA ' HG21 ' A' ' 59' ' ' ILE . 1.4 mt -109.14 -16.44 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 C-N-CA 126.098 1.759 . . . . 0.0 115.436 170.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -91.54 -8.09 48.47 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 120.801 1.637 . . . . 0.0 111.894 170.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' O ' HG22 ' A' ' 59' ' ' ILE . 3.4 m-80 -85.27 136.86 33.32 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 118.379 0.536 . . . . 0.0 109.962 174.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -65.19 10.04 0.44 Allowed Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.459 -1.189 . . . . 0.0 114.47 168.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.9 -10.1 59.39 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.374 1.587 . . . . 0.0 112.369 171.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.419 0.0 OUTLIER -101.02 86.86 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 125.815 2.722 . . . . 0.0 106.981 178.669 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -79.09 95.19 5.49 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 110.678 -2.965 . . . . 0.0 106.701 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.674 HG21 HD13 ' A' ' 72' ' ' ILE . 22.3 t -79.12 142.6 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.64 HD22 HG12 ' A' ' 61' ' ' VAL . 2.7 p30 54.86 15.21 1.06 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 176.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.24 10.86 47.19 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 128.716 3.055 . . . . 0.0 113.225 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.84 131.52 14.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 119.466 1.633 . . . . 0.0 111.4 -163.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.21 109.1 0.39 Allowed 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 128.517 2.727 . . . . 0.0 109.805 -172.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.514 ' HB3' HD11 ' A' ' 72' ' ' ILE . 76.6 mt -139.18 71.01 1.37 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.337 0.971 . . . . 0.0 109.057 178.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.418 ' CD ' ' H ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -81.39 50.59 1.48 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.755 2.422 . . . . 0.0 112.442 -175.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -152.3 146.82 25.69 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 12.6 t -66.37 -30.47 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 127.47 2.308 . . . . 0.0 111.352 169.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -82.46 -2.36 90.6 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.557 1.075 . . . . 0.0 112.449 170.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.39 -60.63 1.84 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 117.398 -1.287 . . . . 0.0 109.322 164.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.674 HD13 HG21 ' A' ' 61' ' ' VAL . 1.4 mp -135.24 138.12 49.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-N 120.587 1.54 . . . . 0.0 113.12 -172.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 33' ' ' PRO . 90.1 mt -110.36 -96.62 0.41 Allowed 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 103.6 -2.741 . . . . 0.0 103.6 163.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.0 p -94.9 -169.27 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 122.763 1.268 . . . . 0.0 113.631 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.15 -49.34 78.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 124.94 1.296 . . . . 0.0 113.459 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -70.78 -14.61 62.49 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 119.017 0.826 . . . . 0.0 112.069 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CG ' ' H ' ' A' ' 73' ' ' LEU . 52.3 t-80 -84.07 -2.11 56.1 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 171.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.471 ' HA ' ' HE ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -115.76 -86.72 0.61 Allowed 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 166.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.652 HD11 ' H ' ' A' ' 83' ' ' PHE . 0.5 OUTLIER -91.27 -166.56 1.6 Allowed 'General case' 0 N--CA 1.423 -1.785 0 C-N-CA 126.658 1.983 . . . . 0.0 110.284 -170.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -51.6 1.52 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 130.01 3.324 . . . . 0.0 116.18 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 86.81 55.79 2.34 Favored Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 124.932 1.253 . . . . 0.0 110.54 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -135.26 -65.31 0.62 Allowed 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 118.671 -0.681 . . . . 0.0 110.434 171.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.652 ' H ' HD11 ' A' ' 79' ' ' LEU . 96.6 m-85 -122.77 179.18 4.72 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 118.609 0.64 . . . . 0.0 109.439 -174.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -143.93 136.24 26.75 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 103.348 -2.834 . . . . 0.0 103.348 163.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 61' ' ' VAL 0.251 33.0 t -108.74 131.52 59.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 116.26 -1.829 . . . . 0.0 106.969 -163.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 59' ' ' ILE . 49.7 mm -133.27 106.29 9.43 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 CA-C-N 120.93 1.695 . . . . 0.0 110.869 -169.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -97.43 99.21 10.63 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 164.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 56.6 ttp85 -86.78 112.78 22.03 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 120.785 1.629 . . . . 0.0 108.562 164.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.87 166.71 1.89 Allowed Glycine 0 CA--C 1.533 1.175 0 CA-C-O 121.864 0.702 . . . . 0.0 112.471 172.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.6 mptt 63.59 -56.79 0.2 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 126.563 1.945 . . . . 0.0 112.282 -165.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -94.41 0.07 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 121.268 1.849 . . . . 0.0 110.183 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.88 -179.29 7.44 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 124.422 2.058 . . . . 0.0 108.709 -172.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 86' ' ' ILE . 90.0 t80 -79.43 157.78 27.47 Favored 'General case' 0 N--CA 1.409 -2.503 0 CA-C-N 111.569 -2.56 . . . . 0.0 106.667 163.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -145.57 160.31 41.83 Favored 'General case' 0 N--CA 1.423 -1.788 0 C-N-CA 128.521 2.728 . . . . 0.0 109.013 164.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.449 HD13 ' CD2' ' A' ' 19' ' ' PHE . 43.6 tp -117.86 137.49 52.75 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.468 1.507 . . . . 0.0 108.22 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 23.6 mm -121.44 136.51 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.478 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 8.8 ttt180 -138.43 -177.7 4.97 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 124.333 2.016 . . . . 0.0 109.168 164.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.478 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -120.78 161.59 21.21 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 113.006 -1.906 . . . . 0.0 108.873 163.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.242 0 C-N-CA 126.723 2.009 . . . . 0.0 111.873 -172.814 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.767 0 CA-C-O 121.667 0.746 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -148.36 -149.44 0.3 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -178.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.74 100.9 3.85 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 163.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.4 m 55.08 -177.19 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.375 1.07 . . . . 0.0 112.153 -164.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 76.14 -89.02 0.89 Allowed Glycine 0 CA--C 1.526 0.768 0 O-C-N 120.492 -1.38 . . . . 0.0 110.3 -174.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -79.24 171.72 14.8 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 122.16 0.981 . . . . 0.0 108.745 173.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.507 ' CD1' HD22 ' A' ' 79' ' ' LEU . 2.0 pp -53.88 93.32 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 128.04 2.536 . . . . 0.0 109.076 163.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.4 -17.83 25.2 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.063 -1.648 . . . . 0.0 115.15 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -78.05 -41.1 36.6 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 128.925 2.89 . . . . 0.0 108.546 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.645 ' HB3' HD11 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -81.57 101.04 9.72 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 179.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.41 162.43 13.49 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.488 -1.687 . . . . 0.0 107.401 176.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.95 -44.66 54.19 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 124.14 0.976 . . . . 0.0 109.097 -171.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.14 77.38 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 123.399 0.437 . . . . 0.0 109.901 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -71.78 -41.83 67.87 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.645 HD11 ' HB3' ' A' ' 10' ' ' LEU . 49.4 mt -67.38 -51.96 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 123.65 0.78 . . . . 0.0 110.265 177.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.05 -45.11 87.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 119.673 1.124 . . . . 0.0 111.313 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.24 -35.32 66.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -178.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.23 97.5 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 126.743 2.116 . . . . 0.0 109.952 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.524 ' CZ ' HG13 ' A' ' 85' ' ' VAL . 11.8 m-85 -101.76 6.19 41.6 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.798 0.439 . . . . 0.0 111.29 -170.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -64.75 -2.99 2.83 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -79.14 -15.46 58.09 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.94 1.296 . . . . 0.0 111.975 172.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.611 HG22 ' HD2' ' A' ' 23' ' ' PRO . 0.4 OUTLIER -132.82 168.92 15.49 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 175.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.611 ' HD2' HG22 ' A' ' 22' ' ' VAL . 33.9 Cg_endo -81.77 162.58 18.74 Favored 'Trans proline' 0 N--CA 1.437 -1.819 0 C-N-CA 121.512 1.475 . . . . 0.0 108.507 173.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.6 m -111.68 162.6 15.03 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -116.81 156.43 27.27 Favored 'General case' 0 CA--C 1.511 -0.53 0 O-C-N 121.219 -0.926 . . . . 0.0 108.575 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 3.2 p -134.33 127.24 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 173.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.413 ' CD2' ' H ' ' A' ' 27' ' ' HIS . 0.3 OUTLIER -108.15 135.6 49.22 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.405 1.098 . . . . 0.0 108.687 163.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.91 61.9 3.97 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 170.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -154.37 171.02 32.87 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.811 1.196 . . . . 0.0 111.366 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -98.74 -150.72 26.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.349 1.452 . . . . 0.0 109.843 170.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.463 ' HA ' ' CG2' ' A' ' 74' ' ' THR 0.278 0.0 OUTLIER -55.37 135.62 50.03 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.926 1.29 . . . . 0.0 113.53 -163.899 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -158.6 142.83 11.39 Favored Pre-proline 0 CA--C 1.518 -0.269 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -163.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.468 ' HA ' HD23 ' A' ' 73' ' ' LEU . 33.1 Cg_endo -69.32 147.86 66.61 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.106 1.87 . . . . 0.0 111.957 -171.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.261 0.1 OUTLIER -39.37 -45.8 1.52 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.815 1.646 . . . . 0.0 113.421 170.256 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.555 ' HA ' HD22 ' A' ' 38' ' ' LEU . 8.4 p -79.02 -11.81 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.54 1.536 . . . . 0.0 113.218 -175.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -91.06 -43.86 9.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 118.822 0.737 . . . . 0.0 109.278 165.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.05 -30.23 67.44 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.668 -168.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.673 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -74.66 -36.58 62.84 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 120.129 1.331 . . . . 0.0 110.476 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.551 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -72.23 -43.28 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.478 0 C-N-CA 125.186 1.394 . . . . 0.0 107.566 -172.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.4 -40.08 81.43 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 126.415 1.886 . . . . 0.0 108.248 175.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.6 -20.56 50.2 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.799 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.55 17.17 11.58 Favored Glycine 0 C--N 1.335 0.502 0 CA-C-N 119.085 0.857 . . . . 0.0 113.863 171.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -43.69 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 N-CA-C 104.872 -2.269 . . . . 0.0 104.872 -171.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m -160.58 110.77 1.34 Allowed Pre-proline 0 N--CA 1.464 0.243 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -81.24 -20.96 6.84 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.467 2.111 . . . . 0.0 112.516 -172.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -86.97 115.94 24.7 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -167.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -48.16 -36.77 14.13 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.972 1.309 . . . . 0.0 113.337 -172.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 9.1 ttm-85 -67.04 -52.51 41.4 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.756 1.162 . . . . 0.0 111.152 174.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -56.26 -53.95 51.13 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.673 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -47.33 -54.61 10.63 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 126.409 1.884 . . . . 0.0 110.838 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 25.7 ttm-85 -50.23 -49.31 53.31 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 123.634 0.773 . . . . 0.0 110.771 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -80.99 -31.89 34.54 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 118.537 0.608 . . . . 0.0 112.482 -173.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -60.81 -21.96 63.67 Favored 'General case' 0 N--CA 1.433 -1.281 0 C-N-CA 125.514 1.525 . . . . 0.0 109.245 170.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.642 ' CD1' HD13 ' A' ' 38' ' ' LEU . 1.1 mp -91.44 -43.22 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-O 116.254 -1.831 . . . . 0.0 112.766 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -73.98 -10.74 59.94 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 120.222 1.374 . . . . 0.0 111.226 -173.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 58' ' ' ALA . 3.9 m120 -84.95 144.33 28.4 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -70.52 25.44 0.48 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 124.772 1.177 . . . . 0.0 113.486 166.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.545 ' HB1' ' NH2' ' A' ' 88' ' ' ARG . . . -117.93 4.35 12.15 Favored 'General case' 0 N--CA 1.432 -1.334 0 C-N-CA 128.628 2.771 . . . . 0.0 109.471 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.461 HD11 HD12 ' A' ' 86' ' ' ILE 0.327 0.0 OUTLIER -111.59 98.1 6.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 124.743 2.211 . . . . 0.0 107.573 163.624 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -81.07 100.39 8.98 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 112.687 -2.051 . . . . 0.0 107.776 171.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.478 HG21 HD13 ' A' ' 72' ' ' ILE . 57.2 t -78.91 128.25 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 175.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 61.43 0.93 0.49 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.932 1.293 . . . . 0.0 113.727 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 109.7 7.89 27.06 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 117.673 -1.626 . . . . 0.0 112.751 -172.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.56 123.18 35.15 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 119.904 1.852 . . . . 0.0 108.555 -176.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -50.37 102.29 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.927 2.091 . . . . 0.0 110.68 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.547 ' CB ' HD11 ' A' ' 72' ' ' ILE . 80.3 mt -141.81 110.1 5.96 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -175.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.33 44.61 2.12 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.541 2.736 . . . . 0.0 113.616 -163.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -143.32 154.62 43.96 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.003 -1.061 . . . . 0.0 111.785 167.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -64.09 134.72 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-O 122.975 1.369 . . . . 0.0 107.546 167.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.71 -6.57 46.25 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.006 -173.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.37 -46.59 32.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 163.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.547 HD11 ' CB ' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -134.04 146.23 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 124.646 1.179 . . . . 0.0 108.235 165.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 33' ' ' PRO . 82.6 mt -124.17 -94.9 0.48 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 102.076 -3.305 . . . . 0.0 102.076 163.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.463 ' CG2' ' HA ' ' A' ' 31' ' ' ASP . 1.3 p -100.97 -173.89 2.49 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 120.774 1.624 . . . . 0.0 115.072 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 98' ' ' TYR . . . -50.4 -56.53 11.0 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.384 1.473 . . . . 0.0 114.075 171.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -67.23 -9.44 40.43 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 119.547 1.067 . . . . 0.0 113.166 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -89.64 -14.01 35.8 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.426 -0.796 . . . . 0.0 110.536 170.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.427 HH11 ' HA ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -103.29 -66.6 0.93 Allowed 'General case' 0 C--N 1.338 0.095 0 O-C-N 119.85 -1.782 . . . . 0.0 108.027 174.421 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.507 HD22 ' CD1' ' A' ' 7' ' ' ILE . 0.9 OUTLIER -88.04 -168.97 2.39 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 128.335 2.654 . . . . 0.0 110.907 -171.313 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 pm0 -64.44 -5.66 5.76 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.146 1.379 . . . . 0.0 114.022 165.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.19 75.81 1.1 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.983 1.754 . . . . 0.0 113.612 -170.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -139.52 -81.74 0.28 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.839 0.856 . . . . 0.0 109.417 163.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.496 ' H ' HD12 ' A' ' 79' ' ' LEU . 5.7 m-85 -128.36 -162.63 1.2 Allowed 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 125.455 1.502 . . . . 0.0 110.076 -170.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -154.39 121.15 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 119.205 -2.184 . . . . 0.0 107.151 168.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.524 HG13 ' CZ ' ' A' ' 19' ' ' PHE . 2.3 t -79.02 143.99 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 169.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.461 HD12 HD11 ' A' ' 59' ' ' ILE . 26.1 mm -126.26 136.59 60.38 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.71 0 C-N-CA 127.781 2.433 . . . . 0.0 106.293 172.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 67.7 mtt85 -127.43 84.4 2.25 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 164.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.6 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -84.37 91.93 7.91 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.844 2.057 . . . . 0.0 106.249 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -28.59 -63.82 0.11 Allowed Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.367 2.413 . . . . 0.0 115.447 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.6 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 35.1 tttp -44.14 -37.85 3.35 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.707 2.403 . . . . 0.0 113.727 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -111.6 -117.63 0.3 Allowed 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 -170.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -147.13 -151.35 0.38 Allowed 'General case' 0 C--O 1.246 0.887 0 CA-C-O 122.662 1.22 . . . . 0.0 110.941 176.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.454 ' HB3' ' CE2' ' A' ' 19' ' ' PHE . 3.3 m-30 -110.83 104.14 12.73 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.951 2.5 . . . . 0.0 106.59 -165.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -113.05 165.86 11.96 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 124.593 1.157 . . . . 0.0 110.199 -173.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.1 tp -130.14 132.85 46.26 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 113.972 -1.467 . . . . 0.0 108.541 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.37 135.0 65.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 9.9 ptm180 -132.22 175.3 9.38 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.365 1.866 . . . . 0.0 109.633 170.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 75' ' ' ALA . 0.1 OUTLIER -118.78 168.35 10.83 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.898 0.879 . . . . 0.0 110.26 166.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.775 0 C-N-CA 125.259 1.423 . . . . 0.0 109.818 166.584 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.444 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.1 tp -59.43 -52.71 64.42 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -139.08 135.52 34.25 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.183 2.193 . . . . 0.0 107.462 -169.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 8' ' ' ALA . 7.3 p -151.42 175.67 12.03 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 125.152 1.381 . . . . 0.0 108.17 163.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -74.52 -29.42 61.75 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 108.311 -1.915 . . . . 0.0 108.311 163.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -78.64 172.88 13.07 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.884 1.274 . . . . 0.0 109.233 176.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.736 HD11 HD22 ' A' ' 79' ' ' LEU . 3.0 pt -54.46 87.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 127.096 2.158 . . . . 0.0 111.269 164.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.478 ' HB2' ' OG ' ' A' ' 4' ' ' SER . . . -76.83 -29.26 55.85 Favored 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 123.101 0.56 . . . . 0.0 112.191 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -78.47 -19.0 54.03 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.724 -175.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' A' ' 7' ' ' ILE . 2.6 mm? -96.23 72.04 2.84 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.73 176.14 9.79 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.57 -41.29 69.23 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 120.513 -1.367 . . . . 0.0 112.898 -167.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.57 -21.59 41.56 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 118.99 -1.084 . . . . 0.0 110.163 171.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.93 -40.77 78.83 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' A' ' 10' ' ' LEU . 8.9 mt -68.89 -56.59 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 116.873 -1.536 . . . . 0.0 109.198 173.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -52.96 -55.09 26.05 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 120.026 1.284 . . . . 0.0 111.373 -177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.4 tp60 -83.26 -13.22 55.7 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.06 -1.025 . . . . 0.0 110.202 -175.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.8 -27.99 63.79 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 118.222 -1.321 . . . . 0.0 111.771 172.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -126.93 4.35 6.56 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -171.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -59.82 0.32 0.15 Allowed 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -77.5 -6.4 53.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.607 1.094 . . . . 0.0 109.761 171.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -129.22 160.25 64.88 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 126.876 2.07 . . . . 0.0 106.509 170.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.475 ' HD2' HG12 ' A' ' 22' ' ' VAL . 86.0 Cg_endo -78.87 174.28 12.43 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 121.415 1.41 . . . . 0.0 110.429 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.7 p -110.33 174.21 5.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 112.396 -2.183 . . . . 0.0 109.096 175.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -140.19 158.39 44.12 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 164.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.68 128.33 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 176.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -110.61 156.09 21.44 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 169.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -81.27 51.08 1.54 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.248 1.019 . . . . 0.0 111.414 -172.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 71.93 -175.96 40.88 Favored Glycine 0 CA--C 1.526 0.759 0 O-C-N 121.144 -0.972 . . . . 0.0 113.11 173.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.12 152.05 2.45 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 106.344 -2.702 . . . . 0.0 106.344 -163.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.01 162.09 22.87 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.17 164.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 92.0 t -154.18 127.7 4.34 Favored Pre-proline 0 CA--C 1.509 -0.631 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -167.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.451 ' HA ' HD23 ' A' ' 73' ' ' LEU . 87.7 Cg_endo -72.95 148.03 44.67 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 C-N-CA 122.358 2.039 . . . . 0.0 110.302 -175.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.276 13.0 tp -39.29 -47.78 1.75 Allowed 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 128.522 2.729 . . . . 0.0 112.042 173.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.0 p -77.0 -7.56 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 126.134 1.773 . . . . 0.0 114.849 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -103.32 -34.84 8.63 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 117.301 -1.333 . . . . 0.0 111.376 165.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.89 -30.12 44.75 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 120.675 1.58 . . . . 0.0 108.823 -170.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.673 HD22 HD11 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -85.2 -28.45 25.43 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 119.837 1.199 . . . . 0.0 108.656 -174.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.441 ' N ' HD23 ' A' ' 38' ' ' LEU . 1.1 t -66.78 -52.36 45.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 171.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 t -66.56 -39.66 88.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.414 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.77 -16.53 57.06 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.345 -177.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.38 21.93 12.32 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.179 0.899 . . . . 0.0 111.852 165.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.414 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.1 mp -78.55 -40.95 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.4 t -160.37 105.83 1.36 Allowed Pre-proline 0 C--N 1.346 0.437 0 CA-C-N 120.517 1.508 . . . . 0.0 108.101 174.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -83.32 -20.21 5.07 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.971 1.781 . . . . 0.0 113.799 -176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.7 t -85.61 103.41 14.41 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 51.5 mttm -56.63 -22.41 33.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -163.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -47.93 58.51 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 121.917 2.144 . . . . 0.0 110.006 169.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -56.73 -51.24 69.6 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.526 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -53.02 -50.88 63.36 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 125.144 1.378 . . . . 0.0 110.953 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -64.04 -32.7 74.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 116.712 -1.613 . . . . 0.0 111.314 -177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.56 -29.13 28.08 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 120.886 1.676 . . . . 0.0 112.891 175.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -65.88 -16.11 63.54 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.55 1.94 . . . . 0.0 112.036 171.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.673 HD11 HD22 ' A' ' 38' ' ' LEU . 71.1 mt -88.32 -61.73 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.666 0 C-N-CA 126.078 1.751 . . . . 0.0 108.0 163.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -16.26 61.69 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 119.488 1.04 . . . . 0.0 112.713 -164.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.2 m120 -85.14 138.69 32.23 Favored 'General case' 0 CA--C 1.499 -1.007 0 CA-C-N 119.023 0.829 . . . . 0.0 109.833 173.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.05 7.02 0.07 OUTLIER Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.494 1.521 . . . . 0.0 114.851 171.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.45 -14.79 59.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 118.536 1.168 . . . . 0.0 110.434 175.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.522 HG22 ' O ' ' A' ' 56' ' ' ASN 0.39 0.0 OUTLIER -90.31 90.96 3.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 CA-C-O 125.972 2.796 . . . . 0.0 106.992 172.605 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -83.24 94.16 7.84 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 110.299 -3.137 . . . . 0.0 105.397 173.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.454 HG23 HD13 ' A' ' 86' ' ' ILE . 9.4 p -78.46 134.48 28.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 177.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.629 HD22 ' HG3' ' A' ' 78' ' ' ARG . 78.3 m-20 56.94 22.78 7.54 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.942 -1.099 . . . . 0.0 113.263 175.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.71 18.06 73.9 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 125.08 1.324 . . . . 0.0 113.617 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -132.38 119.93 21.35 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.674 2.39 . . . . 0.0 107.029 -164.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -61.27 108.88 0.99 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 117.02 -1.467 . . . . 0.0 108.048 -177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 79.1 mt -143.97 103.24 4.0 Favored 'General case' 0 C--O 1.225 -0.184 0 CA-C-N 120.214 1.37 . . . . 0.0 107.742 176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.98 25.73 8.38 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.576 1.151 . . . . 0.0 112.595 -172.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -131.29 137.06 48.66 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.034 -1.041 . . . . 0.0 112.509 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.8 p -56.38 -38.92 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 125.976 1.71 . . . . 0.0 110.402 166.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.53 -12.95 74.08 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-O 119.524 -0.598 . . . . 0.0 113.077 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.32 -36.84 13.62 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.198 0.999 . . . . 0.0 111.46 170.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.2 mt -142.0 121.9 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 120.068 1.304 . . . . 0.0 111.829 -175.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 33' ' ' PRO . 61.4 mt -111.15 -94.27 0.44 Allowed 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 101.365 -3.568 . . . . 0.0 101.365 163.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -99.72 -172.72 2.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 -177.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.24 -49.88 74.65 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 124.328 1.051 . . . . 0.0 112.26 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.87 -14.08 62.81 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.458 0.703 . . . . 0.0 111.691 176.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -81.91 -18.73 42.66 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 118.484 -0.77 . . . . 0.0 109.481 172.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.629 ' HG3' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -112.3 -60.5 1.86 Allowed 'General case' 0 C--N 1.345 0.411 0 CA-C-N 119.932 1.242 . . . . 0.0 110.507 -171.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.736 HD22 HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -90.37 -177.02 4.98 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 125.521 1.528 . . . . 0.0 108.636 167.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -48.63 -36.71 16.45 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.795 164.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.26 93.63 0.53 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 124.737 1.16 . . . . 0.0 112.06 172.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -139.07 -64.44 0.5 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 164.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.628 ' O ' HD21 ' A' ' 79' ' ' LEU . 35.7 m-85 -134.9 -169.75 2.42 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 126.805 2.042 . . . . 0.0 107.354 -176.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.43 124.1 6.62 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 163.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.3 t -79.3 145.65 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.454 HD13 HG23 ' A' ' 61' ' ' VAL . 20.3 mm -129.06 91.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 175.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -91.4 81.83 5.42 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 103.822 -2.659 . . . . 0.0 103.822 179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 60.0 ttp85 -78.7 102.86 8.27 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.769 -2.308 . . . . 0.0 104.769 168.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -43.98 -49.3 7.77 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 125.566 1.555 . . . . 0.0 113.022 -173.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.77 -0.28 3.97 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.1 tptm -132.42 -100.61 0.28 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 164.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.6 -164.67 1.6 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 121.056 1.753 . . . . 0.0 109.127 -178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -91.48 82.49 5.36 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 130.937 3.695 . . . . 0.0 110.753 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -78.37 166.82 22.21 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.464 HD12 ' H ' ' A' ' 96' ' ' ILE . 40.1 tp -130.07 140.62 50.81 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.677 -169.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 95' ' ' LEU . 9.3 mm -134.99 127.64 48.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -170.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.4 ptt85 -136.62 172.46 12.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 122.519 1.152 . . . . 0.0 112.556 163.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.99 161.21 13.84 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 125.093 1.357 . . . . 0.0 110.78 165.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.851 0 C-N-CA 129.213 3.005 . . . . 0.0 106.374 165.461 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 5.3 tt -139.83 76.44 1.56 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 120.034 1.288 . . . . 0.0 107.831 159.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -140.81 162.56 35.14 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 128.047 2.539 . . . . 0.0 105.912 163.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.7 p -50.6 -34.43 25.92 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 126.141 1.776 . . . . 0.0 114.402 -166.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 46.29 -145.89 3.33 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.899 1.238 . . . . 0.0 114.349 164.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.537 ' HB3' HD13 ' A' ' 7' ' ' ILE . 1.6 m-20 -85.54 -95.22 0.08 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 166.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.662 HD11 ' HA ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -91.01 66.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 125.489 1.516 . . . . 0.0 109.973 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.48 -6.39 19.34 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 121.42 -0.8 . . . . 0.0 112.704 164.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -78.26 -12.01 59.97 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.854 1.262 . . . . 0.0 109.553 168.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.842 ' HB3' HD11 ' A' ' 15' ' ' ILE . 2.4 mp -123.5 64.6 1.02 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.225 1.81 . . . . 0.0 107.406 178.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.93 171.5 15.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 168.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.86 -37.03 49.17 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.255 -0.903 . . . . 0.0 111.255 -165.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.09 -37.76 88.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.806 0.812 . . . . 0.0 109.894 169.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.25 -43.19 61.56 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 124.358 1.063 . . . . 0.0 108.183 -167.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.842 HD11 ' HB3' ' A' ' 10' ' ' LEU . 42.0 mt -66.21 -50.5 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 117.617 -1.182 . . . . 0.0 108.909 174.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -58.09 -51.07 71.21 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 118.83 -1.148 . . . . 0.0 110.517 -173.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 70.9 tp60 -79.76 -22.98 42.54 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 118.304 0.502 . . . . 0.0 109.831 -175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.49 -41.27 99.31 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 108.867 -1.693 . . . . 0.0 108.867 176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -127.75 13.47 6.9 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -164.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mttp -53.81 -8.18 0.15 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.018 2.527 . . . . 0.0 113.312 165.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -78.43 -27.8 46.6 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 128.19 2.596 . . . . 0.0 112.452 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.624 HG22 ' HD2' ' A' ' 23' ' ' PRO . 1.3 p -131.05 173.05 6.33 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -173.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.624 ' HD2' HG22 ' A' ' 22' ' ' VAL . 66.7 Cg_endo -77.09 177.47 8.84 Favored 'Trans proline' 0 N--CA 1.448 -1.152 0 C-N-CA 121.719 1.613 . . . . 0.0 110.066 -175.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 81.9 p -136.39 167.68 20.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.252 1.021 . . . . 0.0 108.659 173.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -134.93 155.34 50.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.1 p -136.48 129.91 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 C-N-CA 125.209 1.404 . . . . 0.0 108.336 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -121.07 176.73 5.43 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 122.02 0.914 . . . . 0.0 112.809 167.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -79.01 32.15 0.21 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.456 2.302 . . . . 0.0 113.723 -163.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.18 -170.77 25.2 Favored Glycine 0 CA--C 1.528 0.906 0 O-C-N 120.494 -1.379 . . . . 0.0 110.296 -165.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.85 138.14 2.59 Favored Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -174.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -68.84 147.78 51.23 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 117.957 0.878 . . . . 0.0 111.174 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.3 t -160.33 135.16 5.53 Favored Pre-proline 0 CA--C 1.519 -0.244 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -164.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.511 ' HA ' HD23 ' A' ' 73' ' ' LEU . 95.9 Cg_endo -76.63 149.99 30.88 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.565 2.177 . . . . 0.0 112.311 -166.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.789 HD22 HG13 ' A' ' 54' ' ' ILE 0.3 0.1 OUTLIER -46.81 -41.29 15.25 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.072 178.614 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 p -75.09 -10.73 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 C-N-CA 128.685 2.794 . . . . 0.0 114.815 -176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -98.75 -43.79 6.65 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 166.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 pp -76.44 -19.91 57.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 116.79 -1.576 . . . . 0.0 109.682 -166.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.618 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -77.98 -33.27 51.5 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 120.836 1.653 . . . . 0.0 110.324 173.058 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -70.42 -50.64 44.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 126.003 1.721 . . . . 0.0 107.773 -177.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -36.2 83.2 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 127.361 2.264 . . . . 0.0 110.51 174.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.65 -22.59 46.63 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.471 176.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.07 33.04 7.14 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 169.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.452 HD13 ' HB3' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -78.1 -52.72 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 176.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.2 m -145.54 99.95 4.43 Favored Pre-proline 0 C--N 1.344 0.364 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 -173.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -78.41 -17.82 12.72 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.382 2.054 . . . . 0.0 112.918 -168.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.3 t -90.94 109.28 20.5 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 -173.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -52.38 -37.48 56.5 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 117.533 -1.223 . . . . 0.0 114.051 -168.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -46.52 80.27 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 121.397 1.908 . . . . 0.0 110.38 174.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -51.11 71.11 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.618 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -52.48 -47.2 66.67 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 125.992 1.717 . . . . 0.0 110.371 177.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.0 mtt180 -56.89 -47.87 79.49 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 117.434 -1.27 . . . . 0.0 111.358 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.68 -35.73 75.38 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.594 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.21 -12.68 21.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 124.267 1.027 . . . . 0.0 112.704 172.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.789 HG13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -107.07 -29.39 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.669 1.988 . . . . 0.0 114.408 173.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -89.56 -9.66 49.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.062 1.345 . . . . 0.0 110.144 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.459 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.4 m120 -100.06 146.54 26.65 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 122.262 1.03 . . . . 0.0 110.847 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -64.77 11.54 0.26 Allowed Glycine 0 CA--C 1.528 0.875 0 CA-C-N 114.17 -1.377 . . . . 0.0 113.32 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.6 -9.06 58.64 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 125.49 1.516 . . . . 0.0 110.583 171.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.553 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.315 0.0 OUTLIER -99.49 89.95 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 125.042 2.353 . . . . 0.0 107.36 171.335 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -83.46 95.91 8.41 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 111.681 -2.508 . . . . 0.0 106.34 170.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.9 p -78.75 134.75 27.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 103.629 -2.73 . . . . 0.0 103.629 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 59.75 19.78 8.56 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 120.713 1.597 . . . . 0.0 111.84 170.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.9 6.21 76.27 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.683 1.611 . . . . 0.0 114.298 -176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -130.8 116.92 18.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.622 1.711 . . . . 0.0 107.889 -164.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.18 106.16 0.35 Allowed 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 125.571 1.548 . . . . 0.0 109.08 -177.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 51.3 mt -140.43 104.12 4.7 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -177.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -124.87 68.9 1.11 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.849 1.26 . . . . 0.0 112.563 -172.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -157.54 153.27 26.69 Favored 'General case' 0 N--CA 1.44 -0.971 0 O-C-N 120.673 -1.267 . . . . 0.0 109.205 167.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.03 -32.03 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.373 0.669 . . . . 0.0 109.872 164.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -65.16 -24.43 70.43 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 123.017 0.341 . . . . 0.0 113.847 172.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.82 -45.25 8.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.812 1.245 . . . . 0.0 111.023 -172.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.534 HD12 HD23 ' A' ' 34' ' ' LEU . 2.2 mt -141.76 129.31 21.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.266 0 CA-C-N 119.462 1.028 . . . . 0.0 109.369 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 33' ' ' PRO . 92.0 mt -110.15 -93.83 0.43 Allowed 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 101.177 -3.638 . . . . 0.0 101.177 163.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -99.27 -171.41 2.07 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -173.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.99 -43.55 86.66 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.58 1.152 . . . . 0.0 112.288 174.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.53 -17.74 64.77 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.806 0.73 . . . . 0.0 111.837 175.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.444 ' CG ' ' H ' ' A' ' 73' ' ' LEU . 38.6 t-80 -89.31 2.04 54.91 Favored 'General case' 0 N--CA 1.438 -1.054 0 C-N-CA 123.581 0.752 . . . . 0.0 109.729 177.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.488 ' HB3' HD23 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -119.97 -70.25 0.8 Allowed 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.791 1.178 . . . . 0.0 109.596 169.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.662 ' HA ' HD11 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -91.79 -170.86 2.7 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 129.195 2.998 . . . . 0.0 110.226 172.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -57.8 -7.17 0.65 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.391 2.277 . . . . 0.0 114.346 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 101.29 73.55 1.03 Allowed Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 124.286 0.946 . . . . 0.0 111.527 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.97 -66.02 0.53 Allowed 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -140.93 -175.4 4.29 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 126.564 1.946 . . . . 0.0 106.913 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.67 138.2 18.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 104.848 -2.278 . . . . 0.0 104.848 163.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.9 t -104.08 148.04 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 24.7 mm -126.83 101.65 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 128.268 2.627 . . . . 0.0 105.531 -172.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 -94.3 80.86 3.98 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 169.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.439 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -78.93 85.08 4.91 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 169.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -4.94 -88.82 0.0 OUTLIER Glycine 0 CA--C 1.525 0.659 1 C-N-CA 130.997 4.141 . . . . 0.0 116.033 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.439 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 0.1 OUTLIER -65.49 -19.78 66.07 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 117.861 0.83 . . . . 0.0 112.138 -172.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -85.0 -111.63 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 166.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.38 -157.22 0.57 Allowed 'General case' 0 C--O 1.239 0.534 0 CA-C-N 120.276 1.398 . . . . 0.0 110.661 -175.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -106.5 65.05 0.67 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 130.14 3.376 . . . . 0.0 111.087 -167.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -78.59 167.08 21.79 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 120.753 -1.217 . . . . 0.0 110.653 -170.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 96' ' ' ILE . 31.5 tp -132.09 133.52 44.42 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.273 1.029 . . . . 0.0 108.946 -166.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 95' ' ' LEU . 36.2 mm -135.61 124.81 40.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -166.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -138.53 174.07 10.92 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 122.754 1.264 . . . . 0.0 111.647 173.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.48 167.62 10.72 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.242 1.017 . . . . 0.0 109.798 164.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.525 0 C-N-CA 127.186 2.195 . . . . 0.0 110.295 178.523 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.493 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.6 tp -147.88 158.96 44.3 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 164.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -76.05 -74.37 0.23 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 165.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.1 t 55.75 178.87 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.179 1.392 . . . . 0.0 113.175 -164.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -137.36 -49.31 0.07 OUTLIER Glycine 0 CA--C 1.522 0.525 0 C-N-CA 125.899 1.714 . . . . 0.0 109.42 172.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -78.82 -52.23 8.63 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -174.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.701 HD13 HD13 ' A' ' 79' ' ' LEU . 4.7 pt -90.96 30.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 122.107 0.956 . . . . 0.0 111.275 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.21 -2.62 4.48 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 120.859 -1.151 . . . . 0.0 112.135 173.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -98.44 -20.36 17.16 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 127.103 2.161 . . . . 0.0 109.341 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -151.43 78.59 1.27 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 127.458 2.303 . . . . 0.0 108.434 -174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 72.2 p -78.17 179.89 6.6 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-O 122.782 1.277 . . . . 0.0 109.397 -166.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.2 -39.84 78.39 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 119.127 -2.233 . . . . 0.0 111.099 -175.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.61 -36.02 82.44 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -67.58 -37.61 82.85 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 40.8 mt -73.23 -50.75 29.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 125.81 1.644 . . . . 0.0 108.548 -174.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -61.66 -46.54 89.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.15 177.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -71.26 -27.65 63.59 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.142 -0.974 . . . . 0.0 109.433 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -73.74 -41.32 42.85 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 126.28 1.895 . . . . 0.0 109.807 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -116.39 13.12 15.43 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.197 0.599 . . . . 0.0 111.208 -164.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? -45.81 -25.65 0.54 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.745 2.418 . . . . 0.0 112.99 163.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.05 -12.08 59.96 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.755 2.422 . . . . 0.0 111.42 -174.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.564 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -133.51 169.9 12.74 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 127.257 2.223 . . . . 0.0 106.193 -174.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.564 ' HD2' HG12 ' A' ' 22' ' ' VAL . 43.6 Cg_endo -76.42 176.66 9.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 CA-C-N 121.134 1.441 . . . . 0.0 109.503 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.5 p -129.64 165.8 21.06 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.254 164.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -133.47 158.76 42.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.763 1.225 . . . . 0.0 107.87 173.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 9.4 p -134.59 137.25 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.975 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -122.28 173.28 7.71 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 122.86 1.315 . . . . 0.0 110.956 163.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -79.46 37.14 0.33 Allowed 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 127.833 2.453 . . . . 0.0 113.527 -163.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 60.7 -167.85 10.18 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -165.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.22 145.31 1.65 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -73.62 152.05 40.65 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 121.558 -0.966 . . . . 0.0 112.467 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 55.4 t -158.76 133.08 5.24 Favored Pre-proline 0 C--N 1.343 0.302 0 CA-C-O 117.693 -1.146 . . . . 0.0 109.394 -163.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -55.76 141.19 85.06 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.666 2.91 . . . . 0.0 112.058 177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.364 0.4 OUTLIER -48.07 -36.38 12.99 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.779 165.166 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.431 ' HA ' HD11 ' A' ' 54' ' ' ILE 0.259 12.1 p -71.41 -15.44 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.464 1.506 . . . . 0.0 114.617 179.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -98.44 -44.04 6.66 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 118.785 0.72 . . . . 0.0 109.284 173.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -71.87 -25.94 62.15 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 116.887 -1.53 . . . . 0.0 109.133 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.593 HD22 HD11 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -84.32 -25.32 29.34 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 120.955 1.707 . . . . 0.0 110.469 -177.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.434 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -76.07 -45.88 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 177.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.63 -45.36 90.61 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.66 1.584 . . . . 0.0 107.994 175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.73 -18.61 53.99 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 118.817 -0.611 . . . . 0.0 112.139 -177.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.92 33.87 7.13 Favored Glycine 0 C--N 1.332 0.355 0 CA-C-N 119.071 0.851 . . . . 0.0 111.171 164.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.25 -49.31 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 N-CA-C 103.499 -2.778 . . . . 0.0 103.499 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.42 107.44 2.76 Favored Pre-proline 0 C--N 1.345 0.399 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 172.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -82.55 -15.73 8.42 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.539 2.159 . . . . 0.0 113.04 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 42.8 t -82.65 119.05 23.8 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -56.04 -36.13 67.66 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 120.662 1.574 . . . . 0.0 114.459 -165.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.83 -56.17 24.39 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 120.288 1.404 . . . . 0.0 109.118 170.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -55.08 -49.06 72.62 Favored 'General case' 0 C--O 1.207 -1.179 0 O-C-N 124.218 0.949 . . . . 0.0 108.442 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -47.99 -58.72 4.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.336 1.454 . . . . 0.0 111.198 177.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.0 ttt85 -65.66 -26.57 67.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.672 -174.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 61.7 tt0 -89.59 -29.11 19.1 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 120.094 1.315 . . . . 0.0 112.532 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.62 -20.08 65.39 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.771 1.629 . . . . 0.0 109.76 169.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.593 HD11 HD22 ' A' ' 38' ' ' LEU . 64.9 mt -82.99 -66.5 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.339 0 CA-C-O 116.251 -1.833 . . . . 0.0 109.394 163.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -64.96 -5.85 7.13 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 119.864 1.211 . . . . 0.0 112.663 -164.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 58' ' ' ALA . 2.9 m120 -76.62 134.99 39.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 122.244 1.021 . . . . 0.0 113.166 164.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.27 34.3 0.66 Allowed Glycine 0 CA--C 1.533 1.173 0 C-N-CA 126.145 1.831 . . . . 0.0 111.773 164.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -118.66 4.4 11.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 127.58 2.352 . . . . 0.0 111.161 167.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.478 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.328 0.0 OUTLIER -102.46 100.4 10.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 124.378 2.037 . . . . 0.0 106.585 163.635 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -88.94 98.98 12.05 Favored 'General case' 0 N--CA 1.433 -1.32 0 CA-C-N 112.928 -1.942 . . . . 0.0 107.631 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.654 HG21 HD13 ' A' ' 72' ' ' ILE . 40.3 t -79.36 135.16 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.447 HD21 ' CD2' ' A' ' 79' ' ' LEU . 1.6 m120 55.59 27.5 10.54 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.915 0.864 . . . . 0.0 109.87 -174.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.75 9.27 86.97 Favored Glycine 0 CA--C 1.526 0.729 0 CA-C-O 117.498 -1.723 . . . . 0.0 113.256 -179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.6 133.46 38.29 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 120.997 2.399 . . . . 0.0 109.411 -171.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.27 109.75 0.65 Allowed 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 127.497 2.319 . . . . 0.0 109.403 -166.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.627 ' HB3' HD11 ' A' ' 72' ' ' ILE . 55.6 mt -145.28 110.82 5.35 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 175.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -118.75 27.76 8.71 Favored 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.997 2.519 . . . . 0.0 112.793 -163.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -142.18 156.91 45.36 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 120.939 -1.101 . . . . 0.0 113.76 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 p -69.63 -39.44 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 127.139 2.176 . . . . 0.0 110.882 173.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -71.2 -12.77 72.66 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.658 -0.577 . . . . 0.0 111.658 170.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.31 -58.35 3.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 116.267 -1.825 . . . . 0.0 109.991 167.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.654 HD13 HG21 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -139.66 137.78 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 121.601 2.001 . . . . 0.0 114.049 -176.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.6 mt -108.05 -95.06 0.39 Allowed 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 101.792 -3.41 . . . . 0.0 101.792 163.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.9 -176.66 3.14 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 119.941 -1.724 . . . . 0.0 115.627 -164.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.44 -54.74 42.09 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 123.808 0.843 . . . . 0.0 111.04 173.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.63 -4.07 21.5 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.797 1.239 . . . . 0.0 113.329 175.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CE1' ' HA ' ' A' ' 72' ' ' ILE . 63.7 t-80 -88.53 -23.89 23.06 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.322 166.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.491 HH21 HD11 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -105.42 -65.12 1.07 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -171.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.701 HD13 HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -90.88 -176.68 4.74 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.523 1.129 . . . . 0.0 108.262 174.455 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -54.3 -21.57 9.65 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.128 0.971 . . . . 0.0 112.362 170.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 121.73 85.53 0.81 Allowed Glycine 0 N--CA 1.434 -1.476 0 C-N-CA 125.647 1.594 . . . . 0.0 112.829 173.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.2 mtp85 -141.28 -67.03 0.41 Allowed 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 163.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -128.27 -168.11 1.86 Allowed 'General case' 0 C--O 1.223 -0.291 0 C-N-CA 124.786 1.234 . . . . 0.0 109.795 -170.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.16 130.88 12.36 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 163.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.9 t -81.78 136.59 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.7 mm -127.53 94.96 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 124.283 1.033 . . . . 0.0 108.316 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -91.28 83.26 5.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -78.89 99.16 6.65 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 170.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -53.71 159.76 4.26 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.806 -0.918 . . . . 0.0 110.806 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 82.0 tttt 71.98 -48.29 0.68 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 127.194 2.198 . . . . 0.0 109.686 -164.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -88.58 -153.65 0.26 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 164.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.472 ' HB3' HG11 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -120.53 -158.13 0.74 Allowed 'General case' 0 C--O 1.244 0.765 0 C-N-CA 124.955 1.302 . . . . 0.0 110.912 -167.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -95.22 93.99 7.63 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.111 2.565 . . . . 0.0 107.886 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -78.55 164.92 24.28 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 120.478 -1.389 . . . . 0.0 107.779 168.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.3 tt -133.06 123.88 26.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -172.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.3 mm -116.49 132.55 65.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.9 ptt180 -136.5 179.92 6.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 122.322 1.058 . . . . 0.0 111.477 171.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -118.5 165.11 14.32 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 123.737 0.815 . . . . 0.0 111.328 165.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.369 0 C-N-CA 128.392 2.677 . . . . 0.0 110.075 -177.197 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -153.37 106.97 3.01 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 102.652 -3.092 . . . . 0.0 102.652 169.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -56.2 -39.36 72.32 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.494 1.517 . . . . 0.0 113.948 -163.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.0 m -153.19 112.39 3.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 120.37 1.441 . . . . 0.0 108.882 174.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.22 -141.7 8.46 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 108.131 -1.987 . . . . 0.0 108.131 -176.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -78.75 164.52 24.48 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -169.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -66.44 90.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.717 1.207 . . . . 0.0 111.701 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -84.88 -3.13 58.56 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.61 1.164 . . . . 0.0 111.825 168.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -78.12 -25.26 47.35 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 171.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.595 ' HB3' HD11 ' A' ' 15' ' ' ILE . 2.6 mm? -84.3 64.16 8.16 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 164.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.76 167.89 20.53 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 172.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.89 -49.27 47.71 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.226 -0.921 . . . . 0.0 111.901 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.03 -32.77 74.44 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.35 -39.37 65.26 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -173.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.595 HD11 ' HB3' ' A' ' 10' ' ' LEU . 12.6 mt -66.88 -51.53 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 124.755 1.222 . . . . 0.0 109.554 174.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -53.14 -59.11 4.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 118.829 0.74 . . . . 0.0 110.307 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 mm-40 -76.35 -19.37 58.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.698 -174.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -69.89 -40.47 74.42 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -119.27 6.11 11.2 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 112.748 0.647 . . . . 0.0 112.748 -164.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 37.5 mttt -58.82 15.34 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.808 2.043 . . . . 0.0 114.963 163.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -78.49 -25.08 45.61 Favored 'General case' 0 CA--C 1.534 0.353 0 O-C-N 120.71 -1.244 . . . . 0.0 109.802 164.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.435 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -127.94 160.22 62.5 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 126.395 1.878 . . . . 0.0 107.142 -176.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.435 ' HD2' HG12 ' A' ' 22' ' ' VAL . 96.3 Cg_endo -71.23 179.21 4.67 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.086 1.857 . . . . 0.0 110.569 172.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.1 p -121.45 -178.37 3.78 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.325 1.05 . . . . 0.0 110.561 -174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -140.8 154.37 46.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 164.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 4.2 p -135.23 124.97 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 C-N-CA 124.954 1.302 . . . . 0.0 108.455 175.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.22 170.99 7.78 Favored 'General case' 0 C--O 1.224 -0.24 0 CA-C-O 122.556 1.17 . . . . 0.0 111.288 171.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -79.17 8.0 6.61 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 126.69 1.996 . . . . 0.0 113.865 -163.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.6 -179.52 49.07 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.698 1.618 . . . . 0.0 112.774 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.38 139.05 3.07 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -163.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -66.62 136.62 55.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 118.174 0.987 . . . . 0.0 111.333 177.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.7 t -144.93 136.54 12.79 Favored Pre-proline 0 C--O 1.225 -0.198 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -163.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.415 ' HA ' HD23 ' A' ' 73' ' ' LEU . 88.8 Cg_exo -50.51 140.6 35.43 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 124.903 3.735 . . . . 0.0 114.816 -176.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.683 HD22 HG13 ' A' ' 54' ' ' ILE 0.254 0.0 OUTLIER -47.61 -45.02 27.18 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.821 0.819 . . . . 0.0 111.519 164.461 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.719 ' HA ' HD12 ' A' ' 38' ' ' LEU . 8.8 p -77.49 8.02 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 128.047 2.539 . . . . 0.0 113.548 -177.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -120.55 -45.47 2.41 Favored 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 124.58 1.152 . . . . 0.0 108.089 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.92 -24.89 64.34 Favored 'General case' 0 C--O 1.216 -0.665 0 O-C-N 120.015 -1.678 . . . . 0.0 108.959 -177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.719 HD12 ' HA ' ' A' ' 35' ' ' VAL . 0.0 OUTLIER -75.71 -33.83 60.35 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 120.552 1.524 . . . . 0.0 110.296 177.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.626 ' N ' HD13 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -72.97 -46.27 52.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 127.005 2.122 . . . . 0.0 108.536 -173.297 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.8 m -62.82 -45.65 91.64 Favored 'General case' 0 N--CA 1.425 -1.701 0 C-N-CA 128.34 2.656 . . . . 0.0 109.098 169.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.42 -11.91 59.98 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.409 1.004 . . . . 0.0 112.647 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.43 27.09 23.62 Favored Glycine 0 C--N 1.339 0.7 0 CA-C-N 119.222 0.919 . . . . 0.0 112.096 167.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -77.99 -42.66 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.1 m -156.17 101.78 2.09 Favored Pre-proline 0 C--N 1.347 0.484 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 165.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.28 -14.69 13.09 Favored 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 122.379 2.053 . . . . 0.0 113.32 -171.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.8 t -81.87 108.62 15.54 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.401 -2.074 . . . . 0.0 105.401 -176.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HE3' HG11 ' A' ' 39' ' ' VAL . 14.8 mptt -50.1 -35.28 24.86 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -164.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.29 -47.35 67.89 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 121.137 1.789 . . . . 0.0 110.444 173.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.21 -50.0 72.49 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.608 ' HB1' HD11 ' A' ' 38' ' ' LEU . . . -50.91 -48.0 60.71 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.946 1.699 . . . . 0.0 111.48 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -61.68 -40.79 96.2 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 115.961 -1.971 . . . . 0.0 110.478 -178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.81 -25.11 48.69 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 116.332 -2.147 . . . . 0.0 112.861 173.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.513 ' HA ' HH11 ' A' ' 88' ' ' ARG . 0.3 OUTLIER -66.65 -18.79 65.56 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 117.666 -1.159 . . . . 0.0 112.093 174.67 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.683 HG13 HD22 ' A' ' 34' ' ' LEU . 1.1 mp -92.38 -51.64 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 116.633 -1.651 . . . . 0.0 110.707 164.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -68.82 -13.48 62.44 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 120.821 1.646 . . . . 0.0 110.627 -164.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.652 ' O ' HG22 ' A' ' 59' ' ' ILE . 9.5 m120 -85.76 132.58 34.1 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 118.317 0.508 . . . . 0.0 111.143 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -66.68 17.29 0.25 Allowed Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.208 0.909 . . . . 0.0 114.129 169.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.17 -1.39 54.24 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 119.039 1.419 . . . . 0.0 111.006 164.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 56' ' ' ASN 0.286 0.0 OUTLIER -88.8 89.25 3.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 163.093 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -78.69 103.24 8.5 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 166.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.444 HG12 ' HB2' ' A' ' 66' ' ' LEU . 8.5 p -78.4 137.14 22.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 102.111 -3.292 . . . . 0.0 102.111 175.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.555 HD21 ' CD2' ' A' ' 79' ' ' LEU . 12.8 m-20 75.81 -54.43 0.62 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 127.192 2.197 . . . . 0.0 109.645 174.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' H ' ' H ' ' A' ' 64' ' ' GLU . . . 172.76 5.04 0.03 OUTLIER Glycine 0 CA--C 1.536 1.352 1 C-N-CA 131.969 4.604 . . . . 0.0 111.577 174.798 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' H ' ' H ' ' A' ' 63' ' ' GLY . 15.0 pm0 -122.33 128.3 50.86 Favored 'General case' 0 C--N 1.341 0.228 0 C-N-CA 126.682 1.993 . . . . 0.0 108.362 -169.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.32 106.8 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.319 1.848 . . . . 0.0 109.145 -177.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.444 ' HB2' HG12 ' A' ' 61' ' ' VAL . 57.3 mt -144.23 110.51 5.49 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.426 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -121.63 16.51 11.16 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.507 2.323 . . . . 0.0 112.639 -169.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -118.98 141.08 48.99 Favored 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 125.468 1.507 . . . . 0.0 109.231 -172.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.482 HG22 HD21 ' A' ' 73' ' ' LEU . 9.8 p -57.47 -42.8 81.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 C-N-CA 125.216 1.406 . . . . 0.0 110.39 177.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.9 -8.48 73.32 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-O 119.622 -0.543 . . . . 0.0 113.61 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.43 ' C ' HG13 ' A' ' 72' ' ' ILE . . . -85.17 -45.06 12.39 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 117.736 0.768 . . . . 0.0 109.466 170.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.621 HD12 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -140.99 127.76 21.01 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 CA-C-N 120.298 1.408 . . . . 0.0 112.657 -178.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.482 HD21 HG22 ' A' ' 69' ' ' VAL . 97.7 mt -116.41 -92.64 0.51 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 102.241 -3.244 . . . . 0.0 102.241 163.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -103.66 -175.48 2.81 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.782 -1.199 . . . . 0.0 113.502 -175.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.45 -43.2 79.29 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -82.82 -6.0 59.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.81 1.186 . . . . 0.0 111.078 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -81.58 -11.39 59.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 121.768 -0.583 . . . . 0.0 109.61 165.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.409 ' HD3' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -117.2 -71.42 0.74 Allowed 'General case' 0 C--N 1.346 0.416 0 CA-C-N 119.646 1.112 . . . . 0.0 109.505 -173.57 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.555 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.9 -168.4 2.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.884 2.473 . . . . 0.0 109.271 176.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -53.0 -9.88 0.15 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.396 1.878 . . . . 0.0 115.644 166.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 98.67 71.22 1.0 Allowed Glycine 0 C--N 1.338 0.641 0 C-N-CA 124.64 1.114 . . . . 0.0 113.021 -177.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -141.35 -64.85 0.44 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.17 0.485 . . . . 0.0 110.614 173.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -133.82 -169.06 2.23 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.559 1.544 . . . . 0.0 107.953 -176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.4 m -158.08 155.79 29.87 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 164.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 39.5 t -120.72 150.61 23.55 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 22.9 mm -135.0 97.64 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -170.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -99.49 81.14 2.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 104.678 -2.341 . . . . 0.0 104.678 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.513 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -78.62 117.54 19.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 171.137 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -45.85 -49.68 12.6 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.038 1.304 . . . . 0.0 111.837 173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.99 -1.04 0.79 Allowed 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.56 1.544 . . . . 0.0 115.001 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -146.92 -95.86 0.09 Allowed 'General case' 0 C--O 1.226 -0.152 0 CA-C-N 121.448 1.931 . . . . 0.0 109.176 164.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -153.93 -163.1 1.56 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 120.53 1.514 . . . . 0.0 109.513 -171.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 m-30 -107.41 75.64 1.03 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 127.949 2.499 . . . . 0.0 109.969 -170.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -78.45 165.05 24.23 Favored 'General case' 0 N--CA 1.445 -0.702 0 O-C-N 120.965 -1.085 . . . . 0.0 109.568 -172.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.8 tp -115.63 134.67 54.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.111 1.365 . . . . 0.0 107.987 -172.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 38.7 mm -128.62 133.5 66.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -174.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 8.1 ptt-85 -139.25 174.49 10.46 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 122.948 1.356 . . . . 0.0 111.432 167.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -117.57 162.52 17.87 Favored 'General case' 0 N--CA 1.432 -1.368 0 C-N-CA 124.328 1.051 . . . . 0.0 110.199 164.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.408 0 C-N-CA 129.453 3.101 . . . . 0.0 108.276 175.887 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.7 tt -156.64 96.04 1.6 Allowed 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 171.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -108.94 158.52 17.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 166.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.5 p -124.62 173.13 8.71 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 123.626 0.771 . . . . 0.0 112.943 -163.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.69 -48.33 3.05 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 125.856 1.693 . . . . 0.0 109.573 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -78.96 -170.99 2.41 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.865 1.317 . . . . 0.0 109.917 175.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.427 HG21 ' HB3' ' A' ' 62' ' ' ASN . 1.3 pp -54.2 64.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 131.697 3.999 . . . . 0.0 112.144 166.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.55 -3.98 34.2 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 126.329 1.852 . . . . 0.0 111.675 175.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -78.58 -21.87 47.95 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.617 1.167 . . . . 0.0 109.679 167.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.742 ' HB3' HD11 ' A' ' 15' ' ' ILE . 2.7 mp -99.21 73.59 1.91 Allowed 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 167.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.9 165.86 19.4 Favored 'General case' 0 C--O 1.223 -0.34 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 163.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.17 -46.36 67.71 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 120.609 -1.307 . . . . 0.0 112.106 -169.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.95 -33.63 76.27 Favored 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.132 174.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -74.4 -24.2 59.08 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 123.597 0.759 . . . . 0.0 110.251 -175.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 10' ' ' LEU . 8.9 mt -77.96 -57.35 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 C-N-CA 125.732 1.613 . . . . 0.0 107.629 175.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -52.82 -45.34 67.25 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.93 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -91.19 -19.06 23.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.573 0.749 . . . . 0.0 111.346 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.51 -37.79 69.01 Favored Glycine 0 N--CA 1.441 -0.98 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 170.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.561 ' CD2' HG21 ' A' ' 85' ' ' VAL . 58.5 m-85 -120.61 15.45 11.94 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 119.581 -0.847 . . . . 0.0 110.497 -164.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.73 -0.33 0.1 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.509 1.924 . . . . 0.0 115.297 174.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -78.82 -20.92 48.55 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 120.934 -1.104 . . . . 0.0 111.219 176.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.415 HG12 ' HD2' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -127.2 160.08 61.68 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 178.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.415 ' HD2' HG12 ' A' ' 22' ' ' VAL . 39.6 Cg_endo -80.58 176.88 8.67 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 CA-C-N 120.626 1.259 . . . . 0.0 109.926 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 44.5 p -112.12 165.62 11.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.594 -1.185 . . . . 0.0 110.716 172.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -130.04 157.96 40.93 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.692 2.397 . . . . 0.0 106.956 169.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 4.1 p -135.21 136.12 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -127.42 -172.87 2.76 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 119.503 1.047 . . . . 0.0 112.533 163.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 6.78 8.17 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 125.577 1.551 . . . . 0.0 113.983 -163.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.54 -173.1 34.1 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.082 1.325 . . . . 0.0 111.26 -170.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.84 135.57 1.65 Allowed Glycine 0 CA--C 1.523 0.544 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -175.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -53.26 134.55 39.33 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 117.543 0.672 . . . . 0.0 112.692 -167.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 t -157.47 131.66 5.04 Favored Pre-proline 0 CA--C 1.515 -0.384 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -166.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.543 ' HA ' HD23 ' A' ' 73' ' ' LEU . 87.1 Cg_endo -74.64 150.9 40.73 Favored 'Trans proline' 0 N--CA 1.437 -1.84 0 C-N-CA 122.529 2.153 . . . . 0.0 111.403 -167.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.719 HD22 HG13 ' A' ' 54' ' ' ILE 0.299 0.0 OUTLIER -44.01 -42.09 5.83 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.568 174.149 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.66 ' HA ' HD22 ' A' ' 38' ' ' LEU . 1.4 p -79.76 -5.59 8.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 126.907 2.083 . . . . 0.0 115.342 -174.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -105.06 -35.61 7.57 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.352 -0.832 . . . . 0.0 109.22 165.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.83 -21.03 57.69 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 120.914 1.688 . . . . 0.0 109.298 -175.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.705 HD13 ' CD1' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -77.72 -30.37 51.69 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 120.302 1.41 . . . . 0.0 110.27 173.437 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.583 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -74.35 -47.86 38.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -173.738 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.51 -47.68 84.48 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.627 1.971 . . . . 0.0 109.482 171.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.417 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -78.82 -10.81 59.91 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 119.242 -0.983 . . . . 0.0 112.353 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.39 33.95 18.32 Favored Glycine 0 CA--C 1.522 0.514 0 CA-C-N 119.111 0.869 . . . . 0.0 111.068 166.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.484 ' CG2' HD12 ' A' ' 38' ' ' LEU . 1.0 OUTLIER -78.56 -51.37 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 103.651 -2.722 . . . . 0.0 103.651 172.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 m -151.56 105.78 2.91 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 169.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -84.31 -12.67 7.84 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.811 2.341 . . . . 0.0 113.642 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -87.57 115.8 25.25 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -52.01 -34.85 44.71 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -165.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmm_? -62.95 -54.7 34.31 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.948 1.704 . . . . 0.0 109.039 172.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.06 -48.31 78.86 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-O 117.172 -1.394 . . . . 0.0 108.482 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.545 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -48.31 -58.68 4.23 Favored 'General case' 0 CA--C 1.519 -0.239 0 C-N-CA 125.319 1.448 . . . . 0.0 111.104 175.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HG2' HG21 ' A' ' 35' ' ' VAL . 64.0 mtt180 -67.35 -27.74 67.37 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 117.332 -1.318 . . . . 0.0 110.616 -170.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -83.07 -34.23 26.23 Favored 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 120.302 1.41 . . . . 0.0 112.234 172.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.564 ' HA ' HH11 ' A' ' 88' ' ' ARG . 1.8 m-20 -64.65 -16.82 63.38 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 117.927 -1.035 . . . . 0.0 110.511 174.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.719 HG13 HD22 ' A' ' 34' ' ' LEU . 1.0 OUTLIER -92.26 -53.59 8.48 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 116.054 -1.927 . . . . 0.0 111.728 166.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -71.61 -5.11 31.04 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 120.941 1.7 . . . . 0.0 112.076 -171.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.543 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.1 m120 -80.62 136.48 36.23 Favored 'General case' 0 N--CA 1.437 -1.118 0 O-C-N 121.373 -0.829 . . . . 0.0 112.462 173.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.72 33.87 0.86 Allowed Glycine 0 CA--C 1.527 0.814 0 C-N-CA 124.486 1.041 . . . . 0.0 112.141 167.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.46 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -121.39 0.39 10.01 Favored 'General case' 0 N--CA 1.439 -1.015 0 C-N-CA 126.901 2.08 . . . . 0.0 111.509 168.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 56' ' ' ASN 0.315 0.0 OUTLIER -91.99 98.73 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 163.533 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -88.72 105.22 17.55 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 113.136 -1.847 . . . . 0.0 108.333 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.506 HG21 ' CD1' ' A' ' 72' ' ' ILE . 7.9 t -88.43 130.34 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 174.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.538 HD21 ' CD2' ' A' ' 79' ' ' LEU . 5.9 m-80 57.37 18.09 4.17 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.565 0.698 . . . . 0.0 111.577 -173.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.13 11.71 78.01 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 120.599 -1.313 . . . . 0.0 113.5 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -119.37 123.27 43.75 Favored 'General case' 0 C--O 1.228 -0.062 0 CA-C-N 119.735 1.768 . . . . 0.0 108.421 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.59 112.1 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 124.138 0.975 . . . . 0.0 108.854 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.441 ' CB ' HD11 ' A' ' 72' ' ' ILE . 64.8 mt -144.89 108.26 4.6 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 -174.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -131.09 31.49 4.42 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 126.718 2.007 . . . . 0.0 113.891 -163.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.1 t0 -142.38 157.27 44.97 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.6 -0.687 . . . . 0.0 111.182 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.5 p -62.72 137.47 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 163.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.33 -8.41 46.97 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.645 -173.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.17 -53.68 7.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 163.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.506 ' CD1' HG21 ' A' ' 61' ' ' VAL . 0.8 OUTLIER -139.58 145.0 27.57 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 CA-C-N 119.244 0.929 . . . . 0.0 110.137 170.221 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 33' ' ' PRO . 92.5 mt -124.15 -91.32 0.55 Allowed 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 102.486 -3.153 . . . . 0.0 102.486 163.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -99.89 -175.56 3.0 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.729 -1.232 . . . . 0.0 113.548 -174.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.627 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . . . -58.57 -41.85 86.65 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.876 175.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -76.3 -7.47 55.0 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 123.727 0.642 . . . . 0.0 110.981 -177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -92.99 -4.8 51.99 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.927 1.291 . . . . 0.0 110.393 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -120.34 -65.17 1.18 Allowed 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.953 -1.717 . . . . 0.0 109.498 175.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.538 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.14 -172.68 3.57 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 125.475 1.51 . . . . 0.0 109.501 170.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -50.43 -17.87 0.55 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.712 2.005 . . . . 0.0 113.918 166.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 106.36 80.4 1.33 Allowed Glycine 0 N--CA 1.439 -1.102 0 C-N-CA 125.435 1.493 . . . . 0.0 111.507 -174.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -143.62 -63.58 0.39 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 122.802 0.441 . . . . 0.0 111.548 163.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -131.46 -174.11 3.31 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.99 2.116 . . . . 0.0 108.172 -172.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -160.73 164.12 31.84 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.839 1.656 . . . . 0.0 107.186 164.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 19' ' ' PHE . 72.1 t -134.22 143.97 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 O-C-N 120.59 -1.319 . . . . 0.0 107.516 176.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.488 HD13 HG22 ' A' ' 61' ' ' VAL . 25.4 mm -125.06 98.38 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 127.774 2.429 . . . . 0.0 107.221 -172.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -96.13 84.62 3.83 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.564 HH11 ' HA ' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -82.14 114.08 20.43 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 172.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -60.77 1.78 0.7 Allowed Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.712 1.045 . . . . 0.0 115.712 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.459 ' H ' ' HG3' ' A' ' 88' ' ' ARG . 34.0 tptt -69.4 -46.23 67.36 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 119.58 1.69 . . . . 0.0 109.395 166.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -125.43 -90.27 0.55 Allowed 'General case' 0 C--N 1.339 0.148 0 C-N-CA 124.801 1.24 . . . . 0.0 108.844 175.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.433 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.31 -159.88 1.02 Allowed 'General case' 0 C--O 1.24 0.583 0 CA-C-N 119.671 1.123 . . . . 0.0 109.197 -163.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.433 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -99.46 83.84 2.88 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 130.826 3.65 . . . . 0.0 109.578 -176.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -78.46 158.97 28.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 106.131 -1.804 . . . . 0.0 106.131 173.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.9 tt -126.37 129.9 49.7 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -163.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 30.5 mm -120.82 122.53 68.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -168.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 11.5 ptt85 -128.63 171.89 11.73 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 124.044 1.878 . . . . 0.0 110.294 176.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.627 ' CE1' ' HB2' ' A' ' 75' ' ' ALA . 6.0 m-85 -143.56 158.47 43.63 Favored 'General case' 0 N--CA 1.416 -2.126 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 -164.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.796 0 C-N-CA 128.487 2.715 . . . . 0.0 111.127 169.901 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.225 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 93.0 mt -64.04 93.53 0.09 Allowed 'General case' 0 C--O 1.233 0.184 0 C-N-CA 126.14 1.776 . . . . 0.0 109.078 178.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.21 -162.72 0.93 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.063 1.345 . . . . 0.0 107.781 178.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.416 ' HB2' HG23 ' A' ' 11' ' ' THR . 8.1 m 60.65 71.57 0.56 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 126.231 1.812 . . . . 0.0 110.863 -176.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -63.08 -23.88 66.48 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.69 166.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -78.29 -79.86 0.12 Allowed 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.79 HD13 ' H ' ' A' ' 7' ' ' ILE . 0.2 OUTLIER -90.97 72.01 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.182 0 CA-C-O 123.435 1.588 . . . . 0.0 109.787 -171.304 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.02 8.07 0.81 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 125.362 1.465 . . . . 0.0 112.335 165.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -99.29 -13.83 19.5 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.564 1.146 . . . . 0.0 109.029 164.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -159.67 80.22 0.72 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.465 0.706 . . . . 0.0 110.14 -172.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.416 HG23 ' HB2' ' A' ' 4' ' ' SER . 0.2 OUTLIER -78.03 174.76 10.76 Favored 'General case' 0 C--O 1.215 -0.72 0 C-N-CA 126.861 2.064 . . . . 0.0 107.371 -178.173 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.44 -49.71 70.43 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 119.841 -1.787 . . . . 0.0 112.039 -176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.8 -32.23 73.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.631 0.651 . . . . 0.0 111.033 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.31 -38.45 71.73 Favored 'General case' 0 C--O 1.218 -0.582 0 C-N-CA 125.261 1.425 . . . . 0.0 109.158 -178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.413 ' CG2' HD13 ' A' ' 95' ' ' LEU . 27.4 mt -69.3 -45.96 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 C-N-CA 126.518 1.927 . . . . 0.0 106.61 178.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -54.28 -57.91 9.41 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.463 175.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -71.85 -29.68 64.65 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 119.401 1.0 . . . . 0.0 109.94 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.54 -29.6 72.94 Favored Glycine 0 N--CA 1.437 -1.243 0 C-N-CA 126.335 1.921 . . . . 0.0 110.414 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -117.11 -1.82 11.81 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.165 -0.921 . . . . 0.0 112.027 -173.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -59.02 -0.53 0.12 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -78.8 -13.35 59.86 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.844 1.202 . . . . 0.0 111.243 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 4.1 p -127.39 157.46 72.69 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 128.598 2.759 . . . . 0.0 105.785 167.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -87.08 176.66 4.29 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 121.313 1.342 . . . . 0.0 109.801 174.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.4 p -106.36 177.74 4.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.254 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -123.6 157.29 34.06 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 164.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 p -136.94 133.92 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 124.923 1.289 . . . . 0.0 108.347 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -123.72 -177.56 3.77 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 121.115 0.483 . . . . 0.0 111.743 163.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.78 39.43 0.95 Allowed 'General case' 0 C--N 1.318 -0.768 0 O-C-N 120.485 -1.384 . . . . 0.0 113.635 -163.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 55.67 -175.58 0.86 Allowed Glycine 0 CA--C 1.532 1.142 0 O-C-N 120.903 -1.123 . . . . 0.0 112.788 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.18 131.83 0.23 Allowed Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -171.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.49 147.71 52.18 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.12 1.155 . . . . 0.0 114.12 -167.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.5 t -152.88 136.59 10.13 Favored Pre-proline 0 C--O 1.222 -0.382 0 C-N-CA 124.743 1.217 . . . . 0.0 108.345 -171.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.46 ' HA ' HD23 ' A' ' 73' ' ' LEU . 61.3 Cg_endo -65.4 145.38 82.93 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.348 2.699 . . . . 0.0 111.394 -173.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.428 HD22 HG13 ' A' ' 54' ' ' ILE 0.375 0.1 OUTLIER -43.22 -39.19 2.85 Favored 'General case' 0 CA--C 1.552 1.027 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 170.354 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.488 ' HA ' HD22 ' A' ' 38' ' ' LEU . 3.6 p -77.24 -13.0 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 124.963 1.305 . . . . 0.0 113.992 -177.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -100.1 -32.79 10.75 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 120.119 1.327 . . . . 0.0 109.444 167.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 pp -72.48 -30.79 64.85 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 121.829 2.104 . . . . 0.0 108.237 -174.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.691 HD21 ' HB1' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -75.9 -31.4 59.18 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 120.658 1.572 . . . . 0.0 110.076 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.489 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -72.27 -46.09 58.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 126.402 1.881 . . . . 0.0 107.265 -176.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.2 t -65.69 -41.86 91.9 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 128.145 2.578 . . . . 0.0 107.776 175.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HB3' HD13 ' A' ' 43' ' ' ILE . . . -80.77 -18.14 48.62 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -177.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.74 29.86 9.54 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 118.531 0.605 . . . . 0.0 111.776 168.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.471 HD13 ' HB3' ' A' ' 41' ' ' ALA . 1.4 mp -78.81 -47.06 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 104.522 -2.399 . . . . 0.0 104.522 175.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.7 m -155.34 113.65 2.27 Favored Pre-proline 0 CA--C 1.517 -0.299 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 174.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -82.77 -17.17 7.29 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.41 2.074 . . . . 0.0 113.532 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.63 116.17 23.75 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 -167.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -36.96 66.79 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -163.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -69.06 -42.71 75.91 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 120.15 1.341 . . . . 0.0 110.197 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.1 tp60 -61.65 -51.99 66.18 Favored 'General case' 0 CA--C 1.505 -0.777 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.691 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -50.52 -51.53 46.75 Favored 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 126.49 1.916 . . . . 0.0 110.0 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.1 mtt-85 -53.56 -48.48 69.1 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.583 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -78.35 -32.11 48.91 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.69 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -62.78 -17.71 61.5 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 124.746 1.218 . . . . 0.0 111.001 174.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.669 ' CD1' HD13 ' A' ' 38' ' ' LEU . 1.2 mp -90.07 -55.92 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.092 0 CA-C-O 117.193 -1.384 . . . . 0.0 112.599 169.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -73.18 -6.74 47.81 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 119.567 1.076 . . . . 0.0 111.416 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.466 ' O ' HG22 ' A' ' 59' ' ' ILE . 1.2 m-80 -78.32 138.5 38.6 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.367 1.08 . . . . 0.0 112.041 169.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.31 46.07 2.43 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.055 164.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.449 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -126.26 11.01 7.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 128.979 2.912 . . . . 0.0 110.456 165.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 56' ' ' ASN 0.332 0.0 OUTLIER -111.25 91.9 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 N-CA-C 104.08 -2.563 . . . . 0.0 104.08 162.907 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -82.85 122.1 27.8 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 113.02 -1.9 . . . . 0.0 107.618 174.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.62 HG21 HD13 ' A' ' 72' ' ' ILE . 25.1 t -115.28 135.83 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER 61.11 -16.88 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.795 2.038 . . . . 0.0 114.205 -174.524 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 61' ' ' VAL . . . 152.19 -7.24 0.54 Allowed Glycine 0 N--CA 1.442 -0.927 0 C-N-CA 126.683 2.087 . . . . 0.0 113.328 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -145.99 153.68 41.04 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 119.876 1.838 . . . . 0.0 110.651 -163.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -70.16 105.45 2.93 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.168 1.787 . . . . 0.0 110.066 -164.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.488 ' CB ' HD11 ' A' ' 72' ' ' ILE . 71.5 mt -134.36 102.73 5.45 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -173.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.86 38.61 3.92 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 128.151 2.58 . . . . 0.0 111.656 -163.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -139.66 146.83 40.17 Favored 'General case' 0 N--CA 1.457 -0.099 0 O-C-N 121.725 -0.609 . . . . 0.0 111.135 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.08 -37.01 65.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.382 0.673 . . . . 0.0 110.615 173.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -75.14 -12.8 83.24 Favored Glycine 0 C--N 1.336 0.543 0 O-C-N 121.418 -0.801 . . . . 0.0 112.779 176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.434 ' C ' HG13 ' A' ' 72' ' ' ILE . . . -76.5 -54.51 6.61 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 118.063 0.931 . . . . 0.0 109.177 177.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.62 HD13 HG21 ' A' ' 61' ' ' VAL . 5.1 mt -145.14 130.54 13.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 123.747 0.819 . . . . 0.0 109.367 -167.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.46 HD23 ' HA ' ' A' ' 33' ' ' PRO . 92.7 mt -122.26 -70.5 0.77 Allowed 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 168.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.13 178.67 4.54 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 120.288 -1.507 . . . . 0.0 112.205 -177.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.52 -34.22 72.35 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -81.93 -12.17 58.53 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.535 0.607 . . . . 0.0 111.645 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -86.42 -1.24 57.39 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.219 1.408 . . . . 0.0 110.056 168.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.417 ' HD2' ' HB2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -116.53 -79.1 0.58 Allowed 'General case' 0 C--N 1.341 0.216 0 O-C-N 120.109 -1.62 . . . . 0.0 106.875 175.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.59 -171.7 3.73 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 128.848 2.859 . . . . 0.0 108.735 176.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -48.99 -11.7 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 129.183 2.993 . . . . 0.0 115.664 163.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.21 82.35 1.59 Allowed Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 125.281 1.42 . . . . 0.0 111.728 -168.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.94 -81.56 0.34 Allowed 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 164.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -127.94 -162.19 1.15 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.429 1.491 . . . . 0.0 108.866 -179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -157.35 139.0 14.01 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 120.291 -1.506 . . . . 0.0 108.041 170.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.84 113.52 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -170.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.8 mm -95.72 139.71 18.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -128.12 82.89 2.11 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 163.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.411 ' NH2' ' H ' ' A' ' 90' ' ' LYS . 1.3 tpm_? -79.0 95.12 5.41 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 172.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -42.25 -48.57 5.57 Favored Glycine 0 CA--C 1.538 1.492 0 N-CA-C 115.258 0.863 . . . . 0.0 115.258 -171.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.411 ' H ' ' NH2' ' A' ' 88' ' ' ARG . 20.5 tptm -68.21 -21.6 64.85 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.354 1.462 . . . . 0.0 113.859 -176.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -103.95 -98.67 0.31 Allowed 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 179.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.504 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.4 OUTLIER -159.3 -162.64 1.08 Allowed 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 123.001 1.381 . . . . 0.0 108.806 171.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.504 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 6.0 m-30 -78.48 147.23 34.0 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 163.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -144.15 174.05 11.21 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 128.646 2.778 . . . . 0.0 108.389 171.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.413 HD13 ' CG2' ' A' ' 15' ' ' ILE . 22.0 tp -135.33 137.03 42.01 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 126.187 1.795 . . . . 0.0 107.639 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.4 mm -130.69 131.85 64.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -173.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 14.5 ptt85 -139.22 173.1 11.91 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 123.46 1.6 . . . . 0.0 110.539 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.01 169.9 8.74 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.851 164.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.315 0 C-N-CA 128.491 2.716 . . . . 0.0 109.903 176.43 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.536 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.03 -78.0 0.08 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 154.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -140.41 -166.2 2.07 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.35 1.46 . . . . 0.0 108.405 166.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.6 m -155.92 172.28 18.63 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.982 1.313 . . . . 0.0 109.174 172.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 150.17 -92.87 0.14 Allowed Glycine 0 C--N 1.335 0.477 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.71 -63.47 1.4 Allowed 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.577 1.179 . . . . 0.0 107.923 -176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.457 HD13 HD13 ' A' ' 79' ' ' LEU . 15.2 pt -91.62 49.57 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 C-N-CA 125.0 1.32 . . . . 0.0 111.459 -173.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -17.27 63.13 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.551 -0.718 . . . . 0.0 112.655 -176.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -91.31 -17.04 26.56 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.162 1.785 . . . . 0.0 110.707 178.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.435 HD12 HG21 ' A' ' 85' ' ' VAL . 1.7 pt? -154.08 78.15 1.1 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.669 1.188 . . . . 0.0 109.848 -166.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 52.6 p -77.97 179.78 6.55 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 121.115 -0.991 . . . . 0.0 109.031 176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.5 -42.47 82.82 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 120.107 -1.62 . . . . 0.0 110.495 -171.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.96 94.84 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 122.065 0.936 . . . . 0.0 109.693 174.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -75.32 -19.99 59.33 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 124.38 1.072 . . . . 0.0 110.268 -175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.0 mt -81.7 -55.47 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 127.569 2.348 . . . . 0.0 106.927 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -56.19 -44.14 79.12 Favored 'General case' 0 N--CA 1.462 0.127 0 C-N-CA 118.992 -1.083 . . . . 0.0 111.17 178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -31.17 50.23 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.67 0.668 . . . . 0.0 109.345 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.45 -35.5 81.85 Favored Glycine 0 N--CA 1.443 -0.868 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -177.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -119.18 17.54 13.15 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.461 1.105 . . . . 0.0 110.077 -168.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -56.62 5.37 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 128.906 2.883 . . . . 0.0 113.468 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.48 -27.66 46.3 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 127.728 2.411 . . . . 0.0 110.221 175.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.95 166.65 27.73 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 126.454 1.902 . . . . 0.0 107.406 -174.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.02 173.43 13.63 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 N-CA-C 109.055 -1.171 . . . . 0.0 109.055 167.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 77.4 p -106.46 177.77 4.76 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.927 -1.488 . . . . 0.0 108.767 167.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -123.47 152.98 41.13 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 106.26 -1.756 . . . . 0.0 106.26 163.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 7.7 p -139.68 134.01 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -119.92 -178.08 3.56 Favored 'General case' 0 C--O 1.222 -0.346 0 CA-C-O 121.487 0.66 . . . . 0.0 111.637 164.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -82.34 5.68 19.45 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.553 1.941 . . . . 0.0 115.624 -163.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.98 -175.16 20.47 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.908 1.718 . . . . 0.0 110.176 -165.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.78 155.41 28.7 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -174.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . 0.349 11.2 p-10 -91.75 143.81 26.15 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.628 1.171 . . . . 0.0 111.551 163.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 87.2 t -159.48 136.33 6.71 Favored Pre-proline 0 C--O 1.225 -0.188 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -163.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.425 ' HA ' HD23 ' A' ' 73' ' ' LEU . 72.3 Cg_endo -70.49 147.3 57.87 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.86 1.707 . . . . 0.0 112.068 -172.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.402 0.4 OUTLIER -49.59 -26.6 3.69 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.435 1.094 . . . . 0.0 113.899 177.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.592 ' HA ' HD11 ' A' ' 54' ' ' ILE . 14.6 p -63.18 -61.5 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 119.926 1.239 . . . . 0.0 111.249 168.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -66.16 -36.68 83.75 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 119.083 0.856 . . . . 0.0 109.528 -171.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 38' ' ' LEU . 1.3 pp -80.52 -24.4 39.39 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 116.598 -1.667 . . . . 0.0 110.034 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.416 HD22 ' NH1' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -75.31 -37.81 60.59 Favored 'General case' 0 C--N 1.344 0.35 0 CA-C-N 121.833 2.106 . . . . 0.0 109.82 176.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.5 t -73.82 -43.35 53.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -175.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.3 t -63.7 -32.52 74.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.941 0.896 . . . . 0.0 109.936 170.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.33 -17.09 57.02 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.602 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.27 27.68 39.22 Favored Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 174.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.471 HG21 ' HE ' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -78.58 -44.71 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 176.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -157.07 91.46 2.42 Favored Pre-proline 0 C--N 1.348 0.541 0 CA-C-N 120.571 1.532 . . . . 0.0 106.968 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.72 -15.45 21.48 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.476 2.118 . . . . 0.0 112.588 -164.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.59 105.03 17.06 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 -174.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 50' ' ' ALA . 81.0 mttt -53.27 -22.59 7.24 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.505 1.668 . . . . 0.0 115.505 -166.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HD2' ' H ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -62.04 -60.36 3.73 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 120.314 1.415 . . . . 0.0 110.719 168.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.516 ' H ' ' HD2' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -53.0 -49.14 66.82 Favored 'General case' 0 C--O 1.216 -0.681 0 C-N-CA 125.983 1.713 . . . . 0.0 107.058 178.817 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB3' ' HA ' ' A' ' 47' ' ' LYS . . . -48.59 -58.43 4.73 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 124.391 1.057 . . . . 0.0 111.566 174.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.409 ' HA ' HD12 ' A' ' 54' ' ' ILE . 11.2 mtt-85 -65.81 -24.28 66.88 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 115.688 -2.101 . . . . 0.0 112.49 -175.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -77.87 -39.9 41.81 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 121.442 1.928 . . . . 0.0 111.746 167.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.62 -25.03 52.0 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 123.995 0.918 . . . . 0.0 111.23 176.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.592 HD11 ' HA ' ' A' ' 35' ' ' VAL . 70.3 mt -83.59 -57.47 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 116.007 -1.949 . . . . 0.0 109.117 171.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -77.69 -5.77 51.63 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 124.879 1.362 . . . . 0.0 113.009 -163.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.473 ' O ' HG22 ' A' ' 59' ' ' ILE . 7.9 m120 -81.01 141.34 34.51 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.591 163.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.27 10.03 0.07 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.492 1.52 . . . . 0.0 113.341 163.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 56' ' ' ASN . . . -78.34 -11.07 59.92 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 126.286 1.834 . . . . 0.0 110.085 172.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 56' ' ' ASN 0.357 0.0 OUTLIER -102.74 92.77 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 124.855 2.264 . . . . 0.0 109.73 174.251 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -79.6 99.12 7.18 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 111.44 -2.618 . . . . 0.0 107.89 173.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.719 HG21 HD13 ' A' ' 72' ' ' ILE . 89.3 t -84.07 133.34 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.616 HD21 ' CD2' ' A' ' 79' ' ' LEU . 1.0 OUTLIER 60.92 14.76 5.49 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 122.699 0.4 . . . . 0.0 111.594 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.15 -1.84 57.72 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.083 1.325 . . . . 0.0 113.203 -174.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -131.73 123.63 28.1 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 119.791 1.795 . . . . 0.0 109.546 -164.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.46 111.25 0.35 Allowed 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 127.836 2.454 . . . . 0.0 109.788 -178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.569 ' HB3' HD11 ' A' ' 72' ' ' ILE . 18.9 mt -145.87 102.25 3.63 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -114.06 40.7 2.42 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.478 1.911 . . . . 0.0 110.95 -165.046 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -148.23 153.49 38.8 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.282 -0.886 . . . . 0.0 111.866 -168.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 p -69.87 -41.43 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 126.518 1.927 . . . . 0.0 109.376 169.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -72.41 -0.99 50.01 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-O 119.902 -0.388 . . . . 0.0 112.686 172.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.81 -61.82 1.55 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.905 -1.045 . . . . 0.0 111.672 163.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.719 HD13 HG21 ' A' ' 61' ' ' VAL . 1.0 OUTLIER -137.46 132.47 45.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 120.13 1.332 . . . . 0.0 113.149 -176.036 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 33' ' ' PRO . 82.7 mt -99.6 -89.78 0.32 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 163.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 p -112.57 -168.8 1.37 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 -173.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.26 -56.24 23.44 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.296 1.439 . . . . 0.0 114.577 177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -68.26 -14.57 63.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 118.519 0.599 . . . . 0.0 111.781 176.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -80.8 -15.01 57.52 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 173.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.96 -82.09 0.54 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -178.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.616 ' CD2' HD21 ' A' ' 62' ' ' ASN . 0.1 OUTLIER -89.91 174.47 7.66 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.568 1.547 . . . . 0.0 108.914 -178.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -25.65 -51.12 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.285 3.034 . . . . 0.0 115.238 173.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.74 64.32 0.01 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 78.0 mmt-85 -140.82 -82.8 0.23 Allowed 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.826 0.813 . . . . 0.0 109.727 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.444 ' H ' HD11 ' A' ' 79' ' ' LEU . 12.1 m-85 -130.29 -161.51 1.13 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.284 1.434 . . . . 0.0 110.361 -164.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -161.1 120.59 2.6 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.378 1.871 . . . . 0.0 108.899 167.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.435 HG21 HD12 ' A' ' 10' ' ' LEU . 63.3 t -78.95 134.04 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 173.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.4 mm -120.26 98.66 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 C-N-CA 126.339 1.856 . . . . 0.0 106.274 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.7 ttm180 -92.84 82.25 4.69 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 171.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.471 ' HE ' HG21 ' A' ' 43' ' ' ILE . 15.8 tpp180 -84.04 96.24 8.82 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.274 2.63 . . . . 0.0 105.68 175.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -54.97 -24.16 33.66 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 123.395 0.521 . . . . 0.0 113.346 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.53 -32.26 68.69 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.364 1.082 . . . . 0.0 112.638 171.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -135.96 -75.15 0.44 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 119.924 1.238 . . . . 0.0 112.037 -172.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.54 -173.49 4.0 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 120.634 1.561 . . . . 0.0 109.465 -172.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 4.4 m-30 -95.56 75.99 3.28 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 126.549 1.939 . . . . 0.0 110.393 174.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -78.57 171.62 14.85 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.947 -1.096 . . . . 0.0 110.567 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 83' ' ' PHE . 28.2 tp -128.18 137.72 52.18 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.309 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.5 mm -131.28 132.92 62.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 -175.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 18.5 ptt180 -149.36 174.31 12.58 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 123.387 1.565 . . . . 0.0 112.449 177.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.16 169.62 8.66 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.785 163.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.428 -1.557 0 C-N-CA 130.948 3.699 . . . . 0.0 106.768 172.359 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 9.5 mp -74.34 148.42 41.34 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 170.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -144.71 -47.6 0.25 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.443 1.897 . . . . 0.0 107.932 172.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.4 m -69.19 170.84 9.35 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.715 0.769 . . . . 0.0 109.239 163.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -86.04 57.19 4.81 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 124.839 1.209 . . . . 0.0 111.031 -170.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -78.7 -177.95 5.68 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 176.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 79' ' ' LEU . 2.0 pp -61.92 72.11 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 128.649 2.78 . . . . 0.0 113.065 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.8 -15.47 62.16 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 125.453 1.501 . . . . 0.0 112.516 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -78.62 -19.6 52.3 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.093 0.957 . . . . 0.0 110.176 173.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.93 80.06 1.28 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.064 0.945 . . . . 0.0 109.502 -172.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.34 177.11 8.71 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 120.959 -1.088 . . . . 0.0 108.205 174.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.07 -53.0 52.43 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.634 1.174 . . . . 0.0 112.018 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.45 -26.85 66.6 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 123.1 0.25 . . . . 0.0 110.38 175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.99 -43.67 70.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 mt -68.23 -53.47 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-O 118.2 -0.905 . . . . 0.0 108.82 177.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -59.36 -50.58 73.42 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 118.236 -1.385 . . . . 0.0 111.695 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -69.36 -30.81 68.9 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 120.143 1.338 . . . . 0.0 109.065 -178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.21 -42.72 99.29 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . 0.258 40.6 m-85 -113.56 1.62 15.05 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -165.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -59.14 17.82 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 128.103 2.561 . . . . 0.0 114.258 163.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -78.09 -37.5 46.31 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 127.284 2.233 . . . . 0.0 107.591 164.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.829 HG22 ' HD2' ' A' ' 23' ' ' PRO . 4.3 p -125.91 165.14 28.93 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.895 1.678 . . . . 0.0 106.6 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.829 ' HD2' HG22 ' A' ' 22' ' ' VAL . 34.1 Cg_endo -80.68 177.84 7.63 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.45 2.1 . . . . 0.0 109.292 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 p -113.61 -177.93 3.25 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.601 -1.181 . . . . 0.0 109.837 -173.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -140.39 162.91 34.18 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.259 1.024 . . . . 0.0 108.541 167.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 97' ' ' ARG . 9.3 p -143.34 138.43 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 C-N-CA 125.294 1.438 . . . . 0.0 107.931 172.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 98' ' ' TYR . 0.2 OUTLIER -117.99 139.33 51.34 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.928 0.871 . . . . 0.0 109.558 163.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -81.35 73.11 8.4 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -140.89 153.97 24.11 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 114.209 -1.359 . . . . 0.0 113.182 -171.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.85 -157.15 15.65 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 163.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -60.97 140.32 57.81 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 122.582 0.353 . . . . 0.0 111.16 -174.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 t -155.06 137.1 9.76 Favored Pre-proline 0 C--O 1.223 -0.3 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -164.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -48.95 131.28 25.13 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.729 3.619 . . . . 0.0 112.559 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . 0.33 0.7 OUTLIER -47.64 -36.27 10.67 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 168.119 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.777 ' HA ' HD22 ' A' ' 38' ' ' LEU . 7.3 p -83.23 -2.61 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.157 1.383 . . . . 0.0 113.605 -177.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -98.85 -44.05 6.51 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 168.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.38 -20.73 56.88 Favored 'General case' 0 C--O 1.217 -0.656 0 CA-C-O 116.499 -1.715 . . . . 0.0 109.944 -174.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.777 HD22 ' HA ' ' A' ' 35' ' ' VAL . 0.3 OUTLIER -77.4 -26.97 52.26 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 121.656 2.026 . . . . 0.0 110.777 175.246 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.57 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.5 OUTLIER -79.68 -42.35 22.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 126.48 1.912 . . . . 0.0 106.862 -172.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.66 -48.91 77.26 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 127.185 2.194 . . . . 0.0 109.002 167.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.57 -15.96 57.96 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.74 -171.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.36 36.34 7.06 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.752 -0.939 . . . . 0.0 110.752 164.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.42 HG13 ' CD1' ' A' ' 94' ' ' TYR . 1.3 mp -78.39 -56.37 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 102.423 -3.177 . . . . 0.0 102.423 171.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.9 m -150.75 103.91 3.04 Favored Pre-proline 0 C--N 1.342 0.259 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.66 -10.49 13.1 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.851 2.367 . . . . 0.0 113.7 -172.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.6 t -90.9 116.3 28.61 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -53.07 -36.1 60.29 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.16 -54.18 48.97 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 120.16 1.345 . . . . 0.0 109.12 173.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -57.3 -52.41 65.45 Favored 'General case' 0 C--O 1.209 -1.047 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.639 ' HB1' HD21 ' A' ' 38' ' ' LEU . . . -45.79 -55.47 6.53 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 125.518 1.527 . . . . 0.0 111.127 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -58.18 -41.73 84.5 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.162 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -72.43 -37.95 68.47 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 119.633 1.106 . . . . 0.0 111.778 175.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -60.77 -15.27 27.84 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 126.274 1.829 . . . . 0.0 110.794 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.738 ' HA ' HG21 ' A' ' 59' ' ' ILE . 2.2 mt -117.03 -15.87 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 176.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -91.56 -5.94 53.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 120.675 1.58 . . . . 0.0 111.375 168.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.659 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -82.34 135.56 35.17 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 176.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -60.36 3.74 0.31 Allowed Glycine 0 CA--C 1.537 1.42 0 CA-C-N 115.42 -0.809 . . . . 0.0 114.304 165.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.43 ' H ' ' HB3' ' A' ' 56' ' ' ASN . . . -94.09 -0.71 55.2 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 125.683 1.593 . . . . 0.0 112.373 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.738 HG21 ' HA ' ' A' ' 54' ' ' ILE 0.321 0.0 OUTLIER -102.87 96.92 5.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 124.913 2.292 . . . . 0.0 107.892 173.931 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -90.32 98.51 11.81 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 111.735 -2.484 . . . . 0.0 108.361 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.802 HG21 HD13 ' A' ' 72' ' ' ILE . 5.2 t -81.38 127.55 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.465 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.403 HD21 ' HG ' ' A' ' 79' ' ' LEU . 90.1 m-20 52.76 25.08 3.57 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.205 1.002 . . . . 0.0 112.062 -169.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.65 8.23 61.0 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.617 -1.657 . . . . 0.0 113.518 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -128.81 126.63 40.28 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 120.758 2.279 . . . . 0.0 109.288 -174.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.45 110.64 0.73 Allowed 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.249 1.42 . . . . 0.0 108.781 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.616 ' HB3' HD11 ' A' ' 72' ' ' ILE . 80.7 mt -145.96 81.66 1.6 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -175.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.02 46.6 1.04 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.724 2.01 . . . . 0.0 112.088 -169.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -148.55 150.02 32.61 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 120.165 -1.584 . . . . 0.0 114.213 -174.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.4 p -63.29 -43.69 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 125.967 1.707 . . . . 0.0 111.852 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -76.38 -9.6 85.82 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.846 -0.502 . . . . 0.0 111.846 174.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.3 -56.32 4.43 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 116.215 -1.85 . . . . 0.0 108.263 167.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.802 HD13 HG21 ' A' ' 61' ' ' VAL . 1.3 mp -138.31 138.41 43.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 CA-C-N 121.409 1.913 . . . . 0.0 113.726 177.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.6 mt -110.47 -88.02 0.51 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 101.777 -3.416 . . . . 0.0 101.777 163.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.1 p -102.49 -174.31 2.54 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 119.888 1.222 . . . . 0.0 113.689 -174.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.13 87.59 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.63 -17.26 64.07 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.723 0.692 . . . . 0.0 111.87 175.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.44 ' ND1' ' HA ' ' A' ' 72' ' ' ILE . 55.4 t-80 -78.61 -9.56 59.41 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.491 -0.756 . . . . 0.0 109.358 174.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -110.7 -75.07 0.63 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 119.334 0.97 . . . . 0.0 109.8 174.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.679 HD11 ' H ' ' A' ' 82' ' ' ARG . 1.3 pp -91.67 -170.17 2.51 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 124.787 1.235 . . . . 0.0 109.95 178.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -55.89 -26.82 49.09 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.428 ' H ' ' CD1' ' A' ' 79' ' ' LEU . . . 127.51 69.81 0.16 Allowed Glycine 0 N--CA 1.441 -1.026 0 C-N-CA 127.374 2.416 . . . . 0.0 112.192 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.679 ' H ' HD11 ' A' ' 79' ' ' LEU . 90.3 mtt-85 -143.02 -45.63 0.3 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 -177.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.577 ' H ' HD11 ' A' ' 79' ' ' LEU . 39.6 m-85 -157.94 -176.65 6.05 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.457 1.903 . . . . 0.0 109.348 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -150.49 124.4 9.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 120.259 -1.526 . . . . 0.0 107.014 163.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.2 t -79.23 147.59 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 166.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 93' ' ' TYR . 27.5 mm -129.7 93.01 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 C-N-CA 125.504 1.522 . . . . 0.0 107.069 173.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -89.77 84.34 6.27 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.76 98.38 6.26 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 166.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -52.72 143.65 23.48 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 170.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.4 tptm 69.08 -0.31 2.51 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.226 2.61 . . . . 0.0 114.035 -169.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -117.47 -104.88 0.4 Allowed 'General case' 0 CA--C 1.52 -0.203 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 165.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 93' ' ' TYR . 0.0 OUTLIER -154.1 -171.91 4.04 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 119.831 1.196 . . . . 0.0 108.062 175.006 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.529 ' H ' ' HG3' ' A' ' 92' ' ' LYS . 1.3 m-30 -114.1 82.88 1.78 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 126.743 2.017 . . . . 0.0 107.942 -173.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.42 ' CD1' HG13 ' A' ' 43' ' ' ILE . 77.2 m-85 -79.45 169.14 18.5 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.386 0.674 . . . . 0.0 109.866 -175.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.525 HD11 ' CD1' ' A' ' 83' ' ' PHE . 33.4 tp -130.74 135.73 48.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.244 1.018 . . . . 0.0 108.699 -175.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.1 mt -134.53 134.69 54.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -173.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.489 ' HG2' ' H ' ' A' ' 98' ' ' TYR . 9.4 ttt180 -135.24 -175.6 3.98 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 123.715 1.722 . . . . 0.0 112.067 171.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.489 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -122.73 158.59 29.81 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 112.875 -1.966 . . . . 0.0 111.188 165.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.399 0 C-N-CA 128.693 2.797 . . . . 0.0 107.921 172.469 . . . . . . . . 0 0 . 1 stop_ save_